0001493152-24-013015.txt : 20240403 0001493152-24-013015.hdr.sgml : 20240403 20240403164043 ACCESSION NUMBER: 0001493152-24-013015 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 134 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vislink Technologies, Inc. CENTRAL INDEX KEY: 0001565228 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATIONS EQUIPMENT, NEC [3669] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 205856795 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35988 FILM NUMBER: 24819517 BUSINESS ADDRESS: STREET 1: 350 CLARK DRIVE STREET 2: SUITE 125 CITY: MT. OLIVE STATE: NJ ZIP: 07828 BUSINESS PHONE: 941 953 9035 MAIL ADDRESS: STREET 1: 350 CLARK DRIVE STREET 2: SUITE 125 CITY: MT. OLIVE STATE: NJ ZIP: 07828 FORMER COMPANY: FORMER CONFORMED NAME: xG TECHNOLOGY, INC. DATE OF NAME CHANGE: 20121220 10-K 1 form10-k.htm
false FY 0001565228 0001565228 2023-01-01 2023-12-31 0001565228 2023-06-30 0001565228 2024-03-29 0001565228 2023-12-31 0001565228 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001565228 2022-01-01 2022-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001565228 us-gaap:CommonStockMember 2021-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2021-12-31 0001565228 us-gaap:RetainedEarningsMember 2021-12-31 0001565228 2021-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-12-31 0001565228 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001565228 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-12-31 0001565228 us-gaap:CommonStockMember 2023-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2023-12-31 0001565228 us-gaap:RetainedEarningsMember 2023-12-31 0001565228 country:GB 2023-12-31 0001565228 country:NL 2023-12-31 0001565228 VISL:SingleCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember 2023-12-31 0001565228 srt:MaximumMember 2023-12-31 0001565228 VISL:PatentsAndLicensesMember srt:MinimumMember 2023-12-31 0001565228 VISL:PatentsAndLicensesMember srt:MaximumMember 2023-12-31 0001565228 VISL:PatentsAndLicensesMember 2023-01-01 2023-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember us-gaap:OtherIntangibleAssetsMember 2023-12-31 0001565228 srt:MaximumMember us-gaap:OtherIntangibleAssetsMember 2023-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember 2022-01-01 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-01 2022-11-30 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-30 0001565228 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001565228 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001565228 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001565228 VISL:PeriodEndGBPToUSDollarOneExchangeRateMember 2023-12-31 0001565228 VISL:GBPToUSDMember 2023-12-31 0001565228 VISL:PeriodEndEURToUSDollarOneExchangeRateMember 2023-12-31 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2023-12-31 0001565228 VISL:PeriodAverageGBPToUSDollarOneExchangeRateMember 2023-12-31 0001565228 VISL:PeriodAverageEURToUSDollarOneExchangeRateMember 2023-12-31 0001565228 VISL:PeriodEndGBPToUSDollarOneExchangeRateMember 2022-12-31 0001565228 VISL:GBPToUSDMember 2022-12-31 0001565228 VISL:PeriodEndEURToUSDollarOneExchangeRateMember 2022-12-31 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2022-12-31 0001565228 VISL:PeriodAverageGBPToUSDollarOneExchangeRateMember 2022-12-31 0001565228 VISL:PeriodAverageEURToUSDollarOneExchangeRateMember 2022-12-31 0001565228 VISL:HSBCUSAINCCPMember 2023-01-23 0001565228 VISL:HSBCUSAINCCPMember 2023-10-24 2023-10-24 0001565228 VISL:FederalHomeLoanBanksMember 2023-02-01 0001565228 VISL:FederalHomeLoanBanksMember 2023-02-01 2023-02-01 0001565228 VISL:FederalNationalMortgageAssociationMember 2023-02-28 0001565228 VISL:FederalNationalMortgageAssociationMember 2023-12-31 0001565228 VISL:HSBCUSAINCCPMember 2023-10-11 0001565228 VISL:HSBCUSAINCCPMember 2023-12-31 0001565228 VISL:FederalBondsMember 2023-12-31 0001565228 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member VISL:FederalBondsHeldToMaturityMember 2023-12-31 0001565228 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member VISL:FederalBondsHeldToMaturityMember 2023-12-31 0001565228 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member VISL:FederalBondsHeldToMaturityMember 2023-12-31 0001565228 VISL:FederalBondsHeldToMaturityMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel1Member VISL:RightOfUseAssetImpairmentMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel2Member VISL:RightOfUseAssetImpairmentMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel3Member VISL:RightOfUseAssetImpairmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2023-12-31 0001565228 VISL:RightOfUseAssetImpairmentMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-12-31 0001565228 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001565228 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member VISL:FederalBondsHeldToMaturityMember 2022-12-31 0001565228 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member VISL:FederalBondsHeldToMaturityMember 2022-12-31 0001565228 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member VISL:FederalBondsHeldToMaturityMember 2022-12-31 0001565228 VISL:FederalBondsHeldToMaturityMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel1Member VISL:RightOfUseAssetImpairmentMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member VISL:RightOfUseAssetImpairmentMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member VISL:RightOfUseAssetImpairmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0001565228 VISL:RightOfUseAssetImpairmentMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0001565228 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001565228 VISL:BMSLLCMember VISL:VislinkPowayLLCMember 2023-09-14 2023-09-14 0001565228 VISL:BMSLLCMember VISL:VislinkPowayLLCMember 2023-10-02 0001565228 VISL:BMSLLCMember VISL:VislinkPowayLLCMember 2023-09-14 0001565228 VISL:BMSLLCMember 2023-09-14 2023-09-14 0001565228 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2023-12-31 0001565228 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2023-12-31 0001565228 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001565228 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001565228 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2023-12-31 0001565228 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2023-12-31 0001565228 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001565228 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001565228 us-gaap:ComputerEquipmentMember srt:MinimumMember 2023-12-31 0001565228 us-gaap:ComputerEquipmentMember srt:MaximumMember 2023-12-31 0001565228 us-gaap:ComputerEquipmentMember 2023-12-31 0001565228 us-gaap:ComputerEquipmentMember 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember 2023-01-01 2023-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2023-01-01 2023-12-31 0001565228 VISL:ProprietaryTechnologyMember 2023-12-31 0001565228 VISL:PatentsAndLicensesMember 2023-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2023-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2023-12-31 0001565228 VISL:ProprietaryTechnologyMember 2021-12-31 0001565228 VISL:PatentsAndLicensesMember 2021-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2021-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2021-12-31 0001565228 VISL:ProprietaryTechnologyMember 2022-01-01 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-01-01 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember srt:MinimumMember 2023-12-31 0001565228 VISL:ProprietaryTechnologyMember srt:MaximumMember 2023-12-31 0001565228 VISL:NotesPayableOneMember 2023-12-31 0001565228 VISL:NotesPayableOneMember 2022-12-31 0001565228 VISL:NotesPayableTwoMember 2023-12-31 0001565228 VISL:NotesPayableTwoMember 2022-12-31 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2022-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2022-04-04 2022-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2023-01-01 2023-12-31 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2022-01-01 2022-12-31 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2023-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2023-04-04 2023-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2023-01-01 2023-12-31 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2022-01-01 2022-12-31 0001565228 VISL:ColchesterUKWatersideHouseMember 2023-12-31 0001565228 VISL:ColchesterUKWatersideHouseMember 2023-01-01 2023-12-31 0001565228 VISL:LuttonUKMember 2023-12-31 0001565228 VISL:LuttonUKMember 2023-01-01 2023-12-31 0001565228 VISL:BillericaMaMember 2023-12-31 0001565228 VISL:BillericaMaMember 2023-01-01 2023-12-31 0001565228 VISL:MountOliveNJMember 2023-12-31 0001565228 VISL:MountOliveNJMember 2023-01-01 2023-12-31 0001565228 VISL:TrivexSingaporeMember 2023-12-31 0001565228 VISL:TrivexSingaporeMember 2023-01-01 2023-12-31 0001565228 VISL:LuttonUKMember 2023-09-01 0001565228 VISL:LuttonUKMember 2023-09-01 2023-09-01 0001565228 VISL:LuttonUKMember 2023-02-01 0001565228 VISL:LuttonUKMember 2023-02-01 2023-02-01 0001565228 VISL:DubaiUAEMember 2023-01-01 2023-12-31 0001565228 VISL:DubaiUAEMember 2023-07-03 0001565228 VISL:DubaiUAEMember 2023-07-03 2023-07-03 0001565228 VISL:PowayCAMember 2022-01-01 2022-12-31 0001565228 VISL:PowayCAMember 2023-09-14 0001565228 VISL:PowayCAMember 2023-09-14 2023-09-14 0001565228 VISL:PowayCAMember us-gaap:SubsequentEventMember 2024-02-12 2024-02-12 0001565228 VISL:PowayCAMember us-gaap:SubsequentEventMember 2024-02-14 2024-02-14 0001565228 VISL:ColchesterUKMember 2023-09-30 0001565228 VISL:ColchesterUKMember 2023-12-31 0001565228 VISL:ColchesterUKMember 2023-09-01 2023-09-30 0001565228 VISL:HemelUnitedKingdomMember 2023-01-01 2023-12-31 0001565228 VISL:HemelUnitedKingdomMember 2023-12-31 0001565228 VISL:TrivexSingaporeMember 2023-08-10 0001565228 VISL:TrivexSingaporeMember 2023-08-10 2023-08-10 0001565228 VISL:LuttonUKMember 2022-01-01 2022-12-31 0001565228 VISL:LuttonUKMember 2022-04-28 0001565228 VISL:LuttonUKMember 2022-04-27 2022-04-28 0001565228 VISL:DubaiUAEMember 2022-01-01 2022-12-31 0001565228 VISL:DubaiUAEMember 2022-07-03 0001565228 VISL:DubaiUAEMember 2022-07-01 2022-07-03 0001565228 VISL:BillericaMaMember 2022-10-01 2022-12-31 0001565228 srt:MaximumMember 2013-03-31 0001565228 2013-03-31 0001565228 us-gaap:SeriesBPreferredStockMember 2016-02-05 0001565228 us-gaap:SeriesDPreferredStockMember 2016-04-25 0001565228 us-gaap:SeriesEPreferredStockMember 2016-12-21 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-08 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember 2023-01-10 2023-01-23 0001565228 VISL:SeriesDConvertiblePreferredStockMember 2016-04-25 0001565228 VISL:SeriesEConvertiblePreferredStockMember 2016-12-21 0001565228 VISL:SeriesDPreferredStockAndSeriesEPreferredStockMember 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember 2023-03-22 0001565228 us-gaap:SeriesAPreferredStockMember 2023-03-24 0001565228 VISL:SpecificBoardMembersMember 2023-01-01 2023-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2022-05-04 2022-05-04 0001565228 VISL:ConsultingAgreementMember 2022-05-04 0001565228 VISL:ConsultingAgreementMember 2022-07-19 2022-07-19 0001565228 VISL:ConsultingAgreementMember 2022-07-19 0001565228 VISL:CommonStockWarrantsMember 2023-01-01 2023-12-31 0001565228 VISL:CommonStockWarrantsMember 2023-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeOneMember 2023-01-01 2023-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeOneMember 2023-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeOneMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeOneMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeTwoMember 2023-01-01 2023-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeTwoMember 2023-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeTwoMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeTwoMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeThreeMember 2023-01-01 2023-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeThreeMember 2023-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeThreeMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeThreeMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFourMember 2023-01-01 2023-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFourMember 2023-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFourMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFourMember 2022-12-31 0001565228 VISL:WarrantsMember 2023-01-01 2023-12-31 0001565228 VISL:WarrantsMember 2023-12-31 0001565228 VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember 2022-12-31 0001565228 VISL:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2023-08-23 0001565228 VISL:VariousEquityCompensationPlansMember 2023-01-01 2023-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-01-01 2023-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-01-01 2022-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-01-01 2023-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-01-01 2022-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-01-01 2023-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-01-01 2022-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2021-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2021-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2021-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2021-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2023-01-01 2023-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2023-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2021-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-01-01 2023-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-12-31 0001565228 VISL:GroupPersonalPensionPlanUKMember 2023-01-01 2023-12-31 0001565228 VISL:GroupPersonalPensionPlanUKMember 2022-01-01 2022-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:SingleVendorMember 2023-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:SingleVendorMember 2023-01-01 2023-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:OneVendorMember 2023-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:OneVendorMember 2023-01-01 2023-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:OneVendorMember 2022-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:OneVendorMember 2022-01-01 2022-12-31 0001565228 srt:NorthAmericaMember 2023-01-01 2023-12-31 0001565228 srt:NorthAmericaMember 2022-01-01 2022-12-31 0001565228 srt:SouthAmericaMember 2023-01-01 2023-12-31 0001565228 srt:SouthAmericaMember 2022-01-01 2022-12-31 0001565228 srt:EuropeMember 2023-01-01 2023-12-31 0001565228 srt:EuropeMember 2022-01-01 2022-12-31 0001565228 srt:AsiaMember 2023-01-01 2023-12-31 0001565228 srt:AsiaMember 2022-01-01 2022-12-31 0001565228 VISL:RestOfWorldMember 2023-01-01 2023-12-31 0001565228 VISL:RestOfWorldMember 2022-01-01 2022-12-31 0001565228 VISL:EquipmentSalesMember 2023-01-01 2023-12-31 0001565228 VISL:EquipmentSalesMember 2022-01-01 2022-12-31 0001565228 VISL:InstallationIntegrationAndRepairsMember 2023-01-01 2023-12-31 0001565228 VISL:InstallationIntegrationAndRepairsMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantiesMember 2023-01-01 2023-12-31 0001565228 VISL:WarrantiesMember 2022-01-01 2022-12-31 0001565228 country:US 2023-12-31 0001565228 country:US 2022-12-31 0001565228 country:NL 2022-12-31 0001565228 country:GB 2022-12-31 0001565228 us-gaap:HerMajestysRevenueAndCustomsHMRCMember 2023-01-01 2023-12-31 0001565228 us-gaap:HerMajestysRevenueAndCustomsHMRCMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2023-01-01 2023-12-31 0001565228 VISL:DividendsPayableMember 2023-01-01 2023-12-31 0001565228 VISL:DividendsPayableMember 2022-01-01 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-05-04 2022-05-04 0001565228 us-gaap:CommonStockMember 2022-07-19 2022-07-19 0001565228 us-gaap:CommonStockMember 2022-05-04 0001565228 us-gaap:CommonStockMember 2022-07-19 0001565228 2022-11-21 2022-11-21 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-21 2022-11-21 0001565228 us-gaap:DomesticCountryMember 2023-12-31 0001565228 us-gaap:DomesticCountryMember VISL:CarriedForwardIndefinitelyMember 2023-12-31 0001565228 us-gaap:StateAndLocalJurisdictionMember 2023-12-31 0001565228 us-gaap:ForeignCountryMember 2023-12-31 0001565228 us-gaap:SubsequentEventMember 2024-02-12 2024-02-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:GBP utr:sqft iso4217:AED iso4217:EUR VISL:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark One)

 

  ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2023

or

 

  ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from__________ to__________

 

Commission File Number: 001-35988

 

Vislink Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   20-5856795
(State or other jurisdiction of
incorporation or organization)		   (I.R.S. Employer
Identification No.)

 

350 Clark Drive, Suite 125,

Mt. Olive, NJ 07828

(Address of principal executive offices) (Zip Code)

 

(Registrant’s telephone number, including area code): (908) 852-3700

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.00001   VISL   The Nasdaq Capital Market

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

(Title of class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Act. Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically on its corporate Website, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for a such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
  Emerging growth company ☐

 

If an emerging growth company, indicate by a check mark if the registrant has elected not to use the extended transition period to comply with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

 

As of June 30, 2023, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of the common stock held by non-affiliates of the registrant was approximately $13.5 million based on the closing price of $5.66 for the registrant’s common stock as quoted on the Nasdaq Capital Market on that date. Shares of common stock held by each director, each officer, and each person who owns 10% or more of the outstanding common stock have been excluded from this calculation in that such persons may be deemed affiliates. The determination of affiliate status is not necessarily conclusive.

 

The registrant had 2,448,482 shares of its common stock outstanding as of March 29, 2024.

 

 

 

 

 

 

VISLINK TECHNOLOGIES, INC.

FORM 10-K

ANNUAL REPORT

For the Fiscal Year Ended December 31, 2023

 

TABLE OF CONTENTS

 

      Page
PART I    
  Item 1. Business 4
  Item 1A. Risk Factors 12
  Item 1B. Unresolved Staff Comments 29
  Item 1C. Cybersecurity 29
  Item 2. Properties 31
  Item 3. Legal Proceedings 31
  Item 4. Mine Safety Disclosures 31
PART II    
  Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 32
  Item 6. Reserved 32
  Item 7. Management’s Discussion and Analysis of Financial Conditions and Results of Operations 33
  Item 7A. Quantitative and Qualitative Disclosures About Market Risk 46
  Item 8. Financial Statements and Supplementary Data 46
  Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 46
  Item 9A. Controls and Procedures 47
  Item 9B. Other Information 47
  Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 47
PART III    
  Item 10. Directors, Executive Officers, and Corporate Governance 48
  Item 11. Executive Compensation 48
  Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 48
  Item 13. Certain Relationships and Related Transactions, and Director Independence 48
  Item 14. Principal Accountant Fees and Services 48
PART IV    
  Item 15. Exhibits, Financial Statement Schedules 49
SIGNATURES 52
FINANCIAL STATEMENTS F-1

 

2
 

 

FORWARD-LOOKING INFORMATION

 

This Annual Report on Form 10-K (including the section regarding Management’s Discussion and Analysis of Financial Condition and Results of Operations) (this “Report”) contains forward-looking statements regarding the business, financial condition, results of operations, and prospects of Vislink Technologies, Inc. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and similar words and phrases are intended to identify forward-looking statements. However, this report does not include an all-inclusive list of words or phrases identifying forward-looking statements. Also, all information concerning future matters is forward-looking statements.

 

Although forward-looking statements in this Report reflect our management’s good faith judgment, such information can only be based on facts and circumstances currently known by us. Forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from those discussed or anticipated by the forward-looking statements. Without limitation, factors that could cause or contribute to such differences in results and outcomes include those discussed elsewhere in this Report.

 

We undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date of this Report. We urge you to carefully review and consider all the disclosures made in this Report.

 

References to Vislink in this report, unless otherwise stated or the context otherwise requires, reference to “VISL,” “Vislink,” “the Company,” “we,” “us,” “our,” and similar reference refer to Vislink Technologies, Inc., a Delaware corporation and its subsidiaries.

 

Risk Factor Summary

 

The following summarizes certain factors that may make our company’s investment speculative or risky. You should carefully consider the entire risk factor disclosure outlined in this Annual Report and the other information herein, including the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section and our financial statements and related notes.

 

  ● We have incurred losses in the past and may be unable to achieve or sustain profitability in the future.
  ● We may require additional capital to fund our existing commercial operations, develop, market, and commercialize new products, and expand our operations. If we do not obtain additional financing, our business prospects, financial condition, and results of operations will be adversely affected if required.
  ● Our industry is highly competitive, and we may need to compete more effectively.
  ● Defects or errors in our products and services or products made by our suppliers could harm our brand and relations with our customers and expose us to liability. If we experience product recalls, we may incur significant expenses and experience decreased demand for our products.
  ● We acknowledge material weaknesses in our internal controls and procedures over financial reporting. In the future, we may identify additional material weaknesses that may cause us to fail to meet our reporting obligations, including timeliness, or result in material misstatements of our financial statements.
  ● We rely extensively on information technology systems and could face cybersecurity risks.
  ● We rely on key executive officers, and their knowledge of our business and technical expertise would be difficult to replace.
  ● We purchase some components, subassemblies, and products from a limited number of suppliers. The loss of these suppliers may substantially disrupt our ability to obtain orders and fulfill sales as we design and qualify new components.
  ● Our intellectual property protections may be insufficient to safeguard our technology adequately.
  ● We may be subject to claims of intellectual property infringement or invalidity. Expenses incurred for monitoring, protecting, and defending our intellectual property rights could adversely affect our business.
  ● Enforcement of our intellectual property rights abroad, particularly in China, is limited, and it is often difficult to protect and enforce such rights.
  ● The intellectual property rights of others may prevent us from developing new products or entering new markets.
  ● We may be subject to infringement claims in the future.
  ● If our technology did not work as planned or if we were unsuccessful in developing and selling new products or penetrating new markets, our business and operating results would suffer.
  ● Demand for our defense-related products and products for emergency response services depends on government spending.
  ● Regulation of the telecommunications industry could harm our operating results and prospects.
  ● New regulations or standards or changes in existing laws or standards in the United States or internationally related to our products may result in unanticipated costs or liabilities, which could have a material adverse effect on our business, results of operations, and future sales and could place additional burdens on our business operations.
  ● Our industry is subject to rapid technological change, and to compete successfully, we must make substantial investments in new products, services, and technologies.
  ● At several of our annual stockholder meetings, including our 2019 Annual Meeting of Stockholders, we failed to obtain ratification by our stockholders of specific proposals submitted for approval of our stockholders at prior annual meetings, which could be deemed defective corporate acts.
  ● Our failure to meet Nasdaq’s continued listing requirements could result in our common stock’s delisting, which could negatively impact its market price and liquidity and our ability to access the capital markets.

 

3
 

 

PART I

 

Item 1. Business

 

Overview

 

Vislink Technologies, Inc., incorporated in Delaware in 2006, is a global technology business that collects, delivers, and manages high-quality, live video and associated data from the action scene to the viewing screen. We provide solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. We also furnish the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. Our team also provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in the terrestrial microwave, fiber optic, surveillance, and wireless communications systems, delivering a broad spectrum of customer solutions.

 

Live Broadcast:

 

We deliver an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, cellular, IP (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing AI (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, we have the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions that encompass hardware components, hosted systems management platforms, related software licenses and ancillary support services.

 

Industry-wide contributors acknowledge our live broadcast solutions. Our equipment is used to transmit most outside wireless broadcast video content, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Our wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events. 

 

Military and Government:

 

We have developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Our solutions are specifically designed with interagency cooperation, utilizing the internationally recognized IP platform and a web interface for video delivery. We provide comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:

 

  ● integrated suites of airborne downlink transmitters, receivers, and antenna systems
  ● data and video connectivity for airborne, marine, and ground assets
  ● UAV video distribution
  ● flexible support for COFDM and bonded cellular/5G Networks
  ● terrestrial point-to-point
  ● tactical mobile command
  ● IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges
  ● high-throughput air/marine/ground-to-anywhere uplink and downlink systems
  ● secure live streaming platforms for use in mobile and fixed assets, and
  ● personal portable products

 

Our public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation for criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.

 

4
 

 

Connected Edge Solutions:

 

Mobile Viewpoint (MVP) offers the hardware and software solutions needed to acquire, produce, contribute to, and deliver video over all private and public networks. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:

 

  ● live video encoding, stream adaptation, decoding, and production solutions,
  ● remote production workflows,
  ● wireless cameras,
  ● AI-driven automated production, and
  ● the ability to contribute video over
    ○ bonded cellular (3G and 4G)
    ○ satellite,
    ○ fiber, and
    ○ emerging networks, including 5G and Starlink

 

Our Strategy

 

Our participation in the Live Production and Mil/Gov sectors allows us to offer various end-to-end, high-reliability, high-data-rate, long-range wireless video transmission solutions.

 

We use our solutions for applications in growing market segments, including in-game sports, mobile video feeds, real-time capture and display footage from drones and other aerial platforms, and rapid-response electronic newsgathering operations.

 

The acquisition of MVP in August 2021 is a component of our strategy to provide an industry-leading portfolio of live video acquisition, contribution, and distribution solutions that meet the demanding needs of media, enterprise, defense, and government organizations. Our customers can benefit from the ability to address the most transformative trends in today’s live video market, such as:

 

  ● live internet video traffic is growing fast: from 2016 to 2021, there was a 15-fold increase in live video internet traffic (71.9% CAGR);
  ● the acceleration towards cloud-based remote production;
  ● the increasing demand for enhanced video content formats such as 4K, 8K, and 360-degree video, and
  ● the proliferation of new video transport capable networks such as 5G and Starlink.

 

MPV has allowed us to expand our offerings, which serve most of these transformative live video trends and economically bring high-quality live production to the previously challenging presentation of historical events involving amateur and semi-pro athletics. MVP’s technology enhances our go-to-market strategy as we seek to take advantage of new technologies such as 5G and other new networks and machine learning, which we believe are revolutionizing how video is generated and transported.

 

The recent acquisition of the assets of Broadcast Microwave Services, LLC. (“BMS”) assets represents a pivotal step in our ongoing mission to enhance our product offerings, extend our market reach, and solidify our position as a force in the Airborne Video Downlink Systems (AVDS) market. The integration of BMS’s assets into our operations is expected to enhance the reach of product offerings to our customers as follows:

 

  ● it provides us with a long-standing customer base in U.S federal sectors, global OEMs, and EMEA markets,
     
  ● combinations to make Vislink the de facto leader in the COFDM/Mesh/5G-Based AVDS,
     
  ● access to advanced, reliable, and robust video downlink solutions to drive additional software and services recurring revenue via the air to anywhere platform,
     
  ● the positioning of the Company in the growing drone command and control market,
     
  ● one-stop solutions for live video communications needs, using proprietary COFDM bonded cellular, 5G, and AI-driven technologies for public safety, air-to-ground video distribution, streamlining operational processes and enhancing efficiency,
     
  ● a more responsive and globally accessible support network ensuring that customers remain connected with their audiences, teams, and operations, and
     
  ● new opportunities for our customers to access a more comprehensive array of cutting-edge solutions.

 

5
 

 

Market

 

Our services and product offerings broadly address Live Production and Mil/Gov.

 

Within the sports and entertainment market, we have identified the e-sports live-streaming applications markets as those where our solutions have applicability. The live production market is focused on applying more agile wireless video systems for live production and broadcasting sports, entertainment, and news events. Drivers in this market include small, lightweight, easy-to-use equipment, low-latency video systems, reliability of the wireless links, and the ability to use licensed and unlicensed bands. Current trends within the market reduce the size of these products further and improve the wireless video systems’ agility as users demand higher link reliability at longer ranges. There is also an increased desire to provide audiences with new views and camera angles to enhance the viewing experience. We address this need by incorporating 4K, HDR, and other emerging video technologies.

 

The Live Production market’s broadcast news sector looks to improve operational efficiencies in gathering, producing, and transmitting wireless content. Recent trends in the market include a movement towards I.P. connectivity over point-to-point links for infrastructure, high-definition upgrades of remote newsgathering vehicles, and continued pressure to reduce expenses by improving operational efficiencies. We focus on how these customers create and gather content wirelessly. As the wireless communications industry begins transitioning to fifth generation (5G) networks, the speed increases they will usher in expect to augment the availability of on-demand live streaming, where our equipment is already in use.

 

The Mil/Gov market comprises vital segments, including state and local law enforcement agencies, federal agencies, and military system integrators. The market looks to improve video content’s reliability and quality without adding complexity and omitting technical intervention while operating video systems. State and local agencies benefit from the Department of Homeland Security grant programs to improve overall security. Recent trends within these segments include improved interoperability within agencies and demand for fully integrated systems, including robust microwave combined with ubiquitous I.P. networks; as the wireless video systems become more reliable and straightforward to deploy, the wireless systems’ option rate increases. Customers within this market include state police forces, sheriff’s departments, fire departments, first responders, the Department of Justice, and Homeland Security.

 

Our Products and Solutions: Overview

 

We offer a full spectrum of wireless video products built around providing complete solutions. We have traditionally focused on developing core product technologies for the final assembled products that cross-market segments. Such technology focus areas include R.F., Live Streaming, and microwave component development spanning the frequency range from D.C. to 18GHz, waveform modulation, advanced video encoding (HEVC) and decoding, 4K UHD (Ultra High Definition) camera systems, and digital signal processing. Through these products, we are positioned with significant technology I.P. and an established reputation for rapidly and economically delivering complex, bespoke engineering products and solutions to customers that are expertly managed to tight deadlines. Production of these products can quickly be scaled to respond to changes in market demand.

 

Live Production Products and Solutions

 

Our Live Production Solutions include high-definition communication links that reliably capture, transmit and manage live event footage. We offer a line of high-margin wireless camera transmitter and receiver products that may be interconnected over I.P. networks, expanding and simplifying their widespread use and significantly reducing deployment costs. HCAM is a 4K Ultra HD-capable on-camera wireless system designed to cover significant events among our transmitter products. Our flagship receiver product is the Quantum Receiver. The Quantum is an ultra-low latency, waveform agnostic central receiver representing our premier receiver in all market verticals, including MilGov. Features include HEVC quad signal decode, seamless geographical coverage, and an I.P. stream engine with cloud integration possibilities, OTT, and social media platforms. IP Link 3.0 is a studio-transmitter link system that enables broadcasting service platforms to access new monetization opportunities. Other essential receiver products include the ViewBack, CRx6, and CIRAS-X6. ViewBack is a lightweight, low-power, low latency, dual-channel diversity receiver-decoder that enables quicker production, more efficient editing, and more effective collaboration between camera operators and studio teams. We also offer ultra-compact onboard solutions integrating our MDR (Modular Diversity Receiver) technology with ruggedized support components designed to capture video from high-speed motorsports.

 

6
 

 

As a result of our acquisition of Mobile Viewpoint, we also offer a portfolio of products that includes the WMT line of mobile encoders and TerraLink rack encoders for live streaming over 4G and 5G, and systems developed using AI technologies for the automated coverage of news and sports productions., The TrolleyLive Remote Pro is an all-in-one production unit for remote live broadcasts. LinkMatrix is a central platform for managing all devices and synchronizing all data sources. 

 

 

Quantum

 

 

IP Link 3.0

 

 

WMT BaseLink Encoder

 

 

TerraLink 4CM Rack Encoder

 

7
 

 

Mil/Gov Products and Solutions

 

In the Mil/Gov sector, the Vislink Airborne Video Downlink System (AVDS) is a comprehensive aerial-based video transmission solution that delivers real-time surveillance to enhance law enforcement, emergency, and critical infrastructure operations. It includes an integrated suite of downlink transmitters, receivers, and antennas that capture real-time, reliable, high-definition video from drones, helicopters, and other aircraft for display at command centers, mobile units, and video management systems. AVDS allows an unlimited number of observers to view the video over any network connection, including wired Ethernet, Wi-Fi, I.P. satellite, and I.P. cellular. AeroLink is an aircraft-based transmitter unit that provides bi-directional data transmission and is tightly integrated with other elements of the AVDS, including the Quantum and our other central receivers. In addition to supporting Mil/Gov applications, AeroLink supports broadcast/ENG applications for transmitting air-based feeds from breaking news and sporting events. The Aero5 is an airborne downlink transmitter that provides an extended bidirectional link using local cellular infrastructure as the receive system. The HHT3 and Mobil Commander are handheld receivers/monitors designed for tactical situations.

 

As a result of our acquisition of the assets of BMS in September 2023, we now also offer their wireless microwave equipment designed for use in government surveillance, law enforcement, uncrewed aerial vehicles (“UAV”), and uncrewed ground vehicles (“UGV”) markets.

 

 

HHT3

 

 

Mobil Commander

 

 

AeroLink

 

 

Aero5

 

8
 

 

Competition and Competitive Positioning

 

We believe our primary competitors are Domo Tactical Communications (formerly a division of Cobham), Silvus Technologies, Persistent Systems, Troll Systems, and several smaller market-specific businesses.

 

We believe that we are one of the market share leaders in the professional broadcast and media video transmission sector. We have successfully leveraged our history of broadcast industry leadership, reputation for advanced technology, and the ability to provide end-to-end solutions to maintain and increase our customer base and continue delivering highly competitive offerings. Our products solve a growing market need for regular, high-definition, wireless video communications. Our product offerings address applications in growing market segments, including in-game sports video mobile feeds, real-time capture and display footage from drones and other aerial platforms, and rapid-response electronic newsgathering operations.

 

Since completing the global rebranding of our solutions under the single Vislink Technologies, Inc. entity in 2018 and the acquisition of MVP in 2021, we believe we can now offer an expanded range of product offerings, additional services, and enhanced capabilities. We think this expansion of product offerings will position us for growth in the Live Production and Mil/Gov markets. We seek to improve margins and control product quality and our competitive agility as we refine our production processes.

 

Sales and Marketing

 

Our sales team comprises sales managers responsible for defined regional areas, inside sales personnel, and business development representatives focused on targeted sectors and regions, supported by solution engineers trained in technical sales with a given market focus. The sales team focuses on helping current customers and nurturing relationships with prospective customers in key domestic and international markets. We employ a combination of sales channels, including direct-to-end customer sales, network group sales, reseller/integrators, and Original Equipment Manufacturer (“OEM”) sales channels to use the most efficient means of reaching customers depending on the market segment. Marketing and public relations activities, digital and print marketing initiatives, the creation of support materials, trade shows, and other event appearances support our sales efforts.

 

As of December 31, 2023, our business development, sales, and marketing team comprised 20 full-time employees and five contractors.

 

Customers

 

We have developed a significant following based on our product offerings’ reputation for performance, reliability, and advanced technology use. We have created a diverse and stable customer base among blue-chip, tier-1 clients in Live Production markets and high-profile agencies and organizations in Mil/Gov markets.

 

Manufacturing and Suppliers

 

We utilize a combination of external contract manufacturers and internal resources to manufacture, test, assure the quality of, and ship our products, allowing us to develop supply chains tailored to our needs on a per-product and per-solution basis. As we advance, we anticipate focusing on our core strengths: innovation and technology design and developing, creating, and exploiting our intellectual property.

 

We may continue to rely upon third-party components and technology to build our products, particularly in the short term, as we procure components, subassemblies, and products necessary to manufacture our products based on our design, development, and production needs. While parts and supplies are generally available from various sources, we currently depend on a single or limited number of suppliers for several components for our products. We rely on purchase orders rather than long-term contracts with our suppliers. A delay in production could result if a supply disruption of critical components required us to re-engineer our products to incorporate alternate features.

 

9
 

 

Intellectual Property

 

We have developed a broad intellectual property portfolio covering wired and wireless communications systems. As of December 31, 2023, we have 11 patents granted in the United States, no patent applications pending, no provisional applications pending, and one disclosure. Internationally, we have two patents granted, no patent applications pending, and no Patent Cooperation Treaty (PCT) applications.

 

Areas of our development activities that have culminated in filings and/or awarded patents include:

 

  ● Self-Organizing Networks;
  ● R.F. Modulation;
  ● Compression (protocols, payload, signaling, etc.);
  ● Modulators/Demodulators;
  ● Antennas/Shielding;
  ● Wired and Wireless Networks;
  ● Media Access Control Protocols; and
  ● Interference Mitigation.

 

We protect our intellectual property rights using federal, state, and common law rights and contractual restrictions. We control access to our proprietary technology by entering confidentiality and invention assignment agreements with our employees and contractors and confidentiality agreements with third parties. We also actively monitor activities concerning third parties’ infringing uses of our intellectual property.

 

In addition to these contractual arrangements, we rely on a combination of trade secrets, copyrights, trademarks, trade dress, domain names, and patents to protect our products and other intellectual property. We own a substantial portion of the copyright interests in the software code used in connection with our products and the brand or title name trademark under our marketed products. We pursue our domain names, trademarks, and service marks in the United States and locations outside the United States. Our registered trademarks in the United States include “xG,” “IMT,” “Vislink,” “Mobile Viewpoint,” and the names of our products, among others.

 

Circumstances outside our control could pose a threat to our intellectual property rights. For example, adequate intellectual property protection may not be available in the United States or other countries where our products are sold or distributed. Also, our efforts to protect our proprietary rights may need to be revised. Any significant impairment of our intellectual property rights could harm our business or our ability to compete. Also, protecting our intellectual property rights is costly and time-consuming. Any unauthorized disclosure or use of our intellectual property could make it more expensive to do business, harming our operating results.

 

Mobile wireless communications technology and other industries may own many patents, copyrights, and trademarks. They may frequently request license agreements, threaten litigation, or file a suit against us based on infringement allegations or other violations of intellectual property rights. We may face third-party claims that our competitors and non-practicing entities infringe on their trademarks, copyrights, patents, and other intellectual property rights. As our business grows, we might face more claims of infringement.

 

10
 

 

Company Information

 

Effective February 11, 2019, xG Technology, Inc. changed its name to Vislink Technologies, Inc. Our predecessor company was initially incorporated in Delaware in 2006. Our executive offices are at 350 Clark Dr., Suite 125, Mt. Olive, NJ 07828, and (908) 852-3700 is the telephone number. Our website address is www.vislink.com. Our website’s information is not part of the report but only for informational purposes.

 

Available Information

 

We file reports with the Securities and Exchange Commission (“SEC”), and those reports are available free of charge on our website (www.vislink.com) under “About/Investor Information/SEC Filings.” The reports available include our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports, which are available as soon as reasonably practicable after we electronically file such materials or furnish them to the SEC. You can also read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, DC 20549. You can obtain additional information about the Public Reference Room’s operation by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site (www.sec.gov) containing reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us. The information contained on the SEC’s website is not incorporated by reference into this Form 10-K and should not be considered to be part of this Report. Within the Investors section of our website, we provide information concerning corporate governance, including our corporate governance guidelines, board committee charters, Code of Ethics and other information. A copy of the Code of Ethics may be provided to any person without charge upon written request to: Vislink Technologies, Inc., Attn: Corporate Secretary, 350 Clark Dr., Suite 125, Mt. Olive, NJ 07828. The content reflected on any website reflected in this Report is not incorporated by reference herein unless expressly noted.

 

Human Capital

 

Overall

 

Our business results depend partly on our ability to successfully manage our human capital resources, including attracting, identifying, and retaining key talent. As of December 31, 2023, we employed 112 full-time employees and 11 independent contractors, including 22 in development (including one contractor), two officers, 16 in general and administrative (includes two contractors), 58 in operations (includes three contractors), and 25 in sales and marketing (consists of five contractors). As a global industrial technology company, many of our employees are engineers or trained trade or technical workers focusing on advanced manufacturing, and many possess advanced college degrees. No labor union represented our employees at any of our worldwide facilities as of December 31, 2023.

 

We emphasize several measures and objectives in managing its human capital assets, including, among others, employee safety and wellness, talent acquisition and retention, employee engagement, development and training, diversity and inclusion, and compensation. These targeted ideals vary by country/region. They may include annual bonuses, stock-based compensation awards, a 401(k) plan with matching opportunities, healthcare and insurance benefits, health savings and flexible spending accounts, paid time off, family leaves, family care resources, employee assistance programs, and tuition assistance. We also provide our employees with access to various innovative, flexible, and convenient health and wellness programs. We designed these programs to support employees’ physical and mental health by providing tools and resources to improve or maintain their health status and encourage engagement in healthy behaviors. We generally consider our employee relations to be good.

 

11
 

 

Item 1A. Risk Factors

 

In addition to the other information in this Form 10-K, readers should consider the following essential factors carefully. These factors, among others, in some cases, have affected, and in the future could affect, our financial condition and results of operations and could cause our future results to differ materially from those expressed or implied in any forward-looking statements that appear in this Form 10-K or that we have made or will make elsewhere.

 

Risks Related to the Company and Our Business

 

We have incurred losses in the past and may be unable to achieve or sustain profitability in the future.

 

We have incurred net losses since inception, including net losses of $9.1 million and $13.6 million for the years ended December 31, 2023, and 2022, respectively. As a result of ongoing losses, as of December 31, 2023, we had an accumulated deficit of $309.2 million, $8.5 million of cash, and $5.7 million of investments in governmental securities. We expect to continue to incur significant sales and marketing, product development, regulatory, and other expenses as we seek to expand existing relationships with our customers, obtain new customers, reach new markets, and develop new products or add new features to our existing products. Our net income (loss) may fluctuate significantly from fiscal period to period. We will need to generate significant additional revenues and/or cost-cutting to achieve and sustain profitability, and even if we achieve profitability, we cannot be sure that we will remain profitable for any substantial period. Our failure to gain or maintain profitability could negatively impact the value of our common stock.

 

We may require additional capital to fund our existing commercial operations, develop, market, and commercialize new products, and expand our operations. If we do not obtain additional financing, our business prospects, financial condition, and results of operations will be adversely affected if required.

 

Our available cash balances, potential borrowing capacity, and anticipated cash flow from operations may need to be revised to satisfy our liquidity requirements, including because of lower demand for our products, whether as a result of the risks described in this Annual Report or otherwise. As such, we may seek to sell common or preferred equity or debt securities, other forms of third-party funding, or seek debt financing. Our current and future funding requirements will depend on many different factors, including:

 

  ● the cost of expanding our operations and offerings, including our sales and marketing efforts;
  ● our rate of progress in, and cost of the sales and marketing activities associated with, establishing adoption of our products and maintaining or improving our sales to our current customers;
  ● the cost of research and development activities, including research and development relating to new products and technologies or features for existing products;
  ● the effect of competing technological and market developments;
  ● costs related to international expansion, and
  ● the potential cost and delays resulting from regulatory oversight of our business and products.

 

We may also consider raising additional capital in the future to expand our business, pursue strategic investments, take advantage of financing opportunities, or for other reasons, including:

 

  ● expanding our sales and marketing efforts to increase market adoption of our products and address competitive developments;
  ● funding development and marketing efforts of any future products or additional features to then-current products;
  ● acquiring, licensing, or investing in new technologies;
  ● providing for supply and inventory costs associated with plans to accommodate potential increases in demand for our products;
  ● acquiring or investing in complementary businesses or assets, and
  ● financing capital expenditures and general and administrative expenses.

 

12
 

 

Additional capital may not be available to us at such times or in needed amounts. Even if capital is available, it might be available only on unfavorable terms. Any issuance of additional equity or equity-linked securities could be dilutive to our existing stockholders, and any new equity securities could have rights, preferences, and privileges superior to those of holders of our common stock. Debt financing, if available, may involve restrictive covenants on our operations or our ability to incur additional debt, pay dividends, repurchase our stock, make investments, and engage in merger, consolidation, or asset sale transactions. If we raise additional funds through collaboration and licensing arrangements with third parties. It may be necessary to relinquish or license some rights to our technologies or products on terms that are not favorable to us. If access to sufficient capital is unavailable as and when needed, our business will be materially impaired. We may be required to cease operations, curtail one or more product development or expansion programs, significantly reduce expenses, sell assets, seek a merger or joint venture partner, file for protection from creditors, or liquidate all our assets.

 

Furthermore, we may require additional capital to develop new products in the future, and we may not be able to secure adequate additional financing when needed on acceptable terms or at all. To execute our business strategy, we may issue additional equity securities in public or private offerings, potentially at discounts to our common stock’s current or future market price. If we can secure further funding, we may be able to forego strategic opportunities or delay, scale back, and eliminate future product development.

 

Our global operations expose us to risks associated with public health crises or pandemic outbreaks. These crises or outbreaks could disrupt our operations and materially and adversely affect our results of operations and financial condition.

 

Our business may be exposed to risks associated with public health crises, such as pandemics and epidemics. Widespread outbreaks of a pandemic, such as the COVID-19 pandemic, have created a significant global economic downturn, disrupted global trade and supply chains, adversely impacted many industries, and contributed to significant volatility in financial markets. A public health crisis or an outbreak of a pandemic in one or more of the geographic areas in which we operate could affect our ability to source product materials and components, labor, and otherwise to provide products and services to our customers and adversely affect our results of operations and financial condition.

 

Our industry is highly competitive, and we may need to compete more effectively.

 

The communications industry is highly competitive, rapidly evolving, and constantly changing. We expect that new competitors are likely to join existing competitors. Many of our competitors may be larger and have more excellent financial, technical, operational, marketing, and other resources and experience than we do. If a competitor expends significant resources, we may not compete successfully. Also, the pace of technological change makes it impossible for us to predict whether we will face new competitors using different technologies to provide products. If our competitors were to offer better and more cost-effective products than our products, we might not be able to capture any significant market share.

 

Defects or errors in our products and services or products made by our suppliers could harm our brand and relations with our customers and expose us to liability. If we experience product recalls, we may incur significant expenses and experience decreased demand for our products.

 

Our products are inherently complex and may contain defects and errors that are only detectable when the products are in use. Because our products are used for personal and business purposes, such faults or errors could severely impact our end customers, damaging our reputation and customer relationships and exposing us to liability. Defects or impurities in our components, materials, or software, equipment failures, or other difficulties could adversely affect our customers’ ability to ship products on a timely basis and customer or licensee demand for our products. Any shipment delays or declines in demand could reduce our revenues and harm our ability to achieve or sustain desired levels of profitability. Our customers may also experience component or software failures or defects requiring significant product recalls, rework, and repairs not covered by warranty reserves.

 

13
 

 

Future impairment charges could have a material adverse effect on our financial condition and the results of operations.

 

We must test our finite-lived intangible assets for impairment if events occur or circumstances change that would indicate that the remaining net book value of the intangible assets might not be recoverable. These events or circumstances could include a significant change in the business climate, including a substantial, sustained decline in an entity’s market value, legal factors, operating performance indicators, competition, sale, or disposition of a considerable portion of our business, potential government actions, and other factors. If our finite-lived intangible assets’ fair value is less than their book value in the future, we could be required to record impairment charges. The amount of any future impairment could be significant and could have a material adverse effect on our reported financial results for the period in which the charge is taken.

 

Although our products may not cause users technical issues, our business and reputation may be harmed if users perceive our solutions to cause a slow or unreliable network connection or a high-profile network failure.

 

We expect our products to be in many different locations and user environments and can provide video transmission, mobile broadband connectivity, and interference mitigation, among other applications. Our products’ ability to operate effectively can be negatively impacted by many different elements unrelated to our products. Although our products may not cause technical issues, users often may perceive the underlying cause of our technology’s poor performance. This perception, even if incorrect, could harm our business and reputation. Similarly, a high-profile network failure may be caused by improper operation or failure of a network component we did not supply. Still, other service providers may perceive that our products were implicated, which, even if incorrect, could harm our business, operating results, and financial condition.

 

Our ability to sell our products will be highly dependent on the quality of our support and service offerings, and our failure to offer high-quality support and services would adversely affect our sales and the results of operations.

 

Once our products are deployed, our channel partners and end customers will depend on our support organization to resolve any issues relating to our products. Significant support will be necessary for our products’ successful marketing and sales. In many cases, our channel partners will likely provide support directly to our end customers, and we will need more control over the quality of the support supplied by our channel partners. These channel partners may also support other third-party products, potentially distracting resources from support for our products. Our channel partners need to effectively assist our end customers in deploying our products, succeed in helping our end customers quickly, resolve post-deployment issues, or provide adequate ongoing support to maintain our ability to sell our products to existing end customers. Our reputation with potential end customers could be harmed. We sometimes guarantee a certain performance level to our channel partners and end customers, which could prove resource-intensive and expensive if unforeseen technical problems arise.

 

We are subject to increasing operating costs and inflation risks, which may adversely affect our performance.

 

While we attempt to offset increases in operating costs through various measures focused on increasing revenues, there is no assurance that we will do so. Therefore, operating expenses may rise faster than associated revenues, resulting in a material adverse impact on our cash flow and margins.

 

We are also impacted by inflationary increases in wages and benefits, whether driven by competition for talent or ordinary course pay increases and other rising costs. Increases in the inflation rate could also significantly impact our cost base. In all countries in which we operate, wage inflation, whether driven by competition for talent or ordinary course pay increases, may also increase our cost of providing services and reduce our profitability if we are not able to pass those costs on to our clients or charge premium prices when justified by market demand. 

 

14
 

 

We may need to recruit and retain qualified personnel, which may affect our business, financial condition, results of operations, and prospects.

 

We expect to rapidly expand our operations and grow our sales, development, and administrative functions. This expansion is expected to significantly strain our management and require hiring a considerable quantity of qualified personnel. Accordingly, recruiting and retaining such personnel in the future will be critical to our success. There is intense competition from other companies for qualified personnel in our activities. If we fail to identify, attract, retain, and motivate these highly skilled personnel, we may be unable to continue our marketing and development activities, which could adversely affect our business, financial condition, results of operations, and prospects.

 

We rely on key executive officers, and their knowledge of our business and technical expertise would be difficult to replace.

 

We depend highly on our executive officers because of their expertise and experience in the telecommunications industry. We have agreements with our executive officers containing customary non-disclosure, non-compete, confidentiality, and assignment of inventions provisions. Our officers do not have “key person” life insurance policies. The loss of our key personnel’s technical knowledge, management, and industry expertise could result in delays in product development, the loss of customers and sales, and the diversion of management resources, adversely affecting our operating results.

 

We purchase some components, subassemblies, and products from a limited number of suppliers. The loss of these suppliers may substantially disrupt our ability to obtain orders and fulfill sales as we design and qualify new components.

 

We sometimes rely on third-party components and technology to build and operate our products. Until full integration with IMT and VCS, we may rely on our contract manufacturers to obtain the parts, subassemblies, and products necessary to manufacture our products. Shortages in components we use in our products are possible, and our ability to predict such components’ availability is limited. While parts and supplies are generally available from various sources, our contract manufacturers currently depend on a single or limited number of suppliers for several of our products. If our suppliers of these components or technology were to enter into exclusive relationships with other providers of wireless networking equipment or were to discontinue providing such components and technology to us, and we could not replace them cost-effectively or at all, our ability to deliver our products would be impaired. Our contract manufacturers generally rely on purchase orders rather than long-term contracts with these suppliers.

 

Specific supply chain disruptions may also arise because of global conflicts, such as the armed conflict between Russia and Ukraine, the war in Gaza, trade sanctions, and similar events. It may be difficult for us to assess our suppliers’ ability to meet our future demand promptly based on past performance. As a result, even if available, our contract manufacturers and we may not secure sufficient components at reasonable prices or acceptable quality to build our products on time. Therefore, we may be unable to meet customer demand for our products, adversely affecting our business, operating results, and financial condition.

 

We do not have long-term contracts with our existing contract manufacturers. The loss of any of our current contract manufacturers could adversely affect our business, operating results, and financial condition.

 

We do not have long-term contracts with our existing contract manufacturers. If any of our current contract manufacturers are unable or unwilling to manufacture our products in the future, the loss of such contract manufacturers could adversely affect our business, operating results, and financial condition.

 

15
 

 

Our intellectual property protections may be insufficient to safeguard our technology adequately.

 

Given the rapid pace of innovation and technological change within the wireless and broadband industries, our personnel, consultants, and contractors’ technical and creative skills and ability to develop, enhance, and market new products and upgrade existing products are critical to continued success. Our success and ability to compete effectively depend on the proprietary technology we have developed internally. We rely primarily on patent laws to protect our proprietary rights. As of December 31, 2023, in the United States, we have 11 patents granted, no patent applications pending, and no provisional applications pending. Internationally, we have two patents granted, no patent applications pending, and no Patent Cooperation Treaty (PCT) applications. There can be no assurance that patents are awaiting, that future patent applications will be issued, or that we will have the resources to protect any such issued patent from infringement if issued.

 

Further, we cannot patent critical technology for our business. To date, we have relied on copyright, trademark, and trade secret laws, as well as confidentiality procedures, non-compete and work-for-hire invention assignment agreements, and licensing arrangements with our employees, consultants, contractors, customers, and vendors, to establish and protect our rights to this technology and, to the best extent possible, control the access to and distribution of our technology, software, documentation, and other proprietary information. Despite these precautions, it may be possible for a third party to copy or otherwise obtain and use this technology without authorization. Policing unauthorized use of this technology is challenging. We need to be confident that our steps will prevent the misappropriation of or prevent unauthorized third parties from obtaining or using the technology we rely on. Also, adequate protection may be unavailable or limited in some jurisdictions. Litigation may be necessary in the future to enforce or protect our rights.

 

We may be subject to claims of intellectual property infringement or invalidity. Expenses incurred for monitoring, protecting, and defending our intellectual property rights could adversely affect our business.

 

Competitors and others may infringe on our intellectual property rights or allege we have violated theirs. If we are found to infringe on others’ rights, we could be required to discontinue offering certain products or systems, pay damages, or purchase a license from its owner to use the intellectual property in question. Monitoring infringement and misappropriation of intellectual property can be difficult and expensive, and we may be unable to detect infringement or misappropriation of our proprietary rights. We may also incur significant litigation expenses in protecting our intellectual property or defending our use of intellectual property, reducing our ability to fund product initiatives. These expenses could hurt our future cash flows and the results of operations. Litigation can also distract management from the day-to-day operations of the business.

 

Enforcement of our intellectual property rights abroad, particularly in China, is limited, and it is often difficult to protect and enforce such rights.

 

Many companies have encountered substantial intellectual property infringement in countries where we sell, or intend to sell, products or have our products manufactured. Patent protection outside the United States is generally less comprehensive than in the United States. It may not protect our intellectual property in some countries where our products are sold or may be sold in the future. Even if patents are granted outside the United States, effective enforcement may not be available in those countries.

 

In particular, the legal regime relating to China’s intellectual property rights is limited, and it is often difficult to protect and enforce such rights. The regulatory scheme for implementing China’s intellectual property laws may not be as developed as other countries’ regulatory schemes. Any advancement of an intellectual property enforcement claim through China’s regulatory system may require extensive time, allowing intellectual property infringers to continue mostly unimpeded, to our commercial detriment in the Chinese and other export markets. Also, rules of evidence may be unclear, inconsistent, or difficult to comply with, making it difficult to prove infringement of our intellectual property rights. As a result, enforcement cases involving technology, such as copyright infringement of software code or unauthorized manufacture or sale of products containing patented inventions, may be difficult or impossible to sustain.

 

These factors may make it increasingly complicated for us to enforce our intellectual property rights against parties misappropriating or copying our technology or products without our authorization, allowing competing enterprises to harm our business in the Chinese or other export markets by affecting the pricing for our products, reducing our sales, and diluting our brand or product quality reputation.

 

The intellectual property rights of others may prevent us from developing new products or entering new markets.

 

The telecommunications industry is characterized by the rapid development of new technologies, which requires us to continuously introduce new products and expand into new markets that may be created. Therefore, our success depends on adapting our products and systems, incorporating new technologies, and growing into markets that new technologies may design. If technologies are protected by others’ intellectual property rights, including our competitors, we may be prevented from introducing new products or expanding into new markets created by these technologies. If others’ intellectual property rights prevent us from using innovative technologies, our financial condition, operating results, or prospects may be harmed.

 

16
 

 

We may be subject to infringement claims in the future.

 

We may need to be made aware of filed patent applications and issued patents that could include claims covering our products. Parties making claims of infringement may be able to obtain injunctive or other equitable relief that could effectively block our ability to sell or supply our products or license our technology and cause us to pay substantial royalties, licensing fees, or damages. The defense of any lawsuit could divert management’s efforts and attention from ordinary business operations and result in time-consuming and expensive litigation, regardless of the merits of such claims. These outcomes may (i) require us to stop selling products or using technology that contains the allegedly infringing intellectual property; (ii) need us to redesign those products that have the allegedly infringing intellectual property; (iii) require us to pay substantial damages to the party whose intellectual property rights we may be found to be infringing; (iv) result in the loss of existing customers or prohibit the acquisition of new customers; (v) cause us to attempt to obtain a license to the relevant intellectual property from third parties, which may not be available on reasonable terms or at all; (vi) materially and adversely affect our brand in the market place and cause a substantial loss of goodwill; (vii) cause our stock price to decline significantly; (viii) materially and adversely affect our liquidity, including our ability to pay debts and other obligations as they become due; or (ix) lead to our bankruptcy or liquidation.

 

We rely on the availability of third-party licenses. If these licenses are available only on less favorable terms or not in the future, our business and operating results will be harmed.

 

We have incorporated third-party licensed technology into our products. It may be necessary to renew licenses relating to these products or seek additional licenses for existing or new products. There can be no assurance that the required licenses will be available on acceptable terms or at all. The inability to obtain specific licenses or other rights, or to obtain those licenses or rights on favorable terms, or the need to engage in litigation regarding these matters could result in delays in product releases until such time, if ever, as equivalent technology could be identified, licensed or developed and integrated into our products and might have a material adverse effect on our business, operating results and financial condition. Moreover, including intellectual property licensed from third parties in our products on a nonexclusive basis could limit our ability to protect our proprietary rights.

 

We expect to base our inventory purchasing decisions on our forecasts of customers’ demand, and if our projections are inaccurate, our operating results could be materially harmed.

 

As our customer base increases, we expect to place orders based on customer demand forecasts with our contract manufacturers. Our projections will be based on multiple assumptions, each of which may cause our estimates to be inaccurate, affecting our ability to provide products to our customers. When demand for our products increases significantly, we may not be able to meet demand on a timely basis, and we may need to expend a significant amount of time working with our customers to allocate limited supply and maintain positive customer relations, or we may incur additional costs to rush the manufacture and delivery of other products. If we underestimate customers’ demand, we may forego revenue opportunities, lose market share, and damage customer relationships. Conversely, if we overestimate customer demand, we may purchase more inventory than we can sell at any given time or at all. Also, we grant our distributors stock rotation rights, which require us to accept stock back from a distributor’s inventory, including obsolete inventory. As a result of our failure to correctly estimate the demand for our products, we could have excess or obsolete inventory, resulting in a decline in our inventory value, which would increase our costs of revenues and reduce our liquidity. Our failure to accurately manage inventory relative to demand would adversely affect our operating results.

 

17
 

 

If our technology did not work as planned or if we were unsuccessful in developing and selling new products or penetrating new markets, our business and operating results would suffer.

 

Our ability to compete successfully depends on our ability to design, develop, manufacture, assemble, test, market, and support new products and enhancements on a timely and cost-effective basis to keep pace with market needs and satisfy customers’ demands. Our success and ability to compete depend on the technology we have developed or may develop in the future. There is a risk that the technology we have developed or may develop may not work as intended or that the technology marketing may not be as successful as anticipated. Further, the markets in which our customers and we compete or plan to compete are characterized by regularly and rapidly changing technologies and technological obsolescence. A fundamental technological shift in our target markets could harm our competitive position. Our failure to anticipate these shifts, develop new technologies, or react to changes in existing technologies could materially delay our development of new products, resulting in product obsolescence, decreased revenue, and a loss of customer wins to our competitors. New technologies and products require substantial investment, prolonged development, and testing before being commercially viable. We intend to continue investing significantly in developing new technologies and products. We may not be able to build or acquire new products or product enhancements that compete effectively within our target markets or differentiate our products based on functionality, performance, or cost, and our latest technologies and products will not result in meaningful revenue. Any delays in developing and releasing new or enhanced products could cause us to lose revenue opportunities and customers. Any technical flaws in product releases could diminish our products’ innovative impact and harm customer adoption and reputation. If we fail to introduce new products that meet our customers’ demands or target markets, do not achieve market acceptance, or forget to penetrate new markets, our revenue will not increase over time, and our operating results and competitive position will suffer.

 

We rely extensively on information technology systems and could face cybersecurity risks.

 

We rely extensively and increasingly on information technologies and infrastructure to manage our business, including developing new business opportunities and digital streaming products and services. Our business operations depend on secure transmission and other data and video processing over the internet and interconnected systems. Malicious technology-related events, such as cyberattacks, computer hacking, computer viruses, ransomware, worms, and other destructive or disruptive software and other attempts to access confidential or personal data, denial of service attacks, and other malicious activities, are becoming increasingly diverse and sophisticated. These events are rising worldwide, highlighting the need for continual and effective cybersecurity awareness and education. Our business, which involves the collection, use, transmission, and other distribution of data and video, may make us and our clients and business partners attractive targets of hackers, denial of service attacks, malicious code, phishing attacks, ransomware attacks, and other threat actors, including malicious insiders (such as employees and prior employees), which may result in security incidents, including the unauthorized access, misuse, loss, corruption, inaccessibility, or destruction of this data (including personal, confidential and sensitive information), unavailability of services, or other adverse events. In the past, we have faced cyber-attacks of this nature, and we expect to continue to face such attacks in the future. Some of these attacks have been successful, although we believe that none to date have been material. We cannot guarantee that our defensive measures will prevent such attacks in the future. These types of cyber-attacks and incidents can give rise to various losses and costs, including legal exposure and regulatory fines, damage to reputation, and others. If successful, these incidents could also materially disrupt operational systems and result in the loss of intellectual property, trade secrets, other proprietary or competitively sensitive information, and general data (including personal information).

 

Data breaches and improper use of social media by employees and others may risk sensitive data, such as personal information, strategic plans, and trade secrets, being exposed to third parties or the public. Any such breaches or breakdowns could expose us to legal liability, be expensive to remedy, result in a loss of our or our clients’ or vendors’ proprietary information, and damage our reputation. Efforts to develop, implement, and maintain security measures are costly, may not successfully prevent these events from occurring, and may require ongoing monitoring and updating as technologies and cyberattack techniques change frequently or are not recognized until they are successful.

 

Furthermore, computer malware, viruses, hacking, and phishing attacks have become more prevalent in our industry and may occur in future systems. Though it is difficult to determine what, if any, harm may directly result from any specific interruption or attack, any failure to maintain performance, reliability, security, and availability of our products and technical infrastructure to the satisfaction of our users may harm our reputation and our ability to attract and retain customers. 

 

18
 

 

Our industry is subject to rapid technological change, and to compete successfully, we must make substantial investments in new products, services, and technologies.

 

New technological innovations generally require a substantial investment before they are commercially viable. We intend to continue to make significant investments in developing new products and technologies, and it is possible that our development efforts will not be successful and that our latest technologies will not result in meaningful revenues. Our future success will depend on our ability to quickly develop and introduce new products, technologies, and enhancements. Our future success will also rely on our ability to keep pace with technological developments, protect our intellectual property, satisfy customer requirements, meet customer expectations, price our products and services competitively, and achieve market acceptance. Introducing products embodying new technologies and emerging new industry standards could render our existing products and technologies and products currently under development obsolete and unmarketable. If we fail to anticipate or respond adequately to technological developments or customer requirements or experience any significant delays in the development, introduction, or shipment of our products and technologies in commercial quantities, demand for our products and our customer’s and licensees’ products that use our technologies could decrease, and our competitive position could be damaged.

 

Adopting and implementing such regulations could decrease demand for our products, increase the cost of building and selling them, impact our ability to ship products into affected areas, and reduce our ability to recognize revenue on time. Any of these impacts could have a material adverse effect on our business, financial condition, and results of operations.

 

At several of our annual stockholder meetings, including our 2019 Annual Meeting of Stockholders, we failed to obtain ratification by our stockholders of specific proposals submitted for approval of our stockholders at prior annual meetings, which could be deemed defective corporate acts.

 

At our 2015 Annual Meeting of Stockholders, our Board submitted to our stockholders for their approval (i) a proposal to approve our 2015 Employee Stock Purchase Plan and (ii) a proposal to approve our 2015 Incentive Compensation Plan. At our 2016 Annual Meeting of Stockholders, our Board submitted to our stockholders for their approval (i) a proposal to approve our 2016 Employee Stock Purchase Plan and (ii) a proposal to approve our 2016 Incentive Compensation Plan. At our 2017 Annual Meeting of Stockholders, our Board submitted to our stockholders, for their approval, (i) a proposal to approve an amendment to our 2016 Employee Stock Purchase Plan to increase the number of shares of common stock available for sale under such plan; (ii) a proposal to approve an amendment to our 2016 Incentive Compensation Plan to increase the number of shares of Common stock available for sale under such plan; and (iii) a proposal to approve our 2017 Incentive Compensation Plan.

 

At each of these annual meetings, our inspector of elections determined that the applicable proposal received the requisite stockholder approval under our amended and restated bylaws (“Bylaws”) and certified that the proposal passed, which was subsequently disclosed in an applicable Current Report on Form 8-K. Questions have been raised about whether the votes on such proposals were tabulated following our Bylaws’ provisions and whether the requisite votes were obtained to approve each of these proposals.

 

According to the provisions of Section 204 of the General Corporation Law of the State of Delaware (“DGCL”) and to continue to remain in compliance with Nasdaq’s Listing Rules, we submitted all these proposals, again, to our stockholders at our 2019 Annual Meeting of Stockholders for ratification to resolve any defects in the corporate acts relating to the approval of these proposals by our stockholders at the prior meetings. We could not obtain ratification by our stockholders for any proposals submitted to them at the 2019 Annual Meeting of Stockholders. Although we intend to resubmit these proposals to our stockholders for ratification, there can be no assurance that any of these proposals will be ratified. If we cannot secure such ratifications or are deemed inadequate, this could result in a determination that none of the shares issued by us under these plans were duly authorized and validly issued, which could create accounting issues, affect our liquidity and capital structure, and expose us to claims from recipients of any stock awards granted according to such plans, any of which could have a material adverse effect on our business and results of operations.

 

19
 

 

Demand for our defense-related products and products for emergency response services depends on government spending.

 

A portion of our business is derived from military and government markets. The military and government market largely depends on government budgets and is subject to governmental appropriations. Although multi-year contracts may be authorized with major procurements, funds are generally appropriated on a fiscal-year basis, even though a program may be expected to continue for several years. Consequently, programs are often only partially funded, and additional funds are committed if further appropriations are made. We cannot assure you that maintenance of or increases in military and government spending will be allocated to programs that would benefit our business. A decrease in levels of military and government spending or the government’s termination of, or failure to fully fund, one or more of the contracts for the programs in which we participate could have a material adverse effect on our financial position and the results of operations. Moreover, we cannot assure you that the new military and government-related communication and broadcasting programs we participate in will enter full-scale production as expected.

 

Our potential customers for our communication and surveillance products and solutions will likely include the U.S. Government or Government-related entities subject to congressional appropriations. Reduced funding for military and government procurement and research and development programs would likely adversely impact our ability to generate revenues.

 

We anticipate that a portion of our revenue will be derived from our communication, surveillance, and satellite products and solutions, at least in the foreseeable future, from U.S. Government and Government-related entities, including the U.S. Department of Defense and other departments and agencies. Government programs where we may seek to participate and contracts for our products must compete with different programs for consideration during Congress’ budget and appropriations hearings. They may be affected by political power changes, appointments, general economic conditions, and other factors beyond our control. A government closure based on a failure of Congress to agree on federal appropriations or the uncertainty surrounding a continuing resolution may result in the termination or delay of federal funding opportunities we are pursuing. Reductions, extensions, or terminations in a program in which we seek to participate, or overall defense or another spending could adversely affect our ability to generate revenues and realize profits. We cannot predict whether potential changes in security, military, communications, and intelligence priorities will afford opportunities for our business regarding research and development or product contracts. Still, a possible reduction in government spending on such programs could negatively impact our ability to generate revenues. In addition, our ability to participate in U.S. Government programs may be affected by the adoption of new laws or regulations relating to government contracting, changes in existing laws or regulations, changes in political or public support for security, military, and government programs, and uncertainties associated with the current global threat environment and other geo-political matters.

 

Contracting with government entities can be complex, expensive, and time-consuming.

 

The procurement process for government entities is, in many ways, more challenging than contracting in the private sector. We must comply with laws and regulations relating to the formation, administration, performance, and pricing of contracts with government entities, including U.S. federal, state, and local governmental bodies.

 

Government entities often require highly specialized contract terms that may differ from our standard arrangements. Government entities frequently impose complicated compliance requirements, require preferential pricing or “most favored nation” terms and conditions, or are otherwise time-consuming and expensive. Compliance with these exceptional standards or satisfaction with such requirements could complicate our efforts to obtain business or increase costs. Even if we meet these standards or conditions, the increased costs of providing our solutions to government customers could harm our margins.

 

Unstable market and economic conditions may seriously affect our business, financial condition, and share price.

 

The global economy, including credit and financial markets, has experienced extreme volatility and disruptions, including severely diminished liquidity and credit availability, bank failures, consumer confidence, economic growth, unemployment rates, inflation rates, and uncertainty about financial stability. For example, the COVID-19 pandemic resulted in widespread unemployment, economic slowdown, and extreme volatility in the global capital markets. Similarly, the current Russia-Ukraine war and other conflicts, including military activities in the Red Sea and the Persian Gulf, as well as those relating to the Gaza Strip and Israel, may exacerbate volatility in the global capital markets or disrupt the global supply chain and energy markets. Any such fluctuations and disruptions may adversely affect us or the third parties we rely on. If the equity and credit markets deteriorate, including because of political unrest or war. In that case, it may make any necessary debt or equity financing more challenging to obtain promptly or, on favorable terms, more costly or more dilutive. Inflation can adversely affect us by increasing our costs, including personnel costs. Any significant increases in inflation and related increases in interest rates could have a material adverse effect on our business, operations, and financial condition.

 

20
 

 

Our failure to comply with complex U.S. and foreign laws and regulations could have a material adverse effect on our operations.

 

We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”), and other anti-corruption, anti-bribery, and anti-money laundering laws in the jurisdictions in which we do business, both domestically and abroad. These laws generally prohibit us and our employees from improperly influencing government officials to obtain or retain business, direct business to any person, or gain any improper advantage. The FCPA and other applicable anti-bribery and anti-corruption laws may also hold us liable for acts of corruption and bribery committed by our third-party business partners, representatives, and agents. While we have policies and procedures that seek to address compliance with such laws, we cannot assure you that our employees and agents will not act in violation of our policies or applicable law, for which we may be ultimately held responsible. Our for violating these laws increases as our international presence expands and as we increase sales and operations in foreign jurisdictions. Any violation of such laws could result in whistleblower complaints, adverse media coverage, investigations, imposition of significant legal fees, and other consequences that may have an adverse effect on our reputation, business, results of operations, and financial condition. Our international operations could also increase our exposure to foreign and international laws and regulations. We could incur unexpected costs and potential litigation if we cannot comply with foreign laws and regulations, which are often complex and subject to variation, differing or inconsistent government interpretation, and unexpected changes. For example, the governments of foreign countries might attempt to regulate our products or levy sales or other taxes relating to our activities. In addition, foreign countries may impose tariffs, duties, price controls, or other restrictions on foreign currencies or trade barriers, any of which could make it more difficult for us to conduct our business internationally. Our international operations could also increase our exposure to complex international tax rules and regulations. Changes in, or interpretations of, tax rules and regulations may adversely affect our income tax provision. In addition, our operations outside the United States may be affected by changes in trade protection laws, policies and measures, and other regulatory requirements affecting trade and investment, including the FCPA and local laws prohibiting corrupt payments by our employees, vendors, or agents. Our sales to customers or sales by our customers to their end customers in some areas outside the United States could be subject to government export regulations or restrictions that prohibit us or [our licensees? distributors?] from selling to customers in some countries or that require us [or our licensees? distributors?] to obtain licenses or approvals to export such products internationally. Delays or denial of the grant of any required license or approval, or changes to the regulations, could make it difficult or impossible to sell to foreign customers in some countries and could adversely affect our revenue. In addition, we could be subject to fines and penalties for violating these export regulations if found in violation. Such violation could result in penalties, including prohibiting us from exporting our products to one or more countries, and could materially and adversely affect our business.

 

Risks Related to Our Industry and its Regulatory Context

 

Regulation of the telecommunications industry could harm our operating results and prospects.

 

The traditional telecommunications industry is highly regulated, and our business and financial condition could be adversely affected by changes in regulations relating to the Internet telecommunications industry. Few laws or regulations apply directly to access to or commerce on intellectual property networks. Still, future regulations could include sales taxes, tariffs in previously unregulated areas, and provider access charges. We could be adversely affected by the regulation of intellectual property networks and commerce in any country where we market equipment and services to service or content providers. Rules governing the range of services and business models that service providers or content providers can offer could adversely affect those customers’ needs for products designed to enable a wide range of such services or business models. For instance, the U.S. Federal Communications Commission (“FCC”) has issued regulations governing aspects of fixed broadband networks and wireless networks. These regulations might impact service providers and content providers’ business models, and providers’ need for Internet telecommunications equipment and services. Also, many jurisdictions evaluate or implement cybersecurity, privacy, and data protection regulations, which could affect the market and networking and security equipment requirements.

 

Environmental regulations concerning electronic equipment manufacturing or operations may adversely impact our business and financial condition. For instance, the European Union has adopted electronic waste, e-waste, e-scrap, or electrical and electronic equipment waste, Restriction of the Use of Certain Hazardous Substances, Registration, Evaluation, Authorization, and Restriction of Chemicals. Furthermore, some governments have regulations prohibiting government entities from purchasing security products that do not meet specified indigenous certification criteria, even though those criteria may conflict with accepted international standards. Similar laws are in effect or under consideration in several jurisdictions where we do business.

 

Adopting and implementing such regulations could decrease demand for our products, increase the cost of building and selling them, impact our ability to ship products into affected areas, and reduce our ability to recognize revenue on time. Any of these impacts could have a material adverse effect on our business, financial condition, and results of operations.

 

21
 

 

New regulations or standards or changes in existing laws or standards in the United States or internationally related to our products may result in unanticipated costs or liabilities, which could have a material adverse effect on our business, results of operations, and future sales, and could place additional burdens on the our business operations.

 

Our products may be subject to governmental regulations in a variety of jurisdictions. Our technology and products must comply with these regulations and many industry standards to achieve and maintain market acceptance. In the United States, our technology and products must comply with various FCC rules and others. We may also have to comply with similar international regulations. For example, our wireless communication products operate through the transmission of radio signals, and radio emissions are subject to regulation in the United States and other countries in which we intend to do business. In the United States, various federal agencies, including the Center for Devices and Radiological Health of the Food and Drug Administration, the FCC, the Occupational Safety and Health Administration, and various state agencies, have promulgated regulations that concern the use of radio/electromagnetic emissions standards. Member countries of the European Union have enacted similar standards relating to electrical safety, electromagnetic compatibility and emissions, and chemical substances and use standards.

 

As these regulations and standards evolve, and if new rules or standards are implemented, we may be required to modify our technology or products or develop and support new versions. Our compliance with these regulations and standards may become more burdensome. The failure of technology or our products to comply, or delays in compliance with the various existing and evolving industry regulations and standards, could prevent or delay the introduction of our technology or products, harming our business. End-customer uncertainty regarding future policies may also affect demand for communications products, including our products. Moreover, channel partners or end customers may require us, or we may otherwise deem it necessary or advisable, to alter our technology or products to address actual or anticipated changes in the regulatory environment. Our inability to change our technology or products to address these requirements and any regulatory changes may adversely affect our business, operating results, and financial condition.

 

Compliance with environmental, health, and safety laws and regulations, including new rules requiring higher standards, may increase costs, limit our ability to utilize supply chains, and force product design changes.

 

Our operations are subject to various environmental, health, and safety laws and regulations and equivalent local, state, and regulatory agencies in each jurisdiction we operate or may operate in the future. Our products manufacturing uses substances regulated under various federal, state, and local laws governing the environment and worker health and safety. If we, including any contract manufacturers that we may employ, do not comply with these laws, including any new regulations, such non-compliance could reduce our products’ net realizable value, resulting in an immediate charge to our income statements. Our non-compliance with such laws could also negatively impact our operations and financial position as a result of fines and penalties that may be imposed on us and increase the cost of mandated remediation or delays to any contract manufacturers we may utilize; thus, we may suffer a loss of revenues, be unable to sell our products in specific markets and countries, be subject to penalties and enforced fees and suffer a competitive disadvantage. If applicable, costs to comply with current laws and regulations and similar future laws and regulations could include costs associated with modifying our products, recycling and other waste processing costs, legal and regulatory costs, and insurance costs. We cannot assure you that the costs of complying with these new laws or current and future environmental and worker health and safety laws will not adversely affect our business, operating results, and financial condition.

 

Governmental regulations affecting the import or export of products or affecting products containing encryption capabilities could negatively impact our revenues.

 

The United States and various foreign governments have imposed controls, export license requirements, and restrictions on importing or exporting some technologies, especially encryption technology. Also, governmental agencies have occasionally proposed additional regulation of encryption technology, such as requiring certification, notifications, review of source code, or the escrow and governmental recovery of private encryption keys. For example, Russia and China recently have implemented new requirements for encryption products, and India has imposed certain warranties and other obligations associated with critical technology. Governmental regulation of encryption or IP networking technology and regulation of imports or exports, or our failure to obtain required import or export approval for our products, could harm our international and domestic sales prospects and adversely affect our revenue expectations. In addition, the U.S. and other international organizations have imposed numerous sanctions and restrictions, such as the EU, on exporting specific goods and services to Russia due to the armed conflict with Ukraine. Failure to comply with such regulations could result in penalties, costs, and restrictions on import or export privileges or adversely affect sales to government agencies or government-funded projects.

 

22
 

 

If wireless devices pose safety risks, we may be subject to new regulations, and demand for our products, licensees, and customers may decrease.

 

In recent years, the FCC and foreign regulatory agencies have updated the guidelines and methods for evaluating radiofrequency emissions from radio equipment, including wireless phones and other wireless devices. Even if unfounded, concerns over the effects of radiofrequency emissions may discourage the use of wireless devices, decreasing demand for our products and those of our licensees and customers. Interest groups have also requested that the FCC investigate claims that wireless communication technologies pose health concerns and cause interference with airbags, hearing aids, and medical devices. Concerns have also been expressed over the possibility of safety risks due to a lack of attention associated with wireless devices while driving. Any legislation adopted in response to these expressions of concern could reduce demand for our products and those of our licensees and customers in the United States and foreign countries.

 

Risks Related to our Common Stock

 

Our charter documents and Delaware law could prevent a takeover that stockholders consider favorable and reduce our common stock’s market price.

 

Our amended and restated certificate of incorporation (“Certificate of Incorporation”), and our Bylaws contain provisions that could delay or prevent a change in our Vislink Technology Inc.’s control. These provisions could also make it more difficult for stockholders to elect directors and take other corporate actions. These provisions include:

 

  ● authorizing the Board to issue, without stockholder approval, preferred stock with rights senior to those of our common stock; and
  ● they require advance notification of stockholder nominations and proposals.

 

Also, the provisions of Section 203 of the DGCL govern us. These provisions may prohibit large stockholders, particularly those owning 15% or more of our outstanding voting stock, from merging or combining with us for a specific time without our Board’s consent. These and other provisions in our Certificate of Incorporation and our Bylaws and under Delaware law could discourage potential takeover attempts, reduce the price that investors might be willing to pay in the future for shares of our common stock, and result in the market price of our common stock being lower than it would be without these provisions.

 

We acknowledge material weaknesses in our internal controls and procedures over financial reporting and have determined that our disclosure controls were ineffective. In the future, we may identify additional material weaknesses that may cause us to fail to meet our reporting obligations, including timeliness, or result in material misstatements of our financial statements. If we fail to remediate our material weaknesses or implement adequate controls and procedures for our financial reporting, our ability to accurately and timely report our financial results could be adversely affected, which would likely adversely affect the value of our common stock.

 

Our management is responsible for establishing and maintaining internal controls over financial reporting. Internal control over financial reporting is a process designed by and under the supervision of our principal executive and principal financial officers or persons performing similar functions and effected by our Board, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes under generally accepted accounting principles and includes those policies and procedures that:

 

  ● pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
     
  ● provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements following generally accepted accounting principles and that our receipts and expenditures are being made only by authorizations of its management and board; and
     
  ● provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on its financial statements.

 

Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of our consolidated financial statements will be prevented or detected. Also, projections of any effectiveness evaluation to future periods are subject to the risks that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management evaluated the effectiveness of our internal control over financial reporting and our disclosure controls as of December 31, 2023, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013). In their assessment of the effectiveness of internal control over financial reporting and our disclosure controls as of December 31, 2023 and 2022, respectively, our certifying officers concluded that such controls were ineffective and that there were control deficiencies that constituted material weaknesses because (i) we currently do not employ the appropriate number of accounting personnel to ensure (a) we maintain proper segregation of duties, (b) conduct a tolerable risk assessment, and (ii) we have not adequately documented a complete assessment of the effectiveness of the design and operation of our internal control over financial reporting.

 

23
 

 

We are designing and implementing measures to improve our internal control over financial reporting and disclosure controls to remediate the material weaknesses related to our financial reporting as of December 31, 2023. As a result, until we can remediate this situation, there are no assurances that the material weaknesses in our disclosure controls and procedures and internal control over financial reporting will not result in errors in our financial statements, which could lead to a restatement of those financial statements.

 

We are in the process of affecting the following:

 

  ● additional review procedures within our accounting and finance department,
  ● implementation of application controls in our accounting system, and
  ● implementation of suitable accounting controls and processes.

 

If we cannot conclude on an ongoing basis that we have effective internal control over financial reporting and disclosure controls under Section 404 of the Sarbanes Oxley Act of 2002, in that case, our independent registered public accounting firm may not issue an unqualified opinion or cause us to be untimely concerning our reporting obligations. If we cannot conclude that we have effective internal control over financial reporting and disclosure controls, investors could lose confidence in our reported financial information, which could have a material adverse effect on the trading price of our common stock. Failure to remedy any material weakness in our internal control over financial reporting and disclosure controls or to implement or maintain other effective control systems required of public companies could also restrict our future access to the capital markets. We will not fully correct the identified material weaknesses until the ongoing steps described above are effectively attained and operating efficiently for an appropriate time.

 

Our stock price may be volatile, and you may not be able to resell shares of our common stock at or above the price you paid.

 

Our Common stock trading price could be highly volatile and subject to wide fluctuations in response to various factors, including factors beyond our control. These factors include those discussed in the other “Risk Factors” section of this Report on Form 10-K.

 

Also, the stock markets in general and the markets for telecommunication stocks have experienced volatility. These broad market fluctuations may adversely affect our common stock’s trading price or liquidity. In the past, when the market price was volatile, holders of that stock sometimes instituted securities class action litigation against the issuer. If any of our stockholders were to bring such a lawsuit against us, we could incur substantial costs defending the case, and our management’s attention would be diverted from the operation of our business, which could seriously harm our financial position. Any adverse determination in litigation could also subject us to significant liabilities. 

 

Some companies that have had volatile market prices for their securities have been the target of a hostile takeover or subject to involvement by activist stockholders. If, for any reason, we were to become the target of a hostile takeover attempt or activist campaign, it could result in substantial costs and divert resources and the attention of executive management from our business.

 

Our failure to meet Nasdaq’s continued listing requirements could result in our common stock’s delisting, which could negatively impact its market price and liquidity and our ability to access the capital markets.

 

Any Nasdaq action relating to failure to comply with Nasdaq’s continued listing requirement, including a formal delisting, could hurt the price of our common stock, impair the ability to sell or purchase our common stock when persons wish to do so, and any such delisting action may materially adversely affect our ability to raise capital or pursue strategic restructuring, refinancing or other transactions on acceptable terms, or at all. Delisting or potentially delisting from the Nasdaq Capital Market could also have other negative results, including the potential loss of institutional investor interest and fewer business development opportunities.

 

24
 

 

In the event of any delisting or potential delisting, we may attempt to take action to restore our compliance with Nasdaq’s listing requirements. We cannot assure that any such action taken by us would allow our common stock to remain listed or be re-listed, stabilize the market price or improve the liquidity of our common stock, maintain a minimum closing bid price of $1.00 per share as required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5450(a)(1) or prevent future non-compliance with Nasdaq’s listing requirements. If Nasdaq delists our shares of common stock from trading on its exchange for failure to meet Nasdaq’s listing standards, we and our stockholders could face significant material adverse consequences, including:

 

  ● a limited availability of market quotations for our securities;
  ● reduced liquidity for our securities;
  ● a determination that our common stock is a “penny stock,” which will require brokers trading in our common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;
  ● a limited amount of news and analyst coverage, and
  ● a decreased ability to issue additional securities or obtain additional financing.

 

In addition, the stock market, in general, the Nasdaq Capital Market, and telecommunication companies, in particular, frequently experience extreme price and volume fluctuations unrelated or disproportionate to the operating performance of such companies. Broad market and industry factors, including potentially worsening economic conditions and other adverse effects or developments, may negatively affect the market price of our common stock, regardless of our actual operating performance. Realizing any of the above risks or a broad range of other risks, including those described in this “Risk Factors” section, could have a dramatic and negative impact on the market price of our common stock.

 

If our common stock is delisted from Nasdaq, U.S. broker-dealers may be discouraged from effecting transactions in shares of our common stock because they may be considered penny stocks and thus be subject to the penny stock rules.

 

The SEC has adopted several rules to regulate “penny stock” that restrict transactions involving stock deemed penny stock. Such rules include Rules 3a51-1, 15g-1, 15g-2, 15g-3, 15g-4, 15g-5, 15g-6, 15g-7, and 15g-9 under the Exchange Act. These rules may reduce the liquidity of penny stocks. “Penny stocks” generally are equity securities with a price of less than $5.00 per share (other than securities registered on certain national securities exchanges or quoted on Nasdaq if the exchange or system provides current price and volume information concerning transactions in such securities). Our shares of common stock have in the past constituted, and may again in the future constitute, “penny stock” within the meaning of the rules. The additional sales practice and disclosure requirements imposed upon U.S. broker-dealers may discourage them from effecting transactions in shares of our common stock, which could severely limit the market liquidity of such shares of common stock and impede their sale in the secondary market.

 

A U.S. broker-dealer selling penny stock to anyone other than an established customer or “accredited investor” (generally, an individual with a net worth above $1,000,000 or an annual income exceeding $200,000 or $300,000 together with their spouse) must make a unique suitability determination for the purchaser and must receive the purchaser’s written consent to the transaction before a sale unless the broker-dealer or the transaction is otherwise exempt. Also, the “penny stock” regulations require the U.S. broker-dealer to deliver, before any transaction involving a “penny stock,” a disclosure schedule prepared under SEC standards relating to the “penny stock” market unless the broker-dealer or the transaction is otherwise exempt. A U.S. broker-dealer must also disclose commissions payable to the U.S. broker-dealer, the registered representative, and current quotations for the securities. Finally, a U.S. broker-dealer must submit monthly statements disclosing recent price information concerning the “penny stock” held in a customer’s account and information for the limited market in “penny stocks.”

 

According to the SEC, stockholders should know that the “penny stocks” market has suffered from fraud and abuse patterns in recent years. Such practices include (i) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (ii) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (iii) “boiler room” practices involving high-pressure sales tactics and unrealistic price projections by inexperienced salespersons; (iv) excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and (v) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to the desired level, resulting in investor losses. Our management is aware of the historical abuses in the penny stock market. Although we do not expect to dictate the market’s behavior or broker-dealers who participate, management will strive within the confines of practical limitations to prevent the described patterns from being established concerning our securities.

 

25
 

 

We may face various risks associated with shareholder activists or shareholder demands for better performance.

 

There is no assurance that we will not be subject to shareholder activism or demands. Such activities could interfere with our ability to execute our strategic plan, be costly and time-consuming, disrupt our operations, and divert management and employees’ attention.

 

If securities analysts do not publish research or reports about our business or if they downgrade our common stock or our sector, our common stock price and its trading volume could decline.

 

The research may partly impact the trading market for our common stock and reports that industry or financial analysts publish about us or our business or business sectors. We do not control these analysts. There is no guarantee that analysts will cover our common stock. The lack of research coverage may adversely affect our market price if analysts do not cover our common stock. In addition, some financial analysts may have limited expertise with our model and operations. Furthermore, if one or more of the analysts who do cover our business downgrade our common stock or industry, or the stock of any of our competitors, or publish inaccurate or unfavorable research about our company, the price of our common stock could decline. If one or more of these analysts cease coverage of us or fail to publish reports on it regularly, we could lose visibility in the market, which could cause our stock price or trading volume to decline.

 

General Risk Factors

 

We may fail to meet publicly announced financial guidance or other expectations about our business, which would cause our common stock to decline in value.

 

We may provide preliminary financial results or forward-looking financial guidance to our investors from time to time. Such statements are based on our current views, expectations, and assumptions, and they involve unknown risks and uncertainties that may cause actual results, performance, achievements, or share prices to materially differ from future performance, achievements, or share prices expressed or implied by such statements. Such risks and uncertainties include, among others, changes to the assumptions used to forecast or calculate such guidance or expectations or the occurrence of risks related to our performance and business, including those discussed in these risk factors. Failure to meet financial guidance or expectations regarding our future performance could harm our reputation and cause our stock price to decline.

 

The requirements of being a U.S. public company may strain our resources and divert management’s attention.

 

As a U.S. public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the listing requirements of Nasdaq, and other applicable securities rules and regulations. The Exchange Act requires, among other things, that we file annual and current reports concerning our business and operating results. Compliance with these rules and regulations will increase our legal and financial compliance costs, make some activities more difficult, time-consuming, or costly, and increase demand for our systems and resources.

 

As a result of the disclosure of information filing, our business and financial condition are more visible, which we believe may result in threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business and operating results could be harmed. Even if the claims do not result in litigation or are resolved in our favor, these claims and the time and resources necessary to fix them could divert resources from our management and harm our business and operating results.

 

26
 

 

If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our market, or if they adversely change their recommendations regarding our common stock, our share price and trading volume could decline.

 

The research will influence the trading market for our shares of common stock and reports that industry or securities analysts may publish about us, our business, our market, or our competitors. If any analysts who may cover us change their recommendation regarding our common stock adversely or provide more favorable relative recommendations about our competitors, our share price would likely decline. If any analyst who may cover us were to cease coverage of our Company or fail to publish reports on us regularly, we could lose visibility in the financial markets, which could cause our common stock price or trading volume to decline.

 

Any impairment of goodwill, other intangible assets, or long-lived assets could negatively impact our operations.

 

Our goodwill, other intangible assets, and long-lived assets are subject to an impairment test annually and tested whenever events and circumstances indicate that goodwill, intangible assets, and long-lived assets may be impaired. Any excess goodwill resulting from the impairment test is written off in the determination period. Intangible assets (other than goodwill and indefinite-lived intangible assets) and other long-lived assets are generally amortized or depreciated over the useful life of such assets. From time to time, we may acquire or invest in a business that will require us to record goodwill based on the purchase price and the value of the acquired tangible and intangible assets. We may subsequently experience unforeseen issues with the businesses we acquire, which may adversely affect our anticipated returns or value of the intangible assets and trigger an evaluation of the recoverability of the recorded goodwill and intangible assets. Future determinations of significant write-offs of goodwill, intangible assets, or other long-lived assets due to an impairment test or any accelerated amortization or depreciation of other intangible or long-lived assets could adversely impact our results of operations and financial condition.

 

If our estimates relating to our critical accounting policies are based on assumptions or judgments that change or prove incorrect, our operating results could fall below the expectations of securities analysts and investors, resulting in a decline in our stock price.

 

Preparing financial statements conforming to generally accepted U.S. accounting principles requires our management to make estimates, assumptions, and judgments that affect the amounts reported in the financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue, and expenses that are not readily apparent from other sources. Our operating results may be adversely affected if our assumptions change or circumstances differ from those in our assumptions. This could cause our operating results to fall below the expectations of financial analysts and investors, resulting in a decline in our stock price. Management makes estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include reserves and write-downs related to receivables and inventories, the recoverability of long-lived assets, the valuation allowance relating to our deferred tax assets, the valuation of equity and derivative instruments, and debt discounts, and the valuation of the assets and liabilities acquired by us.

 

Future sales and issuances of our common stock or rights to purchase our common stock, stock incentive plans, and upon the exercise of outstanding securities exercisable for shares of our common stock could result in substantial additional dilution of our stockholders, cause our stock price to fall and adversely affect our ability to raise capital.

 

We will require additional capital to continue to execute our business plan and advance our research and development efforts. If we raise additional capital by issuing additional equity securities and exercising outstanding warrants, our stockholders may experience substantial dilution. We may sell shares of preferred or common stock in one or more transactions at prices that may be at a discount to the then-current market value of our common stock and on other terms and conditions as we determine from time to time. Any such transaction could result in substantial dilution of our existing stockholders. If we sell shares of our common stock in more than one transaction, stockholders who purchase our common stock may be materially diluted by subsequent sales. Such sales could also cause a drop in the market price of our common stock. The issuance of shares of our common stock in connection with public or private financing, in connection with our compensation programs, and upon exercise of outstanding warrants will have a dilutive impact on our other stockholders, and the issuance, or even potential issuance, of such shares, could hurt the market price of our common stock.

 

The exercise of stock options, warrants, and other securities could cause our stockholders to experience substantial dilution. In addition to warrants issued in 2018, 2019, and 2020, in February 2021, we issued warrants to purchase up to 454,546 shares of our common stock. Moreover, holders of our stock options and warrants are likely to exercise them, if ever, when we otherwise could obtain a price for the sale of our securities that is higher than the exercise price per security of the options or warrants. Such exercises, or the possibility of such exercises, may impede our efforts to obtain additional financing by selling additional securities or making such financing more costly. It may also reduce the price of our common stock.

 

Risks Relating to Acquisitions

 

Our business strategy may include acquisitions, a strategy which may entail numerous risks, including the risk of management diversion and increased costs and expenses, all of which could negatively affect the Company’s profitability.

 

Our business strategy may include, among other things, strategic acquisitions, as well as potential opportunistic acquisitions and strategic actions. An acquisition strategy may entail several risks, including diverting management’s attention from other business concerns, the incurrence of substantial legal and other advisory fees, and the potential need to finance such acquisitions with additional equity and/or debt. Once completed, acquisitions, including those we have made over the past several years, may entail additional risks, including unanticipated costs and liabilities of the acquired businesses, including environmental liabilities, that could materially adversely affect our results of operations; increased regulatory compliance relating to the acquired business; difficulties in assimilating acquired businesses, their personnel and their financial reporting systems, which would prevent the expected benefits from the transaction from being realized within the anticipated timeframe; negative effects on existing business relationships with suppliers and customers; and loss of key employees of the acquired businesses. In addition, any future acquisitions could result in the incurrence of additional debt and related interest expense, contingent liabilities, and amortization expense related to intangible assets, which could have a material adverse effect on our business, financial condition, operating results, and cash flows, or the issuance of additional equity, which could dilute our stockholder’s equity interests. There can be no assurance that we can negotiate any acquisitions we may pursue successfully, receive the required approvals for any acquisition, otherwise conclude any acquisition successfully, or that any acquisition will achieve the anticipated synergies or other positive results. Overall, if our acquisition strategy is not successful or if acquisitions are not well integrated into our existing operations, the Company’s profitability, business, and financial condition could be negatively affected.

 

27
 

 

Our acquisition strategy involves several risks.

 

As we engage in the acquisition discussion with other companies anticipating potential acquisition opportunities, including those that would be material or could involve businesses with operating characteristics that differ from our existing business operations, it may become available shortly. We intend to pursue them actively if appropriate acquisition opportunities are available. Acquisitions involve several unique risks, including:

 

  ● failure of the acquired business to achieve expected results, as well as the potential impairment of the acquired assets if operating results decline after acquisition;
  ● diversion of management’s attention;
  ● additional financing, if necessary and available, which could increase leverage and costs, dilute equity, or both;
  ● the potential adverse effect on our financial statements from the increase in goodwill and other intangibles;
  ● difficulties in integrating the operations, systems, technologies, products, and personnel of acquired companies;
  ● initial dependence on unfamiliar supply chains or relatively small supply partners;
  ● the potential loss of key employees, customers, distributors, vendors, and other business partners of the companies we acquire after the acquisition;
  ● the high cost and expenses of identifying, negotiating, and completing acquisitions;
  ● the integration of acquisitions requires significant time and resources, and
  ● risks associated with unanticipated events or liabilities.

 

These risks could adversely affect our business, the operating results, and financial condition. Furthermore, the inability to effectively manage the integration of acquisitions could reduce our focus on subsequent acquisitions and current operations, which, in turn, could negatively impact our earnings and growth.

 

We have faced intense competition for acquisition candidates and expect to continue to meet them, limiting our ability to make acquisitions and leading to higher acquisition prices. We cannot assure you that we can identify, acquire, or manage other businesses profitably or successfully integrate any acquired businesses into our existing business without substantial costs, delays, or other operational or financial difficulties. In future acquisitions, we could incur additional indebtedness or pay consideration above fair value, which could have a material adverse effect on our business, results of operations, and financial condition. 

 

28
 

 

Item 1B. Unresolved Staff Comments

 

None

 

Item 1C. Cybersecurity

 

Risk Management and Strategy

 

Managing Material Risks & Integrated Overall Risk Management

 

We are developing processes, that seek to assess, identify, and manage material risks from cybersecurity threats to the IT systems and information that we create, use, transmit, receive, and maintain. We also seek to integrate these processes and policies into our overall enterprise risk management system and processes. The processes for assessing, identifying, and managing material risks from cybersecurity threats, including threats associated with our use of third-party service providers, include our efforts to identify the relevant assets that could be affected, determine possible threat sources and threat events, assess threats based on their potential likelihood and impact, and identify controls that are in place or necessary to manage and/or mitigate such risks.

 

Engage Third Parties on Risk Management

 

We engage a range of external experts, including consultants, and cybersecurity assessors, who assist us in evaluating and testing our cybersecurity systems and processes. These engagements are intended to give us access to specialized knowledge and insights to inform our cybersecurity strategies and processes, including industry-standard control frameworks and applicable regulations, laws, and standards.

 

Oversee Third-Party Risk

 

We plan to implement and conduct security assessments of all third-party service providers before engagement and maintain ongoing monitoring to ensure compliance with relevant cybersecurity standards.

 

Risks from Cybersecurity Threats

 

We have not experienced any material cybersecurity incidents, and the expenses incurred from any security incidents have been immaterial. However, as discussed under “Risk Factors” in Part I, Item 1A of this Annual Report, cybersecurity threats pose multiple and potentially material risks to us, including potentially to our results of operations and financial condition. We rely extensively on information technology systems and could face cybersecurity risk. As cybersecurity threats become more frequent, sophisticated, and coordinated, it is reasonably likely that we may expend greater resources to continue to modify and enhance protective measures against such security risks.

 

Governance

 

Board of Directors Oversight

 

Our Board of Directors is responsible for exercising oversight of management’s identification and management of, and planning for, risks from cybersecurity threats. While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board’s Audit Committee. The Audit Committee discusses with management not less than annually our significant financial risk exposures, including those related to data privacy, data security, and network security, and management’s program to monitor, assess, and control such exposures, including our risk assessment and risk management policies. The Audit Committee reports to the Board as necessary concerning its activities, including making such reports and recommendations to the Board as it deems necessary and appropriate.

 

29
 

 

Management’s Role in Managing Risk

 

Ben Mann, our Global IT Manager, is responsible for information security, and has 33 years of IT-related work experience. Our Chief Financial Officer leads our management’s efforts to keep the Audit Committee informed regarding on cybersecurity risks and events, and will provide briefings to the Audit Committee on no less than an annual or ad hoc basis when needed. These briefings encompass:

 

  ● evaluation of existing cybersecurity risks;
  ● status of ongoing cybersecurity initiatives and strategies, and
  ● incident reports and learnings from cybersecurity events.

 

Risk Management Personnel

 

Management’s role in assessing, monitoring, and managing our material cybersecurity risks is primarily the responsibility of our Global IT Manager, who reports to our CFO. Both the Global IT Manager and CFO rely on third-party experts, including consultants, and cybersecurity assessors. The Global IT Manager manages vendor work related to cybersecurity and is primarily responsible for the evolving cybersecurity processes and policies, remediating known risks and leading our employee training program, pursuant to which we provide annual privacy and security training for all employees. Our security training incorporates awareness of cyber threats (including but not limited to malware, ransomware, and social engineering attacks), password hygiene, incident reporting processes, and physical security practices. Our management has also developed security policies and processes, including regular system updates and patches, employee training on cybersecurity and privacy requirements, incident reporting, and encryption to secure sensitive information. In addition, we also regularly perform phishing tests on our employees and update our training plan at least annually. We maintain business continuity and disaster recovery capabilities to mitigate interruptions to critical information systems and the loss of data and services from natural or artificial disasters’ effects on our physical operations.

 

Monitor Cybersecurity Incidents

 

The Global IT Manager implements and oversees processes for regularly monitoring our IT systems. This includes deploying security measures to identify potential vulnerabilities. The Global IT Manager runs an incident response plan for a cybersecurity incident. This plan provides actions to mitigate the impact and long-term strategies for remediation and preventing future incidents.

 

Reporting to the Board of Directors

 

The Global IT Manager regularly informs the CFO of cybersecurity risks and incidents. Furthermore, significant cybersecurity matters and strategic risk management decisions would be escalated by the CFO to the Audit Committee and the Board of Directors.

 

30
 

 

Item 2. Properties

 

Mount Olive, NJ

 

On November 1, 2021, the Company entered into a lease agreement with a non-affiliated third party to rent approximately 7,979 square feet of commercial space for general business offices, light manufacturing, operating of a testing laboratory, assembly, and inventory storage in Mount Olive, NJ. The lease commencement date was November 1, 2021, and the expiration date is January 31, 2027. The initial monthly obligation is $10,869, with annual rent increases of 3.0% until the lease expires.

 

Poway, CA

 

Included in the September 14, 2023, acquisition of assets from BMS was a sublease of approximately 11,715 square feet of general office use facilities previously held under a six-month agreement with BMS, with lease responsibilities conveyed to our subsidiary Vislink Poway, LLC. The initial lease term commenced with a monthly rent of approximately $22,300 and concluded on March 13, 2024. On February 12, 2024, Vislink Poway, LLC signed a renewal agreement for the same space. The renewal term is set for one year and ten and a half months, commencing on March 14, 2024, and ending on January 31, 2026. The base rent for the renewal period is established at $22,926 per month.

 

Colchester, U.K.

 

Approximately 2,700 square feet of manufacturing space at the Colchester, U.K. facility were abandoned as part of the Company’s strategic decision to relocate its U.K. manufacturing division to the United States commencing in September 2023, with approximately 13,200 square feet of remaining space. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and we assessed whether the lease “Right of use assets, operating leases” (ROU) assets were impaired. It was determined that approximately $83,000 of the Company’s right-of-use operating assets were impaired.

 

Hemel, United Kingdom

 

Under the original lease agreement dated April 28, 2017, a “break clause” signifying a “break date” of October 28, 2020, sighted the following: the Company may terminate this lease on the “break date” by giving the landlord such notice within six months of the “break date.” At the lease’s commencement, it was not reasonably sure if the Company would exercise its right by the break clause’s date. These measures upheld the determination of the lease’s noncancellable period for adopting ASC 842 on January 1, 2019. The lease term of 22 months as of January 1, 2019, helped calculate the remaining lease payments’ net present value assigned to the right-of-use asset and operating lease liability upon the adoption date. The total annual rent under this lease is approximately $175,000, covering 12,870 square feet of manufacturing and administrative office space. Neither party exercised their unilateral termination rights by the “break date,” triggering a lease extension. Both parties’ inaction creates new enforceable rights and obligations in the extended period, such that the lease agreement had terminated on October 27, 2023.

 

Item 3. Legal Proceedings

 

The nature of our business and activities are such that we may face frequent claims and litigation, including securities litigation, claims regarding patent and other intellectual property rights, and other liability claims. As a result, we may be involved in various legal proceedings from time to time. We are not currently a party to any material litigation, nor are we aware of any pending or threatened litigation against us that we believe, if adversely determined against us, would materially affect our business, operating results, financial condition, or cash flows.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

31
 

 

PART II

 

Item 5. The market for Registrant’s Common Equity Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

Our common stock shares are listed on the Nasdaq Capital Market under “VISL.”

 

Holders

 

As of March 29, 2024, 2,448,482 shares of common stock were outstanding, held by 26 shareholders of record.

 

Our transfer agent and registrar is Continental Stock Transfer & Trust Company, 17 Battery Place, 8th Floor, New York, New York 10004.

 

Dividend Policy

 

We have never declared or paid any cash dividend on our common stock. We intend to retain any future earnings and do not expect to pay any cash dividends in the foreseeable future.

 

Securities Authorized for Issuance under Equity Compensation Plans

 

Reference is made to “Item 12.” Security Ownership of Certain Beneficial Owners and Management” for the information required by this item.

 

Recent Sales of Unregistered Securities

 

None.

 

Item 6. Reserved

 

Not applicable.

 

32
 

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Annual Report on Form 10-K. In addition to historical financial information, the following discussion contains forward-looking statements based on current plans, expectations, and beliefs that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements due to various factors, including but not limited to factors discussed in the “Risk Factors” section and other parts of this Annual Report on Form 10-K.

 

Overview

 

Vislink Technologies, Inc., incorporated in Delaware in 2006, is a global technology business that collects, delivers, manages high-quality, live video and associated data from the action scene to the viewing screen. We provide solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. We also furnish the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The Vislink Technologies, Inc. team also provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in the terrestrial microwave, , fiber optic, surveillance, and wireless communications systems, delivering a broad spectrum of customer solutions.

 

Live Broadcast:

 

We deliver an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, cellular, I.P. (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing A.I. (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, we have the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions that encompass hardware components, hosted systems management platforms, related software licenses and ancillary support services.

 

Industry-wide contributors acknowledge our live broadcast solutions. Our equipment is used to transmit most outside wireless broadcast video content, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Our wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events. 

 

Military and Government:

 

We have developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Our solutions are specifically designed with interagency cooperation, utilizing the internationally recognized I.P. platform and a web interface for video delivery. We provide comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:

 

  ● integrated suites of airborne downlink transmitters, receivers, and antenna systems
  ● data and video connectivity for airborne, marine, and ground assets
  ● UAV video distribution
  ● flexible support for COFDM and bonded cellular/5G Networks
  ● terrestrial point-to-point
  ● tactical mobile command
  ● IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges
  ● high-throughput air/marine/ground-to-anywhere uplink and downlink systems
  ● secure live streaming platforms for use in mobile and fixed assets, and
  ● personal portable products

 

33
 

 

Military and Government (continued):

 

Our public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation for criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.

 

Connected Edge Solutions:

 

Mobile Viewpoint (MVP) offers the hardware and software solutions needed to acquire, produce, contribute to, and deliver video over all private and public networks. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:

 

  ● live video encoding, stream adaptation, decoding, and production solutions,
  ● remote production workflows,
  ● wireless cameras,
  ● AI-driven automated production, and
  ● the ability to contribute video over
    ○ bonded cellular (3G and 4G)
    ○ satellite,
    ○ fiber, and
    ○ emerging networks, including 5G and Starlink

 

Ukraine/Russian Conflict

 

The Ukraine-Russia war increasingly affects economic and global financial markets and exacerbates ongoing economic challenges, including rising inflation and global supply-chain disruption. The degree to which entities are or will be mainly affected depends on the nature and duration of uncertain and unpredictable events, such as further military action, additional sanctions, and reactions to ongoing developments by global financial markets. Because of its broader impact on these macroeconomic conditions, many companies globally may need to consider the war’s effect on specific accounting and financial reporting matters.

 

We do not generate revenue from Russia or Ukraine or have a physical presence, employees, or contractors in these countries. The Russian government’s invasion of Ukraine and the resultant sanctions imposed by the U.S., EU, and other governments and international organizations—designed to inflict severe consequences on the Russian economy—are impacting business continuity, liquidity, and asset values in Ukraine and Russia. It is difficult to estimate the impact of the ongoing invasion on the global economy, including increased inflation and higher energy and transportation costs. As a result, the invasion of Ukraine could adversely impact our financial results. Although we do not presently foresee risks that may affect our Company’s liquidity, operating results, and financial reporting, we continue to monitor developments in Ukraine to assess material adverse effects on our business, financial condition, or results of operations.

 

Israel-Hamas Conflict

 

The conflict between Israel and Hamas affects regional stability and potentially influences global economic and financial markets. While our Company has no direct operations or revenue from the affected regions, the conflict’s implications, such as energy price fluctuations and supply chain disruptions, could indirectly impact our business.

 

The situation’s uncertainty, marked by potential military escalations and sanctions, poses risks to market conditions. We monitor these developments for indirect effects on our costs, operations, and financial health. We do not foresee material adverse impacts on our liquidity or financial results but remain alert to the conflict’s evolving nature and global economic implications.

 

34
 

 

Climate Change-Related Effects

 

Climate change is an important global issue that presents opportunities and challenges for us, our partners, and our communities. It matters to us and will likely be driven by changes in physical climate parameters, regulations, public policy, technology, and product demand.

 

The lack of empirical data surrounding the credit and other financial risks posed by climate change renders it impossible to predict how specifically climate change may impact our financial condition and results of operations; however, the physical effects of climate change may also directly affect us. The global business community has increased its political and social awareness surrounding the issue, and the United States has entered into international agreements to reduce global temperatures, such as reentering the Paris Climate Accords. Further, the U.S. Congress, state legislatures, and federal and state regulatory agencies continue to propose numerous initiatives to supplement the global effort to combat climate change.

 

Further, the effects of climate change may negatively impact regional and local economic activity, which could adversely affect our customers and the communities in which we operate. In addition, advocacy groups and the general public are growing concerned that greenhouse gas emissions and other human activities have caused or will cause significant changes in weather patterns and temperatures and the frequency and severity of natural disasters.

 

While we seek to mitigate the risks associated with climate change, we recognize inherent climate-related risks regardless of where we conduct our businesses. Any of our locations may be vulnerable to the adverse effects of climate change. Climate-related events can disrupt our business, including our customers, and cause us to experience higher attrition, losses, and additional costs to resume operations.

 

Income Taxes

 

Under Section 382 of the Internal Revenue Code of 1986, as amended, or the “Code,” a corporation that undergoes an “ownership change” is, generally, a greater than 50 percentage point change in our equity ownership by certain stockholders or groups of stockholders and would be subject to limitations on its ability to use its pre-change net operating losses (“NOLs”) to offset future taxable income. Similar rules may apply under state tax laws. We have undergone ownership changes in the ordinary course of business, which have limited our ability to utilize these NOLs in the future. For these reasons, we believe it is likely that these NOLs may not be able to be realized and would thus expire. A full valuation allowance has been recorded against the entire NOL balance.

 

35
 

 

Results of Operations

 

The following table sets forth the items in the consolidated statements of operations and comprehensive loss of the financial statements included herewith for the fiscal years ended December 31, 2023, and 2022 (in thousands).

 

   For the Years Ended 
   December 31, 
   2023   2022 
         
Revenue, net  $27,482   $28,131 
           
Cost of revenue and operating expenses          
           
Cost of components and personnel   13,380    15,204 
Inventory valuation adjustments   487    2,930 
General and administrative expenses   19,376    18,195 
Research and development   3,493    4,058 
Impairment of right-of-use assets   83    88 
Amortization and depreciation   1,261    1,722 
Total cost of revenue and operating expenses   38,080    42,197 
           
Loss from operations   (10,598)   (14,066)
           
Other income (expenses)          
Unrealized gains on investments held to maturity   68    — 
Realized loss on redemption of investments   (82)   — 
Gain on settlement of debt   —    46 
Other income   332    303 
Dividend income   375    — 
Interest income (expense), net   560    (38)
Total other income   1,253    311 
           
Net loss before income taxes  $(9,345)  $(13,755)

 

Revenue

 

For the fiscal year ending December 31, 2023, revenue decreased to $27.5 million from $28.1 million in the prior year. This approximate 2% decrease is primarily due to market and operational influences, including shifting consumer preferences that led to diminished demand for specific products and global economic conditions that curtailed expenditures by our telecommunications customers, directly affecting the company’s revenue streams.

 

In 2023, our efforts concentrated on strengthening our key capabilities, focusing on the Military/Government (Mil/Gov) sector. Several operational changes and strategic integrations demonstrated our commitment to enhancing our product range and customer engagement methods. A significant move in this direction was relocating our UK manufacturing division from Colchester, UK, to the United States. We believe this move will help to boost our manufacturing efficiency, decrease operational expenses, and strengthen our position in the global marketplace.

 

36
 

 

Cost of Revenue and Operating Expenses

 

Cost of Components and Personnel

 

In the fiscal year ending December 31, 2023, our cost of components and personnel decreased to $13.4 million from $15.2 million in the previous year, a reduction of $1.8 million or 12%. This reduction directly results from streamlining our product offerings by discontinuing several underperforming product lines.

 

The relocation of our Colchester, UK manufacturing division to the United States is also expected to decrease operational expenses by centralizing manufacturing operations within the United States.

 

The combined impact of these strategic decisions—streamlining product lines and relocating manufacturing operations—demonstrates our commitment to operational excellence and financial prudence. These measures are expected to contribute to a leaner cost structure and position us to capitalize on more profitable opportunities, thereby enhancing shareholder value in the long term.

 

Inventory Valuation Adjustments

 

In the fiscal year ending December 31, 2023, inventory valuation adjustments amounted to $0.5 million, a substantial decrease from $2.9 million in the prior year. This 83% was due to reduction initiatives to streamline our product portfolio and enhance operational efficiencies.

 

General and Administrative Expenses

 

In the fiscal year ending on December 31, 2023, our general and administrative expenses increased to $19.4 million from $18.2 million in the prior year. This escalation of $1.2 million, equivalent to a 7% rise, reflects the Company’s strategic initiatives to promote future growth and expand its operational capacity. The increase includes a $0.4 million rise in rent and utilities, reflecting our expansion into more efficient and strategically located facilities to support our operations.

 

The expense increase also reflects an additional $0.4 million in professional fees and consulting and $0.3 million each in enhancing external services and warranty provisions. The period also reflects an increase of $0.3 million in stock-based compensation and an increase of $0.2 million in allowances for bad debts.

 

Offsetting these increases, we spent $0.4 million less on freight and postage and $0.2 million less on advertising, salaries, and benefits. These reductions were attributable to our ongoing efforts to realign our marketing strategies and optimize logistics and distribution channels to achieve greater operational efficiency and effectiveness.

 

Research and Development

 

For the fiscal year ending December 31, 2023, we reported research and development expenses of $3.5 million, a decrease from $4.1 million in the previous year. This reduction of $0.6 million, or 15%, primarily reflects a realignment of our research and development investments towards more targeted and potentially high-impact projects. The decrease includes a $0.3 million in compensation expenses due to lower staffing. These results include a $0.3 million decrease in miscellaneous research and consulting fees.

 

Despite the reduction in overall R&D expenditure, we continue to invest in crucial areas of technological development, including advanced communication solutions and next-generation broadcast technologies. These investments are critical to sustaining our leadership in delivering high-quality live video and associated data capture solutions.

 

Amortization and Depreciation

 

For the fiscal year ending December 31, 2023, our reported amortization and depreciation expenses were $1.3 million, a 24% decrease from $1.7 million in the previous year. This decrease was primarily due to a reduction in the net book value of intangible assets.

 

Net Loss

 

The decrease in net losses before income taxes from $13.8 million in 2022 to $9.3 million in 2023, representing a 33% reduction, can be attributed to our efforts in seeking to enhance operational efficiency, reduce costs, and optimize our product portfolio. These strategic measures, including discontinuing underperforming product lines and relocating our UK manufacturing division to the United States, contributed to the reduction in net loss.

 

37
 

 

Liquidity and Capital Resources

 

For the fiscal year ending December 31, 2023, we incurred an operational loss of approximately $10.6 million and utilized $9.7 million in cash for operating activities. As of December 31, 2023, we had $8.5 million in cash and an investment in Federal bonds (Federal National Mortgage Association and HSBC bonds) valued at $5.7 million.

 

Developments, including those beyond our control, may cause us to consume our available capital more quickly than we expect. These include potential economic conditions, including inflation, foreign exchange fluctuations, the markets we compete in or wish to enter, strategic acquisitions, our market strategy, research and development activities, regulatory matters, and technology and product innovations. We believe we will have sufficient funds to continue our operations for at least 12 months from the date of filing these financial statements in our Annual Report.

 

Our cash balances were as follows (in thousands):

 

   For the Years Ended
December 31,		 
   2023   2022 
Cash  $8,482   $25,627 

 

Cash Flows

 

The following table sets forth the significant components of our consolidated statements of cash flow data for the periods presented (in thousands).

 

   For the Years Ended 
   December 31, 
   2023   2022 
         
Net cash used in operating activities  $(9,748)  $(9,419)
Net cash used in investment activities   (6,700)   (466)
Net cash provided by financing activities   (607)   (765)
Effect of exchange rate changes on cash   (90)   46 
           
Net decrease in cash  $(17,145)  $(10,604)

 

Operating Activities

 

During the fiscal year ending December 31, 2023, the Company reported net cash outflows from operating activities totaling approximately $9.7 million. This was primarily due to a $2.7 million increase in accounts receivable and a $2.3 million rise in inventory, both efforts aimed at enhancing our market position and preparing for expected demand. These increases were partially offset by the recognition of $1.9 million in stock-based compensation, $1.3 million in depreciation and amortization expenses, and a net loss of $9.1 million.

 

During the fiscal year ending December 31, 2022, the Company recorded approximately $9.2 million in net cash outflows for operating activities. This was mainly due to a reduction of $3.2 million in accounts receivable, $2.1 million in prepaid expenses and other current assets, and $1.8 million in accrued fees and interest expenses. These outflows were partially balanced by a $3.7 million increase in inventory. Moreover, the Company reported a net loss of $13.5 million, which included $1.8 million in inventory impairment, $1.7 million in depreciation and amortization, and $1.1 million in adjustments to inventory valuation.

 

38
 

 

Investing Activities

 

During the year ending December 31, 2023, the Company recorded approximately $6.7 million in net cash used for investing activities to strengthen its asset portfolio via investments and acquisitions. These expenditures entailed an allocation of $15.5 million towards government bond investments, augmented by specific investments in property and equipment valued at $0.7 million and the strategic BMS asset acquisition for $0.3 million. These outlays were offset by $9.7 million received from redeeming a portion of the government bond investments.

 

During the year ending December 31, 2022, the Company recorded approximately $0.5 million in net cash for investing activities, mainly purchasing furniture and computer equipment.

 

Financing Activities

 

In the year ending December 31, 2023, the Company recorded approximately $0.6 million in net cash for financing activities, mainly due to principal payments on the Company’s Directors and Officers (D&O) insurance policy.

 

During the year ending December 31, 2022, the Company recorded approximately $0.8 in net cash used for financing activities, which was principally attributable to the principal payments of $0.8 on the Company’s Directors and Officers (D&O) insurance policy.

 

Nasdaq Compliance

 

On January 11, 2023, we held a special meeting of stockholders (the “Special Meeting”), at which stockholders approved a proposal to authorize the Board, at its discretion but before the one-year anniversary of the date of the Special Meeting, to implement an amendment to our certificate of incorporation to effect a reverse stock split of all of the outstanding shares of common stock, at a ratio in the range of 1-for-2 to 1-for-50.

 

On May 1, 2023, we effected a 1-for-20 reverse stock split (the “Reverse Stock Split”). Upon its effectiveness, every 20 shares of outstanding common stock decreased to one share of common stock. We have retroactively applied the Reverse Stock Split throughout this Annual Report to all periods presented.

 

Off-Balance Sheet Arrangements

 

We had no off-balance sheet arrangements for December 31, 2023, and 2022.

 

39
 

 

Critical Accounting Policies, Estimates, and Judgments

 

Our consolidated financial statements are prepared under U.S. GAAP, which requires us to make estimates, judgments, and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These policies influence our most significant accounts and require an understanding of highly uncertain matters or the susceptibility of such matters to change. We consider our policies on business combinations, asset acquisitions, use of estimates, risks, and uncertainties, revenue recognition, leases, stock-based compensation, impairment and abandonment, and income taxes as critical due to their significance to our financial statements and the degree of judgment involved in their application.

 

Business Combinations and Asset Acquisitions

 

The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.

 

The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets. Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.

 

The distinction between business combinations and asset acquisitions involves judgment, particularly when applying the screen test to determine the nature of the transaction. Incorrect judgments or changes in decisions in these areas could materially affect the determination of goodwill, the recognition and measurement of acquired assets and assumed liabilities, and, consequently, our financial position and results of operations.

 

Principles of Consolidation

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the Company’s accounts and wholly-owned subsidiaries. We have eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.

 

Segment Reporting

 

The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.

 

40
 

 

Critical Accounting Policies, Estimates, and Judgments (continued)

 

Use of Estimates

 

Preparing the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Changes in the assumptions or conditions underlying our estimates could lead to material adjustments in our financial statements, affecting our reported financial position and results of operations. Actual results could differ from estimates, and any such differences may be material to our consolidated financial statements.

 

Risks and Uncertainties

 

The Company operates in a dynamic global environment significantly influenced by various geopolitical events, including the ongoing conflict in the Gaza Strip between Israel and Hamas. This situation, the Russian-Ukraine war, and the COVID-19 pandemic contribute to an uncertain economic landscape. These events have led to widespread economic repercussions, such as an inflationary environment, currency fluctuations, supply chain disruptions, and global labor market shifts.

 

Our management team is responsible for carefully evaluating and responding to the uncertainties brought about by these geopolitical and global health events. This involves adjusting our financial statements to accurately reflect the current economic and geopolitical environment. In formulating our financial estimates, we draw upon various sources, including historical experiences, external market data, and economic forecasts.

 

While we are proactively taking steps to mitigate the impacts of these challenging and unpredictable conditions, including the current global conflicts, there is an inherent uncertainty in the efficacy of these measures. We are committed to continuously monitoring these situations to gauge their direct and indirect effects on our business operations, financial stability, and performance outcomes. The evolving nature of these global events may lead to changes in our accounting estimates and assumptions, requiring ongoing vigilance and adaptation.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

On January 1, 2023, the Company adopted Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments. The Company extends credit to its customers in the ordinary course of business and has applied the new standard in evaluating estimated losses through an allowance for doubtful accounts. The Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

 

Inventories

 

Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.

 

41
 

 

Critical Accounting Policies, Estimates, and Judgments (continued)

 

Investment in Debt Securities

 

Vislink Technologies, Inc. invests in government bonds with the intent and ability to hold these investments until maturity. In alignment with ASC Topic 320, Investments—Debt and Equity Securities, such investments are classified as “Held-to-Maturity” (HTM) securities and are measured at amortized cost.

 

  ● Classification: The Company classifies its investments in government bonds as “Held-to-Maturity” (HTM) securities based on management’s intent and ability to hold the securities to maturity. These HTM securities are recognized in the Company’s financial statements at their amortized cost, adjusted for the amortization of premiums and accretion of discounts to maturity.
  ● Measurement: HTM securities are initially recognized at their acquisition cost, including transaction costs. Subsequently, they are measured at amortized cost using the effective interest method. This method considers the amortization of any discount or premium on the acquisition cost until maturity.
  ● Interest Income: Interest income is accrued using the security’s effective yield, reflecting the time value of money.
  ● Amortization of Discount and Premium: The amortization of the discount (or accretion of the premium) is included as part of the interest income recognized in the income statement, reflecting the adjustment to the investment’s yield.
  ● Impairment: The Company periodically assesses HTM investments for impairment if objective evidence indicates an impairment has been incurred. It recognizes any loss when the present value of estimated future cash flows, discounted at the original effective interest rate, is less than the carrying amount.
  ● Derecognition: A Held-to-Maturity investment is removed from the balance sheet when the right to receive cash flows has expired, or the Company has substantially transferred all ownership risks and rewards.

 

Property and Equipment

 

Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from 1 to 14 years. The costs of the day-to-day servicing of property and equipment, as well as repairs and maintenance, are recognized in the expenses as incurred.

 

Intangible Assets

 

Patents and licenses:

 

Patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s balance sheet and amortized on a straight-line basis over their estimated useful lives of 18.5 to 20 years. Amortization totaled approximately $-0- and $0.5 million for the years ended December 31, 2023, and 2022, respectively.

 

Other intangible assets:

 

The Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink Technologies, Inc., Mobile Viewpoint Corporate B.V. (“MVP”), and the assets of BMS. The Company amortizes intangible asset costs over their useful lives of 3 to 15 years with its net book value reported on the balance sheet. Amortization totaled approximately $1.0 million each for the years ended December 31, 2023, and 2022, respectively.

 

42
 

 

Critical Accounting Policies, Estimates, and Judgments (continued)

 

Revenue Recognition

 

We account for the Company’s operating results under ASC Topic 606, adopted on January 1, 2019. This comprehensive revenue recognition model requires recognition when the Company transfers control of the promised goods or services to our customers at an amount that reflects the consideration we expect to receive. The application of ASC Topic 606 requires us to use more judgment and make more estimates than under previously issued guidance. Variations in judgments or assumptions about performance obligations or transaction prices could materially affect the timing and amount of revenue recognized, impacting our financial results.

 

The Company generates all its revenue from contracts with customers. We recognize revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration we expect to receive in exchange for those services.

 

The Company determines revenue recognition through the following steps:

 

1. identification of the contract, or contracts, with a customer.

2. identification of the performance obligations in the contract.

3. determination of the transaction price.

4. allocation of the transaction price to the performance obligations in the contract; and

5. recognition of revenue when, or as, we satisfy a performance obligation.

 

At contract inception, the Company assesses the goods and services promised in our customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges we collect concurrent with revenue-producing activities are excluded from income.

 

Remaining Performance Obligations:

 

The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.

 

Leases

 

We determine if an arrangement is a lease at inception. We recognize lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets, such as “Right of use assets, operating leases,” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. We recognize Operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all our real estate contracts. Changes in lease term or discount rate assumptions could materially affect our ROU assets, lease liabilities, and lease expense recognition.

 

There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2023. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of our leases do not provide an implicit rate, we determined our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.

 

43
 

 

Critical Accounting Policies, Estimates, and Judgments (continued)

 

Stock-Based Compensation

 

The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date. Variations in these assumptions could significantly affect the fair value of stock-based awards, impacting our compensation expense and equity.

 

The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from non-employees. The measurement date for equity-classified non-employee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of non-employee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the non-employee share-based payment awards with performance conditions and accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the non-employee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for non-employee awards.

 

Stock-Option Awards — Time-Based and Performance-Based

 

Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For non-employee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.

 

The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.

 

Restricted Stock Unit Awards (“RSUs”) — Time-Based

 

Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.

 

Restricted Stock Unit Awards (“RSUs”) — Performance-Based

 

The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.

 

44
 

 

Critical Accounting Policies, Estimates, and Judgments (continued)

 

Impairment and Abandonment

 

We evaluate the impairment of long-lived assets and the abandonment of leased assets, requiring judgments about future cash flows, asset utilization, and market conditions. Changes in market conditions or our operational strategy could lead to impairment or abandonment charges, materially affecting our financial condition and results of operations.

 

Right-Of-Use Operating Lease Abandonment:

 

Approximately 2,700 square feet of manufacturing space at the Colchester, UK facility were abandoned as part of the Company’s strategic decision to relocate its UK manufacturing division to the United States commencing in September 2023. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and the Company assessed whether the lease ROU assets were impaired. It was determined that approximately $0.1 million of the Company’s right-of-use operating assets were impaired.

 

Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The location’s economic environment precluded subletting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment.

 

For the years ending December 31, 2023, and 2022, the Company recognized a loss on impairment of ROU assets of approximately $0.1 million each.

 

Commitments and Contingencies

 

Unless otherwise disclosed in this Report, we have no material commitments or contingent liabilities.

 

Foreign Currency and Other Comprehensive (Gains) Losses

 

We record gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. We have two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2023, and 2022, respectively. We included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.

 

Transaction gains and losses are recognized in our operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying Consolidated Statements of Operations.

 

Income Taxes

 

Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expenses and penalties as general and administrative expenses.

 

Changes in tax laws, our operations, or our assessment of future taxable income could materially affect our income tax provision, deferred tax assets, and liabilities.

 

45
 

 

Critical Accounting Policies, Estimates, and Judgments (continued)

 

Recently Issued Accounting Pronouncements

 

Recently Issued Accounting Standards Adopted and Not Yet Adopted

 

Adopted:

 

On January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable. The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

 

Not yet adopted:

 

In February 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280). This update revises the reporting requirements for operating segments of public entities, aiming to enhance the transparency and usefulness of segment reporting. As of the date of these financial statements, we have not formally adopted ASU 2023-07, which becomes effective for public entities for reporting periods beginning after December 15, 2023. However, it is essential to note that our Company operates as a single reporting segment. Due to this structure, we inherently meet the updated disclosure requirements of ASU 2023-07 without the need for additional segment-specific information. Our current operating segment structure aligns with the objectives of the new standard, emphasizing explicit and meaningful segment reporting. We have assessed that there will be no significant impact on our financial statements upon adopting ASU 2023-07. We will continue to monitor any further guidance FASB provides and ensure compliance with the reporting standards. As we formally adopt ASU 2023-07, we remain committed to transparency and clarity in our financial reporting. Our subsequent financial statements will provide further updates regarding compliance with this and other accounting standards.

 

In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-09, enhancing transparency in income tax disclosures. This ASU applies to entities under Topic 740, requiring detailed rate reconciliation and disclosures of taxes paid. It mandates public business entities to disclose rate reconciliation categories annually and specifies a quantitative threshold for reconciling items. Other entities must provide qualitative disclosures. The update is effective for public business entities for annual periods beginning after December 15, 2024, and other entities after December 15, 2025, with early adoption permitted. The Company is evaluating the impact of ASU 2023-09 on its financial statements and will provide updates, if necessary, alongside other accounting standards in future financial statements.

 

Recent Accounting Pronouncements

 

Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC, did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

 

There is no requirement to include the disclosures required under Item 7A as a smaller reporting company under SEC rules.

 

Item 8. Financial Statements and Supplementary Data

 

The Company’s audited financial statements and notes appear in this report beginning on page F-1.

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

46
 

 

Item 9A. Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures designed to ensure that the disclosure of required information in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information requiring disclosure in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer (our “Certifying Officers”), to allow timely decisions regarding required disclosure.

 

Management’s assessment of our design and operation of disclosure controls is ongoing. Based on the evaluation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of December 31, 2023, our Certifying Officers have concluded that, as of December 31, 2023, our disclosure controls and procedures were not adequate at the reasonable assurance level, due to material weaknesses in internal control over financial reporting, as described below.

 

(b) Management’s Report on Internal Control over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our Certifying Officers, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes under GAAP. Our internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance (a) that transactions are recorded as necessary to permit preparation of financial statements under GAAP, (b) that our receipts and expenditures are being made only following authorizations of our management and directors; and (3) provide reasonable assurance regarding the prevention or timely detection of the unauthorized acquisition, use or disposition of assets that could have a material effect on our consolidated financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any effectiveness evaluation in future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

 

As required by Rule 13a-15(c) under the Exchange Act, our Certifying Officers evaluated the effectiveness of our internal control over financial reporting as of December 31, 2023, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013). In their assessment of the effectiveness of internal control over financial reporting as of December 31, 2023, management concluded that such control was ineffective and that there were control deficiencies that constituted material weaknesses because (i) we currently do not employ the appropriate number of accounting personnel to ensure (a) we maintain proper segregation of duties, (b) conduct a tolerable risk assessment, and (ii) we have not adequately documented a complete assessment of the effectiveness of the design and operation of our internal control over financial reporting.

 

Notwithstanding the identified material weakness as of December 31, 2023, management, including the Certifying Officers, believe that the condensed consolidated financial statements contained in this Annual Report filing reasonably present, in all material respect, our financial condition, results of operations, and cash flows for the fiscal period presented in conformity with GAAP.

 

(c) Changes in Internal Controls over Financial Reporting

 

Although we have continued our remediation efforts in connection with identified material weaknesses, the material weakness, as discussed above, has yet to be fully remediated. As we remediate the material weakness in our internal controls, we made changes to our internal controls, including changes to enhance the supervisory review of our accounting procedures.

 

(d) Auditor’s Report on Internal Control over Financial Reporting

 

This Annual Report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. According to SEC rules, management reports were not subject to attestation by our registered public accounting firm, which permits us to provide only management reports on internal control over financial reporting in this Annual Report.

 

Item 9B. Other Information

 

On March 29, 2024, our Compensation Committee and our Board of Directors approved incentive target bonus goals and objectives for 2024 for Carleton Miller, our Chief Executive Officer, and Michael Bond, our Chief Financial Officer. Mr. Miller’s standard target annual bonus opportunity is equal to up to 100% of his annual base salary and up to 200% of his annual base salary for maximum performance. Under Mr. Bond’s employment offer letter, his standard target annual bonus opportunity is equal to up to 50% of his annual base salary and up to 100% of his annual base salary for maximum performance. These bonuses will subject to the following:

 

  ● A maximum payout of 20% per quarter of the annual standard targeted bonus opportunity for Q1 and Q2 2024, respectively;
  ● A maximum payout of 30% per quarter of the annual standard targeted bonus opportunity for Q3 and Q4 2024 respectively; and
  ● The potential maximum performance bonus opportunities will be considered in connection with the review of our audited financial results for 2024 by our Board of Directors and our Audit Committee.

 

Payment of the quarterly and year-end bonuses are at the discretion of the Compensation Committee and the Board of Directors taking into account achievement of specific quarterly and annual financial performance measures and operational and strategic goals and objectives. All such bonuses are subject to our Clawback Policy.

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

None.

 

47
 

 

PART III

 

Item 10. Directors, Executive Officers, and Corporate Governance

 

The information required by Item 10 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2024 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

Item 11. Executive Compensation

 

The information required by Item 10 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2024 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management

 

The information required by Item 12 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2024 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

The information required by Item 13 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2024 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

Item 14. Principal Accountant Fees and Services

 

The information required by Item 14 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2024 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

48
 

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules

 

(a) The following documents are filed as part of this Report:

 

  (1) Financial Statements:

 

The audited consolidated balance sheets of the Company as of December 31, 2023, and 2022, the related consolidated statements of operations and comprehensive loss, changes in stockholders’ equity and cash flows for each of the two years in the period ended December 31, 2023, the footnotes to it, and the report of Marcum LLP, independent registered public accountants, are filed herewith.

 

  (2) Financial Schedules:

 

None.

 

Financial statement schedules have been omitted because they are not applicable, or the required information is included in the financial statements or notes.

 

  (3) Exhibits:

 

The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Report.

 

(b) The following are exhibits to this Report, and, if incorporated by reference, we have indicated the document previously filed with the SEC in which the exhibit was included.

 

Certain agreements filed as exhibits to this Report contain representations and warranties by the parties to the agreements made solely for the agreement’s benefit. These representations and warranties:

 

  ● may have been qualified by disclosures that were made to the other parties in connection with the negotiation of the agreements, which disclosures are not necessarily reflected in the contracts;
  ● may apply standards of materiality that differ from those of a reasonable investor; and
  ● were made only as specified dates in the agreements and subject to subsequent developments and changed circumstances.

 

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date that these representations and warranties were made or at any other time. Investors should not rely on them as statements of fact.

 

49
 

 

Exhibit
Number		   Description of Exhibit
3.1(i)   Amended & Restated Certificate of Incorporation, incorporated by reference to the Company’s Registration Statement on Form S-1 No. 333-191867, as filed with the Commission on October 23, 2013.
3.1(i)(a)   Amendment to Certificate of Incorporation, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on June 13, 2014.
3.1 (i)(b)   Amendment to Certificate of Incorporation, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on July 20, 2015.
3.1(i)(c)   Amended and Restated Certificate of Designation of Series B Convertible Preferred Stock, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on February 10, 2016.
3.1(i)(d)   Certificate of Designation of Series C Convertible Preferred Stock, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on February 26, 2015.
3.1(i)(e)   Certificate of Designation of Series D Convertible Preferred Stock, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on April 27, 2016.
3.1(i)(f)   Certificate of Designation of Series E Convertible Preferred Stock, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on December 27, 2016.
3.1(i)(g)   Certificate of Designation of the Series A Preferred Stock of the Company, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on November 9, 2022.
3.1(i)(h)   Certificate of Elimination for Series C Convertible Preferred Stock, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on February 10, 2016.
3.1(i)(i)   Certificate of Elimination for Series B Convertible Preferred Stock, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on December 7, 2016.
3.1(i)(j)   Certificate of Elimination for Series D Preferred Stock of the Company, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on November 9, 2022.
3.1(i)(k)   Certificate of Elimination for Series E Preferred Stock of the Company, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on November 9, 2022.
3.1(i)(l)   Certificate of Elimination for Series A Preferred Stock of the Company, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on March 27, 2023.
3.1(i)(m)   Amendment to Certificate of Incorporation, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on June 20, 2016.
3.1(i)(n)   Certificate of Amendment to Certificate of Incorporation of the Company, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on February 26, 2019.
3.1(i)(o)   Certificate of Amendment to the Certificate of Incorporation of the Company, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on August 5, 2020.
3.1(i)(p)   Certificate of Amendment to the Certificate of Incorporation, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on April 28, 2023.
3.1(ii)   Third Amended & Restated Bylaws, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on August 20, 2021.
4.1   Form of Common Stock Certificate of the Registrant, incorporated by reference to the Company’s Amendment to the Registration Statement on Form S-1 No. 333-187094, as filed with the Commission on May 21, 2013.
4.2   Warrant Agreement, including Form of Common Warrant and Form of Pre-Funded Warrant from July 2019 Offering, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on July 16, 2019.
4.3*   Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.

 

50
 

 

Exhibit
Number		   Description of Exhibit
10.1   2023 Omnibus Equity Incentive Plan, incorporated by reference to the Company’s Registration Statement on Form S-8 No. 333-274366, as filed with Commission on September 6, 2023.
10.2   Employment Agreement by and between the Company and Carleton M. Miller, incorporated by reference to the Company’s Amendment to the Current Report on Form 8-K, as filed with the Commission on January 25, 2020
10.3   Notice of Grant of Stock Option for Time-Vested Options and Stock Option Agreement by and between the Company and Carleton M. Miller, incorporated by reference to the Company’s Amendment to the Current Report on Form 8-K, as filed with Commission on January 25, 2020
10.4   Notice of Grant of Stock Option for Performance-Vested Options and Stock Option Agreement by and between the Company and Carleton M. Miller, incorporated by reference to the Company’s Amendment to the Current Report on Form 8-K, as filed with Commission on January 25, 2020
10.5   Offer Letter by and between the Company and Michael Bond, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on January 17, 2024.
10.6   Inducement RSU Award Agreement between the Company and Michael Bond, incorporated by reference to the Company’s Current Report on Form 8-K, as filed with Commission on January 17, 2024.
10.7   Form of Indemnification Agreement by and between the Company and its officers and directors, incorporated by reference to the Company’s Annual Report on Form 10-K for the period ended December 31, 2019, as filed with the Commission on April 1, 2020-.
10.8   Non-Employee Director Compensation Policy, incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2020 as filed with the Commission on November 12, 2020.
10.9   Form of Non-Employee Director Restricted Shares Agreement, incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2020 as filed with the Commission on November 12, 2020.
14.1   Code of Ethics, incorporated by reference to the Company’s Annual Report on Form 10-K for the period ended December 31, 2013, as filed with the Commission on March 6, 2014.
21.1*   List of Subsidiaries
23.1*   Consent of Marcum LLP
31.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
97.1*   Clawback Policy
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Schema
101.CAL   Inline XBRL Taxonomy Calculation Linkbase
101.DEF   Inline XBRL Taxonomy Definition Linkbase
101.LAB   Inline XBRL Taxonomy Label Linkbase
101.PRE   Inline XBRL Taxonomy Presentation Linkbase
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

51
 

 

SIGNATURES

 

Pursuant to the requirement of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  VISLINK TECHNOLOGIES, INC.
     
Date: April 3, 2024 By: /s/ Carleton M. Miller
    Carleton M. Miller
   

Chief Executive Officer

(Duly Authorized Officer and Principal Executive Officer)

     
Date: April 3, 2024 By: /s/ Michael C. Bond
    Michael C. Bond
   

Chief Financial Officer

(Duly Authorized Officer and Principal Financial Officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Carleton M. Miller   Chief Executive Officer   April 3, 2024
Carleton M. Miller   (Principal Executive Officer)    
         
/s/ Michael C. Bond   Chief Financial Officer   April 3, 2024
Michael C. Bond   (Principal Financial and Accounting Officer)    
         
/s/ Susan G. Swenson   Chairman of the Board of Directors   April 3, 2024
Susan G. Swenson        
         
/s/ Jude T. Panetta   Director   April 3, 2024
Jude T. Panetta        
         
/s/ Ralph E. Faison   Director   April 3, 2024
Ralph E. Faison        
         
/s/ Brian K. Krolicki   Director   April 3, 2024
Brian K. Krolicki        

 

52
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

December 31, 2023, and 2022

 

    Page
Consolidated Financial Statements    
Report of Independent Registered Public Accounting Firm (PCAOB ID Number 688)   F-2
Consolidated Balance Sheets   F-3
Consolidated Statements of Operations and Comprehensive Loss   F-4
Consolidated Statements of Changes in Stockholders’ Equity   F-5
Consolidated Statements of Cash Flows   F-6
Notes to Consolidated Financial Statements   F-8

 

F-1
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of

Vislink Technologies, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Vislink Technologies, Inc. (the “Company”) as of December 31, 2023 and 2022, the related consolidated statements of operations, comprehensive loss, change in stockholders’ equity and cash flows for each of the two years in the period ended December 31, 2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2023 and 2022, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our commitment is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

 

/s/ Marcum LLP  
   
Marcum LLP  
   
We have served as the Company’s auditor since 2015  
   
New York, NY  
April 3, 2024  

 

F-2
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS, EXCEPT SHARE DATA)

 

       
   December 31, 
   2023   2022 
ASSETS          
Current assets          
Cash  $8,482   $25,627 
Accounts receivable, net   8,680    6,007 
Inventories, net   14,029    12,021 
Investments held to maturity   5,731    — 
Prepaid expenses and other current assets   1,560    1,232 
Total current assets   38,482    44,887 
Right of use assets, operating leases   742    1,075 
Property and equipment, net   1,902    1,434 
Intangible assets, net   3,866    4,400 
Total assets  $44,992   $51,796 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities          
Accounts payable  $3,183   $2,626 
Accrued expenses   1,578    1,568 
Notes payable   —    84 
Operating lease obligations, current   463    455 
Customer deposits and deferred revenue   1,490    1,540 
Total current liabilities   6,714    6,273 
Operating lease obligations, net of current portion   755    1,107 
Deferred tax liabilities   546    764 
Total liabilities   8,015    8,144 
Commitments and contingencies (See Note 17)   -     -  
           
Series A Preferred stock, $0.00001 par value per share: -0- and 47,419 shares authorized on December 31, 2023, and 2022, respectively; -0- and 47,419 shares issued and outstanding on December 31, 2023, and 2022, respectively at a redemption value equal to $0.10 in cash for each ten thousand (10,000) whole shares.   —    — 
           
Stockholders’ equity          
Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on December 31, 2023, and 2022, respectively   —    — 
Common stock, $0.00001 par value per share, 100,000,000 shares authorized on December 31, 2023, and 2022, respectively:          
Common stock 2,439,923 and 2,367,362 were issued, and 2,439,790 and 2,367,229 were outstanding on December 31, 2023, and 2022, respectively.   —    — 
           
Additional paid-in capital   347,507    345,365 
Accumulated other comprehensive loss   (1,027)   (1,337)
Treasury stock, at cost – 133 shares as of December 31, 2023, and 2022, respectively   (277)   (277)
Accumulated deficit   (309,226)   (300,099)
Total stockholders’ equity   36,977    43,652 
Total liabilities and stockholders’ equity  $44,992   $51,796 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(IN THOUSANDS, EXCEPT NET LOSS PER SHARE DATA)

 

       
   For the Years Ended 
   December 31, 
   2023   2022 
Revenue, net  $27,482   $28,131 
Cost of revenue and operating expenses          
Cost of components and personnel   13,380    15,204 
Inventory valuation adjustments   487    2,930 
General and administrative expenses   19,376    18,195 
Research and development   3,493    4,058 
Impairment of right-of-use assets   83    88 
Depreciation and amortization   1,261    1,722 
Total cost of revenue and operating expenses   38,080    42,197 
Loss from operations   (10,598)   (14,066)
Other income (expenses)          
Unrealized gain on investments in debt securities held to maturity   68    — 
Realized loss on investments in debt securities   (82)   — 
Gain on settlement of debt   —    46 
Other income   332    303 
Dividend income   375    — 
Interest income (expense), net   560    (38)
Total other income   1,253    311 
           
Net loss before income taxes   (9,345)   (13,755)
           
Income taxes          
Deferred tax benefits   218    215 
           
Net loss   (9,127)   (13,540)
           
Dividends   —    (20)
           
Net loss attributable to common shareholders  $(9,127)  $(13,560)
           
Net loss per share attributable to Common Shareholders:          
Basic and diluted loss per share  $(3.83)  $(5.81)
           
Weighted average number of shares outstanding:          
Basic and diluted   2,381    2,335 
           
Comprehensive loss:          
Net loss  $(9,127)  $(13,540)
Unrealized gain on currency translation adjustment   310    1,040 
Comprehensive loss  $(8,817)  $(12,500)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

(IN THOUSANDS, EXCEPT SHARE DATA)

 

                       Accumulated             
   Series A           Additional   Other             
   Preferred Stock   Common Stock   Paid In   Comprehensive   Treasury   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Income (Loss)   Stock   Deficit   Total 
                                     
Balance, January 1, 2022,*   —   $—    2,287,651   $—   $343,746   $(297)  $(277)  $(286,539)  $56,633 
Net loss   —    —    —    —    —    —    —    (13,540)     (13,540)
Unrealized loss on currency translation adjustment   —    —    —    —    —    (1,040)   —    —    (1,040)
Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders   47,419                                  (20)   (20)
Issuance of common stock in connection with:                                             
Satisfaction of accounts payable vendor balance   —    —    3,870    —    54    —    —    —    54 
Satisfaction of withholding tax upon conversion of restricted stock units   —    —    17,889    —    —    —    —    —    — 
Satisfaction with the conversion of restricted stock units   —    —    57,952    —    —    —    —    —    — 
Stock-based compensation   —    —    —    —    1,565    —    —    —    1,565 
Balance, December 31, 2022   47,419   $—    2,367,362   $—   $345,365   $(1,337)  $(277)  $(300,099)  $43,652 
                                              
Net loss   —    —    —    —    —    —    —    (9,127)   (9,127)
Unrealized gain on currency translation adjustment   —    —    —    —    —    310    —    —    310 
Elimination of Series A Preferred Stock   (47,419)   —    —    —    —    —    —    —    — 
Issuance of common stock in connection with:                                             
Compensation awards for services previously accrued   —    —    10,000    —    200    —    —    —    200 
Satisfaction of withholding tax upon conversion of restricted stock units   —    —    14,193    —    —    —    —    —    — 
Satisfaction with the conversion of restricted stock unit awards   —    —    48,368    —    —    —    —    —    — 
Stock-based compensation   —    —    —    —    1,942    —    —    —    1,942 
Balance, December 31, 2023   —   $—    2,439,923   $—   $347,507   $(1,027)  $(277)  $(309,226)  $36,977 

 

* In connection with the reverse stock split implemented by the Company on May 1, 2023, the company’s stock transfer agent calculated a de minimus adjustment to the opening quantity of shares issued.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

 

       
   Years Ended December 31, 
   2023   2022 
Cash flows used in operating activities          
Net loss  $(9,127)  $(13,540)
Adjustments to reconcile net loss to net cash used in operating activities          
Gain on settlement of debt   —    (46)
Unrealized gain on investments in debt securities   68    — 
Realized loss on investments in debt securities   (82)   — 
Accretion of bond discount   16    — 
Stock-based compensation   1,942    1,565 
Stock issuance commitments   —    200 
Provision for bad debt   25    21 
Recovery of bad debt   (10)   (517)
Inventory valuation adjustments   487    2,930 
Amortization of right-of-use assets, operating assets   375    201 
Impairment of right-of-use assets   83    88 
Depreciation and amortization   1,261    1,722 
Deferred tax benefits   (218)   (215)
Changes in assets and liabilities          
Accounts receivable   (2,666)   3,197 
Inventory   (2,185)   (3,731)
Prepaid expenses and other current assets   200    1,897 
Accounts payable   559    (347)
Accrued expenses and interest expense   218    (1,780)
Accrued directors’ compensation   (8)   — 
Operating lease liabilities   (344)   (506)
Deferred revenue and customer deposits   (342)   (558)
Net cash used in operating activities   (9,748)   (9,419)
Cash flows used in investing activities          
Cash used for investment in securities held to maturity   (15,473)   — 
Cash used in asset acquisition   (269)   — 
Proceeds for bond redemption   9,740    — 
Cash used for property and equipment   (698)   (466)
Net cash used in investing activities   (6,700)   (466)
Cash flows used in financing activities          
Principal payments made on D & O notes payable   (607)   (765)
Net cash used in financing activities   (607)   (765)
Effect of exchange rate changes on cash   (90)   46 
Net decrease in cash   (17,145)   (10,604)
Cash and cash equivalents, beginning of the period   25,627    36,231 
Cash and cash equivalents, end of the period  $8,482   $25,627 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(IN THOUSANDS)

 

   Years Ended December 31 
   2023   2022 
Supplemental disclosure of cash payments:        
Cash paid during the period for interest  $12   $41 
           
Supplemental disclosure of non-cash information:          
Notes payable recognized on D & O Insurance policy (Note 15)  $523   $750 
           
Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders  $—   $20 
           
Common stock issued in connection with:          
Board compensation awards previously accrued  $200   $200 
           
Settlement of amounts due accounts payable  $—   $54 
           
ROU assets and operating lease obligations recognized (Note 16):          
Operating lease assets recognized  $125   $— 
Less: non-cash changes to operating lease assets amortization          
amortization   (375)   (201)
impairments   (83)   (43)
loss on lease impairments   83   (88)
ROU assets and operating lease obligations recognized  $(375)  $(332)
           
Operating lease liabilities recognized  $125   $— 
Less: non-cash changes to operating lease liabilities accretion   (469)   (506)
Operating lease liabilities recognized  $(344)  $(506)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-7
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 — NATURE OF OPERATIONS

 

Vislink Technologies, Inc., (“Vislink”, “Company”, “we”, “us”, or “our”) incorporated in Delaware in 2006, is a global technology business that collects, delivers, and manages high-quality, live video and associated data from the action scene to the viewing screen. We provide solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. We also provide the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. Our team also offers professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in terrestrial microwave, fiber optic, surveillance, and wireless communications systems, delivering a broad spectrum of customer solutions.

 

Live Broadcast:

 

We deliver an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, cellular, IP (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing AI (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, we have the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions encompassing hardware components, hosted systems management platforms, related software licenses and ancillary support services.

 

Industry-wide contributors acknowledge our live broadcast solutions. Our equipment transmits most outside wireless broadcast video content, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Our wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events. 

 

Military and Government:

 

We have developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Our solutions are specifically designed with interagency cooperation, utilizing the internationally recognized IP platform and a web interface for video delivery. We provide comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:

 

  ● integrated suites of airborne downlink transmitters, receivers, and antenna systems
  ● data and video connectivity for airborne, marine, and ground assets
  ● UAV video distribution
  ● flexible support for COFDM and bonded cellular/5G Networks
  ● terrestrial point-to-point
  ● tactical mobile command
  ● IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges
  ● high-throughput air/marine/ground-to-anywhere uplink and downlink systems
  ● secure live streaming platforms for use in mobile and fixed assets, and
  ● personal portable products

 

Vislink Technologies, Inc. public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation, criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.

 

F-8
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 — NATURE OF OPERATIONS (continued)

 

Connected Edge Solutions:

 

Our Mobile Viewpoint Technologies (MVP) offers the hardware and software solutions needed to acquire, produce, contribute to, and deliver video over all private and public networks. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:

 

  ● live video encoding, stream adaptation, decoding, and production solutions,
  ● remote production workflows,
  ● wireless cameras,
  ● AI-driven automated production, and
  ● the ability to contribute video over
    ○ bonded cellular (3G and 4G)
    ○ satellite,
    ○ fiber, and
    ○ emerging networks, including 5G and Starlink

 

NOTE 2 — LIQUIDITY AND FINANCIAL CONDITION

 

For the fiscal year ending December 31, 2023, we incurred a net loss of approximately $10.6 million and utilized $9.7 million in cash for operating activities. The Company maintained a working capital of $31.8 million, alongside $8.5 million in cash, against $309.2 million in accumulated deficits.

 

Developments, including those beyond our control, may cause us to consume our available capital more quickly than we expect. These include potential economic conditions, including inflation, foreign exchange fluctuations, the markets we compete in or wish to enter, strategic acquisitions, our market strategy, research and development activities, regulatory matters, and technology and product innovations. We believe we will have sufficient funds to continue our operations for at least 12 months from the date of filing these financial statements in our Annual Report.

 

Asset Acquisitions

 

The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets.

 

Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.

 

F-9
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation

 

The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the Company’s accounts and wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating the Company’s subsidiaries.

 

Segment Reporting

 

The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.

 

Use of Estimates

 

Preparing the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our consolidated financial statements.

 

Risks and Uncertainties

 

The future impacts of the Russia-Ukraine war and the Israel-Hamas conflict, as well as their residual effects, include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries, remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.

 

F-10
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Allowance for Credit Losses

 

In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

 

The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund as of December 31, 2023, and 2022.

 

Concentrations

 

The Company does not possess any off-balance-sheet concentrations of credit risk. Credit risk, defined as the likelihood of a counterparty defaulting on contractual obligations, poses a potential financial loss for the Company. The primary sources of the Company’s credit risk are its cash, investments and accounts receivable. To mitigate the risk of loss exposure, the Company follows a policy of holding its cash in high-credit quality financial institutions. Cash deposits, representing a concentration of credit risk, are the main economic instruments exposing the Company to such risks. The Company has allocated $5.7 million towards investments in government bonds held to maturity to diversify our credit risk exposure further and enhance our risk mitigation strategies. These bonds, issued by the United States Federal Government, are evaluated for credit risk based on the issuing entity’s creditworthiness. This investment strategy is aligned with our overarching objective to minimize potential financial losses by spreading risk across various high-credit quality assets and instruments. The Federal Deposit Insurance Corporation (“FDIC”) insures up to $250,000 for accounts held within the United States. In the United Kingdom, the Company maintains cash balance accounts at financial institutions insured by the Financial Services Compensation Scheme, covering up to £85,000 (subject to currency translation rates to the United States dollar). Additionally, in the Netherlands, the Company’s cash balance accounts at financial institutions are insured by the “Dutch deposit guarantee scheme,” providing coverage up to €100,000 per person per bank.

 

As of December 31, 2023, and 2022, the Company held approximately $7.7 million and $24.5 million above insured limits, respectively, remaining unaffected by any losses in its bank accounts during this period.

 

During the year ending December 31, 2023, the Company did not report any sales to an individual customer that constituted more than 10% of its total sales. During the year ending December 31, 2022, the Company noted sales to a single customer amounting to $3.4 million, representing 12% of the Company’s total sales, in excess of 10% of its total sales.

 

As of December 31, 2023, and 2022, the Company’s accounts receivable from a single customer were recorded at approximately $1.1 million (13%) and $1.1 million (19%), respectively. Each instance surpassed the 10% mark of the Company’s total consolidated accounts receivable, indicating a significant concentration in customer receivables.

 

F-11
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Accounts Receivable and Allowance for Doubtful Accounts

 

On January 1, 2023, the Company adopted Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments. The Company extends credit to its customers in the ordinary course of business and has applied a new standard in evaluating estimated losses through an allowance for doubtful accounts. The Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

 

Inventories

 

Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.

 

Investment in Debt Securities

 

Vislink Technologies, Inc. invests in government bonds with the intent and ability to hold these investments until maturity. In alignment with ASC Topic 320, Investments—Debt and Equity Securities, such investments are classified as “Held-to-Maturity” (HTM) securities and are measured at amortized cost.

 

  ● Classification: The Company classifies its investments in government bonds as “Held-to-Maturity” (HTM) securities based on management’s intent and ability to hold the securities to maturity. These HTM securities are recognized in the Company’s financial statements at their amortized cost, adjusted for the amortization of premiums and accretion of discounts to maturity.
  ● Measurement: HTM securities are initially recognized at their acquisition cost, including transaction costs. Subsequently, they are measured at amortized cost using the effective interest method. This method considers the amortization of any discount or premium on the acquisition cost until maturity.
  ● Interest Income: Interest income is accrued using the security’s effective yield, reflecting the time value of money.
  ● Amortization of Discount and Premium: The amortization of the discount (or accretion of the premium) is included as part of the interest income recognized in the income statement, reflecting the adjustment to the investment’s yield.
  ● Impairment: The Company periodically assesses HTM investments for impairment if objective evidence indicates an impairment has been incurred. It recognizes any loss when the present value of estimated future cash flows, discounted at the original effective interest rate, is less than the carrying amount.
  ● Derecognition: A Held-to-Maturity investment is removed from the balance sheet when the right to receive cash flows has expired, or the Company has substantially transferred all ownership risks and rewards.

 

F-12
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Business Combinations and Asset Acquisitions

 

The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.

 

The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets. Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.

 

The distinction between business combinations and asset acquisitions involves judgment, particularly when applying the screen test to determine the nature of the transaction. Incorrect judgments or changes in decisions in these areas could materially affect the determination of goodwill, the recognition and measurement of acquired assets and assumed liabilities, and, consequently, our financial position and results of operations.

 

Property and Equipment

 

Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from 1 to 14 years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in the expenses as incurred.

 

Intangible Assets

 

Patents and licenses: patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s consolidated balance sheet and amortized on a straight-line basis over their estimated useful lives of 18.5 to 20 years. Amortization totaled approximately $-0- and $0.5 million for the years ended December 31, 2023, and 2022, respectively.

 

Other intangible assets: the Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink Technologies, Inc., Mobile Viewpoint Corporate B.V. (“MVP”), and the assets of BMS. An independent third-party appraiser evaluated the acquired assets for these business transactions. In the absence of fair market values from potential buyers or comparable transactions, we concluded that the methodologies applied provided a reasonable estimate for the values assigned. The Company amortizes intangible asset costs over their useful lives of 3 to 15 years with its net book value reported on the balance sheet. Amortization totaled approximately $1.0 million each for the years ended December 31, 2023, and 2022, respectively.

 

Warranty Reserve

 

Although the Company tests its products under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data, required revisions to the estimated warranty liability will occur.

 

The claims made during the year ended December 31, 2023, and 2022 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.

 

   Warranty Reserve 
December 31, 2021  $131,000 
Warranty reserve expense   98,000 
Warranty claims settled and true-up of accrual.   (117,000)
December 31, 2022  $112,000 
Warranty reserve expense   432,000 
Warranty claims settled, and true-up of accrual   (411,000)
December 31, 2023  $133,000 

 

Shipping and Handling Costs

 

The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2023, and 2022, the shipping and handling costs incurred were $0.4 million and $0.7 million, respectively.

 

Treasury Stock

 

Treasury stock is recorded at cost upon the repurchasing of common shares, and the cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.

 

F-13
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Revenue Recognition

 

The Company accounts for its operating results under ASC Topic 606, adopted on January 1, 2019. This comprehensive revenue recognition model requires recognition when the Company transfers control of the promised goods or services to the Company’s customers at an amount that reflects the consideration the Company expects to receive. The application of ASC Topic 606 requires the Company to use more judgment and make more estimates than under previously issued guidance.

 

The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those services.

 

The Company determines revenue recognition through the following steps:

 

1. identification of the contract, or contracts, with a customer.

2. identification of the performance obligations in the contract.

3. determination of the transaction price.

4. allocation of the transaction price to the performance obligations in the contract; and

5. recognition of revenue when, or as, the Company satisfies a performance obligation.

 

At contract inception, the Company assesses the goods and services promised in the Company’s customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. The Company measures revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges the Company collects concurrent with revenue-producing activities are excluded from income.

 

Remaining Performance Obligations:

 

The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.

 

Research and Development Expenses

 

As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the consolidated statements of operations and comprehensive loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.

 

F-14
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Leases

 

The Company determines if an arrangement is a lease at inception. The Company recognizes lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets, such as “Right of use assets, operating leases,” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. The Company recognizes operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all of the Company’s real estate contracts.

 

There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2023. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of the Company’s leases do not provide an implicit rate, the Company determines our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.

 

Stock-Based Compensation

 

The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.

 

The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from non-employees. The measurement date for equity-classified non-employee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of non-employee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the non-employee share-based payment awards with performance conditions and accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the non-employee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for non-employee awards.

 

Stock-Option Awards — Time-Based and Performance-Based

 

Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For non-employee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.

 

The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.

 

F-15
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Stock-Based Compensation (continued)

 

Restricted Stock Unit Awards (“RSUs”) — Time-Based

 

Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.

 

Restricted Stock Unit Awards (“RSUs”) — Performance-Based

 

The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.

 

Impairment and Abandonment

 

Right-of-use operating lease abandonment:

 

Approximately 2,700 square feet of manufacturing space at the Colchester, UK facility were abandoned as part of the Company’s strategic decision to relocate its UK manufacturing division to the United States commencing in September 2023. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and the Company assessed whether the lease ROU assets were impaired. It was determined that approximately $0.1 million of the Company’s right-of-use operating assets were impaired.

 

Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The location’s economic environment precluded subletting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment.

 

For the years ending December 31, 2023, and 2022, the Company recognized a loss on impairment of ROU assets of approximately $0.1 million each, respectively.

 

Income Taxes

 

Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expenses and penalties as general and administrative expenses.

 

F-16
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Advertising Costs

 

Advertising costs are charged to operations as incurred. For the years ended December 31, 2023, and 2022, respectively, advertising costs amounted to approximately $0.7 million and $1.0 million. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.

 

Sales Tax and Value-Added Taxes

 

The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.

 

Loss Per Share

 

The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, excellent for the period determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.

 

Foreign Currency and Other Comprehensive (Gains) Losses

 

The Company records gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. The Company has two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2023, and 2022, respectively. The Company has included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.

 

Transaction gains and losses are recognized in the Company’s operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying consolidated statements of operations.

 

Fair Value of Financial Instruments and Fair Value Measurements

 

The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” defines fair value as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not assumptions specific to the entity. ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques reflect assumptions other market participants would use based on the market data obtained from independent sources (observable inputs). In accordance with ASC 820, the following summarizes the fair value hierarchy:

 

  ● Level 1 is observable inputs such as quoted prices in active markets,
  ● Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable, and
  ● Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.

 

F-17
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Fair Value of Financial Instruments and Fair Value Measurements (continued)

 

Our financial instruments include cash equivalents, investments, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.

 

Redeemable Preferred Stock

 

In November 2022, the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders relating to the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder not participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole on March 24, 2023, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.

 

Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the consolidated balance sheets.

 

Recently Issued Accounting Pronouncements

 

Adopted:

 

On January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable. The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

 

F-18
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Recently Issued Accounting Pronouncements (continued)

 

Not yet adopted:

 

In February 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280). This update revises the reporting requirements for operating segments of public entities, aiming to enhance the transparency and usefulness of segment reporting. As of the date of these financial statements, the Company has not formally adopted ASU 2023-07, which becomes effective for public entities for reporting periods beginning after December 15, 2023. However, it is essential to note that our Company operates as a single reporting segment. Due to this structure, the Company inherently met the updated disclosure requirements of ASU 2023-07 without needing additional segment-specific information. Our current operating segment structure aligns with the objectives of the new standard, emphasizing explicit and meaningful segment reporting. We have assessed that there will be no significant impact on our financial statements upon adopting ASU 2023-07. We will continue to monitor any further guidance FASB provides and ensure compliance with the reporting standards. As the Company formally adopted ASU 2023-07, the Company remained committed to transparency and clarity in our financial reporting. Our subsequent financial statements will provide further updates regarding compliance with this and other accounting standards.

 

In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-09, enhancing transparency in income tax disclosures. This ASU applies to entities under Topic 740, requiring detailed rate reconciliation and disclosures of taxes paid. It mandates public business entities to disclose rate reconciliation categories annually and specifies a quantitative threshold for reconciling items. Other entities must provide qualitative disclosures. The update is effective for public business entities for annual periods beginning after December 15, 2024, and other entities after December 15, 2025, with early adoption permitted. The Company is evaluating the impact of ASU 2023-09 on its financial statements and will provide updates, if necessary, alongside other accounting standards in future financial statements.

 

Recent Accounting Pronouncements

 

Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC, did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

 

NOTE 4 — LOSS PER SHARE

 

The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

 

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
Stock options   51    41 
Warrants   456    459 
Total   507    500 

 

F-19
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 — FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES

 

The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive loss approximately as follows:

 

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
Net foreign exchange transactions:          
(Gains) Losses  $49,000   $24,000 
            
Accumulated comprehensive income:          
Unrealized (gains) losses on currency translation adjustment  $(310,000)  $1,040,000 

 

Amounts were converted from British Pounds to U.S. Dollars and Euros to British Pounds using the following exchange rates:

 

  ● As of December 31, 2023 – £1.273840 to $1.00; €1.105890 to $1.00
  ● The average exchange rate for the year ended December 31, 2023 – £1.243463 to $1.00; €1.081317 to $1.00
  ● As of December 31, 2022 – £ 1.208970 to $1.00; € 1.069850 to $1.00
  ● The average exchange rate for the year ended December 31, 2022 – £ 1.236579 to $1.00; € 1.052082 to $1.00

 

NOTE 6 — CASH AND CASH EQUIVALENTS

 

The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund. The following table illustrates the Company’s cash and cash equivalents:

 

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
         
Cash on hand  $1,776,000   $25,627,000 
Federally insured money market mutual funds   6,706,000    — 
Total cash and cash equivalents  $8,482,000   $25,627,000 

 

NOTE 7 — INVESTMENTS

 

The Company used cash to purchase the following debt instruments:

 

  ● On January 23, 2023, the Company purchased a bond for $4,812,500, “HSBC USA INC CP,” with a face value of $5,065,789, a par value of $5,000,000, maturing October 24, 2023, a 5.1948% interest rate, at a discount of $253,289. The bond was redeemed on maturity at a loss of approximately $82,000.
     
  ● On February 1, 2023, the Company purchased a bond for $5,025,479, “Federal Home Loan Banks,” with a face value of $4,999,750 and accrued interest of $25,729, a par value of $5,000,000, maturing December 22, 2023, at an interest rate of 4.750%. The bond was redeemed at face value on the date of maturity.
     
  ● On February 28, 2023, the Company purchased a bond for $950,000, “Federal National Mortgage Association,” with a face and par value of $950,000, maturing February 28, 2024, at an interest rate of 5.07%. The value on December 31, 2023, was $949,000.
     
  ● On October 11, 2023, the Company purchased a bond for $4,711,000, “HSBC USA INC CP,” with a face value of $5,000,000, maturing October 11, 2024, at a 6.262291% interest rate. The value on December 31, 2023, was $4,714,000.

 

F-20
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 7 — INVESTMENTS (continued)

 

The Company identified these transactions as investments in debt securities. It applies the guidance under ASC Topic 320, “Investments in debt securities,” and for interest income guidance under ASC Topic 310-20, “Receivables.” As of December 31, the abovementioned investments have a stated maturity of one year or less. Management intends to treat these investments as held to maturity.

 

The Company’s investments held to maturity are as follows as of December 31, 2023:

 

  

Amortized

Cost

  

Unrealized

Gains

   Unrealized Losses   Fair Value 
                     
Federal Bonds  $5,663,000   $68,000   $     —   $5,731,000 

 

NOTE 8 — FAIR VALUE OF ASSETS AND LIABILITIES

 

As defined under ASC 820, “Fair Value Measurement and Disclosures,” the following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis on December 31, 2023, and 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.

 

  

Quoted Prices in Active Markets of Identical Assets/Liabilities

(Level 1)

  

Significant Other Observable Inputs

(Level 2)

  

Significant Unobservable Inputs

(Level 3)

   Total 
Assets                    
December 31, 2023:                    
Federal Bonds Held to Maturity  $—   $5,731,000   $—   $5,731,000 
Right of use asset impairment   —    —    83,000    83,000 
   $        —   $5,731,000   $83,000   $5,814,000 
                     
Liabilities  $—   $—   $—   $— 
                     
Assets                    
December 31, 2022:                    
Federal Bonds Held to Maturity  $—   $—   $—   $— 
Right of use asset impairment   —    —    88,000    88,000 
   $—   $—   $88,000   $88,000 
                     
Liabilities  $—   $—   $—   $— 

 

NOTE 9 — ASSET ACQUISITION

 

On September 14, 2023, Vislink Poway, LLC (“Poway”), a wholly-owned subsidiary of the Company formed on September 13, 2023, entered into an asset purchase agreement with BMS, acquiring working in process inventory consisting of microwave technology systems involving long-range data transmission and assuming certain liabilities in exchange for $200,000 in cash consideration paid at together with a commitment to acquire additional inventory for $230,000 on October 2, 2023, with title to the inventory passing to Poway on October 2, 2023.The transaction was accounted for as an acquisition of assets under U.S. GAAP. Accordingly, the acquisition cost was allocated on a relative fair value basis, and transaction costs were capitalized as a component of the cost of the assets acquired.

 

F-21
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 9 — ASSET ACQUISITION (continued)

 

The Company recorded the purchase of this agreement under purchase price accounting, recording the fair value of the assets acquired and the liabilities assumed based upon the purchase price, as summarized in the table below:

 

      
Assets acquired:     
Work-in-process inventory  $66,042 
Intangible assets - customer relationships   495,372 
total assets   561,414 
      
Liabilities assumed:     
Deferred revenue   292,014 
total liabilities   292,014 
      
Total cash used for asset acquisition  $269,400 
      
Cash used in acquisition:     
Acquisition price  $200,000 
Transaction costs   69,400 
Total cash used for asset acquisition  $269,400 

 

NOTE 10 — ACCOUNTS RECEIVABLE

 

Accounts receivable consist of the following:

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
Accounts receivable  $9,389,000   $6,680,000 
Allowance for doubtful accounts   (709,000)   (673,000)
Net accounts receivable  $8,680,000   $6,007,000 

 

During the years ended December 31, 2023, and 2022, the Company incurred bad debt expenses of $25,000 and $21,000, respectively. Additionally, for the years ended December 31, 2023, and 2022, we experienced bad debt recoveries of $10,000 and $517,000, respectively.

 

NOTE 11 — INVENTORIES

 

Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
Raw materials  $12,890,000   $12,038,000 
Work-in-process   1,458,000    1,474,000 
Finished goods   5,599,000    4,460,000 
Sub-total inventories   19,947,000    17,972,000 
Less reserve for slow-moving and excess inventory   (5,918,000)   (5,951,000)
Total inventories, net  $14,029,000   $12,021,000 

 

Inventory valuation adjustments consist primarily of written-off items due to obsolescence or reserved for slow-moving or excess inventory. The Company recorded inventory valuation adjustments of $487,000 and $1,143,000 as of December 31, 2023, and 2022, respectively. Additionally, under the Company’s product rationalization program, management eliminated specific product lines impairing $-0- and $1,787,000 of inventory as of December 31, 2023, and 2022, respectively.

 

F-22
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 12 — PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following:

 

   (Years)  2023   2022 
      For the years ended 
   Useful Life  December 31, 
   (Years)  2023   2022 
Cost:             
Furniture and fixtures  1 – 10  $347,000   $308,000 
Leasehold improvements (a)  1 – 14   443,000    443,000 
Computers, software, and equipment  1 – 11   3,677,000    3,016,000 
Property and equipment, cost      4,467,000    3,767,000 
Accumulated depreciation      (2,565,000)   (2,333,000)
Property and equipment, net     $1,902,000  $1,434,000 

 

Property and equipment depreciation amounted to $232,000 and $201,000 for the years ended December 31, 2023, and 2022, respectively. Additionally, the Company removed $228,000 of fully depreciated leasehold improvement from its records during December 31, 2022, and none for the year ending December 31, 2023.

 

(a)The shorter economic life or remaining lease term.

 

NOTE 13 — INTANGIBLE ASSETS

 

The Company continuously monitors operating results, events, and circumstances that may indicate potential impairment of intangible assets. Management concluded that no triggering events occurred during the year ended December 31, 2023.

 

The following table illustrates finite intangible assets as of December 31, 2023, and 2022:

 

   Proprietary Technology   Patents and Licenses   Trade Names & Technology   Customer Relationships     
       Accumulated       Accumulated       Accumulated       Accumulated     
   Cost   Amortization   Cost   Amortization   Cost   Amortization   Cost   Amortization   Net 
                                     
December 31, 2023:                                             
Balance, January 1, 2023  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 
                                              
Additions   —    —    —    —    —    —    496,000    —    496,000 
                                              
Amortization   —    (593,000)   —    —    —    (138,000)   —    (299,000)   (1,030,000)
Balance, December 31, 2023  $2,132,000   $(1,408,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,327,000)  $5,591,000   $(3,373,000)  $3,866,000 
                                              
December 31, 2022:                                             
Balance, January 1, 2022   2,132,000    (223,000)   12,378,000    (11,843,000)   2,251,000    (1,052,000)   5,095,000    (2,817,000)   5,921,000 
                                              
Amortization   —    (592,000)   —    (535,000)   —    (137,000)   —    (257,000)   (1,521,000)
                                              
Balance, December 31, 2022  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 

 

F-23
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13 — INTANGIBLE ASSETS (continued)

 

The Company’s groups of intangible assets consist primarily of:

 

Proprietary Technology:

 

Generally, the Company amortizes proprietary technology over 3 to 5 years. MVP uses wireless multiplex transmitters and artificial intelligence internally to produce and sell products and services to customers.

 

Patents and Licenses:

 

Patents and licenses filed by the Company are amortized for 18.5 to 20 years. The amortization of the costs associated with provisional patents and pending applications begins after successful review and filing.

 

Trade Name, Technology, and Customer Relationships:

 

Other intangible assets are amortized for 3 to 15 years. IMT, Vislink Technologies, Inc., MVP, and Poway acquisitions contributed to developing these intangible assets, including trade names, technology, and customer lists.

 

The Company has recognized net capitalized intangible costs as follows:

 

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
Proprietary Technology  $726,000   $1,319,000 
Patents and Licenses   —    — 
Trade Names and Technology   922,000    1,060,000 
Customer Relationships   2,218,000    2,021,000 
Net capitalized intangible costs  $3,866,000   $4,400,000 

 

The Company has recognized the amortization of intangible assets as follows:

 

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
         
Proprietary Technology  $593,000   $592,000 
Patents and Licenses   —    535,000 
Trade Names and Technology   138,000    137,000 
Customer Relationships   299,000    257,000 
Amortization of intangible assets   $1,030,000   $1,521,000 

 

The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 4.9 years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:

  

Period ending December 31,     
2024  $783,000 
2025   781,000 
2026   651,000 
2027   346,000 
2028   288,000 
Thereafter   1,017,000 
Intangible assets, estimated amortization expense  $3,866,000 

 

F-24
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 14 — ACCRUED EXPENSES

 

Accrued expenses consist of the following:

 

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
Compensation  $567,000   $246,000 
Commissions   106,000    47,000 
Warranty   135,000    112,000 
Accrued expenses other   770,000    908,000 
Deferred equity   —    255,000 
Accrued expenses  $1,578,000   $1,568,000 

 

NOTE 15 — NOTES PAYABLE

 

The table below represents the Company’s notes payable as of December 31, 2023, and 2022:

 SCHEDULE OF NOTES PAYABLE

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
         
On April 5, 2022,   $—   $84,000 
On April 5, 2022, the Company renewed its D & O insurance policy, decreasing the premium to approximately $1,037,000, less a down payment of $194,000, financing the remaining balance of approximately $943,000. The loan’s terms are nine months at a 2.09% annual interest rate and a monthly principal and interest payment of approximately $84,000. The Company recorded interest expense of $6,000 and $-0- for the years ended December 31, 2022, and 2021, respectively.  $—   $84,000 
           
On April 5, 2023, the Company renewed its D & O insurance policy, reducing the premium to approximately $811,000, less a down payment of $288,000, financing the remaining balance of approximately $523,000. The loan’s terms are for nine months at a 6.14% annual interest rate and a monthly principal and interest payment of approximately $67,000. Accordingly, the Company recorded interest expenses of $12,100 and $-0- for the years ending December 31, 2023, and 2022, respectively.   —    — 
Notes payable  $—   $84,000 

 

 

NOTE 16 — LEASES

 

Aside from renting office spaces, deployment sites, and storage warehouses, the company leases warehouse facilities internationally and domestically. As of December 31, 2023, the operating leases exhibit diverse terms and provisions, with lease durations spanning one to four years. Some individual leases include rent escalation clauses and lease concessions that entail additional rental payments in the latter years of the lease period. Such contracts are accounted for on a straight-line basis throughout the minimum lease term.

 

The table below lists the location and lease expiration date from 2025 through 2027: 

 

Location   Square Footage     Lease-End Date   Approximate Future Payments  
Colchester, U.K. – Waterside House     13,223     Dec   2025     $ 502,000  
Lutton, UK     600     Jan   2025       32,000  
Billerica, MA     2,000     Dec   2026       316,000  
Mount Olive, NJ     7,979     May   2027       470,000  
Trivex, Singapore     950     Aug   2025       60,000  

 

F-25
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — LEASES (continued):

 

The following represents lease activity for the year ending December 31, 2023:

 

Lutton, UK

 

A one-year lease for 600 square feet of administrative office space in Lutton, UK, was signed on September 1, 2023, and will run through May 31, 2024, at approximately $2,100 per month. A two-year lease for 600 square feet was executed at another location and will run from February 1, 2023, through January 31, 2025, at approximately $2,500 per month.

 

Dubai, UAE

 

The Company renewed its lease for 976 square feet of administrative office space in Dubai Studio City, UAE, commencing on July 3, 2023, and terminating on July 2, 2024, for approximately $1,632 monthly.

 

Poway, CA

 

Included in the September 14, 2023, acquisition of assets from Broadcast Microwave Services, LLC (BMS) was a sublease of approximately 11,715 square feet of general office use facilities previously held under a six-month agreement with BMS, with lease responsibilities conveyed to Vislink Poway, LLC. The initial lease term commenced with a monthly rent of approximately $22,300 and concluded on March 13, 2024. On February 12, 2024, Vislink Poway, LLC signed a renewal agreement for the same space. The renewal term is set for one year and ten and a half months, commencing on March 14, 2024, and ending on January 31, 2026. The base rent for the renewal period is established at $22,926 per month.

 

Colchester, U.K.

 

Approximately 2,700 square feet of manufacturing space at the Colchester, U.K. facility were abandoned as part of the Company’s strategic decision to relocate its U.K. manufacturing division to the United States commencing in September 2023, with approximately 13,200 square feet of remaining space. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and we assessed whether the lease “Right of use assets, operating leases” (ROU) assets were impaired. It was determined that approximately $83,000 of the Company’s right-of-use operating assets were impaired.

 

Hemel, United Kingdom

 

Under the original lease agreement dated April 28, 2017, a “break clause” signifying a “break date” of October 28, 2020, sighted the following: the Company may terminate this lease on the “break date” by giving the landlord such notice within six months of the “break date.” At the lease’s commencement, it was not reasonably sure if the Company would exercise its right by the break clause’s date. These measures upheld the determination of the lease’s noncancellable period for adopting ASC 842 on January 1, 2019. The lease term of 22 months as of January 1, 2019, helped calculate the remaining lease payments’ net present value assigned to the right-of-use asset and operating lease liability upon the adoption date. The total annual rent under this lease is approximately $175,000, covering 12,870 square feet of manufacturing and administrative office space. Neither party exercised their unilateral termination rights by the “break date,” triggering a lease extension. Both parties’ inaction creates new enforceable rights and obligations in the extended period, such that the lease agreement terminates on October 27, 2023.

 

Trivex, Singapore

 

The Company renewed its lease for 950 square feet of administrative office space commencing on August 10, 2023, and terminating on August 92, 2025, for approximately $3,100 monthly.

 

The following represents lease activity for the year ending December 31, 2022:

 

Lutton, UK

 

On April 28, 2022, the Company entered a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on May 31, 2023, for £1,320 monthly or approximately $1,800 per month.

 

Dubai, UAE

 

The Company renewed its lease for 976 square feet of administrative office space commencing on July 3, 2022, and terminating on July 2, 2023, in Dubai Studio City, UAE, for AED 5,995 or approximately US$ 1,632 monthly. 

 

F-26
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — LEASES (continued):

 

The following represents lease activity for the year ending December 31, 2022 (continued):

 

Billerica, MA

 

Management vacated the Billerica property during the third quarter of the fiscal year 2022. The economic environment of this location precluded subletting an unoccupied site, and the leased facility was determined to be abandoned. Under ASC 360, leased space abandonment is an impairment indicator. The Company assessed the lease ROU assets for impairment, recognizing a loss on impairment of right-of-use assets of approximately $88,000.

 

The following table illustrates Right-Of-Use operating lease data recorded for the years ended December 31, 2023, and 2022:

 

   2023   2022 
   For the years ended 
   December 31, 
   2023   2022 
Right-of-use assets:          
Cost  $2,385,000   $2,260,000 
Accumulated amortization   (1,643,000)   (1,185,000)
           
  $742,000   $1,075,000 
           
Operating lease liability:          
Current portion  $463,000   $455,000 
Non-current portion   755,000    1,107,000 
           
   $1,218,000   $1,562,000 
           
Weighted average discount rate   9.4%   9.4%
           
Weighted average remaining term for lease contracts   2.6 years    3.4 years 
           
Lease maturity dates for right-of-use operating leases   July 2025 to May 2027    July 2023 to May 2027 
           
Lease cost:          
Operating lease cost  $435,000   $438,000 
Short-term lease cost   126,000    93,000 
           
Total lease cost  $561,000   $531,000 
           
Cash paid for lease liabilities:          
Cash flows from operating leases  $643,000   $543,000 
           
Right-of-use assets obtained in exchange for new operating lease liabilities  $171,000   $— 

 

Maturities of our operating lease liabilities were as follows as of December 31, 2023:

 

   Amount 
     
2024  $559,000 
2025   513,000 
2026   249,000 
2027   59,000 
2028   — 
Thereafter   — 
Total lease payments   1,380,000 
Less: imputed interest   162,000 
Present value of lease liabilities   1,218,000 
Less: Current lease liabilities   463,000 
Non-current lease liabilities  $755,000 

 

F-27
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 17 — PREFERRED SHARES

 

Preferred Stock

 

In March 2013, the issuance of up to 10.0 million shares of “Blank Check” preferred stock with a par value of $0.00001 per share received approval from the stockholders of the Company.

 

The following shares were designated as authorized:

 

  ● Three million shares of Series A Convertible Preferred Stock (“Series A Preferred Stock”) on December 31, 2014.
  ● Three million shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”) on February 11, 2015.
  ● Three million shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”) on February 24, 2015.

 

On February 5, 2016, the Company terminated the Series A Preferred Stock and Series C Preferred Stock and increased the number of designated shares of Series B Preferred Stock to 5,000,000. The following shares were designated as authorized: Five million shares of Series D Convertible Preferred Stock (“Series D Preferred Stock”) on April 25, 2016. On December 6, 2016, the Company terminated the Series B Preferred Stock. The following shares were designated as authorized: Five thousand shares of Series E Convertible Preferred Stock (“Series E Preferred Stock”) on December 21, 2016. On November 9, 2022, the Company’s Board of Directors (i) terminated the Series D Preferred Stock and Series E Preferred Stock and (ii) designated the following shares as authorized: 47,500 shares of new Series A Preferred Stock.

 

Series A Preferred Stock

 

On November 9, 2022, the Company’s Board of directors declared a dividend of one one-thousandth of a share of Series A Preferred Stock, par value $0.00001 per share (“Series A Preferred Stock”), for each outstanding share of the Company’s common stock, to stockholders of record on November 21, 2022.

 

Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes. The outstanding shares of Series A Preferred Stock voted together with the outstanding shares of the Company’s common stock as a single class exclusively concerning the proposal to adopt an amendment to the Company’s Certificate of Incorporation, as amended, to reclassify the outstanding shares of the Company’s Common Stock into a smaller number of shares of common stock at a ratio specified in or determined under the terms of such amendment (the “Reverse Stock Split”). The Series A Preferred Stock was not entitled to vote on any other matter except to the extent required under the Delaware General Corporation Law.

 

The Series A Preferred Stock was not convertible into, or exchangeable for, shares of any other class, series of stock, or other securities of the Company. The Series A Preferred Stock had no stated maturity and is not subject to any sinking fund. The Series A Preferred Stock was not restricted to the Company’s redemption or repurchase of shares when there was any arrearage in the payment of dividends or sinking fund installments. The Certificate of Designation was filed with the Delaware Secretary of State and became effective on November 9, 2022. The holders of Series A Preferred Stock were not entitled to receive dividends.

 

On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted on a proposal to authorize the Board, at its discretion, to affect the Reverse Stock Split. All shares of Series A Preferred Stock that were not present in person or by proxy at the Special Meeting held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) were automatically redeemed in whole, but not in part, by the Company at the Initial Redemption Time without further action on the part of the Company or the holder of shares of Series A Preferred Stock (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed according to an Initial Redemption were redeemed in whole but not in part on March 24, 2023 (i) if the Board ordered such redemption in its sole discretion, automatically and effective on such time and date specified by the Board in its sole discretion or (ii) automatically upon the approval by the Company’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on such proposal (“the Subsequent Redemption”).

 

Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time.

 

F-28
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 17 — PREFERRED SHARES (continued)

 

Series A Preferred Stock (continued)

 

The Company was not solely in control of the redemption of the shares of Series A Preferred Stock since the holders had the option of deciding whether to vote in respect of the above-described Reverse Stock Split, which determined whether a given holder’s shares of Series A Preferred Stock were redeemed in the Initial Redemption or the Subsequent Redemption. Since the redemption of the Series A Preferred Stock was not solely in the control of the Company, the shares of Series A Preferred Stock were classified within mezzanine equity in the Company’s audited consolidated balance sheet. The shares of Series A Preferred Stock were measured at redemption value. The value of Series A Preferred Stock shares as of December 31, 2023 and 2022, was de minimis.

 

Certificate of Elimination

 

On April 25, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating 5,000,000 shares out of the Company’s authorized but unissued shares of its preferred stock as Series D Convertible Preferred Stock, par value $0.00001 per share.

 

On December 21, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating 5,000 shares out of the Company’s authorized but unissued shares of its preferred stock as Series E Convertible Preferred Stock, par value $0.00001 per share.

 

On November 9, 2022, the Company filed Certificates of Elimination for each of the Series D Preferred Stock and Series E Preferred Stock with the Secretary of State of the State of Delaware, which, effective upon filing, eliminated all matters outlined in the Certificates of Designation of Series D Preferred Stock and Series E Preferred Stock previously filed by the Company. According to the Certificates of Elimination, the shares that were previously designated as Series D Preferred Stock and Series E Preferred Stock resume the status of authorized but unissued shares of preferred stock, par value $0.00001 per share, of the Company, issuable from time to time, in one or more series, under the Certificate of Incorporation.

 

On March 22, 2023, the Board of Directors of the Company (the “Board”) approved a resolution to eliminate the Company’s Certificate of Designation, Preferences, and Rights (the “Certificate of Elimination”) of the Series A Preferred Stock, par value $0.00001 per share (the “Series A Preferred Stock”), that was filed with the Secretary of State of the State of Delaware on November 9, 2022. Upon the effective filing of this Certificate of Elimination, the shares previously designated under the certificate of designation as Series A Preferred Stock shall resume the status of authorized but unissued shares of the Company’s preferred stock.

 

On March 24, 2023, the Company filed a certificate of elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware for the Series A Preferred Stock. The Certificate of Elimination (i) eliminated the previous designation of 47,500 shares of Series A Preferred Stock from the Company’s Certificate of Incorporation, as amended, none of which were outstanding at the time of the filing of such Certificate of Elimination, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of preferred stock of the Company.

 

As of December 31, 2023, -0- shares are authorized, and no Series A Preferred Stock are issued or outstanding.

 

F-29
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 18 — STOCKHOLDERS’ EQUITY

 

Common Stock

 

The Company is authorized to issue up to 100,000,000 shares of Common Stock, $0.00001 par value per share. As of December 31, 2023, and 2022, the Company had 2,439,923 and 2,367,362 issued and 2,439,790 and 2,367,229 shares outstanding, respectively.

 

Common Stock Activity

 

For the year ending December 31, 2023
     
  ● Issued 10,000 shares of common stock to specific board members as part of a commitment agreement valued at $200,000. The common stock’s value was determined on the agreement’s original date.
     
  ● Issued 14,193 shares of common stock as payment of the minimum withholding tax obligation due upon the vesting of shares restricted stock units.
     
  ● Issued 48,368 shares of common stock, net of 14,193 shares attributable to withholding tax, upon the exercise of restricted stock units under the Company’s various stock compensation plans.
     
  ● Recognized approximately $1,942,000 of stock-based compensation costs associated with outstanding stock options in general and administrative expenses offsetting additional capital investments.
     
For the year ending December 31, 2022
     
  ● Issued 357,778 shares of common stock as payment of the minimum withholding tax obligation due upon the vesting of shares restricted stock units.
     
  ● Issued 1,159,044 shares of common stock, net of 357,778 shares attributable to withholding tax, upon the exercise of restricted stock units under the Company’s various stock compensation plans.
     
  ● Under the terms of an $80,000 consulting agreement, on May 4, 2022, 38,703 shares of common stock were valued at $0.81 per share on the issuance date with a total value of $31,349 in satisfaction of $40,000. The value of the common stock issued was based on the fair value of the stock at the time of the issuance. On July 19, 2022, 38,703 shares of common stock were valued at $0.59 per share on the issuance date, with a total value of $22,835 in satisfaction of the remaining balance of $40,000. The Company recognized a total gain on debt settlement of $25,816.
     
  ● Recognized approximately $1,565,000 of stock-based compensation costs associated with outstanding stock options recorded in general and administrative expenses offsetting additional paid-in capital.

 

F-30
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 18 — STOCKHOLDERS’ EQUITY (continued)

 

Common Stock Warrants

 

During the year ended December 31, 2023, 2,666 warrants expired. As of December 31, 2023, these outstanding warrants contained no intrinsic value. The weighted average exercise price of warrants outstanding on December 31, 2023, is $65.10, with a weighted average remaining contractual life of 2.1 years.

 

The following tables set forth common stock purchase warrants outstanding as of December 31, 2023, and 2022:

  

Number of Warrants

(in shares)

  

Weighted

Average

Exercise

Price

 
         
Outstanding, December 31, 2021   460,491   $82.00 
Warrants expired   (1,745)   (2624.00)
Outstanding and exercisable, December 31, 2022   458,746    71.60 
Warrants expired   (2,666)   (1,200.30)
Outstanding and exercisable, December 31, 2023   456,080   $65.10 

 

    Common stock issuable upon exercise of warrants outstanding and exercisable 
    For the year-ending   For the year-ending 
    December 31, 2023   December 31, 2022 
Range of Exercise Prices   Warrants Outstanding and Exercisable (in shares)   Weighted Average Remaining Contractual Life (years)  

Weighted Average Exercise

Price

  

Warrants Outstanding and Exercisable

(in shares)

   Weighted Average Remaining Exercisable Contractual Life (years) 

Weighted Average Exercise

Price

 
$65.00    454,546    3.11 yrs   $65.00    454,546   3.11 yrs  $65.00 
$68.20    1,500    1.18 yrs   $68.20    1,500   1.18 yrs  $68.20 
$600.00    34    1.54 yrs   $600.00    34   1.54 yrs  $600.00 
$1,200.00    —    —   $—    2,666   0.41 yrs  $1,200.00 
      456,080    3.10 yrs   $65.10    458,746   3.10 yrs  $71.60 

 

F-31
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 19 — STOCK-BASED COMPENSATION

 

Overview

 

Vislink Technologies, Inc. and its subsidiaries (“the Company”) leverage stock-based compensation as a strategic tool to attract, motivate, and retain key personnel. This aligns their interests with those of our shareholders by offering them a stake in the Company’s success. We administer various plans that grant stock options and Restricted Stock Units (RSUs) to our officers, directors, key employees, and consultants.

 

Long-Term Stock Incentive Plan Awards

 

The Company operates multiple equity incentive plans, including the 2013 Stock Option Plan, 2015 Incentive Compensation Plan, 2016 Incentive Compensation Plan, and 2017 Incentive Compensation Plan. These plans facilitate the granting of stock options, which may be settled in shares or net-settled, emphasizing our flexible approach to compensation. The options vest over three years and are exercisable up to ten years from the grant date.

 

Significant modifications and enhancements have been made to our plans over time to ensure they continue to serve the intended purpose effectively. This includes the immediate vesting provisions for terminated employees and removing a cap on the annual share awards per participant, reflecting our adaptability to changing business and operational needs.

 

Inducement Awards

 

The Company grants time-vested and performance-based stock options under inducement awards, consistent with NASDAQ Listing Rule 5653(c)(4). These inducement awards, granted outside of our existing equity compensation plans, are designed to reward employees for their commitment and performance toward achieving our strategic goals.

 

Time-Based and Performance-Based Stock Option Awards

 

The Company’s stock option awards are granted under terms that ensure they vest based on time or performance-based criteria. Performance-based awards are tied to achieving specific financial metrics, aligning employee rewards with the Company’s success. The Company granted time-vested stock options and performance-based stock options to various employees in connection with their employment agreements. The ten-year, non-statutory time-vested, and performance-based option inducement awards were granted under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment).

 

Time-based and Performance-Based Restricted Stock Unit Awards (“RSUs”)

 

The Company’s RSUs are granted under terms that ensure they vest based on time or performance-based criteria. Performance-based awards are tied to achieving specific financial metrics, aligning employee rewards with the Company’s success.

 

The Company granted awards under the amended plan for time-based restricted stock units (“RSUs”) to various employees subject to continued employment. The RSUs initially vest between 25% and 33% on their one-year anniversary dates and will vest between 24 and 36 equal monthly periods thereafter. Additionally, the Company granted awards under the amended plan for performance-based restricted stock units subject to performance vesting conditions and continued employment. The RSUs will vest in three equal tranches upon reaching performance conditions for each tranche.

 

2023 Omnibus Equity Incentive Plan

 

The Company received stockholder approval on August 23, 2023, to adopt the 2023 Omnibus Equity Incentive Plan (the “2023 Plan”), which will enable it to continue to grant equity-based compensation awards to employees (including officers), non-employee consultants, non-employee directors, and affiliates. The 2023 Plan replaces the 2015 Incentive Compensation Plan, 2016 Incentive Compensation Plan, and 2017 Incentive Compensation Plan. The Company has ceased granting awards under the 2015 Incentive Compensation Plan, 2016 Incentive Compensation Plan, and 2017 Incentive Compensation Plan. The Company has been authorized to reserve 166,415 shares of its common stock for delivery under the 2023 Plan. The 2023 Plan rewards eligible participants for contributing to the Company’s success and encourages retaining and recruiting qualified personnel. The Company’s Board of Directors and Compensation Committee will administer the 2023 Plan.

 

The 2023 Plan generally grants awards without consideration other than prior and future service. The Company’s compensation committee may grant awards under the 2023 Plan either alone or in addition to, in tandem with, or as a substitute for any other award granted under the 2023 Plan or other company plans. It is important to note, however, that if a SAR is granted in conjunction with an ISO, the grant date and term of the SAR and ISO must be the same, and the exercise price of the SAR cannot be lower than the exercise price of the ISO. A written award agreement between us and the grantee will outline the material terms of the award.

 

As shown in the following table, stock-based compensation expense is included in general and administrative costs under the following plans:

 

SCHEDULE OF STOCK BASED COMPENSATION EXPENSE

Equity-based plans:  2023   2022 
   For the years ended 
   December 31, 
Equity-based plans:  2023   2022 
         
Long-term stock incentive plan awards  $—   $1,000 
Time-vested option inducement awards   181,000    179,000 
Time-based restricted stock awards   1,761,000    1,385,000 
Stock-based compensation expense  $1,942,000   $1,565,000 

 

F-32
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 19 — STOCK-BASED COMPENSATION (continued)

 

The following table illustrates supplementary data under various equity compensation plans:

 

    For the years ended     For the years ended  
    December 31,     December 31,  
    2023     2022     2023     2022  
   

Quantity

    

Weighted Average

    

Quantity

    

Weighted Average

    

Quantity

    

Weighted Average

    

Quantity

    

Weighted Average

  
             
    Long-term stock incentive plan awards     Time-vested option inducement awards  
Balance-January 1, outstanding     2,250     $ 1,756.01       2,496     $ 1,760.80       24,725     $ 12.90       24,725     $ 20.20  
Canceled, expired, forfeited     (88 )     (1,431.14 )     (246 )     (1,934.00 )     (6,759 )     (8.63 )     —       —  
Balance-December 31, outstanding     2,162     $ 1,768.46       2,250     $ 1,756.01       17,966     $ 6.27       24,725     $ 12.90  
Balance-December 31, exercisable     2,162     $ 1,768.46       2,250     $ 1,756.01       17,592     $ 27.23       18,027     $ 21.13  
Remaining compensation expense     $—       $—       $113,000       $319,000  
Remaining amortization period     0.0 years       0.0 years       0.1 years       1.1 years  
Weighted average remaining contractual life – options outstanding and exercisable     3.5 years and 3.5 years       4.5 years and 4.5 years       6.1 years and 6.1 years       7.1 years and 7.1 years  
Intrinsic value per share     $—       $—       $—       $—  
Range of exercise prices     $139.20 to $1,944.00       $139.20 to $1,944.00       $34.20       $19.20 to $34.20  
                                                                 
     

Performance-based stock option

inducement awards

       Time-based restricted stock awards  
Balance-January 1, outstanding     12,500     $ 33.12       12,500     $ 33.12       140,736     $ 23.09       39,933     $ 63.40  
Granted     —       —       —       —       53,750       8.17       107,053       20.80  
Canceled, expired, forfeited     —       —       —       —       (19,415 )     (21.48 )      (6,250 )     (13.60 )
Stock units exercised     —       —       —       —       (48,368 )     (41.58 )     —       —  
Balance-December 31, outstanding     12,500      $ 33.12       12,500      $ 33.12       126,703      $ 11.92       140,736       23.09  
Balance-December 31, exercisable     —     $ —       —     $ —       30,692     $ 36.98       20,794     $ 66.60  
Remaining compensation expense     $414,000       $414,000       $1,511,000       $3,248,000  
Remaining amortization period     1.1 years       2.1 years       1.6 years       2.3 years  
Weighted average remaining contractual life – options outstanding and exercisable     6.1 years and 0.0 years       7.1 years and 0.0 years       1.9 years and 1.7 years       2.5 years and 1.4 years  
Intrinsic value per share     $—       $—       $—       $—  
Range of exercise prices     $34.20       $34.20       $5.71 to $72.00       $19.60 to $72.00  
                               
                                      Performance-based restricted stock awards  
Balance-January 1, outstanding                                     71,303     $ 21.01       63,369     $ 58.00  
Granted                                     12,500       5.68       71,303       21.00  
Canceled, expired, forfeited                                     (19,649 )     (21.62 )     —       —  
Stock units exercised                                     —       —       (63,369 )     (58.00 )
Balance-December 31, outstanding                                     64,154     $ 18.02       71,303     $ 21.01  
Balance-December 31, exercisable                                     —     $ —       —     $ —  
Remaining compensation expense                                     $1,156,000       $1,498,000  
Remaining amortization period                                     2.1 years       2.8 years  
Weighted average remaining contractual life – options outstanding and exercisable                                     2.1 years and 0.0 years       2.8 years and 0.0 years  
Intrinsic value per share                                     $—       $—  
Range of exercise prices                                     $5.80 to $21.00       $21.00  

 

F-33
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 20 — COMMITMENTS AND CONTINGENCIES

 

Pension:

 

The Company may make a matching contribution to its employees’ 401(k) plan. Furthermore, Vislink Technologies, Inc. operates a Group Personal Plan through its UK subsidiary, investing funds with Royal London. Employees of the Company in the United Kingdom are entitled to participate in the Company’s employee benefit plan, to which varying amounts are contributed according to their status. Additionally, the Company operates a stakeholder pension plan in the United Kingdom.

 

The table below represents the Company’s matching contributions as follows:

 

   For the year ended 
   December 31, 
   2023   2022 
Company matching contributions - Group Personal Pension Plan, U.K.  $140,000   $166,000 

 

NOTE 21 — CONCENTRATIONS

 

Customer Concentration Risk

 

During the year ending December 31, 2023, the Company did not report any sales to an individual customer that constituted more than 10% of its total sales. Conversely, during the year ending December 31, 2022, the Company noted sales to a single customer amounting to $3,436,000, representing 12% of the Company’s total sales, in excess of 10% of its total sales.

 

As of December 31, 2023, and 2022, the Company’s accounts receivable from a single customer were recorded at approximately $1,111,000 (13%) and $1,138,000 (19%), respectively. Each instance surpassed the 10% mark of the Company’s total consolidated accounts receivable, indicating a significant concentration in customer receivables.

 

Vendor Concentration Risk

 

During the fiscal year ending December 31, the Company recorded $2,132,000 to a single vendor, exceeding 10% of the Company’s total consolidated vendor purchases. During the year ending December 31, 2022, there were no instances where the Company’s purchases from any single vendor exceeded 10% of its total annual consolidated inventory purchases.

 

However, on December 31 of 2023 and 2022, the Company recorded accounts payable to a particular vendor at approximately $652,000 (20%) and $273,000 (10%), respectively. Each amount exceeded 10% of the Company’s total consolidated accounts payable, highlighting a concentration risk associated with this vendor.

 

F-34
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 22 – REVENUE

 

The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:

 

   For the years ended 
   December 31, 
   2023   2022 
Primary geographical markets:          
North America  $13,501,000   $12,037,000 
South America   528,000    182,000 
Europe   6,420,000    8,958,000 
Asia   3,354,000    1,851,000 
Rest of World   3,679,000    5,103,000 
   $27,482,000   $28,131,000 
Primary revenue source:          
Equipment sales  $24,054,000   $25,667,000 
Installation, integration, and repairs   1,688,000    1,450,000 
Warranties   1,740,000    1,014,000 
   $27,482,000   $28,131,000 
Long-lived assets:          
United States  $2,767,000   $1,970,000 
Netherlands   20,000    27,000 
United Kingdom   3,723,000    4,912,000 
   $6,510,000   $6,909,000 

 

NOTE 23 — REBATES

 

The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary, which are included in other income.

 

   For the years ended 
   December 31, 
   2023   2022 
           
Total tax rebates  $331,000   $271,000 

 

While the Company plans to continue filing rebate forms for the 2023 fiscal year, it cannot guarantee that rebates will be available at a similar level or at all in future years.

 

F-35
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 24 — GAINS ON SETTLEMENT OF DEBT

 

The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2023, and 2022:

   2023   2022 
   For the Years Ended 
   December 31, 
   2023   2022 
         
On May 4, 2022, and July 19, 2022, the Company issued 38,703 shares of common stock on each date with an accumulated value of $54,184 in satisfaction of an amount payable of $80,000  $—   $25,816 
           
On November 21, 2022, the Company settled the dividends payable in the amount of $19,916 by issuing 47,419 Series A Preferred shares with a zero carrying value.   —    19,916 
           
Gains on settlement of debt  $—   $45,732 

 

F-36
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 25 — INCOME TAXES

 

The provision (benefit) for income taxes consists of the following:

 

   2023   2022 
   For the Years Ended 
   December 31, 
   2023   2022 
Current tax provision          
Federal  $—   $— 
State   4,400    25,000 
Current income tax expense, total   4,400    25,000 
Deferred tax provision (benefit)          
Federal   (982,000)   (532,000)
State   (2,457,000)   (427,000)
Foreign   (1,516,000)   (978,000)
Change in the valuation allowance   4,737,000    1,722,000 
Total deferred tax provision (benefit)   (218,000)   (215,000)
           
Income tax provision  $(214,000)  $(190,000)

 

A reconciliation of the statutory tax rate to the effective tax rate is as follows:

 

   2023   2022 
   For the Years Ended 
   December 31, 
   2023   2022 
Statutory federal income tax rate   21.00%   21.00%
State and local taxes, net of federal benefit   1.15    0.30 
Permanent differences   0.49    5.28 
Executive compensation   0.00    (2.26)
Equity compensation   (3.63)   (11.06)
Provision to return   7.49    0.00 
DTA adjustment for state NOL   0.00    0.00 
Foreign Rate Differential   1.44    (1.27)
Change rate   27.13    2.66 
Valuation allowance   (52.73)   (13.27)
Effective tax rate   2.34%   1.37%

 

Under the provisions of ASC 740, the Company may recognize the benefits of uncertain tax positions when it is more likely than not that the merits of the position(s) will be sustained upon audit by the relevant tax authorities. No uncertain tax positions were taken or expected on a tax return that would be determined to be an unrecognized tax benefit recorded on the Company’s financial statements for the years ended December 31, 2023, or 2022. The Company does not expect its unrecognized tax benefit position to change during the next twelve months.

 

F-37
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 25 — INCOME TAXES (continued) 

 

Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial accounting purposes and the amounts used for income tax reporting. Significant components of the Company’s deferred tax assets are as follows:

 

   2023   2022 
   For the Years Ended 
   December 31, 
   2023   2022 
Deferred Tax Assets          
Federal R&D credit  $3,007,000   $3,007,000 
Inventory   422,000    576,000 
Allowance for bad debt   73,000    72,000 
Compensation related   12,000    7,000 
Pension   55,000    72,000 
Other accruals   34,000    7,000 
State net operating losses   7,235,000    4,779,000 
Federal net operating losses   47,296,000    44,821,000 
Interest disallowance   1,150,000    1,151,000 
Stock options   6,995,000    7,172,000 
Other   465,000    296,000 
Valuation Allowance   (66,468,000)   (61,731,000)
Total Deferred Tax Assets   276,000    229,000 
Deferred Tax Liabilities          
Property and Equipment   (178,000)   (90,000)
Intangibles   (616,000)   (870,000)
Prepaid Expenses   (29,000)   (33,000)
Total Deferred Tax Liabilities   (822,000)   (993,000)
Net Deferred Tax Liability  $(546,000)  $(764,000)

 

As of December 31, 2023, the Company has federal net operating losses (“NOL”) of approximately $187.3 million that will expire beginning in 2027. The Company has federal NOLs of approximately $30.6 million that may be carried forward indefinitely. The Company also has state NOL carryforwards of $160.9 million, which will expire beginning in 2027. Besides, the Company has foreign NOL carryforwards of approximately $30.6 million that generally do not expire except under certain circumstances. The Company also has research and development credits of approximately $3.0 million, which will begin to expire in 2027. The years that remain open for review by taxing authorities are 2020 to 2023 for Federal, Foreign, and State Income Tax returns. Finally, the federal and state NOLs and various income tax credits are subject to annual limitations under Sections 382 and 383 of the Internal Revenue Code, in addition to state provisions, and may not be able to be fully realized.

 

Realizing the NOL carryforwards and other temporary deferred tax differences is contingent on future taxable earnings. The Company’s deferred tax assets were reviewed for expected utilization using a “more likely than not” approach by assessing the available positive and negative evidence surrounding its recoverability. Accordingly, a valuation allowance has been recorded against the Company’s deferred tax assets, as it was determined, based on past and present losses, that it was “more likely than not” that the Company’s deferred tax assets would not be realized. The valuation allowance was increased to the full carrying amount of the Company’s deferred tax assets. In future years, if management determines that the deferred tax assets are “more likely than not” to be realized, the recognized tax benefits relating to reversing the valuation allowance will be recorded. The Company will continue to assess and evaluate strategies that enable the deferred tax asset, or portion thereof, to be utilized. It will reduce the valuation allowance appropriately when it is determined that the “more likely than not” criteria are satisfied.

 

The net operating loss carryovers may be subject to annual limitations under Internal Revenue Code Section 382 and similar state provisions should there be a greater than 50% ownership change as determined under the applicable income tax regulations. The limitation amount would be determined based on the company’s value immediately before the ownership change, and subsequent ownership changes could further impact the annual limitation amount. An ownership change under Section 382 may have occurred in the past or could happen in the future, such that the NOLs available for utilization could be significantly limited. The Company plans to perform a Section 382 analysis in the future.

 

F-38
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 25 — INCOME TAXES (continued)

 

Effective for tax years beginning after December 31, 2017, the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary.

 

For tax years beginning after December 31, 2017, the Tax Act introduced a new limitation on the deduction of interest expense. Current-year interest deductions are limited (among other restrictions) to 30% of adjusted taxable income, with various modifications and exceptions. The Company does incur interest expenses and evaluates each year the impact, if any, of the new limitation.

 

The Company has not provided for deferred taxes and foreign withholding taxes on the excess of the financial reporting basis over the tax basis in our investments in foreign subsidiaries that are nearly permanent in duration. In general, it is the Company’s practice and intention to reinvest our foreign subsidiary’s earnings in those operations. Generally, our foreign subsidiary’s earnings have become subject to U.S. taxation based on specific U.S. tax law provisions, such as the recently enacted territorial transition tax under section 965 and under certain other circumstances. Due to the complexities of the provisions introduced with the Tax Act, and the underlying assumptions that would have to be made, it is not practicable to estimate the amount of tax provision required to account for these foreign undistributed earnings. The Company will account for any additional expense or deduction in the year it is claimed. The Company will continue to review each year whether this treatment is appropriate.

 

The Company did not identify any material uncertain tax positions and is not under any income tax examinations.

 

NOTE 26 — RECLASSIFICATION OF PRIOR YEAR PRESENTATION

 

For consistency in financial reporting, we’ve updated the presentation of our prior period financial statements. This involved reclassifying certain items for the fiscal years ending December 31, 2023, and December 31, 2022, to align with this year’s reporting standards. The adjustments were only for presentation and did not affect our overall financial results.

 

NOTE 27 — SUBSEQUENT EVENTS

 

Under ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2023, and has determined that it does not have any other material subsequent events to disclose in these financial statements except for the following:

 

On February 12, 2024, Vislink Poway, LLC signed a renewal agreement with CPI Apartment Fund 10 LLC for the premises at 13475 Danielson Street, Suite 100, 130, and 160, Poway, California. The renewal term is set for one year and ten and a half months, commencing on March 14, 2024, and ending on January 31, 2026. The base rent for the renewal period is established at $22,926 per month.

 

F-39

 

 EX-4.3 2 ex4-3.htm

 

Exhibit 4.3

 

DESCRIPTION OF SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

As of December 31, 2023, Vislink Technologies, Inc. (the “Company,” “we,” “us,” or “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, par value $0.00001 per share (the “Common Stock).

 

General

 

The following description of our capital stock and specific provisions of our Certificate of Incorporation and Bylaws are summaries and are qualified by reference to our Certificate of Incorporation and Bylaws. Copies of these documents can be accessed through hyperlinks to those documents in the list of exhibits in our Annual Report on Form 10-K for the fiscal year ending December 31, 2023.

 

Our authorized capital stock comprises 100,000,000 shares of common stock, a par value of $0.00001 per share, and 10,000,000 shares of  “blank check” preferred stock. As of March 20, 2024, we had 2,447,975 shares of common stock issued and outstanding, and no shares of preferred stock were outstanding.

 

Common Stock

 

Voting Rights

 

Each stockholder has one vote for each share of Common Stock held on all matters submitted to a vote of stockholders. A stockholder may vote in person or by proxy. A plurality of the votes cast determines the elections of directors. Because our stockholders do not have cumulative voting rights, stockholders holding a majority of the voting power of our shares of Common Stock will be able to elect all of our directors. Our Certificate of Incorporation and Bylaws provide that stockholder actions may be effected at a duly called meeting of stockholders or pursuant to the written consent of the majority of stockholders. A special meeting of stockholders may be called by the majority of our Board of Directors or by a committee determined by the Board of Directors with the power to call such meetings.

 

Dividend Rights

 

The holders of outstanding shares of Common Stock are entitled to receive dividends out of funds legally available at times and in the amounts that our Board of Directors may determine, provided that required dividends, if any, on the preferred stock have been paid or provided. However, to date, we have not paid or declared cash distributions or dividends on our common stock and do not currently intend to pay cash dividends on our common stock in the foreseeable future. The Board of Directors will determine the declaration of cash dividends in the future based on our earnings, financial condition, capital requirements, and other relevant factors. To finance our operations, we intend to retain all earnings if and when generated.

 

No Preemptive or Similar Rights

 

Holders of our Common Stock do not have preemptive rights, and our Common Stock is not convertible or redeemable.

 

Right to Receive Liquidation Distributions

 

Upon our dissolution, liquidation, or winding-up, the assets legally available for distribution to our stockholders and remaining after payment to holders of preferred stock of the amounts, if any, to which they are entitled are distributable ratably among the holders of our common stock subject to any senior class of securities.

 

 

 

 

Anti-Takeover Provisions

 

The authorization of undesignated preferred stock makes it possible for our Board of Directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change our control. Provisions such as these, which are intended to make an acquisition of control by a third party more difficult, are designed to enhance the likelihood of continued stability in the composition of our Board of Directors and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of us. These provisions are also designed to reduce our vulnerability to an unsolicited acquisition proposal and discourage certain tactics used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of deterring hostile takeovers or delaying changes in our control or management. Consequently, these provisions also may inhibit fluctuations in the market price of our stock that may result from actual or rumored takeover attempts.

 

Our Certificate of Incorporation and Bylaws

 

Our certificate of incorporation and bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our company, including the following:

 

  ● No Cumulative Voting. The Delaware General Corporation Law (“DGCL”) provides that stockholders are denied the right to cumulate votes in the election of directors unless the company’s certificate of incorporation provides otherwise. Our amended and restated certificate of incorporation does not provide for cumulative voting.
     
  ● Special Meetings of Stockholders and Stockholder Action by Written Consent. Our certificate of incorporation and bylaws provide that all stockholder actions must be effected at a duly called meeting of stockholders and eliminate the right of stockholders to act by written consent without a meeting. Our bylaws also provide that only our chairman of the board, Chief Executive Officer (or if there is no Chief Executive Officer, the President) or the board of directors, pursuant to a resolution adopted by a majority of the total number of authorized directors may call a special meeting of stockholders.
     
  ● Advance Notice Requirements for Stockholder Proposals. Our bylaws provide that stockholders seeking to present proposals before a meeting of stockholders, including the nomination of director candidates, must provide timely advance notice in writing and specifies requirements as to the form and content of a stockholder’s notice.
     
  ● Amendment to Certificate of Incorporation and Bylaws. Our certificate of incorporation and bylaws provide that the stockholders cannot amend the provisions described above except by a vote of 66 2/3% or more of our outstanding common stock.

 

These provisions are intended to enhance the likelihood of continued stability in the composition of our Board and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and discourage tactics used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of delaying changes in our control or management. Consequently, these provisions may also inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts. We believe that the benefits of these provisions, including increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals because negotiation of takeover proposals could result in an improvement of their terms.

 

Choice of Forum

 

Our certificate of incorporation provides that the Court of Chancery of the state of Delaware (the “Chancery Court”) is the exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim for breach of a fiduciary duty owed by any director, officer, employee or agent of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL, the Corporation’s certificate of incorporation or by-laws or (iv) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein.

 

 

 

 

This exclusive forum provision does not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934 (the “Exchange Act”)or any other claim for which the federal courts have exclusive jurisdiction. To the extent that any such claims may be based upon federal law claims, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Our bylaws further provide that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. However, stockholders cannot waive compliance with the federal securities laws and the rules and regulations thereunder. The enforceability of similar choice of forum provisions in some other companies’ bylaws has been challenged in legal proceedings, and it is possible that, in connection with any action, a court could find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable.

 

Section 203 of the DGCL

 

We are subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in any “business combination” with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder. In general, Section 203 defines an “interested stockholder” as an entity or person who, together with the person’s affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.

 

We are subject to Section 203 with the following exceptions:

 

  ● before the date that such a stockholder became an interested stockholder, the Board of Directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;
     
  ● upon closing of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
     
  ● on or after such date that such stockholder became an interested stockholder, the business combination is approved by the Board of Directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that the interested stockholder does not own.

 

In general, Section 203 defines business combination to include the following:

 

  ● any merger or consolidation involving the corporation and the interested stockholder;
     
  ● any sale, transfer, pledge, or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;
     
  ● subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;
     
  ● any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or
     
  ● guarantees, pledges or other financial benefits provided by or through the corporation.

 

Transfer Agent, Warrant Agent, and Registrars

 

Our transfer agent and registrar for our Common Stock in the United States is Continental Stock Transfer & Trust Company. Our Common Stock is listed on the Nasdaq Capital Market under the symbol “VISL.”

 

Series A Preferred Stock

 

On March 24, 2023, the Company filed a certificate of elimination (the “Certificate of Elimination”), with the Secretary of State of the State of Delaware with respect to the Series A Preferred Stock, par value $0.00001 per share (the “Series A Preferred Stock”). The Certificate of Elimination (i) eliminated the previous designation of 47,500 shares of Series A Preferred Stock from the Company’s Certificate of Incorporation, none of which were outstanding at the time of the filing of such Certificate of Elimination, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of Preferred Stock.

 

 

 EX-4.11 3 ex4-11.htm

 

Exhibit 4.11

 

DESCRIPTION OF SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

As of December 31, 2022, Vislink Technologies, Inc. (the “Company,” “we,” “us,” or “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, par value $0.00001 per share (the “Common Stock).

 

General

 

The following description of our capital stock and specific provisions of our Certificate of Incorporation and Bylaws are summaries and are qualified by reference to our Certificate of Incorporation and Bylaws. Copies of these documents can be accessed through hyperlinks to those documents in the list of exhibits in our Annual Report on Form 10-K for the fiscal year ending December 31, 2022.

 

Our authorized capital stock comprises 100,000,000 shares of common stock, a par value of $0.00001 per share, and 10,000,000 shares of ”blank check” preferred stock. As of March 20, 2024, we had 2,447,975 shares of common stock issued and outstanding, and no shares of preferred stock were outstanding.

 

Common Stock

 

Voting Rights

 

Each stockholder has one vote for each share of Common Stock held on all matters submitted to a vote of stockholders. A stockholder may vote in person or by proxy. A plurality of the votes cast determines the elections of directors.

 

Because our stockholders do not have cumulative voting rights, stockholders holding a majority of the voting power of our shares of Common Stock will be able to elect all of our directors. Our Certificate of Incorporation and Bylaws provide that stockholder actions may be effected at a duly called meeting of stockholders or pursuant to the written consent of the majority of stockholders. A special meeting of stockholders may be called by the majority of our Board of Directors or by a committee determined by the Board of Directors with the power to call such meetings.

 

Dividend Rights

 

The holders of outstanding shares of Common Stock are entitled to receive dividends out of funds legally available at times and in the amounts that our Board of Directors may determine, provided that required dividends, if any, on the preferred stock have been paid or provided. However, to date, we have not paid or declared cash distributions or dividends on our common stock and do not currently intend to pay cash dividends on our common stock in the foreseeable future. The Board of Directors will determine the declaration of cash dividends in the future based on our earnings, financial condition, capital requirements, and other relevant factors. To finance our operations, we intend to retain all earnings if and when generated.

 

No Preemptive or Similar Rights

 

Holders of our Common Stock do not have preemptive rights, and our Common Stock is not convertible or redeemable.

 

Right to Receive Liquidation Distributions

 

Upon our dissolution, liquidation, or winding-up, the assets legally available for distribution to our stockholders and remaining after payment to holders of preferred stock of the amounts, if any, to which they are entitled are distributable ratably among the holders of our common stock subject to any senior class of securities.

 

Anti-Takeover Provisions

 

The authorization of undesignated preferred stock allows our Board of Directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change our control.

 

Provisions such as these, intended to make a third party’s acquisition of control more difficult, are designed to enhance the likelihood of continued stability in the composition of our Board of Directors and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of us.

 

These provisions are also designed to reduce our vulnerability to an unsolicited acquisition proposal and discourage certain tactics used in proxy fights. However, such provisions could prevent others from making tender offers for our shares and may deter hostile takeovers or delay changes in our control or management. Consequently, these provisions also may inhibit fluctuations in the market price of our stock that may result from actual or rumored takeover attempts.

 

 

 

 

Our Certificate of Incorporation and Bylaws

 

Our certificate of incorporation and bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our company, including the following:

 

 

 

 ● No Cumulative Voting. The Delaware General Corporation Law (“DGCL”) provides that stockholders are denied the right to cumulate votes in the election of directors unless the company’s certificate of incorporation provides otherwise. Our amended and restated Certificate of Incorporation does not provide for cumulative voting.
     
  ● Special Meetings of Stockholders and Stockholder Action by Written Consent. Our Certificate of Incorporation and Bylaws provide that all stockholder actions must be effected at a duly called meeting of stockholders and eliminate the right of stockholders to act by written consent without a meeting. Our Bylaws also provide that only our Board Chairperson, Chief Executive Officer (or if there is no Chief Executive Officer, the President), or the Board of Directors, pursuant to a resolution adopted by a majority of the total number of authorized directors, may call a special meeting of stockholders.
     
  ● Advance Notice Requirements for Stockholder Proposals. Our Bylaws require stockholders seeking to present proposals before a meeting of stockholders, including the nomination of director candidates, to provide timely advance notice in writing and specify requirements as to the form and content of a stockholder’s notice.
     
  ● Amendment to Certificate of Incorporation and Bylaws. Our Certificate of Incorporation and Bylaws provide that the stockholders cannot amend the provisions described above except by a vote of 66 2/3% or more of our outstanding common stock.

 

These provisions are intended to enhance the likelihood of continued stability in the composition of our Board and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and discourage tactics used in proxy fights. However, such provisions could prevent others from making tender offers for our shares and may delay changes in our control or management. Consequently, these provisions may also inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts. We believe that the benefits of these provisions, including increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals because negotiation of takeover proposals could result in an improvement of their terms.

 

Choice of Forum

 

Our certificate of incorporation provides that the Court of Chancery of the state of Delaware (the “Chancery Court”) is the exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim for breach of a fiduciary duty owed by any director, officer, employee or agent of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL, the Corporation’s certificate of incorporation or by-laws or (iv) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein.

 

This exclusive forum provision does not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934 (the “Exchange Act”)or any other claim for which the federal courts have exclusive jurisdiction. To the extent that any such claims may be based upon federal law claims, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder.

 

Our Bylaws further provide that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. However, stockholders cannot waive compliance with the federal securities laws and the rules and regulations thereunder. The enforceability of similar choice of forum provisions in some other companies’ bylaws has been challenged in legal proceedings, and it is possible that, in connection with any action, a court could find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable.

 

 

 

 

Section 203 of the DGCL

 

We are subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in any “business combination” with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder. In general, Section 203 defines an “interested stockholder” as an entity or person who, together with the person’s affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.

We are subject to Section 203 with the following exceptions:

 

  ● before the date that such a stockholder became an interested stockholder, the Board of Directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;
     
  ● upon closing of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
     
  ● on or after such date that such stockholder became an interested stockholder, the business combination is approved by the Board of Directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that the interested stockholder does not own.

 

In general, Section 203 defines business combination to include the following:

 

  ● any merger or consolidation involving the corporation and the interested stockholder;
     
  ● any sale, transfer, pledge, or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;
     
  ● subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;
     
  ● any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or
     
  ● guarantees, pledges or other financial benefits provided by or through the corporation.

 

Transfer Agent, Warrant Agent, and Registrars

 

Continental Stock Transfer & Trust Company is our transfer agent and registrar for our Common Stock in the United States. Our Common Stock is listed on the Nasdaq Capital Market under the symbol “VISL.”

 

 

 

 EX-21.1 4 ex21-1.htm

 

Exhibit 21.1

List of Subsidiaries of Vislink Technologies, Inc.

 

Subsidiary   Jurisdiction of Incorporation or Organization
Vislink, LLC   State of Delaware
Vislink, Ltd.   United Kingdom
Vislink Poway, LLC   State of Delaware
Mobile Viewpoint, B.V.   Netherlands

 

 

 

 EX-23.1 5 ex23-1.htm

 

Exhibit 23.1

 

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

 

We consent to the incorporation by reference in this Registration Statement of Vislink Technologies, Inc. on Forms S-3 File Nos. 333-228793 and 333-238013 and Forms S-8 File Nos. 333-274366, 333-270912, 333-264124, 333-255305, 333-233849, 333-233848, 333-224107, 333-224106, 333-224105, 333-215461, 333-214658, 333-212621, 333-210773, 333-208313, 333-206486, 333-205687, and 333-203399 of our report dated April 3, 2024, with respect to our audits of the consolidated financial statements of Vislink Technologies, Inc. as of December 31, 2023 and for the years ended December 31, 2023 and 2022 appearing in the Annual Report on Form 10-K of Vislink Technologies, Inc. for the year ended December 31, 2023.

 

/s/ Marcum LLP  
   
Marcum LLP  
New York, NY  
April 3, 2024  

 

 

 

 EX-31.1 6 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION

OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Carleton M. Miller, certify that:

 

1. I have reviewed this annual report on Form 10-K of Vislink Technologies, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared.

 

(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether material, involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 3, 2024  
   
  /s/ Carleton M. Miller
  Carleton M. Miller
  Chief Executive Officer

 

 

 

 EX-31.2 7 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION

OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Michael C. Bond, certify that:

 

1. I have reviewed this annual report on Form 10-K of Vislink Technologies, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether material, involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 3, 2024  
   
  /s/ Michael C. Bond
  Michael C. Bond
  Chief Financial Officer

 

 

 

 EX-32.1 8 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION

OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Vislink Technologies, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Carleton M. Miller, Chief Executive Officer of Vislink Technologies, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 3, 2024  
   
  /s/ Carleton M. Miller
  Carleton M. Miller
  Chief Executive Officer

 

 

 

 EX-32.2 9 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION

OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Vislink Technologies, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Carleton M. Miller, Chief Executive Officer of Vislink Technologies, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 3, 2024  
   
  /s/ Michael C. Bond
  Michael C. Bond
  Chief Financial Officer

 

 

 

 EX-97.1 10 ex97-1.htm

 

Exhibit 97.1

 

VISLINK TECHNOLOGIES, INC.

 

CLAWBACK POLICY

 

Introduction

 

Vislink Technologies, Inc. (the “Company”) believes that it is in the best interests of the Company and its stockholders to create and foster a culture of business ethics, integrity and accountability, and that, among other purposes, reinforces the Company’s incentive compensation philosophy.

 

The Board of Directors (the “Board”) therefore adopts this policy to provide for the Company’s recovery of certain compensation in the event of an accounting restatement of the Company’s financial statements resulting from material noncompliance with applicable financial reporting requirements under the federal securities laws (this “Policy”).

 

This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations promulgated thereunder.

 

General Administration

 

This Policy shall be administered by the Board or, if so designated by the Board, the Compensation Committee of the Board, in which case references herein to the Board shall be deemed to be references to the Compensation Committee of the Board. Any determinations made by the Board in respect of this Policy, or to matters as to this Policy’s amendment, enforcement, or otherwise, shall be final and binding on all individuals governed under this Policy as well as any related actions or procedures carried out by the Company’s Executive Officers (as defined herein) that are deemed necessary, appropriate, or advisable to effectuate the purposes of this Policy.

 

Applicability

 

This Policy applies to the Company’s current and former Executive Officers, as determined by the Board in accordance with Section 10D of the Exchange Act and the listing standards of the national securities exchange on which the Company’s securities are listed (such as Section 303A.14 of the New York Stock Exchange’s listing standards or Rule 5608 of Nasdaq’s listing rules, which are each approved by the U.S. Securities and Exchange Commission (the “SEC”) to implement Rule 10D-1 promulgated under the Exchange Act).

 

For purposes of this Policy, “Executive Officer” means the Company’s president, principal financial officer, principal accounting officer (or, if there is no such accounting officer, the controller); any vice president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance); any other officer who performs a policy-making function; and any other person who performs a function similar to a policy-making function on behalf of the Company. Executive officers of the Company’s parent(s) or subsidiaries are deemed Executive Officers of the Company if they perform such policy-making or similar functions for or on behalf of the Company.

 

This Policy also applies to other senior executives, employees, or classes of employees of the Company as may be determined by the Board in its sole discretion from time to time (together with Executive Officers, “Covered Persons”).

 

 

 

 

Recoupment

 

If the Company is required to prepare an accounting restatement of its financial statements, due to the Company’s material noncompliance with financial reporting requirements under the applicable federal securities laws (including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period) (an “Accounting Restatement”), without regard to any fault or misconduct of a Covered Person, then, the Board shall mandate the Company’s recovery, in the form of reimbursement, or forfeiture, as applicable (“Recoupment”), of any Excess Incentive Compensation (as defined herein) received by a Covered Person, provided that:

 

the receipt of any such Excess Incentive Compensation by a Covered Person occurred after the Covered Person became a Covered Person;

 

the Covered Person served as a Covered Person at any time during the performance period applicable to the Covered Person’s Incentive Compensation (as defined herein);

 

the Company had a class of securities listed on a national securities exchange or a national securities association during the Covered Person’s service as a Covered Person and during the performance period applicable to the Covered Person’s Incentive Compensation; and

 

the receipt of the Excess Incentive Compensation by the Covered Person occurred during the three completed fiscal years immediately preceding the date that the Company is required to prepare an Accounting Restatement, or during any transition period (that results from a change in the Company’s fiscal year) within or immediately following such three completed fiscal years.

 

For purposes of this Policy, a transition period between the last day of the Company’s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months is a completed fiscal year.

 

For purposes of this Policy, any Incentive Compensation is deemed to be “received” by a Covered Person at the point in time when a Financial Reporting Measure (as defined herein), as specified in a Covered Person’s incentive compensation agreement (or other equity or incentive compensation plan of the Company) providing for a Covered Person’s compensation that is contingent upon or tied to the attainment of a Financial Reporting Measure, is attained during the relevant fiscal period of the Company.

 

Therefore, under this Policy, a Covered Person is deemed to receive Incentive Compensation even if, for instance, the payment or grant of Incentive Compensation occurs after the end of the relevant fiscal period of the Company.

 

For purposes of this Policy, the date on which the Company is required to prepare an Accounting Restatement is deemed to have occurred on the earlier of (i) the date the Board concludes, or reasonably should have concluded, that the Company’s previously issued financial statements contain a material error and (ii) the date a court, regulator, or other legally authorized body directs the Company to restate its previously issued financial statements to correct a material error.

 

The Company’s obligation to seek Recoupment of a Covered Person’s Excess Incentive Compensation is not dependent on whether or when the restated financial statements are filed with the SEC.

 

 

 

 

Incentive Compensation; Financial Reporting Measures

 

For purposes of this Policy, “Incentive Compensation” means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure.1

 

Incentive Compensation includes (but is not limited to):

 

● Annual bonuses and other short- and long-term cash incentives;
   
● Stock options;
   
● Stock appreciation rights;
   
● Restricted stock;
   
● Restricted stock units;
   
● Performance shares; and
   
● Performance units.

 

For purposes of this Policy, “Financial Reporting Measure” means a measure that is determined and presented in accordance with the generally accepted accounting principles used in preparing the Company’s financial statements, or any measure that is derived wholly or in part therefrom. For avoidance of doubt, a Financial Reporting Measure need not be presented within the Company’s financial statements or included in a filing with the SEC.

 

Financial Reporting Measures include (but are not limited to):

 

● Company stock price;
   
● Total shareholder return;
   
● Revenues;
   
● Net income;
   
● Earnings before interest, taxes, depreciation and amortization, EBITDA, or adjusted EBITDA;
   
● Funds from operations;
   
● Liquidity measures, such as working capital or operating cash flow;
   
● Return measures, such as return on invested capital or return on assets; and
   
● Earnings measures, such as earnings per share.

 

 

1 Equity awards that vest exclusively upon completion of a specified employment period, without any performance condition, and bonus awards that are discretionary or exclusively based on subjective goals or goals unrelated to Financial Reporting Measures do not constitute Incentive Compensation under this Policy.

 

 

 

 

Excess Incentive Compensation

 

The amount subject to Recoupment is any Incentive Compensation received by a Covered Person that is determined by the Board, in good faith and upon the exercise of due care, to have been based on erroneous information that caused the Company’s material noncompliance with financial reporting requirements under the federal securities laws (without regard to any fault or misconduct of a Covered Person), which would not have been received by a Covered Person had the Incentive Compensation of a Covered Person been based on the restated financial statements’ results (“Excess Incentive Compensation”).

 

If the Board cannot calculate Excess Incentive Compensation received by a Covered Person from the information in an Accounting Restatement (i.e., the amount of Excess Incentive Compensation is not subject to mathematical recalculation directly from the information in an Accounting Restatement), then, the Board shall determine such Excess Incentive Compensation based on a reasonable estimate of the effect of such Accounting Restatement on the applicable Financial Reporting Measures upon which the Excess Incentive Compensation was received and in consideration of all facts relevant to the Company’s Recoupment of Excess Incentive Compensation received by a Covered Person in the circumstances.

 

The Company shall maintain documentation of any such reasonable estimates and provide such documentation, when and if reasonably requested, to the applicable national securities exchange on which the Company’s securities are listed in accordance with the applicable standards or rules of the national securities exchange.

 

With respect to Incentive Compensation based in part or whole on stock price or measures of shareholder return, the Board shall calculate Excess Incentive Compensation relating thereto in such manner as the Board deems appropriate or reasonable.

 

In no event shall the Company be required to award a Covered Person additional Incentive Compensation if the restated financial statements’ results would have resulted in the provision of Incentive Compensation that is higher in monetary value relative to the monetary value received by a Covered Person prior to the Accounting Restatement.

 

Recoupment Method

 

The Board shall determine in its sole discretion, to be exercised in good faith, and not inconsistent with applicable law, the method for Recoupment of a Covered Person’s Excess Incentive Compensation, which may include, without limitation, one or more of the following acts:

 

  (a) mandating reimbursement of cash-based Incentive Compensation previously paid to a Covered Person;
     
  (b) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based Incentive Compensation of a Covered Person;
     
  (c) offsetting the recouped amount from any compensation otherwise owed by the Company to a Covered Person;
     
  (d) cancelling outstanding vested or unvested equity-based Incentive Compensation of a Covered Person; and
     
  (e) taking any other remedial and recovery action not disallowed by applicable law, as determined by the Board, consistent with Sections 4, 6, 10, and 13 under this Policy.

 

 

 

 

The Board shall, in the exercise of its fiduciary duty to safeguard the assets of the Company (including the time value of any potentially recoverable Incentive Compensation), and, in the light of the particular facts and circumstances of a Covered Person who is determined by the Board to owe Excess Incentive Compensation to the Company, pursue the most appropriate balance of cost and speed in determining the means to seek Recoupment of a Covered Person’s Excess Incentive Compensation.

 

Consistent with this Section 7 and Rule 10D-1 of the Exchange Act, regardless of the means of Recoupment used, the Board intends that Recoupment of a Covered Person’s Excess Incentive Compensation shall be effected by the Company reasonably promptly. The Board further intends that the administration of this Policy shall abide by the Company’s recognition that what is reasonable may depend on the additional cost incident to Recoupment.

 

No Indemnification

 

In no event shall the Company indemnify any Covered Persons against the loss of any incorrectly awarded Incentive Compensation pursuant to Rule 10D-1 and applicable stock exchange listing rules.

 

Cooperation

 

Covered Persons shall facilitate the Company’s compliance with its disclosure obligations relating to this Policy in accordance with the requirements of the federal securities laws and applicable stock exchange listing rules.

 

Interpretation

 

Consistent with Section 2 of this Policy, the Board shall be authorized to construe and interpret this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy in accordance with the Company’s constitutional documents.

 

This Policy memorializes the Board’s intention that this Policy be interpreted in a manner that is consistent with Section 10D of the Exchange Act and any applicable rules, regulations, or standards adopted by the SEC (such as Rule 10D-1) and those adopted by the national securities exchange on which the Company’s securities are listed as well as any other relevant law, in each case as in effect from time to time (the “Applicable Rules”).

 

To the extent the Applicable Rules require recovery of Incentive Compensation in additional circumstances beyond those specified above, nothing in this Policy shall be deemed to limit or restrict the right or obligation of the Company to recover Incentive Compensation to the fullest extent required by the Applicable Rules.

 

Effective Date

 

This Policy is effective as of October 2, 2023 (the “Effective Date”) and shall be duly adopted by the Board in accordance with the Company’s constitutional documents. This Policy shall apply to all Incentive Compensation that is received by Covered Persons on or after the Effective Date.

 

 

 

 

Amendment; Termination

 

Consistent with Section 2 of this Policy, the Board may amend this Policy from time to time in its sole discretion and shall amend this Policy as the Board deems necessary or proper to (i) reflect any modification to the rules and regulations adopted by the SEC interpreting Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules and regulations adopted by the SEC under Section 10D of the Exchange Act and to (ii) comply with any rules or standards adopted by a national securities exchange on which the Company’s securities are listed.

 

The Board may, but is not required to, reassess the contents of this Policy on a yearly basis as part of the Company’s analysis of material risks.

 

The Board may terminate this Policy at any time.

 

Other Recoupment Rights

 

The Board intends that this Policy shall be applied to the fullest extent of the law.

 

In the Board’s good-faith determination, the Board may require that any employment agreement, equity award agreement, or similar enforceable agreement by and between the Company and a Covered Person entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, be amended and restated, or otherwise validly modified or supplemented, under the governing law of any such agreement, to require a Covered Person to agree to abide by the terms of this Policy.

 

All of the Company’s actions or powers associated with Recoupment contemplated by this Policy are in addition to, and not in lieu of, any contract or other rights of a compensation-recovery nature that may be available to the Company (including, without limitation, any right of repayment, forfeiture, or right of offset against any employees that is required pursuant to any statutory repayment requirement (regardless of whether implemented at any time prior to or following the adoption or amendment of this Policy), including Section 304 of the Sarbanes-Oxley Act of 2002 (“SOX”)).

 

Any amounts paid to the Company in accordance with Section 304 of SOX shall be considered by the Company in determining any amounts recovered under this Policy.

 

The application and enforcement of this Policy does not preclude the Company from taking any other action to enforce a Covered Person’s obligations to the Company, including termination of employment or institution of legal proceedings. Nothing in this Policy restricts the Company from seeking Recoupment under any other compensation recoupment-based policy or any applicable provisions in plans, agreements, awards, or other arrangements that contemplate the recovery of compensation from a Covered Person.

 

If a Covered Person fails to repay Excess Incentive Compensation that is owed to the Company under this Policy, then, the Company shall take all appropriate action to recover such Excess Incentive Compensation from the Covered Person, and the Covered Person shall be required to reimburse the Company for all expenses (including legal expenses) incurred by the Company in recovering such Excess Incentive Compensation.

 

Impracticability

 

The Board shall mandate Recoupment of any Excess Incentive Compensation of a Covered Person in accordance with this Policy unless effecting Recoupment would be impracticable, as the Compensation Committee of the Board may so determine (i) in consistence with its fiduciary duties owed to the Company’s shareholders and (ii) in accordance with Rule 10D-1 of the Exchange Act and the applicable listing standards of the national securities exchange on which the Company’s securities are traded.

 

 

 

 

Under Rule 10D-1 of the Exchange Act, a company’s obligation to recover any erroneously awarded compensation is subject only to the following limited instances in which recovery would be considered impracticable:

 

  (a) The direct expense paid to a third party to assist in enforcing the policy would exceed the amount to be recovered after a company has made and documented a reasonable attempt to recover;
     
  (b) Recovery would violate home country law where that law was adopted prior to November 28, 2022, and the issuer provides an opinion of home country counsel to the exchange; or
     
  (c) Recovery would likely cause an otherwise tax-qualified retirement plan to fail to meet the requirements of the Internal Revenue Code of 1986, as amended.

 

Therefore, the Board intends that this Policy shall be implemented in a manner that follows the aforementioned exceptions (as applicable to the Company), and that Recoupment of any Excess Incentive Compensation of a Covered Person under this Policy shall be mandatory unless one of the exceptions under Rule 10D-1 apply.

 

Severability

 

If any provision of this Policy or the application of such provision to any Covered Person shall be adjudicated to be invalid, illegal, or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provisions of this Policy, and the invalid, illegal, or unenforceable provisions shall be deemed amended to the minimum extent necessary to render any such provision (or the application of such provision) valid, legal or enforceable.

 

Successors

 

This Policy shall be binding and enforceable against all Covered Persons and their beneficiaries, heirs, executors, administrators, or other legal representatives.

 

 

 

 

VISLINK TECHNOLOGIES, INC.

CLAWBACK POLICY

 

ACKNOWLEDGEMENT AND AGREEMENT FORM

 

By signing below, the undersigned acknowledges and confirms that the undersigned has received and reviewed a copy of the Vislink Technologies, Inc. (the “Company”) Clawback Policy (the “Policy”).

 

By signing this Acknowledgement and Agreement Form, the undersigned acknowledges and agrees that the undersigned is and will continue to be subject to the Policy, and that the Policy will apply both during and after the undersigned’s employment with the Company. Further, by signing below, the undersigned agrees to abide by the terms of the Policy, including, without limitation, by returning any Excess Incentive Compensation (as defined in the Policy) reasonably promptly to the Company to the extent required by, and in a manner consistent with, the Policy.

 

In addition, by signing below, the undersigned acknowledges that the Policy applies to all Incentive Compensation (as defined in the Policy); agrees to waive any legal right that might conflict or otherwise interfere with the Company’s Recoupment (as defined in the Policy) of any Excess Incentive Compensation in consistence with the terms of the Policy; and acknowledges that the Company may seek Recoupment of any Excess Incentive Compensation through any method of recovery it deems appropriate or necessary under the circumstances (which may include offsetting against any compensation payable to the undersigned, among other methods of recovery), as contemplated by Sections 7 and 13 under the Policy.

 

  COVERED PERSON
   
   
  Signature
   
   
  Printed Name
   
   
  Date

 

 

 GRAPHIC 11 form10-k_001.jpg begin 644 form10-k_001.jpg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
  •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end GRAPHIC 12 form10-k_002.jpg begin 644 form10-k_002.jpg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form10-k_003.jpg begin 644 form10-k_003.jpg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form10-k_004.jpg begin 644 form10-k_004.jpg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form10-k_006.jpg begin 644 form10-k_006.jpg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
    XML 26 R2.htm IDEA: XBRL DOCUMENT v3.24.1
    Consolidated Balance Sheets - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Current assets    
    Cash $ 8,482,000 $ 25,627,000
    Accounts receivable, net 8,680,000 6,007,000
    Inventories, net 14,029,000 12,021,000
    Investments held to maturity 5,731,000
    Prepaid expenses and other current assets 1,560,000 1,232,000
    Total current assets 38,482,000 44,887,000
    Right of use assets, operating leases 742,000 1,075,000
    Property and equipment, net 1,902,000 1,434,000
    Intangible assets, net 3,866,000 4,400,000
    Total assets 44,992,000 51,796,000
    Current liabilities    
    Accounts payable 3,183,000 2,626,000
    Accrued expenses 1,578,000 1,568,000
    Notes payable 84,000
    Operating lease obligations, current 463,000 455,000
    Customer deposits and deferred revenue 1,490,000 1,540,000
    Total current liabilities 6,714,000 6,273,000
    Operating lease obligations, net of current portion 755,000 1,107,000
    Deferred tax liabilities 546,000 764,000
    Total liabilities 8,015,000 8,144,000
    Commitments and contingencies (See Note 17)
    Series A Preferred stock, $0.00001 par value per share: -0- and 47,419 shares authorized on December 31, 2023, and 2022, respectively; -0- and 47,419 shares issued and outstanding on December 31, 2023, and 2022, respectively at a redemption value equal to $0.10 in cash for each ten thousand (10,000) whole shares.
    Stockholders’ equity    
    Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on December 31, 2023, and 2022, respectively
    Common stock value
    Additional paid-in capital 347,507,000 345,365,000
    Accumulated other comprehensive loss (1,027,000) (1,337,000)
    Treasury stock, at cost – 133 shares as of December 31, 2023, and 2022, respectively (277,000) (277,000)
    Accumulated deficit (309,226,000) (300,099,000)
    Total stockholders’ equity 36,977,000 43,652,000
    Total liabilities and stockholders’ equity $ 44,992,000 $ 51,796,000
    XML 27 R3.htm IDEA: XBRL DOCUMENT v3.24.1
    Consolidated Balance Sheets (Parenthetical) - $ / shares
    Dec. 31, 2023
    Dec. 31, 2022
    Preferred stock, par value $ 0.00001 $ 0.00001
    Preferred stock, shares authorized 10,000,000 10,000,000
    Common stock, par value $ 0.00001 $ 0.00001
    Common stock, shares authorized 100,000,000 100,000,000
    Common stock, shares issued 2,439,923 2,367,362
    Common stock, shares outstanding 2,439,790 2,367,229
    Treasury stock, shares 133 133
    Series A Preferred Stock [Member]    
    Temporary equity, par value $ 0.00001 $ 0.00001
    Temporary equity, shares authorized 0 47,419
    Temporary equity, shares issued 0 47,419
    Temporary equity, shares outstanding 0 47,419
    Temporary equity, redemption value per share $ 0.10 $ 0.10
    Temporary equity, redemption shares 10,000 10,000
    Preferred stock, shares authorized 0  
    XML 28 R4.htm IDEA: XBRL DOCUMENT v3.24.1
    Consolidated Statements of Operations and Comprehensive Loss - USD ($)
    shares in Thousands
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Income Statement [Abstract]    
    Revenue, net $ 27,482,000 $ 28,131,000
    Cost of revenue and operating expenses    
    Cost of components and personnel 13,380,000 15,204,000
    Inventory valuation adjustments 487,000 2,930,000
    General and administrative expenses 19,376,000 18,195,000
    Research and development 3,493,000 4,058,000
    Impairment of right-of-use assets 83,000 88,000
    Depreciation and amortization 1,261,000 1,722,000
    Total cost of revenue and operating expenses 38,080,000 42,197,000
    Loss from operations (10,598,000) (14,066,000)
    Other income (expenses)    
    Unrealized gain on investments in debt securities held to maturity 68,000
    Realized loss on investments in debt securities (82,000)
    Gain on settlement of debt 45,732
    Other income 332,000 303,000
    Dividend income 375,000
    Interest income (expense), net 560,000 (38,000)
    Total other income 1,253,000 311,000
    Net loss before income taxes (9,345,000) (13,755,000)
    Income taxes    
    Deferred tax benefits 218,000 215,000
    Net loss (9,127,000) (13,540,000)
    Dividends (20,000)
    Net loss attributable to common shareholders $ (9,127,000) $ (13,560,000)
    Net loss per share attributable to Common Shareholders:    
    Basic $ (3.83) $ (5.81)
    Diluted $ (3.83) $ (5.81)
    Weighted average number of shares outstanding:    
    Basic 2,381 2,335
    Diluted 2,381 2,335
    Comprehensive loss:    
    Unrealized gain on currency translation adjustment $ 310,000 $ 1,040,000
    Comprehensive loss $ (8,817,000) $ (12,500,000)
    XML 29 R5.htm IDEA: XBRL DOCUMENT v3.24.1
    Consolidated Statement of Changes in Stockholders' Equity - USD ($)
    Preferred Stock [Member]
    Series A Preferred Stock [Member]
    Common Stock [Member]
    Additional Paid-in Capital [Member]
    AOCI Attributable to Parent [Member]
    Treasury Stock, Common [Member]
    Retained Earnings [Member]
    Total
    Balance at Dec. 31, 2021 [1] $ 343,746,000 $ (297,000) $ (277,000) $ (286,539,000) $ 56,633,000
    Balance, shares at Dec. 31, 2021 [1] 2,287,651          
    Net loss (13,540,000) (13,540,000)
    Unrealized gain on currency translation adjustment (1,040,000) (1,040,000)
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders           (20,000) (20,000)
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares 47,419            
    Issuance of common stock in connection with:              
    Satisfaction of accounts payable vendor balance 54,000 54,000
    Satisfaction of accounts payable vendor balance, shares   3,870          
    Satisfaction of withholding tax upon conversion of restricted stock units
    Satisfaction of withholding tax upon conversion of restricted stock units, shares   17,889          
    Satisfaction with the conversion of restricted stock units
    Satisfaction with the conversion of restricted stock units, shares   57,952          
    Stock-based compensation 1,565,000 1,565,000
    Balance at Dec. 31, 2022 345,365,000 (1,337,000) (277,000) (300,099,000) 43,652,000
    Balance, shares at Dec. 31, 2022 47,419 2,367,362          
    Net loss (9,127,000) (9,127,000)
    Unrealized gain on currency translation adjustment 310,000 310,000
    Issuance of common stock in connection with:              
    Satisfaction of withholding tax upon conversion of restricted stock units
    Satisfaction of withholding tax upon conversion of restricted stock units, shares   14,193          
    Stock-based compensation 1,942,000 1,942,000
    Elimination of Series A Preferred Stock
    Elimination of Series A Preferred Stock, shares (47,419)            
    Compensation awards for services previously accrued 200,000 200,000
    Compensation awards for services previously accrued, shares   10,000          
    Satisfaction with the conversion of restricted stock unit awards
    Satisfaction with the conversion of restricted stock unit awards, shares   48,368          
    Balance at Dec. 31, 2023 $ 347,507,000 $ (1,027,000) $ (277,000) $ (309,226,000) $ 36,977,000
    Balance, shares at Dec. 31, 2023 2,439,923          
    [1] In connection with the reverse stock split implemented by the Company on May 1, 2023, the company’s stock transfer agent calculated a de minimus adjustment to the opening quantity of shares issued.
    XML 30 R6.htm IDEA: XBRL DOCUMENT v3.24.1
    Consolidated Statements of Cash Flows - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Cash flows used in operating activities    
    Net loss $ (9,127,000) $ (13,540,000)
    Adjustments to reconcile net loss to net cash used in operating activities    
    Gain on settlement of debt (45,732)
    Unrealized gain on investments in debt securities 68,000
    Realized loss on investments in debt securities (82,000)
    Accretion of bond discount 16,000
    Stock-based compensation 1,942,000 1,565,000
    Stock issuance commitments 200,000
    Provision for bad debt 25,000 21,000
    Recovery of bad debt (10,000) (517,000)
    Inventory valuation adjustments 487,000 2,930,000
    Amortization of right-of-use assets, operating assets 375,000 201,000
    Impairment of right-of-use assets 83,000 88,000
    Depreciation and amortization 1,261,000 1,722,000
    Deferred tax benefits (218,000) (215,000)
    Changes in assets and liabilities    
    Accounts receivable (2,666,000) 3,197,000
    Inventory (2,185,000) (3,731,000)
    Prepaid expenses and other current assets 200,000 1,897,000
    Accounts payable 559,000 (347,000)
    Accrued expenses and interest expense 218,000 (1,780,000)
    Accrued directors’ compensation (8,000)
    Operating lease liabilities (344,000) (506,000)
    Deferred revenue and customer deposits (342,000) (558,000)
    Net cash used in operating activities (9,748,000) (9,419,000)
    Cash flows used in investing activities    
    Cash used for investment in securities held to maturity (15,473,000)
    Cash used in asset acquisition (269,000)
    Proceeds for bond redemption 9,740,000
    Cash used for property and equipment (698,000) (466,000)
    Net cash used in investing activities (6,700,000) (466,000)
    Cash flows used in financing activities    
    Principal payments made on D & O notes payable (607,000) (765,000)
    Net cash used in financing activities (607,000) (765,000)
    Effect of exchange rate changes on cash (90,000) 46,000
    Net decrease in cash (17,145,000) (10,604,000)
    Cash and cash equivalents, beginning of the period 25,627,000 36,231,000
    Cash and cash equivalents, end of the period 8,482,000 25,627,000
    Supplemental disclosure of cash payments:    
    Cash paid during the period for interest 12,000 41,000
    Supplemental disclosure of non-cash information:    
    Notes payable recognized on D & O Insurance policy (Note 15) 523,000 750,000
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders 20,000
    Common stock issued in connection with:    
    Board compensation awards previously accrued 200,000 200,000
    Settlement of amounts due accounts payable 54,000
    ROU assets and operating lease obligations recognized (Note 16):    
    Operating lease assets recognized 125,000
    Less: non-cash changes to operating lease assets amortization    
    amortization (375,000) (201,000)
    impairments (83,000) (43,000)
    loss on lease impairments 83,000 (88,000)
    ROU assets and operating lease obligations recognized (375,000) (332,000)
    Operating lease liabilities recognized 125,000
    Less: non-cash changes to operating lease liabilities accretion (469,000) (506,000)
    Operating lease liabilities recognized $ (344,000) $ (506,000)
    XML 31 R7.htm IDEA: XBRL DOCUMENT v3.24.1
    NATURE OF OPERATIONS
    		 12 Months Ended
    Dec. 31, 2023
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    NATURE OF OPERATIONS

    NOTE 1 — NATURE OF OPERATIONS

     

    Vislink Technologies, Inc., (“Vislink”, “Company”, “we”, “us”, or “our”) incorporated in Delaware in 2006, is a global technology business that collects, delivers, and manages high-quality, live video and associated data from the action scene to the viewing screen. We provide solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. We also provide the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. Our team also offers professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in terrestrial microwave, fiber optic, surveillance, and wireless communications systems, delivering a broad spectrum of customer solutions.

     

    Live Broadcast:

     

    We deliver an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, cellular, IP (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing AI (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, we have the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions encompassing hardware components, hosted systems management platforms, related software licenses and ancillary support services.

     

    Industry-wide contributors acknowledge our live broadcast solutions. Our equipment transmits most outside wireless broadcast video content, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Our wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events. 

     

    Military and Government:

     

    We have developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Our solutions are specifically designed with interagency cooperation, utilizing the internationally recognized IP platform and a web interface for video delivery. We provide comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:

     

      ● integrated suites of airborne downlink transmitters, receivers, and antenna systems
      ● data and video connectivity for airborne, marine, and ground assets
      ● UAV video distribution
      ● flexible support for COFDM and bonded cellular/5G Networks
      ● terrestrial point-to-point
      ● tactical mobile command
      ● IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges
      ● high-throughput air/marine/ground-to-anywhere uplink and downlink systems
      ● secure live streaming platforms for use in mobile and fixed assets, and
      ● personal portable products

     

    Vislink Technologies, Inc. public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation, criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 1 — NATURE OF OPERATIONS (continued)

     

    Connected Edge Solutions:

     

    Our Mobile Viewpoint Technologies (MVP) offers the hardware and software solutions needed to acquire, produce, contribute to, and deliver video over all private and public networks. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:

     

      ● live video encoding, stream adaptation, decoding, and production solutions,
      ● remote production workflows,
      ● wireless cameras,
      ● AI-driven automated production, and
      ● the ability to contribute video over
        ○ bonded cellular (3G and 4G)
        ○ satellite,
        ○ fiber, and
        ○ emerging networks, including 5G and Starlink

     
    XML 32 R8.htm IDEA: XBRL DOCUMENT v3.24.1
    LIQUIDITY AND FINANCIAL CONDITION
    		 12 Months Ended
    Dec. 31, 2023
    Liquidity And Financial Condition  
    LIQUIDITY AND FINANCIAL CONDITION

    NOTE 2 — LIQUIDITY AND FINANCIAL CONDITION

     

    For the fiscal year ending December 31, 2023, we incurred a net loss of approximately $10.6 million and utilized $9.7 million in cash for operating activities. The Company maintained a working capital of $31.8 million, alongside $8.5 million in cash, against $309.2 million in accumulated deficits.

     

    Developments, including those beyond our control, may cause us to consume our available capital more quickly than we expect. These include potential economic conditions, including inflation, foreign exchange fluctuations, the markets we compete in or wish to enter, strategic acquisitions, our market strategy, research and development activities, regulatory matters, and technology and product innovations. We believe we will have sufficient funds to continue our operations for at least 12 months from the date of filing these financial statements in our Annual Report.

     

    Asset Acquisitions

     

    The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets.

     

    Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 33 R9.htm IDEA: XBRL DOCUMENT v3.24.1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
    		 12 Months Ended
    Dec. 31, 2023
    Accounting Policies [Abstract]  
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     

    Principles of Consolidation

     

    The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the Company’s accounts and wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating the Company’s subsidiaries.

     

    Segment Reporting

     

    The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.

     

    Use of Estimates

     

    Preparing the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our consolidated financial statements.

     

    Risks and Uncertainties

     

    The future impacts of the Russia-Ukraine war and the Israel-Hamas conflict, as well as their residual effects, include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries, remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Allowance for Credit Losses

     

    In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

     

    The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

     

    Cash and Cash Equivalents

     

    The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund as of December 31, 2023, and 2022.

     

    Concentrations

     

    The Company does not possess any off-balance-sheet concentrations of credit risk. Credit risk, defined as the likelihood of a counterparty defaulting on contractual obligations, poses a potential financial loss for the Company. The primary sources of the Company’s credit risk are its cash, investments and accounts receivable. To mitigate the risk of loss exposure, the Company follows a policy of holding its cash in high-credit quality financial institutions. Cash deposits, representing a concentration of credit risk, are the main economic instruments exposing the Company to such risks. The Company has allocated $5.7 million towards investments in government bonds held to maturity to diversify our credit risk exposure further and enhance our risk mitigation strategies. These bonds, issued by the United States Federal Government, are evaluated for credit risk based on the issuing entity’s creditworthiness. This investment strategy is aligned with our overarching objective to minimize potential financial losses by spreading risk across various high-credit quality assets and instruments. The Federal Deposit Insurance Corporation (“FDIC”) insures up to $250,000 for accounts held within the United States. In the United Kingdom, the Company maintains cash balance accounts at financial institutions insured by the Financial Services Compensation Scheme, covering up to £85,000 (subject to currency translation rates to the United States dollar). Additionally, in the Netherlands, the Company’s cash balance accounts at financial institutions are insured by the “Dutch deposit guarantee scheme,” providing coverage up to €100,000 per person per bank.

     

    As of December 31, 2023, and 2022, the Company held approximately $7.7 million and $24.5 million above insured limits, respectively, remaining unaffected by any losses in its bank accounts during this period.

     

    During the year ending December 31, 2023, the Company did not report any sales to an individual customer that constituted more than 10% of its total sales. During the year ending December 31, 2022, the Company noted sales to a single customer amounting to $3.4 million, representing 12% of the Company’s total sales, in excess of 10% of its total sales.

     

    As of December 31, 2023, and 2022, the Company’s accounts receivable from a single customer were recorded at approximately $1.1 million (13%) and $1.1 million (19%), respectively. Each instance surpassed the 10% mark of the Company’s total consolidated accounts receivable, indicating a significant concentration in customer receivables.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Accounts Receivable and Allowance for Doubtful Accounts

     

    On January 1, 2023, the Company adopted Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments. The Company extends credit to its customers in the ordinary course of business and has applied a new standard in evaluating estimated losses through an allowance for doubtful accounts. The Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

     

    Inventories

     

    Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.

     

    Investment in Debt Securities

     

    Vislink Technologies, Inc. invests in government bonds with the intent and ability to hold these investments until maturity. In alignment with ASC Topic 320, Investments—Debt and Equity Securities, such investments are classified as “Held-to-Maturity” (HTM) securities and are measured at amortized cost.

     

      ● Classification: The Company classifies its investments in government bonds as “Held-to-Maturity” (HTM) securities based on management’s intent and ability to hold the securities to maturity. These HTM securities are recognized in the Company’s financial statements at their amortized cost, adjusted for the amortization of premiums and accretion of discounts to maturity.
      ● Measurement: HTM securities are initially recognized at their acquisition cost, including transaction costs. Subsequently, they are measured at amortized cost using the effective interest method. This method considers the amortization of any discount or premium on the acquisition cost until maturity.
      ● Interest Income: Interest income is accrued using the security’s effective yield, reflecting the time value of money.
      ● Amortization of Discount and Premium: The amortization of the discount (or accretion of the premium) is included as part of the interest income recognized in the income statement, reflecting the adjustment to the investment’s yield.
      ● Impairment: The Company periodically assesses HTM investments for impairment if objective evidence indicates an impairment has been incurred. It recognizes any loss when the present value of estimated future cash flows, discounted at the original effective interest rate, is less than the carrying amount.
      ● Derecognition: A Held-to-Maturity investment is removed from the balance sheet when the right to receive cash flows has expired, or the Company has substantially transferred all ownership risks and rewards.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Business Combinations and Asset Acquisitions

     

    The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.

     

    The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets. Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.

     

    The distinction between business combinations and asset acquisitions involves judgment, particularly when applying the screen test to determine the nature of the transaction. Incorrect judgments or changes in decisions in these areas could materially affect the determination of goodwill, the recognition and measurement of acquired assets and assumed liabilities, and, consequently, our financial position and results of operations.

     

    Property and Equipment

     

    Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from 1 to 14 years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in the expenses as incurred.

     

    Intangible Assets

     

    Patents and licenses: patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s consolidated balance sheet and amortized on a straight-line basis over their estimated useful lives of 18.5 to 20 years. Amortization totaled approximately $-0- and $0.5 million for the years ended December 31, 2023, and 2022, respectively.

     

    Other intangible assets: the Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink Technologies, Inc., Mobile Viewpoint Corporate B.V. (“MVP”), and the assets of BMS. An independent third-party appraiser evaluated the acquired assets for these business transactions. In the absence of fair market values from potential buyers or comparable transactions, we concluded that the methodologies applied provided a reasonable estimate for the values assigned. The Company amortizes intangible asset costs over their useful lives of 3 to 15 years with its net book value reported on the balance sheet. Amortization totaled approximately $1.0 million each for the years ended December 31, 2023, and 2022, respectively.

     

    Warranty Reserve

     

    Although the Company tests its products under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data, required revisions to the estimated warranty liability will occur.

     

    The claims made during the year ended December 31, 2023, and 2022 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.

     

       Warranty Reserve 
    December 31, 2021  $131,000 
    Warranty reserve expense   98,000 
    Warranty claims settled and true-up of accrual.   (117,000)
    December 31, 2022  $112,000 
    Warranty reserve expense   432,000 
    Warranty claims settled, and true-up of accrual   (411,000)
    December 31, 2023  $133,000 

     

    Shipping and Handling Costs

     

    The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2023, and 2022, the shipping and handling costs incurred were $0.4 million and $0.7 million, respectively.

     

    Treasury Stock

     

    Treasury stock is recorded at cost upon the repurchasing of common shares, and the cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Revenue Recognition

     

    The Company accounts for its operating results under ASC Topic 606, adopted on January 1, 2019. This comprehensive revenue recognition model requires recognition when the Company transfers control of the promised goods or services to the Company’s customers at an amount that reflects the consideration the Company expects to receive. The application of ASC Topic 606 requires the Company to use more judgment and make more estimates than under previously issued guidance.

     

    The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those services.

     

    The Company determines revenue recognition through the following steps:

     

    1. identification of the contract, or contracts, with a customer.

    2. identification of the performance obligations in the contract.

    3. determination of the transaction price.

    4. allocation of the transaction price to the performance obligations in the contract; and

    5. recognition of revenue when, or as, the Company satisfies a performance obligation.

     

    At contract inception, the Company assesses the goods and services promised in the Company’s customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. The Company measures revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges the Company collects concurrent with revenue-producing activities are excluded from income.

     

    Remaining Performance Obligations:

     

    The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.

     

    Research and Development Expenses

     

    As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the consolidated statements of operations and comprehensive loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Leases

     

    The Company determines if an arrangement is a lease at inception. The Company recognizes lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets, such as “Right of use assets, operating leases,” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. The Company recognizes operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all of the Company’s real estate contracts.

     

    There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2023. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of the Company’s leases do not provide an implicit rate, the Company determines our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.

     

    Stock-Based Compensation

     

    The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.

     

    The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from non-employees. The measurement date for equity-classified non-employee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of non-employee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the non-employee share-based payment awards with performance conditions and accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the non-employee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for non-employee awards.

     

    Stock-Option Awards — Time-Based and Performance-Based

     

    Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For non-employee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.

     

    The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Stock-Based Compensation (continued)

     

    Restricted Stock Unit Awards (“RSUs”) — Time-Based

     

    Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.

     

    Restricted Stock Unit Awards (“RSUs”) — Performance-Based

     

    The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.

     

    Impairment and Abandonment

     

    Right-of-use operating lease abandonment:

     

    Approximately 2,700 square feet of manufacturing space at the Colchester, UK facility were abandoned as part of the Company’s strategic decision to relocate its UK manufacturing division to the United States commencing in September 2023. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and the Company assessed whether the lease ROU assets were impaired. It was determined that approximately $0.1 million of the Company’s right-of-use operating assets were impaired.

     

    Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The location’s economic environment precluded subletting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment.

     

    For the years ending December 31, 2023, and 2022, the Company recognized a loss on impairment of ROU assets of approximately $0.1 million each, respectively.

     

    Income Taxes

     

    Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expenses and penalties as general and administrative expenses.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Advertising Costs

     

    Advertising costs are charged to operations as incurred. For the years ended December 31, 2023, and 2022, respectively, advertising costs amounted to approximately $0.7 million and $1.0 million. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.

     

    Sales Tax and Value-Added Taxes

     

    The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.

     

    Loss Per Share

     

    The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, excellent for the period determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.

     

    Foreign Currency and Other Comprehensive (Gains) Losses

     

    The Company records gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. The Company has two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2023, and 2022, respectively. The Company has included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.

     

    Transaction gains and losses are recognized in the Company’s operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying consolidated statements of operations.

     

    Fair Value of Financial Instruments and Fair Value Measurements

     

    The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” defines fair value as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not assumptions specific to the entity. ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques reflect assumptions other market participants would use based on the market data obtained from independent sources (observable inputs). In accordance with ASC 820, the following summarizes the fair value hierarchy:

     

      ● Level 1 is observable inputs such as quoted prices in active markets,
      ● Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable, and
      ● Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Fair Value of Financial Instruments and Fair Value Measurements (continued)

     

    Our financial instruments include cash equivalents, investments, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.

     

    Redeemable Preferred Stock

     

    In November 2022, the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders relating to the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder not participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole on March 24, 2023, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.

     

    Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the consolidated balance sheets.

     

    Recently Issued Accounting Pronouncements

     

    Adopted:

     

    On January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable. The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Recently Issued Accounting Pronouncements (continued)

     

    Not yet adopted:

     

    In February 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280). This update revises the reporting requirements for operating segments of public entities, aiming to enhance the transparency and usefulness of segment reporting. As of the date of these financial statements, the Company has not formally adopted ASU 2023-07, which becomes effective for public entities for reporting periods beginning after December 15, 2023. However, it is essential to note that our Company operates as a single reporting segment. Due to this structure, the Company inherently met the updated disclosure requirements of ASU 2023-07 without needing additional segment-specific information. Our current operating segment structure aligns with the objectives of the new standard, emphasizing explicit and meaningful segment reporting. We have assessed that there will be no significant impact on our financial statements upon adopting ASU 2023-07. We will continue to monitor any further guidance FASB provides and ensure compliance with the reporting standards. As the Company formally adopted ASU 2023-07, the Company remained committed to transparency and clarity in our financial reporting. Our subsequent financial statements will provide further updates regarding compliance with this and other accounting standards.

     

    In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-09, enhancing transparency in income tax disclosures. This ASU applies to entities under Topic 740, requiring detailed rate reconciliation and disclosures of taxes paid. It mandates public business entities to disclose rate reconciliation categories annually and specifies a quantitative threshold for reconciling items. Other entities must provide qualitative disclosures. The update is effective for public business entities for annual periods beginning after December 15, 2024, and other entities after December 15, 2025, with early adoption permitted. The Company is evaluating the impact of ASU 2023-09 on its financial statements and will provide updates, if necessary, alongside other accounting standards in future financial statements.

     

    Recent Accounting Pronouncements

     

    Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC, did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

     
    XML 34 R10.htm IDEA: XBRL DOCUMENT v3.24.1
    LOSS PER SHARE
    		 12 Months Ended
    Dec. 31, 2023
    Net loss per share attributable to Common Shareholders:  
    LOSS PER SHARE

    NOTE 4 — LOSS PER SHARE

     

    The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
    Stock options   51    41 
    Warrants   456    459 
    Total   507    500 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 35 R11.htm IDEA: XBRL DOCUMENT v3.24.1
    FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES
    		 12 Months Ended
    Dec. 31, 2023
    Foreign Currency [Abstract]  
    FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES

    NOTE 5 — FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES

     

    The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive loss approximately as follows:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Net foreign exchange transactions:          
    (Gains) Losses  $49,000   $24,000 
                
    Accumulated comprehensive income:          
    Unrealized (gains) losses on currency translation adjustment  $(310,000)  $1,040,000 

     

    Amounts were converted from British Pounds to U.S. Dollars and Euros to British Pounds using the following exchange rates:

     

      ● As of December 31, 2023 – £1.273840 to $1.00; €1.105890 to $1.00
      ● The average exchange rate for the year ended December 31, 2023 – £1.243463 to $1.00; €1.081317 to $1.00
      ● As of December 31, 2022 – £ 1.208970 to $1.00; € 1.069850 to $1.00
      ● The average exchange rate for the year ended December 31, 2022 – £ 1.236579 to $1.00; € 1.052082 to $1.00

     
    XML 36 R12.htm IDEA: XBRL DOCUMENT v3.24.1
    CASH AND CASH EQUIVALENTS
    		 12 Months Ended
    Dec. 31, 2023
    Cash and Cash Equivalents [Abstract]  
    CASH AND CASH EQUIVALENTS

    NOTE 6 — CASH AND CASH EQUIVALENTS

     

    The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund. The following table illustrates the Company’s cash and cash equivalents:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
             
    Cash on hand  $1,776,000   $25,627,000 
    Federally insured money market mutual funds   6,706,000    — 
    Total cash and cash equivalents  $8,482,000   $25,627,000 

     
    XML 37 R13.htm IDEA: XBRL DOCUMENT v3.24.1
    INVESTMENTS
    		 12 Months Ended
    Dec. 31, 2023
    Investments, All Other Investments [Abstract]  
    INVESTMENTS

    NOTE 7 — INVESTMENTS

     

    The Company used cash to purchase the following debt instruments:

     

      ● On January 23, 2023, the Company purchased a bond for $4,812,500, “HSBC USA INC CP,” with a face value of $5,065,789, a par value of $5,000,000, maturing October 24, 2023, a 5.1948% interest rate, at a discount of $253,289. The bond was redeemed on maturity at a loss of approximately $82,000.
         
      ● On February 1, 2023, the Company purchased a bond for $5,025,479, “Federal Home Loan Banks,” with a face value of $4,999,750 and accrued interest of $25,729, a par value of $5,000,000, maturing December 22, 2023, at an interest rate of 4.750%. The bond was redeemed at face value on the date of maturity.
         
      ● On February 28, 2023, the Company purchased a bond for $950,000, “Federal National Mortgage Association,” with a face and par value of $950,000, maturing February 28, 2024, at an interest rate of 5.07%. The value on December 31, 2023, was $949,000.
         
      ● On October 11, 2023, the Company purchased a bond for $4,711,000, “HSBC USA INC CP,” with a face value of $5,000,000, maturing October 11, 2024, at a 6.262291% interest rate. The value on December 31, 2023, was $4,714,000.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 7 — INVESTMENTS (continued)

     

    The Company identified these transactions as investments in debt securities. It applies the guidance under ASC Topic 320, “Investments in debt securities,” and for interest income guidance under ASC Topic 310-20, “Receivables.” As of December 31, the abovementioned investments have a stated maturity of one year or less. Management intends to treat these investments as held to maturity.

     

    The Company’s investments held to maturity are as follows as of December 31, 2023:

     

      

    Amortized

    Cost

    		  

    Unrealized

    Gains

    		   Unrealized Losses   Fair Value 
                         
    Federal Bonds  $5,663,000   $68,000   $     —   $5,731,000 

     
    XML 38 R14.htm IDEA: XBRL DOCUMENT v3.24.1
    FAIR VALUE OF ASSETS AND LIABILITIES
    		 12 Months Ended
    Dec. 31, 2023
    Fair Value Disclosures [Abstract]  
    FAIR VALUE OF ASSETS AND LIABILITIES

    NOTE 8 — FAIR VALUE OF ASSETS AND LIABILITIES

     

    As defined under ASC 820, “Fair Value Measurement and Disclosures,” the following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis on December 31, 2023, and 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.

     

      

    Quoted Prices in Active Markets of Identical Assets/Liabilities

    (Level 1)

    		  

    Significant Other Observable Inputs

    (Level 2)

    		  

    Significant Unobservable Inputs

    (Level 3)

    		   Total 
    Assets                    
    December 31, 2023:                    
    Federal Bonds Held to Maturity  $—   $5,731,000   $—   $5,731,000 
    Right of use asset impairment   —    —    83,000    83,000 
       $        —   $5,731,000   $83,000   $5,814,000 
                         
    Liabilities  $—   $—   $—   $— 
                         
    Assets                    
    December 31, 2022:                    
    Federal Bonds Held to Maturity  $—   $—   $—   $— 
    Right of use asset impairment   —    —    88,000    88,000 
       $—   $—   $88,000   $88,000 
                         
    Liabilities  $—   $—   $—   $— 

     
    XML 39 R15.htm IDEA: XBRL DOCUMENT v3.24.1
    ASSET ACQUISITION
    		 12 Months Ended
    Dec. 31, 2023
    Business Combination and Asset Acquisition [Abstract]  
    ASSET ACQUISITION

    NOTE 9 — ASSET ACQUISITION

     

    On September 14, 2023, Vislink Poway, LLC (“Poway”), a wholly-owned subsidiary of the Company formed on September 13, 2023, entered into an asset purchase agreement with BMS, acquiring working in process inventory consisting of microwave technology systems involving long-range data transmission and assuming certain liabilities in exchange for $200,000 in cash consideration paid at together with a commitment to acquire additional inventory for $230,000 on October 2, 2023, with title to the inventory passing to Poway on October 2, 2023.The transaction was accounted for as an acquisition of assets under U.S. GAAP. Accordingly, the acquisition cost was allocated on a relative fair value basis, and transaction costs were capitalized as a component of the cost of the assets acquired.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 9 — ASSET ACQUISITION (continued)

     

    The Company recorded the purchase of this agreement under purchase price accounting, recording the fair value of the assets acquired and the liabilities assumed based upon the purchase price, as summarized in the table below:

     

          
    Assets acquired:     
    Work-in-process inventory  $66,042 
    Intangible assets - customer relationships   495,372 
    total assets   561,414 
          
    Liabilities assumed:     
    Deferred revenue   292,014 
    total liabilities   292,014 
          
    Total cash used for asset acquisition  $269,400 
          
    Cash used in acquisition:     
    Acquisition price  $200,000 
    Transaction costs   69,400 
    Total cash used for asset acquisition  $269,400 

     
    XML 40 R16.htm IDEA: XBRL DOCUMENT v3.24.1
    ACCOUNTS RECEIVABLE
    		 12 Months Ended
    Dec. 31, 2023
    Receivables [Abstract]  
    ACCOUNTS RECEIVABLE

    NOTE 10 — ACCOUNTS RECEIVABLE

     

    Accounts receivable consist of the following:

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Accounts receivable  $9,389,000   $6,680,000 
    Allowance for doubtful accounts   (709,000)   (673,000)
    Net accounts receivable  $8,680,000   $6,007,000 

     

    During the years ended December 31, 2023, and 2022, the Company incurred bad debt expenses of $25,000 and $21,000, respectively. Additionally, for the years ended December 31, 2023, and 2022, we experienced bad debt recoveries of $10,000 and $517,000, respectively.

     
    XML 41 R17.htm IDEA: XBRL DOCUMENT v3.24.1
    INVENTORIES
    		 12 Months Ended
    Dec. 31, 2023
    Inventory Disclosure [Abstract]  
    INVENTORIES

    NOTE 11 — INVENTORIES

     

    Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Raw materials  $12,890,000   $12,038,000 
    Work-in-process   1,458,000    1,474,000 
    Finished goods   5,599,000    4,460,000 
    Sub-total inventories   19,947,000    17,972,000 
    Less reserve for slow-moving and excess inventory   (5,918,000)   (5,951,000)
    Total inventories, net  $14,029,000   $12,021,000 

     

    Inventory valuation adjustments consist primarily of written-off items due to obsolescence or reserved for slow-moving or excess inventory. The Company recorded inventory valuation adjustments of $487,000 and $1,143,000 as of December 31, 2023, and 2022, respectively. Additionally, under the Company’s product rationalization program, management eliminated specific product lines impairing $-0- and $1,787,000 of inventory as of December 31, 2023, and 2022, respectively.
    XML 42 R18.htm IDEA: XBRL DOCUMENT v3.24.1
    PROPERTY AND EQUIPMENT
    		 12 Months Ended
    Dec. 31, 2023
    Property, Plant and Equipment [Abstract]  
    PROPERTY AND EQUIPMENT

    NOTE 12 — PROPERTY AND EQUIPMENT

     

    Property and equipment consist of the following:

     

       (Years)  2023   2022 
          For the years ended 
       Useful Life  December 31, 
       (Years)  2023   2022 
    Cost:             
    Furniture and fixtures  1 – 10  $347,000   $308,000 
    Leasehold improvements (a)  1 – 14   443,000    443,000 
    Computers, software, and equipment  1 – 11   3,677,000    3,016,000 
    Property and equipment, cost      4,467,000    3,767,000 
    Accumulated depreciation      (2,565,000)   (2,333,000)
    Property and equipment, net     $1,902,000  $1,434,000 

     

    Property and equipment depreciation amounted to $232,000 and $201,000 for the years ended December 31, 2023, and 2022, respectively. Additionally, the Company removed $228,000 of fully depreciated leasehold improvement from its records during December 31, 2022, and none for the year ending December 31, 2023.

     

    (a)The shorter economic life or remaining lease term.

     
    XML 43 R19.htm IDEA: XBRL DOCUMENT v3.24.1
    INTANGIBLE ASSETS
    		 12 Months Ended
    Dec. 31, 2023
    Goodwill and Intangible Assets Disclosure [Abstract]  
    INTANGIBLE ASSETS

    NOTE 13 — INTANGIBLE ASSETS

     

    The Company continuously monitors operating results, events, and circumstances that may indicate potential impairment of intangible assets. Management concluded that no triggering events occurred during the year ended December 31, 2023.

     

    The following table illustrates finite intangible assets as of December 31, 2023, and 2022:

     

       Proprietary Technology   Patents and Licenses   Trade Names & Technology   Customer Relationships     
           Accumulated       Accumulated       Accumulated       Accumulated     
       Cost   Amortization   Cost   Amortization   Cost   Amortization   Cost   Amortization   Net 
                                         
    December 31, 2023:                                             
    Balance, January 1, 2023  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 
                                                  
    Additions   —    —    —    —    —    —    496,000    —    496,000 
                                                  
    Amortization   —    (593,000)   —    —    —    (138,000)   —    (299,000)   (1,030,000)
    Balance, December 31, 2023  $2,132,000   $(1,408,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,327,000)  $5,591,000   $(3,373,000)  $3,866,000 
                                                  
    December 31, 2022:                                             
    Balance, January 1, 2022   2,132,000    (223,000)   12,378,000    (11,843,000)   2,251,000    (1,052,000)   5,095,000    (2,817,000)   5,921,000 
                                                  
    Amortization   —    (592,000)   —    (535,000)   —    (137,000)   —    (257,000)   (1,521,000)
                                                  
    Balance, December 31, 2022  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 13 — INTANGIBLE ASSETS (continued)

     

    The Company’s groups of intangible assets consist primarily of:

     

    Proprietary Technology:

     

    Generally, the Company amortizes proprietary technology over 3 to 5 years. MVP uses wireless multiplex transmitters and artificial intelligence internally to produce and sell products and services to customers.

     

    Patents and Licenses:

     

    Patents and licenses filed by the Company are amortized for 18.5 to 20 years. The amortization of the costs associated with provisional patents and pending applications begins after successful review and filing.

     

    Trade Name, Technology, and Customer Relationships:

     

    Other intangible assets are amortized for 3 to 15 years. IMT, Vislink Technologies, Inc., MVP, and Poway acquisitions contributed to developing these intangible assets, including trade names, technology, and customer lists.

     

    The Company has recognized net capitalized intangible costs as follows:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Proprietary Technology  $726,000   $1,319,000 
    Patents and Licenses   —    — 
    Trade Names and Technology   922,000    1,060,000 
    Customer Relationships   2,218,000    2,021,000 
    Net capitalized intangible costs  $3,866,000   $4,400,000 

     

    The Company has recognized the amortization of intangible assets as follows:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
             
    Proprietary Technology  $593,000   $592,000 
    Patents and Licenses   —    535,000 
    Trade Names and Technology   138,000    137,000 
    Customer Relationships   299,000    257,000 
    Amortization of intangible assets   $1,030,000   $1,521,000 

     

    The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 4.9 years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:

      

    Period ending December 31,     
    2024  $783,000 
    2025   781,000 
    2026   651,000 
    2027   346,000 
    2028   288,000 
    Thereafter   1,017,000 
    Intangible assets, estimated amortization expense  $3,866,000 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 44 R20.htm IDEA: XBRL DOCUMENT v3.24.1
    ACCRUED EXPENSES
    		 12 Months Ended
    Dec. 31, 2023
    Payables and Accruals [Abstract]  
    ACCRUED EXPENSES

    NOTE 14 — ACCRUED EXPENSES

     

    Accrued expenses consist of the following:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Compensation  $567,000   $246,000 
    Commissions   106,000    47,000 
    Warranty   135,000    112,000 
    Accrued expenses other   770,000    908,000 
    Deferred equity   —    255,000 
    Accrued expenses  $1,578,000   $1,568,000 

     
    XML 45 R21.htm IDEA: XBRL DOCUMENT v3.24.1
    NOTES PAYABLE
    		 12 Months Ended
    Dec. 31, 2023
    Debt Disclosure [Abstract]  
    NOTES PAYABLE

    NOTE 15 — NOTES PAYABLE

     

    The table below represents the Company’s notes payable as of December 31, 2023, and 2022:

     SCHEDULE OF NOTES PAYABLE

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
             
    On April 5, 2022,   $—   $84,000 
    On April 5, 2022, the Company renewed its D & O insurance policy, decreasing the premium to approximately $1,037,000, less a down payment of $194,000, financing the remaining balance of approximately $943,000. The loan’s terms are nine months at a 2.09% annual interest rate and a monthly principal and interest payment of approximately $84,000. The Company recorded interest expense of $6,000 and $-0- for the years ended December 31, 2022, and 2021, respectively.  $—   $84,000 
               
    On April 5, 2023, the Company renewed its D & O insurance policy, reducing the premium to approximately $811,000, less a down payment of $288,000, financing the remaining balance of approximately $523,000. The loan’s terms are for nine months at a 6.14% annual interest rate and a monthly principal and interest payment of approximately $67,000. Accordingly, the Company recorded interest expenses of $12,100 and $-0- for the years ending December 31, 2023, and 2022, respectively.   —    — 
    Notes payable  $—   $84,000 

     

     
    XML 46 R22.htm IDEA: XBRL DOCUMENT v3.24.1
    LEASES
    		 12 Months Ended
    Dec. 31, 2023
    Leases  
    LEASES

    NOTE 16 — LEASES

     

    Aside from renting office spaces, deployment sites, and storage warehouses, the company leases warehouse facilities internationally and domestically. As of December 31, 2023, the operating leases exhibit diverse terms and provisions, with lease durations spanning one to four years. Some individual leases include rent escalation clauses and lease concessions that entail additional rental payments in the latter years of the lease period. Such contracts are accounted for on a straight-line basis throughout the minimum lease term.

     

    The table below lists the location and lease expiration date from 2025 through 2027: 

     

    Location   Square Footage     Lease-End Date   Approximate Future Payments  
    Colchester, U.K. – Waterside House     13,223     Dec   2025     $ 502,000  
    Lutton, UK     600     Jan   2025       32,000  
    Billerica, MA     2,000     Dec   2026       316,000  
    Mount Olive, NJ     7,979     May   2027       470,000  
    Trivex, Singapore     950     Aug   2025       60,000  

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 16 — LEASES (continued):

     

    The following represents lease activity for the year ending December 31, 2023:

     

    Lutton, UK

     

    A one-year lease for 600 square feet of administrative office space in Lutton, UK, was signed on September 1, 2023, and will run through May 31, 2024, at approximately $2,100 per month. A two-year lease for 600 square feet was executed at another location and will run from February 1, 2023, through January 31, 2025, at approximately $2,500 per month.

     

    Dubai, UAE

     

    The Company renewed its lease for 976 square feet of administrative office space in Dubai Studio City, UAE, commencing on July 3, 2023, and terminating on July 2, 2024, for approximately $1,632 monthly.

     

    Poway, CA

     

    Included in the September 14, 2023, acquisition of assets from Broadcast Microwave Services, LLC (BMS) was a sublease of approximately 11,715 square feet of general office use facilities previously held under a six-month agreement with BMS, with lease responsibilities conveyed to Vislink Poway, LLC. The initial lease term commenced with a monthly rent of approximately $22,300 and concluded on March 13, 2024. On February 12, 2024, Vislink Poway, LLC signed a renewal agreement for the same space. The renewal term is set for one year and ten and a half months, commencing on March 14, 2024, and ending on January 31, 2026. The base rent for the renewal period is established at $22,926 per month.

     

    Colchester, U.K.

     

    Approximately 2,700 square feet of manufacturing space at the Colchester, U.K. facility were abandoned as part of the Company’s strategic decision to relocate its U.K. manufacturing division to the United States commencing in September 2023, with approximately 13,200 square feet of remaining space. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and we assessed whether the lease “Right of use assets, operating leases” (ROU) assets were impaired. It was determined that approximately $83,000 of the Company’s right-of-use operating assets were impaired.

     

    Hemel, United Kingdom

     

    Under the original lease agreement dated April 28, 2017, a “break clause” signifying a “break date” of October 28, 2020, sighted the following: the Company may terminate this lease on the “break date” by giving the landlord such notice within six months of the “break date.” At the lease’s commencement, it was not reasonably sure if the Company would exercise its right by the break clause’s date. These measures upheld the determination of the lease’s noncancellable period for adopting ASC 842 on January 1, 2019. The lease term of 22 months as of January 1, 2019, helped calculate the remaining lease payments’ net present value assigned to the right-of-use asset and operating lease liability upon the adoption date. The total annual rent under this lease is approximately $175,000, covering 12,870 square feet of manufacturing and administrative office space. Neither party exercised their unilateral termination rights by the “break date,” triggering a lease extension. Both parties’ inaction creates new enforceable rights and obligations in the extended period, such that the lease agreement terminates on October 27, 2023.

     

    Trivex, Singapore

     

    The Company renewed its lease for 950 square feet of administrative office space commencing on August 10, 2023, and terminating on August 92, 2025, for approximately $3,100 monthly.

     

    The following represents lease activity for the year ending December 31, 2022:

     

    Lutton, UK

     

    On April 28, 2022, the Company entered a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on May 31, 2023, for £1,320 monthly or approximately $1,800 per month.

     

    Dubai, UAE

     

    The Company renewed its lease for 976 square feet of administrative office space commencing on July 3, 2022, and terminating on July 2, 2023, in Dubai Studio City, UAE, for AED 5,995 or approximately US$ 1,632 monthly. 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 16 — LEASES (continued):

     

    The following represents lease activity for the year ending December 31, 2022 (continued):

     

    Billerica, MA

     

    Management vacated the Billerica property during the third quarter of the fiscal year 2022. The economic environment of this location precluded subletting an unoccupied site, and the leased facility was determined to be abandoned. Under ASC 360, leased space abandonment is an impairment indicator. The Company assessed the lease ROU assets for impairment, recognizing a loss on impairment of right-of-use assets of approximately $88,000.

     

    The following table illustrates Right-Of-Use operating lease data recorded for the years ended December 31, 2023, and 2022:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Right-of-use assets:          
    Cost  $2,385,000   $2,260,000 
    Accumulated amortization   (1,643,000)   (1,185,000)
               
      $742,000   $1,075,000 
               
    Operating lease liability:          
    Current portion  $463,000   $455,000 
    Non-current portion   755,000    1,107,000 
               
       $1,218,000   $1,562,000 
               
    Weighted average discount rate   9.4%   9.4%
               
    Weighted average remaining term for lease contracts   2.6 years    3.4 years 
               
    Lease maturity dates for right-of-use operating leases   July 2025 to May 2027    July 2023 to May 2027 
               
    Lease cost:          
    Operating lease cost  $435,000   $438,000 
    Short-term lease cost   126,000    93,000 
               
    Total lease cost  $561,000   $531,000 
               
    Cash paid for lease liabilities:          
    Cash flows from operating leases  $643,000   $543,000 
               
    Right-of-use assets obtained in exchange for new operating lease liabilities  $171,000   $— 

     

    Maturities of our operating lease liabilities were as follows as of December 31, 2023:

     

       Amount 
         
    2024  $559,000 
    2025   513,000 
    2026   249,000 
    2027   59,000 
    2028   — 
    Thereafter   — 
    Total lease payments   1,380,000 
    Less: imputed interest   162,000 
    Present value of lease liabilities   1,218,000 
    Less: Current lease liabilities   463,000 
    Non-current lease liabilities  $755,000 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 47 R23.htm IDEA: XBRL DOCUMENT v3.24.1
    PREFERRED SHARES
    		 12 Months Ended
    Dec. 31, 2023
    Equity [Abstract]  
    PREFERRED SHARES

    NOTE 17 — PREFERRED SHARES

     

    Preferred Stock

     

    In March 2013, the issuance of up to 10.0 million shares of “Blank Check” preferred stock with a par value of $0.00001 per share received approval from the stockholders of the Company.

     

    The following shares were designated as authorized:

     

      ● Three million shares of Series A Convertible Preferred Stock (“Series A Preferred Stock”) on December 31, 2014.
      ● Three million shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”) on February 11, 2015.
      ● Three million shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”) on February 24, 2015.

     

    On February 5, 2016, the Company terminated the Series A Preferred Stock and Series C Preferred Stock and increased the number of designated shares of Series B Preferred Stock to 5,000,000. The following shares were designated as authorized: Five million shares of Series D Convertible Preferred Stock (“Series D Preferred Stock”) on April 25, 2016. On December 6, 2016, the Company terminated the Series B Preferred Stock. The following shares were designated as authorized: Five thousand shares of Series E Convertible Preferred Stock (“Series E Preferred Stock”) on December 21, 2016. On November 9, 2022, the Company’s Board of Directors (i) terminated the Series D Preferred Stock and Series E Preferred Stock and (ii) designated the following shares as authorized: 47,500 shares of new Series A Preferred Stock.

     

    Series A Preferred Stock

     

    On November 9, 2022, the Company’s Board of directors declared a dividend of one one-thousandth of a share of Series A Preferred Stock, par value $0.00001 per share (“Series A Preferred Stock”), for each outstanding share of the Company’s common stock, to stockholders of record on November 21, 2022.

     

    Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes. The outstanding shares of Series A Preferred Stock voted together with the outstanding shares of the Company’s common stock as a single class exclusively concerning the proposal to adopt an amendment to the Company’s Certificate of Incorporation, as amended, to reclassify the outstanding shares of the Company’s Common Stock into a smaller number of shares of common stock at a ratio specified in or determined under the terms of such amendment (the “Reverse Stock Split”). The Series A Preferred Stock was not entitled to vote on any other matter except to the extent required under the Delaware General Corporation Law.

     

    The Series A Preferred Stock was not convertible into, or exchangeable for, shares of any other class, series of stock, or other securities of the Company. The Series A Preferred Stock had no stated maturity and is not subject to any sinking fund. The Series A Preferred Stock was not restricted to the Company’s redemption or repurchase of shares when there was any arrearage in the payment of dividends or sinking fund installments. The Certificate of Designation was filed with the Delaware Secretary of State and became effective on November 9, 2022. The holders of Series A Preferred Stock were not entitled to receive dividends.

     

    On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted on a proposal to authorize the Board, at its discretion, to affect the Reverse Stock Split. All shares of Series A Preferred Stock that were not present in person or by proxy at the Special Meeting held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) were automatically redeemed in whole, but not in part, by the Company at the Initial Redemption Time without further action on the part of the Company or the holder of shares of Series A Preferred Stock (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed according to an Initial Redemption were redeemed in whole but not in part on March 24, 2023 (i) if the Board ordered such redemption in its sole discretion, automatically and effective on such time and date specified by the Board in its sole discretion or (ii) automatically upon the approval by the Company’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on such proposal (“the Subsequent Redemption”).

     

    Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 17 — PREFERRED SHARES (continued)

     

    Series A Preferred Stock (continued)

     

    The Company was not solely in control of the redemption of the shares of Series A Preferred Stock since the holders had the option of deciding whether to vote in respect of the above-described Reverse Stock Split, which determined whether a given holder’s shares of Series A Preferred Stock were redeemed in the Initial Redemption or the Subsequent Redemption. Since the redemption of the Series A Preferred Stock was not solely in the control of the Company, the shares of Series A Preferred Stock were classified within mezzanine equity in the Company’s audited consolidated balance sheet. The shares of Series A Preferred Stock were measured at redemption value. The value of Series A Preferred Stock shares as of December 31, 2023 and 2022, was de minimis.

     

    Certificate of Elimination

     

    On April 25, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating 5,000,000 shares out of the Company’s authorized but unissued shares of its preferred stock as Series D Convertible Preferred Stock, par value $0.00001 per share.

     

    On December 21, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating 5,000 shares out of the Company’s authorized but unissued shares of its preferred stock as Series E Convertible Preferred Stock, par value $0.00001 per share.

     

    On November 9, 2022, the Company filed Certificates of Elimination for each of the Series D Preferred Stock and Series E Preferred Stock with the Secretary of State of the State of Delaware, which, effective upon filing, eliminated all matters outlined in the Certificates of Designation of Series D Preferred Stock and Series E Preferred Stock previously filed by the Company. According to the Certificates of Elimination, the shares that were previously designated as Series D Preferred Stock and Series E Preferred Stock resume the status of authorized but unissued shares of preferred stock, par value $0.00001 per share, of the Company, issuable from time to time, in one or more series, under the Certificate of Incorporation.

     

    On March 22, 2023, the Board of Directors of the Company (the “Board”) approved a resolution to eliminate the Company’s Certificate of Designation, Preferences, and Rights (the “Certificate of Elimination”) of the Series A Preferred Stock, par value $0.00001 per share (the “Series A Preferred Stock”), that was filed with the Secretary of State of the State of Delaware on November 9, 2022. Upon the effective filing of this Certificate of Elimination, the shares previously designated under the certificate of designation as Series A Preferred Stock shall resume the status of authorized but unissued shares of the Company’s preferred stock.

     

    On March 24, 2023, the Company filed a certificate of elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware for the Series A Preferred Stock. The Certificate of Elimination (i) eliminated the previous designation of 47,500 shares of Series A Preferred Stock from the Company’s Certificate of Incorporation, as amended, none of which were outstanding at the time of the filing of such Certificate of Elimination, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of preferred stock of the Company.

     

    As of December 31, 2023, -0- shares are authorized, and no Series A Preferred Stock are issued or outstanding.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 48 R24.htm IDEA: XBRL DOCUMENT v3.24.1
    STOCKHOLDERS’ EQUITY
    		 12 Months Ended
    Dec. 31, 2023
    Equity [Abstract]  
    STOCKHOLDERS’ EQUITY

    NOTE 18 — STOCKHOLDERS’ EQUITY

     

    Common Stock

     

    The Company is authorized to issue up to 100,000,000 shares of Common Stock, $0.00001 par value per share. As of December 31, 2023, and 2022, the Company had 2,439,923 and 2,367,362 issued and 2,439,790 and 2,367,229 shares outstanding, respectively.

     

    Common Stock Activity

     

    For the year ending December 31, 2023
         
      ● Issued 10,000 shares of common stock to specific board members as part of a commitment agreement valued at $200,000. The common stock’s value was determined on the agreement’s original date.
         
      ● Issued 14,193 shares of common stock as payment of the minimum withholding tax obligation due upon the vesting of shares restricted stock units.
         
      ● Issued 48,368 shares of common stock, net of 14,193 shares attributable to withholding tax, upon the exercise of restricted stock units under the Company’s various stock compensation plans.
         
      ● Recognized approximately $1,942,000 of stock-based compensation costs associated with outstanding stock options in general and administrative expenses offsetting additional capital investments.
         
    For the year ending December 31, 2022
         
      ● Issued 357,778 shares of common stock as payment of the minimum withholding tax obligation due upon the vesting of shares restricted stock units.
         
      ● Issued 1,159,044 shares of common stock, net of 357,778 shares attributable to withholding tax, upon the exercise of restricted stock units under the Company’s various stock compensation plans.
         
      ● Under the terms of an $80,000 consulting agreement, on May 4, 2022, 38,703 shares of common stock were valued at $0.81 per share on the issuance date with a total value of $31,349 in satisfaction of $40,000. The value of the common stock issued was based on the fair value of the stock at the time of the issuance. On July 19, 2022, 38,703 shares of common stock were valued at $0.59 per share on the issuance date, with a total value of $22,835 in satisfaction of the remaining balance of $40,000. The Company recognized a total gain on debt settlement of $25,816.
         
      ● Recognized approximately $1,565,000 of stock-based compensation costs associated with outstanding stock options recorded in general and administrative expenses offsetting additional paid-in capital.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 18 — STOCKHOLDERS’ EQUITY (continued)

     

    Common Stock Warrants

     

    During the year ended December 31, 2023, 2,666 warrants expired. As of December 31, 2023, these outstanding warrants contained no intrinsic value. The weighted average exercise price of warrants outstanding on December 31, 2023, is $65.10, with a weighted average remaining contractual life of 2.1 years.

     

    The following tables set forth common stock purchase warrants outstanding as of December 31, 2023, and 2022:

      

    Number of Warrants

    (in shares)

    		  

    Weighted

    Average

    Exercise

    Price

    		 
             
    Outstanding, December 31, 2021   460,491   $82.00 
    Warrants expired   (1,745)   (2624.00)
    Outstanding and exercisable, December 31, 2022   458,746    71.60 
    Warrants expired   (2,666)   (1,200.30)
    Outstanding and exercisable, December 31, 2023   456,080   $65.10 

     

        Common stock issuable upon exercise of warrants outstanding and exercisable 
        For the year-ending   For the year-ending 
        December 31, 2023   December 31, 2022 
    Range of Exercise Prices   Warrants Outstanding and Exercisable (in shares)   Weighted Average Remaining Contractual Life (years)  

    Weighted Average Exercise

    Price

    		  

    Warrants Outstanding and Exercisable

    (in shares)

    		   Weighted Average Remaining Exercisable Contractual Life (years) 

    Weighted Average Exercise

    Price

    		 
    $65.00    454,546    3.11 yrs   $65.00    454,546   3.11 yrs  $65.00 
    $68.20    1,500    1.18 yrs   $68.20    1,500   1.18 yrs  $68.20 
    $600.00    34    1.54 yrs   $600.00    34   1.54 yrs  $600.00 
    $1,200.00    —    —   $—    2,666   0.41 yrs  $1,200.00 
          456,080    3.10 yrs   $65.10    458,746   3.10 yrs  $71.60 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 49 R25.htm IDEA: XBRL DOCUMENT v3.24.1
    STOCK-BASED COMPENSATION
    		 12 Months Ended
    Dec. 31, 2023
    Share-Based Payment Arrangement [Abstract]  
    STOCK-BASED COMPENSATION

    NOTE 19 — STOCK-BASED COMPENSATION

     

    Overview

     

    Vislink Technologies, Inc. and its subsidiaries (“the Company”) leverage stock-based compensation as a strategic tool to attract, motivate, and retain key personnel. This aligns their interests with those of our shareholders by offering them a stake in the Company’s success. We administer various plans that grant stock options and Restricted Stock Units (RSUs) to our officers, directors, key employees, and consultants.

     

    Long-Term Stock Incentive Plan Awards

     

    The Company operates multiple equity incentive plans, including the 2013 Stock Option Plan, 2015 Incentive Compensation Plan, 2016 Incentive Compensation Plan, and 2017 Incentive Compensation Plan. These plans facilitate the granting of stock options, which may be settled in shares or net-settled, emphasizing our flexible approach to compensation. The options vest over three years and are exercisable up to ten years from the grant date.

     

    Significant modifications and enhancements have been made to our plans over time to ensure they continue to serve the intended purpose effectively. This includes the immediate vesting provisions for terminated employees and removing a cap on the annual share awards per participant, reflecting our adaptability to changing business and operational needs.

     

    Inducement Awards

     

    The Company grants time-vested and performance-based stock options under inducement awards, consistent with NASDAQ Listing Rule 5653(c)(4). These inducement awards, granted outside of our existing equity compensation plans, are designed to reward employees for their commitment and performance toward achieving our strategic goals.

     

    Time-Based and Performance-Based Stock Option Awards

     

    The Company’s stock option awards are granted under terms that ensure they vest based on time or performance-based criteria. Performance-based awards are tied to achieving specific financial metrics, aligning employee rewards with the Company’s success. The Company granted time-vested stock options and performance-based stock options to various employees in connection with their employment agreements. The ten-year, non-statutory time-vested, and performance-based option inducement awards were granted under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment).

     

    Time-based and Performance-Based Restricted Stock Unit Awards (“RSUs”)

     

    The Company’s RSUs are granted under terms that ensure they vest based on time or performance-based criteria. Performance-based awards are tied to achieving specific financial metrics, aligning employee rewards with the Company’s success.

     

    The Company granted awards under the amended plan for time-based restricted stock units (“RSUs”) to various employees subject to continued employment. The RSUs initially vest between 25% and 33% on their one-year anniversary dates and will vest between 24 and 36 equal monthly periods thereafter. Additionally, the Company granted awards under the amended plan for performance-based restricted stock units subject to performance vesting conditions and continued employment. The RSUs will vest in three equal tranches upon reaching performance conditions for each tranche.

     

    2023 Omnibus Equity Incentive Plan

     

    The Company received stockholder approval on August 23, 2023, to adopt the 2023 Omnibus Equity Incentive Plan (the “2023 Plan”), which will enable it to continue to grant equity-based compensation awards to employees (including officers), non-employee consultants, non-employee directors, and affiliates. The 2023 Plan replaces the 2015 Incentive Compensation Plan, 2016 Incentive Compensation Plan, and 2017 Incentive Compensation Plan. The Company has ceased granting awards under the 2015 Incentive Compensation Plan, 2016 Incentive Compensation Plan, and 2017 Incentive Compensation Plan. The Company has been authorized to reserve 166,415 shares of its common stock for delivery under the 2023 Plan. The 2023 Plan rewards eligible participants for contributing to the Company’s success and encourages retaining and recruiting qualified personnel. The Company’s Board of Directors and Compensation Committee will administer the 2023 Plan.

     

    The 2023 Plan generally grants awards without consideration other than prior and future service. The Company’s compensation committee may grant awards under the 2023 Plan either alone or in addition to, in tandem with, or as a substitute for any other award granted under the 2023 Plan or other company plans. It is important to note, however, that if a SAR is granted in conjunction with an ISO, the grant date and term of the SAR and ISO must be the same, and the exercise price of the SAR cannot be lower than the exercise price of the ISO. A written award agreement between us and the grantee will outline the material terms of the award.

     

    As shown in the following table, stock-based compensation expense is included in general and administrative costs under the following plans:

     

    SCHEDULE OF STOCK BASED COMPENSATION EXPENSE

    Equity-based plans:  2023   2022 
       For the years ended 
       December 31, 
    Equity-based plans:  2023   2022 
             
    Long-term stock incentive plan awards  $—   $1,000 
    Time-vested option inducement awards   181,000    179,000 
    Time-based restricted stock awards   1,761,000    1,385,000 
    Stock-based compensation expense  $1,942,000   $1,565,000 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 19 — STOCK-BASED COMPENSATION (continued)

     

    The following table illustrates supplementary data under various equity compensation plans:

     

        For the years ended     For the years ended  
        December 31,     December 31,  
        2023     2022     2023     2022  
       

    Quantity

    		    

    Weighted Average

    		    

    Quantity

    		    

    Weighted Average

    		    

    Quantity

    		    

    Weighted Average

    		    

    Quantity

    		    

    Weighted Average

    		  
                 
        Long-term stock incentive plan awards     Time-vested option inducement awards  
    Balance-January 1, outstanding     2,250     $ 1,756.01       2,496     $ 1,760.80       24,725     $ 12.90       24,725     $ 20.20  
    Canceled, expired, forfeited     (88 )     (1,431.14 )     (246 )     (1,934.00 )     (6,759 )     (8.63 )     —       —  
    Balance-December 31, outstanding     2,162     $ 1,768.46       2,250     $ 1,756.01       17,966     $ 6.27       24,725     $ 12.90  
    Balance-December 31, exercisable     2,162     $ 1,768.46       2,250     $ 1,756.01       17,592     $ 27.23       18,027     $ 21.13  
    Remaining compensation expense     $—       $—       $113,000       $319,000  
    Remaining amortization period     0.0 years       0.0 years       0.1 years       1.1 years  
    Weighted average remaining contractual life – options outstanding and exercisable     3.5 years and 3.5 years       4.5 years and 4.5 years       6.1 years and 6.1 years       7.1 years and 7.1 years  
    Intrinsic value per share     $—       $—       $—       $—  
    Range of exercise prices     $139.20 to $1,944.00       $139.20 to $1,944.00       $34.20       $19.20 to $34.20  
                                                                     
         

    Performance-based stock option

    inducement awards

    		       Time-based restricted stock awards  
    Balance-January 1, outstanding     12,500     $ 33.12       12,500     $ 33.12       140,736     $ 23.09       39,933     $ 63.40  
    Granted     —       —       —       —       53,750       8.17       107,053       20.80  
    Canceled, expired, forfeited     —       —       —       —       (19,415 )     (21.48 )      (6,250 )     (13.60 )
    Stock units exercised     —       —       —       —       (48,368 )     (41.58 )     —       —  
    Balance-December 31, outstanding     12,500      $ 33.12       12,500      $ 33.12       126,703      $ 11.92       140,736       23.09  
    Balance-December 31, exercisable     —     $ —       —     $ —       30,692     $ 36.98       20,794     $ 66.60  
    Remaining compensation expense     $414,000       $414,000       $1,511,000       $3,248,000  
    Remaining amortization period     1.1 years       2.1 years       1.6 years       2.3 years  
    Weighted average remaining contractual life – options outstanding and exercisable     6.1 years and 0.0 years       7.1 years and 0.0 years       1.9 years and 1.7 years       2.5 years and 1.4 years  
    Intrinsic value per share     $—       $—       $—       $—  
    Range of exercise prices     $34.20       $34.20       $5.71 to $72.00       $19.60 to $72.00  
                                   
                                          Performance-based restricted stock awards  
    Balance-January 1, outstanding                                     71,303     $ 21.01       63,369     $ 58.00  
    Granted                                     12,500       5.68       71,303       21.00  
    Canceled, expired, forfeited                                     (19,649 )     (21.62 )     —       —  
    Stock units exercised                                     —       —       (63,369 )     (58.00 )
    Balance-December 31, outstanding                                     64,154     $ 18.02       71,303     $ 21.01  
    Balance-December 31, exercisable                                     —     $ —       —     $ —  
    Remaining compensation expense                                     $1,156,000       $1,498,000  
    Remaining amortization period                                     2.1 years       2.8 years  
    Weighted average remaining contractual life – options outstanding and exercisable                                     2.1 years and 0.0 years       2.8 years and 0.0 years  
    Intrinsic value per share                                     $—       $—  
    Range of exercise prices                                     $5.80 to $21.00       $21.00  

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 50 R26.htm IDEA: XBRL DOCUMENT v3.24.1
    COMMITMENTS AND CONTINGENCIES
    		 12 Months Ended
    Dec. 31, 2023
    Commitments and Contingencies Disclosure [Abstract]  
    COMMITMENTS AND CONTINGENCIES

    NOTE 20 — COMMITMENTS AND CONTINGENCIES

     

    Pension:

     

    The Company may make a matching contribution to its employees’ 401(k) plan. Furthermore, Vislink Technologies, Inc. operates a Group Personal Plan through its UK subsidiary, investing funds with Royal London. Employees of the Company in the United Kingdom are entitled to participate in the Company’s employee benefit plan, to which varying amounts are contributed according to their status. Additionally, the Company operates a stakeholder pension plan in the United Kingdom.

     

    The table below represents the Company’s matching contributions as follows:

     

       For the year ended 
       December 31, 
       2023   2022 
    Company matching contributions - Group Personal Pension Plan, U.K.  $140,000   $166,000 

     
    XML 51 R27.htm IDEA: XBRL DOCUMENT v3.24.1
    CONCENTRATIONS
    		 12 Months Ended
    Dec. 31, 2023
    Risks and Uncertainties [Abstract]  
    CONCENTRATIONS

    NOTE 21 — CONCENTRATIONS

     

    Customer Concentration Risk

     

    During the year ending December 31, 2023, the Company did not report any sales to an individual customer that constituted more than 10% of its total sales. Conversely, during the year ending December 31, 2022, the Company noted sales to a single customer amounting to $3,436,000, representing 12% of the Company’s total sales, in excess of 10% of its total sales.

     

    As of December 31, 2023, and 2022, the Company’s accounts receivable from a single customer were recorded at approximately $1,111,000 (13%) and $1,138,000 (19%), respectively. Each instance surpassed the 10% mark of the Company’s total consolidated accounts receivable, indicating a significant concentration in customer receivables.

     

    Vendor Concentration Risk

     

    During the fiscal year ending December 31, the Company recorded $2,132,000 to a single vendor, exceeding 10% of the Company’s total consolidated vendor purchases. During the year ending December 31, 2022, there were no instances where the Company’s purchases from any single vendor exceeded 10% of its total annual consolidated inventory purchases.

     

    However, on December 31 of 2023 and 2022, the Company recorded accounts payable to a particular vendor at approximately $652,000 (20%) and $273,000 (10%), respectively. Each amount exceeded 10% of the Company’s total consolidated accounts payable, highlighting a concentration risk associated with this vendor.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 52 R28.htm IDEA: XBRL DOCUMENT v3.24.1
    REVENUE
    		 12 Months Ended
    Dec. 31, 2023
    Revenue from Contract with Customer [Abstract]  
    REVENUE

    NOTE 22 – REVENUE

     

    The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:

     

       For the years ended 
       December 31, 
       2023   2022 
    Primary geographical markets:          
    North America  $13,501,000   $12,037,000 
    South America   528,000    182,000 
    Europe   6,420,000    8,958,000 
    Asia   3,354,000    1,851,000 
    Rest of World   3,679,000    5,103,000 
       $27,482,000   $28,131,000 
    Primary revenue source:          
    Equipment sales  $24,054,000   $25,667,000 
    Installation, integration, and repairs   1,688,000    1,450,000 
    Warranties   1,740,000    1,014,000 
       $27,482,000   $28,131,000 
    Long-lived assets:          
    United States  $2,767,000   $1,970,000 
    Netherlands   20,000    27,000 
    United Kingdom   3,723,000    4,912,000 
       $6,510,000   $6,909,000 

     
    XML 53 R29.htm IDEA: XBRL DOCUMENT v3.24.1
    REBATES
    		 12 Months Ended
    Dec. 31, 2023
    Rebates  
    REBATES

    NOTE 23 — REBATES

     

    The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary, which are included in other income.

     

       For the years ended 
       December 31, 
       2023   2022 
               
    Total tax rebates  $331,000   $271,000 

     

    While the Company plans to continue filing rebate forms for the 2023 fiscal year, it cannot guarantee that rebates will be available at a similar level or at all in future years.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 54 R30.htm IDEA: XBRL DOCUMENT v3.24.1
    GAINS ON SETTLEMENT OF DEBT
    		 12 Months Ended
    Dec. 31, 2023
    Gains On Settlement Of Debt  
    GAINS ON SETTLEMENT OF DEBT

    NOTE 24 — GAINS ON SETTLEMENT OF DEBT

     

    The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2023, and 2022:

       2023   2022 
       For the Years Ended 
       December 31, 
       2023   2022 
             
    On May 4, 2022, and July 19, 2022, the Company issued 38,703 shares of common stock on each date with an accumulated value of $54,184 in satisfaction of an amount payable of $80,000  $—   $25,816 
               
    On November 21, 2022, the Company settled the dividends payable in the amount of $19,916 by issuing 47,419 Series A Preferred shares with a zero carrying value.   —    19,916 
               
    Gains on settlement of debt  $—   $45,732 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     
    XML 55 R31.htm IDEA: XBRL DOCUMENT v3.24.1
    INCOME TAXES
    		 12 Months Ended
    Dec. 31, 2023
    Income taxes  
    INCOME TAXES

    NOTE 25 — INCOME TAXES

     

    The provision (benefit) for income taxes consists of the following:

     

       2023   2022 
       For the Years Ended 
       December 31, 
       2023   2022 
    Current tax provision          
    Federal  $—   $— 
    State   4,400    25,000 
    Current income tax expense, total   4,400    25,000 
    Deferred tax provision (benefit)          
    Federal   (982,000)   (532,000)
    State   (2,457,000)   (427,000)
    Foreign   (1,516,000)   (978,000)
    Change in the valuation allowance   4,737,000    1,722,000 
    Total deferred tax provision (benefit)   (218,000)   (215,000)
               
    Income tax provision  $(214,000)  $(190,000)

     

    A reconciliation of the statutory tax rate to the effective tax rate is as follows:

     

       2023   2022 
       For the Years Ended 
       December 31, 
       2023   2022 
    Statutory federal income tax rate   21.00%   21.00%
    State and local taxes, net of federal benefit   1.15    0.30 
    Permanent differences   0.49    5.28 
    Executive compensation   0.00    (2.26)
    Equity compensation   (3.63)   (11.06)
    Provision to return   7.49    0.00 
    DTA adjustment for state NOL   0.00    0.00 
    Foreign Rate Differential   1.44    (1.27)
    Change rate   27.13    2.66 
    Valuation allowance   (52.73)   (13.27)
    Effective tax rate   2.34%   1.37%

     

    Under the provisions of ASC 740, the Company may recognize the benefits of uncertain tax positions when it is more likely than not that the merits of the position(s) will be sustained upon audit by the relevant tax authorities. No uncertain tax positions were taken or expected on a tax return that would be determined to be an unrecognized tax benefit recorded on the Company’s financial statements for the years ended December 31, 2023, or 2022. The Company does not expect its unrecognized tax benefit position to change during the next twelve months.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 25 — INCOME TAXES (continued) 

     

    Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial accounting purposes and the amounts used for income tax reporting. Significant components of the Company’s deferred tax assets are as follows:

     

       2023   2022 
       For the Years Ended 
       December 31, 
       2023   2022 
    Deferred Tax Assets          
    Federal R&D credit  $3,007,000   $3,007,000 
    Inventory   422,000    576,000 
    Allowance for bad debt   73,000    72,000 
    Compensation related   12,000    7,000 
    Pension   55,000    72,000 
    Other accruals   34,000    7,000 
    State net operating losses   7,235,000    4,779,000 
    Federal net operating losses   47,296,000    44,821,000 
    Interest disallowance   1,150,000    1,151,000 
    Stock options   6,995,000    7,172,000 
    Other   465,000    296,000 
    Valuation Allowance   (66,468,000)   (61,731,000)
    Total Deferred Tax Assets   276,000    229,000 
    Deferred Tax Liabilities          
    Property and Equipment   (178,000)   (90,000)
    Intangibles   (616,000)   (870,000)
    Prepaid Expenses   (29,000)   (33,000)
    Total Deferred Tax Liabilities   (822,000)   (993,000)
    Net Deferred Tax Liability  $(546,000)  $(764,000)

     

    As of December 31, 2023, the Company has federal net operating losses (“NOL”) of approximately $187.3 million that will expire beginning in 2027. The Company has federal NOLs of approximately $30.6 million that may be carried forward indefinitely. The Company also has state NOL carryforwards of $160.9 million, which will expire beginning in 2027. Besides, the Company has foreign NOL carryforwards of approximately $30.6 million that generally do not expire except under certain circumstances. The Company also has research and development credits of approximately $3.0 million, which will begin to expire in 2027. The years that remain open for review by taxing authorities are 2020 to 2023 for Federal, Foreign, and State Income Tax returns. Finally, the federal and state NOLs and various income tax credits are subject to annual limitations under Sections 382 and 383 of the Internal Revenue Code, in addition to state provisions, and may not be able to be fully realized.

     

    Realizing the NOL carryforwards and other temporary deferred tax differences is contingent on future taxable earnings. The Company’s deferred tax assets were reviewed for expected utilization using a “more likely than not” approach by assessing the available positive and negative evidence surrounding its recoverability. Accordingly, a valuation allowance has been recorded against the Company’s deferred tax assets, as it was determined, based on past and present losses, that it was “more likely than not” that the Company’s deferred tax assets would not be realized. The valuation allowance was increased to the full carrying amount of the Company’s deferred tax assets. In future years, if management determines that the deferred tax assets are “more likely than not” to be realized, the recognized tax benefits relating to reversing the valuation allowance will be recorded. The Company will continue to assess and evaluate strategies that enable the deferred tax asset, or portion thereof, to be utilized. It will reduce the valuation allowance appropriately when it is determined that the “more likely than not” criteria are satisfied.

     

    The net operating loss carryovers may be subject to annual limitations under Internal Revenue Code Section 382 and similar state provisions should there be a greater than 50% ownership change as determined under the applicable income tax regulations. The limitation amount would be determined based on the company’s value immediately before the ownership change, and subsequent ownership changes could further impact the annual limitation amount. An ownership change under Section 382 may have occurred in the past or could happen in the future, such that the NOLs available for utilization could be significantly limited. The Company plans to perform a Section 382 analysis in the future.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 25 — INCOME TAXES (continued)

     

    Effective for tax years beginning after December 31, 2017, the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary.

     

    For tax years beginning after December 31, 2017, the Tax Act introduced a new limitation on the deduction of interest expense. Current-year interest deductions are limited (among other restrictions) to 30% of adjusted taxable income, with various modifications and exceptions. The Company does incur interest expenses and evaluates each year the impact, if any, of the new limitation.

     

    The Company has not provided for deferred taxes and foreign withholding taxes on the excess of the financial reporting basis over the tax basis in our investments in foreign subsidiaries that are nearly permanent in duration. In general, it is the Company’s practice and intention to reinvest our foreign subsidiary’s earnings in those operations. Generally, our foreign subsidiary’s earnings have become subject to U.S. taxation based on specific U.S. tax law provisions, such as the recently enacted territorial transition tax under section 965 and under certain other circumstances. Due to the complexities of the provisions introduced with the Tax Act, and the underlying assumptions that would have to be made, it is not practicable to estimate the amount of tax provision required to account for these foreign undistributed earnings. The Company will account for any additional expense or deduction in the year it is claimed. The Company will continue to review each year whether this treatment is appropriate.

     

    The Company did not identify any material uncertain tax positions and is not under any income tax examinations.

     
    XML 56 R32.htm IDEA: XBRL DOCUMENT v3.24.1
    RECLASSIFICATION OF PRIOR YEAR PRESENTATION
    		 12 Months Ended
    Dec. 31, 2023
    Reclassification Of Prior Year Presentation  
    RECLASSIFICATION OF PRIOR YEAR PRESENTATION

    NOTE 26 — RECLASSIFICATION OF PRIOR YEAR PRESENTATION

     

    For consistency in financial reporting, we’ve updated the presentation of our prior period financial statements. This involved reclassifying certain items for the fiscal years ending December 31, 2023, and December 31, 2022, to align with this year’s reporting standards. The adjustments were only for presentation and did not affect our overall financial results.

     
    XML 57 R33.htm IDEA: XBRL DOCUMENT v3.24.1
    SUBSEQUENT EVENTS
    		 12 Months Ended
    Dec. 31, 2023
    Subsequent Events [Abstract]  
    SUBSEQUENT EVENTS

    NOTE 27 — SUBSEQUENT EVENTS

     

    Under ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2023, and has determined that it does not have any other material subsequent events to disclose in these financial statements except for the following:

     

    On February 12, 2024, Vislink Poway, LLC signed a renewal agreement with CPI Apartment Fund 10 LLC for the premises at 13475 Danielson Street, Suite 100, 130, and 160, Poway, California. The renewal term is set for one year and ten and a half months, commencing on March 14, 2024, and ending on January 31, 2026. The base rent for the renewal period is established at $22,926 per month.
    XML 58 R34.htm IDEA: XBRL DOCUMENT v3.24.1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
    		 12 Months Ended
    Dec. 31, 2023
    Accounting Policies [Abstract]  
    Principles of Consolidation

    Principles of Consolidation

     

    The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the Company’s accounts and wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating the Company’s subsidiaries.

     
    Segment Reporting

    Segment Reporting

     

    The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.

     
    Use of Estimates

    Use of Estimates

     

    Preparing the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our consolidated financial statements.

     
    Risks and Uncertainties

    Risks and Uncertainties

     

    The future impacts of the Russia-Ukraine war and the Israel-Hamas conflict, as well as their residual effects, include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries, remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.
    Allowance for Credit Losses

    Allowance for Credit Losses

     

    In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

     

    The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

     
    Cash and Cash Equivalents

    Cash and Cash Equivalents

     

    The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund as of December 31, 2023, and 2022.

     
    Concentrations

    Concentrations

     

    The Company does not possess any off-balance-sheet concentrations of credit risk. Credit risk, defined as the likelihood of a counterparty defaulting on contractual obligations, poses a potential financial loss for the Company. The primary sources of the Company’s credit risk are its cash, investments and accounts receivable. To mitigate the risk of loss exposure, the Company follows a policy of holding its cash in high-credit quality financial institutions. Cash deposits, representing a concentration of credit risk, are the main economic instruments exposing the Company to such risks. The Company has allocated $5.7 million towards investments in government bonds held to maturity to diversify our credit risk exposure further and enhance our risk mitigation strategies. These bonds, issued by the United States Federal Government, are evaluated for credit risk based on the issuing entity’s creditworthiness. This investment strategy is aligned with our overarching objective to minimize potential financial losses by spreading risk across various high-credit quality assets and instruments. The Federal Deposit Insurance Corporation (“FDIC”) insures up to $250,000 for accounts held within the United States. In the United Kingdom, the Company maintains cash balance accounts at financial institutions insured by the Financial Services Compensation Scheme, covering up to £85,000 (subject to currency translation rates to the United States dollar). Additionally, in the Netherlands, the Company’s cash balance accounts at financial institutions are insured by the “Dutch deposit guarantee scheme,” providing coverage up to €100,000 per person per bank.

     

    As of December 31, 2023, and 2022, the Company held approximately $7.7 million and $24.5 million above insured limits, respectively, remaining unaffected by any losses in its bank accounts during this period.

     

    During the year ending December 31, 2023, the Company did not report any sales to an individual customer that constituted more than 10% of its total sales. During the year ending December 31, 2022, the Company noted sales to a single customer amounting to $3.4 million, representing 12% of the Company’s total sales, in excess of 10% of its total sales.

     

    As of December 31, 2023, and 2022, the Company’s accounts receivable from a single customer were recorded at approximately $1.1 million (13%) and $1.1 million (19%), respectively. Each instance surpassed the 10% mark of the Company’s total consolidated accounts receivable, indicating a significant concentration in customer receivables.
    Accounts Receivable and Allowance for Doubtful Accounts

    Accounts Receivable and Allowance for Doubtful Accounts

     

    On January 1, 2023, the Company adopted Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments. The Company extends credit to its customers in the ordinary course of business and has applied a new standard in evaluating estimated losses through an allowance for doubtful accounts. The Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

     
    Inventories

    Inventories

     

    Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.

     
    Investment in Debt Securities

    Investment in Debt Securities

     

    Vislink Technologies, Inc. invests in government bonds with the intent and ability to hold these investments until maturity. In alignment with ASC Topic 320, Investments—Debt and Equity Securities, such investments are classified as “Held-to-Maturity” (HTM) securities and are measured at amortized cost.

     

      ● Classification: The Company classifies its investments in government bonds as “Held-to-Maturity” (HTM) securities based on management’s intent and ability to hold the securities to maturity. These HTM securities are recognized in the Company’s financial statements at their amortized cost, adjusted for the amortization of premiums and accretion of discounts to maturity.
      ● Measurement: HTM securities are initially recognized at their acquisition cost, including transaction costs. Subsequently, they are measured at amortized cost using the effective interest method. This method considers the amortization of any discount or premium on the acquisition cost until maturity.
      ● Interest Income: Interest income is accrued using the security’s effective yield, reflecting the time value of money.
      ● Amortization of Discount and Premium: The amortization of the discount (or accretion of the premium) is included as part of the interest income recognized in the income statement, reflecting the adjustment to the investment’s yield.
      ● Impairment: The Company periodically assesses HTM investments for impairment if objective evidence indicates an impairment has been incurred. It recognizes any loss when the present value of estimated future cash flows, discounted at the original effective interest rate, is less than the carrying amount.
      ● Derecognition: A Held-to-Maturity investment is removed from the balance sheet when the right to receive cash flows has expired, or the Company has substantially transferred all ownership risks and rewards.
    Business Combinations and Asset Acquisitions

    Business Combinations and Asset Acquisitions

     

    The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.

     

    The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets. Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.

     

    The distinction between business combinations and asset acquisitions involves judgment, particularly when applying the screen test to determine the nature of the transaction. Incorrect judgments or changes in decisions in these areas could materially affect the determination of goodwill, the recognition and measurement of acquired assets and assumed liabilities, and, consequently, our financial position and results of operations.

     
    Property and Equipment

    Property and Equipment

     

    Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from 1 to 14 years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in the expenses as incurred.

     
    Intangible Assets

    Intangible Assets

     

    Patents and licenses: patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s consolidated balance sheet and amortized on a straight-line basis over their estimated useful lives of 18.5 to 20 years. Amortization totaled approximately $-0- and $0.5 million for the years ended December 31, 2023, and 2022, respectively.

     

    Other intangible assets: the Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink Technologies, Inc., Mobile Viewpoint Corporate B.V. (“MVP”), and the assets of BMS. An independent third-party appraiser evaluated the acquired assets for these business transactions. In the absence of fair market values from potential buyers or comparable transactions, we concluded that the methodologies applied provided a reasonable estimate for the values assigned. The Company amortizes intangible asset costs over their useful lives of 3 to 15 years with its net book value reported on the balance sheet. Amortization totaled approximately $1.0 million each for the years ended December 31, 2023, and 2022, respectively.

     
    Warranty Reserve

    Warranty Reserve

     

    Although the Company tests its products under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data, required revisions to the estimated warranty liability will occur.

     

    The claims made during the year ended December 31, 2023, and 2022 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.

     

       Warranty Reserve 
    December 31, 2021  $131,000 
    Warranty reserve expense   98,000 
    Warranty claims settled and true-up of accrual.   (117,000)
    December 31, 2022  $112,000 
    Warranty reserve expense   432,000 
    Warranty claims settled, and true-up of accrual   (411,000)
    December 31, 2023  $133,000 

     
    Shipping and Handling Costs

    Shipping and Handling Costs

     

    The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2023, and 2022, the shipping and handling costs incurred were $0.4 million and $0.7 million, respectively.

     
    Treasury Stock

    Treasury Stock

     

    Treasury stock is recorded at cost upon the repurchasing of common shares, and the cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.
    Revenue Recognition

    Revenue Recognition

     

    The Company accounts for its operating results under ASC Topic 606, adopted on January 1, 2019. This comprehensive revenue recognition model requires recognition when the Company transfers control of the promised goods or services to the Company’s customers at an amount that reflects the consideration the Company expects to receive. The application of ASC Topic 606 requires the Company to use more judgment and make more estimates than under previously issued guidance.

     

    The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those services.

     

    The Company determines revenue recognition through the following steps:

     

    1. identification of the contract, or contracts, with a customer.

    2. identification of the performance obligations in the contract.

    3. determination of the transaction price.

    4. allocation of the transaction price to the performance obligations in the contract; and

    5. recognition of revenue when, or as, the Company satisfies a performance obligation.

     

    At contract inception, the Company assesses the goods and services promised in the Company’s customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. The Company measures revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges the Company collects concurrent with revenue-producing activities are excluded from income.

     

    Remaining Performance Obligations:

     

    The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.

     
    Research and Development Expenses

    Research and Development Expenses

     

    As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the consolidated statements of operations and comprehensive loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.
    Leases

    Leases

     

    The Company determines if an arrangement is a lease at inception. The Company recognizes lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets, such as “Right of use assets, operating leases,” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. The Company recognizes operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all of the Company’s real estate contracts.

     

    There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2023. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of the Company’s leases do not provide an implicit rate, the Company determines our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.

     
    Stock-Based Compensation

    Stock-Based Compensation

     

    The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.

     

    The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from non-employees. The measurement date for equity-classified non-employee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of non-employee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the non-employee share-based payment awards with performance conditions and accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the non-employee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for non-employee awards.

     

    Stock-Option Awards — Time-Based and Performance-Based

     

    Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For non-employee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.

     

    The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Stock-Based Compensation (continued)

     

    Restricted Stock Unit Awards (“RSUs”) — Time-Based

     

    Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.

     

    Restricted Stock Unit Awards (“RSUs”) — Performance-Based

     

    The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.

     
    Impairment and Abandonment

    Impairment and Abandonment

     

    Right-of-use operating lease abandonment:

     

    Approximately 2,700 square feet of manufacturing space at the Colchester, UK facility were abandoned as part of the Company’s strategic decision to relocate its UK manufacturing division to the United States commencing in September 2023. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and the Company assessed whether the lease ROU assets were impaired. It was determined that approximately $0.1 million of the Company’s right-of-use operating assets were impaired.

     

    Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The location’s economic environment precluded subletting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment.

     

    For the years ending December 31, 2023, and 2022, the Company recognized a loss on impairment of ROU assets of approximately $0.1 million each, respectively.

     
    Income Taxes

    Income Taxes

     

    Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expenses and penalties as general and administrative expenses.
    Advertising Costs

    Advertising Costs

     

    Advertising costs are charged to operations as incurred. For the years ended December 31, 2023, and 2022, respectively, advertising costs amounted to approximately $0.7 million and $1.0 million. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.

     
    Sales Tax and Value-Added Taxes

    Sales Tax and Value-Added Taxes

     

    The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.

     
    Loss Per Share

    Loss Per Share

     

    The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, excellent for the period determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.

     
    Foreign Currency and Other Comprehensive (Gains) Losses

    Foreign Currency and Other Comprehensive (Gains) Losses

     

    The Company records gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. The Company has two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2023, and 2022, respectively. The Company has included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.

     

    Transaction gains and losses are recognized in the Company’s operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying consolidated statements of operations.

     
    Fair Value of Financial Instruments and Fair Value Measurements

    Fair Value of Financial Instruments and Fair Value Measurements

     

    The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” defines fair value as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not assumptions specific to the entity. ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques reflect assumptions other market participants would use based on the market data obtained from independent sources (observable inputs). In accordance with ASC 820, the following summarizes the fair value hierarchy:

     

      ● Level 1 is observable inputs such as quoted prices in active markets,
      ● Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable, and
      ● Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Fair Value of Financial Instruments and Fair Value Measurements (continued)

     

    Our financial instruments include cash equivalents, investments, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.

     
    Redeemable Preferred Stock

    Redeemable Preferred Stock

     

    In November 2022, the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders relating to the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder not participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole on March 24, 2023, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.

     

    Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the consolidated balance sheets.

     
    Recently Issued Accounting Pronouncements

    Recently Issued Accounting Pronouncements

     

    Adopted:

     

    On January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable. The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Recently Issued Accounting Pronouncements (continued)

     

    Not yet adopted:

     

    In February 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280). This update revises the reporting requirements for operating segments of public entities, aiming to enhance the transparency and usefulness of segment reporting. As of the date of these financial statements, the Company has not formally adopted ASU 2023-07, which becomes effective for public entities for reporting periods beginning after December 15, 2023. However, it is essential to note that our Company operates as a single reporting segment. Due to this structure, the Company inherently met the updated disclosure requirements of ASU 2023-07 without needing additional segment-specific information. Our current operating segment structure aligns with the objectives of the new standard, emphasizing explicit and meaningful segment reporting. We have assessed that there will be no significant impact on our financial statements upon adopting ASU 2023-07. We will continue to monitor any further guidance FASB provides and ensure compliance with the reporting standards. As the Company formally adopted ASU 2023-07, the Company remained committed to transparency and clarity in our financial reporting. Our subsequent financial statements will provide further updates regarding compliance with this and other accounting standards.

     

    In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-09, enhancing transparency in income tax disclosures. This ASU applies to entities under Topic 740, requiring detailed rate reconciliation and disclosures of taxes paid. It mandates public business entities to disclose rate reconciliation categories annually and specifies a quantitative threshold for reconciling items. Other entities must provide qualitative disclosures. The update is effective for public business entities for annual periods beginning after December 15, 2024, and other entities after December 15, 2025, with early adoption permitted. The Company is evaluating the impact of ASU 2023-09 on its financial statements and will provide updates, if necessary, alongside other accounting standards in future financial statements.

     
    Recent Accounting Pronouncements

    Recent Accounting Pronouncements

     

    Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC, did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.
    XML 59 R35.htm IDEA: XBRL DOCUMENT v3.24.1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Accounting Policies [Abstract]  
    SCHEDULE OF PRODUCT WARRANTY LIABILITY

    The claims made during the year ended December 31, 2023, and 2022 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.

     

       Warranty Reserve 
    December 31, 2021  $131,000 
    Warranty reserve expense   98,000 
    Warranty claims settled and true-up of accrual.   (117,000)
    December 31, 2022  $112,000 
    Warranty reserve expense   432,000 
    Warranty claims settled, and true-up of accrual   (411,000)
    December 31, 2023  $133,000 
    XML 60 R36.htm IDEA: XBRL DOCUMENT v3.24.1
    LOSS PER SHARE (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Net loss per share attributable to Common Shareholders:  
    SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE

    The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
    Stock options   51    41 
    Warrants   456    459 
    Total   507    500 
    XML 61 R37.htm IDEA: XBRL DOCUMENT v3.24.1
    FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Foreign Currency [Abstract]  
    SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME

    The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive loss approximately as follows:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Net foreign exchange transactions:          
    (Gains) Losses  $49,000   $24,000 
                
    Accumulated comprehensive income:          
    Unrealized (gains) losses on currency translation adjustment  $(310,000)  $1,040,000 
    XML 62 R38.htm IDEA: XBRL DOCUMENT v3.24.1
    CASH AND CASH EQUIVALENTS (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Cash and Cash Equivalents [Abstract]  
    SCHEDULE OF CASH AND CASH EQUIVALENTS

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
             
    Cash on hand  $1,776,000   $25,627,000 
    Federally insured money market mutual funds   6,706,000    — 
    Total cash and cash equivalents  $8,482,000   $25,627,000 
    XML 63 R39.htm IDEA: XBRL DOCUMENT v3.24.1
    INVESTMENTS (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Investments, All Other Investments [Abstract]  
    SCHEDULE OF INVESTMENTS HELD TO MATURITY

    The Company’s investments held to maturity are as follows as of December 31, 2023:

     

      

    Amortized

    Cost

    		  

    Unrealized

    Gains

    		   Unrealized Losses   Fair Value 
                         
    Federal Bonds  $5,663,000   $68,000   $     —   $5,731,000 
    XML 64 R40.htm IDEA: XBRL DOCUMENT v3.24.1
    FAIR VALUE OF ASSETS AND LIABILITIES (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Fair Value Disclosures [Abstract]  
    SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS

     

      

    Quoted Prices in Active Markets of Identical Assets/Liabilities

    (Level 1)

    		  

    Significant Other Observable Inputs

    (Level 2)

    		  

    Significant Unobservable Inputs

    (Level 3)

    		   Total 
    Assets                    
    December 31, 2023:                    
    Federal Bonds Held to Maturity  $—   $5,731,000   $—   $5,731,000 
    Right of use asset impairment   —    —    83,000    83,000 
       $        —   $5,731,000   $83,000   $5,814,000 
                         
    Liabilities  $—   $—   $—   $— 
                         
    Assets                    
    December 31, 2022:                    
    Federal Bonds Held to Maturity  $—   $—   $—   $— 
    Right of use asset impairment   —    —    88,000    88,000 
       $—   $—   $88,000   $88,000 
                         
    Liabilities  $—   $—   $—   $— 
    XML 65 R41.htm IDEA: XBRL DOCUMENT v3.24.1
    ASSET ACQUISITION (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Business Combination and Asset Acquisition [Abstract]  
    SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED

    The Company recorded the purchase of this agreement under purchase price accounting, recording the fair value of the assets acquired and the liabilities assumed based upon the purchase price, as summarized in the table below:

     

          
    Assets acquired:     
    Work-in-process inventory  $66,042 
    Intangible assets - customer relationships   495,372 
    total assets   561,414 
          
    Liabilities assumed:     
    Deferred revenue   292,014 
    total liabilities   292,014 
          
    Total cash used for asset acquisition  $269,400 
          
    Cash used in acquisition:     
    Acquisition price  $200,000 
    Transaction costs   69,400 
    Total cash used for asset acquisition  $269,400 
    XML 66 R42.htm IDEA: XBRL DOCUMENT v3.24.1
    ACCOUNTS RECEIVABLE (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Receivables [Abstract]  
    SCHEDULE OF ACCOUNTS RECEIVABLE

    Accounts receivable consist of the following:

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Accounts receivable  $9,389,000   $6,680,000 
    Allowance for doubtful accounts   (709,000)   (673,000)
    Net accounts receivable  $8,680,000   $6,007,000 
    XML 67 R43.htm IDEA: XBRL DOCUMENT v3.24.1
    INVENTORIES (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Inventory Disclosure [Abstract]  
    SCHEDULE OF INVENTORIES

    Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Raw materials  $12,890,000   $12,038,000 
    Work-in-process   1,458,000    1,474,000 
    Finished goods   5,599,000    4,460,000 
    Sub-total inventories   19,947,000    17,972,000 
    Less reserve for slow-moving and excess inventory   (5,918,000)   (5,951,000)
    Total inventories, net  $14,029,000   $12,021,000 
    XML 68 R44.htm IDEA: XBRL DOCUMENT v3.24.1
    PROPERTY AND EQUIPMENT (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Property, Plant and Equipment [Abstract]  
    SCHEDULE OF PROPERTY AND EQUIPMENT

    Property and equipment consist of the following:

     

       (Years)  2023   2022 
          For the years ended 
       Useful Life  December 31, 
       (Years)  2023   2022 
    Cost:             
    Furniture and fixtures  1 – 10  $347,000   $308,000 
    Leasehold improvements (a)  1 – 14   443,000    443,000 
    Computers, software, and equipment  1 – 11   3,677,000    3,016,000 
    Property and equipment, cost      4,467,000    3,767,000 
    Accumulated depreciation      (2,565,000)   (2,333,000)
    Property and equipment, net     $1,902,000  $1,434,000 
    XML 69 R45.htm IDEA: XBRL DOCUMENT v3.24.1
    INTANGIBLE ASSETS (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Goodwill and Intangible Assets Disclosure [Abstract]  
    SCHEDULE OF INTANGIBLE ASSETS

    The following table illustrates finite intangible assets as of December 31, 2023, and 2022:

     

       Proprietary Technology   Patents and Licenses   Trade Names & Technology   Customer Relationships     
           Accumulated       Accumulated       Accumulated       Accumulated     
       Cost   Amortization   Cost   Amortization   Cost   Amortization   Cost   Amortization   Net 
                                         
    December 31, 2023:                                             
    Balance, January 1, 2023  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 
                                                  
    Additions   —    —    —    —    —    —    496,000    —    496,000 
                                                  
    Amortization   —    (593,000)   —    —    —    (138,000)   —    (299,000)   (1,030,000)
    Balance, December 31, 2023  $2,132,000   $(1,408,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,327,000)  $5,591,000   $(3,373,000)  $3,866,000 
                                                  
    December 31, 2022:                                             
    Balance, January 1, 2022   2,132,000    (223,000)   12,378,000    (11,843,000)   2,251,000    (1,052,000)   5,095,000    (2,817,000)   5,921,000 
                                                  
    Amortization   —    (592,000)   —    (535,000)   —    (137,000)   —    (257,000)   (1,521,000)
                                                  
    Balance, December 31, 2022  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 
    SCHEDULE OF CAPITALIZED INTANGIBLE COSTS

    The Company has recognized net capitalized intangible costs as follows:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Proprietary Technology  $726,000   $1,319,000 
    Patents and Licenses   —    — 
    Trade Names and Technology   922,000    1,060,000 
    Customer Relationships   2,218,000    2,021,000 
    Net capitalized intangible costs  $3,866,000   $4,400,000 
    SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS

    The Company has recognized the amortization of intangible assets as follows:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
             
    Proprietary Technology  $593,000   $592,000 
    Patents and Licenses   —    535,000 
    Trade Names and Technology   138,000    137,000 
    Customer Relationships   299,000    257,000 
    Amortization of intangible assets   $1,030,000   $1,521,000 
    SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS

    The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 4.9 years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:

      

    Period ending December 31,     
    2024  $783,000 
    2025   781,000 
    2026   651,000 
    2027   346,000 
    2028   288,000 
    Thereafter   1,017,000 
    Intangible assets, estimated amortization expense  $3,866,000 
    XML 70 R46.htm IDEA: XBRL DOCUMENT v3.24.1
    ACCRUED EXPENSES (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Payables and Accruals [Abstract]  
    SCHEDULE OF ACCRUED EXPENSES

    Accrued expenses consist of the following:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Compensation  $567,000   $246,000 
    Commissions   106,000    47,000 
    Warranty   135,000    112,000 
    Accrued expenses other   770,000    908,000 
    Deferred equity   —    255,000 
    Accrued expenses  $1,578,000   $1,568,000 
    XML 71 R47.htm IDEA: XBRL DOCUMENT v3.24.1
    NOTES PAYABLE (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Debt Disclosure [Abstract]  
    SCHEDULE OF NOTES PAYABLE

    The table below represents the Company’s notes payable as of December 31, 2023, and 2022:

     SCHEDULE OF NOTES PAYABLE

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
             
    On April 5, 2022,   $—   $84,000 
    On April 5, 2022, the Company renewed its D & O insurance policy, decreasing the premium to approximately $1,037,000, less a down payment of $194,000, financing the remaining balance of approximately $943,000. The loan’s terms are nine months at a 2.09% annual interest rate and a monthly principal and interest payment of approximately $84,000. The Company recorded interest expense of $6,000 and $-0- for the years ended December 31, 2022, and 2021, respectively.  $—   $84,000 
               
    On April 5, 2023, the Company renewed its D & O insurance policy, reducing the premium to approximately $811,000, less a down payment of $288,000, financing the remaining balance of approximately $523,000. The loan’s terms are for nine months at a 6.14% annual interest rate and a monthly principal and interest payment of approximately $67,000. Accordingly, the Company recorded interest expenses of $12,100 and $-0- for the years ending December 31, 2023, and 2022, respectively.   —    — 
    Notes payable  $—   $84,000 
    XML 72 R48.htm IDEA: XBRL DOCUMENT v3.24.1
    LEASES (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Leases  
    SCHEDULE OF LEASE OBLIGATIONS ASSUMED

    The table below lists the location and lease expiration date from 2025 through 2027: 

     

    Location   Square Footage     Lease-End Date   Approximate Future Payments  
    Colchester, U.K. – Waterside House     13,223     Dec   2025     $ 502,000  
    Lutton, UK     600     Jan   2025       32,000  
    Billerica, MA     2,000     Dec   2026       316,000  
    Mount Olive, NJ     7,979     May   2027       470,000  
    Trivex, Singapore     950     Aug   2025       60,000  
    SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA

    The following table illustrates Right-Of-Use operating lease data recorded for the years ended December 31, 2023, and 2022:

     

       2023   2022 
       For the years ended 
       December 31, 
       2023   2022 
    Right-of-use assets:          
    Cost  $2,385,000   $2,260,000 
    Accumulated amortization   (1,643,000)   (1,185,000)
               
      $742,000   $1,075,000 
               
    Operating lease liability:          
    Current portion  $463,000   $455,000 
    Non-current portion   755,000    1,107,000 
               
       $1,218,000   $1,562,000 
               
    Weighted average discount rate   9.4%   9.4%
               
    Weighted average remaining term for lease contracts   2.6 years    3.4 years 
               
    Lease maturity dates for right-of-use operating leases   July 2025 to May 2027    July 2023 to May 2027 
               
    Lease cost:          
    Operating lease cost  $435,000   $438,000 
    Short-term lease cost   126,000    93,000 
               
    Total lease cost  $561,000   $531,000 
               
    Cash paid for lease liabilities:          
    Cash flows from operating leases  $643,000   $543,000 
               
    Right-of-use assets obtained in exchange for new operating lease liabilities  $171,000   $— 
    SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES

    Maturities of our operating lease liabilities were as follows as of December 31, 2023:

     

       Amount 
         
    2024  $559,000 
    2025   513,000 
    2026   249,000 
    2027   59,000 
    2028   — 
    Thereafter   — 
    Total lease payments   1,380,000 
    Less: imputed interest   162,000 
    Present value of lease liabilities   1,218,000 
    Less: Current lease liabilities   463,000 
    Non-current lease liabilities  $755,000 
    XML 73 R49.htm IDEA: XBRL DOCUMENT v3.24.1
    STOCKHOLDERS’ EQUITY (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Equity [Abstract]  
    SCHEDULE OF WARRANT OUTSTANDING

    The following tables set forth common stock purchase warrants outstanding as of December 31, 2023, and 2022:

      

    Number of Warrants

    (in shares)

    		  

    Weighted

    Average

    Exercise

    Price

    		 
             
    Outstanding, December 31, 2021   460,491   $82.00 
    Warrants expired   (1,745)   (2624.00)
    Outstanding and exercisable, December 31, 2022   458,746    71.60 
    Warrants expired   (2,666)   (1,200.30)
    Outstanding and exercisable, December 31, 2023   456,080   $65.10 
    SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE

        Common stock issuable upon exercise of warrants outstanding and exercisable 
        For the year-ending   For the year-ending 
        December 31, 2023   December 31, 2022 
    Range of Exercise Prices   Warrants Outstanding and Exercisable (in shares)   Weighted Average Remaining Contractual Life (years)  

    Weighted Average Exercise

    Price

    		  

    Warrants Outstanding and Exercisable

    (in shares)

    		   Weighted Average Remaining Exercisable Contractual Life (years) 

    Weighted Average Exercise

    Price

    		 
    $65.00    454,546    3.11 yrs   $65.00    454,546   3.11 yrs  $65.00 
    $68.20    1,500    1.18 yrs   $68.20    1,500   1.18 yrs  $68.20 
    $600.00    34    1.54 yrs   $600.00    34   1.54 yrs  $600.00 
    $1,200.00    —    —   $—    2,666   0.41 yrs  $1,200.00 
          456,080    3.10 yrs   $65.10    458,746   3.10 yrs  $71.60 
    XML 74 R50.htm IDEA: XBRL DOCUMENT v3.24.1
    STOCK-BASED COMPENSATION (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
    SCHEDULE OF STOCK BASED COMPENSATION EXPENSE

    As shown in the following table, stock-based compensation expense is included in general and administrative costs under the following plans:

     

    SCHEDULE OF STOCK BASED COMPENSATION EXPENSE

    Equity-based plans:  2023   2022 
       For the years ended 
       December 31, 
    Equity-based plans:  2023   2022 
             
    Long-term stock incentive plan awards  $—   $1,000 
    Time-vested option inducement awards   181,000    179,000 
    Time-based restricted stock awards   1,761,000    1,385,000 
    Stock-based compensation expense  $1,942,000   $1,565,000 
    Various Equity Compensation Plans [Member]  
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
    SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN

    The following table illustrates supplementary data under various equity compensation plans:

     

        For the years ended     For the years ended  
        December 31,     December 31,  
        2023     2022     2023     2022  
       

    Quantity

    		    

    Weighted Average

    		    

    Quantity

    		    

    Weighted Average

    		    

    Quantity

    		    

    Weighted Average

    		    

    Quantity

    		    

    Weighted Average

    		  
                 
        Long-term stock incentive plan awards     Time-vested option inducement awards  
    Balance-January 1, outstanding     2,250     $ 1,756.01       2,496     $ 1,760.80       24,725     $ 12.90       24,725     $ 20.20  
    Canceled, expired, forfeited     (88 )     (1,431.14 )     (246 )     (1,934.00 )     (6,759 )     (8.63 )     —       —  
    Balance-December 31, outstanding     2,162     $ 1,768.46       2,250     $ 1,756.01       17,966     $ 6.27       24,725     $ 12.90  
    Balance-December 31, exercisable     2,162     $ 1,768.46       2,250     $ 1,756.01       17,592     $ 27.23       18,027     $ 21.13  
    Remaining compensation expense     $—       $—       $113,000       $319,000  
    Remaining amortization period     0.0 years       0.0 years       0.1 years       1.1 years  
    Weighted average remaining contractual life – options outstanding and exercisable     3.5 years and 3.5 years       4.5 years and 4.5 years       6.1 years and 6.1 years       7.1 years and 7.1 years  
    Intrinsic value per share     $—       $—       $—       $—  
    Range of exercise prices     $139.20 to $1,944.00       $139.20 to $1,944.00       $34.20       $19.20 to $34.20  
                                                                     
         

    Performance-based stock option

    inducement awards

    		       Time-based restricted stock awards  
    Balance-January 1, outstanding     12,500     $ 33.12       12,500     $ 33.12       140,736     $ 23.09       39,933     $ 63.40  
    Granted     —       —       —       —       53,750       8.17       107,053       20.80  
    Canceled, expired, forfeited     —       —       —       —       (19,415 )     (21.48 )      (6,250 )     (13.60 )
    Stock units exercised     —       —       —       —       (48,368 )     (41.58 )     —       —  
    Balance-December 31, outstanding     12,500      $ 33.12       12,500      $ 33.12       126,703      $ 11.92       140,736       23.09  
    Balance-December 31, exercisable     —     $ —       —     $ —       30,692     $ 36.98       20,794     $ 66.60  
    Remaining compensation expense     $414,000       $414,000       $1,511,000       $3,248,000  
    Remaining amortization period     1.1 years       2.1 years       1.6 years       2.3 years  
    Weighted average remaining contractual life – options outstanding and exercisable     6.1 years and 0.0 years       7.1 years and 0.0 years       1.9 years and 1.7 years       2.5 years and 1.4 years  
    Intrinsic value per share     $—       $—       $—       $—  
    Range of exercise prices     $34.20       $34.20       $5.71 to $72.00       $19.60 to $72.00  
                                   
                                          Performance-based restricted stock awards  
    Balance-January 1, outstanding                                     71,303     $ 21.01       63,369     $ 58.00  
    Granted                                     12,500       5.68       71,303       21.00  
    Canceled, expired, forfeited                                     (19,649 )     (21.62 )     —       —  
    Stock units exercised                                     —       —       (63,369 )     (58.00 )
    Balance-December 31, outstanding                                     64,154     $ 18.02       71,303     $ 21.01  
    Balance-December 31, exercisable                                     —     $ —       —     $ —  
    Remaining compensation expense                                     $1,156,000       $1,498,000  
    Remaining amortization period                                     2.1 years       2.8 years  
    Weighted average remaining contractual life – options outstanding and exercisable                                     2.1 years and 0.0 years       2.8 years and 0.0 years  
    Intrinsic value per share                                     $—       $—  
    Range of exercise prices                                     $5.80 to $21.00       $21.00  
    XML 75 R51.htm IDEA: XBRL DOCUMENT v3.24.1
    COMMITMENTS AND CONTINGENCIES (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Commitments and Contingencies Disclosure [Abstract]  
    SCHEDULE OF MATCHING CONTRIBUTIONS

    The table below represents the Company’s matching contributions as follows:

     

       For the year ended 
       December 31, 
       2023   2022 
    Company matching contributions - Group Personal Pension Plan, U.K.  $140,000   $166,000 
    XML 76 R52.htm IDEA: XBRL DOCUMENT v3.24.1
    REVENUE (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Revenue from Contract with Customer [Abstract]  
    SCHEDULE OF DISAGGREGATION OF REVENUE

    The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:

     

       For the years ended 
       December 31, 
       2023   2022 
    Primary geographical markets:          
    North America  $13,501,000   $12,037,000 
    South America   528,000    182,000 
    Europe   6,420,000    8,958,000 
    Asia   3,354,000    1,851,000 
    Rest of World   3,679,000    5,103,000 
       $27,482,000   $28,131,000 
    Primary revenue source:          
    Equipment sales  $24,054,000   $25,667,000 
    Installation, integration, and repairs   1,688,000    1,450,000 
    Warranties   1,740,000    1,014,000 
       $27,482,000   $28,131,000 
    Long-lived assets:          
    United States  $2,767,000   $1,970,000 
    Netherlands   20,000    27,000 
    United Kingdom   3,723,000    4,912,000 
       $6,510,000   $6,909,000 
    XML 77 R53.htm IDEA: XBRL DOCUMENT v3.24.1
    REBATES (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Rebates  
    SCHEDULE OF TAX REBATES

    The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary, which are included in other income.

     

       For the years ended 
       December 31, 
       2023   2022 
               
    Total tax rebates  $331,000   $271,000 
    XML 78 R54.htm IDEA: XBRL DOCUMENT v3.24.1
    GAINS ON SETTLEMENT OF DEBT (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Gains On Settlement Of Debt  
    SCHEDULE OF GAINS ON SETTLEMENT OF DEBT

    The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2023, and 2022:

       2023   2022 
       For the Years Ended 
       December 31, 
       2023   2022 
             
    On May 4, 2022, and July 19, 2022, the Company issued 38,703 shares of common stock on each date with an accumulated value of $54,184 in satisfaction of an amount payable of $80,000  $—   $25,816 
               
    On November 21, 2022, the Company settled the dividends payable in the amount of $19,916 by issuing 47,419 Series A Preferred shares with a zero carrying value.   —    19,916 
               
    Gains on settlement of debt  $—   $45,732 
    XML 79 R55.htm IDEA: XBRL DOCUMENT v3.24.1
    INCOME TAXES (Tables)
    		 12 Months Ended
    Dec. 31, 2023
    Income taxes  
    SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)

    The provision (benefit) for income taxes consists of the following:

     

       2023   2022 
       For the Years Ended 
       December 31, 
       2023   2022 
    Current tax provision          
    Federal  $—   $— 
    State   4,400    25,000 
    Current income tax expense, total   4,400    25,000 
    Deferred tax provision (benefit)          
    Federal   (982,000)   (532,000)
    State   (2,457,000)   (427,000)
    Foreign   (1,516,000)   (978,000)
    Change in the valuation allowance   4,737,000    1,722,000 
    Total deferred tax provision (benefit)   (218,000)   (215,000)
               
    Income tax provision  $(214,000)  $(190,000)
    SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION

    A reconciliation of the statutory tax rate to the effective tax rate is as follows:

     

       2023   2022 
       For the Years Ended 
       December 31, 
       2023   2022 
    Statutory federal income tax rate   21.00%   21.00%
    State and local taxes, net of federal benefit   1.15    0.30 
    Permanent differences   0.49    5.28 
    Executive compensation   0.00    (2.26)
    Equity compensation   (3.63)   (11.06)
    Provision to return   7.49    0.00 
    DTA adjustment for state NOL   0.00    0.00 
    Foreign Rate Differential   1.44    (1.27)
    Change rate   27.13    2.66 
    Valuation allowance   (52.73)   (13.27)
    Effective tax rate   2.34%   1.37%
    SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

     

       2023   2022 
       For the Years Ended 
       December 31, 
       2023   2022 
    Deferred Tax Assets          
    Federal R&D credit  $3,007,000   $3,007,000 
    Inventory   422,000    576,000 
    Allowance for bad debt   73,000    72,000 
    Compensation related   12,000    7,000 
    Pension   55,000    72,000 
    Other accruals   34,000    7,000 
    State net operating losses   7,235,000    4,779,000 
    Federal net operating losses   47,296,000    44,821,000 
    Interest disallowance   1,150,000    1,151,000 
    Stock options   6,995,000    7,172,000 
    Other   465,000    296,000 
    Valuation Allowance   (66,468,000)   (61,731,000)
    Total Deferred Tax Assets   276,000    229,000 
    Deferred Tax Liabilities          
    Property and Equipment   (178,000)   (90,000)
    Intangibles   (616,000)   (870,000)
    Prepaid Expenses   (29,000)   (33,000)
    Total Deferred Tax Liabilities   (822,000)   (993,000)
    Net Deferred Tax Liability  $(546,000)  $(764,000)
    XML 80 R56.htm IDEA: XBRL DOCUMENT v3.24.1
    LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) - USD ($)
    $ in Thousands
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Liquidity And Financial Condition    
    Operating loss $ 10,598 $ 14,066
    Cash for operating activities 9,748 9,419
    Working capital 31,800  
    Cash 8,500  
    Accumulated deficit $ 309,226 $ 300,099
    XML 81 R57.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Accounting Policies [Abstract]    
    Warranty reserve, beginning $ 112,000 $ 131,000
    Warranty reserve expense 432,000 98,000
    Warranty claims settled and true-up of accrual (411,000) (117,000)
    Warranty reserve, ending $ 133,000 $ 112,000
    XML 82 R58.htm IDEA: XBRL DOCUMENT v3.24.1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
    		 1 Months Ended 12 Months Ended
    Jan. 23, 2023
    Nov. 30, 2022
    $ / shares
    Dec. 31, 2023
    USD ($)
    Segment
    $ / shares
    Dec. 31, 2022
    USD ($)
    $ / shares
    Dec. 31, 2023
    GBP (£)
    Dec. 31, 2023
    EUR (€)
    Mar. 31, 2013
    $ / shares
    Product Information [Line Items]              
    Number of operating segments | Segment     1        
    Cash FDIC insured amount     $ 250,000        
    Cash uninsured amount     7,700,000 $ 24,500,000      
    Revenue     27,482,000 28,131,000      
    Amortization of intangible assets     1,030,000 1,521,000      
    Shipping and handling costs     400,000 700,000      
    Right-of-use operating assets impaired     100,000        
    Loss on impairment of right-of-use assets     100,000 100,000      
    Advertising costs     $ 700,000 $ 1,000,000.0      
    Preferred stock, par value | $ / shares     $ 0.00001 $ 0.00001     $ 0.00001
    Series A Preferred Stock [Member]              
    Product Information [Line Items]              
    Preferred stock redemption terms Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders relating to the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder not participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole on March 24, 2023, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.          
    Preferred stock, par value | $ / shares   $ 0.00001          
    Patents and Licenses [Member]              
    Product Information [Line Items]              
    Amortization of intangible assets     $ 535,000      
    Other Intangible Assets [Member]              
    Product Information [Line Items]              
    Amortization of intangible assets     $ 1,000,000.0 1,000,000.0      
    Minimum [Member]              
    Product Information [Line Items]              
    Property and equipment, estimated useful life     1 year   1 year 1 year  
    Minimum [Member] | Patents and Licenses [Member]              
    Product Information [Line Items]              
    Finite-lived intangible asset, useful life     18 years 6 months   18 years 6 months 18 years 6 months  
    Minimum [Member] | Other Intangible Assets [Member]              
    Product Information [Line Items]              
    Finite-lived intangible asset, useful life     3 years   3 years 3 years  
    Maximum [Member]              
    Product Information [Line Items]              
    Property and equipment, estimated useful life     14 years   14 years 14 years  
    Maximum [Member] | Patents and Licenses [Member]              
    Product Information [Line Items]              
    Finite-lived intangible asset, useful life     20 years   20 years 20 years  
    Maximum [Member] | Other Intangible Assets [Member]              
    Product Information [Line Items]              
    Finite-lived intangible asset, useful life     15 years   15 years 15 years  
    Single Customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]              
    Product Information [Line Items]              
    Revenue       $ 3,436,000      
    Risk percentage       12.00%      
    Single Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]              
    Product Information [Line Items]              
    Risk percentage     13.00% 19.00%      
    Accounts receivable     $ 1,111,000 $ 1,138,000      
    UNITED KINGDOM              
    Product Information [Line Items]              
    Cash FSCS insured amount | £         £ 85,000    
    NETHERLANDS              
    Product Information [Line Items]              
    Dutch deposit guarantee scheme | €           € 100,000  
    XML 83 R59.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE (Details) - shares
    shares in Thousands
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:    
    Total 507 500
    Share-Based Payment Arrangement, Option [Member]    
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:    
    Total 51 41
    Warrant [Member]    
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:    
    Total 456 459
    XML 84 R60.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Foreign Currency [Abstract]    
    (Gains) Losses $ 49,000 $ 24,000
    Unrealized (gains) losses on currency translation adjustment $ (310,000) $ 1,040,000
    XML 85 R61.htm IDEA: XBRL DOCUMENT v3.24.1
    FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative)
    Dec. 31, 2023
    Dec. 31, 2022
    GBP to USD [Member]    
    Trading Activity, Gains and Losses, Net [Line Items]    
    Foreign currency exchange rate, translation 1.00 1.00
    Average foreign currency exchange rate remeasurement 1.00 1.00
    Euro to GBP [Member] | GBP [Member]    
    Trading Activity, Gains and Losses, Net [Line Items]    
    Foreign currency exchange rate, translation 1.00 1.00
    Average foreign currency exchange rate remeasurement 1.00 1.00
    Period End GBP to $1 Exchange Rate [Member]    
    Trading Activity, Gains and Losses, Net [Line Items]    
    Foreign currency exchange rate, translation 1.273840 1.208970
    Period End EUR to $1 Exchange Rate [Member]    
    Trading Activity, Gains and Losses, Net [Line Items]    
    Foreign currency exchange rate, translation 1.105890 1.069850
    Period Average GBP to $1 Exchange Rate [Member]    
    Trading Activity, Gains and Losses, Net [Line Items]    
    Foreign currency exchange rate, translation 1.243463 1.236579
    Period Average EUR to $1 Exchange Rate [Member]    
    Trading Activity, Gains and Losses, Net [Line Items]    
    Foreign currency exchange rate, translation 1.081317 1.052082
    XML 86 R62.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Cash and Cash Equivalents [Abstract]    
    Cash on hand $ 1,776,000 $ 25,627,000
    Federally insured money market mutual funds 6,706,000
    Total cash and cash equivalents $ 8,482,000 $ 25,627,000
    XML 87 R63.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details) - Federal Bonds [Member]
    $ in Thousands
    Dec. 31, 2023
    USD ($)
    Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]  
    Investments held to maturity, amortized cost $ 5,663,000
    Investments held to maturity, unrealized gain 68,000
    Investments held to maturity, unrealized loss
    Investments held to maturity, fair value $ 5,731,000
    XML 88 R64.htm IDEA: XBRL DOCUMENT v3.24.1
    INVESTMENTS (Details Narrative) - USD ($)
    Oct. 24, 2023
    Feb. 01, 2023
    Dec. 31, 2023
    Oct. 11, 2023
    Feb. 28, 2023
    Jan. 23, 2023
    HSBC USA INC CP [Member]            
    Schedule of Investments [Line Items]            
    Investment Owned, Fair Value     $ 4,714,000 $ 4,711,000   $ 4,812,500
    Investment Owned, Balance, Principal Amount       $ 5,000,000   $ 5,065,789
    Investment par value           $ 5,000,000
    Investment Maturity Date       Oct. 11, 2024   Oct. 24, 2023
    Investment Interest Rate       6.26229%   5.1948%
    Investment discount           $ 253,289
    Gain (Loss) on Investments $ 82,000          
    Federal Home Loan Banks [Member]            
    Schedule of Investments [Line Items]            
    Investment Owned, Fair Value   $ 5,025,479        
    Investment Owned, Balance, Principal Amount   $ 4,999,750        
    Investment par value   $ 5,000,000        
    Investment Maturity Date   Dec. 22, 2023        
    Investment Interest Rate   4.75%        
    Investment Income, Interest   $ 25,729        
    Federal National Mortgage Association [Member]            
    Schedule of Investments [Line Items]            
    Investment Owned, Fair Value     $ 949,000   $ 950,000  
    Investment Owned, Balance, Principal Amount         $ 950,000  
    Investment Maturity Date         Feb. 28, 2024  
    Investment Interest Rate         5.07%  
    XML 89 R65.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) - USD ($)
    $ in Thousands
    Dec. 31, 2023
    Dec. 31, 2022
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets $ 5,814,000 $ 88,000
    Total Liabilities
    Federal Bonds Held To Maturity [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets 5,731,000
    Right Of Use Asset Impairment [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets 83,000 88,000
    Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets
    Total Liabilities
    Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Federal Bonds Held To Maturity [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets
    Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Right Of Use Asset Impairment [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets
    Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets 5,731,000
    Total Liabilities
    Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Federal Bonds Held To Maturity [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets 5,731,000
    Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Right Of Use Asset Impairment [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets
    Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Liabilities
    Fair Value, Nonrecurring [Member] | Fair Value, Inputs, Level 3 [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets 83,000 88,000
    Fair Value, Nonrecurring [Member] | Fair Value, Inputs, Level 3 [Member] | Federal Bonds Held To Maturity [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets
    Fair Value, Nonrecurring [Member] | Fair Value, Inputs, Level 3 [Member] | Right Of Use Asset Impairment [Member]    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Total Assets $ 83,000 $ 88,000
    XML 90 R66.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) - BMS, LLC [Member]
    Sep. 14, 2023
    USD ($)
    Liabilities assumed:  
    Total cash used for asset acquisition $ 269,400
    Vislink Poway LLC [Member]  
    Assets acquired:  
    Work-in-process inventory 66,042
    Intangible assets - customer relationships 495,372
    total assets 561,414
    Liabilities assumed:  
    Deferred revenue 292,014
    total liabilities 292,014
    Total cash used for asset acquisition 269,400
    Acquisition price 200,000
    Transaction costs $ 69,400
    XML 91 R67.htm IDEA: XBRL DOCUMENT v3.24.1
    ASSET ACQUISITION (Details Narrative) - BMS, LLC [Member] - Vislink Poway LLC [Member] - USD ($)
    Sep. 14, 2023
    Oct. 02, 2023
    Business Acquisition [Line Items]    
    Cash consideration paid $ 200,000  
    Acquisition of additional inventory price   $ 230,000
    XML 92 R68.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF ACCOUNTS RECEIVABLE (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Receivables [Abstract]    
    Accounts receivable $ 9,389,000 $ 6,680,000
    Allowance for doubtful accounts (709,000) (673,000)
    Net accounts receivable $ 8,680,000 $ 6,007,000
    XML 93 R69.htm IDEA: XBRL DOCUMENT v3.24.1
    ACCOUNTS RECEIVABLE (Details Narrative) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Receivables [Abstract]    
    Bad debt expense $ 25,000 $ 21,000
    Bad debt recoveries $ 10,000 $ 517,000
    XML 94 R70.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF INVENTORIES (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Inventory Disclosure [Abstract]    
    Raw materials $ 12,890,000 $ 12,038,000
    Work-in-process 1,458,000 1,474,000
    Finished goods 5,599,000 4,460,000
    Sub-total inventories 19,947,000 17,972,000
    Less reserve for slow-moving and excess inventory (5,918,000) (5,951,000)
    Total inventories, net $ 14,029,000 $ 12,021,000
    XML 95 R71.htm IDEA: XBRL DOCUMENT v3.24.1
    INVENTORIES (Details Narrative) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Inventory Disclosure [Abstract]    
    Inventory written-off due to obsolescence $ 487,000 $ 1,143,000
    Product lines impairing of inventories $ 0 $ 1,787,000
    XML 96 R72.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Property, Plant and Equipment [Line Items]    
    Property and equipment, cost $ 4,467,000 $ 3,767,000
    Accumulated depreciation (2,565,000) (2,333,000)
    Property and equipment, net $ 1,902,000 1,434,000
    Minimum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 1 year  
    Maximum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 14 years  
    Furniture and Fixtures [Member]    
    Property, Plant and Equipment [Line Items]    
    Property and equipment, cost $ 347,000 308,000
    Furniture and Fixtures [Member] | Minimum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 1 year  
    Furniture and Fixtures [Member] | Maximum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 10 years  
    Leasehold Improvements [Member]    
    Property, Plant and Equipment [Line Items]    
    Property and equipment, cost [1] $ 443,000 443,000
    Leasehold Improvements [Member] | Minimum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life [1] 1 year  
    Leasehold Improvements [Member] | Maximum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life [1] 14 years  
    Computer Equipment [Member]    
    Property, Plant and Equipment [Line Items]    
    Property and equipment, cost $ 3,677,000 $ 3,016,000
    Computer Equipment [Member] | Minimum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 1 year  
    Computer Equipment [Member] | Maximum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 11 years  
    [1] The shorter economic life or remaining lease term.
    XML 97 R73.htm IDEA: XBRL DOCUMENT v3.24.1
    PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Property, Plant and Equipment [Abstract]    
    Property and equipment, depreciation $ 232,000 $ 201,000
    Depreciation leasehold improvement $ 0 $ 228,000
    XML 98 R74.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Finite-Lived Intangible Assets [Line Items]    
    Beginning balance net $ 4,400,000 $ 5,921,000
    Intangible assets, Additions 496,000  
    Intangible assets, amortization (1,030,000) (1,521,000)
    Ending balance net 3,866,000 4,400,000
    Proprietary Technology [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Beginning balance cost 2,132,000 2,132,000
    Beginning balance, accumulated amortization (815,000) (223,000)
    Intangible assets, Additions  
    Intangible assets, amortization (593,000) (592,000)
    Ending balance cost 2,132,000 2,132,000
    Ending balance, accumulated Amortization (1,408,000) (815,000)
    Patents and Licenses [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Beginning balance cost 12,378,000 12,378,000
    Beginning balance, accumulated amortization (12,378,000) (11,843,000)
    Intangible assets, amortization (535,000)
    Ending balance cost 12,378,000 12,378,000
    Ending balance, accumulated Amortization (12,378,000) (12,378,000)
    Trade Names and Technology [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Beginning balance cost 2,251,000 2,251,000
    Beginning balance, accumulated amortization (1,189,000) (1,052,000)
    Intangible assets, amortization (138,000) (137,000)
    Ending balance cost 2,251,000 2,251,000
    Ending balance, accumulated Amortization (1,327,000) (1,189,000)
    Customer Relationships [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Beginning balance cost 5,095,000 5,095,000
    Beginning balance, accumulated amortization (3,074,000) (2,817,000)
    Intangible assets, Additions 496,000  
    Intangible assets, amortization (299,000) (257,000)
    Ending balance cost 5,591,000 5,095,000
    Ending balance, accumulated Amortization $ (3,373,000) $ (3,074,000)
    XML 99 R75.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Finite-Lived Intangible Assets [Line Items]    
    Net capitalized intangible costs $ 3,866,000 $ 4,400,000
    Proprietary Technology [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Net capitalized intangible costs 726,000 1,319,000
    Patents and Licenses [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Net capitalized intangible costs
    Trade Names and Technology [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Net capitalized intangible costs 922,000 1,060,000
    Customer Relationships [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Net capitalized intangible costs $ 2,218,000 $ 2,021,000
    XML 100 R76.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Finite-Lived Intangible Assets [Line Items]    
    Amortization of intangible assets  $ 1,030,000 $ 1,521,000
    Proprietary Technology [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Amortization of intangible assets  593,000 592,000
    Patents and Licenses [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Amortization of intangible assets  535,000
    Trade Names and Technology [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Amortization of intangible assets  138,000 137,000
    Customer Relationships [Member]    
    Finite-Lived Intangible Assets [Line Items]    
    Amortization of intangible assets  $ 299,000 $ 257,000
    XML 101 R77.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Dec. 31, 2021
    Goodwill and Intangible Assets Disclosure [Abstract]      
    2024 $ 783,000    
    2025 781,000    
    2026 651,000    
    2027 346,000    
    2028 288,000    
    Thereafter 1,017,000    
    Intangible assets, estimated amortization expense $ 3,866,000 $ 4,400,000 $ 5,921,000
    XML 102 R78.htm IDEA: XBRL DOCUMENT v3.24.1
    INTANGIBLE ASSETS (Details Narrative)
    Dec. 31, 2023
    Finite-Lived Intangible Assets [Line Items]  
    Weighted average remaining life of intangible assets 4 years 10 months 24 days
    Proprietary Technology [Member] | Minimum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 3 years
    Proprietary Technology [Member] | Maximum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 5 years
    Patents and Licenses [Member] | Minimum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 18 years 6 months
    Patents and Licenses [Member] | Maximum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 20 years
    Other Intangible Assets [Member] | Minimum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 3 years
    Other Intangible Assets [Member] | Maximum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 15 years
    XML 103 R79.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Payables and Accruals [Abstract]    
    Compensation $ 567,000 $ 246,000
    Commissions 106,000 47,000
    Warranty 135,000 112,000
    Accrued expenses other 770,000 908,000
    Deferred equity 255,000
    Accrued expenses $ 1,578,000 $ 1,568,000
    XML 104 R80.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF NOTES PAYABLE (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Short-Term Debt [Line Items]    
    Notes payable $ 84,000
    Notes Payable One [Member]    
    Short-Term Debt [Line Items]    
    Notes payable 84,000
    Notes Payable Two [Member]    
    Short-Term Debt [Line Items]    
    Notes payable
    XML 105 R81.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) - D & O Insurance Policy Renewed [Member] - USD ($)
    		 12 Months Ended
    Apr. 05, 2023
    Apr. 05, 2022
    Dec. 31, 2023
    Dec. 31, 2022
    Notes Payable One [Member]        
    Short-Term Debt [Line Items]        
    Debt instrument, face amount   $ 1,037,000    
    Debt instrument down payment   194,000    
    Notes Payable   $ 943,000    
    Annual interest rate   2.09%    
    Debt monthly principal and interest payment   $ 84,000    
    Interest expense     $ 6,000 $ 0
    Notes Payable Two [Member]        
    Short-Term Debt [Line Items]        
    Debt instrument, face amount $ 811,000      
    Debt instrument down payment 288,000      
    Notes Payable $ 523,000      
    Annual interest rate 6.14%      
    Debt monthly principal and interest payment $ 67,000      
    Interest expense     $ 12,100 $ 0
    XML 106 R82.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details)
    		 12 Months Ended
    Dec. 31, 2023
    USD ($)
    ft²
    Sep. 01, 2023
    ft²
    Aug. 10, 2023
    ft²
    Feb. 01, 2023
    ft²
    Apr. 28, 2022
    ft²
    Approximate Future Payments $ 1,380,000        
    Colchester, U.K. - Waterside House [Member]          
    Area of land | ft² 13,223        
    Lease-End Month Dec        
    Lease-End Year 2025        
    Approximate Future Payments $ 502,000        
    Lutton, UK [Member]          
    Area of land | ft² 600 600   600 600
    Lease-End Month Jan        
    Lease-End Year 2025        
    Approximate Future Payments $ 32,000        
    Billerica, MA [Member]          
    Area of land | ft² 2,000        
    Lease-End Month Dec        
    Lease-End Year 2026        
    Approximate Future Payments $ 316,000        
    Mount Olive, NJ [Member]          
    Area of land | ft² 7,979        
    Lease-End Month May        
    Lease-End Year 2027        
    Approximate Future Payments $ 470,000        
    Trivex Singapore [Member]          
    Area of land | ft² 950   950    
    Lease-End Month Aug        
    Lease-End Year 2025        
    Approximate Future Payments $ 60,000        
    XML 107 R83.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Leases    
    Cost $ 2,385,000 $ 2,260,000
    Accumulated amortization (1,643,000) (1,185,000)
    Operating lease right of use asset 742,000 1,075,000
    Operating lease liability, Current portion 463,000 455,000
    Non-current portion 755,000 1,107,000
    Operating lease liability $ 1,218,000 $ 1,562,000
    Weighted-average discount rate-operating leases 9.40% 9.40%
    Weighted-average remaining lease term-operating leases 2 years 7 months 6 days 3 years 4 months 24 days
    Lease maturity dates for right-of-use operating leases July 2025 to May 2027 July 2023 to May 2027
    Operating lease cost $ 435,000 $ 438,000
    Short-term lease cost 126,000 93,000
    Total lease cost 561,000 531,000
    Cash flows from operating leases 643,000 543,000
    Right-of-use assets obtained in exchange for new operating lease liabilities $ 171,000
    XML 108 R84.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Leases    
    2024 $ 559,000  
    2025 513,000  
    2026 249,000  
    2027 59,000  
    2028  
    Thereafter  
    Total lease payments 1,380,000  
    Less: imputed interest 162,000  
    Present value of lease liabilities 1,218,000 $ 1,562,000
    Less: Current lease liabilities 463,000 455,000
    Non-current lease liabilities $ 755,000 $ 1,107,000
    XML 109 R85.htm IDEA: XBRL DOCUMENT v3.24.1
    LEASES (Details Narrative)
    		 1 Months Ended 3 Months Ended 12 Months Ended
    Feb. 14, 2024
    USD ($)
    Feb. 12, 2024
    USD ($)
    Sep. 14, 2023
    USD ($)
    ft²
    Sep. 01, 2023
    GBP (£)
    ft²
    Aug. 10, 2023
    USD ($)
    ft²
    Jul. 03, 2023
    USD ($)
    ft²
    Feb. 01, 2023
    GBP (£)
    ft²
    Jul. 03, 2022
    USD ($)
    ft²
    Jul. 03, 2022
    AED (د.إ)
    ft²
    Apr. 28, 2022
    USD ($)
    ft²
    Apr. 28, 2022
    GBP (£)
    ft²
    Sep. 30, 2023
    USD ($)
    ft²
    Dec. 31, 2022
    USD ($)
    Dec. 31, 2023
    USD ($)
    ft²
    Dec. 31, 2023
    GBP (£)
    ft²
    Dec. 31, 2022
    USD ($)
    Loss on impairment of Right Of Use Asset | $                           $ 100,000   $ 100,000
    Subsequent Event [Member]                                
    Payments for rent | $   $ 22,926                            
    Lutton, UK [Member]                                
    Area of Land | ft²       600     600     600 600     600 600  
    Lease expiration       May 31, 2024     Jan. 31, 2025     May 31, 2023 May 31, 2023          
    Payments for rent       £ 2,100     £ 2,500     $ 1,800 £ 1,320          
    Lease description                               the Company entered a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on May 31, 2023, for £1,320 monthly or approximately $1,800 per month
    Dubai, UAE [Member]                                
    Area of Land | ft²           976   976 976              
    Lease expiration           Jul. 02, 2024   Jul. 02, 2023 Jul. 02, 2023              
    Payments for rent           $ 1,632   $ 1,632 د.إ 5,995              
    Lease description                           lease for 976 square feet of administrative office space in Dubai Studio City, UAE, commencing on July 3, 2023, and terminating on July 2, 2024, for approximately $1,632 monthly lease for 976 square feet of administrative office space in Dubai Studio City, UAE, commencing on July 3, 2023, and terminating on July 2, 2024, for approximately $1,632 monthly lease for 976 square feet of administrative office space commencing on July 3, 2022, and terminating on July 2, 2023, in Dubai Studio City, UAE, for AED 5,995 or approximately US$ 1,632 monthly
    Poway CA [Member]                                
    Area of Land | ft²     11,715                          
    Lease expiration     Mar. 13, 2024                          
    Payments for rent | $     $ 22,300                          
    Lease description                               Included in the September 14, 2023, acquisition of assets from Broadcast Microwave Services, LLC (BMS) was a sublease of approximately 11,715 square feet of general office use facilities previously held under a six-month agreement with BMS, with lease responsibilities conveyed to Vislink Poway, LLC. The initial lease term commenced with a monthly rent of approximately $22,300 and concluded on March 13, 2024. On February 12, 2024, Vislink Poway, LLC signed a renewal agreement for the same space. The renewal term is set for one year and ten and a half months, commencing on March 14, 2024, and ending on January 31, 2026. The base rent for the renewal period is established at $22,926 per month
    Poway CA [Member] | Subsequent Event [Member]                                
    Lease expiration   Jan. 31, 2026                            
    Payments for rent | $ $ 22,926                              
    Colchester UK [Member]                                
    Area of Land | ft²                       2,700   13,200 13,200  
    Loss on impairment of Right Of Use Asset | $                       $ 83,000        
    Hemel United Kingdom [Member]                                
    Area of Land | ft²                           12,870 12,870  
    Payments for rent | £                             £ 175,000  
    Trivex Singapore [Member]                                
    Area of Land | ft²         950                 950 950  
    Payments for rent | $         $ 3,100                      
    Area of land description                           lease for 950 square feet of administrative office space commencing on August 10, 2023, and terminating on August 92, 2025, for approximately $3,100 monthly lease for 950 square feet of administrative office space commencing on August 10, 2023, and terminating on August 92, 2025, for approximately $3,100 monthly  
    Billerica, MA [Member]                                
    Area of Land | ft²                           2,000 2,000  
    Loss on impairment of Right Of Use Asset | $                         $ 88,000      
    XML 110 R86.htm IDEA: XBRL DOCUMENT v3.24.1
    PREFERRED SHARES (Details Narrative) - $ / shares
    		 1 Months Ended
    Jan. 23, 2023
    Nov. 09, 2022
    Nov. 30, 2022
    Dec. 31, 2023
    Mar. 24, 2023
    Mar. 22, 2023
    Dec. 31, 2022
    Dec. 21, 2016
    Apr. 25, 2016
    Feb. 05, 2016
    Mar. 31, 2013
    Class of Stock [Line Items]                      
    Preferred stock shares authorized       10,000,000     10,000,000        
    Preferred Stock, Par or Stated Value Per Share       $ 0.00001     $ 0.00001       $ 0.00001
    Series B Preferred Stock [Member]                      
    Class of Stock [Line Items]                      
    Preferred stock shares authorized                   5,000,000  
    Series D Preferred Stock [Member]                      
    Class of Stock [Line Items]                      
    Preferred stock shares authorized                 5,000,000    
    Series E Preferred Stock [Member]                      
    Class of Stock [Line Items]                      
    Preferred stock shares authorized               5,000      
    Series A Preferred Stock [Member]                      
    Class of Stock [Line Items]                      
    Preferred stock shares authorized   47,500   0              
    Preferred Stock, Par or Stated Value Per Share     $ 0.00001                
    Share issued price per share   $ 0.00001                  
    Preferred stock voting rights   Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes                  
    Preferred stock redemption terms, description Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time   the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders relating to the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder not participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole on March 24, 2023, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.                
    Preferred stock unissued         47,500            
    Preferred stock par value           $ 0.00001          
    Preferred stock shares, issued       0              
    Preferred stock shares, outstanding       0              
    Series D Convertible Preferred Stock [Member]                      
    Class of Stock [Line Items]                      
    Preferred stock unissued                 5,000,000    
    Preferred stock par value                 $ 0.00001    
    Series E Convertible Preferred Stock [Member]                      
    Class of Stock [Line Items]                      
    Preferred stock unissued               5,000      
    Preferred stock par value               $ 0.00001      
    Series D Preferred Stock and Series E Preferred Stock [Member]                      
    Class of Stock [Line Items]                      
    Preferred stock par value   $ 0.00001                  
    Maximum [Member]                      
    Class of Stock [Line Items]                      
    Preferred stock shares authorized                     10,000,000.0
    XML 111 R87.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF WARRANT OUTSTANDING (Details) - $ / shares
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Equity [Abstract]    
    Number of warrants beginning balance 458,746 460,491
    Weighted average exercise price beginning outstanding $ 71.60 $ 82.00
    Number of warrants expired (2,666) (1,745)
    Weighted average exercise price expired $ (1,200.30) $ (2,624.00)
    Number of warrants ending outstanding 456,080 458,746
    Weighted average exercise price ending outstanding $ 65.10 $ 71.60
    XML 112 R88.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details) - Warrants [Member] - $ / shares
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants Outstanding and Exercisable (in shares) 456,080 458,746
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 3 years 1 month 6 days 3 years 1 month 6 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 65.10 $ 71.60
    Exercise Price Range One [Member]    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 65.00  
    Warrants Outstanding and Exercisable (in shares) 454,546 454,546
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 3 years 1 month 9 days 3 years 1 month 9 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 65.00 $ 65.00
    Exercise Price Range Two [Member]    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 68.20  
    Warrants Outstanding and Exercisable (in shares) 1,500 1,500
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 1 year 2 months 4 days 1 year 2 months 4 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 68.20 $ 68.20
    Exercise Price Range Three [Member]    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 600.00  
    Warrants Outstanding and Exercisable (in shares) 34 34
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 1 year 6 months 14 days 1 year 6 months 14 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 600.00 $ 600.00
    Exercise Price Range Four [Member].    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 1,200.00  
    Warrants Outstanding and Exercisable (in shares) 2,666
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)   4 months 28 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 1,200.00
    XML 113 R89.htm IDEA: XBRL DOCUMENT v3.24.1
    STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
    		 12 Months Ended
    Jul. 19, 2022
    May 04, 2022
    Dec. 31, 2023
    Dec. 31, 2022
    Accumulated Other Comprehensive Income (Loss) [Line Items]        
    Common stock shares authorized     100,000,000 100,000,000
    Common stock, par value     $ 0.00001 $ 0.00001
    Common stock, shares issued     2,439,923 2,367,362
    Common stock shares outstanding     2,439,790 2,367,229
    Issuance of common stock share value       $ (20,000)
    Stock compensation costs     $ 1,942,000 $ 1,565,000
    Warrants expired     2,666 1,745
    Consulting Agreement [Member]        
    Accumulated Other Comprehensive Income (Loss) [Line Items]        
    Issuance of common stock share value       $ 80,000
    Stock issued during period for services, shares 38,703 38,703    
    Shares issued price per share $ 0.59 $ 0.81    
    Stock issued during period for services, value+ $ 22,835 $ 31,349    
    Services liabilities 40,000 $ 40,000    
    Gain on extinguishment debt $ 25,816      
    Common Stock Warrants [Member]        
    Accumulated Other Comprehensive Income (Loss) [Line Items]        
    Warrants expired     2,666  
    Weighted average exercise price ending exercisable     $ 65.10  
    Weighted average remaining contractual life     2 years 1 month 6 days  
    Restricted Stock Units (RSUs) [Member]        
    Accumulated Other Comprehensive Income (Loss) [Line Items]        
    Shares attributable to withholding tax     14,193 357,778
    Restricted Stock Units (RSUs) [Member] | Common Stock [Member]        
    Accumulated Other Comprehensive Income (Loss) [Line Items]        
    Restricted stock options, granted     48,368 1,159,044
    Specific Board Members [Member]        
    Accumulated Other Comprehensive Income (Loss) [Line Items]        
    Issuance of common stock share     10,000  
    Issuance of common stock share value     $ 200,000  
    XML 114 R90.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF STOCK BASED COMPENSATION EXPENSE (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense $ 1,942,000 $ 1,565,000
    Long Term Stock Incentive Plan Awards [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense 1,000
    Time Vested Option Inducement Awards [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense 181,000 179,000
    Time Based Restricted Stock Awards [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense $ 1,761,000 $ 1,385,000
    XML 115 R91.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN (Details) - USD ($)
    $ / shares in Units, $ in Thousands
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Remaining compensation expense $ 1,942 $ 1,565
    Long Term Stock Incentive Plan Awards [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Number of options, Outstanding, Beginning balance 2,250 2,496
    Weighted average exercise price, outstanding beginning balance $ 1,756.01 $ 1,760.80
    Number of options, Stock options forfeited (88) (246)
    Weighted average exercise price, Canceled, expired, forfeited $ (1,431.14) $ (1,934.00)
    Number of options, ending outstanding 2,162 2,250
    Weighted average exercise price, outstanding ending balance $ 1,768.46 $ 1,756.01
    Number of options exercisable 2,162 2,250
    Weighted average exercise price, exercisable balance $ 1,768.46 $ 1,756.01
    Remaining compensation expense
    Remaining amortization period 0 years 0 years
    Weighted average remaining contractual life - options exercisable 3 years 6 months 4 years 6 months
    Weighted average remaining contractual life - options exercisable 3 years 6 months 4 years 6 months
    Intrinsic value per share  
    Range of exercise prices, lower limit 139.20 $ 139.20
    Range of exercise prices, upper limit $ 1,944.00 $ 1,944.00
    Time Vested Option Inducement Awards [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Number of options, Outstanding, Beginning balance 24,725 24,725
    Weighted average exercise price, outstanding beginning balance $ 12.90 $ 20.20
    Number of options, Stock options forfeited (6,759)  
    Weighted average exercise price, Canceled, expired, forfeited $ (8.63)
    Number of options, ending outstanding 17,966 24,725
    Weighted average exercise price, outstanding ending balance $ 6.27 $ 12.90
    Number of options exercisable 17,592 21.13
    Weighted average exercise price, exercisable balance $ 27.23 $ 18,027
    Remaining compensation expense $ 113,000 $ 319,000
    Remaining amortization period 1 month 6 days 1 year 1 month 6 days
    Weighted average remaining contractual life - options exercisable 6 years 1 month 6 days 7 years 1 month 6 days
    Weighted average remaining contractual life - options exercisable 6 years 1 month 6 days 7 years 1 month 6 days
    Intrinsic value per share  
    Range of exercise prices, lower limit $ 34.20 $ 19.20
    Range of exercise prices, upper limit   $ 34.20
    Performance Based Stock Option Inducement [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Number of options, Outstanding, Beginning balance 12,500 12,500
    Weighted average exercise price, outstanding beginning balance $ 33.12 $ 33.12
    Number of options, Stock options forfeited
    Weighted average exercise price, Canceled, expired, forfeited
    Number of options, ending outstanding 12,500 12,500
    Weighted average exercise price, outstanding ending balance $ 33.12 $ 33.12
    Number of options exercisable
    Weighted average exercise price, exercisable balance
    Remaining compensation expense $ 414,000 $ 414,000
    Remaining amortization period 1 year 1 month 6 days 2 years 1 month 6 days
    Weighted average remaining contractual life - options exercisable 6 years 1 month 6 days 7 years 1 month 6 days
    Weighted average remaining contractual life - options exercisable 0 years 0 years
    Intrinsic value per share  
    Range of exercise prices, lower limit $ 34.20 $ 34.20
    Number of options, Granted
    Weighted average exercise price, Granted
    Number of options, Stock units exercised
    Weighted average exercise price, Stock units exercised
    Time Based Restricted Stock Awards [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Remaining compensation expense $ 1,511,000 $ 3,248,000
    Remaining amortization period 1 year 7 months 6 days 2 years 3 months 18 days
    Intrinsic value per share  
    Range of exercise prices, lower limit 5.71 $ 19.60
    Range of exercise prices, upper limit $ 72.00 $ 72.00
    Number of restricted stock, Outstanding, Beginning balance 140,736 39,933
    Weighted average exercise price, restricted stock, beginning balance $ 23.09 $ 63.40
    Number of restricted stock, Granted 53,750 107,053
    Weighted average exercise price, restricted stock, Granted $ 8.17 $ 20.80
    Number of restricted stock, Canceled, expired, forfeited (19,415) (6,250)
    Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited $ (21.48) $ (13.60)
    Number of restricted stock, Stock units exercised (48,368)
    Weighted average exercise price, restricted stock, Stock units exercised $ (41.58)
    Number of restricted stock, Outstanding, Ending balance 126,703 140,736
    Weighted average exercise price, Outstanding, Ending balance $ 11.92 $ 23.09
    Number of restricted stock, Exercisable 30,692 20,794
    Weighted average exercise price, restricted stock, Exercisable $ 36.98 $ 66.60
    Weighted average remaining contractual life, options outstanding 1 year 10 months 24 days 2 years 6 months
    Weighted average remaining contractual life, exercisable 1 year 8 months 12 days 1 year 4 months 24 days
    Weighted average exercise price, restricted stock, Stock units exercised $ 41.58
    Performance Based Restricted Stock Awards [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Remaining compensation expense $ 1,156,000 $ 1,498,000
    Remaining amortization period 2 years 1 month 6 days 2 years 9 months 18 days
    Intrinsic value per share  
    Range of exercise prices, lower limit 5.80 $ 21.00
    Range of exercise prices, upper limit $ 21.00  
    Number of restricted stock, Outstanding, Beginning balance 71,303 63,369
    Weighted average exercise price, restricted stock, beginning balance $ 21.01 $ 58.00
    Number of restricted stock, Granted 12,500 71,303
    Weighted average exercise price, restricted stock, Granted $ 5.68 $ 21.00
    Number of restricted stock, Canceled, expired, forfeited (19,649)
    Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited $ (21.62)
    Number of restricted stock, Stock units exercised (63,369)
    Weighted average exercise price, restricted stock, Stock units exercised $ 58.00
    Number of restricted stock, Outstanding, Ending balance 64,154 71,303
    Weighted average exercise price, Outstanding, Ending balance   $ 21.01
    Number of restricted stock, Exercisable
    Weighted average exercise price, restricted stock, Exercisable
    Weighted average remaining contractual life, options outstanding 2 years 1 month 6 days 2 years 9 months 18 days
    Weighted average remaining contractual life, exercisable 0 years 0 years
    Weighted average exercise price, restricted stock, Stock units exercised $ (58.00)
    Weighted average exercise price, restricted stock, Ending balance $ 18.02 $ 21.01
    XML 116 R92.htm IDEA: XBRL DOCUMENT v3.24.1
    STOCK-BASED COMPENSATION (Details Narrative)
    Aug. 23, 2023
    shares
    2023 Omnibus Equity Incentive Plan [Member]  
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
    Share based compensation authorized, shares 166,415
    XML 117 R93.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF MATCHING CONTRIBUTIONS (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Group Personal Pension Plan, UK [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Company matching contributions $ 140,000 $ 166,000
    XML 118 R94.htm IDEA: XBRL DOCUMENT v3.24.1
    CONCENTRATIONS (Details Narrative) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Concentration Risk [Line Items]    
    Revenue from Contract with Customer, Excluding Assessed Tax $ 27,482,000 $ 28,131,000
    Accounts payable $ 3,183,000 2,626,000
    Accounts Payable [Member] | Supplier Concentration Risk [Member] | Single Vendor [Member]    
    Concentration Risk [Line Items]    
    Concentration risk percentage 10.00%  
    Accounts payable $ 2,132,000  
    Single Customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
    Concentration Risk [Line Items]    
    Revenue from Contract with Customer, Excluding Assessed Tax   $ 3,436,000
    Concentration risk percentage   12.00%
    Single Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
    Concentration Risk [Line Items]    
    Concentration risk percentage 13.00% 19.00%
    Accounts receivable $ 1,111,000 $ 1,138,000
    One Vendor [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]    
    Concentration Risk [Line Items]    
    Concentration risk percentage 20.00% 10.00%
    Accounts payable $ 652,000 $ 273,000
    XML 119 R95.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF DISAGGREGATION OF REVENUE (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Disaggregation of Revenue [Line Items]    
    Revenue, net $ 27,482,000 $ 28,131,000
    Long-Lived Assets 6,510,000 6,909,000
    Equipment Sales [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 24,054,000 25,667,000
    Installation, Integration and Repairs [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 1,688,000 1,450,000
    Warranties [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 1,740,000 1,014,000
    North America [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 13,501,000 12,037,000
    South America [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 528,000 182,000
    Europe [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 6,420,000 8,958,000
    Asia [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 3,354,000 1,851,000
    Rest of World [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 3,679,000 5,103,000
    UNITED STATES    
    Disaggregation of Revenue [Line Items]    
    Long-Lived Assets 2,767,000 1,970,000
    NETHERLANDS    
    Disaggregation of Revenue [Line Items]    
    Long-Lived Assets 20,000 27,000
    UNITED KINGDOM    
    Disaggregation of Revenue [Line Items]    
    Long-Lived Assets $ 3,723,000 $ 4,912,000
    XML 120 R96.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF TAX REBATES (Details) - USD ($)
    $ in Thousands
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Her Majesty's Revenue and Customs (HMRC) [Member]    
    Operating Loss Carryforwards [Line Items]    
    Total tax rebates $ 331,000 $ 271,000
    XML 121 R97.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
    Gains on settlement of debt $ 45,732
    Consulting Agreement [Member]    
    Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
    Gains on settlement of debt 25,816
    Dividends Payable [Member]    
    Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
    Gains on settlement of debt $ 19,916
    XML 122 R98.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical) - USD ($)
    Nov. 21, 2022
    Jul. 19, 2022
    May 04, 2022
    Dec. 31, 2023
    Dec. 31, 2022
    Amount payable       $ 3,183,000 $ 2,626,000
    Dividends settlement amount $ 19,916        
    Series A Preferred Stock [Member]          
    Shares issued for dividend settlement 47,419        
    Common Stock [Member]          
    Shares of common stock issued   38,703 38,703    
    Common stock accumulated value   $ 54,184 $ 54,184    
    Amount payable   $ 80,000 $ 80,000    
    XML 123 R99.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) - USD ($)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Current tax provision    
    Federal
    State 4,400 25,000
    Current income tax expense, total 4,400 25,000
    Deferred tax provision (benefit)    
    Federal (982,000) (532,000)
    State (2,457,000) (427,000)
    Foreign (1,516,000) (978,000)
    Change in the valuation allowance 4,737,000 1,722,000
    Total deferred tax provision (benefit) (218,000) (215,000)
    Income tax provision $ (214,000) $ (190,000)
    XML 124 R100.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)
    		 12 Months Ended
    Dec. 31, 2023
    Dec. 31, 2022
    Income taxes    
    Statutory federal income tax rate 21.00% 21.00%
    State and local taxes, net of federal benefit 1.15% 0.30%
    Permanent differences 0.49% 5.28%
    Executive compensation 0.00% (2.26%)
    Equity compensation (3.63%) (11.06%)
    Provision to return 7.49% 0.00%
    DTA adjustment for state NOL 0.00% 0.00%
    Foreign Rate Differential 1.44% (1.27%)
    Change rate 27.13% 2.66%
    Valuation allowance (52.73%) (13.27%)
    Effective tax rate 2.34% 1.37%
    XML 125 R101.htm IDEA: XBRL DOCUMENT v3.24.1
    SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
    Dec. 31, 2023
    Dec. 31, 2022
    Income taxes    
    Federal R&D credit $ 3,007,000 $ 3,007,000
    Inventory 422,000 576,000
    Allowance for bad debt 73,000 72,000
    Compensation related 12,000 7,000
    Pension 55,000 72,000
    Other accruals 34,000 7,000
    State net operating losses 7,235,000 4,779,000
    Federal net operating losses 47,296,000 44,821,000
    Interest disallowance 1,150,000 1,151,000
    Stock options 6,995,000 7,172,000
    Other 465,000 296,000
    Valuation Allowance (66,468,000) (61,731,000)
    Total Deferred Tax Assets 276,000 229,000
    Property and Equipment (178,000) (90,000)
    Intangibles (616,000) (870,000)
    Prepaid Expenses (29,000) (33,000)
    Total Deferred Tax Liabilities (822,000) (993,000)
    Net Deferred Tax Liability $ (546,000) $ (764,000)
    XML 126 R102.htm IDEA: XBRL DOCUMENT v3.24.1
    INCOME TAXES (Details Narrative)
    $ in Millions
    		 12 Months Ended
    Dec. 31, 2023
    USD ($)
    Operating Loss Carryforwards [Line Items]  
    Deferred tax assets, tax credit carryforwards, research $ 3.0
    Operating loss carryforwards, expiration description expire in 2027
    Effective for tax years, description the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary.
    Domestic Tax Authority [Member]  
    Operating Loss Carryforwards [Line Items]  
    Operating loss carryforwards $ 187.3
    Domestic Tax Authority [Member] | Hale Capital Partners, LP [Member]  
    Operating Loss Carryforwards [Line Items]  
    Operating loss carryforwards 30.6
    State and Local Jurisdiction [Member]  
    Operating Loss Carryforwards [Line Items]  
    Operating loss carryforwards 160.9
    Foreign Tax Authority [Member]  
    Operating Loss Carryforwards [Line Items]  
    Operating loss carryforwards $ 30.6
    XML 127 R103.htm IDEA: XBRL DOCUMENT v3.24.1
    SUBSEQUENT EVENTS (Details Narrative)
    Feb. 12, 2024
    USD ($)
    Subsequent Event [Member]  
    Subsequent Event [Line Items]  
    Base rent $ 22,926
    EXCEL 128 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 129 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 130 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 132 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 307 465 1 true 100 0 false 9 false false R1.htm 00000001 - Document - Cover Sheet http://vislink.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://vislink.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://vislink.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity Sheet http://vislink.com/role/StatementOfChangesInStockholdersEquity Consolidated Statement of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://vislink.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - NATURE OF OPERATIONS Sheet http://vislink.com/role/NatureOfOperations NATURE OF OPERATIONS Notes 7 false false R8.htm 00000008 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION Sheet http://vislink.com/role/LiquidityAndFinancialCondition LIQUIDITY AND FINANCIAL CONDITION Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://vislink.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - LOSS PER SHARE Sheet http://vislink.com/role/LossPerShare LOSS PER SHARE Notes 10 false false R11.htm 00000011 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES Sheet http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLosses FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES Notes 11 false false R12.htm 00000012 - Disclosure - CASH AND CASH EQUIVALENTS Sheet http://vislink.com/role/CashAndCashEquivalents CASH AND CASH EQUIVALENTS Notes 12 false false R13.htm 00000013 - Disclosure - INVESTMENTS Sheet http://vislink.com/role/Investments INVESTMENTS Notes 13 false false R14.htm 00000014 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES Sheet http://vislink.com/role/FairValueOfAssetsAndLiabilities FAIR VALUE OF ASSETS AND LIABILITIES Notes 14 false false R15.htm 00000015 - Disclosure - ASSET ACQUISITION Sheet http://vislink.com/role/AssetAcquisition ASSET ACQUISITION Notes 15 false false R16.htm 00000016 - Disclosure - ACCOUNTS RECEIVABLE Sheet http://vislink.com/role/AccountsReceivable ACCOUNTS RECEIVABLE Notes 16 false false R17.htm 00000017 - Disclosure - INVENTORIES Sheet http://vislink.com/role/Inventories INVENTORIES Notes 17 false false R18.htm 00000018 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://vislink.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 18 false false R19.htm 00000019 - Disclosure - INTANGIBLE ASSETS Sheet http://vislink.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 19 false false R20.htm 00000020 - Disclosure - ACCRUED EXPENSES Sheet http://vislink.com/role/AccruedExpenses ACCRUED EXPENSES Notes 20 false false R21.htm 00000021 - Disclosure - NOTES PAYABLE Notes http://vislink.com/role/NotesPayable NOTES PAYABLE Notes 21 false false R22.htm 00000022 - Disclosure - LEASES Sheet http://vislink.com/role/Leases LEASES Notes 22 false false R23.htm 00000023 - Disclosure - PREFERRED SHARES Sheet http://vislink.com/role/PreferredShares PREFERRED SHARES Notes 23 false false R24.htm 00000024 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://vislink.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 24 false false R25.htm 00000025 - Disclosure - STOCK-BASED COMPENSATION Sheet http://vislink.com/role/Stock-basedCompensation STOCK-BASED COMPENSATION Notes 25 false false R26.htm 00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://vislink.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 26 false false R27.htm 00000027 - Disclosure - CONCENTRATIONS Sheet http://vislink.com/role/Concentrations CONCENTRATIONS Notes 27 false false R28.htm 00000028 - Disclosure - REVENUE Sheet http://vislink.com/role/Revenue REVENUE Notes 28 false false R29.htm 00000029 - Disclosure - REBATES Sheet http://vislink.com/role/Rebates REBATES Notes 29 false false R30.htm 00000030 - Disclosure - GAINS ON SETTLEMENT OF DEBT Sheet http://vislink.com/role/GainsOnSettlementOfDebt GAINS ON SETTLEMENT OF DEBT Notes 30 false false R31.htm 00000031 - Disclosure - INCOME TAXES Sheet http://vislink.com/role/IncomeTaxes INCOME TAXES Notes 31 false false R32.htm 00000032 - Disclosure - RECLASSIFICATION OF PRIOR YEAR PRESENTATION Sheet http://vislink.com/role/ReclassificationOfPriorYearPresentation RECLASSIFICATION OF PRIOR YEAR PRESENTATION Notes 32 false false R33.htm 00000033 - Disclosure - SUBSEQUENT EVENTS Sheet http://vislink.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 33 false false R34.htm 00000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 34 false false R35.htm 00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://vislink.com/role/SummaryOfSignificantAccountingPolicies 35 false false R36.htm 00000036 - Disclosure - LOSS PER SHARE (Tables) Sheet http://vislink.com/role/LossPerShareTables LOSS PER SHARE (Tables) Tables http://vislink.com/role/LossPerShare 36 false false R37.htm 00000037 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables) Sheet http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesTables FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables) Tables http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLosses 37 false false R38.htm 00000038 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) Sheet http://vislink.com/role/CashAndCashEquivalentsTables CASH AND CASH EQUIVALENTS (Tables) Tables http://vislink.com/role/CashAndCashEquivalents 38 false false R39.htm 00000039 - Disclosure - INVESTMENTS (Tables) Sheet http://vislink.com/role/InvestmentsTables INVESTMENTS (Tables) Tables http://vislink.com/role/Investments 39 false false R40.htm 00000040 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES (Tables) Sheet http://vislink.com/role/FairValueOfAssetsAndLiabilitiesTables FAIR VALUE OF ASSETS AND LIABILITIES (Tables) Tables http://vislink.com/role/FairValueOfAssetsAndLiabilities 40 false false R41.htm 00000041 - Disclosure - ASSET ACQUISITION (Tables) Sheet http://vislink.com/role/AssetAcquisitionTables ASSET ACQUISITION (Tables) Tables http://vislink.com/role/AssetAcquisition 41 false false R42.htm 00000042 - Disclosure - ACCOUNTS RECEIVABLE (Tables) Sheet http://vislink.com/role/AccountsReceivableTables ACCOUNTS RECEIVABLE (Tables) Tables http://vislink.com/role/AccountsReceivable 42 false false R43.htm 00000043 - Disclosure - INVENTORIES (Tables) Sheet http://vislink.com/role/InventoriesTables INVENTORIES (Tables) Tables http://vislink.com/role/Inventories 43 false false R44.htm 00000044 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://vislink.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://vislink.com/role/PropertyAndEquipment 44 false false R45.htm 00000045 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://vislink.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://vislink.com/role/IntangibleAssets 45 false false R46.htm 00000046 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://vislink.com/role/AccruedExpensesTables ACCRUED EXPENSES (Tables) Tables http://vislink.com/role/AccruedExpenses 46 false false R47.htm 00000047 - Disclosure - NOTES PAYABLE (Tables) Notes http://vislink.com/role/NotesPayableTables NOTES PAYABLE (Tables) Tables http://vislink.com/role/NotesPayable 47 false false R48.htm 00000048 - Disclosure - LEASES (Tables) Sheet http://vislink.com/role/LeasesTables LEASES (Tables) Tables http://vislink.com/role/Leases 48 false false R49.htm 00000049 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://vislink.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://vislink.com/role/StockholdersEquity 49 false false R50.htm 00000050 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://vislink.com/role/Stock-basedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://vislink.com/role/Stock-basedCompensation 50 false false R51.htm 00000051 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://vislink.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://vislink.com/role/CommitmentsAndContingencies 51 false false R52.htm 00000052 - Disclosure - REVENUE (Tables) Sheet http://vislink.com/role/RevenueTables REVENUE (Tables) Tables http://vislink.com/role/Revenue 52 false false R53.htm 00000053 - Disclosure - REBATES (Tables) Sheet http://vislink.com/role/RebatesTables REBATES (Tables) Tables http://vislink.com/role/Rebates 53 false false R54.htm 00000054 - Disclosure - GAINS ON SETTLEMENT OF DEBT (Tables) Sheet http://vislink.com/role/GainsOnSettlementOfDebtTables GAINS ON SETTLEMENT OF DEBT (Tables) Tables http://vislink.com/role/GainsOnSettlementOfDebt 54 false false R55.htm 00000055 - Disclosure - INCOME TAXES (Tables) Sheet http://vislink.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://vislink.com/role/IncomeTaxes 55 false false R56.htm 00000056 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) Sheet http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) Details http://vislink.com/role/LiquidityAndFinancialCondition 56 false false R57.htm 00000057 - Disclosure - SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details) Sheet http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details) Details 57 false false R58.htm 00000058 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables 58 false false R59.htm 00000059 - Disclosure - SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE (Details) Sheet http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE (Details) Details 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) Sheet http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) Details 60 false false R61.htm 00000061 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative) Sheet http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative) Details http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesTables 61 false false R62.htm 00000062 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) Sheet http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) Details 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details) Sheet http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details) Details 63 false false R64.htm 00000064 - Disclosure - INVESTMENTS (Details Narrative) Sheet http://vislink.com/role/InvestmentsDetailsNarrative INVESTMENTS (Details Narrative) Details http://vislink.com/role/InvestmentsTables 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) Sheet http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) Details 65 false false R66.htm 00000066 - Disclosure - SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Sheet http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Details 66 false false R67.htm 00000067 - Disclosure - ASSET ACQUISITION (Details Narrative) Sheet http://vislink.com/role/AssetAcquisitionDetailsNarrative ASSET ACQUISITION (Details Narrative) Details http://vislink.com/role/AssetAcquisitionTables 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Sheet http://vislink.com/role/ScheduleOfAccountsReceivableDetails SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Details 68 false false R69.htm 00000069 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative) Sheet http://vislink.com/role/AccountsReceivableDetailsNarrative ACCOUNTS RECEIVABLE (Details Narrative) Details http://vislink.com/role/AccountsReceivableTables 69 false false R70.htm 00000070 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://vislink.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 70 false false R71.htm 00000071 - Disclosure - INVENTORIES (Details Narrative) Sheet http://vislink.com/role/InventoriesDetailsNarrative INVENTORIES (Details Narrative) Details http://vislink.com/role/InventoriesTables 71 false false R72.htm 00000072 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Sheet http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Details 72 false false R73.htm 00000073 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://vislink.com/role/PropertyAndEquipmentDetailsNarrative PROPERTY AND EQUIPMENT (Details Narrative) Details http://vislink.com/role/PropertyAndEquipmentTables 73 false false R74.htm 00000074 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) Sheet http://vislink.com/role/ScheduleOfIntangibleAssetsDetails SCHEDULE OF INTANGIBLE ASSETS (Details) Details 74 false false R75.htm 00000075 - Disclosure - SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) Sheet http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) Details 75 false false R76.htm 00000076 - Disclosure - SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) Sheet http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) Details 76 false false R77.htm 00000077 - Disclosure - SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) Sheet http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) Details 77 false false R78.htm 00000078 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://vislink.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://vislink.com/role/IntangibleAssetsTables 78 false false R79.htm 00000079 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details) Sheet http://vislink.com/role/ScheduleOfAccruedExpensesDetails SCHEDULE OF ACCRUED EXPENSES (Details) Details 79 false false R80.htm 00000080 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) Notes http://vislink.com/role/ScheduleOfNotesPayableDetails SCHEDULE OF NOTES PAYABLE (Details) Details 80 false false R81.htm 00000081 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) Notes http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) Details 81 false false R82.htm 00000082 - Disclosure - SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details) Sheet http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details) Details 82 false false R83.htm 00000083 - Disclosure - SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA (Details) Sheet http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA (Details) Details 83 false false R84.htm 00000084 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Sheet http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Details 84 false false R85.htm 00000085 - Disclosure - LEASES (Details Narrative) Sheet http://vislink.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://vislink.com/role/LeasesTables 85 false false R86.htm 00000086 - Disclosure - PREFERRED SHARES (Details Narrative) Sheet http://vislink.com/role/PreferredSharesDetailsNarrative PREFERRED SHARES (Details Narrative) Details http://vislink.com/role/PreferredShares 86 false false R87.htm 00000087 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING (Details) Sheet http://vislink.com/role/ScheduleOfWarrantOutstandingDetails SCHEDULE OF WARRANT OUTSTANDING (Details) Details 87 false false R88.htm 00000088 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details) Sheet http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details) Details 88 false false R89.htm 00000089 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://vislink.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://vislink.com/role/StockholdersEquityTables 89 false false R90.htm 00000090 - Disclosure - SCHEDULE OF STOCK BASED COMPENSATION EXPENSE (Details) Sheet http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails SCHEDULE OF STOCK BASED COMPENSATION EXPENSE (Details) Details 90 false false R91.htm 00000091 - Disclosure - SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN (Details) Sheet http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN (Details) Details 91 false false R92.htm 00000092 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) Sheet http://vislink.com/role/Stock-basedCompensationDetailsNarrative STOCK-BASED COMPENSATION (Details Narrative) Details http://vislink.com/role/Stock-basedCompensationTables 92 false false R93.htm 00000093 - Disclosure - SCHEDULE OF MATCHING CONTRIBUTIONS (Details) Sheet http://vislink.com/role/ScheduleOfMatchingContributionsDetails SCHEDULE OF MATCHING CONTRIBUTIONS (Details) Details 93 false false R94.htm 00000094 - Disclosure - CONCENTRATIONS (Details Narrative) Sheet http://vislink.com/role/ConcentrationsDetailsNarrative CONCENTRATIONS (Details Narrative) Details http://vislink.com/role/Concentrations 94 false false R95.htm 00000095 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Sheet http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Details 95 false false R96.htm 00000096 - Disclosure - SCHEDULE OF TAX REBATES (Details) Sheet http://vislink.com/role/ScheduleOfTaxRebatesDetails SCHEDULE OF TAX REBATES (Details) Details 96 false false R97.htm 00000097 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) Sheet http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) Details 97 false false R98.htm 00000098 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical) Sheet http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical) Details 98 false false R99.htm 00000099 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) Sheet http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) Details 99 false false R100.htm 00000100 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details) Sheet http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details) Details 100 false false R101.htm 00000101 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 101 false false R102.htm 00000102 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://vislink.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://vislink.com/role/IncomeTaxesTables 102 false false R103.htm 00000103 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://vislink.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://vislink.com/role/SubsequentEvents 103 false false All Reports Book All Reports form10-k.htm visl-20231231.xsd visl-20231231_cal.xml visl-20231231_def.xml visl-20231231_lab.xml visl-20231231_pre.xml form10-k_001.jpg form10-k_002.jpg form10-k_003.jpg form10-k_004.jpg form10-k_006.jpg form10-k_007.jpg form10-k_008.jpg form10-k_009.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 134 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form10-k.htm": { "nsprefix": "VISL", "nsuri": "http://vislink.com/20231231", "dts": { "inline": { "local": [ "form10-k.htm" ] }, "schema": { "local": [ "visl-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "visl-20231231_cal.xml" ] }, "definitionLink": { "local": [ "visl-20231231_def.xml" ] }, "labelLink": { "local": [ "visl-20231231_lab.xml" ] }, "presentationLink": { "local": [ "visl-20231231_pre.xml" ] } }, "keyStandard": 383, "keyCustom": 82, "axisStandard": 29, "axisCustom": 0, "memberStandard": 42, "memberCustom": 58, "hidden": { "total": 205, "http://fasb.org/us-gaap/2023": 136, "http://vislink.com/20231231": 66, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 307, "entityCount": 1, "segmentCount": 100, "elementCount": 742, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1062, "http://xbrl.sec.gov/dei/2023": 37 }, "report": { "R1": { "role": "http://vislink.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://vislink.com/role/BalanceSheets", "longName": "00000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ShortTermInvestments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R3": { "role": "http://vislink.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:TreasuryStockCommonShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R4": { "role": "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss", "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LaborAndRelatedExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R5": { "role": "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "longName": "00000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity", "shortName": "Consolidated Statement of Changes in Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R6": { "role": "http://vislink.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtSecuritiesUnrealizedGainLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R7": { "role": "http://vislink.com/role/NatureOfOperations", "longName": "00000007 - Disclosure - NATURE OF OPERATIONS", "shortName": "NATURE OF OPERATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R8": { "role": "http://vislink.com/role/LiquidityAndFinancialCondition", "longName": "00000008 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION", "shortName": "LIQUIDITY AND FINANCIAL CONDITION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:LiquidityAndFinancialConditionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:LiquidityAndFinancialConditionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R9": { "role": "http://vislink.com/role/SummaryOfSignificantAccountingPolicies", "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R10": { "role": "http://vislink.com/role/LossPerShare", "longName": "00000010 - Disclosure - LOSS PER SHARE", "shortName": "LOSS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R11": { "role": "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLosses", "longName": "00000011 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES", "shortName": "FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ForeignCurrencyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ForeignCurrencyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R12": { "role": "http://vislink.com/role/CashAndCashEquivalents", "longName": "00000012 - Disclosure - CASH AND CASH EQUIVALENTS", "shortName": "CASH AND CASH EQUIVALENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R13": { "role": "http://vislink.com/role/Investments", "longName": "00000013 - Disclosure - INVESTMENTS", "shortName": "INVESTMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R14": { "role": "http://vislink.com/role/FairValueOfAssetsAndLiabilities", "longName": "00000014 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES", "shortName": "FAIR VALUE OF ASSETS AND LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R15": { "role": "http://vislink.com/role/AssetAcquisition", "longName": "00000015 - Disclosure - ASSET ACQUISITION", "shortName": "ASSET ACQUISITION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R16": { "role": "http://vislink.com/role/AccountsReceivable", "longName": "00000016 - Disclosure - ACCOUNTS RECEIVABLE", "shortName": "ACCOUNTS RECEIVABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FinancingReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FinancingReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R17": { "role": "http://vislink.com/role/Inventories", "longName": "00000017 - Disclosure - INVENTORIES", "shortName": "INVENTORIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R18": { "role": "http://vislink.com/role/PropertyAndEquipment", "longName": "00000018 - Disclosure - PROPERTY AND EQUIPMENT", "shortName": "PROPERTY AND EQUIPMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R19": { "role": "http://vislink.com/role/IntangibleAssets", "longName": "00000019 - Disclosure - INTANGIBLE ASSETS", "shortName": "INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R20": { "role": "http://vislink.com/role/AccruedExpenses", "longName": "00000020 - Disclosure - ACCRUED EXPENSES", "shortName": "ACCRUED EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R21": { "role": "http://vislink.com/role/NotesPayable", "longName": "00000021 - Disclosure - NOTES PAYABLE", "shortName": "NOTES PAYABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R22": { "role": "http://vislink.com/role/Leases", "longName": "00000022 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R23": { "role": "http://vislink.com/role/PreferredShares", "longName": "00000023 - Disclosure - PREFERRED SHARES", "shortName": "PREFERRED SHARES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R24": { "role": "http://vislink.com/role/StockholdersEquity", "longName": "00000024 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R25": { "role": "http://vislink.com/role/Stock-basedCompensation", "longName": "00000025 - Disclosure - STOCK-BASED COMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R26": { "role": "http://vislink.com/role/CommitmentsAndContingencies", "longName": "00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R27": { "role": "http://vislink.com/role/Concentrations", "longName": "00000027 - Disclosure - CONCENTRATIONS", "shortName": "CONCENTRATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R28": { "role": "http://vislink.com/role/Revenue", "longName": "00000028 - Disclosure - REVENUE", "shortName": "REVENUE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R29": { "role": "http://vislink.com/role/Rebates", "longName": "00000029 - Disclosure - REBATES", "shortName": "REBATES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:IncomeTaxRebatesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:IncomeTaxRebatesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R30": { "role": "http://vislink.com/role/GainsOnSettlementOfDebt", "longName": "00000030 - Disclosure - GAINS ON SETTLEMENT OF DEBT", "shortName": "GAINS ON SETTLEMENT OF DEBT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:GainOnSettlementOfDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:GainOnSettlementOfDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R31": { "role": "http://vislink.com/role/IncomeTaxes", "longName": "00000031 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R32": { "role": "http://vislink.com/role/ReclassificationOfPriorYearPresentation", "longName": "00000032 - Disclosure - RECLASSIFICATION OF PRIOR YEAR PRESENTATION", "shortName": "RECLASSIFICATION OF PRIOR YEAR PRESENTATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:ReclassificationOfPriorYearPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:ReclassificationOfPriorYearPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R33": { "role": "http://vislink.com/role/SubsequentEvents", "longName": "00000033 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R34": { "role": "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R35": { "role": "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R36": { "role": "http://vislink.com/role/LossPerShareTables", "longName": "00000036 - Disclosure - LOSS PER SHARE (Tables)", "shortName": "LOSS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R37": { "role": "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesTables", "longName": "00000037 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables)", "shortName": "FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R38": { "role": "http://vislink.com/role/CashAndCashEquivalentsTables", "longName": "00000038 - Disclosure - CASH AND CASH EQUIVALENTS (Tables)", "shortName": "CASH AND CASH EQUIVALENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R39": { "role": "http://vislink.com/role/InvestmentsTables", "longName": "00000039 - Disclosure - INVESTMENTS (Tables)", "shortName": "INVESTMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R40": { "role": "http://vislink.com/role/FairValueOfAssetsAndLiabilitiesTables", "longName": "00000040 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES (Tables)", "shortName": "FAIR VALUE OF ASSETS AND LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R41": { "role": "http://vislink.com/role/AssetAcquisitionTables", "longName": "00000041 - Disclosure - ASSET ACQUISITION (Tables)", "shortName": "ASSET ACQUISITION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R42": { "role": "http://vislink.com/role/AccountsReceivableTables", "longName": "00000042 - Disclosure - ACCOUNTS RECEIVABLE (Tables)", "shortName": "ACCOUNTS RECEIVABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R43": { "role": "http://vislink.com/role/InventoriesTables", "longName": "00000043 - Disclosure - INVENTORIES (Tables)", "shortName": "INVENTORIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R44": { "role": "http://vislink.com/role/PropertyAndEquipmentTables", "longName": "00000044 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R45": { "role": "http://vislink.com/role/IntangibleAssetsTables", "longName": "00000045 - Disclosure - INTANGIBLE ASSETS (Tables)", "shortName": "INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R46": { "role": "http://vislink.com/role/AccruedExpensesTables", "longName": "00000046 - Disclosure - ACCRUED EXPENSES (Tables)", "shortName": "ACCRUED EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R47": { "role": "http://vislink.com/role/NotesPayableTables", "longName": "00000047 - Disclosure - NOTES PAYABLE (Tables)", "shortName": "NOTES PAYABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R48": { "role": "http://vislink.com/role/LeasesTables", "longName": "00000048 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:ScheduleOfLeasesObligationsAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:ScheduleOfLeasesObligationsAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R49": { "role": "http://vislink.com/role/StockholdersEquityTables", "longName": "00000049 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R50": { "role": "http://vislink.com/role/Stock-basedCompensationTables", "longName": "00000050 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "shortName": "STOCK-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R51": { "role": "http://vislink.com/role/CommitmentsAndContingenciesTables", "longName": "00000051 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "51", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R52": { "role": "http://vislink.com/role/RevenueTables", "longName": "00000052 - Disclosure - REVENUE (Tables)", "shortName": "REVENUE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "52", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R53": { "role": "http://vislink.com/role/RebatesTables", "longName": "00000053 - Disclosure - REBATES (Tables)", "shortName": "REBATES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "53", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "VISL:IncomeTaxRebatesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "VISL:IncomeTaxRebatesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R54": { "role": "http://vislink.com/role/GainsOnSettlementOfDebtTables", "longName": "00000054 - Disclosure - GAINS ON SETTLEMENT OF DEBT (Tables)", "shortName": "GAINS ON SETTLEMENT OF DEBT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "54", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:GainOnSettlementOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "VISL:GainOnSettlementOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R55": { "role": "http://vislink.com/role/IncomeTaxesTables", "longName": "00000055 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "55", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R56": { "role": "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "longName": "00000056 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrative)", "shortName": "LIQUIDITY AND FINANCIAL CONDITION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "VISL:WorkingCapital", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "p", "VISL:LiquidityAndFinancialConditionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R57": { "role": "http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails", "longName": "00000057 - Disclosure - SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details)", "shortName": "SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R58": { "role": "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000058 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "Segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R59": { "role": "http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails", "longName": "00000059 - Disclosure - SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE (Details)", "shortName": "SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R60": { "role": "http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails", "longName": "00000060 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details)", "shortName": "SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R61": { "role": "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "longName": "00000061 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative)", "shortName": "FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_GBPToUSDMember", "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_GBPToUSDMember", "name": "us-gaap:ForeignCurrencyExchangeRateTranslation1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ForeignCurrencyDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R62": { "role": "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails", "longName": "00000062 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "shortName": "SCHEDULE OF CASH AND CASH EQUIVALENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R63": { "role": "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails", "longName": "00000063 - Disclosure - SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details)", "shortName": "SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_FederalBondsMember", "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_FederalBondsMember", "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R64": { "role": "http://vislink.com/role/InvestmentsDetailsNarrative", "longName": "00000064 - Disclosure - INVESTMENTS (Details Narrative)", "shortName": "INVESTMENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_HSBCUSAINCCPMember", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_HSBCUSAINCCPMember", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:InvestmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R65": { "role": "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "longName": "00000065 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)", "shortName": "SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R66": { "role": "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "longName": "00000066 - Disclosure - SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "shortName": "SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2023-09-142023-09-14_custom_BMSLLCMember", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-09-142023-09-14_custom_BMSLLCMember", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R67": { "role": "http://vislink.com/role/AssetAcquisitionDetailsNarrative", "longName": "00000067 - Disclosure - ASSET ACQUISITION (Details Narrative)", "shortName": "ASSET ACQUISITION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "From2023-09-142023-09-14_custom_BMSLLCMember_custom_VislinkPowayLLCMember", "name": "us-gaap:BusinessCombinationConsiderationTransferredOther1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-09-142023-09-14_custom_BMSLLCMember_custom_VislinkPowayLLCMember", "name": "us-gaap:BusinessCombinationConsiderationTransferredOther1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R68": { "role": "http://vislink.com/role/ScheduleOfAccountsReceivableDetails", "longName": "00000068 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsReceivableGrossCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R69": { "role": "http://vislink.com/role/AccountsReceivableDetailsNarrative", "longName": "00000069 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)", "shortName": "ACCOUNTS RECEIVABLE (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ProvisionForDoubtfulAccounts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R70": { "role": "http://vislink.com/role/ScheduleOfInventoriesDetails", "longName": "00000070 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "shortName": "SCHEDULE OF INVENTORIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryRawMaterialsAndSupplies", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:InventoryRawMaterialsAndSupplies", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R71": { "role": "http://vislink.com/role/InventoriesDetailsNarrative", "longName": "00000071 - Disclosure - INVENTORIES (Details Narrative)", "shortName": "INVENTORIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryWriteDown", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:InventoryWriteDown", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R72": { "role": "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "longName": "00000072 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R73": { "role": "http://vislink.com/role/PropertyAndEquipmentDetailsNarrative", "longName": "00000073 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)", "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R74": { "role": "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "longName": "00000074 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)", "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R75": { "role": "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "longName": "00000075 - Disclosure - SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details)", "shortName": "SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R76": { "role": "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "longName": "00000076 - Disclosure - SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details)", "shortName": "SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null }, "R77": { "role": "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails", "longName": "00000077 - Disclosure - SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details)", "shortName": "SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R78": { "role": "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "longName": "00000078 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R79": { "role": "http://vislink.com/role/ScheduleOfAccruedExpensesDetails", "longName": "00000079 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)", "shortName": "SCHEDULE OF ACCRUED EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:WorkersCompensationLiabilityCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:WorkersCompensationLiabilityCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R80": { "role": "http://vislink.com/role/ScheduleOfNotesPayableDetails", "longName": "00000080 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details)", "shortName": "SCHEDULE OF NOTES PAYABLE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:NotesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_NotesPayableOneMember", "name": "us-gaap:NotesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R81": { "role": "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical", "longName": "00000081 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical)", "shortName": "SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "AsOf2022-04-05_custom_DAndOInsurancePolicyRenewedMember_custom_NotesPayableOneMember", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-04-05_custom_DAndOInsurancePolicyRenewedMember_custom_NotesPayableOneMember", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R82": { "role": "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails", "longName": "00000082 - Disclosure - SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details)", "shortName": "SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_ColchesterUKWatersideHouseMember", "name": "us-gaap:AreaOfLand", "unitRef": "SquareFeet", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "VISL:ScheduleOfLeasesObligationsAssumedTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R83": { "role": "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails", "longName": "00000083 - Disclosure - SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA (Details)", "shortName": "SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "VISL:OperatingLeaseRightOfUseAssetLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "VISL:OperatingLeaseRightOfUseAssetLeaseCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R84": { "role": "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "longName": "00000084 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "shortName": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R85": { "role": "http://vislink.com/role/LeasesDetailsNarrative", "longName": "00000085 - Disclosure - LEASES (Details Narrative)", "shortName": "LEASES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OperatingLeaseImpairmentLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "span", "span", "p", "VISL:ImpairmentAndAbandonmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-09-012023-09-01_custom_LuttonUKMember", "name": "us-gaap:LeaseExpirationDate1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R86": { "role": "http://vislink.com/role/PreferredSharesDetailsNarrative", "longName": "00000086 - Disclosure - PREFERRED SHARES (Details Narrative)", "shortName": "PREFERRED SHARES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2016-02-05_us-gaap_SeriesBPreferredStockMember", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R87": { "role": "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails", "longName": "00000087 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING (Details)", "shortName": "SCHEDULE OF WARRANT OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R88": { "role": "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "longName": "00000088 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details)", "shortName": "SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_WarrantsMember", "name": "VISL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "VISL:ScheduleOfWarrantOutstandingExercisePriceTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_WarrantsMember", "name": "VISL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "VISL:ScheduleOfWarrantOutstandingExercisePriceTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R89": { "role": "http://vislink.com/role/StockholdersEquityDetailsNarrative", "longName": "00000089 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_ConsultingAgreementMember", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R90": { "role": "http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails", "longName": "00000090 - Disclosure - SCHEDULE OF STOCK BASED COMPENSATION EXPENSE (Details)", "shortName": "SCHEDULE OF STOCK BASED COMPENSATION EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_LongTermStockIncentivePlanAwardsMember", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R91": { "role": "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails", "longName": "00000091 - Disclosure - SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN (Details)", "shortName": "SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_custom_LongTermStockIncentivePlanAwardsMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "VISL:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R92": { "role": "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "longName": "00000092 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)", "shortName": "STOCK-BASED COMPENSATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "AsOf2023-08-23_custom_TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-08-23_custom_TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R93": { "role": "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "longName": "00000093 - Disclosure - SCHEDULE OF MATCHING CONTRIBUTIONS (Details)", "shortName": "SCHEDULE OF MATCHING CONTRIBUTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_GroupPersonalPensionPlanUKMember", "name": "us-gaap:DefinedContributionPlanCostRecognized", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_GroupPersonalPensionPlanUKMember", "name": "us-gaap:DefinedContributionPlanCostRecognized", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R94": { "role": "http://vislink.com/role/ConcentrationsDetailsNarrative", "longName": "00000094 - Disclosure - CONCENTRATIONS (Details Narrative)", "shortName": "CONCENTRATIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_AccountsPayableMember_us-gaap_SupplierConcentrationRiskMember_custom_SingleVendorMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R95": { "role": "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "longName": "00000095 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "shortName": "SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AssetsNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R96": { "role": "http://vislink.com/role/ScheduleOfTaxRebatesDetails", "longName": "00000096 - Disclosure - SCHEDULE OF TAX REBATES (Details)", "shortName": "SCHEDULE OF TAX REBATES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_HerMajestysRevenueAndCustomsHMRCMember", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "VISL:IncomeTaxRebatesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_HerMajestysRevenueAndCustomsHMRCMember", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock", "VISL:IncomeTaxRebatesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R97": { "role": "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "longName": "00000097 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details)", "shortName": "SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "VISL:GainOnSettlementOfDebtTableTextBlock", "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_ConsultingAgreementMember", "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "VISL:GainOnSettlementOfDebtTableTextBlock", "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R98": { "role": "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "longName": "00000098 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical)", "shortName": "SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-11-212022-11-21", "name": "us-gaap:DebtConversionConvertedInstrumentAmount1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "td", "tr", "table", "VISL:GainOnSettlementOfDebtTableTextBlock", "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "unique": true } }, "R99": { "role": "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails", "longName": "00000099 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details)", "shortName": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R100": { "role": "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails", "longName": "00000100 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)", "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R101": { "role": "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "longName": "00000101 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R102": { "role": "http://vislink.com/role/IncomeTaxesDetailsNarrative", "longName": "00000102 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true, "unique": true } }, "R103": { "role": "http://vislink.com/role/SubsequentEventsDetailsNarrative", "longName": "00000103 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "From2024-02-122024-02-12_us-gaap_SubsequentEventMember", "name": "us-gaap:PaymentsForRent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "form10-k.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://vislink.com/role/AccruedExpenses" ], "lang": { "en-us": { "role": { "label": "ACCRUED EXPENSES", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r29" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "verboseLabel": "Amount payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r28", "r926" ] }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Accounts Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r121", "r1080" ] }, "us-gaap_AccountsPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableMember", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Payable [Member]", "documentation": "Obligations incurred and payable to vendors for goods and services received." } } }, "auth_ref": [ "r24" ] }, "us-gaap_AccountsReceivableGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableGrossCurrent", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfAccountsReceivableDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r230", "r314", "r315", "r893" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r876" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNet", "crdr": "debit", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r755", "r875", "r931", "r1083" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 }, "http://vislink.com/role/ScheduleOfAccountsReceivableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net", "totalLabel": "Net accounts receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r314", "r315" ] }, "VISL_AccretionOfBondDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "AccretionOfBondDiscount", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accretion of bond discount", "documentation": "Accretion of bond discount.", "label": "AccretionOfBondDiscount" } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued expenses", "totalLabel": "Accrued expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r33" ] }, "us-gaap_AccruedSalesCommissionCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedSalesCommissionCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Commissions", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r33", "r894" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r73", "r224", "r686" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r241", "r242", "r604", "r605", "r606", "r607", "r608", "r610" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive loss", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r42", "r43", "r140", "r231", "r682", "r701", "r702" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r241", "r242", "r604", "r605", "r606", "r607", "r608", "r610" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r17", "r43", "r579", "r582", "r629", "r697", "r698", "r991", "r992", "r993", "r1003", "r1004", "r1005" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r132", "r926", "r1088" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r530", "r531", "r532", "r713", "r1003", "r1004", "r1005", "r1062", "r1089" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r94", "r95", "r494" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising Costs", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r202" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advertising costs", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r539" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock compensation costs", "verboseLabel": "Stock-based compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r526", "r538" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfAccountsReceivableDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfAccountsReceivableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r232", "r318", "r360" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "crdr": "credit", "presentation": [ "http://vislink.com/role/AccountsReceivableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bad debt recoveries", "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery." } } }, "auth_ref": [ "r365" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets", "negatedLabel": "Intangible assets, amortization", "verboseLabel": "Amortization of intangible assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r9", "r65", "r69" ] }, "VISL_AmortizationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vislink.com/20231231", "localname": "AmortizationPeriod", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Remaining amortization period", "documentation": "Amortization period." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r958" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Total", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r283" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r53" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r53" ] }, "us-gaap_AreaOfLand": { "xbrltype": "areaItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AreaOfLand", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Area of land", "verboseLabel": "Area of Land", "documentation": "Area of land held." } } }, "auth_ref": [] }, "VISL_AreaOfLandDescription": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "AreaOfLandDescription", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Area of land description", "documentation": "Area of land description." } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r573" ] }, "srt_AsiaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaMember", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Asia [Member]" } } }, "auth_ref": [ "r1091", "r1093", "r1095", "r1097" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r181", "r226", "r256", "r290", "r303", "r307", "r354", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r574", "r576", "r597", "r675", "r760", "r926", "r939", "r1024", "r1025", "r1071" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r219", "r235", "r256", "r354", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r574", "r576", "r597", "r926", "r1024", "r1025", "r1071" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Total Assets", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r114" ] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r256", "r354", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r574", "r576", "r597", "r1024", "r1025", "r1071" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r958" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r955", "r957", "r958" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r955", "r957", "r958" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r955", "r957", "r958" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails", "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r497", "r498", "r499", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r521", "r522", "r523", "r524", "r525" ] }, "VISL_BMSLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "BMSLLCMember", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "BMS, LLC [Member]", "documentation": "BMS, LLC [Member]" } } }, "auth_ref": [] }, "VISL_BillericaMaMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "BillericaMaMember", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Billerica, MA [Member]", "documentation": "Billerica, MA [Member]" } } }, "auth_ref": [] }, "VISL_BoardCompensationAwardsPreviouslyAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "BoardCompensationAwardsPreviouslyAccrued", "crdr": "debit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Board compensation awards previously accrued", "documentation": "Board compensation awards previously accrued." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r571", "r920", "r921" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r101", "r102", "r571", "r920", "r921" ] }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Transaction costs", "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r571" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Total cash used for asset acquisition", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r13" ] }, "us-gaap_BusinessCombinationConsiderationTransferredOther1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredOther1", "crdr": "credit", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash consideration paid", "documentation": "Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash." } } }, "auth_ref": [ "r14" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://vislink.com/role/AssetAcquisition" ], "lang": { "en-us": { "role": { "label": "ASSET ACQUISITION", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r177", "r572" ] }, "us-gaap_BusinessCombinationPriceOfAcquisitionExpected": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationPriceOfAcquisitionExpected", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Acquisition price", "documentation": "Purchase price of expected business acquisition prior to consideration being transferred. Excludes asset acquisition." } } }, "auth_ref": [ "r968" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "total assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r104" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Assets acquired:" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Work-in-process inventory", "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r104" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Deferred revenue", "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r104" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets - customer relationships", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r104" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Acquisition of additional inventory price", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r103", "r104" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "total liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r104" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities assumed:" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Business Combinations and Asset Acquisitions", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r100" ] }, "VISL_CarriedForwardIndefinitelyMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "CarriedForwardIndefinitelyMember", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Hale Capital Partners, LP [Member]", "documentation": "Carried Forward Indefinitely [Member]" } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash", "label": "Cash [Default Label]", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r199", "r678", "r724", "r754", "r926", "r939", "r983" ] }, "us-gaap_CashAndCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAbstract", "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "totalLabel": "Total cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r47", "r222", "r891" ] }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsDisclosureTextBlock", "presentation": [ "http://vislink.com/role/CashAndCashEquivalents" ], "lang": { "en-us": { "role": { "label": "CASH AND CASH EQUIVALENTS", "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify." } } }, "auth_ref": [ "r222", "r678" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r48" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents, beginning of the period", "periodEndLabel": "Cash and cash equivalents, end of the period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r47", "r152", "r252" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r152" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash on hand", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r983", "r1082" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash FDIC insured amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "VISL_CashFSCSInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "CashFSCSInsuredAmount", "crdr": "debit", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash FSCS insured amount", "documentation": "Cash FSCS insured amount." } } }, "auth_ref": [] }, "us-gaap_CashUninsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashUninsuredAmount", "crdr": "debit", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash uninsured amount", "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "VISL_CashUsedForInvestmentInSecuritiesHeldToMaturity": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "CashUsedForInvestmentInSecuritiesHeldToMaturity", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash used for investment in securities held to maturity", "documentation": "Cash used for investment in securities held to maturity.", "label": "CashUsedForInvestmentInSecuritiesHeldToMaturity" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r216", "r227", "r228", "r229", "r256", "r276", "r277", "r280", "r282", "r288", "r289", "r354", "r407", "r409", "r410", "r411", "r414", "r415", "r445", "r446", "r449", "r452", "r459", "r597", "r706", "r707", "r708", "r709", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r725", "r746", "r769", "r789", "r868", "r869", "r870", "r871", "r872", "r966", "r999", "r1006" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r227", "r228", "r229", "r288", "r445", "r446", "r447", "r449", "r452", "r457", "r459", "r706", "r707", "r708", "r709", "r909", "r966", "r999" ] }, "VISL_ColchesterUKMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "ColchesterUKMember", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Colchester UK [Member]", "documentation": "Colchester UK [Member]" } } }, "auth_ref": [] }, "VISL_ColchesterUKWatersideHouseMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "ColchesterUKWatersideHouseMember", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Colchester, U.K. - Waterside House [Member]", "documentation": "Colchester, U.K. - Waterside House [Member]" } } }, "auth_ref": [] }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r573" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (See Note 17)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r37", "r122", "r677", "r745" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://vislink.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r163", "r394", "r395", "r877", "r1021" ] }, "VISL_CommonStockIssuedInConnectionWithAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "CommonStockIssuedInConnectionWithAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Common stock issued in connection with:", "documentation": "Common stock issued in connection with abstract." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r928", "r929", "r930", "r932", "r933", "r934", "r935", "r1003", "r1004", "r1062", "r1086", "r1089" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r131" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "verboseLabel": "Common stock shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r131", "r746" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r131" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "verboseLabel": "Common stock shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r18", "r131", "r746", "r766", "r1089", "r1090" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock value", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r131", "r680", "r926" ] }, "VISL_CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "CommonStockWarrantsMember", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock Warrants [Member]", "documentation": "Common Stock Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r44", "r237", "r239", "r244", "r670", "r691" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Comprehensive loss:" } } }, "auth_ref": [] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r56", "r58", "r117", "r118", "r312", "r876" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r56", "r58", "r117", "r118", "r312", "r703", "r876" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r56", "r58", "r117", "r118", "r312", "r876", "r971" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentrations", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r123", "r205" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://vislink.com/role/Concentrations" ], "lang": { "en-us": { "role": { "label": "CONCENTRATIONS", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r156" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r876" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Risk percentage", "verboseLabel": "Concentration risk percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r56", "r58", "r117", "r118", "r312" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r55", "r56", "r58", "r59", "r117", "r180", "r876" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r56", "r58", "r117", "r118", "r312", "r876" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r106", "r896" ] }, "VISL_ConsultingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "ConsultingAgreementMember", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consulting Agreement [Member]", "documentation": "Consulting Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Customer deposits and deferred revenue", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r461", "r462", "r481" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total cost of revenue and operating expenses", "label": "Costs and Expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r143" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Cost of revenue and operating expenses" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditLossFinancialInstrumentPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Allowance for Credit Losses", "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status." } } }, "auth_ref": [ "r212", "r357", "r358", "r359", "r361", "r362", "r366", "r368", "r369", "r370", "r371", "r373", "r374", "r375", "r376", "r377", "r378", "r380" ] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Current tax provision" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Federal", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r973", "r1002", "r1060" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Current income tax expense, total", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r176", "r560", "r566", "r1002" ] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "State", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r973", "r1002", "r1060" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r57", "r312" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r105" ] }, "VISL_DAndOInsurancePolicyRenewedMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "DAndOInsurancePolicyRenewedMember", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "D & O Insurance Policy Renewed [Member]", "documentation": "D & O Insurance Policy Renewed [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Dividends settlement amount", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r49", "r51" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Shares issued for dividend settlement", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r49", "r51" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://vislink.com/role/NotesPayable" ], "lang": { "en-us": { "role": { "label": "NOTES PAYABLE", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r164", "r254", "r416", "r422", "r423", "r424", "r425", "r426", "r427", "r432", "r439", "r440", "r442" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r26", "r125", "r126", "r182", "r184", "r258", "r417", "r418", "r419", "r420", "r421", "r423", "r428", "r429", "r430", "r431", "r433", "r434", "r435", "r436", "r437", "r438", "r613", "r904", "r905", "r906", "r907", "r908", "r1000" ] }, "VISL_DebtInstrumentDownPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "DebtInstrumentDownPayment", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Debt instrument down payment", "documentation": "Debt instrument down payment." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Debt instrument, face amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r119", "r120", "r417", "r613", "r905", "r906" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Annual interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r35", "r418" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r36", "r258", "r417", "r418", "r419", "r420", "r421", "r423", "r428", "r429", "r430", "r431", "r433", "r434", "r435", "r436", "r437", "r438", "r613", "r904", "r905", "r906", "r907", "r908", "r1000" ] }, "us-gaap_DebtInstrumentPeriodicPaymentInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentPeriodicPaymentInterest", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Debt monthly principal and interest payment", "documentation": "Amount of the required periodic payments applied to interest." } } }, "auth_ref": [ "r36" ] }, "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]", "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r1019" ] }, "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Investments held to maturity, amortized cost", "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r323", "r339", "r341", "r669" ] }, "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1019" ] }, "us-gaap_DebtSecuritiesRealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesRealizedGainLoss", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Realized loss on investments in debt securities", "label": "Debt Securities, Realized Gain (Loss)", "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading)." } } }, "auth_ref": [ "r693", "r994", "r995" ] }, "VISL_DebtSecuritiesRealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "DebtSecuritiesRealizedLoss", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Realized loss on investments in debt securities", "documentation": "Debt securities realized loss.", "label": "DebtSecuritiesRealizedLoss" } } }, "auth_ref": [] }, "us-gaap_DebtSecuritiesUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesUnrealizedGainLoss", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized gain on investments in debt securities", "label": "Debt Securities, Unrealized Gain (Loss)", "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading)." } } }, "auth_ref": [ "r694", "r994", "r995" ] }, "us-gaap_DeferredCompensationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationLiabilityCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred equity", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date." } } }, "auth_ref": [ "r87", "r169" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1002", "r1059", "r1060" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax provision (benefit)" } } }, "auth_ref": [] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "label": "Foreign", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r176", "r1002", "r1059" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 }, "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails", "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred tax benefits", "label": "Deferred tax benefits", "totalLabel": "Total deferred tax provision (benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r9", "r176", "r211", "r565", "r566", "r1002" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total Deferred Tax Liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r127", "r128", "r183", "r554" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r545", "r546", "r676" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "State", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1002", "r1059", "r1060" ] }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetInterestCarryforward", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Interest disallowance", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward." } } }, "auth_ref": [ "r1058" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total Deferred Tax Assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r555" ] }, "us-gaap_DeferredTaxAssetsInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsInventory", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Federal net operating losses", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "State net operating losses", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Federal R&D credit", "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards." } } }, "auth_ref": [ "r98", "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch", "crdr": "debit", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets, tax credit carryforwards, research", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards." } } }, "auth_ref": [ "r98", "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Compensation related", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Pension", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from pension benefits." } } }, "auth_ref": [ "r1058" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Stock options", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Allowance for bad debt", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other accruals", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation Allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r556" ] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilities", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Net Deferred Tax Liability", "label": "Deferred Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r96", "r1057" ] }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Intangibles", "label": "Deferred Tax Liabilities, Intangible Assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPrepaidExpenses", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid Expenses", "label": "Deferred Tax Liabilities, Prepaid Expenses", "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Property and Equipment", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r99", "r1058" ] }, "us-gaap_DefinedContributionPlanCostRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanCostRecognized", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails" ], "lang": { "en-us": { "role": { "label": "Company matching contributions", "documentation": "Amount of cost for defined contribution plan." } } }, "auth_ref": [ "r490" ] }, "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanDisclosuresTableTextBlock", "presentation": [ "http://vislink.com/role/CommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF MATCHING CONTRIBUTIONS", "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans." } } }, "auth_ref": [ "r88" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://vislink.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property and equipment, depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r9", "r72" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 6.0 }, "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r9", "r72" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r733", "r736", "r751", "r752", "r753", "r756", "r757", "r758", "r759", "r761", "r762", "r763", "r764", "r776", "r777", "r778", "r779", "r782", "r783", "r784", "r785", "r843", "r844", "r845", "r846", "r928", "r930" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r107", "r108", "r109", "r110", "r733", "r736", "r751", "r752", "r753", "r756", "r757", "r758", "r759", "r761", "r762", "r763", "r764", "r776", "r777", "r778", "r779", "r782", "r783", "r784", "r785", "r843", "r844", "r845", "r846", "r895", "r928", "r930" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r480", "r910", "r911", "r912", "r913", "r914", "r915", "r916" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r480", "r910", "r911", "r912", "r913", "r914", "r915", "r916" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://vislink.com/role/RevenueTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DISAGGREGATION OF REVENUE", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1029" ] }, "VISL_DisclosureGainsOnSettlementOfDebtAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "DisclosureGainsOnSettlementOfDebtAbstract", "lang": { "en-us": { "role": { "label": "Gains On Settlement Of Debt" } } }, "auth_ref": [] }, "VISL_DisclosureLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "DisclosureLeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases", "verboseLabel": "Schedule Of Right Of Use Operating Lease Data", "terseLabel": "Schedule Of Future Minimum Rental Payments For Operating Leases" } } }, "auth_ref": [] }, "VISL_DisclosureLiquidityAndFinancialConditionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "DisclosureLiquidityAndFinancialConditionAbstract", "lang": { "en-us": { "role": { "label": "Liquidity And Financial Condition" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://vislink.com/role/Stock-basedCompensation" ], "lang": { "en-us": { "role": { "label": "STOCK-BASED COMPENSATION", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r492", "r496", "r527", "r528", "r529", "r923" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "VISL_DisclosureRebatesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "DisclosureRebatesAbstract", "lang": { "en-us": { "role": { "label": "Rebates" } } }, "auth_ref": [] }, "VISL_DisclosureReclassificationOfPriorYearPresentationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "DisclosureReclassificationOfPriorYearPresentationAbstract", "lang": { "en-us": { "role": { "label": "Reclassification Of Prior Year Presentation" } } }, "auth_ref": [] }, "us-gaap_DividendIncomeOperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendIncomeOperating", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Dividend income", "documentation": "Amount of operating dividend income on securities." } } }, "auth_ref": [ "r191", "r712", "r770", "r860", "r861", "r936", "r937", "r1098" ] }, "VISL_DividendsPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "DividendsPayableMember", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Dividends Payable [Member]", "documentation": "Dividends Payable [Member]" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r957" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r955", "r957", "r958" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r955", "r957", "r958", "r960" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r956" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r944" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r957" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r957" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r959" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r947" ] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Domestic Tax Authority [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "VISL_DubaiUAEMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "DubaiUAEMember", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dubai, UAE [Member]", "documentation": "Dubai, UAE [Member]" } } }, "auth_ref": [] }, "VISL_DutchDepositGuaranteeScheme": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "DutchDepositGuaranteeScheme", "crdr": "debit", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Dutch deposit guarantee scheme", "documentation": "Dutch deposit guarantee scheme." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Net loss per share attributable to Common Shareholders:", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r245", "r264", "r265", "r266", "r267", "r268", "r273", "r276", "r280", "r281", "r282", "r286", "r587", "r588", "r671", "r692", "r898" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r245", "r264", "r265", "r266", "r267", "r268", "r276", "r280", "r281", "r282", "r286", "r587", "r588", "r671", "r692", "r898" ] }, "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss Per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r53", "r54" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://vislink.com/role/LossPerShare" ], "lang": { "en-us": { "role": { "label": "LOSS PER SHARE", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r272", "r283", "r284", "r285" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1064" ] }, "VISL_EffectiveForTaxYearsDescription": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "EffectiveForTaxYearsDescription", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective for tax years, description", "documentation": "Effective for tax years, description." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Effective tax rate", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r548" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Statutory federal income tax rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r257", "r548", "r567" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Valuation allowance", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r1056", "r1061" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Change rate", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates." } } }, "auth_ref": [ "r567", "r1056" ] }, "VISL_EffectiveIncomeTaxRateReconciliationExecutiveCompensationTaxBenefitPercent": { "xbrltype": "percentItemType", "nsuri": "http://vislink.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationExecutiveCompensationTaxBenefitPercent", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Executive compensation", "documentation": "Effective income tax rate reconciliation executive compensation tax benefit percent" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Foreign Rate Differential", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile." } } }, "auth_ref": [ "r1056", "r1061" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Permanent differences", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r1056", "r1061" ] }, "VISL_EffectiveIncomeTaxRateReconciliationProvisionToReturn": { "xbrltype": "percentItemType", "nsuri": "http://vislink.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationProvisionToReturn", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Provision to return", "documentation": "Effective income tax rate reconciliation in respect of provision to return." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "Equity compensation", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r969", "r1056" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "State and local taxes, net of federal benefit", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r1056", "r1061" ] }, "VISL_EffectiveIncomeTaxRateReconciliationTaxContingenciesDtaAdjustmentForStateNol": { "xbrltype": "percentItemType", "nsuri": "http://vislink.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationTaxContingenciesDtaAdjustmentForStateNol", "calculation": { "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "lang": { "en-us": { "role": { "label": "DTA adjustment for state NOL", "documentation": "Effective income tax rate reconciliation tax contingencies DTA adjustment for state NOL." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r950" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r946" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r946" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r964" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r946" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r961" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r958" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r946" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r946" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r946" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r946" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r962" ] }, "VISL_EquipmentSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "EquipmentSalesMember", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Equipment Sales [Member]", "documentation": "Equipment Sales [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r18", "r217", "r241", "r242", "r243", "r259", "r260", "r261", "r263", "r269", "r271", "r287", "r355", "r356", "r460", "r530", "r531", "r532", "r561", "r562", "r578", "r579", "r580", "r581", "r582", "r583", "r586", "r604", "r605", "r606", "r607", "r608", "r610", "r629", "r697", "r698", "r699", "r713", "r789" ] }, "VISL_EuroToGBPMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "EuroToGBPMember", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Euro to GBP [Member]", "documentation": "Euro To GBP [Member]" } } }, "auth_ref": [] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Europe [Member]" } } }, "auth_ref": [ "r1091", "r1093", "r1095", "r1097" ] }, "VISL_ExercisePriceRangeFourMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "ExercisePriceRangeFourMember", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range Four [Member].", "documentation": "Exercise Price Range Four [Member]." } } }, "auth_ref": [] }, "VISL_ExercisePriceRangeOneMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "ExercisePriceRangeOneMember", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range One [Member]", "documentation": "Exercise Price Range One [Member]" } } }, "auth_ref": [] }, "VISL_ExercisePriceRangeThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "ExercisePriceRangeThreeMember", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range Three [Member]", "documentation": "Exercise Price Range Three [Member]" } } }, "auth_ref": [] }, "VISL_ExercisePriceRangeTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "ExercisePriceRangeTwoMember", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range Two [Member]", "documentation": "Exercise Price Range Two [Member]" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtGainLossNetOfTax", "crdr": "credit", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gain on extinguishment debt", "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax." } } }, "auth_ref": [ "r74" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r590", "r591", "r595" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r590", "r591", "r595" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "presentation": [ "http://vislink.com/role/FairValueOfAssetsAndLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS", "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances." } } }, "auth_ref": [ "r22", "r114", "r115", "r179" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://vislink.com/role/InvestmentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INVESTMENTS HELD TO MATURITY", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r114", "r116" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r430", "r484", "r485", "r486", "r487", "r488", "r489", "r591", "r636", "r637", "r638", "r905", "r906", "r917", "r918", "r919" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r590", "r591", "r592", "r593", "r596" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://vislink.com/role/FairValueOfAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "FAIR VALUE OF ASSETS AND LIABILITIES", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r589" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r430", "r484", "r489", "r591", "r636", "r917", "r918", "r919" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r430", "r484", "r489", "r591", "r637", "r905", "r906", "r917", "r918", "r919" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r430", "r484", "r485", "r486", "r487", "r488", "r489", "r591", "r638", "r905", "r906", "r917", "r918", "r919" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r430", "r484", "r485", "r486", "r487", "r488", "r489", "r636", "r637", "r638", "r905", "r906", "r917", "r918", "r919" ] }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsNonrecurringMember", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Nonrecurring [Member]", "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value." } } }, "auth_ref": [ "r590", "r591", "r592", "r593", "r594", "r596" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r589", "r596" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments and Fair Value Measurements", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r11", "r23" ] }, "VISL_FederalBondsHeldToMaturityMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "FederalBondsHeldToMaturityMember", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Federal Bonds Held To Maturity [Member]", "documentation": "Federal Bonds Held To Maturity [Member]" } } }, "auth_ref": [] }, "VISL_FederalBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "FederalBondsMember", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Federal Bonds [Member]", "documentation": "Federal Bonds [Member]" } } }, "auth_ref": [] }, "VISL_FederalHomeLoanBanksMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "FederalHomeLoanBanksMember", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Federal Home Loan Banks [Member]", "documentation": "Federal Home Loan Banks [Member]" } } }, "auth_ref": [] }, "VISL_FederalNationalMortgageAssociationMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "FederalNationalMortgageAssociationMember", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Federal National Mortgage Association [Member]", "documentation": "Federal National Mortgage Association [Member]" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r362", "r363", "r366", "r367", "r372", "r379", "r380", "r381", "r441", "r457", "r584", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r690", "r903", "r976", "r977", "r978", "r979", "r980", "r981", "r982", "r1014", "r1015", "r1016", "r1017" ] }, "us-gaap_FinancingReceivablesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivablesTextBlock", "presentation": [ "http://vislink.com/role/AccountsReceivable" ], "lang": { "en-us": { "role": { "label": "ACCOUNTS RECEIVABLE", "documentation": "The entire disclosure for financing receivable." } } }, "auth_ref": [ "r313", "r319", "r320", "r321", "r902" ] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Finite-lived intangible asset, useful life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, accumulated amortization", "periodEndLabel": "Ending balance, accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r225", "r390" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Thereafter", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r159" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS", "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2028", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r159" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r159" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r159" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r159" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r387", "r389", "r390", "r391", "r667", "r668" ] }, "us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails" ], "lang": { "en-us": { "role": { "label": "Net capitalized intangible costs", "documentation": "The amount of capitalized costs incurred in the period to renew or extend the term of a recognized finite-lived (amortizing and amortizable) intangible asset." } } }, "auth_ref": [ "r70" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance cost", "periodEndLabel": "Ending balance cost", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r158", "r668" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r667" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r66", "r68" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance net", "periodEndLabel": "Ending balance net", "totalLabel": "Intangible assets, estimated amortization expense", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r158", "r667" ] }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining life of intangible assets", "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r667" ] }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinitelivedIntangibleAssetsAcquired1", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets, Additions", "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition." } } }, "auth_ref": [ "r388" ] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyAbstract", "lang": { "en-us": { "role": { "label": "Foreign Currency [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyDisclosureTextBlock", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLosses" ], "lang": { "en-us": { "role": { "label": "FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES", "documentation": "The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items." } } }, "auth_ref": [ "r598", "r612", "r940", "r941", "r942", "r943", "r967" ] }, "us-gaap_ForeignCurrencyExchangeRateRemeasurement1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyExchangeRateRemeasurement1", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Average foreign currency exchange rate remeasurement", "documentation": "Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency." } } }, "auth_ref": [ "r612" ] }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyExchangeRateTranslation1", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Foreign currency exchange rate, translation", "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency." } } }, "auth_ref": [ "r611", "r612" ] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails" ], "lang": { "en-us": { "role": { "label": "(Gains) Losses", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r599", "r600", "r601", "r603", "r786" ] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign Currency and Other Comprehensive (Gains) Losses", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r598" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "country_GB": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "GB", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM" } } }, "auth_ref": [] }, "VISL_GBPMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "GBPMember", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "GBP [Member]", "documentation": "GBP [Member]" } } }, "auth_ref": [] }, "VISL_GBPToUSDMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "GBPToUSDMember", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "GBP to USD [Member]", "documentation": "GBP To USD [Member]" } } }, "auth_ref": [] }, "us-gaap_GainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnInvestments", "crdr": "credit", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Investments", "documentation": "Amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r147", "r965" ] }, "VISL_GainOnSettlementOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "GainOnSettlementOfDebtTableTextBlock", "presentation": [ "http://vislink.com/role/GainsOnSettlementOfDebtTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GAINS ON SETTLEMENT OF DEBT", "documentation": "Gain On Settlement Of Debt [Table Text Block]" } } }, "auth_ref": [] }, "VISL_GainOnSettlementOfDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "GainOnSettlementOfDebtTextBlock", "presentation": [ "http://vislink.com/role/GainsOnSettlementOfDebt" ], "lang": { "en-us": { "role": { "label": "GAINS ON SETTLEMENT OF DEBT", "documentation": "Gain On Settlement Of Debt [Text Block]" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 }, "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Gain on settlement of debt", "negatedLabel": "Gain on settlement of debt", "verboseLabel": "Gains on settlement of debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r9", "r74", "r75" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r145", "r772" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets", "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined." } } }, "auth_ref": [ "r12" ] }, "VISL_GroupPersonalPensionPlanUKMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "GroupPersonalPensionPlanUKMember", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails" ], "lang": { "en-us": { "role": { "label": "Group Personal Pension Plan, UK [Member]", "documentation": "Group Personal Pension Plan, UK [Member]" } } }, "auth_ref": [] }, "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Warranty Reserve", "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities." } } }, "auth_ref": [ "r400" ] }, "VISL_HSBCUSAINCCPMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "HSBCUSAINCCPMember", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "HSBC USA INC CP [Member]", "documentation": "HSBC USA INC CP [Member]" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Investments held to maturity, unrealized gain", "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r196", "r347" ] }, "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Investments held to maturity, unrealized loss", "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r197", "r348" ] }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesFairValue", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "lang": { "en-us": { "role": { "label": "Investments held to maturity, fair value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r195", "r346", "r669", "r674" ] }, "VISL_HemelUnitedKingdomMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "HemelUnitedKingdomMember", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Hemel United Kingdom [Member]", "documentation": "Hemel United Kingdom [Member]" } } }, "auth_ref": [] }, "us-gaap_HerMajestysRevenueAndCustomsHMRCMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HerMajestysRevenueAndCustomsHMRCMember", "presentation": [ "http://vislink.com/role/ScheduleOfTaxRebatesDetails" ], "lang": { "en-us": { "role": { "label": "Her Majesty's Revenue and Customs (HMRC) [Member]", "documentation": "Designated tax department of the government of United Kingdom." } } }, "auth_ref": [] }, "VISL_ImpairmentAndAbandonmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "ImpairmentAndAbandonmentPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment and Abandonment", "documentation": "Impairment And Abandonment [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "crdr": "debit", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Right-of-use operating assets impaired", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale." } } }, "auth_ref": [ "r9", "r161" ] }, "VISL_ImpairmentOfRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "ImpairmentOfRightofuseAssets", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment of right-of-use assets", "documentation": "Impairment on right of use assets.", "label": "ImpairmentOfRightofuseAssets" } } }, "auth_ref": [] }, "VISL_ImpairmentOnRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "ImpairmentOnRightofuseAssets", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Impairment of right-of-use assets", "documentation": "Impairment on right of use assets." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Net loss before income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r141", "r188", "r290", "r302", "r306", "r308", "r672", "r688", "r900" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r392", "r393", "r773" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "auth_ref": [ "r393", "r773" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r15" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameAxis", "presentation": [ "http://vislink.com/role/ScheduleOfTaxRebatesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority, Name [Axis]", "documentation": "Information by name of taxing authority." } } }, "auth_ref": [ "r15" ] }, "us-gaap_IncomeTaxAuthorityNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityNameDomain", "presentation": [ "http://vislink.com/role/ScheduleOfTaxRebatesDetails" ], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Income taxes", "verboseLabel": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://vislink.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r257", "r542", "r549", "r551", "r558", "r563", "r568", "r569", "r570", "r711" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income tax provision", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r198", "r213", "r270", "r271", "r294", "r547", "r564", "r695" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r240", "r543", "r544", "r551", "r552", "r557", "r559", "r705" ] }, "VISL_IncomeTaxRebatesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "IncomeTaxRebatesTextBlock", "presentation": [ "http://vislink.com/role/Rebates" ], "lang": { "en-us": { "role": { "label": "REBATES", "documentation": "Income Tax Rebates [Text Block]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r8" ] }, "VISL_IncreaseDecreaseInAccruedDirectorsCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "IncreaseDecreaseInAccruedDirectorsCompensation", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrued directors\u2019 compensation", "documentation": "Increase decrease in accrued directors compensation." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilities", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrued expenses and interest expense", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deferred revenue and customer deposits", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r664", "r997" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r972", "r997" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r8" ] }, "VISL_InstallationIntegrationAndRepairsMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "InstallationIntegrationAndRepairsMember", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Installation, Integration and Repairs [Member]", "documentation": "Installation, Integration and Repairs [Member]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://vislink.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r386" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r64", "r67" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r149", "r436", "r443", "r907", "r908" ] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Interest income (expense), net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r190" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the period for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r248", "r250", "r251" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://vislink.com/role/Inventories" ], "lang": { "en-us": { "role": { "label": "INVENTORIES", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r382" ] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r986" ] }, "us-gaap_InventoryGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryGross", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Sub-total inventories", "label": "Inventory, Gross", "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r988" ] }, "us-gaap_InventoryLIFOReserveEffectOnIncomeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryLIFOReserveEffectOnIncomeNet", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory valuation adjustments", "label": "Inventory, LIFO Reserve, Effect on Income, Net", "documentation": "The difference between the change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods and any LIFO decrement which have been reflected in the statement of income during the period." } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://vislink.com/role/ScheduleOfInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventories, net", "totalLabel": "Total inventories, net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r234", "r892", "r926" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inventories", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r200", "r221", "r233", "r382", "r383", "r385", "r665", "r897" ] }, "us-gaap_InventoryRawMaterialsAndSupplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsAndSupplies", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials", "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed." } } }, "auth_ref": [ "r988" ] }, "VISL_InventoryValuationAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "InventoryValuationAdjustments", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Inventory valuation adjustments", "documentation": "Inventory valuation adjustments." } } }, "auth_ref": [] }, "us-gaap_InventoryValuationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryValuationReserves", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less reserve for slow-moving and excess inventory", "label": "Inventory Valuation Reserves", "documentation": "Amount of valuation reserve for inventory." } } }, "auth_ref": [ "r63", "r988" ] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcess", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "parentTag": "us-gaap_InventoryGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Work-in-process", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r987" ] }, "us-gaap_InventoryWriteDown": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWriteDown", "crdr": "debit", "presentation": [ "http://vislink.com/role/InventoriesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory written-off due to obsolescence", "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels." } } }, "auth_ref": [ "r384" ] }, "VISL_InvestmentDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "InvestmentDiscount", "crdr": "debit", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment discount", "documentation": "Investment discount." } } }, "auth_ref": [] }, "VISL_InvestmentInDebtSecuritiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "InvestmentInDebtSecuritiesPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Investment in Debt Securities", "documentation": "InvestmentInDebtSecurities [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r146", "r293" ] }, "us-gaap_InvestmentInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentInterestRate", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment Interest Rate", "documentation": "Rate of interest on investment." } } }, "auth_ref": [ "r797", "r798", "r816", "r817", "r821", "r822", "r856", "r857", "r930", "r1010", "r1012" ] }, "us-gaap_InvestmentIssuerNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIssuerNameAxis", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment, Issuer Name [Axis]", "documentation": "Information by name of issuer of investment." } } }, "auth_ref": [ "r1092", "r1094", "r1096", "r1099" ] }, "us-gaap_InvestmentIssuerNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIssuerNameDomain", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Name of issuer of investment." } } }, "auth_ref": [ "r1092", "r1094", "r1096", "r1099" ] }, "us-gaap_InvestmentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentMaturityDate", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment Maturity Date", "documentation": "Maturity date of investment, in YYYY-MM-DD format." } } }, "auth_ref": [ "r797", "r798", "r816", "r817", "r821", "r822", "r856", "r857", "r930", "r1011", "r1013" ] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Fair Value", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r704", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r734", "r737", "r738", "r749", "r750", "r794", "r803", "r804", "r813", "r825", "r826", "r839", "r840", "r841", "r851", "r854", "r862", "r864", "r867", "r930", "r939", "r1087" ] }, "us-gaap_InvestmentOwnedBalancePrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedBalancePrincipalAmount", "crdr": "debit", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Balance, Principal Amount", "documentation": "Amount of principal of investment owned." } } }, "auth_ref": [ "r726", "r734", "r801", "r829", "r859", "r930" ] }, "VISL_InvestmentParValue": { "xbrltype": "perShareItemType", "nsuri": "http://vislink.com/20231231", "localname": "InvestmentParValue", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment par value", "documentation": "Investment par value." } } }, "auth_ref": [] }, "us-gaap_InvestmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTextBlock", "presentation": [ "http://vislink.com/role/Investments" ], "lang": { "en-us": { "role": { "label": "INVESTMENTS", "documentation": "The entire disclosure for investment." } } }, "auth_ref": [ "r974", "r975", "r1009" ] }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAllOtherInvestmentsAbstract", "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "auth_ref": [] }, "VISL_IssuanceOfCommonStockInConnectionWithAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "IssuanceOfCommonStockInConnectionWithAbstract", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock in connection with:", "documentation": "Issuance of common stock in connection with abstract." } } }, "auth_ref": [] }, "VISL_IssuanceOfSharesOfSeriesAPreferredStockAsDividendsForCommonStockShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "IssuanceOfSharesOfSeriesAPreferredStockAsDividendsForCommonStockShareholders", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders", "documentation": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders.", "label": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders [Default Label]" } } }, "auth_ref": [] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LaborAndRelatedExpense", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Cost of components and personnel", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r996" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease cost", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r620", "r925" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://vislink.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1068" ] }, "us-gaap_LeaseExpirationDate1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseExpirationDate1", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease expiration", "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "VISL_LeaseExpirationMonth": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "LeaseExpirationMonth", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Lease-End Month", "documentation": "Lease expiration month." } } }, "auth_ref": [] }, "VISL_LeaseExpirationYear": { "xbrltype": "gYearItemType", "nsuri": "http://vislink.com/20231231", "localname": "LeaseExpirationYear", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Lease-End Year", "documentation": "Lease expiration year." } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r162" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r618" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://vislink.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1069" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Approximate Future Payments", "totalLabel": "Total lease payments", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r627" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r627" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r627" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r627" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r627" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r627" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r627" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Less: imputed interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r627" ] }, "us-gaap_LesseeOperatingLeaseOptionToExtend": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseOptionToExtend", "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Lease maturity dates for right-of-use operating leases", "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability." } } }, "auth_ref": [ "r619" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://vislink.com/role/Leases" ], "lang": { "en-us": { "role": { "label": "LEASES", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r614" ] }, "us-gaap_LessorOperatingLeaseDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeaseDescription", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease description", "documentation": "Description of lessor's operating lease." } } }, "auth_ref": [ "r628" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r32", "r256", "r354", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r575", "r576", "r577", "r597", "r744", "r899", "r939", "r1024", "r1071", "r1072" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r136", "r185", "r684", "r926", "r1001", "r1018", "r1063" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r34", "r220", "r256", "r354", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r575", "r576", "r577", "r597", "r926", "r1024", "r1071", "r1072" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Total Liabilities", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r114" ] }, "VISL_LiquidityAndFinancialConditionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "LiquidityAndFinancialConditionTextBlock", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialCondition" ], "lang": { "en-us": { "role": { "label": "LIQUIDITY AND FINANCIAL CONDITION", "documentation": "Liquidity and financial condition [Text block]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "VISL_LongTermStockIncentivePlanAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "LongTermStockIncentivePlanAwardsMember", "presentation": [ "http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails", "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Long Term Stock Incentive Plan Awards [Member]", "documentation": "Long Term Stock Incentive Plan Awards [Member]" } } }, "auth_ref": [] }, "VISL_LossOnLeaseImpairments": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "LossOnLeaseImpairments", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "loss on lease impairments", "documentation": "Loss on lease impairments." } } }, "auth_ref": [] }, "VISL_LuttonUKMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "LuttonUKMember", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Lutton, UK [Member]", "documentation": "Lutton, UK [Member]" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r312", "r912", "r1029", "r1084", "r1085" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r396", "r397", "r398", "r399", "r491", "r663", "r696", "r735", "r736", "r797", "r816", "r822", "r823", "r856", "r887", "r888", "r902", "r909", "r922", "r927", "r1026", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r396", "r397", "r398", "r399", "r491", "r663", "r696", "r735", "r736", "r797", "r816", "r822", "r823", "r856", "r887", "r888", "r902", "r909", "r922", "r927", "r1026", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078" ] }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsAtCarryingValue", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails": { "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Federally insured money market mutual funds", "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months." } } }, "auth_ref": [] }, "VISL_MountOliveNJMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "MountOliveNJMember", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Mount Olive, NJ [Member]", "documentation": "Mount Olive, NJ [Member]" } } }, "auth_ref": [] }, "country_NL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "NL", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "NETHERLANDS" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r312", "r912", "r1029", "r1084", "r1085" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://vislink.com/role/NatureOfOperations" ], "lang": { "en-us": { "role": { "label": "NATURE OF OPERATIONS", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r201", "r214" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r249" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows used in financing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r249" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows used in investing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "negatedLabel": "Cash for operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r152", "r153", "r154" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows used in operating activities" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r142", "r154", "r189", "r218", "r236", "r238", "r243", "r256", "r262", "r264", "r265", "r266", "r267", "r270", "r271", "r278", "r290", "r302", "r306", "r308", "r354", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r588", "r597", "r689", "r768", "r787", "r788", "r900", "r937", "r1024" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Net loss attributable to common shareholders", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r247", "r264", "r265", "r266", "r267", "r273", "r274", "r279", "r282", "r290", "r302", "r306", "r308", "r900" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "VISL_NewlyIssuedAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "NewlyIssuedAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Issued Accounting Pronouncements", "documentation": "Newly Issued Accounting Pronouncements Policy [Policy Text Block]" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "VISL_NoncashChangesToOperatingLeaseAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "NoncashChangesToOperatingLeaseAssetsAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Less: non-cash changes to operating lease assets amortization", "documentation": "Noncash Changes To Operating Lease Assets [Abstract]" } } }, "auth_ref": [] }, "VISL_NoncashChangesToOperatingLeaseLiabilitiesAccretion": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "NoncashChangesToOperatingLeaseLiabilitiesAccretion", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Less: non-cash changes to operating lease liabilities accretion", "documentation": "Noncash changes to operating lease liabilities accretion." } } }, "auth_ref": [] }, "VISL_NoncashDisclosuresOfRouAssetsAndOperatingLeaseObligationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "NoncashDisclosuresOfRouAssetsAndOperatingLeaseObligationAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "ROU assets and operating lease obligations recognized (Note 16):", "documentation": "Non cash disclosures of rou assets and operating lease obligation abstract." } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash information:" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r148" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other income (expenses)" } } }, "auth_ref": [] }, "srt_NorthAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NorthAmericaMember", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "North America [Member]" } } }, "auth_ref": [ "r1091", "r1093", "r1095", "r1097" ] }, "us-gaap_NotesIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesIssued1", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Notes payable recognized on D & O Insurance policy (Note 15)", "documentation": "The fair value of notes issued in noncash investing and financing activities." } } }, "auth_ref": [ "r49", "r50", "r51" ] }, "us-gaap_NotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayable", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Notes Payable", "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r26", "r184", "r1081" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Notes payable", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r31" ] }, "VISL_NotesPayableOneMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "NotesPayableOneMember", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Notes Payable One [Member]", "documentation": "Notes Payable One [Member]" } } }, "auth_ref": [] }, "VISL_NotesPayableTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "NotesPayableTwoMember", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Notes Payable Two [Member]", "documentation": "Notes Payable Two [Member]" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of operating segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r1007" ] }, "VISL_OneVendorMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "OneVendorMember", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "One Vendor [Member]", "documentation": "One Vendor [Member]" } } }, "auth_ref": [] }, "VISL_OperatingImpairments": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "OperatingImpairments", "crdr": "debit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "impairments", "documentation": "Operating impairments." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "negatedLabel": "Operating loss", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r290", "r302", "r306", "r308", "r900" ] }, "VISL_OperatingLeaseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "OperatingLeaseAssetAmortization", "crdr": "debit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "amortization", "documentation": "Operating lease asset amortization." } } }, "auth_ref": [] }, "VISL_OperatingLeaseAssetsRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "OperatingLeaseAssetsRecognized", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease assets recognized", "documentation": "Operating lease assets recognized." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r621", "r925" ] }, "us-gaap_OperatingLeaseImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseImpairmentLoss", "crdr": "debit", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loss on impairment of right-of-use assets", "verboseLabel": "Loss on impairment of Right Of Use Asset", "documentation": "Amount of loss from impairment of right-of-use asset from operating lease." } } }, "auth_ref": [ "r1067" ] }, "VISL_OperatingLeaseLiabilitiesRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "OperatingLeaseLiabilitiesRecognized", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities recognized", "documentation": "Operating lease liabilities recognized." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Operating lease liability", "label": "Present value of lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r616" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease obligations, current", "verboseLabel": "Operating lease liability, Current portion", "terseLabel": "Less: Current lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r616" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 }, "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Operating lease obligations, net of current portion", "verboseLabel": "Non-current portion", "terseLabel": "Non-current lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r616" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating leases", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r617", "r623" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 }, "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Right of use assets, operating leases", "totalLabel": "Operating lease right of use asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r615" ] }, "VISL_OperatingLeaseRightOfUseAssetAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails": { "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated amortization", "documentation": "Operating lease right of use asset accumulated amortization." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of right-of-use assets, operating assets", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r998" ] }, "VISL_OperatingLeaseRightOfUseAssetLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "OperatingLeaseRightOfUseAssetLeaseCost", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails": { "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Cost", "documentation": "Operating lease right of use asset lease cost." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-average discount rate-operating leases", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r626", "r925" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-average remaining lease term-operating leases", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r625", "r925" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r98" ] }, "VISL_OperatingLossCarryforwardsExpirationDescription": { "xbrltype": "stringItemType", "nsuri": "http://vislink.com/20231231", "localname": "OperatingLossCarryforwardsExpirationDescription", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating loss carryforwards, expiration description", "documentation": "Operating loss carryforwards, expiration description." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative", "http://vislink.com/role/ScheduleOfTaxRebatesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative", "http://vislink.com/role/ScheduleOfTaxRebatesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]", "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization." } } }, "auth_ref": [ "r97" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued expenses other", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r33" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails", "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Unrealized gain on currency translation adjustment", "negatedLabel": "Unrealized (gains) losses on currency translation adjustment", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized gain on currency translation adjustment", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5", "r6", "r602", "r609" ] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other income", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r150" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r957" ] }, "VISL_PatentsAndLicensesMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "PatentsAndLicensesMember", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Patents and Licenses [Member]", "documentation": "Patents and Licenses [Member]" } } }, "auth_ref": [] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRent", "crdr": "credit", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for rent", "verboseLabel": "Base rent", "documentation": "Cash payments to lessor's for use of assets under operating leases." } } }, "auth_ref": [ "r7" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash used in asset acquisition", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r45" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash used for property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r151" ] }, "VISL_PerformanceBasedRestrictedStockAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "PerformanceBasedRestrictedStockAwardsMember", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Performance Based Restricted Stock Awards [Member]", "documentation": "Performance Based Restricted Stock Awards [Member]" } } }, "auth_ref": [] }, "VISL_PerformanceBasedStockOptionInducementMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "PerformanceBasedStockOptionInducementMember", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Performance Based Stock Option Inducement [Member]", "documentation": "Performance Based Stock Option Inducement [Member]" } } }, "auth_ref": [] }, "VISL_PeriodAverageEURToUSDollarOneExchangeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "PeriodAverageEURToUSDollarOneExchangeRateMember", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Period Average EUR to $1 Exchange Rate [Member]", "documentation": "Period Average EUR to $1 Exchange Rate [Member]" } } }, "auth_ref": [] }, "VISL_PeriodAverageGBPToUSDollarOneExchangeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "PeriodAverageGBPToUSDollarOneExchangeRateMember", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Period Average GBP to $1 Exchange Rate [Member]", "documentation": "Period Average GBP to $1 Exchange Rate [Member]" } } }, "auth_ref": [] }, "VISL_PeriodEndEURToUSDollarOneExchangeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "PeriodEndEURToUSDollarOneExchangeRateMember", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Period End EUR to $1 Exchange Rate [Member]", "documentation": "Period End EUR to $1 Exchange Rate [Member]" } } }, "auth_ref": [] }, "VISL_PeriodEndGBPToUSDollarOneExchangeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "PeriodEndGBPToUSDollarOneExchangeRateMember", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Period End GBP to $1 Exchange Rate [Member]", "documentation": "Period End GBP to $1 Exchange Rate [Member]" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1030", "r1031", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038", "r1039", "r1040", "r1041", "r1042", "r1043", "r1044", "r1045", "r1046", "r1047", "r1048", "r1049", "r1050", "r1051", "r1052", "r1053", "r1054", "r1055" ] }, "VISL_PowayCAMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "PowayCAMember", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Poway CA [Member]", "documentation": "Poway CA [Member]" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r951" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r952" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r928", "r929", "r932", "r933", "r934", "r935", "r1086", "r1089" ] }, "us-gaap_PreferredStockNoParValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockNoParValue", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock par value", "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r130", "r1027" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "verboseLabel": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r130", "r445" ] }, "us-gaap_PreferredStockRedemptionTerms": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockRedemptionTerms", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock redemption terms", "verboseLabel": "Preferred stock redemption terms, description", "documentation": "The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer." } } }, "auth_ref": [ "r80", "r81" ] }, "us-gaap_PreferredStockShareSubscriptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockShareSubscriptions", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock unissued", "documentation": "The number of nonredeemable preferred stock (shares) (or preferred stock redeemable solely at the option of the issuer) allocated to investors to buy shares of a new issue of preferred stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds." } } }, "auth_ref": [ "r130" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r130", "r746" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock shares, issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r130", "r445" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock shares, outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r130", "r746", "r766", "r1089", "r1090" ] }, "us-gaap_PreferredStockTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockTextBlock", "presentation": [ "http://vislink.com/role/PreferredShares" ], "lang": { "en-us": { "role": { "label": "PREFERRED SHARES", "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock." } } }, "auth_ref": [ "r165" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on December 31, 2023, and 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r130", "r679", "r926" ] }, "us-gaap_PreferredStockVotingRights": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockVotingRights", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock voting rights", "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights." } } }, "auth_ref": [ "r81", "r130" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r990" ] }, "VISL_ProceedsForBondRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "ProceedsForBondRedemption", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds for bond redemption", "documentation": "Proceeds for bond redemption." } } }, "auth_ref": [] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProductWarrantyAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrual", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warranty reserve, beginning", "periodEndLabel": "Warranty reserve, ending", "label": "Standard and Extended Product Warranty Accrual", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers." } } }, "auth_ref": [ "r121", "r401", "r403", "r406" ] }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualClassifiedCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Warranty", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r33", "r1022", "r1023" ] }, "us-gaap_ProductWarrantyAccrualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualPayments", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Warranty claims settled and true-up of accrual", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty." } } }, "auth_ref": [ "r404" ] }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualWarrantiesIssued", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Warranty reserve expense", "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued." } } }, "auth_ref": [ "r405" ] }, "us-gaap_ProductionRelatedImpairmentsOrCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductionRelatedImpairmentsOrCharges", "crdr": "debit", "presentation": [ "http://vislink.com/role/InventoriesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product lines impairing of inventories", "documentation": "Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold." } } }, "auth_ref": [ "r144" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r10" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://vislink.com/role/PropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "PROPERTY AND EQUIPMENT", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r160", "r206", "r209", "r210" ] }, "us-gaap_PropertyPlantAndEquipmentDisposals": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisposals", "crdr": "credit", "presentation": [ "http://vislink.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation leasehold improvement", "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, cost", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r162", "r223", "r687" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "totalLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r673", "r687", "r926" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r10", "r206", "r209", "r685" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://vislink.com/role/PropertyAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY AND EQUIPMENT", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r10" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r162" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property and equipment, estimated useful life", "verboseLabel": "Estimated useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "VISL_ProprietaryTechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "ProprietaryTechnologyMember", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Proprietary Technology [Member]", "documentation": "Proprietary Technology [Member]" } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vislink.com/role/AccountsReceivableDetailsNarrative", "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision for bad debt", "verboseLabel": "Bad debt expense", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r246", "r364" ] }, "VISL_ROUAssetsAndOperatingLeaseObligationsRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "ROUAssetsAndOperatingLeaseObligationsRecognized", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "ROU assets and operating lease obligations recognized", "documentation": "ROU assets and operating lease obligations recognized." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r396", "r397", "r398", "r399", "r483", "r491", "r522", "r523", "r524", "r639", "r663", "r696", "r735", "r736", "r797", "r816", "r822", "r823", "r856", "r887", "r888", "r902", "r909", "r922", "r927", "r930", "r1020", "r1026", "r1074", "r1075", "r1076", "r1077", "r1078" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r396", "r397", "r398", "r399", "r483", "r491", "r522", "r523", "r524", "r639", "r663", "r696", "r735", "r736", "r797", "r816", "r822", "r823", "r856", "r887", "r888", "r902", "r909", "r922", "r927", "r930", "r1020", "r1026", "r1074", "r1075", "r1076", "r1077", "r1078" ] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "auth_ref": [] }, "VISL_ReclassificationOfPriorYearPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "ReclassificationOfPriorYearPresentationTextBlock", "presentation": [ "http://vislink.com/role/ReclassificationOfPriorYearPresentation" ], "lang": { "en-us": { "role": { "label": "RECLASSIFICATION OF PRIOR YEAR PRESENTATION", "documentation": "Reclassification of Prior Year Presentation [Text Block]" } } }, "auth_ref": [] }, "VISL_RecognizationOfOperatingLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "RecognizationOfOperatingLeaseLiabilities", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease liabilities recognized", "documentation": "Operating lease liabilities recognized.", "label": "Operating lease liabilities recognized [Default Label]" } } }, "auth_ref": [] }, "VISL_RecoveryOfBadDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "RecoveryOfBadDebt", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Recovery of bad debt", "documentation": "Recovery of bad debt.", "label": "RecoveryOfBadDebt" } } }, "auth_ref": [] }, "us-gaap_RedeemablePreferredStockDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RedeemablePreferredStockDividends", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends", "label": "Redeemable Preferred Stock Dividends", "documentation": "Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r18", "r52", "r168" ] }, "VISL_RedeemablePreferredStockPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "RedeemablePreferredStockPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Redeemable Preferred Stock", "documentation": "Redeemable Preferred Stock [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfMediumTermNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfMediumTermNotes", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Principal payments made on D & O notes payable", "label": "Repayments of Medium-term Notes", "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years." } } }, "auth_ref": [ "r46" ] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Services liabilities", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r46" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Research and development", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r124", "r541", "r1079" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and Development Expenses", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r540" ] }, "VISL_RestOfWorldMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "RestOfWorldMember", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Rest of World [Member]", "documentation": "Rest of World [Member]" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r133", "r168", "r683", "r700", "r702", "r710", "r747", "r926" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r217", "r259", "r260", "r261", "r263", "r269", "r271", "r355", "r356", "r530", "r531", "r532", "r561", "r562", "r578", "r580", "r581", "r583", "r586", "r697", "r699", "r713", "r1089" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue, net", "verboseLabel": "Revenue", "terseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r291", "r292", "r301", "r304", "r305", "r309", "r310", "r312", "r479", "r480", "r666" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r215", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r889" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://vislink.com/role/Revenue" ], "lang": { "en-us": { "role": { "label": "REVENUE", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r215", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r482" ] }, "VISL_RightOfUseAssetImpairmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "RightOfUseAssetImpairmentMember", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Right Of Use Asset Impairment [Member]", "documentation": "Right Of Use Asset Impairment [Member]" } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets obtained in exchange for new operating lease liabilities", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r624", "r925" ] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "VISL_RisksAndUncertaintiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "RisksAndUncertaintiesPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties", "documentation": "Risks And Uncertainties [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r312", "r970" ] }, "VISL_SalesTaxAndValueAddedTaxesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "SalesTaxAndValueAddedTaxesPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Sales Tax and Value-Added Taxes", "documentation": "Sales Tax And Value Added Taxes [Policy Text Block]" } } }, "auth_ref": [] }, "VISL_SatisfactionOfAccountsPayableVendorBalance": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "SatisfactionOfAccountsPayableVendorBalance", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Satisfaction of accounts payable vendor balance", "documentation": "Satisfaction of accounts payable vendor balance." } } }, "auth_ref": [] }, "VISL_SatisfactionOfAccountsPayableVendorBalanceShares": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "SatisfactionOfAccountsPayableVendorBalanceShares", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Satisfaction of accounts payable vendor balance, shares", "documentation": "Satisfaction of accounts payable vendor balance shares." } } }, "auth_ref": [] }, "VISL_SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnits", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Satisfaction of withholding tax upon conversion of restricted stock units", "documentation": "Satisfaction of withholding tax upon conversion of restricted stock units." } } }, "auth_ref": [] }, "VISL_SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnitsShares": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnitsShares", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Satisfaction of withholding tax upon conversion of restricted stock units, shares", "documentation": "Satisfaction of withholding tax upon conversion of restricted stock units shares." } } }, "auth_ref": [] }, "VISL_SatisfactionWithConversionOfRestrictedStockUnitAwards": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "SatisfactionWithConversionOfRestrictedStockUnitAwards", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Satisfaction with the conversion of restricted stock unit awards", "documentation": "Satisfaction with conversion of restricted stock unit awards" } } }, "auth_ref": [] }, "VISL_SatisfactionWithConversionOfRestrictedStockUnitAwardsShares": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "SatisfactionWithConversionOfRestrictedStockUnitAwardsShares", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Satisfaction with the conversion of restricted stock unit awards, shares", "documentation": "Satisfaction with conversion of restricted stock unit awards shares" } } }, "auth_ref": [] }, "VISL_SatisfactionWithConversionOfRestrictedStockUnits": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "SatisfactionWithConversionOfRestrictedStockUnits", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Satisfaction with the conversion of restricted stock units", "documentation": "Satisfaction with conversion of restricted stock units." } } }, "auth_ref": [] }, "VISL_SatisfactionWithTheConversionOfRestrictedStockUnitsShares": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "SatisfactionWithTheConversionOfRestrictedStockUnitsShares", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Satisfaction with the conversion of restricted stock units, shares", "documentation": "Satisfaction of withholding tax upon conversion." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://vislink.com/role/AccountsReceivableTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ACCOUNTS RECEIVABLE", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r41" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://vislink.com/role/AccruedExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ACCRUED EXPENSES", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r43", "r1065", "r1066" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r53" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://vislink.com/role/LossPerShareTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r53" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r101", "r102", "r571" ] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://vislink.com/role/CashAndCashEquivalentsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CASH AND CASH EQUIVALENTS", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r573" ] }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "presentation": [ "http://vislink.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF STOCK BASED COMPENSATION EXPENSE", "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit." } } }, "auth_ref": [ "r93" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://vislink.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r173" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://vislink.com/role/NotesPayableTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF NOTES PAYABLE", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://vislink.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r172" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://vislink.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r171" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r66", "r68", "r667" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INTANGIBLE ASSETS", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r66", "r68" ] }, "us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfImpairedIntangibleAssetsTextBlock", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CAPITALIZED INTANGIBLE COSTS", "documentation": "Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://vislink.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INVENTORIES", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r27", "r137", "r138", "r139" ] }, "us-gaap_ScheduleOfInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsLineItems", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839", "r840", "r841", "r842", "r847", "r848", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r862", "r863", "r864", "r865", "r866", "r867" ] }, "us-gaap_ScheduleOfInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentsTable", "presentation": [ "http://vislink.com/role/InvestmentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Table]", "documentation": "Disclosure of information about investments owned by investment company." } } }, "auth_ref": [ "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839", "r840", "r841", "r842", "r847", "r848", "r849", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r862", "r863", "r864", "r865", "r866", "r867" ] }, "VISL_ScheduleOfLeasesObligationsAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "ScheduleOfLeasesObligationsAssumedTableTextBlock", "presentation": [ "http://vislink.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LEASE OBLIGATIONS ASSUMED", "documentation": "Schedule of Lease Obligations Assumed [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PRODUCT WARRANTY LIABILITY", "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability." } } }, "auth_ref": [ "r402" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://vislink.com/role/AssetAcquisitionTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r178" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails", "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r493", "r495", "r497", "r498", "r499", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r521", "r522", "r523", "r524", "r525" ] }, "VISL_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock", "presentation": [ "http://vislink.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN", "documentation": "Schedule Of Share Based Compensation Employee Stock Purchase Plan Activities [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Schedule of Short-Term Debt [Table]", "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation." } } }, "auth_ref": [ "r30" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r77", "r78", "r79", "r81", "r82", "r83", "r84", "r166", "r167", "r168", "r227", "r228", "r229", "r288", "r445", "r446", "r447", "r449", "r452", "r457", "r459", "r706", "r707", "r708", "r709", "r909", "r966", "r999" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://vislink.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANT OUTSTANDING", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r89" ] }, "VISL_ScheduleOfWarrantOutstandingExercisePriceTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "ScheduleOfWarrantOutstandingExercisePriceTableTextBlock", "presentation": [ "http://vislink.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE", "documentation": "Schedule Of Warrant Outstanding Exercise Price [Table Text Block]" } } }, "auth_ref": [] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r68" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r945" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r949" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r948" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r953" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r310", "r311", "r728", "r730", "r732", "r803", "r818", "r839", "r864", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r890", "r911", "r930", "r1029", "r1084" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Segment Reporting", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r295", "r296", "r297", "r298", "r299", "r300", "r310", "r901" ] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r984", "r985", "r1028" ] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r984", "r985", "r1028" ] }, "VISL_SeriesDConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "SeriesDConvertiblePreferredStockMember", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series D Convertible Preferred Stock [Member]", "documentation": "Series D Convertible Preferred Stock [Member]" } } }, "auth_ref": [] }, "VISL_SeriesDPreferredStockAndSeriesEPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "SeriesDPreferredStockAndSeriesEPreferredStockMember", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series D Preferred Stock and Series E Preferred Stock [Member]", "documentation": "Series D Preferred Stock and Series E Preferred Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_SeriesDPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesDPreferredStockMember", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series D Preferred Stock [Member]", "documentation": "Series D preferred stock." } } }, "auth_ref": [ "r984", "r985", "r1028" ] }, "VISL_SeriesEConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "SeriesEConvertiblePreferredStockMember", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series E Convertible Preferred Stock [Member]", "documentation": "Series E Convertible Preferred Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_SeriesEPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesEPreferredStockMember", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Series E Preferred Stock [Member]", "documentation": "Series E preferred stock." } } }, "auth_ref": [ "r984", "r985", "r1028" ] }, "VISL_SettlementOfAmountsDueAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "SettlementOfAmountsDueAccountsPayable", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Settlement of amounts due accounts payable", "documentation": "Settlement of amounts due accounts payable." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails", "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-based compensation", "label": "Remaining compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of restricted stock, Stock units exercised", "documentation": "Share based compensation arrangement by share based payment award equity instruments other than exercised", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of restricted stock, Canceled, expired, forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r514" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r514" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted stock options, granted", "verboseLabel": "Number of restricted stock, Granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r512" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, restricted stock, Granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r512" ] }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price, restricted stock, Ending balance", "documentation": "Restricted stock units, exercisable weighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Intrinsic value per share", "documentation": "Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r509", "r510" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of restricted stock, Outstanding, Beginning balance", "periodEndLabel": "Number of restricted stock, Outstanding, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r509", "r510" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, restricted stock, beginning balance", "periodEndLabel": "Weighted average exercise price, Outstanding, Ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r509", "r510" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life", "verboseLabel": "Weighted average remaining contractual life, options outstanding", "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r170" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails", "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r493", "r495", "r497", "r498", "r499", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r521", "r522", "r523", "r524", "r525" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of warrants expired", "label": "Warrants expired", "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event." } } }, "auth_ref": [ "r21" ] }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Outstanding and Exercisable (in shares)", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments outstanding and exercisable numbers." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of warrants beginning balance", "periodEndLabel": "Number of warrants ending outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r19", "r20" ] }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableOutstandingWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price ending exercisable", "documentation": "Weighted Average Exercise Price." } } }, "auth_ref": [] }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price beginning outstanding", "periodEndLabel": "Weighted average exercise price ending outstanding", "documentation": "Weighted Average Exercise Price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://vislink.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation authorized, shares", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r924" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of options exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r503" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price, exercisable balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r503" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of options, Stock options forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r1036" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Weighted average exercise price, Canceled, expired, forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r1036" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Number of options, Granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r505" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of options, Outstanding, Beginning balance", "periodEndLabel": "Number of options, ending outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r501", "r502" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, outstanding beginning balance", "periodEndLabel": "Weighted average exercise price, outstanding ending balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r501", "r502" ] }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of restricted stock, Exercisable", "documentation": "Share based compensation arrangements by share based payment award other than options exercisable number.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" } } }, "auth_ref": [] }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price, restricted stock, Exercisable", "documentation": "Share based compensation arrangements by share based payment award other than options exercisable weighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative", "http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails", "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r497", "r498", "r499", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r521", "r522", "r523", "r524", "r525" ] }, "VISL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price expired", "documentation": "Weighted Average Exercise Price, cancelled/expired." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Weighted average exercise price, Stock units exercised", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r506" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r505" ] }, "VISL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Weighted average exercise price, restricted stock, Stock units exercised", "label": "Weighted average exercise price, restricted stock, Stock units exercised", "documentation": "Share based compensation arrangements by share based payment award other than options exercises in period weighted average exercise price." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r492", "r500", "r519", "r520", "r521", "r522", "r525", "r533", "r534", "r535", "r536" ] }, "VISL_ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange": { "xbrltype": "perShareItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding and exercisable, Range of exercise prices", "documentation": "Share based compensation shares authorized under non option outstanding and exercise price range." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Axis]", "documentation": "Information by range of option prices pertaining to options granted." } } }, "auth_ref": [ "r91" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r92" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Range of exercise prices, lower limit", "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range." } } }, "auth_ref": [ "r92" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Range of exercise prices, upper limit", "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range." } } }, "auth_ref": [ "r92" ] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Supplier [Axis]", "documentation": "Information by supplier." } } }, "auth_ref": [] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average remaining contractual life - options exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r90" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life - options exercisable", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r170" ] }, "VISL_SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://vislink.com/20231231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life, exercisable", "documentation": "Share based compensation arrangement by share based payment award other than options exercisable weighted average remaining contractual term 1." } } }, "auth_ref": [] }, "VISL_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1": { "xbrltype": "perShareItemType", "nsuri": "http://vislink.com/20231231", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding and exercisable, Weighted Average Exercise Price", "documentation": "Share based compensation shares authorized under stock option plans exercise price range outstanding and exercisable options weighted average exercise price one." } } }, "auth_ref": [] }, "VISL_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://vislink.com/20231231", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)", "documentation": "Share based compensation shares authorized under stock option plans exercise price range outstanding and exercisable options weighted average remaining contractual term two." } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share issued price per share", "verboseLabel": "Shares issued price per share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, shares", "periodEndLabel": "Balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares attributable to withholding tax", "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [] }, "VISL_ShippingAndHandlingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShippingAndHandlingCosts", "crdr": "debit", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shipping and handling costs", "documentation": "Cost incurred during the period in shipping and handling goods and services to customers." } } }, "auth_ref": [] }, "VISL_ShippingAndHandlingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "ShippingAndHandlingCostsPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Shipping and Handling Costs", "documentation": "Shipping And Handling Costs [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtLineItems", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Investments held to maturity", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r186", "r187", "r989" ] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfRightOfUseOperatingLeaseDataDetails" ], "lang": { "en-us": { "role": { "label": "Short-term lease cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r622", "r925" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r155", "r253" ] }, "VISL_SingleCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "SingleCustomerMember", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Single Customer [Member]", "documentation": "Single Customer [Member]" } } }, "auth_ref": [] }, "VISL_SingleVendorMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "SingleVendorMember", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Single Vendor [Member]", "documentation": "Single Vendor [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r954" ] }, "srt_SouthAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SouthAmericaMember", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "South America [Member]" } } }, "auth_ref": [ "r1091", "r1093", "r1095", "r1097" ] }, "VISL_SpecificBoardMembersMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "SpecificBoardMembersMember", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Specific Board Members [Member]", "documentation": "Specific Board Members [Member]" } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "State and Local Jurisdiction [Member]", "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r216", "r227", "r228", "r229", "r256", "r276", "r277", "r280", "r282", "r288", "r289", "r354", "r407", "r409", "r410", "r411", "r414", "r415", "r445", "r446", "r449", "r452", "r459", "r597", "r706", "r707", "r708", "r709", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r725", "r746", "r769", "r789", "r868", "r869", "r870", "r871", "r872", "r966", "r999", "r1006" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r18", "r40", "r217", "r241", "r242", "r243", "r259", "r260", "r261", "r263", "r269", "r271", "r287", "r355", "r356", "r460", "r530", "r531", "r532", "r561", "r562", "r578", "r579", "r580", "r581", "r582", "r583", "r586", "r604", "r605", "r606", "r607", "r608", "r610", "r629", "r697", "r698", "r699", "r713", "r789" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r310", "r311", "r728", "r730", "r732", "r803", "r818", "r839", "r864", "r874", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r890", "r911", "r930", "r1029", "r1084" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails", "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r259", "r260", "r261", "r287", "r666", "r704", "r725", "r737", "r739", "r740", "r741", "r742", "r743", "r746", "r749", "r750", "r751", "r752", "r753", "r756", "r757", "r758", "r759", "r761", "r762", "r763", "r764", "r765", "r767", "r771", "r772", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r789", "r931" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails", "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r259", "r260", "r261", "r287", "r666", "r704", "r725", "r737", "r739", "r740", "r741", "r742", "r743", "r746", "r749", "r750", "r751", "r752", "r753", "r756", "r757", "r758", "r759", "r761", "r762", "r763", "r764", "r765", "r767", "r771", "r772", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r789", "r931" ] }, "VISL_StockIssuanceCommitments": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "StockIssuanceCommitments", "crdr": "debit", "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stock issuance commitments", "documentation": "Stock issuance commitments." } } }, "auth_ref": [] }, "VISL_StockIssuedDuringPeriodSharesCompensationAwardsForServicesPreviouslyAccrued": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "StockIssuedDuringPeriodSharesCompensationAwardsForServicesPreviouslyAccrued", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Compensation awards for services previously accrued, shares", "documentation": "Stock issued during period shares compensation awards for services previously accrued." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Shares of common stock issued", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r18", "r39", "r81", "r168", "r433" ] }, "VISL_StockIssuedDuringPeriodSharesEliminationOfSeriesAPreferredStock": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "StockIssuedDuringPeriodSharesEliminationOfSeriesAPreferredStock", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Elimination of Series A Preferred Stock, shares", "documentation": "Stock issued during period shares elimination of series A preferred stock." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued during period for services, shares", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares", "verboseLabel": "Issuance of common stock share", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r18", "r130", "r131", "r168", "r706", "r789", "r869" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of options, Stock units exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r18", "r130", "r131", "r168", "r506" ] }, "VISL_StockIssuedDuringPeriodValueCompensationAwardsForServicesPreviouslyAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "StockIssuedDuringPeriodValueCompensationAwardsForServicesPreviouslyAccrued", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Compensation awards for services previously accrued", "documentation": "Stock issued during period value compensation awards for services previously accrued." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock accumulated value", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r18", "r40", "r168" ] }, "VISL_StockIssuedDuringPeriodValueEliminationOfSeriesAPreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "StockIssuedDuringPeriodValueEliminationOfSeriesAPreferredStock", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Elimination of Series A Preferred Stock", "documentation": "Stock issued during period value elimination of series A preferred stock." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued during period for services, value+", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders", "verboseLabel": "Issuance of common stock share value", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r18", "r130", "r131", "r168", "r713", "r789", "r869", "r938" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r131", "r134", "r135", "r157", "r748", "r766", "r790", "r791", "r926", "r939", "r1001", "r1018", "r1063", "r1089" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://vislink.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r165", "r255", "r444", "r446", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r460", "r585", "r792", "r793", "r873" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r611", "r631" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r611", "r631" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r611", "r631" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r611", "r631" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r611", "r631" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://vislink.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r630", "r632" ] }, "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SummaryOfIncomeTaxContingenciesTextBlock", "presentation": [ "http://vislink.com/role/RebatesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF TAX REBATES", "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months." } } }, "auth_ref": [ "r16", "r174", "r175" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash payments:" } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r57" ] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Series A Preferred stock, $0.00001 par value per share: -0- and 47,419 shares authorized on December 31, 2023, and 2022, respectively; -0- and 47,419 shares issued and outstanding on December 31, 2023, and 2022, respectively at a redemption value equal to $0.10 in cash for each ten thousand (10,000) whole shares.", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r407", "r409", "r410", "r411", "r414", "r415", "r537", "r681" ] }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityParOrStatedValuePerShare", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary equity, par value", "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable." } } }, "auth_ref": [ "r25", "r76" ] }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityRedemptionPricePerShare", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary equity, redemption value per share", "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r25", "r76" ] }, "VISL_TemporaryEquityRedemptionShares": { "xbrltype": "sharesItemType", "nsuri": "http://vislink.com/20231231", "localname": "TemporaryEquityRedemptionShares", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary equity, redemption shares", "documentation": "Temporary equity, redemption shares." } } }, "auth_ref": [] }, "us-gaap_TemporaryEquitySharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesAuthorized", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary equity, shares authorized", "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r129" ] }, "us-gaap_TemporaryEquitySharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesIssued", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary equity, shares issued", "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r129" ] }, "us-gaap_TemporaryEquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesOutstanding", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary equity, shares outstanding", "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r129" ] }, "VISL_TimeBasedRestrictedStockAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "TimeBasedRestrictedStockAwardsMember", "presentation": [ "http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails", "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Time Based Restricted Stock Awards [Member]", "documentation": "Time Based Restricted Stock Awards [Member]" } } }, "auth_ref": [] }, "VISL_TimeVestedOptionInducementAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "TimeVestedOptionInducementAwardsMember", "presentation": [ "http://vislink.com/role/ScheduleOfStockBasedCompensationExpenseDetails", "http://vislink.com/role/ScheduleOfVariousEquityStockOptionPlanDetails" ], "lang": { "en-us": { "role": { "label": "Time Vested Option Inducement Awards [Member]", "documentation": "Time Vested Option Inducement Awards [Member]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r1008", "r1070" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "auth_ref": [] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable and Allowance for Doubtful Accounts", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r192", "r193", "r194", "r316", "r317", "r322" ] }, "VISL_TradeNamesAndTechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "TradeNamesAndTechnologyMember", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Trade Names and Technology [Member]", "documentation": "Trade Names and Technology [Member]" } } }, "auth_ref": [] }, "us-gaap_TradingActivitiesGainLossByTypeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradingActivitiesGainLossByTypeTable", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table]", "documentation": "Schedule of gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance by statement location, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit)." } } }, "auth_ref": [ "r112", "r113" ] }, "us-gaap_TradingActivityByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradingActivityByTypeAxis", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trading Activity [Axis]", "documentation": "Information by type of trading activity." } } }, "auth_ref": [ "r111" ] }, "us-gaap_TradingActivityByTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradingActivityByTypeDomain", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit)." } } }, "auth_ref": [ "r111" ] }, "us-gaap_TradingActivityGainsAndLossesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradingActivityGainsAndLossesLineItems", "presentation": [ "http://vislink.com/role/ForeignCurrencyAndOtherComprehensiveGainsLossesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trading Activity, Gains and Losses, Net [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://vislink.com/role/ScheduleOfInvestmentsHeldToMaturityDetails" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r441", "r457", "r584", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r690", "r976", "r977", "r978", "r979", "r980", "r981", "r982", "r1014", "r1015", "r1016", "r1017" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://vislink.com/role/StatementOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r85" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Treasury stock, shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r85" ] }, "VISL_TreasuryStockPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vislink.com/20231231", "localname": "TreasuryStockPolicyTextBlock", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Treasury Stock", "documentation": "Treasury Stock [Policy Text Block]" } } }, "auth_ref": [] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://vislink.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://vislink.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost \u2013 133 shares as of December 31, 2023, and 2022, respectively", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r38", "r85", "r86" ] }, "VISL_TrivexSingaporeMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "TrivexSingaporeMember", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Trivex Singapore [Member]", "documentation": "Trivex Singapore [Member]" } } }, "auth_ref": [] }, "VISL_TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember", "presentation": [ "http://vislink.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2023 Omnibus Equity Incentive Plan [Member]", "documentation": "2023 Omnibus Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r573" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "auth_ref": [] }, "VISL_UnrealizedGainOnInvestmentsInDebtSecuritiesHeldToMaturity": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "UnrealizedGainOnInvestmentsInDebtSecuritiesHeldToMaturity", "crdr": "credit", "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Unrealized gain on investments in debt securities held to maturity", "documentation": "Unrealized gain on investments in debt securities held to maturity." } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://vislink.com/role/ScheduleOfTaxRebatesDetails" ], "lang": { "en-us": { "role": { "label": "Total tax rebates", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return." } } }, "auth_ref": [ "r550" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r60", "r61", "r62", "r203", "r204", "r207", "r208" ] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in the valuation allowance", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r553" ] }, "VISL_VariousEquityCompensationPlansMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "VariousEquityCompensationPlansMember", "presentation": [ "http://vislink.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Various Equity Compensation Plans [Member]", "documentation": "Various Equity Compensation Plans [Member]" } } }, "auth_ref": [] }, "VISL_VislinkPowayLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "VislinkPowayLLCMember", "presentation": [ "http://vislink.com/role/AssetAcquisitionDetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "lang": { "en-us": { "role": { "label": "Vislink Poway LLC [Member]", "documentation": "Vislink Poway LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-dilutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r928", "r929", "r932", "r933", "r934", "r935" ] }, "VISL_WarrantiesMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "WarrantiesMember", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Warranties [Member]", "documentation": "Warranties [Member]" } } }, "auth_ref": [] }, "VISL_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vislink.com/20231231", "localname": "WarrantsMember", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [Member]", "documentation": "Warrants [Member]." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r275", "r282" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Basic", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r273", "r282" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding:" } } }, "auth_ref": [] }, "us-gaap_WorkersCompensationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WorkersCompensationLiabilityCurrent", "crdr": "credit", "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Compensation", "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r33" ] }, "VISL_WorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://vislink.com/20231231", "localname": "WorkingCapital", "crdr": "credit", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working capital", "documentation": "Working capital." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://vislink.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r963" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(3)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2C", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(19)", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(27)", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-11" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "70", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)-(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4F" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4F", "Subparagraph": "(a),(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4F" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "184", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-184" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-15" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-9" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.M.Q4)", "SubTopic": "20", "Topic": "326", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483530/326-20-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//310-10/tableOfContent" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-42" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "44", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-44" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//310-20/tableOfContent" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479391/326-20-30-4A" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479391/326-20-30-5A" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479366/326-20-35-8A" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-5" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-17" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-21" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3C" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3D" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479175/326-30-30-1B" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "13A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479148/326-30-35-13A" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479148/326-30-35-7A" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3A" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3C" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-3D" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//460/tableOfContent" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.E.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-9" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r889": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r890": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r891": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r892": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r893": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r894": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r895": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r896": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r897": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r898": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r899": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r900": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r901": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r902": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r903": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r904": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r905": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r906": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r907": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r908": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r909": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r910": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r911": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r912": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r913": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r914": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r915": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r916": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r917": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r918": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r919": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r920": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r921": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r922": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r923": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r924": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r925": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r926": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r927": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r928": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r929": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r930": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r931": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r932": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r933": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r934": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r935": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r936": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "39", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-39" }, "r937": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r938": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r939": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r940": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-13" }, "r941": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-14" }, "r942": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-15" }, "r943": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-16" }, "r944": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r945": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r946": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r947": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r948": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r949": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r950": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r951": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r952": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r953": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r954": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r955": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r956": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r957": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r958": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r959": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r960": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r961": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r962": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r963": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r964": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r965": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r966": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r967": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-3" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479455/805-10-15-3" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "SubTopic": "740", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480887/718-740-35-2" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//321/tableOfContent" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "325", "Publisher": "FASB", "URI": "https://asc.fasb.org//325/tableOfContent" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 135 0001493152-24-013015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-013015-xbrl.zip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form10-k_007.jpg begin 644 form10-k_007.jpg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end GRAPHIC 17 form10-k_008.jpg begin 644 form10-k_008.jpg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form10-k_009.jpg begin 644 form10-k_009.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" $* 38# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBH@F1G M.!_GKTIN$7)^]GKU'^[LMO-CMIIK+HMD_GKTUV)Z*8#\ MN5&/;Z=3_P#7]?>L+7M?T3P]8OJGB'5M.T33H 1)J&IWMKI]K'N*@1M<74B; M6D.-HC.XE<\$+5PO5Y?9)S7:_VYJ[JQ&QA:S8TNV*!6+?;SB7>/*!\J7' MO8#AK.LPE&-#!32G>TZEX0T3;UDD]EV5W9*YP8C-OGCQK^U!\*_"LL5O:ZW/XTN2(DELO!L,6K3I]I8B.\;4(KZTTYK2(12& MY:Q^V/%E#(L6Y!+^;GBKQ=XI\47BW'BOQ#K&NS1[RO\ :6H":VM#/L,HT_2; M?_B6:2LWE1B<6'_'UY, G'^C0UP\J;2&4YC;.S\.OYY%?^K-WUM9_H#_ ,-G6_VB1;7X?I<6BW3Q!U\8"&\FA0J6O!9? M\(MM:;:?WT7]H'8P4&0[LUV]I^UO\-;FZMK>32?&EK'<1L9M0>QTV:QLW4(9 M5##Q!_:UR 6QG3-+F*AMH5PQ&\*((=>M-.N;MU.?."&X$):,EE\]#)ZCI MU[97\/VBPU"WU*V<*4N;6>VN(&!!/R2VI*,#WR3[=Z_&]/+,JB3[I _+)S4. MJ6NGJL,[^1"JA M8]2==;WJV[#_ /$V'^CB+^+[/D2[E,O^JCKBJ>&V>)OV,Z%:.MG=P;MW7-)+ MY-GH4N*,%4LYQ]G'K+VBDEV^PKW>A^O5%?EWI/[5GQ(?!^A:U<.5$::!< MZSH+1HI?=:4%V.%-UOD-OY&)X(XDPS?-@8SA'>4*J;?1 M6C;76W5;WZ'3'B/+)-+VR5_,_1>BOA^T_;?^&B_9X==\*^/=(N,$3M';:3JM ME 3][?=V?B/[7=IG)4G3@Z@,!%EC7=V/[7_[.^H2QI_PG\6G3/MWQ:GHOBC2 MTC+<;9+B]T>TLV*8^=H[BXCC&"SKN&_QJN19[0;=7*L3&FFTZD85)VTTTC"2 M:;LKW2UW;LGWT8W4#/SM6= 7*L$!\M\>D1A1D J2 O4C=CG& M2#@YYQG&.?>O-JPJT':KA\3!N]E*C..S2=N91;M?6R>OJCK52$FN2I1G'?FA M5C)^6B;W]=BS14/'IGZ'IC\#Q[G\Z H.3@_@1SU]AZ>]8>W@Y*"4U4EM&=.< M$[)M^\XV5DGUU>B->ETTUY-/\FR:BH26 X!4?0_SZTW/7(S[G_ZQ_G6MTE>4 MH1]9K]; U:+ENNR5V^FB7KKY:EBBH@QQ@8'^?_ MO:W_ ?T+TMN[]K?K&-1LIXT?R+J8,7'Y2_P#!Q;^TKKGP9^!7P=\(^%)[WPUXQU;X MGV7C#POK2OAXQ257FG%1O4^*/*[2=HNZO'1NZ^)XGSS%977IT MZ3C\2M>^MC^R[6?VL?BEXJGO+?3K[3?"&ER-=16 M5IXU2:**"74M2U6^UN:1;8N4C&I70\A_+\X@VMIQ:959.'C%?@Y\+_ M /@JQ\(-9,5MKVKZIX-G?RRL/BG2[_[,SC?YHDO[7,&(B4W/=\8D4Q?\M:_0 M#X>_M8_#CQY!%=:!XN\/:R)3& ^B:M8:C.NX/M\FWM,3V)?:VX77,Q0>5S#) M7ZW@N$\DPM*U# 0C+2TVDY=+ZN+D[I+3FMW1\+4SO-\14O/$SC3?-S0]YWT; M6MUUMT/MY9G+*&?8"3L_VN!G\OE_/(%(R;2[>9OW#\L9_F"/RXKQZT^).C7+ M*$NBDAV[OMG_ !\2Y^[O]0N&QZ;CQQ75#Q)'/&CQM&@P3NCYWYQC)R.F,C_> M/X^U3R^$:3H4X*G&5M81M)*+3T:2:VMOLSSJN,;J*512E*[][G:75;-==M^I MT%WYFUMF,9;=^8Q_7VSCVK"GV"+*_>'W^G7/']:KS:K]H ^??LSVZ;L>YZ[> MG?WK,DO.OZ__ %C_ $_#VKHI9=0A9\M3G334Y5)2BK;W@TD[JZW5KWZ',ZU) MR4^5\RO9\R>^C_,N)>8*#T)_SWQ@?3GGUK?MM2\HH?[W].Y/<<^OIS7%I+Y[ MD>A&?QST_+@=JWM.M,N">^W^OKW!Z\=.U==>A&<4]N1=KWTMY6_$N.)2DN5: MWTU773H=,VM[9% ^\V<>O&,_ASZ?_7IW*Q;D)]W/'W^O_H(QCGKBM!+# M>&'IM.<>N?\ #&<]^,\UJPZ;'Y+;_08Z<=*JQ]S1C+ MD;M&5K25[6:3>CNM--SMC>M%J3LG9M:O:S[G(6D,A(W]W3;[N?\^N*[Q+,36<5Q^.?P,_X)I? ]#IL3:!X*\1>&/BI^T+>VDK7YOO!7_"Y_B*^F M_#G1+V_7[+J>E:;X \!^,?$<<[7D>A:M)/ CW?T&#I.K!<[I7>ZE1C./S3<5 M\^CU.'%45.\;U*:EJK3DI:-MMW%AY=Y+9>'["6ZCN==U!,0 Z;I]CJUY(]S;I%8 MRF4*_>_"CXGMKN@:9XX^'?B7QSX;T/5466TDNK+Q?\)_$EQIMB#;F[N='\0Z M%\-M>T_1KQ(?-L=3N_#IL]6BCG?3KZZ2"=Q^1/PMT_P[=:S-XH_8%_9 \7?% MOQWJ=N([O_@H%^W#K?C30=/N87\#E8_$_AWQ/\8[AOVBO&]IJH:\\.7^C?#3 MPKX'T'_2M,CTJ[O+6^BDL.+^-[?!JQ\5VWA?]NS]J/XB_MD?&*_O[Z70_P!B M+]FKP_J]MX"@U^%K/4]/\/1?L_?"^]74?$-[X;2U>PTW5/CE\58KN_T]M:N+ MC1)-FII7MQRO+*M&2K8+!U9-*\W0II+76]XN]]DHIWUU//OC,/52PV8XFE*+ M]U3YZKDG=:4XU6HI13YG5JQY.:-TWO\ TE?#G]I#XBZM#_;'@KX^:SXOTN&[ MNK&2[L_$]]XQL;6[LRBS:3-->?\ "0P)/8EMLX?[()2X#?:/)'D^[:?^UA\? M;-XY'\7V.K1@X,6H^'O#:J A'#&RTW3+I]^X[B]Q$_R_*02Q'\X_AO3_ -LW MQ9X'2Q\.:3\%?^"4'[*/A+2KW5':*R\!>-_C)9^%E:UN[Z:'1]-%E\#/@[X; MU6SU*_:\O=7&K>*/"^O>6UU_:$/]HL,_X5_M<>#/!9\2?"[]@7PU^T__ ,%' MOBGJ6H+9>,?BI\1OBUXKU[X,>'_$6G23&YF\:?'_ ,>7NA_"#PQ>#PUJMQ#) MH?[/_@*#POXAT>+3[>SU2]U#3(9#\WC>$N%\1*V(RC#2B[W5&G3H5.ZY)0I< MRU=W[FJNG9RN?083-,ZC"2_M"51Q:NVK))O1SJ>U=*+LME.5W?EYDC^G _MO M_&Z*>#RM(^&=U'&RK=PR>'/%$=W<1_+DP7MEXYO[:W? 8NT]@B,60Q1,$D5? M4]/_ &\[EI[:'5OA1Y=JRQBZU&T\8^=MDP/,>WT]O#!"+DDK'=ZA'QA1+)B1 ME_FKT?XJ?&#]FH/\>O\ @I'^VK\%OAUX>O+/4(M*^!'PO\&:9:^!FG2QG\J8 M>)_'&D>)/V@OC!J<.@7-GK2Z5\,K'PJ\ER!=Q3:SIK2-INK\.OVV_P!H_P#: M6U^QN/VMU!8F3> MKZVBW;KK9>G3TJ?$F=45S1Q$9J.G/)7I-I:I.:BIRMHE&[)K-5+Y.UKB\TFUM!L((9DGF49&YD!4O_ #2?M"_\ M%$_V7/V7]4C\(?$#QQ_;/Q>U2: ^'O@A\.=$OOB/\9->\074=C%8:=!X2\(' M4KBVU+6VN)8?#T&LZUHNA:J4N?LATPV=\&^@?A+\4&^*7@.Q\>ZQ\*OBI\$A MJPNS9>"_B]!H%A\2-*L81&]I>Z]H6@>+/&T&@)(7NII]*UC7FO\ 08FC\[3M M.DN)HW^:K^%&52;^I8FOAVFVH2BJZ2?1\SA:RO;K9*]]W[-'C',8TE/$X>E6 M@[+2]%SV2:E:3:3:;:BXZ/-M\J"/Q3H9 MN 23@?91,)XV;^[*NXD$#D$UZ%:36]Q'YUM+'/#(%9)H6ADAD'.&CDAX=3ZD MGV[U_+)X4_:X_9E\>_$M_@OX%^/'PG\7_%*&&^%QX)\+^.M%\0:UG22@UM;U MM*'G07=H9K8?9+XEHW,R01CRUD\5:W=VS!NBBT(\@J,#*SC!R O&['K%E^TM\:8! S^,!/!&/EANM!T M$"8<9$L_]E7][/@ ?-]IL&7).Z8OF#Y[$>'_ !!0;<:5&I!/6:J>]EXD%L M\:<[C':ZAI=SY^1SL2XM2N!O=MX*>36X4SVA=RP<91COR58REO96BE=]+ZZ+ M5['HT\TP'9G@-+!:%@I*B7YQ%ZUH_QH^%NMI"]GXQT9WFVF.&YN5AN,MV\M\;6X MP0.A XKRJV6YEATYUL%6A37Q2492:N[+11>[LKMI:IINZ3VAC<+.2C&M%MWM MK'HK]^QZU16&^MZ,+47C:EIR6C %;B6\A6 @^K,ZKVXYJ_:7-I=Q)<6TT4\$ MB*8YH)5E@<<\QLC,N.Q.<'CDX-D9IOHDU? MSZOIJ7:*B.!T)_!@/TQS2K@YZ\=,GGOTZ8K&4W%V<)?)-K[[#4D]FG\]?N)* M*C&S\?\ :_SBBCVM/^9_=_P1^_\ R+[W_P#(GY$?\%KOV.-'_:]_8E\>2P6% MW/\ $OX$Z9XA^-'POGTF)I=:O]4\':#=ZUKO@JP"QN6;QGHFERVUDA:-?^$G MTWPS,6Q"5/\ GD6UBDL(>/88E!5'AA\J"50[L)8>S;U99)^NV[:X]:_UIFVX M 9BH=V0 '&\LLF%)]" 3]0*_RV?VG/AI!^S[^U)^T3\$;2UEL=%^&?QE\>>$ M?#]M)_#X2T[7[UO!\B]?];X[ZKKI\1Q;AU5IX2NXVYW*#=K\O*FT[];VM;2U_D?.EUILBQO*A^YUZ M]^G?/.">@K)M)M1L;F*^L;NXL;R-BT%S;27L4\3*0=R26GW6SM.9.X^7@-7< MW!W.I'^KD#!![C!/X<@?YXQ+JSR7/K_GIWY^OZBOW:E./L_@[=>[7EYGY_4C M&%TEKKKIV?EY=SO/#_[6?[4/PZF23P[\7_%%U9@QYTCQ*R^)]%V6V[RHUTW5 MM*OYXD(E0-&46/^P4MRDF[[:+A?L?YY7MAO!]L_CG&. M#[#V-<[>:.DL.'3S-N['MG&3COG ]?NUUTX0:YK6MTTZVZV\SR,1%R=D[-O> MU^K?=?F?T5_"O_@L;\#?$,<<7BK5-8\'74DW[U?&GAJRALX7Y#A/$GA_5;_[ M(JG;YLFL6UAYH,9M%F\N[$'Z+?#/]K[X0?$JTCU#P[K^B>([294#77AC7[#Q M&V'#^67M+7]\Q;:^U;KYAM?R\D25_$Y_8\<8,:1Q)YN<^9W"]-O&>-QSSW%2 M::+W2+^.ZTZ\N-/O+;=Y-_I5Y>:??6S/C!AOK08MRVWI)G=M&SE6SIR1EHE9 MOKH[=>R_,Y71FEI4OY7W]G7T>X MC ET[CRR<':,\X.. :]JTA8Y%W0M')'B,I)$ORN"'Y$G_+4#'X9/]X8_A$\' M?M>?M'_#Q(K?3?BAJ>MV-N,)I7C"W7Q/ Z&KF(AHVFO? ^NZ[X=SMW;Y)_#UQ_Q3UU]\&)-0^6+] M\(!^^EJ*E!\DK2N^BMY^IC&I.G5CS+F2;OJULGWN?V2)#E%YQQ_GL?\ /M4R M)L)YSD?R(]AZU^!'PG_X+,^!=4-I9:]XKM+.27RQ)!X\\(G2(D9=VY)?%&A? M\2M3\RAI9O\ 9*\>97Z0^ /V]/@YXXMK2=MDMO=+EM3\'ZO8>,]-.T??B@TW M.MP*,D[8N9.=_P#J0:\R6"J*7/KI?3E[IK>_2_;_ ('ITLRC3^*G:/67/MLE MIR]_,^R9W19=CQ>9O((;^YMSG_OK.5;_ (1CQGX?N;\0//%I^H:I9Z1J*-'+#M$]A>?\5/:S M\D0I'_K"LF_[BU7T;]GKX(:/\3+_ .,=I\&?A;;?%N]9DN/BB? .CCXA3PS1 M1Y@F\<_V9-X@BM7 81-/K&C+(-^W[8%<6O-4P=GSU5S0B[RA:U[WY=7=:2:> MSV2=KGHTL?A*MDZJC)]-'Y]T?+$G[5G[4GQO>Z7]DS]EC5O"OA2XFN7@^/\ M^V)/XF^"_@A=.>]T.>WU'P_\$--U[5?V@?'UIJD>K3W,1\6Q?!RRF2ULO[3O M-(M[\,/B+XYQ?LY:;XO'@;]NK]J;XR_\%"?C0;VZN=._8I_9W\+WMO\ #^2[ M\/:M8^)-,L++]EK]G?6KC1]3ETJ_CT^+3+[]IKXI>-="O].;7+B2[MS!KRW' MZ0_'3]DBZ_:!\63-\0OVC?VB++X5731";X$_#;Q5H/PU\'^()&T[5-/U*PUO MQQX T'3?B_XKTZ^TR_O%N?"%I\3-/M-2C$T^H6FI+9Q+;>->*?A-\7_V=K&R M^$/_ 3C_9@_9A^%GAK4M'TRX\1?%GQ_KUSH?AVQNK233;"W@O? GPYT77OB MS\4?$2:?<WC'QAKOA6R>X9;2^O/$"R7#Z3,(X>G)25%+E5HVE[UVK)MM._ M73EU[W7O=*J/64%&5-IWGS)-)IJVJ>]UU2?Y>0V6G_ML^+_A]%I7@3P7\"?^ M"3_[+?AFPU*ZMHYM(\#?$SXTZ7X8TVZFO5O=.\$:(;3]FWX+:-<>&HKB2]77 MS\0K71=1>>1?[#NK2X_M?X6\/:[^QKH7Q#FU#]E/X._&[_@K-^UWISQ:/=_M M#^,O$,OQ*\(>%_$=H\VJZ.UU^T9\5M*L/A!\*](M-/UNX.DS_!/PS?V.AQV% M[I=O+ USISR^]_M!_!/]G3X30>&OB1_P5._:A^)?[67CSQ-J"W/@CX&QZ3JN M@?"V7Q/H=U=/:Z?\+/V4O@V]S'XA:T_M:W\-7/B;XAZA=:?KW_"2Z3;^(!"T M[!];1O&O_!03]H?0--\(?LQ_L^>"/^";_P"SQ96D=GX?\9_'?PEH-U\7[7PU M>-*ED_PX_9ITRYL/!/PMD\.K97>GS>%OB)J<'AR7^W-*U#1+6]U,7(@[83A* M/-!M37PT^775I-*]EHM4W&VVRM;*:JS;<8KE;O*\FE+XFW.44ZDK\TN9*?#US\2/\ @H]^VSX-_9C^#LCC'P!_9DU^X^'FDRQ"*4QZ M5XK^,OBG[-\0_B!>W.D#7;7Q'\./A[H]C>^)I'35/#IG6+,'E?P1^(%W'H,? M@7_@DE^Q#H'A3P+JQMDU7]J7X_:?KWPQ^%FKV5H=3&G:\+O4"/CG\9'EMKN[ MLM,U;5V+:/-K4UE?PF'5X:;XQ\,_\$Z_V4_B)/J_Q/UOXJ_\%(OVU;6%)WT& M_DU/]HKXFZ!J":EI;26EG\.-*@T_X>_"K2-$OY;&YLK#Q#IL7C+1X[\_V+>7 M]C:EH?5KOPY_P4N_:]1Y?&OB71O^"=WP,U"2Y6\\%^ ;VV\6_M.^)-)>9Y[H M7WBV )H'PNFO-!LFN-,O-%:Z\::/K,-G8ZKH>K6$[_9?2ISFZ=E=U':T='+= M-^\U:*LG>ROVZV\Z5*HZGO*,::=VY-PIW2E:U*'OU9)RO%RD]KRM=7\/^-/P MX_9<^#.H^&O'?_!5?]KG6/VJ/BG!/;:QX3_9SB@O-+^&%OKSVNI+X?7PC^RS M\.]OBG5+;=,_@@^-_B$(_#'B33YIH->&Q@![[8^(O^"BWQ^TO3/ W[-OP4\! M_P#!-#]F^QTG2;?0OB)\4-$\'^+?C59>%'MAJ-A'\./@#X!7_A7?PMO='AL[ MVPU[PMX\73VL;;7+W4/#&O:3JSZLMQ\OZ)\7/^"=/["?BV[\)?LO_##Q/^VI M^V7KG]N7-]K'@. _&+XP^*?$%]930Z[K'B3XL1V^I:;\.[B_U,3V_C2#X9Z7 M=2:)JVF7UX?"E@+[6'G^JO!OP6_;S_:PU:?Q7^W'XXT']F?]G1K+4K__ (9< M^!?C"^T?Q;XCL7O;Z1+7XS_&_2M<@U.VTNQMT@74])\'>(X/#WBIKW4Q?^%_ M#%[I4L%_Q8B.)IQE65-U'&UZ<9--\TE%\U5QD[KFO9*^EM-STJ"4I1@YT*:: MDXU<9)4:-U%SM1P\5RKGY'"DYIJI4<(N3>'M)U>;4 M?BAX>\)Z@VZ_\36D.FV*>_V_PZ_X*:?MIR?VK\:?B!I7_!.3]G]W-U?_ R^ M$&J6WB3]I#Q#I,MUINI-!XD^)UC'I^D_# W5M=/'YWA6]\.>+M)N;K7+#Q!\ M,9;"Z2YG\_F_;$_8$_8[\5WOP9_X)V_LUZ9^T-^T)KI6QU3P_P#LS^&]-OD_ MM"T>2&VM_'WQL/AS5);K3;":_OBUIJ$GCNPL2=8;7XM%:YL]0>6\_8N_;@_; M@5O$?_!17X\Q?!'X+R%]5E_9$_9NU:RT:SGTN';/'I'Q-^(MMJ7B :LT<,<< M]YI,-OXRT1Q!J=[H^L>#FLKPQNDJE2#E4HN"2NX*5UKMS2<5>[LG;[A*<7>I M.&(PL*?NNIF%!1Q%>R2B\MP<)36(IJ5FJC5-0@Y5?L,X[PQ^T)_P3Y_8.UF? MX*_L"_ S4/VM/VJM;L)H-1'PIL]-^)7C/6+^[CTV+69_B[\?]5L?$=KH^GQW MV_QG^-!U'Q#!JUU9:/YT7B70-/A\9:) M'9S17NFZOX.\F:*WXJ\_;Q_8<_8EAC_9@_X)R? RW_:.^,VH Z0W@W]GG2)M M0T;5M0TX1PSZS\0_C1I>F:[XE\;,;;4K^"^U+1KKQ]:P)I]_9ZIXYT6.*S-E M&_"5L(&36H[?X@> M.(]9UH7*6D^BSPZBA/C+Q%'=W/\ H/Q'\/3236QS51N%1JG[.4':*BURN[MJ M^6.Z=VM>[3OKT0F_B:<*,HIRQ%9NKC&HI G@MO$,?[(?[.7B#4?"/PLTNR0:+XBN=-^)'C'3'\27?CC3[.>T MO]/\0#1+OQT3?+R?$URN_+:RZ:TJDZBJ-*_P#@J%^SU\%+7PY^R)_P3=^#E]^UE\4-&T_3]"\# M_#[X-6MS??!SPM 9-!A.L^(_B3#?ZT?%-O;Z[K%GKUWXNTS3];\(W?V:>#Q# MX\\&>*+'7K^]^G?V//AU_P %--9\4I\9/VU/VI/"WANPU"==9M?V5_@9X ^% M5[X9T"POM*M+]O#_ (D^,.N>#?%7CK5/['OKJZL=2TWPOXP\2I;MI[_V-\4] M;5[ZST+YW^)'[7O_ 3;_P""1G@B]^%/PI\-^&+'Q_;7!N$^#'PI/]K^.+_Q M##;P0:?<_&#Q7J7B37KS29+&PU.R;[/XX\27_CO4;ZPD_L]+BPLK?1;?Y;M? MA-_P5'_X*L2BX^//B#5/V"/V-+_:L?PE\/QZE!\7_'7AZ>UOXM3M->L+^31_ M$^L/K/AC4-2T+4V^(UW:>&FM+G2;CPI\#_$$8UBX/B8NE#G:YZJOO0C.37E> M=U;E>MVM;;:Z>K!RG3=*+IQPS5I8B<(QJ2L[KD2TO)J/NT]8IOW[Z/\ 0;]J MG_@M%^SS\#_%8^#GP&\/^)/VQOVD[_5+[3=,^%?P(-UX@TRRUJTMVFETC5/B M!I/_ F;075I*C"/3_!L/B[Q7X=U.T=/%^E:#:7%K<'[]_93^)'[57Q)\$7W MB/\ :I^ W@3]GGQ%/>[?#W@+PK\46^)VO6EI%>:I:WZ>+;BTT:V\.Z,\*6NE M_P!B6GASQ+XKLY;&:5;N?2M1M;JP'FO['W[#/[,O[%7A6#P[\"OAQ8>'[ZXL M[:/Q+\0M4AE\3_%CQ3+!I\&G27>L>+=0M[+5Y=*D2!]2TWPZ-+\-^'/#7]L7 MP\.>%-%&I:D]_P#:D3)'M1%("HBQE6_W-4:%*-J<93M;WI2:?>1M;T M?[PZ=.G?KU)]!69JNAV7B"TDTZ[CE>WF1XY/+O+NTQOVD9^Q_P"LSL./-^Y@ M[/O-5A7WO%[;OUV_X?A5Z+B3=Z ?S/3\,USU:49IMRIM_P#/N5)23U6Z;ULM M5IND=%*=16J0BU);:]U9ZV[-]!+'1;'3K6&VM4D2WM+:"VB\R\O;L'R0X.W[ M8<1X##/E?>R-_P!U:KW.DV8Q9TBS< M>_6)V9D9EA#2L1&TXA1,!IQ#GR'FC+ 1&?A"[8ZM7PA^U=^WG\+/V<]9T_X6 MZ?IVO?&K]I7Q5!+=>!?V9OAA_9OB;XE>('E^RK8W_BJ+20VG_#OPW?/=QR7G MB/Q6#90Z+;:Z\ +VL]94LOEB9JC]6PTH2YF[PA034(N;2J6E:34?=5KSE:"^ M*Y5?%XN%*;C.TURO66RYH\SNVEI%MN]E9:M*[7V=KWQ?UOX?Z)=:W>?%3Q!X M-\,>'8WUC5[^]\::YH&@:+I&E(]]J6I:WJ(GL+'3M(T[3;>[O;NXO=3@T)5M MA'JMGJ DM4A^8OV;O^"SGQ&^-_QW@T+X9^'I/B3^RWX"'BF]^+'[4/Q)LK7X M>?#=3X;TF^M;;PS\"-6TFSL]2^)7B%_%=G<66M^,+C2XO 6C^$=*UNZGNM0; M6(I[7\@_B_X7USQ>;?XP?\%4/B3H-WI^DR_\)+X._8$^$>O7<7PC\%:I (]1 MT9/CKXELB=5^-'C[3KNRT?\ M#3-1)\(Z/K"^)4\/?NM8U55_-W]K']OSXS_ M !*^'UI+\'O 6L^"OV:M-UT?#CPMXOTGPW=Z'\+9-5TN+^WH/!'AWQ!;C_A" M-(UF?PW=3S6^BV!&KAM.Q/F0Q$?0Y?P=P]F]&=*M@8X6K)JE.IB(JE53GS14 ML/2?).ND]6XSBXPO*Z2:?SF,XCKQBXX#&2Q$X5*,:M5)PC0E*M3C*UI-5+ZP M2O&+;;:DDD?Z5G[.?QZ\#_M*?"G0_BQ\/9;N7PYJMWK.D*;R&-)5U/PSK-_H M&KI%<6Q;3]1LUU'3KA;74M+EFT^\0%X9%99(8ROC[_@CYX'@^'__ 3&_8QT M:#49M6_MKX*^&OB)=ZE<1ZE'<7NJ?%=KSXGZO/Y_M/Q==0RRRDP2^ M2LEIB!EHK^:<;@Z$<;C(4DHTZ6+Q-&":YO=HUZM%.]U>_L[[:72N[7?[-EWM M:V!PM6I4O.=&G*3Y=VXIM[GZ5W+,L2A.K.5'[P1#=@,F2>OF2B.' Y_>GU.? M\U?_ (*Y>/--\?\ _!37]K[7=&T@:1I4?C[PUHMAMDWC55\-?#3P1X9O]="] M(QK.MZ-JM^!R<3@9.W)_TKKDH/)5MF"Z F3 "R1F,@G ,AN/L\<:@[B\@*J MQ''^=_\ \%Z_V7/&OP _X*"Z[XYDT"\A^$/[0'A:R\9_#CQC&9+RT&N:1>WO M_"R/!.O[\BUUGPGJFO:+/9M')-')X+\1^#+=I6GLYD3Z;@'&1PV?X>6,G+K>W2]S M\A3=>6X;?L[]<9Q^../KWSWQ5G^U4==COYA X']W(P>O7.!TXR*XRYN'D1Y& M80QF0)&B7/G0$)D-)%&3^Y+DKO'\>$_NUGO<[)_O[\JO7MC/7ZY'Y=.E?TYA M8>U=>G?E]C"G-2M?GYI0TMI:RUW9^35]WY7NNU[K]3LY7AWK_2JO8\ZI2N^;FM9[6[WZW\QKIME FX#9V>G&-PSZIJ&ZN=J#CJP_(=>Y]?\ ]=7!3YE[O?OV]"(P46F] M5KIMNK#)45XVV=AST[].GT^OI7*RP[IM@_C)_0C_ !'M^ -=2;M"[*_\2ICZ MX.>WT//3G.*QGV&X+)WP3^8Q_7\:Z::DIIN%UKI=ZZ/^Z_R,:]%-.:TM;IYK MKPKKA&-2 M2@Z2BI7][>UE?;D6]K;G'*FK/F]Y=5M?Y^NI]/\ A+]M;X_>#C%:/XLM/%MI M"J$67BNP35\JN[B?71^^1GSP\/)*9/*K7V[\)O\ @K]XX\)264>JGQCX<$#( M)F\*:[>^(M"3:6RT7A[Q0?[+6,9)*6P^8,1)]R*OQQO7WD>P?]ZY5K;5?B<%3#._/"HX-;*S?_MR/ MZ^_A-_P68\'^)ELH=:U[P1XDE8(AM]8W?#OQ(IDXJ2Z_X3>Z7='>WEBVJ^'\XRY_MW23@3>4Y0X+%/[Q X_AXYYYZ;PI\6_B'X(F6;P M;X[\3>'U 4B/3-6OX45X=QVRP6O[FZ0&1@HNN(P7\O[\E5_8^#JOD4.2_5): M6UVV9A.69THMT<7*HE;]Q[-KG5TK<_M':WQ?"[VMH?Z/WA?Q[\//&D/VSPWX MP\,^(0A4++IFH6%VR^;NV"6"T_?V;.8VVBZYE*/Y?,4M<3\;?@YX1^-?@G6/ M 'C*;QA#X:UZ/[/K!\%>//$WPXU*[M6X:T?Q-X/U+1M?BLYU+)/96FKV:W:$ MI+YH4;/X3O!O_!0#XRZ!-9S:W_8GBJ2W8_\ $QGA70_$)"$;F;6=)_?^8PVD M-?Y*E,P\M/7Z*_!S_@M!K^A/9VNK^)?&^@P(JI);>(;=?'WAI0H(*J]]_P 3 MN")/QIX[UB[U[Q3K4.+V^8:GXAUR_N;(3W8T73KEKZ M_-O\,?%W_@G_ /'S]J'4+)/VJ_VP?&5M\+EDU"[\6? CX >&=/\ A3X+U%KN M[M+-M%UWQ3J^J:]XG\9:%:6+ZLGB*VUV^UZ/Q/>(++ MP*+F"]L;'1M3^*W[1.MZ-K4OB'6+JQ99M0BU,:WXLM+2$6'B.\\$V"^'+V]\ M=M_V$OVS?VU_L'BG_@HK^T%??#3X6R1P7S?LD_LZWZ>&_#%O;6UC9:S);>*? M%$FL:PFJW=M'H]LL][9_\)]K-H)+]M*\76GVB[M(?VNTK7?#]]:'4/#>H:1X MALY%5DU'1[ZPU&#!W%&:ZM<3ON^8J+KD;6$8.9*X7XE_##PG\=_ _B;X;?$G M39]9\"^++#^R?$6D0:OKFD/>:=-*DKPR3Z#B]>V::V@$P& %('\1-*>3XU0D MYS?(E\/LK+R5N9]?^&OJ=='BK NK%OV+J.[U[]M_]H;6?@/\ !>\TS[5KW[*/P3TK1M(O;:>.YAMH= \7^-E\4ZG: M^);BWGT_P\DNN?$&#QK9Z>]S?66D:'X1U".OU\^#O[-G[/?[-NA?\(]\$?A7 MX*^'T?DN]]-X?TQ)9Y+J2**&Z$GB&XTJ_P#$-W?SP0P8.H75@Z-N\AIM\I@^ M5?VJ/V:?VJ_VGO%,/A?1_P!J6X^ O[.?V*U&L^%OA9X>U3P]\7O$ZP7EC=31 M>(/B+J.J7^I06=L+.1=,T;0+>PL]=74-1&M1SI8:?Y'FO!8U0J3ES*--Q_=* M+2FN=+?2R6^S32M;JO7P&=PG4='"U[SK.,/B9XM\3+'$FG1^._'=W>W]Y")[2_LKRUMO&'BOQ;JUOY>J+H&@:QIX_L2 MT\*7X)_\%/?^"FMN-4_:1\;WG[#_ .S#JNI;S\%O $=K-\4_B%X5ETO4[+4] M5\1W5W]FNFBU/3+^/1+JP\30Z+H-W--))9?!C28HYKG6OT)_9B_X)^_LE?L( MZ/J?C'P1X'N+_P ;Z=HPO=>^*_B^WD\?^.KB&TL!%)+F5;;SM/N6@MV@_/;XS?M]_MX_M4^,KSX)_\$\/V:?B'X#T:;4U MTN]_:+^-'A.]\*6L$$&J6MMJ.I:/!X]T^]T?11;)Y]U&Y](O5O,:]-3C#G@\/&&LE&\^9K5)I*#U=E\22O?7KZM.O1JU?;Y7.ECL M?#2IFE::I4<*YWA4?U.4ZE.:J4W*FKSE./,I+2*B_LCPOX._8+_X)2^#(] \ M ^$(8/B-J?@_7-8&CZ!IVH?$;]ICXN:/X(\)77B3QEJ%V;;2M2\5V'@6RMO# M6H^+_$%]6EM=)UY_#LO@6+ M5_!WAN\T+5M)OO%5_I6I^+]8U31M9M(>S_9*_P""+7PY\">)K;XX?M@>--;_ M &M/V@+ZXT_69[OQ?<:SJ/A'1]8%C"\-S!I^LRZE?^-(--E<-IGC+QGJUK'J M&D1:+%IOA+PU_9EU_:'[8V6EVVF116UI':V\%NB0I;VJ6 BB$(V@1-IG^A" MH42&WB.ZW",'^^*\ZO@<3F-6%2E?!4Z%U=1]HYIQ<6W9TDN:]K)NR;U;U)KX MC+\+4]K6E+,,QGJJRFZ-&,[^\U0DJO/%0ORN?+:5I*%DHGYT?L5?\$JOV8?V M.I8/&.G:#<_$WXSFYCO+SXK?$J.#Q#K6F7AM%%]I?A'39K?3=-\,Z4E]^['<; $QUP/3IG MW]\^U=!;G]TK=.,_IG]*YB+[R?A_*N@MT\R-8U0R.[1[8U,[R3 ;BT$%E8$: MCJ-S(,&*RA_T214E:^^58:^"II*I M)K2\N6]M7??HK[_,P_%OQ#T+P'IRZEKQU=[>64010:/X?O?$T\TF57#:1IG_ M !-)-A==MU:'_1MS-+C_M8_M1/<069^'7P\O+>R\&^!H[J.9(M1^+GQ2LXI MM-\!0:2RSSS>'M,M]0\2R7]LD,6F3-%)>Z=\+_$/X?>!_ .KZ?\ M(?\%+?B M[X:_:@^,OAA(];\#? C1Y/[._92^"FK6LL@MD\.^ 9IIM,\;WUDUU816_C/7 M;G4-:O+;2-/FO=3F\R*ST_@PN29AB\2JE*,G*+;C1Y7:<+-3ESW]WDAS3^%W MY;75[KIQ&:8/#4*D:E6%&HH^[JI/F6JC:\?B=HWZ7;L[6/;/$'[2G[3_ .VU M8WUU^R\TW[(7[("3O;ZS^V;\9?"XM?B;\0=%8.EQ>_LY_"[Q(7U.U;6= @NU MM_&.MBQ,FF^*$N/#FAZ08]2^U_ _CO\ :O\ V:/V$]*U[X1_L8^%-=\8?%SQ MQ>&W\;_%[79Y_'7[2/QA\6ZBSQZCX@\6^*=0_P")B?$.LZM>:MJ#>$[<"^AO M=4U2/PYA4OZ\Y\5?'S]LG_@I9X^N_AC^SKH]]I?P^TIXM*UOQ]J3_P!A?#_P MAI3ZCIUM*T>JPPSZ7:Z?):RRK9^%-"MM0UKQ"+'R[+3)_P"SI;S3_6?@!^R+ M9?!_Q/-H_P (=$U;Q;\1KAQ<^*?C]KEIH@\775YM\/7>HZ1\/K/5+OS_ /X M1O8=2U'2;[41J/\ ;;17VG/K?B?,6G:-4\0\2\*\)X=QS"L\RQ<()RR^A4^J M5/;)Q=-^VBL1*U&HHU9Q]E:I"G.F^7GYH^/E&7Y]Q+5JR:GEN C.WUIIXE3A M=V]Q^P_B:0^+W5.^K5GQ7A3]@;XO?$S1;S]I7]ON;Q-9>'K#P[XM\6^ ?V9_ M"6H7EOXE\5:CX:\'>(?%_P!@\:WVE_:M3T.]UW1]&N;2Z\,6>CZGXTN?.ECD M^SB-/M&U_P %@-?D\,_L)?L=_"^"X\'V/A3Q3\=?'_B[P'X$^'6@7GAGX?> M] \ ^"]/\+/I'A#2M2^RZF=)NKOQYK]['J.LZ/IFM:@T@?4/M'EP>3^\EA>> M#YQ\.]0MK>;Q18^$O#^K>'-#?2-.;6YKO683)X/U/3T:>*#1+]K.>PE\/:KK MMS;6(DOAI#1:9I8B?Q/#_//_ ,%T?&EGK7B?]E+X,V%Y;ZEXT^'OA_XA>)+C M1EG^UZMIFE>/KOP'I/@N7Q;$?$%[JEM8;?LMF=+$YO=\6M M:O\ GG"?&.>\;<:9?F&*K5I9=E44TE3C M4E&+C4:FHMKE?TO$&2Y-DF0U<+0A%8^O6RZ+K:1E4D\PPO/)4[MKW>9M#8KTD==QN4D9 ML]VXHKZY\-Z59Z'HFCZ)I\7D6.B:59:)91$YV66D1"PM%^GDP*1[$#)QFBOR M^OC&\3BIGW*DC-K=Z9?W,5V.]L93SMQ7 M3@<3+!XW"XJ+_@5Z3G8.FW M^;\_EX]JT/VAM!M/A7\>?BU\+M(U@:OI/P]^)GCGP;::H8O*EU*#PSXAO-!M MKZ?^]/<66F6AO/345OAGFO*)M5@50QDWLP.[_9QC'YY_/IBO[ RRO*MA\/B8 MPLL50IIQ4K\O+&,K\UES7:MLK;ZGXCBH*EB,9!NZY]':UO?[7^6YW*ZLBEBS M[0V-O'7&<^F,9%2)K:+(@1]V[.>,8QC'?W/Y5Y9)K$?.SUY/;U_QQUJ4ZQ^[ MC_X%T&?3V//KS7O4J3TFU=+[/>^F[[7OLSSZDHJ#:=WIIIW7FSU>;5=JD_WF M3],]>G!S22:JC[]_98P/Q#9_'C'Y<V.O\ P$>E M=].@FN;EVZ:?G;]#F]HNJLO4]6.I(L:R)_!D'\>A/O@'W'MCG/FU/)$F,[\_ M^._GUS[5Y['J6[*XQG']>>@SC/X].].:\DC!*?QC)&,=.GYY)]O2MX4?>7N= M_P O\)G5J1]G*VKTZKNCNQJ&_/&,#^?X#/3IS]*Q+G4O*:0#^/'Y#/\ 4^_' M/-N,YS[]S_P#JQUKHA1?,K1L]?R_PG#.I M[KT[=?/T.G^VY"'UW>_IV_+W[GH*Q[V\Y.??^G<^_7GIT-9$5SL1O?&?PS]< M'IQW_2J<\WG9_P!D-^H'^'3M71"E/F6G?OV]#!SNFK?B*;F-RYD[8Q^.>_?H M/7\:I/,GS;/?/X>O?U]^Q-5W?9N]R?T__7^-4&FY/&?\_45TTZ:0W*4IJ45!/7XH*:U3W3LGI_F:<#3+ M.&AEDB<;BOE+F4D$$%)/^694]_XB1Z5ZOX/_ &A_C3X":*+P]\0=>@LX2OG:ST9^BWP_\ ^"CW MQ-\,W-K?ZSHNGW\MNVU]8\/7E]X2UG!R&+#2!D+'Z->\H3E M0>Z<8\UNNS<4^W0_M*^&_P#P4F\#^*W@%WI.A:R) OF7/P_\4Z)>74>\-\UM MX>U[.MRM)MR8VY0H1U(KZMT#]J7X*^)O+MF\9?\ "/7.X,MEXSB/ARY#OGY9 M9P/(@V%0-T(P^Y<]%%?P*07E[IK"XM;^X27*M');3F%X2F3G@Y8G<-N/N[3Z MU[9X/_:=^,?@YH%TSQSJ-U! %"6&K$:AIY5 1L:R?(F!!PAS?5,P;Y6DH.G*'-%M*2YO:24;Q;3= MMWHF?WVZ;J.EZW"NIZ?>66K6/R]OW?\ :]>!SQC]?R_BD^'_ /P4?\8Z'#-7OO"^ MIQ[?O/;0VG^CHYR,BYR"1^[P#)G]%?AC_P %=[-ULH-2\=ZLDBA4DM/B1H-A MK%K)G(VW7B'2\ZT57&/,BY(8%^@KQ\1D>'Q+;59)-I^S]FM;-.U_:*UK=GZ' M3A,YS?)I*,<#6IX>TEBG"K*LZK<6HR48TKI*HXRMKHGKHVOZ2WOH'+K!VQN_ M'=MZ=\@]_7GTI$YW'U(_D:_,CX<_\%&/ _B^V2.;2=(UE)@CW%S\/_%-C-%& M/GPQTW4_^)U"7PWEQS?,VR0)]TY^F_#?[4WP5UX0JOB[^P+F1@CV?BG3;_3O M+77)5R6OSPAAXKDBGS04?CM%Z\R>EM]GL=V%X MFR^I-O$U:\<1-OD4Z4DH;MIMOM=;(^I0^R%/=I=M!$C.]Y-JI^[#!& M'9QW!QV)K\Y/&_\ P4#\;?%GQ5J?P=_8"\!1_&+QS;S/I^N?&37[C^SO@GX MFES'?ZI_:'_,S:K;&&:6VT0E?MDED=OV[_D":M\SF&!GSRPTU[._+;?2]^A];@/VCO@A^RMX N M?B!\<_'VD^"-% :VTZ.\@GU75=?U(>6(['P_X:L-VI>(;^"26WGGLX?L-I'9 M&9K[7-)5X?M?YL:UX\_:U_;:T=_$WBC5?$?_ 3N_8TN(Y);)+K4X6_:R^+& MEQ 7EG'-&M4DL;47MMX=^W>)=,N;6\5MM2 M?M _M+_$:/\ :N_:JVL;KQSX_N-W@;P1*#X9Q6-;7+R6DG&3A?F2?-M>.Z5MW:]^EAX[B^C0HS MHX.;EB6X*,XR^&\TIZ*+33A=7;7XGWQ\6_VV?V?/V+OAW>? S]C_ ,!Z/X#T MB'[1!J47A^W^W^*==OODLIM3\4>()C_:>MWZ6]O##=ZKKO\ Q.KAQ-]M^Y%7 MX(?%CXU_$#XR:Y=>(?&&K:G>.'N;FQM(KKS;&SC@M;B2-;.WXVZA?6/V[3W' M /G^HP.Z^&_P!\;_ !>GM-?UFXN/#OA?4KV:+_A)]0B^UZKKPN)X+.ZT_0;+ M_EJ7^U1B^N.?LGF6;'_65P/Q+\*:9X.^(.L>%M"FN-6T[3CI%U&NHS"YN7-[ MX7LY;B*[N@!]H^R&^0PVW_+GYSK_ ,MJ^KEEDL!@L14P]."Q6&P.,JZVCS0I M86M.LT[.\U1C4E""NYS48)IR37@.KF&-QF#J5JLZE.KB*"FG=*TJD%O>V[ZK M6UM-S^U+X&)X _9;^"WA#2M8EMO".A^!/AS\+/!=^NEZ9MM+_P ?77AZSU,Z MA;6WFV_]K^(/%>J>(;E=5M/M-CN;4+)O[3TS_C^A^9OA]9^.OV@=8\.OJ4^K M_ ;X _#/7_&FO>+[>:\L;+7OBCX%\.Z)I6J>"=5\3^-K]]&MO#WA:\\0R>/] M:N?#]Q=VUEI U%-7O_ >O6>ES^/A]^_%'Q3\+/#M]:Z)XY\-ZIXGUNRUK2(_ MA7\/K?2].U#Q%\0/&&C^';J:X7P%X2OY8(-?N_#UAJ[C4O$.O7-CX!\ Q:Q9 M^)?'>IZ7I,<5]#YQ/9KK5S\0]5^)UYX+M/$OPPT6Z^*4'P,L=:L!\*?AG?MK MTVHVWBOXRWTT-M'\5O%NDWNB:MK6J:CJ5LOPC^%5QHO]L-X0O_$O@BY^($W^ M>F:U%C\ZQF;8AU<2\9C,5A\LI3A+VKJQ=6-58G#MR>&IQ@IRC4DI)M*R5[K^ MO7_M0_$SQUX,_9/^,/BW]GO7M+^!OA#X?>#-5UOP[\3=?\)3ZKXI^(FKW/ MB1+F>?X:^ _%EC:Z]X8L/%GB_5;S1M.^,_C+0[K6-3*?\))X5\ :OX2U/0OB M%I'\=7PMU*]OOC+X%\:^.M/U7XDW5_\ $WP_XA\::5>ZA/JFM>-VG\36NJ^) M].NM2OI;G4M5O]9O8;B_N]6FN?LEZ;F)+&W5;:6]O_U<_P""HO\ P4_\!+X/ M^)7P"^&NJ:Q\1_"7Q.\1:-<_$7XI^)_[4U*77-5\.:AX;\4W?AGX8:;=%K"R M\ Q:YX(T;6++7]=6Q'BB"XB71]!M]/T ZWXA_/?]G&ZTS1_VC?@+JNKR1RZ) MH/QH^%^M:O&J8J$95(T:GU2K*GRU/W%:?L_:I/E:DJ:336KN[?ZZUEC8#\P=U M5I%DP) R@0;G .,L8#@CY3@D44^V#*J(Y!9(8@^MK ]FOYDX_P#@2:7XO;KL?Y,W_!7GX8WWP/\ ^"FW[:G@ M*816L4OQW\6_$+3H(CD1Z'\7C:?%/P^I/J-"\7:< 1W![YQ^<+:I.SLIDWJF M,CT!S_,#_P"OSQ_2K_P=HY8=P3_\ J;C^=1_:=T0/3;ZX[_7O@# _ M0<5CQH[XW]CQ^..GY#&>G-7UAX'./\_0U]Q2IQTIVWZ^FNWR[G@JHV[2>G7? M]67HK[>A3TXY]#GCKGM_7TK0#NL0*?Q;L_IC\LGKQ],UCQ)L/7.2OZ$^P]:T M@^P#C.0/T'U'K7?"$8QY5'F_#;Y,55KVB?>#[8_7/^'X5I3@ MG-)PLM=?D_[J.)RDDVW==M?\V6EN_F9?H.F>N?T/8YI)"YP5^ZAE.I[KT[=?/T)&=$!V_>/W_PZ M9_-NG7OSFLV5]Y^F?UQ_A^%1E]A/&=@X_K[]<]O7\,U+)-G QC.1T]<>YJ)H ML@GU[?7_ #Z\5NJ<$[V_+_(T2N[%57D0MO&O(YY'Z4DC[\<8QG]<>Y M]*54V%O?'Z9_Q_&DD[?C_2J<8M-)6??3_)&BA9WO^ U5RK'^Z ?SS_A59IMK M$8Z''^>15C^!_H/ZUDR/L=N,Y/\ +\1ZU'L_/\/^"7IU5T:,=SC(Q][ Z?7W M]^N1_@]CD$^H)_,5BM-DKQCK_3W/_P!>IFN=@7WSVSZ?XU4(\LE*][7TVW5A M.,6FDK/OH_T1:5_++2?W3U^I/?\ S]#22/YF)/[V>>O3'?OC_(%4_.\W_@/M MCK_^J@_<;\/Y-6DZCY796>G7S(5*ENX)R[NWSTL6-^SMU_I^(]:43,W0D;?0 MD?U/I58?<7\?Y+2-T/T/\JYY5*CBU&7*]+.S=M==+]5H92PT'+F2AUTE!23N MK:JZ_P"'-*WU?4;219=/N;BVGB(*RP77V5T(/R\]7Q@X.3MY'&[->P^&OVGO MC5X054L?'.K36L2HGV/4&.J6H4;@% 8.(0V2'P5,@ '.SCP$/LW^Y_EG_'\: MH7#[XW]OZJ_^'X=*N.)K4X-QG[Z3M*UK::Z>:NOGU,)Y9@ZS_?X>A43:_P"7 M,%+5K:>K6NN_W'U'\2_VP/C%\1?AGJWPV;4/#VBIX@N+&WN]1TV"?2)M1ABG M-Z=.U.]B86T=M=/:IN%^19LJ2^;A QK]-?V8?V[_ (P?"?\ 9UNO@?XI\.^ M+.[\*2VB^&M5^&\GARYEU:SU2"2_E@\17WA)WT"ZN=+\VV-H8#]M1K^^^W_. M\1/X,P/MN=,!_BUFP_03?X_SK[J^&,9C\/ZU=KG-IK2W4@S_ ,L/LFH0R_\ MH]/Y=>OBT\//'8RI7=JE6E"I)4YRY834(3F[R::@[)N]G>R3Z6C.H4,ORR." MP^'IQ5?VM:-5)1JPE#DO#F3O*G*,$E"5U&3,O%_Q5^/?C&*S:/5 MM=U>^N"^GZ'#'^\BAR/MD[7:_P#(,MX@MN9]4O?^)+:#;_:G^LMJ^VO"O_!/ M3QK\/_AEIG[07Q(\$:MK?A2XUZTT;2[Z2V^Q>%[/7[BTU"]6&&-N?&E\+/3K MT-JME_Q)$DC0:7_Q\7-?6_\ P1.^!V@_%KXPS6^O^&K7QA9V%]XL\1:OX6N3 M^Y\3P?#WPF;[PMX#/$UOJ<]G<19U1-$U6QN;Q+TZ%_Q.K8 MQ0:G9#_B725\;Q9QOB.&>,,IX:PF&I5ZF,RZCF$JD<5RM>W4XNA&E&C/FE#1 MJHYI:.]/56]3@W@:EC\AKYYC6J:;YE*4%+V:4U=\SG%23O:UHM7W9^'7PEM? M&G[,/A/X@?&[Q3X*UO1_&]YI_A[P+\&?$WB+PKID&D>&-:\5V-SJ]_XD*:SX M9U[3H!I/@JWMWLF>YTNZE$LJVANF64VO\Z?QYNXY/B[X\N@(41;K3[26*XAV MK'/8Z+I4HL;B-V%RFG6YL5*"2VMKN4QBRT%6TZ[U\+_0C_P4=_;\^&_CZP\. M>$= T"Q6;0?(:_UO0H_L:G?:Q)?#\=?S7>*]:O?$/B+7O$US:Q?;=9U?5M;%NDBWVD_:[W4+_5+>$: MB")DTU9C"RF'!WIAC\JU]SA)8C%8&>)S7"2PF(Q=)PH4O:^TE/FC.%*DI M04.9OW>;F::5G_7EX2^)]M\%/V2?AU^U!^T5X]DT_P =_'7X::;XR^('QVU& M'0)_B-XNO?%^J^)/%/@?X*?#/PE#+!]CL;3PYI]O:'X8_#ZYLO#MJE_:^,/% M.IZ9I6D:[>P_S[_MN?\ !6BT_:%^(WQ,\#:I=:U\)O@O:ZM;3)\,-!CGU[Q+ MX]U*WU*.YAA\8ZY>&_ ?PP%[/H&EZ1J'C*7Q+XG\ M0_F'^TG\<_B1XF\#V&B>,/'_ (F\;Q>&?"=K\-?!ECXOU?6M:B\/_#ZPG&FV MVF>%X-5_<:;HUJ)].$(L !4T.',ZS: M.'JT\5F^,/_A;)X=\.2ZUJ$VI_'/Q=XMA.LV&JM>)X5UC3_#^F:3JL^IWOVJVN&GF MM[ZU>W36-1U6V&E :B8+231VN?W6_P""4/PX\*_&/_@HA^RUX7U8:%>>&6^+ M>G>)M3M-2-E>Z?K[O"&BO::CK MGCB2SDFGBN!X>T*STZSM]2-X+L740M?T1\,?'OX<_L#?$'3/%OPE\9>$OC+: M?$V#X9>&[/\ :A\/>&_%7ACPQ\-+R[\;_"3XF:I)8:%X#T[6HBVE0>%?$'@/ M6/#FAZ/>_$35-&\*^+[;PQY5S'?^9Y?"V?X3@W)TG"M+%8Z3 ME2E)N3EAU*G4]DH7CU+0+\:OX?N MKR[M@=4D\/:Y'IVD0:_H#:D+IM(UZWTVUM]8LS'J%O%';7$,417PGL'>;<[N M4YSUC_-)NWQ:VO:_71Z_3'."/HW\L?UI],?[R^X8?G M@9_#BM9_!)+[2Y?3F]V_RO>W6Q;Z>L?S7Y['\BW_ =U_!,>+/V7/V5OCK!- M=&Y^%OQR\2_"ZZBM['[8ECH?QP\%MK-[XAF?.8/L.L?!CP[H*$ B0>*'R1L& M?X)6MQEF$(MP\LLC1%_GBGD;S+R!X\'R_LMXT]J!W\D^E?ZKW_!<2RRW4']S[+-(\<.WVW6\_T&.]?T_P""F+>*R3&Y?.7*\LJN MK"6_M5B)P]WETY.5SE+FO+F^&RM<_'>/Z;P^;TJT8WCBZ2C+IRNG&][V?-=Q M2MI:]S-D39CG.<_ICV'K48W[EV>^?TQ_7\<5H"'Y%Y]>_P!/KVQZ?SIZ)L)Y MSD?R(]AZU^V4J?[R.O?IY/S/A7-M-)6?>_\ PQFC?YAW^JX_,Y_I^.:TH_\ M5M]%_P#06JG-_KC]1_.K"]!]!_*N^G!*:;=UKI;R?J9N4DFV[KMK_FRR$WHO M.,?U"^Q]*DC39GG.-_+S)_=QSTZY[]L_P"0:>TT9!D?G?T/KCCK MWQD?3T[5U*,6[)6??3_)&;G=-6_$LAMKJO\ >S^F/\:BF7:S-_>!_0?_ %ZJ MPNCE]G8C/_CV/Z^].E?8/KG],?X_C6L*?O+7OT\O4PJ/E@W:^J_&27ZE5NI^ MI_G44C[,<9SG],>X]:/.C^??[8^ISGVZX[<>]5&=')V=CS_3^OO6ZA9WO^ 4 MH\]G>WE:_3_@DXF^=>/7M]/KWQZ?SH,WSMQZ=OK].^?7^55ZCD?9CC.<_ICW M'K5G2H6=[_@6)'WXXQC/ZX]SZ57D[?C_ $J//F\X^YSZ=?Q/3'M^-21S8R,9 MQ@=/3/N*:5W8INR;(NX^A_FM4I$WROSC&/US['TK2=T=DWC&-V/QVY[GT'XX MJ)T1R^SMC/XYZ_D<^AS5^S\_P_X)*G=VM^)F2)LQSG.?TQ[#UJO(F_'.,9_7 M'L?2M!4V.?<']"/\?QJC/_K6_P ^M)PLF[_@659/W..^[/OTQ]/6H]^_MT_K M^)]*6;K']3_-:Q^F?3N"?;'3-4W.=Q]0?Y5*X)&?3/]*KS$E,'MG^1 MK.7PR_PO\F5"/-)*]K]?37]"?38_.U31XO[VKV)_[Y,G^-?>GP[M_+\,:S.T M>^/^T;Z23/;[-"^WIZ^:WY5\):!SX@\-#^[K5I+_ -^PWU_O9_"OO;P#"\7A M)F640[]6O+M&_B:X\T^3&ONV7!/L*X\!35:IB*3NE4C5IMQERM*5.2;3Z:UJ>MV&OWT)N1XAUVZE@GN=DDF3)_#N'7/$/]DR>'+;5]3M_#UQ<37-UI'_+(W[E/.?Z2$+V] M0:JVW@R>\1'FBG=7$J^3;R213OF-A!O99H(YXTE*7#6CP_A9*CSV?M)U'"-6,)QJRBTTE&\8.*?,[N6SV.5L?#OBSX@>*=( MT72H]7\0^,O%.IVVEZ/9O+]KU+Q!XIU>Z:/2(WO?^6EU=:E=6WVBW_Y=%2%< MXE%8?Q$\$>(?AMXM\;^ /%VC7.D>+/ ?B7Q#X*\2Z9=G-SI^M>&M4N],U6SE MQQ^YU&&[*X)SO],5_1=\2K+X!?\ !/KX1_%'X7>$? %A\:OC%JUQ\$?'.L:O M>>#M?CU[0[KX=?$+P1\6/$WA#X[+XJTCP+KWPO\ A%\5]1\%^"]>TKX56B>) M_&-K%8:UHGC'QGXTT^]\'>,O$7\\FO7EQXQUSQ3X@U6 )>:WK^IZS?VY6_1X M+B[U&]:X3_B9ZCJ%[/$UXEVZ7\ODC59#-JJF3[:=G/E/%%7/*U?F^J2EELIP MAA/KU/ZQ&&L(RC34;M*#YFN7;WE+EWRQO#V)RG!87$+#5(2S-MUI\LG04H^_ M>5>W+[TDDM%=M+6Y^=OQ],MO:Z#Y,>UM3CU^S9!U=!/H-PQ&>NT0]><;J^>M M#O\ 4WN;*"RNFC:/5([NSC'+0SW]WIUHS+Q@%KBWT\'G[L08YR<_I5XL\+P^ M(=0L;9M(CU/39)Y;74+8,(KJWL9;:7?JL$Y8?9[?3KB.V?4KH!C8V,L^I;<6 M)9?!?'WP?\#>&O&L47@C5O$9TB&W\)Z]I\NL6)DN+ZVU+PQIWBDW$J6VIZ3% M:^7#PLR182.W\4^)O%."H<>9G2Q=;DE&<4X\W,HQN[WV MO;>Z72VBU/[EX$\(>*52-)-J*EI7E>+]WF>L8MM< MJNV7M(\+_"GPX='U*UUC4KCQ+X7O+VS\2V:WD$;RZ%J%MKD$(CL8L:Q+"K7^ ME"XU33_]%TA60ZD,7MH19^ ?CSXK:\FM? /P_P"'?&/Q#TKXM>/OAY?V_@#P MKX?U3QCKFH_$?PS\0O"MCHMC\.?#_AK3;W5[KQ3XDT_49/!,W_"*W.GW'BIO M%%C#K)O-1T[PTENR?P/XMU35Y_ 'A^"VO-:M_ WAKQ9)?Z?=1+H":+K4OA2Y MMKN[-YH]MXE-QI\=_-;.=<\0>((-^HR-I*Z=$;K[=_'_ M (\_M0>)_!.C^)_B?I/B7P[\.OAI\1M=M_M[> K:X\.ZKXG^(WA+P7="?%Y<\=EE3/:5+EP=&-)4<1S)QKNM4A2Y8I MV2:YV[1E-Z/HFU\3F6'J9/G57AW-''#YO16^I#XR$)7Z(VF[ M$H;< K[8P5\H&$9,;+;X#0JA+6PW >:+83#(<&BO&-53LDK_ (?\$MU&WWT_ MX%_-:DIK8P?H?IV_7.,4:=?+_@?B5)-JRTUB_DI)O\#B?B%X+\.?$GP%XU^' M7C'3DU?PAX^\*>(?!?BK2G.U-3\.>*=(O-"US3W(!.V[TN_NX6V@MAB5!(P? M\:_X@>!O$_PW\;^,?ASXVL?[#\9> /%OB7P7XMTG_H'>)O"VLWF@^(++_MAK M&GWW_?>.U?[/%PVR-R&C4^7*0TN/*0K&3YLQ+*1$F-KD'^,9('(_RI?^"Y'P MLM_@/_P55_;*\)6+ZJVG>+/B5:?&6QO=7QYEY)\F:_:_!'-84,WSC UFZ?UC#Q=-<7)J-E=N$T_BT M4;:VT_/?$/"J6&H8JVE'E4FHW:YYQ@M?5_UL?E;)^YQ\_F;L]NF,>XZY_2HF MFX/&/\_4UBRZAM.=_F;L]\XQCZ]<_I52;4#*!&!C=G],>W/6OZ>HU(.2=JB; MORITVHRT?VKV6EWL[[=3\CW5TG;NU8O7DV%!]'!/XGOV_3K@5"=2Q)M]%3G\ M#QQZ].O7-84UX 1&#]S/;/7'Y=*2.?S>='_N_P#LV?3T (X/X]*$F_=_YQ_CTQQ^O6L".YSD8^[@=/K[^W7) M_P ;D#[]_&,;?UW>Y]*ZH3NN:VUM+][+?YF;A9-W_ NK-@MQGI_7W'_UJ26; MY#QC\/\ ]?;/I_*H\XY].?RJ.27S<#^YD=,= M,8W<=/\ Z_OUR/\ ]GY_A_P2U.[M;\223M^/]*(^_X?UJ/.>?7G\Z*:A9WO M^!35TT22=OQ_I1'W_#^M1T59'+R^]>]NFV^A))V_'^E1-T/T/\J4??7\?YK0 M?OM^'\VI-730>T\OQ_X!0*;R><8)_4_0^E12)LQSG.?TQ[#UK0D[?C_2HZS< M+)N_X#4[NUOQ,B9-Y3VW?KM_P_"I/)^3\/T_GCWSGOBK\G;\?Z4B^6P:.3^/ M&/PSG^8K*?POY?F68CP]2/\ /U_J1]<=:JD!'\S'*J^1VR:?X>VDZ/*D-Y>ZS"GDV_VN1I;5?MD:16K MDEU>,W7^ 6I';_ &CUR*_7WX/> M%9/$GP1C-M \K6VN^(Y)OL\=HVHN#ITMN+;2GELKB]%^_FM=Q1V5S;JXL6>X MMM3$,5D_G85U5]9]A;VSYXTE*7*G4E'EC'F>W,VHIZZL\'B&=+VN"6(3]E+V M2?*N9^_7E&*Y>MYVN^B=[:'TWI/_ 3_ /'_ (7^ ?Q+_:-^+\L_@FP\!6?A M+6=.^%UL)8O&'B"Q\=:CH.G:/J6JWI_XEWA>#5SJK2:/;ZO_ ,5+K=]$H?YM M-6G^-H_@WJ'Q>_:&U_PA-;:-\&?#7BWXO>+_ I=Z-8:G=6FC_#+1M4U_4[# MR;#6=-U#4;O^P/ ZZ;KEGDPVE]]@T*&SWJ\FS]:O"7@GXG?\%)?$7Q#O?B)X MQL? 'PQ\+P^'?$7A;X#^"M2T[Q9K6H:OJ$.H>$M'N?B9XC\&Q>$O$OB'7(/% M6D^*[3PKX9\3W_@JT\&:Y&T<.F>#EUR]O/$O\^G_ 51^"'Q._8.L_!?P\TB MT^*/@W5?B5#:6&O:AXYT_P /Z6LVHZ'XUL-3TB#PZVG:EK-K;6@T:W\'SZS" M=8UNZN]6CNS?ZYJ)@7[/^-4?$C*X<2YAPM+,ZD.*L*JWUG+I4G+"X:C&,ZTG M4Q+J*FYU*=.4(-TTXN2@I2YFG^CS\/!_B'8?%K3M5U:Q\!^$+;^S?#>O M^(_#>O:='H>N:+IOA?P-XD^)\,'Q#N+#0=6T8^$;UK#PM)\1O#FN:=K'B+PO M?W.LPR,/#A:+\IOVV?\ @GKXF\=?'_XL^(_V:M)\)GX&1Q+>>!-2D\5^3&/# MVAZ78:9J.C73ZW]KU34M1N?%-IXBN?#US<:QJ>M7ND7ECI6K?9_[&LO/^8_A M5^TE\9/&G_!/KXUZY\$?"HEU:[^%'[-WPU\/> /"=FUOXA^*MWH6GZ1X;_:. ML]8\/:#9W-[JNG>-M=G^+/C:6(2H+P,S_9+[RRL/IW['G[87A'0/V>-&TG5% M^*/[/WQ-\2?'/2/'V@>+O#O@70_% U::U\.:AHE\/&-B-3T[Q7JOA[3KQO!N ML:);2^%/ _\ PKU/%.LZ^FOZSN:U3^6,DXMJ95Q+QGQM4H9Q.K_:V/RW#86A M.O4P>'^K4Z[J8ASC3=.HJ]-3IQI^RA[*515%.?+RO]ES?(,/C\MR7A&=?!T< M-_LD:KE[.5>HI3I34E4YH2I^RDE4DN:7M(P<+PYFU^7/CK]FWXT_#.]L=0\; M_#7QOX)U!;34)?"VF>-?#6J>';+Q UU$D4L2#4+*3P[J#ZYHW]I:%H%UJFHV M5G;0:[J&LQ6NIW^G626WZ@^#?C[\#IOV+OVBO '[57C']FCQEIT?@3Q;X9_9 MY^%>G:%X0N_C'X7^)=EHGBGPSX9\1MKN@:!IWQ,M+K0OB'X]L8K_ ,-^._"\ MWBC7AY/Q8T36HO ?@GQS)+Z;^W_X*^ 7QK\)_#+]KS1?$&N:!\4OC]XED^$4 MNJS/87/@9-+^'7A]_%>@W?@^-XH)UUSX<:1X/MQJ%MKMMIQM=7\2>'M9T_3( M#XAN[S4/S+\8?\$^O ?Q)_9Z^+G[8/P/_:+TSQ)XE\!?$31;SXD?!G6O"^LZ M3J6C:M\1/B-X$\-:'%H?B:Y7^Q/$]G;W_BZ]9(]%4+I>GPZ4M_*TFK6N/YTX MJXJRSC+/<3G%:6.P=?%UIPA"IAZMJ;A4:(?VH/'^JZ68+PW9.CP^ / MA3HUGYG:%O.TJ[PG4@DGC%?YU7P(DCU[Q-^T#XCF1C::_P#%#['$[D[Y/[-L M?$MLL)Z<0)JVF8Z)-4 MD^._Q-TN=P.P\C2K9??;VZ5_9-6E#+_!W@S"TJBJO%3C4K5>3V5[Z[# M7^91F5#Y9=4($BC<20X.Y)(U0\<-+%&7!(!VKD$#*_@G_P %G_\ @B-\.?\ M@IUX;M_B?X)\56?PF_:W^'7@G_A&OA_\1-:^VS> ?&&C:7?W^LZ5X%^*D&D6 MMYK&G:,NKZEK=M8^.](L->O_ !;^(->U6;P=XYL9KGPM??OU17=EV88_*,= M',,MQ,L-B(6Y9*-_[LU)7M.,Z=X.,E9:.]TCFQ>%P^-I3HXFDJE.=DXO7:2E M'[I);6TNC_%M_:Q_9+_:2_8F^+NH_!K]I[X5^(?A;XYLU>\TR#4Q97OA_P 3 M: 93#;>(? WB72+K4-#\3^&KRX2=UOM&U"ZM+#49+_1;D6>J:=?Z=9_.HN!U M)(R!VZ\9_+GCUZ\U_M"_M4_LF?L[?ME_#.X^#_[2_P )?"/Q>\!WMP]U::3X MFM98[_0-9,#VR>)/"7B73Y[3Q#X+\16]A-?:;'XB\*WNG:\+'4[S2XM1AT[4 MM2@N_P#/Q_X*E_\ !LQ^T;^RI>:Y\7OV+;;Q7^TS^SO;2_VWJ7A!='FU#]H3 MX6VN)7O(KWP[H5HB?&'2K*QELKR;Q-X*TBW\537WJU84Z5>48W_B3A!49RDKPISDW.34(RDVD_S#/^#JM) MSQ."O.@E=PC3LXZV2;4G=)V5U'3=H_F,2;=G'.,=1CKGTQZ5/'*0><2]202)/=)/?:8S M*;.SU&>\L-5M+" W)0KD@YZ<8].O7U_&OVNAB,)B84_88A5ISU_=P4J2LN:S MJJ5MDTM%=[;GP4\'.G4G3J_75\VFFJWOMOJ^H\[[GX_TQC^@(]L MU?BFP#QGI_7W'_UJYB"\_IC]>I_I^'M6HESOQ[=/Z<].W Z=N*[DZD(V=.\; MI.7-MK&VENK26_4Y)PDGR6WZ^FNWR-R)][CC&/ZD>Y]*D/WV_#^;5GH^_;[$ M?K_^K\*MMT3Z?T%>C1J\L;\M]NO?E7;S.*HY1?+:W]Z^UO+3\Q9.WX_THC[_ M (?UH3[C_A_)ZL1?<'X?R%=L'SQO:WEOV_S(4I)W;NNVO^;(S]QOP_DU 3>B M\XQ_4+['TJ23M^/]*(FVN%_O?T__ %U25W8T56SOR_C_ , CV;._7^GX#UJ. M3M^/]*MNNUG;^\/Y _XUFRIO/7&"WZD>Q]*IPLF[_@:PJ\TE'EM>^M[[*_8? MOV=NO]/Q'K4D;[\\8QC]<^Y]*I[-G?K_ $_ >M,+[)(_?=^FW\NOUJ#5JZ:- M/?L[=?Z?B/6HY'WXXQC/ZX]SZ5$'WD^P'ZY_P_SFEH(]GY_A_P $*CD;;@?W MLC^7\\T2=OQ_I4#=4^O]14S^%_+\RH4_>6O?IY>H_;MY_O<_Y^N?_P!51R=O MQ_I4TGW!_NG^0K.;J?J?YUSS^%_+\S;V?G^'_!'2]/P;^0K-(PQ;TW+_ -]\ M?TJU*^P?7/Z8_P ?QJDDFXO],?GG/\NW3.*PE\,O\+_)AR\OO7O;IZZ?J=AX M+FW^)= M\_\ 'G!K$W49_>):>O\ N?KFOU/^'?QRT_X-? '4]3O[BWAF60KH MZW)LI87\0ZAJ=A!H=Q<65Y_KK#2M1:WUG5)X\FTTW3KLMDS)G\M?A\OF^+M' M0#YFM-:QWQB"#_/^37K?QWT35]3^&?A"WMDDG2U,$YLX%,T]T'DDM@D=J.9P MJSNS<'9Q_?-?,9IB7A,GS?$4[RKTJ4Y481ER25>\51FI)-_NZCC/E2]]1Y;Q MO=<-7#PQ.<95"O:%)SIN;E%25H2JSZV6KBDF]FU+6UC^T+_@F5\4-._8L\-_ M$?5_%EKIGB#Q]<:!X0^-/Q TG3M<\-VF@WFL^+? \NF_!7X67OBNYTO63H^I MZ7X.U8:9>7$5C(;'5/B)J"NRB1"M!^'WBW3-:TJ3PSIW]E-JM\_A^ MVM/&J2ZZT?PU\-(V^']U:7\_B*"QT'X=_8)M M+5#K*ZB-+D MO[(WD3R;'[/7[9GB*#0]*\&W7Q'LM%U_3;_QCXDB76-/MO!5CJM[6&U ME_X3;Q!XX\ B[UG3K"_FBT7Q#KGA*PU;5;S31;SP:CXFLK&?_/3#Y5XB5,YX MNXI_LN>-K3JSJXS$PC*GB<7AJ%9SITJ510G*G)*,5[O/[1)PLN>Z_J&6:\&5 M<'D> QF-J891>&5;DK7I7IRIR3E13@G[T59.6CL];:^T?MH_"?X4_LX>*?!W M[-7[($/Q1L=<\7Q^,=2\+MX6T^]UWP#J?A+XE:RM]I_[/7AF^UK2-&^)^O>) M676?%5GXF\#:D-9O+G;I7@V]\0ZCJ_C34[;3O@RTO_BG\#+WP]8:9X@N+66Y M\$^$O&T6EVAUC6+2QT+XG^"=#\16=MX@T#Q)]KD2[N++Q!HS:AI5[H^IV,>L MOH-K<_9D@7S_ .@7P]\4?'?C;]EY=*\1)I&H?M1_$/XU:1X[^'7AN/3_ GX MTN=+T?3-8TS7I?VDO$.L/K%O/X-T?Q!X,\6CP9\%[G4V\,^)?'OBGQMH>J>' MO#U^MAI]S)\R_M$_L8^$?"'[//Q!^,_Q:\6VTWQQTVS^&7A;PA:>#=/T#0/ M_ARTT%['P]INB6-KX/M]/M+R?3_A]I.G:1I,_A[2X/!O_"-Z7XE/B.\U#Q=) MKSP?>^%'%]/).%:^$XZP&!RJCQ)Q%5AE>#Q5*GC,TQE3,YSP,G6P\Z=&KAHX M+VWUWGDIK$*A[']U[3VL?E/$O*88K,JN9\(8S$8RCE^7O$SKJ#O!'P<\+:#X M5\'>%_ >DVVN6FO:GK?ASP5X#N]'\-6>I>)OB=:^)/B+XO\ $^L6.GZ/IUU\ M%]8&OV6K7M[HT=I\F>+/&'[;'@*V^%7PY^/'AWQ)X%^%NI^./"7BVWTK3_A; MX+^'.C:_KMOXH\2Z;8^,M?G\'>#O"4_BSQ%J5[9:Y%JLWBF/4/$?Q%OO ]S> MWFH7-KX4M)4]*\":QIFD:)XYU:R&N:)KWAR/XQZYJQ$ALK+Q[X*TK7M;N98- M.&HV\\$FHZ==GPY9Z'JNMF?1M!?7OB9J'@_3;C7PMYI?0_$S]N[PI\1?V3?A M]^QSX%N?B?XS\&>#+[XE_&3Q-XE^.$.BCQ38^,[/X>^/7TG3_AWI&A>+?$UC MX<\*+?\ BWQ#>:EIB"-[_6+NZ\47NHW^N>)-;LM%_E7/,17K\09A1PF!P-?) M?[9Q^&G44(X:O&.'Q\\+2JTZ:C42O.5.IR-MI7C&6CD?ZN4#X:P<\7BEC/X^(AEN$Q]7%2PJI-*=3ZS*E*#JR:2=5U)Z'XF>*[]2D1F1KPR"2XU>;Q!J\@0_984N6U[4X74$ "6<1Z= M )R,!<1XX;%?ZZ?[./@F3X:? +X*_#B4#?\ #_X2_#?P2<.'Y\)^#=&T \_7 M3LY[DGOFOZ_XCG'#<$\&Y5"-H8?#NKSN6LW.C3LN77ELF[OFE=+9(_R8R7$K M,O$7C_'124*'LX0:=U4>:9IC<9)+1F?R[<'U[\U1O0BM&6YXE>(M#).%>- RR M+%'_ *R1#]V( 3,"\D14129U**3C!WLIPO9MTZDJ3P7\2M:MF5DM/C#X&T*6Q_MN2\*26(\?\ AJ:S\:)%K%[_ M ,) OB>#3]-\,WG^>7^W9_P3G_:__P""(N?<-2AA_;2QN6 M\UJF%JSY*BCRM1Y,3*-645"7+4:<9*2AR)P4FU\_F_#N#QZ=2C".'K+K&"FI M:WE=>Y9M=4[=TT?XD$4VS;A^1)*)(TB\N%9E\LR/$1C)D!0OP"-HXY%:<5WA MCGKQ_7'T^F3G]#_81_P55_X-7_'GPNN/$_QO_P"":J:O\2/AU##=:YKW[,NO MZDEY\3?!PMU>ZF7X3^,]0N--MO'&@6,$=_:6W@W4M0O_ !QHZV.F66E)\0KG M67CT7^._5;#5]$U34M#UW2=4T'6]%U*\TO6-%US2[C1M8TG5+*00WNGZOIM] M!9:C8:K:RKMO+/4]-TR^BS&TMC"LL9?^H>&>.,JXAPV'C@\7&I6JJ+KT)M0G MAY*/.X-MWDTXVO9)ZM-]/S/,LCKX*K*52$G2C=.LH-6N[1;5[>\VDO>TTU=E M?:CN=^WVZ?\ Z^F>.GX<5J03?T_KC'] 1[9KCX+G9]3C^OXXYZ=>W-:D=SOV M^W3_ /7TSQT_#BOT%2E",$DI1FD^92T5K-;)WO:V_4^5Q6&OS.*;C_-:W7U_ M"_XHZSSON?C_ $QC^@(]LU;63< ?[O.?\_3^EO3M]?<]2^?[?I_]>NJ%2/,K:O7JNQD MI2;LXV7>[_R7YD[=#]#_ "JBR.Q)3^$G)],YQ_(_2I]^_MT_K^)]*1NA^A_E M6KG=-6_$VINTT_7\F5R[L"'_ (0<#TR.?Y"J+=3]3_.K#=3]3_.DV;^_3^OX M'TJ#I]IY?C_P"!>H^H_G5W?L3Z@?H/\ Z_XTV.#KSZ=_K[5)LV=^O]/P'K0- M3N[6_$J*^\M[8_7/^'X4^IV?8#[_ -/_ -?XU55]Y;VQ^N?\/PH:YDU>W_ U M_0T3L[CFZ'Z'^59LO7\6_F*O2IO'TS^N/\/PK)E38?KG],?X_C7'5ER^ZE>[ MMVZ_\ T4[NUOQ&R]/P;^0K./_+3_ '7JY)_JG_#^M5 FX1^TR_K')S^E-0A[ M.4W42:B_=MO=-;WZ;[=#6*O)7VO_ ,']#N? )(\8Z<1U&AZA@?\ 8?\_C7U MQJL$NI>'K6*=))?(TN.2"VB8PS7,K2QPK#;70_U%VWF%H1SY@$G]RODKP&R? M\)=8/)PD7A74U/\ VUM+D ^_W?7CTK[CTO1+V>WTA+2$SR7&D:=#80K!>3/< M7,EE!>/9PBTT^??+=65C=QO;R:C:_:+$7BIIVL[&CM/A,?1J8BGCJ49>[)3E MKI'W'SVDVTDFX6W.G^'IZ;^S]^R M7\7/C!H7CGQ3X/\ "T]MX$^'G@OXE^(==\?W!N+/P]!#\+_ >M_$#4M#-SI] MGK.HZA=3S:/:>'=3U2?11X:MO%7B#P-X5\1:_I2^-]/TSQ%W.A_!+X7^)OVC M-!\ :(GCJ[^&WBG2_#)\/ZQ=:;!8^+M>U6^\"Z+_ *#/HMG>:KIMK=:IXO:[ ML=:T/2];UVPTV.&_@AUG5FTR34[W]Q_!/PJU'XW>)?&MCX6U67P1^RMH_CCQ MCKO@2[T?2K_1[FXT7Q-\,?!?PEO_ (?^ ?#TFH7%WJ'A=](TOQ5K=QX633]. MTKQW9?$?Q)IOB+X>>&]&@N-)^'GT;^U5X1^'7[._P3^%'PN_X133]*F^)?Q\ M_9MNM*TC[+8:I>Z[8Q?M"?"JZT[7/BK=2:E8VFDZ5=Q>+;_4O#F@1_9-4LK/ M4+#4_$6AV6LZUVH4ZE M;VN+Q4*4XTO8JFZ_LIT_WTJ:P_-%U.>/Z7D7AWC>(<91JXNK4PN#PKI5Y572 ME5YXQ<9J"@ZM+E4VHPYKRY>;FL[%?$/QR\8>'/B1XY\*:CKNM:7]IU&[\/>'OA1;7GCKQ-HW@FWA\5V M6D:1X6M1K/CCQ+HP\176I^&O!OBSQCXKT+YU^/W[8_[.W[2-O\0OV/ M$?Q)\::?X,U7XN?#&_F\%6=GX?T?PY\+H3XBU&\EU*'1?"[ZE\9OC!X*AO\ M4O$?A^V\+Z*L>HZ)K?@+QOIVA6VC^$?"?ASZ4_X.0/\ @H)I?PI_84^!7[+V MBV$M5M;2]N=+\0W?V'Q)<>,!XZOJ1TVUO\ X;?$+P+=Z=Y'BC3$UF3P MDS7UC'H%KK(7^4<+6S7B+-,)QMG52>99XLRCC,*XM8/+J=+#8F-54Z. _>P@ MHX>-:$ZL7>I)7Y86:?[?B@:'H>L:EX6^&/C-=3>U^(OA>]\>:CX:LOA+H M6HZM'J37WA;XF7?B[7?#_ABW\(!_&-N[ZWXIN;K1KJX^+FL^&-!L5T+P7XWU M;2,W_@HQ)^R7J'PA^&/C#X,>$OA+\//VC=#^$_Q$M_VB?"GP0\3Z/XF\"1QQ MZIX#^$?@W4S<>$-$T'P';^)/$:ZIXQ\4>($\-VDOF2ZS;DW^L:#'X9US5.*\ M->'?A1>_!S3O#'C75?'W@CPI?>#O"^B^/?"6EV.B/JLFMV]]HP\,^+[?3]9D MNO(O]5U/57\0ZWON-4M=3\#?$SX:K:ZEH]I:^#K+7?#_ /@H!^QQI?[%&FR6 MW@/XU:3\=_AG\=_@9\/O'W@WQEHVC:SX;G;POXS^(%]?>!UU71?$L=CXC@O= M2TKX';BY>\E6UTS[%#;W5S^=P> S#C25#Z]C*6-_M:OB*>'I82 MLL%BI8_&PQ%:G.M[94HO"PE4O[DU5E"$E[!5'%_Z'<58BEE-#"0E[24LFX4S M])3K349/+'SKJ:_P#'6MW$6DF'^Z5D\22>9_>+ D\5_K>V"@*Q4,J; M0B*Z;) $EG W9^;&,;58#: 3_&W&[RC&#ASCD M^>9R.V#V.:_L;C6:ITN'\"G?ZKEU/FELGS4X67+K9II]7I\C_(+PO<\3'B?, MJDN>>+SF=!RUNXX#$9FHRYOM*JL4FHM+DY+>]S>[8HHHKX4_5@HHHH **** M"BBB@ IK8RN<]>.F.W6G44/73^K=?P!WZ:%24*KKD@C#<-'D!LH4?S"#&C*> M45A\['@C::_&K_@I=_P1#_8M_P""E6CZMXA\=^#V^%7[0<>E75OX>_:,^&=A MI6G>/Q'XYK6WQ8>)GL=8TBV?48_"GBSPE+K.J7\G[ M05&X!*D]LGOGMT[=N]=&!Q>+RJ<:N5XBI@ZT9;::=K>I"*V\0> O&L]L M0(O#7B6SATVXN5U&/PS=Z[#I^J>)-8_+^TO IC*L[1RKYL(;8AB@+R1)!+%C MSA=1R0SF>>8EIP\17E&)_P!P7X@>!_"7Q(\*:YX'\>^&M!\9^"?$NFWFD^)? M"7BG2=+U[P[XBTV]C$,FFZQHNM6]UI.I6DV_+6^HV]S:%E#&V>=;>:W_ (L_ M^"G/_!I[X;UX^(_BS_P34UZV\*:R!?:K,=%4J. X@@Z=2/N M/&.M*4&UMSTW2;IN3:U]S^&(3Y96Z9Y!]Q^GZ'//7-7XY^Q.#ZXR"?R.*Z#XU?"CXP? 'XDZ[\,OCK M\./&'PI^)'AU[:RUCP=XW\/WGAS6K6*"VBCMM2-K+#;:=?6VKKOO[?5]!@.C M:C'*L]K=7XW7W0\BIAG&$GRM2TLK>?>QN.^^/Z?U!_P /PI@?8B\9S_0+[CUK+2;Y M'XQ]WM_O?7MGT_E4GG?NO\XZ?3/3M^N:[%73=G&R[W_X".>-*2DKZ+7OV_KJ M:&_?VZ?U_$^E&_9VZ_T_$>M9XF^1>/7M]/IVQZ_SJ2.?KQZ=OK[UHJD9.R>K M]/\ ,V]GY_A_P2RS[RG&,'^9'N?2K2]!]!_*JD<_7CT[?7WJQ&^_/&,8_7/N M?2K#EY?>O>W3;?0DHHHIK?Y/\F-3N[6_$9)]QOI6),F]G]C_ #__ %?A6Q,V M%Q_>!'Y8_P :H[=OF'^\,_D#_C7#6E",TYNT>:S>]N9N*_%HUA\2^?Y&&\>U MN?N,&1OJ>F?Q!R?8^M1H=]L+H?ZM9X;=,9ZP3P[A]/W@/7UXK1E"9#,-_P Y M18_5G# /U_Y9X_\ 'L=\%[3Z8/"\^E1Z/;+KTFK6LLOB&0_Z6;!;A//TRR ' M!NPT8FP 2((L]<5XV=3QF$=-X*B\=&JK.*FZ-E*R;TC5ORIMV:5[=#OPU.-6 MI&$I\EW=2M=+EC-NZNKWLHW3NKK1J]NB^'J/)K[/'PQ\)7X ]SJLX..?P[?G M7]'?_!*"3]GGQ5\=3\'OCQ;75U<^+/A3K&J^ ;6ST+3M9OM8\2^"'TKQ7J7A MO1K[4KZU@\&>(-4\,V.LWUCXV>"\MK"PTC5M U2VO=)\3WVDZI_.)\+G*:S< ML=V(_#$\4>__ %T<+:]^ZMY>H/DX"/&M\&FF\F,7MSX/\56>F.O\ >G349[4P>A+=C7YMXCX_$Y3X?<49 MA1Q'U#&T\MG5IU%'GE3DZM-3HQU@[XB#EAU45O9NJJBC+EY7Z&48.CC.*\FP M]=*I151J46E:7LZ%6<>KTYDGK?S/WD_X*3_$+QG_ ,$R_%WP%^-'CG]G'Q[\ M9O@MXF\2^(_!G@KPEX*^*VA_#7X;?#$VNEZEXV\(>'-8UAZ++^2?7-;T'P]H6N>*_A,_@ M75/#^CW-W/+>&>2:_L=#7POX(\$:G_!UU^WUXH^,?[3/P:_9>\#:G);?"7X6 M?"[3OB1JL4FHSQR>(OB-X^N_$GVZ?5[;[=96-S-HOA?3%TWP]%)Y]Z4\3:O# MI*17]W!YG%_\$C?!^J>-M9TCXI_%_1/!^G67@31O!G[%/PITB'4;ZY?XAZSX M@N?B)\2_':W.KZCJUW<>.M8TOP)XW^(PE,.MZ/I6F+HL'AG1%N-)T&TCLO\ M->O@W@L@_M+&0JU\3F^%ECZBQ$YXS%T76Q2DZL*M23G2HT83;JRH4HQC1O[2 M$F[R_J>E6EAZU;#4%"AAXT*?M::2LXPY7\22Y>5*,VG>[7*K=/BW_@H#8M^U M?\5?V.O%?Q&\7R6GC#5/V8/ -KXGT2UMH+C4-3AT_P"./QA\.ZSJ?AG0WOK* MZO-1U;4+!-*T6.U66&]OGCGU-[;3;6XEK]3OVL?V9?\ A@7_ ()__"WX+:E; M^'M,^+'Q9N_BA^T#\6-(59+36/",WA'P@?#7@OPIX@L;_4M0UNYT#P?%JVO0 MZ/=ZOY5SIGBG2O'7@*Y\S5O NK;/TD^.]G^S[^R/K/P\\)^ /A3X+^+W[65H MEO<_L\_#JP\/V/Q)\5_"&]\::Q9:W8:WK&I_V?J7B73=3O\ 6[BRU'P!X$\% M>*K7Q#/XIGM+YM5TG2-$U.^A_(G]OWX)?%[X4ZX++X\^-K'QC\:?BU\*+'QK MX\M=(U_P]XEE\'ZS\4]?\9^%M ^'$&J>'+V\EFU'0O!5]X9NKO3;K2-%\"K] MHOO#OAW0[[PW-I'BO6OT/@G(,PQ?#JS_ #"A4R[(L#EF;RR^C5][,,SJ4\MQ MKCB'@^6C/!91[24)X?,9NL\15Y:3HIU%./Q&/S:.:<3<.<.93+ZR\XXHX9RS M$8V,K?45BN(,IA4JO#Z^W48TI1._A7+X+T37-"UBPE%K7YU?MQ:7^U!X6;QUX)_:XTKQ#H7Q=TKQ1 M\)/#+Z-K/]C?V'/$^ MMZEK6OPZWJ^HZCJ-V?KOQ_KL7@WX9'4/"'PXUWQWJ>DWOV:]\.6OB/QQ>W7P M&UWP_8>(;72O'?AB^\':]8^3J'@_6[>P\&Z>-636_"OB+X;>'81HV_6M5B^* M\WS;^UW^TKXE_;B^-7@_XI^--(@\.:O\3/V@;3PG#X4@O]1U9-$\/:+X5^&G M@7PQI#/#MYX@OM8U/P_X2\+Z5J%MX5T#\OX1 MHYA7S[+U'#9?5PDZ_P!=JXAU*?U]<];EIT8TTIU&DW&4YN2CRI\B:YK?Z'^, MN:0IX?Q QBE[!83A3-:6'I7ERUJE;,*,*CA4<8*+4*U16Y)2TL[.5E_2!_P1 MT\+V^O?\%%OV8M(CC$,>D>(/%?B1(SCB3PY\-O&.NN#GU;3T '_$OQG#;_9#/YGV[0H MOA4_^D @VY4>-U.!S,/E_A-?W)6ZHK3;>N[Y\]0S,\I&.W^MZ'GL>U?TMQ?- M5,QPZ4K^RP=!6[/EU3]';[]C_*OPAE"IPQB:U-NJUKKS\ MS:5_=WOZVJ***^5/U0**** "BBB@ HHHH **** "F/CC(SU[X]/:GT4T[._Y M":35I*ZZHB&P\<@G_/'_ -?UJ*8;>I8C:R@*NYQN*C*')P%_B!7!.TG& #:H MK&5&G.7,TT[WNI--O=-M=4]1K1JRT2M9^EM_^ ?GE_P4&_X)I_LJ?\%(_A5+ M\-/VB_!$-[J^G07'(8-+^*/PTUF>*$RZEX1\1K;S31VUY)9:<^N>% MKZ&_\/>*(M-L(=8TFY;3--N=._SD?^"D_P#P;\?MR_\ !.M_$_CRQ\,7G[2' M[-6E%[N'XV?"K2IGU/P[I+SS%I?B?\-=,EN/$GP_NK2W-N=4\9Z5<:E\/X/* M:+5-5E%_:V5C_J]UFZE!%23BDX M*[9Y..R?#8U3:C&%62TGR*6JU>FE]+ZWTO>VA_AE07P<1E9%F5B3#,(X+?SH M&),:_T,?\ M@J__ ,&NOP8_:-C\5?';]@1=#^ ?QVGAN=8UKX,7D5M;_ CXKZJ9&OYXM&T] MH7A^"?B/4'GD40Z+9#X675U;06USX!\.W^JZCXVMOX)?V@OV1%XC\/:Q:2W'A3QGH]^T;00>- M?"=WJ&F^)ELX]3?4M0>:*]F_J[@WQ&R+BBAAN?%PPN+HPE&O1J5(SFI\CBEO M3YHRFTE-)K5-\K]T_,,[R"OAIU9\DY05M8TW9J3Y5JFTK.VBNM=-'IYM%.<' M(SG';Z^XJ7S_ &_3_P"O6!'+DJ.!W!/Y\']<$>V>E7Q*549'7^GXCCTK]+2J M.DZDXQIQG9T'&?M%5BVM=.7E]W7KV/D:M!035GS:635NNNMNQH;]_;I_7\3Z M5)'W_#^M9\;[\\8QC]<^Y]*L1]_P_K4TIRC4BV[I7TU5]&N[_(YG2DM]%]_Z M)&C$^PGWQ^F?\?QK6B?>#[8_7/\ A^%?J:+=4^O]14LGW!_NG^0J!GV!.,Y'\@/<>M"OO#\8P/Y@^Y]*T52 MW3OU[JW8SA3]Y:]^GEZE&5]AZ9R6_0CW'K566;(Z8Z_T]S_]>K%S]Q_J?ZU0 M7[C?C_(5RUH1J)N:O&]W'SOIKY.SVZ&ZA9WO^!'&^_S?8#]=W^'X55E3S!(G M]Y7_ #R,4DO7\6_F*BS@I[R ?^.25BN>%VIJRC+E3C>UXM;W-8\RDG%VDM4U MY*_XVM\SO_AI; Z[J40CW[="4[O[F;^SYZ#@@#UZ#KD5^G7[-.K:CH?Q]U;Q M%I%Z;?4_"_P$GN]/N8HQ+=:9_EWDU?F7\-G1 M-?NF9)')T*SV^7V/]I19S]<@CZ&OW7_X)0:;9^+?VZM=\.7=I:W%SJ7[//DZ M?;7\4ES)*)/'/A^QOGBMDBF\ZVAM+^1]3-O!=:E;6'GWNEVLES:^9%^#^,-2 MM/P_XK4Z,L3[2GA:2C%RBU[7,\)332C"I*7(YOAW[2/PAF_:<_X*4>"[33OA MO\1OB#XUUWP=\!/&GPHTQ=,L-(\!^)=!B^%O@N[AU/QKJMYNFLOA1X$\>:9X MHO/BK>644?VI/!'Q7\/S>(/ 3:[#\1_!GZD_M6Z3\.?@)X7_ &)?V./V-_B+ M;^.OVB?A-\;O$?Q&\:>)-%U 06&F?&;6M)O/!:^(;^X\5/'X/@3QGJ'Q!\60 MQ:GK5YIFC:%\-_"VF>)];TGPQX;\6ZSI#]Q\=OVCK>_\5:M^QI^P+J>F:AJN MH:A8Z5\1?CIIY^%/PFT&;Q5X?\'WUQX"OO"46O:FOA+3/%FHZ?87GQ1\ M'^'_ !=X:U3QQ=^%OAY\#M-\5^*O$EKXG\7?G=X*\0:[^S#\0_VN_@YX8N;W M7_B$NI^,/V?1XS6RMO#-S%8>'OB)._B2^U/P[J.A:SXM\.ZAJ\GA73M4?P_I MNM^$O%O@[QI:Z!K;^*/'ES8RZ/=?SUX;^'&:YI5I\1<1X>C1HX#+<+ALIX:Q MW+#&RIRQ-*%+-LRP]248TPFI8O&IK#5$='EJ3BU!257VJIN@I<]/E]HI^\URO]&]3\5?#;_@F M)JWB+6]1U]OVC_V__&N@>&-8D^(&H^)I?%7P_P#AT_B91XK\0_$;2=9T_P 3 M^$OB-=>*_%>I:SI.B6=SXCMUN?B5X"74OB%KMSX>^&_[05[\*KK\:/C#X^UW MQ3H7B'QEXE\51:9KNM^*?AK=ZCXO;3M&-KX7M+;XD_#^6"ZL-!M([+0_#_A; M0+33X$\.>#_"UQ8^&-.2VL?#NC6^BV-S'IS_ $G\ _V&OVI_VS-9^,WBKP\O M]OZ_X+-UXC^)'COX@ZU=69UCQGXNM[O5W\+W'BW5S;0?%%KXYT>TOO#WC#2)/ M)TO6M)35_&UO9:OH$\HVNH:M_:&DZA^E<=TL MLR7ACBB5;$83^VIY6L/6J86=.G0HT<3*EAYX7!9?!N&'P&%HUI5J6"C)R]I3 MA-U(W/(\&<)C'4,/35 MN>O*G!/6Y]/_ <^//BO]G[XZ?!G51\0/%>F6K>+IVUFQ\-^'[35['XE^ M) MU?P0WBV7XJZSH^J0:KH/C;X8^%++65\'^+[7X>^.&TG7?!^B>,HM,^'VHVNF M1^"/SE^,VO:-^TK^V_I_Q-\&>%;/X<_#JV^*GC/XY#2M \+Z)X(T_P />'O^ M$^$W@24^$?#MY?Z=HMR_@[P]X.BU$65Y=-JEVDNKQ75YI]YIE[/]':1H MK; M2[A/#4NFW>I6VGMI'@BQ\1'4+5=2L]-LM.OM2O\ 5S]N^T^%M,T.W2VL+3_2 MS<+%=>)O^*M$7]B>-_)_CIX5T?X>_"SQ<=(U'4Y/$'B2YB;Q5J-K<^5;ZO"*>/HXSCWBNM3I8C+<+.-3&Y%DV)S'!YF\1G-.E*J\)B*M*E4PE/!U M)*=ZJG*5OB?%WX9:GX-^'/A?2(-8E MO_\ A%[SQ=X>U>Y\0ZW-JK[89WUCP3<"TCL4"2) R3 K Y=34 M*51+$596Y>>K5<9RERZVO)OJ_2Y)1117*>L%%%% !1110 4444 %%%% !111 M0 4444 %1N%RNX^N/TS_ )P:DHHUZ.W^77[U=>0:]'9]R JH;.2$?BYX(U:262TTOQ+:F*^T353;R)_;7A M3Q+8RVGB/P;X@2T-Q:Q>(?">H66O6]I<744;SV,M];2_45(2!C/?_/-3A^? MS57!2E0JQJ>T4HRFFI]XR4DXONUH]FFF*<*=6+A6A&K%QY91:5G;5='LTG\M MS_,H_P""L?\ P;8_M"?L2?V[\:?V3F\:_M1?LTQ1W^NZM;KH\.I?''X4Z?;7 M'F >-?#>C6T,OQ-T0Z/)%>7GC[P5:Z!(LMAJMQXS\'Z-<&SU#6?YFQ,=JD@# M+R<[)E;<"H="\5?[F5PBN%&XC:DLBJAC5\J%!>-V M961E#%=P81$2,LW#+7\SG_!5;_@V^_9D_;D?Q/\ &#]GQ-%_9=_::U*&^U*^ MUS0M&-C\(_B=JTHAN@OQ(\,Z7;RVN@:M\(^.- M9TKPI;V?] \">,-;!PHY=Q/*I7H12ITL>ZSOATHVC[2DJ+=&5+NRFN$TNZFN_#HO[+2?$5KH?B 7_ (:T M7Y6A.555.Y0=RR=F+1TY/_P!;]>IK7@[?\ KU8WC)K! M*,G%MI6W5NJ7=FV%W '^Z ?T_IC_ /706W C^Z"/T_IC_P#75?\ Y9GZ#_T% MJ4)O1><8_J%]CZ5JY02;YOR_S.9.SN5W?9N]R?T__7^-9DK[S],_KC_#\*V) M$V(W.Y^3^7]:O-T/T/\JIE-P<_P!UU_4D?Y_SG"4N9./PWT;OLNKZ;*[W.K#R MC&HG)76B?_;SY4_DW?Y'H/PY13J>KR23[$&E:?;^8?X9)]3M"G8]3&03[9]J M_3;X)?LQ?$/X\?%:SO/ 6D^)XH?#&DZ3#X_\<>&K:VU'4?#WA#5=0N?[7C\- M^&)_$7AO4/BI\0;GP]I?B#6?"WP2\(R:]XY^(^E>&?%LOA[PMJ<'AK5;[2/S M%^'#.=6U;:=H(TJ%G_N))><^QW!"/P]:_<+X7WOQ$L/!OQ-\+V%Y<^&O@]XD M\8?!SXE?$;Q-I%]XATG6KV3X+0^+++PAX=FU/PQJVGZY_P (Q=>(/B?_ ,)1 MJ^E>'X+OQ?K>N>#O"5EX-N=(\1&QU&+\\XRSO*>'LBS;%9C/"NG2]A.C5Q5. M-6$JOUNBH5J-.3<8XK#5'&O@ZDO:PHXJG1K3I58TW2G.$R_&9CQ-1P.$A6E& M,5>I1G*G-Q=&3DDXKW5RWOJ[JZMKI]7?$G4?@+\+/ 7Q%_9;_8V\'>+-.@-S M?_#[]K']JOXH>*8[SPAK ^'FE):3GX>6_AW6_%GPRU#Q?+XC\;>-?AO9V/A_ M2?$?PXTGPQK6B0^!G^)/Q+N/#'C[1^-_8\U#]C*#X(?M>ZEXBM;^\\4?!WX8 MS^-M"TE-9?P_XLUMI]&OK!]4L+J^LO$6GW-K_P )=KOP[\*?"KPB=3UFRU_Q MG\1+C6O$VN>,8?"/A_X=H^_T30Y/ O@CQ'XCTWP[#X;L+*V;X;_#X6GAB;3K MQ?#=G'HZ>.OB5I/A[2;'PO\ VG*)Y'\#>"KB?^S?A_HJ2W^N6^N^*/&2_%;X MJ?,_Q6^$?AOXF>$M7T:WEO/"GB/4K'28=*\8Z';6]YJ-LNF>(+'6O##SZ5J7 M_$RUNQN-:0V.F:'=8UF%+BZO+W-C:Z-7^?N>>)V:YSQ$JN'QN(HX#!8J=3VU M+$2C5QLW&4)8O,YTXP6+Q#BVHQ@J.$I+E=+"J<(S/ZBRWA6CEN4*E1HTIU,1 M27MJ5:BJM6.?C_K/A[X?>%?CMX-L?B)K? MACPOI>NZMKWBCPOXL\"6?B&\T7P=XKNX!_PCWB.PNHK34_#EQJGB0?9+C6]: MU^9\:1+KM?G!X$O_ -D^W^,%GXS^*?\ :OB?X;:U8^&UU_3]7E\1G3)!H_AV M+2E\->)2EO-HZVMIJ":C>1:[K$MGHLRZE*?#%[XL^(.@:[I7@7PG\)]6DU;1OA=IWBN*XTZZ\57?C6YGUG4M M/U#PYH=YJ;Z+I^M^+-9UFX\6S:&D]EH]A!IJWOIK!X_C;%TZN75<1F%#$XG" M0Q[]I+DI4OK5"6*C.%Y*JZM*,Z;;<>1R4[2Y;/7 \08O@JK@#R_.,FK M+%Y?B*N$C6C2Q$%-4ZL*3E3M.DYN=.2D[5(PEJHV/P_\/72:+ILFH:OJ$^L^ M(-3*WGB+4#(W[^^>YO[R.TTVU"W$.FV%AJ=VMK9E=-UF[N"\AU;2I-7@O;RR M\ \8>.?@?\>4U#X;ZYJOBS]G/QA>:IIMII\WQ,@74_ FI:5I_B'2)+36]*UX M3>$CX6O+C28_,6V;3_B8=;+VY&IZ4NFBTNM_5/%UOIMA=+<&%7B\A+26)_M$ MD-U::9;VEI!;Z<.+R$6\,,7V@??NH[H]3SR7@CX@^$9/VA?V3/#WQZ^%RV'[ M/S_'?X$7OQA\:^,]1A\/^#KWX:S?%?PK+\3[37;J^%KIVBZ/J7@:'7+#5FEU MC3;N?1;G5#9^>T$AB_IGB*%#ASAV.2Y=A7@ H^PP^&@J]58BLJ=.M-Q^MUZ,8SC6H.#HU:&?M#? ;X-?M*_"SQ-\(?CS\-? M"GQ7^&OBJPN+;7?"?C+1[/5M+A^(/# ME[MU30-=TK6+>RNT_@M_X*?_ /!K-\7?@6/$GQG_ ."?6HZ]\>/A;:QW>K:E M^S_X@DTVY^.O@G3X%2X6/P)J+0>&-*^*6A6L37_V72+JWMO'NCVUO8:3;Z;\ M4?$-QKGB.;_1%JK8CJT00+%*C*P<.VZ7@P[5'24LOTW#O M%6=\,UHU,!BI2HJHISPDI3C2JK9J5IR2GR[5(P4KI-J9Y.8Y/@LQA.-:FE*2 M7OV3:L[KMH[6:OU/\.C4;'4=$U+4-'U>PO-,U72M1O-/U33;_3[C2K_3-4M) M?*OM+U;3+VWL=1TO7+&9?*U33-3TS2[ZU?R?-L8EEC>2:%BVW/\ LD?0_P"? MPZ5_JB?\%4?^"%_[)O\ P4DTC4_&ITNW^!G[4/M">2XB\C4K'4=$\:Z3.7E\.^*8[.\UKPSXJ_SB?VY?\ @GS^ MU9_P3H^*J_"S]I[P(N@OJJZC-X&\>^&Y6UKX6?$W0='N8M.GUCX?>+5M+'[: MME'+IDNJ^%=:TW0?&G@ZRUCP\GB?PUHPUG2OM7];<$>)V2\4X>&&Q]:.59E2 MCRTZ,ZGUCZPXQUE"?+ATE9:_%*+=G&VK_)\^X=Q."=6I0ISEAHM-RY;)7<8Q MOJW=R:2T71M]%\C(^Q#[@?H#_C^-1+-@MQGI_7W'_P!:F92.*.)/ND,PX[OM M_3@#O3HXOKGV-?HEZW(Y5%&$9V=&49\ZJQNG?2W+[NO7U/CW!1ER- MM2[.+7F/+[P>,8!_4?4^E46ZGZG^=:<=MNSWQCOCKGV'I1)"D6-W\6<<@],9 MZ_45"E).[=UVU_S92A9WO^!E,F\'V_K_ /J_"J;Q 13Y[A.GM(.O'\NO6MB7 M9CY?1L]/08Z?C61/]U_P_P#1L=.I5M2K.VOL*UM=FZ4TGMT=GYVMIN:P3E** M3M>4=?1I_H=Q\.D8ZEKS>5'+#_:FE)/',V(9XY;EHI[4Q\^9-/9M=F =C&_3 M-?NY_P $OO\ @I5H7P*D\0Z!\4O!'B37X/$.A>,M5\&ZAX1\*)K6MZ3J%_K5 MDWB_4;W3-0U/3M#N/$V@>'Y=>T_P#J=\)M4TMM?\1-X;\O6+F$2?A1\-&5+G MQ#(\DJ+%KNBR;8_XW4:@$S]"2!]3Q7>^#?%[^ _AW#K5F9+35X]%OI$GN/\ M42O=M9?9K>3_ *[+'*J\_P![\?Y#^D;7Q4\BX9P%-.JL37Q/UB'M716(C!5* ML>:5I =5G\;^)=,TM+=]0UGQ!]N M+:7I,.K:G)>WCM9V4L6FV;V6CZ_J5UJ,B6\LVA>$M#M/&>LWNGZ= WAWQ9:Q M_9-5_'WX=_%_^VH[B'1+6WMM4NIFFU7PEK4.[1M7NB@:=K"^Y_L>^;!>#5.M MJ[#^]7ZC_L@_%;PT=7_X2_6I]1M4\-1,UUJ]K?S1>-O#\]A8ZK]EL)]'>6#3 M?']GH>IM8^)=!U*ZN=/O+/4?#UO>:=J<#&XL]0_BZIE]>A*:P]**HRG".(M5 MO*E&ZM9[JZZ>A]"_M[?M=?"/]@G MP;%\+O!EII'Q*_:/U*WAM7:ZUG7K_P /^&)M-\27-EXHU/4M3EDC\0^*_ OA MWQ#I%WX$M_#NEW?AO7/B-XJT?QCJ%POA_P"$'AK3/A[K_P"4'ACXHO\ &;P= MIWQ 30+?PYJFOB_GO=$TBW_XD^GSVFK7.DW:Z1% D?\ 9UD8()-5-O<16OAW M0;+^T9]/T_3O#.D:E9Q?*_[:_P 7/B;^TU\3_"VO_%/P-H7@;4O /@33/A/X M>TCP]H&JZ'J ^'EGXE\:_$;P?#XON-:BM[_Q3K^C:?XTA\,:-XK:TT^VU'X= M:'X#M+73XH].:ZO?N?\ 8TUO4_V7W^&_C_4_!_@OQE<>%-);5_#NE_$6*]U' M0M(UV>[MM8N/&-OX=L[C3_\ A)-8\,>(IM4GTW3)-4@\R6Y;99:AED@_H?PC ME6RZKB:>3TJ^,5'!XJK5P]&ESSQ=;ZM6M&DVVHRHM^V22DY>SY=')27YGQV\ M+BJ]..,KPRR#E"+KR?M$DVEK%RHKWY-1^+>5UV:?&3]GW]IKX(W7AA/BC\*O M&?PT\77V@V?COP[X=\;>&=2T[49])UFSFO\ 1==^Q:E^_NUN)]/U.VNK=O\ M2='O[&ZTO4\:M;WU?I3_ ,$U?V&_CM_P4,'B+3=*C\,Z;X7\+7MSI/B7QOK> MMZ)_9FD:M+I,#7UM>>!KRZ&M:JUVNNLL2Z?I=YHUL;:0>(KW2S<:2]U^@OQ0 M^._[*7[4NB:5I_CGXV:'^T#XAN)-8T3P^OQ1^).J:#J=C_PE6HR7PT#PMX&7 M6O!-[X3TR6\N-"T>QL(5@MH;M])L[FXU:XN["(?K/_P1[_X).^$?V=O$=Q^V M/XGTKQMX2\3_ !'TZ1?!OPMG\9:CJFCP^%+^:6?0?&WQ+T_7O#_A34#XRU;3 M;N.^\/>$/$%K-#X*LKF;5M:BT_XI>(;GPUX0]>AXHYSF?UG"5,ASC*,?E->K M3CB\ZP,HX?%1G*=&2A2JQI\R5.4G!QE4][EEIN>)1X)PE%X?&1QM/'8.2-+OQ9=^- M=:36[NTLM&F\*^&-)U"73K:TU671])NM9UZZ)U5X;=KC_B;-I$(L[?\ LK3; M!I+M)/UKMP 90&W?,">,)Q-;&5IXC$N$Z\Y.3E3@J4%?=*$;I+5]?,^AP^$ MHX:*C2]K:/PJ524DM+:I[Z?<]0HHHK Z0HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HR,@>O3\***33:LG9Z:VOUUT\UH#5]&-)"\ >^! M_,G^9->'_M"? 7X-?M*_##Q#\)/CU\-/"?Q8^''B*VF_M7PCXPTZVU#3Y;B* M"5+2^TZZD:&\\.>(+(S/+HWBW1;JPUWPW< ZEI>J:;=1)>1>Y4QP3C )Z_TJ MZ,IX>I"M0G*E6IOGA4A*<91FMI)QE%I]FFFKZ,BI2IUH2I58J=.:M*+2:=M5 MO?:23VZ'^=U_P5"_X-@OC;\"KWQM\9_V#)=4^-WP/C@NM>F^#-]/<)\=_A_: MP)-=ZG;>'WG#1?%_P_86L4EOH^FP)I/C29KS3;,Z7?R>'Y/$FN_RAR,J^6@# M HC9+Q;) T5Q/:S"9@ 9)6N[6ZN8_MH_M>"RN;.SU'_CVMJ_V^+K:$3ARY;$ M82)Y90Q78"FT;8B0=K3S8@C#%93LSU* MX^WW5SJVG^);VTT2VB_=>!_&#Z@J6"XLKUJ^&CRTZ./4N>I0;C[.$:E"UZG/ M-PC[2,H\L7.4HMI,=,@C]1Z_EG+9B\HW/P%R5_'&1C'L/YU]S?M]_\$S/VM?\ M@F_X]@\'_M(> 6@\.ZK'CP9\6_!\>IZ]\&?'B/<,GV;0O&>K6FEZG!JT EM1 MJNC^)-&\.^*]+DO+,:GH-OI=QH6I:M\&&Y6&&Y2Z\R)_+DME::/[7,)+?'FV MINCS)#:B6(P@_<$S\\Y/]$QS[*OJ6&S%XNG7P>+C"5&KETHX]I3LHJM&G).E M+FDHRA*THR4HRC&4917YM4P5:A5G1Q$9TJL;J,7!^\XW;6K5M%NKZNW:\3-N M?']T$?GM_P *S+IROF8[X_1XS_G\^U: F!2'#;P8A_RR\KU!X&-P_'L#FL*_ M?=O?'^K0]3_>DA';@] "<9)Z^WK7IXC#5*U&4O8RP]:2E5@Z52WL925J;;;O MHM'IOTL8X>+E646K)-Z[[.RTTW:_$],\#W#&U\16Z1[WN?$6C?@D5AKQDQUZ MAER?:OJWX9_LQ_%#]H7]GGP5)\+/A3X]\:Z='J$&E^*O%?@NQ^V6?@.YUN[\ M)>"O"2^*G'%OHGB?Q3XHL;*0\>8NGSGGRZ^1_A"C8Q^,M%_DCQXC]>PW!Z?[N/]HN@_?Y5+VU5T=9V7(GSZ MMIJUUJC]4\/.>.-SR%)_O%0@XR\U2A)Z>=FM^OR/P7\:?#_Q'X+U"[_LZ9M3 MM--O;D0ZMI;?ZE+1HX('MHP?W<%Y%$EZ@_B:9^ZU]7?"/XA1>+?#<6C7)%IJ M]OH.IS:AJ$C 7USMO-'TY#<1\>88]+U#68D'8W+^M4O&WBGQ#X;^*'BGX8_% M/X/>+?"OBKP[%::%;:5!!<:3XVT22WLDO%M-5\.ZRXTCQC'KNEWVD:E'8QV6 MDW$NFM9M::9:F8M+ZI\"_ /A/6_M/CS3+VPATVT\[1K^.S@GCG@O;DL+_3?$ M.CZME-!N8/LT:PZ9JO\ HD1DNCI65^UU\IG_ (5Y'FM&G1X3S'V6=9?@H3S7 M YA2^JX2I+%4XTHRP>/J5U'&.G.K[:484E\#=TVY'J8'B[&Y9BL94S/"UHY= M0E*5;%X>;Q56"U5-1PL81E/GJ\HV?97WAGQ+\;/%V>=?B#XKU*(1Z7=6*6L,Q@$GZB-+LM/!NEG],\0W=E<6%BG@'3UU6:S9M/\ M[/GA\JSL+F+#17=M]G_XE;--B9I/L'0PIYX.8:^_O^"<7_!.?5?VN_$=G\7O MC9I>IV7P,\)ZS;0:VEU_:!N/B=XB36+*QT[P+X3_ +)BFUE&GO9(H]2/AV"Y M\57R3V6A^%;:37M8LI8?T'A'AK >&/!,'Q#5A5S?$2E4HXC 8N&'KN3DG%1K M16(:4;^^K/VM-2IOEY[KX'/LU7B)G&'670QE3*L/4MC(SISPTICO9K2]SZB_X(0?\ !++2_CE\2_#_ .U#\;O# U[X3>$]?TW4_AGX7UG3 MDCTSXN^(;'4'EMM>UKPW,##=_"S2KR%)-,\/N/LWB?68+R^U_P#XHSP[XJS_ M *!FBQ/"DZ2O&TI96D$+RRQ ^9.BXEE4,[+&B0;7)DAB@AA;Y(XF;YJ_9:^" MC?"CP%I*ZEH6E^%=8?2=)LK/P=IB6']F^ M#T[3+.PM=#0Z1-/HK:Y)9V-FW MB%?#L[^%;":WL?#_ (;N];T;0[;Q5XD^J8=N6"KM"A4 R"-J[@I&#QD=O8#M M7XYGF<8[B3,I8_'XVOB%A)SA@X1DJ5*-*2E!*O"G&*Q,E%MJ<[)22G:Z5OUS M!8/"Y=A,+A:/M4U34>6=5S2:BF[I]DK+SN3T445YIV!1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %,=MI7WSQZXQ^5/HI._ M1VU7GUU7S6@FKJU[>8PO@C&,8!]^?_K5%E=PR=H.<#U__5_7\[%%3*$)6?*N M972;U5I)Q::ZZ-V;V=GT&KJ-E\6BYGKI?73S5UOIOT/%OCG\$_A-^T5\-?%G MP4^.?@7P[\2OA=\1-)NO#_BKP=XGLA>Z;J5K'5-+US3;A8]5T+Q M%H=WI^M>&=0L8]?T?5=+U;3M/OH/\_3_ (*I_P#!M%\>_P!FG4?$'Q9_8;M? M$G[0W[/D[?V]=_#.3R-7^-GPS^RK*MU;BQ@@AA^)/AJQ@D.I:9XH\*0Z9X[L M;2XN?#]YI5Q8:%HWB7Q!_HZ54NX4E51(2J8D!900\9="OG1S+S;21+N*S9&W M)P=Q4CZ?A+BO-^#:DGEF)G4PU::EBL+C9/%4:J4E**@JBE[%QDDXRII-)*+Y MHZ+R,TR3!YI%MQC0Q#C98B-.,VK:OW%R7YEH[R6][WW_ ,/B]M;W2FETS4;> MYL;ZPEN+2_L+F.]@DL[^">2.[BGM+\"]L[U741W=OJ(_M>-XD&H 05R]RVX M.W]PKV]9$X)_X#Z<_G7^H+_P5Z_X-_\ X'?\%"8M0^+WPAN=%^!G[5=K')+% MXNT_2(XO!/Q-1$9X]+^)&DV2?;)-2D6$PP>,=-CN;^,7=Y-=:3K!=3:_Y_G[ M9'_!,/\ ;D_82O;F+]I/]GOQGX,\+QS0Z=9_$_0X)O%/P;U-M1O&?3+:V^)7 MA@2>%;&;4A9F2+2/$[:=XDCYCU'0]*:-&N?ZLR'Q,R7BK+8+$UJ&6YK3HRHQ MPKK0C&K*=/VI;W4ED)8[/_ M %A%X8-OF=,MMZM7[9_L'_&CXK_LS?L]_$OQ7H]QJWASPG\2/A_XCM9/%VG> M%(-8O_"7B&'P/>W6A>+/"^E>)98-.UO6/#-I\0WUVPTQ;G3[N\U'3]/BMM3@ M=C9ZA^-/PCM+[4O$D>V:"WN5\37-^A>06T\$@TR[FF>(PXLTCM+?3G\N2W'^ MD^?F3(CCQ_5I_P $N/$_[-GCG_@GUK_[/O[3WA;Q%K7AJ2ZT?XG^$_!OA_P] M>0?$CQ[8^(OAE\)OA_!H?P8N;/\ Y#_Q,\7>(_#&@Z5HES)_R"+.?460_P"G MM7XOXX4883+>%X8^%.KAWF&'DOJ^(3K5H5,735J:A&3C*TE)-.7H?3\#>TAB MN(/?G1J/#Q4)JFYN_LX)^[>#M%*2F[^ZHREJD?A'X>\/CXH>-O$WQ)\06^H: M;I6K:[:'PUI.H:C#J6HQ6%KI]M:>'$'B>YTVUNKW6?"OAZTT/P[9:F-8\+:Q MJ6G)92^"=#N+^.XUJU^N_!7C_P" AN['3OBC\$[J;Q'HEP;?5?B]X)U:RA\7 M6^FVM[I]S:V.HV'BCPU=>#?B+/X;6TEL;SP7XOLM<^%=_>^$M-N]7^%MAJ]E M\0/&OB?XX\3_ !,T^Y^+OC;PYX%T2&/X=#QGKECX$L[.6\NP/"2:C-!X6M!> MW9_>6UIH<.GZ9';Q_P#'I=V.H!L>8E?H1^SC^R_\0/CMXITC3/#/@3Q3K>OW M1@MK;PMX=T>[U.YB W>7=WD]KQIVFX!:[NI2 (TWI_JVK]7PW"F1<79/@O[2 MC++\LRK+X3P.)JU5DV-PDL?3DJLW2=/$4XO67AWPK\//%WA7[!;:'HNE0WVE_$:^DO;[ MQ)K'C?7=??Q3KD-W\']?L_ MMHUM=7CP^%M9T:70]1_KT_8O^&]QXCMM)^+. MH^#-#^&W@RRTO3=+^ _P>TBVT*[TKX=:-::>+>[\7:^FA+9Z7<>,-5LI+G0/ M#=EHL6G^$OAMX133]$\)Z,L&L:G>7_PE^Q3_ ,$8X/ @\,>,/VA=;MY[[3TA MOX?AIX1:\?2+>\0E[;^V/$-XPFO)8<#[38PH("Q=// =2/Z!/#VC:5H&GQ:3 MHFG6.E:;9(L%M9Z=:I96D2QEP%2UCPJ.%V^9)C=,<.S$]/YUXV>1X'%4*$5.GHI4E[&[A*:E=N,HR<7!_P!UK5.^ MNC1G.G"JN6K%3IMQ(O$OQ,_9 MME\3_LE?$W7-,UU&MOA_:Z#KWPFN=3UK3[[3[JZF^'WBK0-8LO#)FDO)V6:9UT7Y(#!R&D_L1:=\'?^"?O@G]F_Q!\-_#/Q/^,OPO\'_$_P#9 M?.FW8E70-5>[O?$?BO2_&UTF@7!>RUD^&O'/AVYT"W75H+J+59$72=3L]56R ML-0_J"G_ -3*>XBDP>X^4G@]1R!^0]*\@\::+H\GBI=0DTG37O[C1+:.>^>P MM6O)X[>ZO1;I-71QV*JXFIE5>E7P4 MZ\Y58TYTJD)Q4H2E[\?<2LWIW:T(PN&H8+$XK$X6E"E/%49T)KE3BH5:$A\':$\\]U-I&EWAO?$^KQ MS3M&PE' T_J%&G1IQC%*I3I2<:\Y1BDYU+N^J2:1\YDG!/#/#N(S#%95E\ MHXC,JSKXFIC*SQK=5S]HW356-J4>:[48)6TU=BLBJ227!.W@ 8 QGG '&/;_ M /60+AI?W@?)4X!)V_>]?7V]*LT5\G3IQHIQIJRF[U'*\YS?1\[=]^]^O>Y] I.X* EX-101.SCH 19 visl-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - NATURE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - CASH AND CASH EQUIVALENTS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INVESTMENTS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - ASSET ACQUISITION link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - PREFERRED SHARES link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - REBATES link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - GAINS ON SETTLEMENT OF DEBT link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - RECLASSIFICATION OF PRIOR YEAR PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - INVESTMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - FAIR VALUE OF ASSETS AND LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - ASSET ACQUISITION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - ACCOUNTS RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - REBATES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - GAINS ON SETTLEMENT OF DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF INVESTMENTS HELD TO MATURITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - INVESTMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - ASSET ACQUISITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - INVENTORIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000081 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) link:presentationLink link:calculationLink link:definitionLink 00000082 - Disclosure - SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000083 - Disclosure - SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA (Details) link:presentationLink link:calculationLink link:definitionLink 00000084 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000085 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000086 - Disclosure - PREFERRED SHARES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000087 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 00000088 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details) link:presentationLink link:calculationLink link:definitionLink 00000089 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000090 - Disclosure - SCHEDULE OF STOCK BASED COMPENSATION EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000091 - Disclosure - SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN (Details) link:presentationLink link:calculationLink link:definitionLink 00000092 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000093 - Disclosure - SCHEDULE OF MATCHING CONTRIBUTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000094 - Disclosure - CONCENTRATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000095 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000096 - Disclosure - SCHEDULE OF TAX REBATES (Details) link:presentationLink link:calculationLink link:definitionLink 00000097 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 00000098 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000099 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) link:presentationLink link:calculationLink link:definitionLink 00000100 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000101 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000102 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000103 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 20 visl-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 21 visl-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 22 visl-20231231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Treasury Stock, Common [Member] Retained Earnings [Member] Geographical [Axis] UNITED KINGDOM NETHERLANDS Customer [Axis] Single Customer [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Accounts Receivable [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents and Licenses [Member] Other Intangible Assets [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Trading Activity [Axis] Period End GBP to $1 Exchange Rate [Member] Derivative Instrument [Axis] GBP to USD [Member] Period End EUR to $1 Exchange Rate [Member] Award Type [Axis] GBP [Member] Euro to GBP [Member] Period Average GBP to $1 Exchange Rate [Member] Period Average EUR to $1 Exchange Rate [Member] Investment, Issuer Name [Axis] HSBC USA INC CP [Member] Federal Home Loan Banks [Member] Federal National Mortgage Association [Member] Financial Instrument [Axis] Federal Bonds [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Federal Bonds Held To Maturity [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Nonrecurring [Member] Fair Value, Inputs, Level 3 [Member] Right Of Use Asset Impairment [Member] Business Acquisition [Axis] BMS, LLC [Member] Legal Entity [Axis] Vislink Poway LLC [Member] Long-Lived Tangible Asset [Axis] Furniture and Fixtures [Member] Leasehold Improvements [Member] Computer Equipment [Member] Proprietary Technology [Member] Trade Names and Technology [Member] Customer Relationships [Member] Debt Instrument [Axis] Notes Payable One [Member] Notes Payable Two [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] D & O Insurance Policy Renewed [Member] Colchester, U.K. - Waterside House [Member] Lutton, UK [Member] Billerica, MA [Member] Mount Olive, NJ [Member] Trivex Singapore [Member] Dubai, UAE [Member] Poway CA [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Colchester UK [Member] Hemel United Kingdom [Member] Series B Preferred Stock [Member] Series D Preferred Stock [Member] Series E Preferred Stock [Member] Series D Convertible Preferred Stock [Member] Series E Convertible Preferred Stock [Member] Series D Preferred Stock and Series E Preferred Stock [Member] Title of Individual [Axis] Specific Board Members [Member] Restricted Stock Units (RSUs) [Member] Consulting Agreement [Member] Common Stock Warrants [Member] Warrants [Member] Exercise Price Range [Axis] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Exercise Price Range Four [Member]. Plan Name [Axis] 2023 Omnibus Equity Incentive Plan [Member] Various Equity Compensation Plans [Member] Long Term Stock Incentive Plan Awards [Member] Time Vested Option Inducement Awards [Member] Time Based Restricted Stock Awards [Member] Performance Based Stock Option Inducement [Member] Performance Based Restricted Stock Awards [Member] Group Personal Pension Plan, UK [Member] Accounts Payable [Member] Supplier Concentration Risk [Member] Supplier [Axis] Single Vendor [Member] One Vendor [Member] North America [Member] South America [Member] Europe [Member] Asia [Member] Rest of World [Member] Income Statement Location [Axis] Equipment Sales [Member] Installation, Integration and Repairs [Member] Warranties [Member] UNITED STATES Income Tax Authority, Name [Axis] Her Majesty's Revenue and Customs (HMRC) [Member] Dividends Payable [Member] Income Tax Authority [Axis] Domestic Tax Authority [Member] Hale Capital Partners, LP [Member] State and Local Jurisdiction [Member] Foreign Tax Authority [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current assets Cash Accounts receivable, net Inventories, net Investments held to maturity Prepaid expenses and other current assets Total current assets Right of use assets, operating leases Property and equipment, net Intangible assets, net Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable Accrued expenses Notes payable Operating lease obligations, current Customer deposits and deferred revenue Total current liabilities Operating lease obligations, net of current portion Deferred tax liabilities Total liabilities Commitments and contingencies (See Note 17) Series A Preferred stock, $0.00001 par value per share: -0- and 47,419 shares authorized on December 31, 2023, and 2022, respectively; -0- and 47,419 shares issued and outstanding on December 31, 2023, and 2022, respectively at a redemption value equal to $0.10 in cash for each ten thousand (10,000) whole shares. Stockholders’ equity Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on December 31, 2023, and 2022, respectively Common stock value Additional paid-in capital Accumulated other comprehensive loss Treasury stock, at cost – 133 shares as of December 31, 2023, and 2022, respectively Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Statement [Table] Statement [Line Items] Temporary equity, par value Temporary equity, shares authorized Temporary equity, shares issued Temporary equity, shares outstanding Temporary equity, redemption value per share Temporary equity, redemption shares Preferred stock, par value Preferred stock, shares authorized Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Treasury stock, shares Income Statement [Abstract] Revenue, net Cost of revenue and operating expenses Cost of components and personnel Inventory valuation adjustments General and administrative expenses Research and development Impairment of right-of-use assets Depreciation and amortization Total cost of revenue and operating expenses Loss from operations Other income (expenses) Unrealized gain on investments in debt securities held to maturity Realized loss on investments in debt securities Gain on settlement of debt Other income Dividend income Interest income (expense), net Total other income Net loss before income taxes Income taxes Deferred tax benefits Net loss Dividends Net loss attributable to common shareholders Net loss per share attributable to Common Shareholders: Basic Diluted Weighted average number of shares outstanding: Basic Diluted Comprehensive loss: Unrealized gain on currency translation adjustment Comprehensive loss Balance Balance, shares Net loss Unrealized gain on currency translation adjustment Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares Issuance of common stock in connection with: Satisfaction of accounts payable vendor balance Satisfaction of accounts payable vendor balance, shares Satisfaction of withholding tax upon conversion of restricted stock units Satisfaction of withholding tax upon conversion of restricted stock units, shares Satisfaction with the conversion of restricted stock units Satisfaction with the conversion of restricted stock units, shares Stock-based compensation Elimination of Series A Preferred Stock Elimination of Series A Preferred Stock, shares Compensation awards for services previously accrued Compensation awards for services previously accrued, shares Satisfaction with the conversion of restricted stock unit awards Satisfaction with the conversion of restricted stock unit awards, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows used in operating activities Adjustments to reconcile net loss to net cash used in operating activities Gain on settlement of debt Unrealized gain on investments in debt securities Realized loss on investments in debt securities Accretion of bond discount Stock-based compensation Stock issuance commitments Provision for bad debt Recovery of bad debt Inventory valuation adjustments Amortization of right-of-use assets, operating assets Impairment of right-of-use assets Deferred tax benefits Changes in assets and liabilities Accounts receivable Inventory Prepaid expenses and other current assets Accounts payable Accrued expenses and interest expense Accrued directors’ compensation Operating lease liabilities Deferred revenue and customer deposits Net cash used in operating activities Cash flows used in investing activities Cash used for investment in securities held to maturity Cash used in asset acquisition Proceeds for bond redemption Cash used for property and equipment Net cash used in investing activities Cash flows used in financing activities Principal payments made on D & O notes payable Net cash used in financing activities Effect of exchange rate changes on cash Net decrease in cash Cash and cash equivalents, beginning of the period Cash and cash equivalents, end of the period Supplemental disclosure of cash payments: Cash paid during the period for interest Supplemental disclosure of non-cash information: Notes payable recognized on D & O Insurance policy (Note 15) Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders Common stock issued in connection with: Board compensation awards previously accrued Settlement of amounts due accounts payable ROU assets and operating lease obligations recognized (Note 16): Operating lease assets recognized Less: non-cash changes to operating lease assets amortization amortization impairments loss on lease impairments ROU assets and operating lease obligations recognized Operating lease liabilities recognized Less: non-cash changes to operating lease liabilities accretion Operating lease liabilities recognized Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS Liquidity And Financial Condition LIQUIDITY AND FINANCIAL CONDITION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Earnings Per Share [Abstract] LOSS PER SHARE Foreign Currency [Abstract] FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES Cash and Cash Equivalents [Abstract] CASH AND CASH EQUIVALENTS Investments, All Other Investments [Abstract] INVESTMENTS Fair Value Disclosures [Abstract] FAIR VALUE OF ASSETS AND LIABILITIES Business Combination and Asset Acquisition [Abstract] ASSET ACQUISITION Receivables [Abstract] ACCOUNTS RECEIVABLE Inventory Disclosure [Abstract] INVENTORIES Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Payables and Accruals [Abstract] ACCRUED EXPENSES Debt Disclosure [Abstract] NOTES PAYABLE Leases LEASES Equity [Abstract] PREFERRED SHARES STOCKHOLDERS’ EQUITY Share-Based Payment Arrangement [Abstract] STOCK-BASED COMPENSATION Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Risks and Uncertainties [Abstract] CONCENTRATIONS Revenue from Contract with Customer [Abstract] REVENUE Rebates REBATES Gains On Settlement Of Debt GAINS ON SETTLEMENT OF DEBT Income Tax Disclosure [Abstract] INCOME TAXES Reclassification Of Prior Year Presentation RECLASSIFICATION OF PRIOR YEAR PRESENTATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Principles of Consolidation Segment Reporting Use of Estimates Risks and Uncertainties Allowance for Credit Losses Cash and Cash Equivalents Concentrations Accounts Receivable and Allowance for Doubtful Accounts Inventories Investment in Debt Securities Business Combinations and Asset Acquisitions Property and Equipment Intangible Assets Warranty Reserve Shipping and Handling Costs Treasury Stock Revenue Recognition Research and Development Expenses Leases Stock-Based Compensation Impairment and Abandonment Income Taxes Advertising Costs Sales Tax and Value-Added Taxes Loss Per Share Foreign Currency and Other Comprehensive (Gains) Losses Fair Value of Financial Instruments and Fair Value Measurements Redeemable Preferred Stock Recently Issued Accounting Pronouncements Recent Accounting Pronouncements SCHEDULE OF PRODUCT WARRANTY LIABILITY SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME SCHEDULE OF CASH AND CASH EQUIVALENTS SCHEDULE OF INVESTMENTS HELD TO MATURITY SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED SCHEDULE OF ACCOUNTS RECEIVABLE SCHEDULE OF INVENTORIES SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF CAPITALIZED INTANGIBLE COSTS SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS SCHEDULE OF ACCRUED EXPENSES SCHEDULE OF NOTES PAYABLE SCHEDULE OF LEASE OBLIGATIONS ASSUMED SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES SCHEDULE OF WARRANT OUTSTANDING SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] SCHEDULE OF STOCK BASED COMPENSATION EXPENSE SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN SCHEDULE OF MATCHING CONTRIBUTIONS SCHEDULE OF DISAGGREGATION OF REVENUE SCHEDULE OF TAX REBATES SCHEDULE OF GAINS ON SETTLEMENT OF DEBT SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES Operating loss Cash for operating activities Working capital Cash Accumulated deficit Warranty reserve, beginning Warranty reserve expense Warranty claims settled and true-up of accrual Warranty reserve, ending Schedule of Product Information [Table] Product Information [Line Items] Number of operating segments Cash FDIC insured amount Cash FSCS insured amount Dutch deposit guarantee scheme Cash uninsured amount Revenue Risk percentage Accounts receivable Property and equipment, estimated useful life Finite-lived intangible asset, useful life Amortization of intangible assets Shipping and handling costs Right-of-use operating assets impaired Loss on impairment of right-of-use assets Advertising costs Preferred stock redemption terms Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share: Total (Gains) Losses Unrealized (gains) losses on currency translation adjustment Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table] Trading Activity, Gains and Losses, Net [Line Items] Foreign currency exchange rate, translation Average foreign currency exchange rate remeasurement Cash on hand Federally insured money market mutual funds Total cash and cash equivalents Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Investments held to maturity, amortized cost Investments held to maturity, unrealized gain Investments held to maturity, unrealized loss Investments held to maturity, fair value Schedule of Investments [Table] Schedule of Investments [Line Items] Investment Owned, Fair Value Investment Owned, Balance, Principal Amount Investment par value Investment Maturity Date Investment Interest Rate Investment discount Gain (Loss) on Investments Investment Income, Interest Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Total Assets Total Liabilities Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Assets acquired: Work-in-process inventory Intangible assets - customer relationships total assets Liabilities assumed: Deferred revenue total liabilities Total cash used for asset acquisition Acquisition price Transaction costs Cash consideration paid Acquisition of additional inventory price Accounts receivable Allowance for doubtful accounts Net accounts receivable Bad debt expense Bad debt recoveries Raw materials Work-in-process Finished goods Sub-total inventories Less reserve for slow-moving and excess inventory Total inventories, net Inventory written-off due to obsolescence Product lines impairing of inventories Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated useful life Property and equipment, cost Accumulated depreciation Property and equipment, net Property and equipment, depreciation Depreciation leasehold improvement Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Beginning balance cost Beginning balance, accumulated amortization Beginning balance net Intangible assets, Additions Intangible assets, amortization Ending balance cost Ending balance, accumulated Amortization Ending balance net Net capitalized intangible costs Amortization of intangible assets  2024 2025 2026 2027 2028 Thereafter Intangible assets, estimated amortization expense Weighted average remaining life of intangible assets Compensation Commissions Warranty Accrued expenses other Deferred equity Accrued expenses Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Debt instrument, face amount Debt instrument down payment Notes Payable Annual interest rate Debt monthly principal and interest payment Interest expense Area of land Lease-End Month Lease-End Year Approximate Future Payments Schedule Of Right Of Use Operating Lease Data Cost Accumulated amortization Operating lease right of use asset Operating lease liability, Current portion Non-current portion Operating lease liability Weighted-average discount rate-operating leases Weighted-average remaining lease term-operating leases Lease maturity dates for right-of-use operating leases Operating lease cost Short-term lease cost Total lease cost Cash flows from operating leases Right-of-use assets obtained in exchange for new operating lease liabilities Schedule Of Future Minimum Rental Payments For Operating Leases 2024 2025 2026 2027 2028 Thereafter Total lease payments Less: imputed interest Present value of lease liabilities Less: Current lease liabilities Non-current lease liabilities Area of Land Lease expiration Payments for rent Lease description Loss on impairment of Right Of Use Asset Area of land description Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock shares authorized Preferred Stock, Par or Stated Value Per Share Share issued price per share Preferred stock voting rights Preferred stock redemption terms, description Preferred stock unissued Preferred stock par value Preferred stock shares, issued Preferred stock shares, outstanding Number of warrants beginning balance Weighted average exercise price beginning outstanding Number of warrants expired Weighted average exercise price expired Number of warrants ending outstanding Weighted average exercise price ending outstanding Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Warrants outstanding and exercisable, Range of exercise prices Warrants Outstanding and Exercisable (in shares) Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) Warrants outstanding and exercisable, Weighted Average Exercise Price Common stock shares authorized Common stock shares outstanding Issuance of common stock share Issuance of common stock share value Shares attributable to withholding tax Restricted stock options, granted Stock compensation costs Stock issued during period for services, shares Shares issued price per share Stock issued during period for services, value+ Services liabilities Gain on extinguishment debt Warrants expired Weighted average exercise price ending exercisable Weighted average remaining contractual life Stock-based compensation expense Number of options, Outstanding, Beginning balance Weighted average exercise price, outstanding beginning balance Number of options, Stock options forfeited Weighted average exercise price, Canceled, expired, forfeited Number of options, ending outstanding Weighted average exercise price, outstanding ending balance Number of options exercisable Weighted average exercise price, exercisable balance Remaining compensation expense Remaining amortization period Weighted average remaining contractual life - options exercisable Weighted average remaining contractual life - options exercisable Intrinsic value per share Range of exercise prices, lower limit Range of exercise prices, upper limit Number of restricted stock, Outstanding, Beginning balance Weighted average exercise price, restricted stock, beginning balance Number of options, Granted Weighted average exercise price, Granted Number of restricted stock, Granted Weighted average exercise price, restricted stock, Granted Number of restricted stock, Canceled, expired, forfeited Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited Number of options, Stock units exercised Weighted average exercise price, Stock units exercised Number of restricted stock, Stock units exercised Weighted average exercise price, restricted stock, Stock units exercised Number of restricted stock, Outstanding, Ending balance Weighted average exercise price, Outstanding, Ending balance Number of restricted stock, Exercisable Weighted average exercise price, restricted stock, Exercisable Weighted average remaining contractual life, options outstanding Weighted average remaining contractual life, exercisable Weighted average exercise price, restricted stock, Stock units exercised Weighted average exercise price, restricted stock, Ending balance Share based compensation authorized, shares Company matching contributions Concentration Risk [Table] Concentration Risk [Line Items] Revenue from Contract with Customer, Excluding Assessed Tax Concentration risk percentage Accounts payable Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Long-Lived Assets Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Total tax rebates Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Gains on settlement of debt Shares of common stock issued Common stock accumulated value Amount payable Dividends settlement amount Shares issued for dividend settlement Current tax provision Federal State Current income tax expense, total Deferred tax provision (benefit) Federal State Foreign Change in the valuation allowance Total deferred tax provision (benefit) Income tax provision Statutory federal income tax rate State and local taxes, net of federal benefit Permanent differences Executive compensation Equity compensation Provision to return DTA adjustment for state NOL Foreign Rate Differential Change rate Valuation allowance Effective tax rate Federal R&D credit Inventory Allowance for bad debt Compensation related Pension Other accruals State net operating losses Federal net operating losses Interest disallowance Stock options Other Valuation Allowance Total Deferred Tax Assets Property and Equipment Intangibles Prepaid Expenses Total Deferred Tax Liabilities Net Deferred Tax Liability Operating loss carryforwards Deferred tax assets, tax credit carryforwards, research Operating loss carryforwards, expiration description Effective for tax years, description Subsequent Event [Table] Subsequent Event [Line Items] Base rent Liquidity and financial condition [Text block] Working capital. Dutch deposit guarantee scheme. Area of land description. Lutton, UK [Member] Single Customer [Member] Dubai, UAE [Member] Inventory valuation adjustments. Impairment on right of use assets. Mount Olive, NJ [Member] Colchester UK [Member] InvestmentInDebtSecurities [Policy Text Block] Patents and Licenses [Member] Temporary equity, redemption shares. Group Personal Pension Plan, UK [Member] One Vendor [Member] Hemel United Kingdom [Member] Trivex Singapore [Member] Rest of World [Member] Issuance of common stock in connection with abstract. Equipment Sales [Member] Installation, Integration and Repairs [Member] Warranties [Member] Satisfaction with conversion of restricted stock unit awards Shipping And Handling Costs [Policy Text Block] Stock issued during period value elimination of series A preferred stock. Cost incurred during the period in shipping and handling goods and services to customers. Stock issued during period shares elimination of series A preferred stock. Treasury Stock [Policy Text Block] Satisfaction of accounts payable vendor balance. Satisfaction of withholding tax upon conversion of restricted stock units. Impairment And Abandonment [Policy Text Block] Stock issued during period value compensation awards for services previously accrued. Billerica, MA [Member] Schedule of Lease Obligations Assumed [Table Text Block] Satisfaction of accounts payable vendor balance shares. Satisfaction of withholding tax upon conversion of restricted stock units shares. Satisfaction of withholding tax upon conversion. Colchester, U.K. - Waterside House [Member] Sales Tax And Value Added Taxes [Policy Text Block] Stock issued during period shares compensation awards for services previously accrued. Satisfaction with conversion of restricted stock unit awards shares Newly Issued Accounting Pronouncements Policy [Policy Text Block] Gain On Settlement Of Debt [Text Block] Gain On Settlement Of Debt [Table Text Block] Effective income tax rate reconciliation executive compensation tax benefit percent Effective income tax rate reconciliation in respect of provision to return. Effective income tax rate reconciliation tax contingencies DTA adjustment for state NOL. Redeemable Preferred Stock [Policy Text Block] Accretion of bond discount. Stock issuance commitments. Recovery of bad debt. Impairment on right of use assets. Increase decrease in accrued directors compensation. Cash used for investment in securities held to maturity. Carried Forward Indefinitely [Member] Operating loss carryforwards, expiration description. Effective for tax years, description. Reclassification of Prior Year Presentation [Text Block] Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders. Common stock issued in connection with abstract. Settlement of amounts due accounts payable. Board compensation awards previously accrued. Non cash disclosures of rou assets and operating lease obligation abstract. Operating lease assets recognized. Noncash Changes To Operating Lease Assets [Abstract] Operating lease asset amortization. Operating impairments. Loss on lease impairments. Operating lease liabilities recognized. Noncash changes to operating lease liabilities accretion. ROU assets and operating lease obligations recognized. Operating lease liabilities recognized. Operating lease right of use asset lease cost. Operating lease right of use asset accumulated amortization. Federal National Mortgage Association [Member] Proceeds for bond redemption. Series D Convertible Preferred Stock [Member] Series E Convertible Preferred Stock [Member] Series D Preferred Stock and Series E Preferred Stock [Member] BMS, LLC [Member] Consulting Agreement [Member] Unrealized gain on investments in debt securities held to maturity. Debt securities realized loss. Specific Board Members [Member] Common Stock Warrants [Member] Weighted Average Exercise Price. Weighted Average Exercise Price. Weighted Average Exercise Price, cancelled/expired. Schedule Of Warrant Outstanding Exercise Price [Table Text Block] Share based compensation shares authorized under non option outstanding and exercise price range. Warrants [Member]. Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Exercise Price Range Four [Member]. Share based compensation arrangement by share based payment award non option equity instruments outstanding and exercisable numbers. Share based compensation shares authorized under stock option plans exercise price range outstanding and exercisable options weighted average remaining contractual term two. Satisfaction with conversion of restricted stock units. Share based compensation shares authorized under stock option plans exercise price range outstanding and exercisable options weighted average exercise price one. Share based compensation arrangement by share based payment award grant date. Time Vested Option [Member] Proprietary Technology [Member] Trade Names and Technology [Member] Options vesting commencement date. Share based compensation arrangement by share based payment award vesting date. Performance Based Option [Member] Performancebasedstock Option [Member] Options grant date. Vested date. Vested Remaning contractual term Veated Remaning contractual terms. Chief Product Officer [Member] D & O Insurance Policy Renewed [Member] Notes Payable One [Member] Debt instrument down payment. VP Global Operations [Member] Group of 22 Employees [Member] Carleton M. Miller [Member] Notes Payable Two [Member] Income Tax Rebates [Text Block] Share based compensation arrangement by share based payment award equity instruments other than exercised Restricted stock units, exercisable weighted average exercise price. Amortization period. Federal Bonds [Member] Risks And Uncertainties [Policy Text Block] Poway CA [Member] Michael C Bond [Member] Group of 6 Employees [Member] Group of 11 Employees [Member] Steven Teese [Member] Federal Bonds Held To Maturity [Member] Right Of Use Asset Impairment [Member] Long Term Stock Incentive Plan Awards [Member] Time Vested Option Inducement Awards [Member] Various Equity Compensation Plans [Member] Schedule Of Share Based Compensation Employee Stock Purchase Plan Activities [Table Text Block] Cash FSCS insured amount. Vislink Poway LLC [Member] 2023 Omnibus Equity Incentive Plan [Member] Period End GBP to $1 Exchange Rate [Member] Period End EUR to $1 Exchange Rate [Member] Period Average GBP to $1 Exchange Rate [Member] Period Average EUR to $1 Exchange Rate [Member] Investment par value. Performance Based Stock Option Inducement [Member] Time Based Restricted Stock Awards [Member] Performance Based Restricted Stock Awards [Member] Investment discount. HSBC USA INC CP [Member] Federal Home Loan Banks [Member] Lease expiration year. Lease expiration month. Discretionary bonus percentage. Share based compensation arrangements by share based payment award other than options exercises in period weighted average exercise price. Share based compensation arrangements by share based payment award other than options exercisable number. Share based compensation arrangements by share based payment award other than options exercisable weighted average exercise price. Single Vendor [Member] Dividends Payable [Member] Share based compensation arrangement by share based payment award other than options exercisable weighted average remaining contractual term 1. GBP To USD [Member] GBP [Member] Euro To GBP [Member] Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Equity, Attributable to Parent Liabilities and Equity Costs and Expenses Operating Income (Loss) DebtSecuritiesRealizedLoss Nonoperating Income (Expense) Redeemable Preferred Stock Dividends Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Debt Securities, Unrealized Gain (Loss) Debt Securities, Realized Gain (Loss) AccretionOfBondDiscount RecoveryOfBadDebt Inventory, LIFO Reserve, Effect on Income, Net ImpairmentOfRightofuseAssets Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Net Cash Provided by (Used in) Operating Activities CashUsedForInvestmentInSecuritiesHeldToMaturity Payments to Acquire Businesses, Net of Cash Acquired Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Medium-term Notes Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders [Default Label] Operating lease liabilities recognized [Default Label] Lessee, Leases [Policy Text Block] Cash [Default Label] Standard and Extended Product Warranty Accrual Standard and Extended Product Warranty Accrual, Decrease for Payments Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Accounts Receivable, before Allowance for Credit Loss, Current Accounts Receivable, Allowance for Credit Loss, Current Inventory, Gross Inventory Valuation Reserves Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Net Lease, Cost Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid, Year Five Lessee, Operating Lease, Liability, to be Paid, after Year Five Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue Accounts Payable Current Income Tax Expense (Benefit) Deferred Federal Income Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Income Tax Expense (Benefit) Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Gross Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Intangible Assets Deferred Tax Liabilities, Prepaid Expenses Deferred Tax Liabilities, Gross Deferred Tax Liabilities, Net EX-101.PRE 23 visl-20231231_pre.xml XBRL PRESENTATION FILE XML 25 R1.htm IDEA: XBRL DOCUMENT v3.24.1
    Cover - USD ($)
    $ in Millions
    		 12 Months Ended
    Dec. 31, 2023
    Mar. 29, 2024
    Jun. 30, 2023
    Cover [Abstract]      
    Document Type 10-K    
    Amendment Flag false    
    Document Annual Report true    
    Document Transition Report false    
    Document Period End Date Dec. 31, 2023    
    Document Fiscal Period Focus FY    
    Document Fiscal Year Focus 2023    
    Current Fiscal Year End Date --12-31    
    Entity File Number 001-35988    
    Entity Registrant Name Vislink Technologies, Inc.    
    Entity Central Index Key 0001565228    
    Entity Tax Identification Number 20-5856795    
    Entity Incorporation, State or Country Code DE    
    Entity Address, Address Line One 350 Clark Drive    
    Entity Address, Address Line Two Suite 125    
    Entity Address, City or Town Mt. Olive    
    Entity Address, State or Province NJ    
    Entity Address, Postal Zip Code 07828    
    City Area Code 908    
    Local Phone Number 852-3700    
    Title of 12(b) Security Common Stock, par value $0.00001    
    Trading Symbol VISL    
    Security Exchange Name NASDAQ    
    Entity Well-known Seasoned Issuer No    
    Entity Voluntary Filers No    
    Entity Current Reporting Status Yes    
    Entity Interactive Data Current Yes    
    Entity Filer Category Non-accelerated Filer    
    Entity Small Business true    
    Entity Emerging Growth Company false    
    Entity Shell Company false    
    Entity Public Float     $ 13.5
    Entity Common Stock, Shares Outstanding   2,448,482  
    Document Financial Statement Error Correction [Flag] false    
    Auditor Firm ID 688    
    Auditor Name Marcum LLP    
    Auditor Location New York, NY    

  •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
  •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form10-k_htm.xml IDEA: XBRL DOCUMENT 0001565228 2023-01-01 2023-12-31 0001565228 2023-06-30 0001565228 2024-03-29 0001565228 2023-12-31 0001565228 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001565228 2022-01-01 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001565228 us-gaap:CommonStockMember 2021-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2021-12-31 0001565228 us-gaap:RetainedEarningsMember 2021-12-31 0001565228 2021-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0001565228 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0001565228 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001565228 us-gaap:CommonStockMember 2023-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001565228 us-gaap:TreasuryStockCommonMember 2023-12-31 0001565228 us-gaap:RetainedEarningsMember 2023-12-31 0001565228 country:GB 2023-12-31 0001565228 country:NL 2023-12-31 0001565228 VISL:SingleCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember 2023-12-31 0001565228 srt:MaximumMember 2023-12-31 0001565228 srt:MinimumMember VISL:PatentsAndLicensesMember 2023-12-31 0001565228 srt:MaximumMember VISL:PatentsAndLicensesMember 2023-12-31 0001565228 VISL:PatentsAndLicensesMember 2023-01-01 2023-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember us-gaap:OtherIntangibleAssetsMember 2023-12-31 0001565228 srt:MaximumMember us-gaap:OtherIntangibleAssetsMember 2023-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember 2022-01-01 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-01 2022-11-30 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-30 0001565228 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001565228 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001565228 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001565228 VISL:PeriodEndGBPToUSDollarOneExchangeRateMember 2023-12-31 0001565228 VISL:GBPToUSDMember 2023-12-31 0001565228 VISL:PeriodEndEURToUSDollarOneExchangeRateMember 2023-12-31 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2023-12-31 0001565228 VISL:PeriodAverageGBPToUSDollarOneExchangeRateMember 2023-12-31 0001565228 VISL:PeriodAverageEURToUSDollarOneExchangeRateMember 2023-12-31 0001565228 VISL:PeriodEndGBPToUSDollarOneExchangeRateMember 2022-12-31 0001565228 VISL:GBPToUSDMember 2022-12-31 0001565228 VISL:PeriodEndEURToUSDollarOneExchangeRateMember 2022-12-31 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2022-12-31 0001565228 VISL:PeriodAverageGBPToUSDollarOneExchangeRateMember 2022-12-31 0001565228 VISL:PeriodAverageEURToUSDollarOneExchangeRateMember 2022-12-31 0001565228 VISL:HSBCUSAINCCPMember 2023-01-23 0001565228 VISL:HSBCUSAINCCPMember 2023-10-24 2023-10-24 0001565228 VISL:FederalHomeLoanBanksMember 2023-02-01 0001565228 VISL:FederalHomeLoanBanksMember 2023-02-01 2023-02-01 0001565228 VISL:FederalNationalMortgageAssociationMember 2023-02-28 0001565228 VISL:FederalNationalMortgageAssociationMember 2023-12-31 0001565228 VISL:HSBCUSAINCCPMember 2023-10-11 0001565228 VISL:HSBCUSAINCCPMember 2023-12-31 0001565228 VISL:FederalBondsMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VISL:FederalBondsHeldToMaturityMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VISL:FederalBondsHeldToMaturityMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember VISL:FederalBondsHeldToMaturityMember 2023-12-31 0001565228 VISL:FederalBondsHeldToMaturityMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VISL:RightOfUseAssetImpairmentMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VISL:RightOfUseAssetImpairmentMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember VISL:RightOfUseAssetImpairmentMember 2023-12-31 0001565228 VISL:RightOfUseAssetImpairmentMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001565228 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VISL:FederalBondsHeldToMaturityMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VISL:FederalBondsHeldToMaturityMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember VISL:FederalBondsHeldToMaturityMember 2022-12-31 0001565228 VISL:FederalBondsHeldToMaturityMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember VISL:RightOfUseAssetImpairmentMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember VISL:RightOfUseAssetImpairmentMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember VISL:RightOfUseAssetImpairmentMember 2022-12-31 0001565228 VISL:RightOfUseAssetImpairmentMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001565228 VISL:BMSLLCMember VISL:VislinkPowayLLCMember 2023-09-14 2023-09-14 0001565228 VISL:BMSLLCMember VISL:VislinkPowayLLCMember 2023-10-02 0001565228 VISL:BMSLLCMember VISL:VislinkPowayLLCMember 2023-09-14 0001565228 VISL:BMSLLCMember 2023-09-14 2023-09-14 0001565228 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001565228 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001565228 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001565228 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001565228 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2023-12-31 0001565228 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2023-12-31 0001565228 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001565228 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001565228 srt:MinimumMember us-gaap:ComputerEquipmentMember 2023-12-31 0001565228 srt:MaximumMember us-gaap:ComputerEquipmentMember 2023-12-31 0001565228 us-gaap:ComputerEquipmentMember 2023-12-31 0001565228 us-gaap:ComputerEquipmentMember 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember 2023-01-01 2023-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2023-01-01 2023-12-31 0001565228 VISL:ProprietaryTechnologyMember 2023-12-31 0001565228 VISL:PatentsAndLicensesMember 2023-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2023-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2023-12-31 0001565228 VISL:ProprietaryTechnologyMember 2021-12-31 0001565228 VISL:PatentsAndLicensesMember 2021-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2021-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2021-12-31 0001565228 VISL:ProprietaryTechnologyMember 2022-01-01 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-01-01 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember VISL:ProprietaryTechnologyMember 2023-12-31 0001565228 srt:MaximumMember VISL:ProprietaryTechnologyMember 2023-12-31 0001565228 VISL:NotesPayableOneMember 2023-12-31 0001565228 VISL:NotesPayableOneMember 2022-12-31 0001565228 VISL:NotesPayableTwoMember 2023-12-31 0001565228 VISL:NotesPayableTwoMember 2022-12-31 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2022-04-05 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2022-04-04 2022-04-05 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2023-01-01 2023-12-31 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2022-01-01 2022-12-31 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2023-04-05 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2023-04-04 2023-04-05 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2023-01-01 2023-12-31 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2022-01-01 2022-12-31 0001565228 VISL:ColchesterUKWatersideHouseMember 2023-12-31 0001565228 VISL:ColchesterUKWatersideHouseMember 2023-01-01 2023-12-31 0001565228 VISL:LuttonUKMember 2023-12-31 0001565228 VISL:LuttonUKMember 2023-01-01 2023-12-31 0001565228 VISL:BillericaMaMember 2023-12-31 0001565228 VISL:BillericaMaMember 2023-01-01 2023-12-31 0001565228 VISL:MountOliveNJMember 2023-12-31 0001565228 VISL:MountOliveNJMember 2023-01-01 2023-12-31 0001565228 VISL:TrivexSingaporeMember 2023-12-31 0001565228 VISL:TrivexSingaporeMember 2023-01-01 2023-12-31 0001565228 VISL:LuttonUKMember 2023-09-01 0001565228 VISL:LuttonUKMember 2023-09-01 2023-09-01 0001565228 VISL:LuttonUKMember 2023-02-01 0001565228 VISL:LuttonUKMember 2023-02-01 2023-02-01 0001565228 VISL:DubaiUAEMember 2023-01-01 2023-12-31 0001565228 VISL:DubaiUAEMember 2023-07-03 0001565228 VISL:DubaiUAEMember 2023-07-03 2023-07-03 0001565228 VISL:PowayCAMember 2022-01-01 2022-12-31 0001565228 VISL:PowayCAMember 2023-09-14 0001565228 VISL:PowayCAMember 2023-09-14 2023-09-14 0001565228 VISL:PowayCAMember us-gaap:SubsequentEventMember 2024-02-12 2024-02-12 0001565228 VISL:PowayCAMember us-gaap:SubsequentEventMember 2024-02-14 2024-02-14 0001565228 VISL:ColchesterUKMember 2023-09-30 0001565228 VISL:ColchesterUKMember 2023-12-31 0001565228 VISL:ColchesterUKMember 2023-09-01 2023-09-30 0001565228 VISL:HemelUnitedKingdomMember 2023-01-01 2023-12-31 0001565228 VISL:HemelUnitedKingdomMember 2023-12-31 0001565228 VISL:TrivexSingaporeMember 2023-08-10 0001565228 VISL:TrivexSingaporeMember 2023-08-10 2023-08-10 0001565228 VISL:LuttonUKMember 2022-01-01 2022-12-31 0001565228 VISL:LuttonUKMember 2022-04-28 0001565228 VISL:LuttonUKMember 2022-04-27 2022-04-28 0001565228 VISL:DubaiUAEMember 2022-01-01 2022-12-31 0001565228 VISL:DubaiUAEMember 2022-07-03 0001565228 VISL:DubaiUAEMember 2022-07-01 2022-07-03 0001565228 VISL:BillericaMaMember 2022-10-01 2022-12-31 0001565228 srt:MaximumMember 2013-03-31 0001565228 2013-03-31 0001565228 us-gaap:SeriesBPreferredStockMember 2016-02-05 0001565228 us-gaap:SeriesDPreferredStockMember 2016-04-25 0001565228 us-gaap:SeriesEPreferredStockMember 2016-12-21 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-08 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember 2023-01-10 2023-01-23 0001565228 VISL:SeriesDConvertiblePreferredStockMember 2016-04-25 0001565228 VISL:SeriesEConvertiblePreferredStockMember 2016-12-21 0001565228 VISL:SeriesDPreferredStockAndSeriesEPreferredStockMember 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember 2023-03-22 0001565228 us-gaap:SeriesAPreferredStockMember 2023-03-24 0001565228 VISL:SpecificBoardMembersMember 2023-01-01 2023-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2022-05-04 2022-05-04 0001565228 VISL:ConsultingAgreementMember 2022-05-04 0001565228 VISL:ConsultingAgreementMember 2022-07-19 2022-07-19 0001565228 VISL:ConsultingAgreementMember 2022-07-19 0001565228 VISL:CommonStockWarrantsMember 2023-01-01 2023-12-31 0001565228 VISL:CommonStockWarrantsMember 2023-12-31 0001565228 VISL:ExercisePriceRangeOneMember VISL:WarrantsMember 2023-01-01 2023-12-31 0001565228 VISL:ExercisePriceRangeOneMember VISL:WarrantsMember 2023-12-31 0001565228 VISL:ExercisePriceRangeOneMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeOneMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeTwoMember VISL:WarrantsMember 2023-01-01 2023-12-31 0001565228 VISL:ExercisePriceRangeTwoMember VISL:WarrantsMember 2023-12-31 0001565228 VISL:ExercisePriceRangeTwoMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeTwoMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeThreeMember VISL:WarrantsMember 2023-01-01 2023-12-31 0001565228 VISL:ExercisePriceRangeThreeMember VISL:WarrantsMember 2023-12-31 0001565228 VISL:ExercisePriceRangeThreeMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeThreeMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeFourMember VISL:WarrantsMember 2023-01-01 2023-12-31 0001565228 VISL:ExercisePriceRangeFourMember VISL:WarrantsMember 2023-12-31 0001565228 VISL:ExercisePriceRangeFourMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeFourMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:WarrantsMember 2023-01-01 2023-12-31 0001565228 VISL:WarrantsMember 2023-12-31 0001565228 VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember 2022-12-31 0001565228 VISL:TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember 2023-08-23 0001565228 VISL:VariousEquityCompensationPlansMember 2023-01-01 2023-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-01-01 2023-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-01-01 2022-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-01-01 2023-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-01-01 2022-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-01-01 2023-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-01-01 2022-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2022-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2021-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2022-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2021-12-31 0001565228 VISL:LongTermStockIncentivePlanAwardsMember 2023-12-31 0001565228 VISL:TimeVestedOptionInducementAwardsMember 2023-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2021-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2022-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2021-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2023-01-01 2023-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionInducementMember 2023-12-31 0001565228 VISL:TimeBasedRestrictedStockAwardsMember 2023-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2021-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-01-01 2023-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedRestrictedStockAwardsMember 2023-12-31 0001565228 VISL:GroupPersonalPensionPlanUKMember 2023-01-01 2023-12-31 0001565228 VISL:GroupPersonalPensionPlanUKMember 2022-01-01 2022-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:SingleVendorMember 2023-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:SingleVendorMember 2023-01-01 2023-12-31 0001565228 VISL:OneVendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-12-31 0001565228 VISL:OneVendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-12-31 0001565228 VISL:OneVendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001565228 VISL:OneVendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 srt:NorthAmericaMember 2023-01-01 2023-12-31 0001565228 srt:NorthAmericaMember 2022-01-01 2022-12-31 0001565228 srt:SouthAmericaMember 2023-01-01 2023-12-31 0001565228 srt:SouthAmericaMember 2022-01-01 2022-12-31 0001565228 srt:EuropeMember 2023-01-01 2023-12-31 0001565228 srt:EuropeMember 2022-01-01 2022-12-31 0001565228 srt:AsiaMember 2023-01-01 2023-12-31 0001565228 srt:AsiaMember 2022-01-01 2022-12-31 0001565228 VISL:RestOfWorldMember 2023-01-01 2023-12-31 0001565228 VISL:RestOfWorldMember 2022-01-01 2022-12-31 0001565228 VISL:EquipmentSalesMember 2023-01-01 2023-12-31 0001565228 VISL:EquipmentSalesMember 2022-01-01 2022-12-31 0001565228 VISL:InstallationIntegrationAndRepairsMember 2023-01-01 2023-12-31 0001565228 VISL:InstallationIntegrationAndRepairsMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantiesMember 2023-01-01 2023-12-31 0001565228 VISL:WarrantiesMember 2022-01-01 2022-12-31 0001565228 country:US 2023-12-31 0001565228 country:US 2022-12-31 0001565228 country:NL 2022-12-31 0001565228 country:GB 2022-12-31 0001565228 us-gaap:HerMajestysRevenueAndCustomsHMRCMember 2023-01-01 2023-12-31 0001565228 us-gaap:HerMajestysRevenueAndCustomsHMRCMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2023-01-01 2023-12-31 0001565228 VISL:DividendsPayableMember 2023-01-01 2023-12-31 0001565228 VISL:DividendsPayableMember 2022-01-01 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-05-04 2022-05-04 0001565228 us-gaap:CommonStockMember 2022-07-19 2022-07-19 0001565228 us-gaap:CommonStockMember 2022-05-04 0001565228 us-gaap:CommonStockMember 2022-07-19 0001565228 2022-11-21 2022-11-21 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-21 2022-11-21 0001565228 us-gaap:DomesticCountryMember 2023-12-31 0001565228 us-gaap:DomesticCountryMember VISL:CarriedForwardIndefinitelyMember 2023-12-31 0001565228 us-gaap:StateAndLocalJurisdictionMember 2023-12-31 0001565228 us-gaap:ForeignCountryMember 2023-12-31 0001565228 us-gaap:SubsequentEventMember 2024-02-12 2024-02-12 iso4217:USD shares iso4217:USD shares pure iso4217:GBP utr:sqft iso4217:AED iso4217:EUR VISL:Segment false FY 0001565228 10-K true 2023-12-31 --12-31 2023 false 001-35988 Vislink Technologies, Inc. DE 20-5856795 350 Clark Drive Suite 125 Mt. Olive NJ 07828 908 852-3700 Common Stock, par value $0.00001 VISL NASDAQ No No Yes Yes false Non-accelerated Filer true false false 13500000 2448482 688 Marcum LLP New York, NY 8482000 25627000 8680000 6007000 14029000 12021000 5731000 1560000 1232000 38482000 44887000 742000 1075000 1902000 1434000 3866000 4400000 44992000 51796000 3183000 2626000 1578000 1568000 84000 463000 455000 1490000 1540000 6714000 6273000 755000 1107000 546000 764000 8015000 8144000 0.00001 0.00001 0 47419 0 0 47419 47419 0.10 0.10 10000 10000 0.00001 0.00001 10000000 10000000 0.00001 0.00001 100000000 100000000 2439923 2367362 2439790 2367229 347507000 345365000 -1027000 -1337000 133 133 277000 277000 -309226000 -300099000 36977000 43652000 44992000 51796000 27482000 28131000 13380000 15204000 487000 2930000 19376000 18195000 3493000 4058000 83000 88000 1261000 1722000 38080000 42197000 -10598000 -14066000 68000 82000 46000 332000 303000 375000 560000 -38000 1253000 311000 -9345000 -13755000 -218000 -215000 -9127000 -13540000 20000 -9127000 -13560000 -3.83 -3.83 -5.81 -5.81 2381000 2381000 2335000 2335000 -9127000 -13540000 -310000 -1040000 -8817000 -12500000 2287651 343746000 -297000 -277000 -286539000 56633000 -13540000 -13540000 -1040000 -1040000 47419 -20000 -20000 3870 54000 54000 17889 57952 1565000 1565000 47419 2367362 345365000 -1337000 -277000 -300099000 43652000 47419 2367362 345365000 -1337000 -277000 -300099000 43652000 -9127000 -9127000 310000 310000 -47419 10000 200000 200000 14193 48368 1942000 1942000 2439923 347507000 -1027000 -277000 -309226000 36977000 2439923 347507000 -1027000 -277000 -309226000 36977000 -9127000 -13540000 46000 -68000 82000 -16000 1942000 1565000 200000 25000 21000 10000 517000 487000 2930000 375000 201000 83000 88000 1261000 1722000 -218000 -215000 2666000 -3197000 2185000 3731000 -200000 -1897000 559000 -347000 218000 -1780000 -8000 -344000 -506000 -342000 -558000 -9748000 -9419000 15473000 269000 9740000 698000 466000 -6700000 -466000 607000 765000 -607000 -765000 -90000 46000 -17145000 -10604000 25627000 36231000 8482000 25627000 12000 41000 523000 750000 20000 200000 200000 54000 125000 -375000 -201000 -83000 -43000 83000 -88000 -375000 -332000 125000 -469000 -506000 -344000 -506000 <p id="xdx_806_eus-gaap--NatureOfOperations_zFXrIfmHA25" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — <span id="xdx_828_z53dE2qkSC59">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink Technologies, Inc., (“Vislink”, “Company”, “we”, “us”, or “our”) incorporated in Delaware in 2006, is a global technology business that collects, delivers, and manages high-quality, live video and associated data from the action scene to the viewing screen. We provide solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. We also provide the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. Our team also offers professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in terrestrial microwave, fiber optic, surveillance, and wireless communications systems, delivering a broad spectrum of customer solutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Live Broadcast:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We deliver an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, cellular, IP (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing AI (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, we have the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions encompassing hardware components, hosted systems management platforms, related software licenses and ancillary support services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry-wide contributors acknowledge our live broadcast solutions. Our equipment transmits most outside wireless broadcast video content, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Our wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Military and Government:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Our solutions are specifically designed with interagency cooperation, utilizing the internationally recognized IP platform and a web interface for video delivery. We provide comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">integrated suites of airborne downlink transmitters, receivers, and antenna systems</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">data and video connectivity for airborne, marine, and ground assets</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UAV video distribution</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">flexible support for COFDM and bonded cellular/5G Networks</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">terrestrial point-to-point</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tactical mobile command</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">high-throughput air/marine/ground-to-anywhere uplink and downlink systems</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">secure live streaming platforms for use in mobile and fixed assets, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">personal portable products</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink Technologies, Inc. public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation, criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — NATURE OF OPERATIONS (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 408.45pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Connected Edge Solutions:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Mobile Viewpoint Technologies (MVP) offers the hardware and software solutions needed to acquire, produce, contribute to, and deliver video over all private and public networks. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">live video encoding, stream adaptation, decoding, and production solutions,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">remote production workflows,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">wireless cameras,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI-driven automated production, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the ability to contribute video over</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">○ bonded cellular (3G and 4G)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">○ satellite,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">○ fiber, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">○ emerging networks, including 5G and Starlink</span></td></tr></table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_804_ecustom--LiquidityAndFinancialConditionTextBlock_zMkZk8Gq44z9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 — <span id="xdx_82E_zNoRbIxGUCpg">LIQUIDITY AND FINANCIAL CONDITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the fiscal year ending December 31, 2023, we incurred a net loss of approximately $<span id="xdx_900_eus-gaap--OperatingIncomeLoss_iN_pn5n6_di_c20230101__20231231_zZJ4IUPHWYYd" title="Operating loss">10.6</span> million and utilized $<span id="xdx_901_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20230101__20231231_zp4ogDsuVmy5" title="Cash for operating activities">9.7</span> million in cash for operating activities. The Company maintained a working capital of $<span id="xdx_90F_ecustom--WorkingCapital_iI_pn5n6_c20231231_zWxK9cisCKp6" title="Working capital">31.8</span> million, alongside $<span id="xdx_905_eus-gaap--Cash_iI_pn5n6_c20231231_zEHPv18nZ5L8" title="Cash">8.5</span> million in cash, against $<span id="xdx_903_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20231231_z10QULzC7JFi" title="Accumulated deficit">309.2</span> million in accumulated deficits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify">Developments, including those beyond our control, may cause us to consume our available capital more quickly than we expect. These include potential economic conditions, including inflation, foreign exchange fluctuations, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 115%">the markets we compete in or wish to enter, strategic acquisitions, our market strategy, research and development activities, regulatory matters, and technology and product innovations. We believe we will have sufficient funds to continue our operations for at least 12 months from the date of filing these financial statements in our Annual Report.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Asset Acquisitions</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -10600000 -9700000 31800000 8500000 -309200000 <p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_zaGrLYmnyKN8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — <span id="xdx_824_zddvhJgCGcx5">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zxuOoEFjyosb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zihAtg5QNZAb">Principles of Consolidation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the Company’s accounts and wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating the Company’s subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zoWt1P98hbO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_z3orOaNotzmf">Segment Reporting</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as <span id="xdx_903_eus-gaap--NumberOfOperatingSegments_pid_dc_uSegment_c20230101__20231231_zdDWl8B4glWc" title="Number of operating segments">one</span> operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zUtXhOyTIDNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zgf5fqE7wEbb">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--RisksAndUncertaintiesPolicyTextBlock_z6Eq8CcW9dZc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zwquOUCDdGFk">Risks and Uncertainties</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The future impacts of the Russia-Ukraine war and the Israel-Hamas conflict, as well as their residual effects, include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries, remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.</p> <p id="xdx_85C_zuRVZCWef729" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_845_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_z3gwcGHBeK48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zVtWEPQK7Mka">Allowance for Credit Losses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zKlhYlvvCLsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_861_zUVkscJfVP82">Cash and Cash Equivalents</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund as of December 31, 2023, and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zugJiRwfXvci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_z0wBkOe1M6kl">Concentrations</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not possess any off-balance-sheet concentrations of credit risk. Credit risk, defined as the likelihood of a counterparty defaulting on contractual obligations, poses a potential financial loss for the Company. The primary sources of the Company’s credit risk are its cash, investments and accounts receivable. To mitigate the risk of loss exposure, the Company follows a policy of holding its cash in high-credit quality financial institutions. Cash deposits, representing a concentration of credit risk, are the main economic instruments exposing the Company to such risks. <span style="background-color: white">The Company has allocated $5.7 million towards investments in government bonds held to maturity to diversify our credit risk exposure further and enhance our risk mitigation strategies. These bonds, issued by the United States Federal Government, are evaluated for credit risk based on the issuing entity’s creditworthiness. This investment strategy is aligned with our overarching objective to minimize potential financial losses by spreading risk across various high-credit quality assets and instruments. </span>The Federal Deposit Insurance Corporation (“FDIC”) insures up to $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20231231_zqToVlzsKZp3" title="Cash FDIC insured amount">250,000</span> for accounts held within the United States. In the United Kingdom, the Company maintains cash balance accounts at financial institutions insured by the Financial Services Compensation Scheme, covering up to £<span id="xdx_906_ecustom--CashFSCSInsuredAmount_iI_pp0p0_uGBP_c20231231__srt--StatementGeographicalAxis__country--GB_zfXZs8fwCidk" title="Cash FSCS insured amount">85,000</span> (subject to currency translation rates to the United States dollar). Additionally, in the Netherlands, the Company’s cash balance accounts at financial institutions are insured by the “Dutch deposit guarantee scheme,” providing coverage up to €<span id="xdx_902_ecustom--DutchDepositGuaranteeScheme_iI_pp0p0_uEUR_c20231231__srt--StatementGeographicalAxis__country--NL_zCoCsxGEnEvb" title="Dutch deposit guarantee scheme">100,000</span> per person per bank.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, and 2022, the Company held approximately $<span id="xdx_90E_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20231231_znYY6AVFiey6" title="Cash uninsured amount">7.7</span> million and $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20221231_zOYGz7KuUCNe" title="Cash uninsured amount">24.5</span> million above insured limits, respectively, remaining unaffected by any losses in its bank accounts during this period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ending December 31, 2023, the Company did not report any sales to an individual customer that constituted more than 10% of its total sales. During the year ending December 31, 2022, the Company noted sales to a single customer amounting to $<span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zlnSBlkMZ3L" title="Revenue">3.4</span> million, representing <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zSoCzEQ5eId7" title="Concentration risk percentage">12</span>% of the Company’s total sales, in excess of 10% of its total sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, and 2022, the Company’s accounts receivable from a single customer were recorded at approximately $<span id="xdx_904_eus-gaap--AccountsReceivableNet_iI_pn5n6_c20231231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zmXK7iFVIb21" title="Accounts receivable">1.1</span> million (<span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9hvzUKHTEC2" title="Risk percentage">13</span>%) and $<span id="xdx_906_eus-gaap--AccountsReceivableNet_iI_pn5n6_c20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5TMWsPgapEh" title="Accounts receivable">1.1</span> million (<span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9vHrdvkbL3c" title="Risk percentage">19</span>%), respectively. Each instance surpassed the 10% mark of the Company’s total consolidated accounts receivable, indicating a significant concentration in customer receivables.</span></p> <p id="xdx_855_zE1fXzRSbPCa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zGg84PhgAL89" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zd6TSnDJoe05">Accounts Receivable and Allowance for Doubtful Accounts</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2023, the Company adopted Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments. The Company extends credit to its customers in the ordinary course of business and has applied a new standard in evaluating estimated losses through an allowance for doubtful accounts. The Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_848_eus-gaap--InventoryPolicyTextBlock_zubA4zkaYxta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zbPdEP8RAkGb">Inventories</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--InvestmentInDebtSecuritiesPolicyTextBlock_zYIVgYAYunQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zIm5hfJe6cS7">Investment in Debt Securities</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink Technologies, Inc. invests in government bonds with the intent and ability to hold these investments until maturity. In alignment with ASC Topic 320, Investments—Debt and Equity Securities, such investments are classified as “Held-to-Maturity” (HTM) securities and are measured at amortized cost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification: The Company classifies its investments in government bonds as “Held-to-Maturity” (HTM) securities based on management’s intent and ability to hold the securities to maturity. These HTM securities are recognized in the Company’s financial statements at their amortized cost, adjusted for the amortization of premiums and accretion of discounts to maturity.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Measurement: HTM securities are initially recognized at their acquisition cost, including transaction costs. Subsequently, they are measured at amortized cost using the effective interest method. This method considers the amortization of any discount or premium on the acquisition cost until maturity.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest Income: Interest income is accrued using the security’s effective yield, reflecting the time value of money.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of Discount and Premium: The amortization of the discount (or accretion of the premium) is included as part of the interest income recognized in the income statement, reflecting the adjustment to the investment’s yield.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment: The Company periodically assesses HTM investments for impairment if objective evidence indicates an impairment has been incurred. It recognizes any loss when the present value of estimated future cash flows, discounted at the original effective interest rate, is less than the carrying amount.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derecognition: A Held-to-Maturity investment is removed from the balance sheet when the right to receive cash flows has expired, or the Company has substantially transferred all ownership risks and rewards.</span></td></tr> </table> <p id="xdx_858_zvpZPoNrWJ5l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--BusinessCombinationsPolicy_zCBYsHmmRe9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zWqBmbo8zlvl">Business Combinations and Asset Acquisitions</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets. Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The distinction between business combinations and asset acquisitions involves judgment, particularly when applying the screen test to determine the nature of the transaction. Incorrect judgments or changes in decisions in these areas could materially affect the determination of goodwill, the recognition and measurement of acquired assets and assumed liabilities, and, consequently, our financial position and results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zP2KJkVq5ql5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_z3Ng498QGgd4">Property and Equipment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember_zOtnXEYZhPuf" title="Estimated useful life">1</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember_zKlGDz0RolEd" title="Property and equipment, estimated useful life">14</span> years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in the expenses as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zJjLuyqFl1ri" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_z6GNeVYuyfQ3">Intangible Assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Patents and licenses:</i> patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s consolidated balance sheet and amortized on a straight-line basis over their estimated useful lives of <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MinimumMember_zkxXJRUA9kdd" title="Estimated useful life">18.5</span> to <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MaximumMember_zfaQO92vhqJa" title="Estimated useful life">20</span> years. Amortization totaled approximately $-<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_dxL_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zqrDHm7f6CF" title="Amortization::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0765">0</span></span>- and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zEjthTo8Lok9" title="Amortization">0.5</span> million for the years ended December 31, 2023, and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other intangible assets: </i>the Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink Technologies, Inc., Mobile Viewpoint Corporate B.V. (“MVP”), and the assets of BMS. An independent third-party appraiser evaluated the acquired assets for these business transactions. In the absence of fair market values from potential buyers or comparable transactions, we concluded that the methodologies applied provided a reasonable estimate for the values assigned. The Company amortizes intangible asset costs over their useful lives of <span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zyJ0WESDJqsb" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zwmYzopX9cc" title="Finite-lived intangible asset, useful life">15</span> years with its net book value reported on the balance sheet. Amortization totaled approximately $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z2AClcXJphsb" title="Amortization"><span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zqcQFvIKDz3b" title="Amortization of intangible assets">1.0</span></span> million each for the years ended December 31, 2023, and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_841_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zW6zcZUloydh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_z4EZHZ3zzOge">Warranty Reserve</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Company tests its products under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data, required revisions to the estimated warranty liability will occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zWgsg83p3Qui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The claims made during the year ended December 31, 2023, and 2022 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zqevYz5PLem7" style="display: none">SCHEDULE OF PRODUCT WARRANTY LIABILITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty Reserve</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20220101__20221231_zBhJ8rNDHFKa" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Warranty reserve, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">131,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty reserve expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20220101__20221231_zrUKmbfl75Li" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty claims settled and true-up of accrual.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20220101__20221231_zqRQ39EWJqVh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(117,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20230101__20231231_zMXK9XNTK7Eb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty reserve expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20230101__20231231_zhdYrTNzK5Jb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">432,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty claims settled, and true-up of accrual</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20230101__20231231_zGP3y52rWJm5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(411,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20230101__20231231_zvRgeQIaqV09" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zwGzpjKWzYhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--ShippingAndHandlingCostsPolicyTextBlock_z7UCMtHJaqK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zzaPrkxZN3qe">Shipping and Handling Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2023, and 2022, the shipping and handling costs incurred were $<span id="xdx_90D_ecustom--ShippingAndHandlingCosts_pn5n6_c20230101__20231231_zSKmgkrwHvBj" title="Shipping and handling costs">0.4</span> million and $<span id="xdx_90E_ecustom--ShippingAndHandlingCosts_pn5n6_c20220101__20221231_zdLwNSHvpcJ7" title="Shipping and handling costs">0.7</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--TreasuryStockPolicyTextBlock_zOAr7MyoE0q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zAV0mJ8GQOQ2">Treasury Stock</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury stock is recorded at cost upon the repurchasing of common shares, and the cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.</span></p> <p id="xdx_854_zFnN8F8Ah3vk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zDA6gW4HSVfg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zg914laCMNdk">Revenue Recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for its operating results under ASC Topic 606, adopted on January 1, 2019. This comprehensive revenue recognition model requires recognition when the Company transfers control of the promised goods or services to the Company’s customers at an amount that reflects the consideration the Company expects to receive. The application of ASC Topic 606 requires the Company to use more judgment and make more estimates than under previously issued guidance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines revenue recognition through the following steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. identification of the contract, or contracts, with a customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. identification of the performance obligations in the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. determination of the transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. allocation of the transaction price to the performance obligations in the contract; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. recognition of revenue when, or as, the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At contract inception, the Company assesses the goods and services promised in the Company’s customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. The Company measures revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges the Company collects concurrent with revenue-producing activities are excluded from income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Remaining Performance Obligations:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ResearchAndDevelopmentExpensePolicy_zqfB0Wn4lZI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zm8gJKzS7wrb">Research and Development Expenses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the consolidated statements of operations and comprehensive loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.</span></p> <p id="xdx_852_z4Z84CPOHDTj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_z9GHTfyrEUIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_ztSswVWKvHWf">Leases</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines if an arrangement is a lease at inception. The Company recognizes lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets, such as “Right of use assets, operating leases,” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. The Company recognizes operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all of the Company’s real estate contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2023. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of the Company’s leases do not provide an implicit rate, the Company determines our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zF50OabpYJHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zraOZe1X1ki4">Stock-Based Compensation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from non-employees. The measurement date for equity-classified non-employee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of non-employee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the non-employee share-based payment awards with performance conditions and accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the non-employee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for non-employee awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock-Option Awards — Time-Based and Performance-Based</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For non-employee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock-Based Compensation (continued)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Restricted Stock Unit Awards (“RSUs”) — Time-Based</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Restricted Stock Unit Awards (“RSUs”) — Performance-Based</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_847_ecustom--ImpairmentAndAbandonmentPolicyTextBlock_z7SzIXX80Yk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_z909QF5pdAs1">Impairment and Abandonment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Right-of-use operating lease abandonment:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately 2,700 square feet of manufacturing space at the Colchester, UK facility were abandoned as part of the Company’s strategic decision to relocate its UK manufacturing division to the United States commencing in September 2023. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and the Company assessed whether the lease ROU assets were impaired. It was determined that approximately $<span id="xdx_909_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pn5n6_c20230101__20231231_z20PZN9TDodf" title="Right-of-use operating assets impaired">0.1</span> million of the Company’s right-of-use operating assets were impaired.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The location’s economic environment precluded subletting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ending December 31, 2023, and 2022, the Company recognized a loss on impairment of ROU assets of approximately $<span id="xdx_90E_eus-gaap--OperatingLeaseImpairmentLoss_pn5n6_c20230101__20231231_zSTi6DHIdY4g" title="Loss on impairment of right-of-use assets"><span id="xdx_90E_eus-gaap--OperatingLeaseImpairmentLoss_pn5n6_c20220101__20221231_zt22XbDJhhS2" title="Loss on impairment of right-of-use assets">0.1</span></span> million each, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zhx23IkqfZM" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zuYO3dvLppTa">Income Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expenses and penalties as general and administrative expenses.</span></p> <p id="xdx_859_zjXDpgQn203f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zv5KNFovbAD9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zJEaYjukBDyi">Advertising Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are charged to operations as incurred. For the years ended December 31, 2023, and 2022, respectively, advertising costs amounted to approximately $<span id="xdx_90C_eus-gaap--AdvertisingExpense_pn5n6_c20230101__20231231_z9MoJLkqYnO9" title="Advertising costs">0.7</span> million and $<span id="xdx_906_eus-gaap--AdvertisingExpense_pn5n6_c20220101__20221231_zgMGEMJjEZck" title="Advertising costs">1.0</span> million. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84C_ecustom--SalesTaxAndValueAddedTaxesPolicyTextBlock_zdmndYocXKR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zqxyDBJCGTZ9">Sales Tax and Value-Added Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zqCbghaa3eBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zoAEL9oGPcs">Loss Per Share</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, excellent for the period determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8Q8wumjcL63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zr9Z0XYAAlqk">Foreign Currency and Other Comprehensive (Gains) Losses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. The Company has two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2023, and 2022, respectively. The Company has included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction gains and losses are recognized in the Company’s operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84A_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zZEgN8aFBZW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_znP043SLgSg">Fair Value of Financial Instruments and Fair Value Measurements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” defines fair value as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not assumptions specific to the entity. ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques reflect assumptions other market participants would use based on the market data obtained from independent sources (observable inputs). In accordance with ASC 820, the following summarizes the fair value hierarchy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 is observable inputs such as quoted prices in active markets,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Fair Value of Financial Instruments and Fair Value Measurements (continued)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments include cash equivalents, investments, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--RedeemablePreferredStockPolicyTextBlock_zxV0wvM4CxEa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_ziR3lsX3IExk">Redeemable Preferred Stock</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2022, <span id="xdx_90B_eus-gaap--PreferredStockRedemptionTerms_c20221101__20221130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zFX1XGUOuh4d" title="Preferred stock redemption terms">the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders relating to the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zFrcPGXnm0Ej" title="Preferred stock, par value">0.00001</span> per share. The Preferred Stock was redeemable upon the holder not participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole on March 24, 2023, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--NewlyIssuedAccountingPronouncementsPolicyPolicyTextBlock_zMLhVoLDYwFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zM8aWyqwLPKe">Recently Issued Accounting Pronouncements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Adopted</span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable. The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Recently Issued Accounting Pronouncements (continued)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Not yet adopted</span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280). This update revises the reporting requirements for operating segments of public entities, aiming to enhance the transparency and usefulness of segment reporting. As of the date of these financial statements, the Company has not formally adopted ASU 2023-07, which becomes effective for public entities for reporting periods beginning after December 15, 2023. However, it is essential to note that our Company operates as a single reporting segment. Due to this structure, the Company inherently met the updated disclosure requirements of ASU 2023-07 without needing additional segment-specific information. Our current operating segment structure aligns with the objectives of the new standard, emphasizing explicit and meaningful segment reporting. We have assessed that there will be no significant impact on our financial statements upon adopting ASU 2023-07. We will continue to monitor any further guidance FASB provides and ensure compliance with the reporting standards. As the Company formally adopted ASU 2023-07, the Company remained committed to transparency and clarity in our financial reporting. Our subsequent financial statements will provide further updates regarding compliance with this and other accounting standards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-09, enhancing transparency in income tax disclosures. This ASU applies to entities under Topic 740, requiring detailed rate reconciliation and disclosures of taxes paid. It mandates public business entities to disclose rate reconciliation categories annually and specifies a quantitative threshold for reconciling items. Other entities must provide qualitative disclosures. The update is effective for public business entities for annual periods beginning after December 15, 2024, and other entities after December 15, 2025, with early adoption permitted. The Company is evaluating the impact of ASU 2023-09 on its financial statements and will provide updates, if necessary, alongside other accounting standards in future financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zCaIH6raFoS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zY5qhfM0xg7">Recent Accounting Pronouncements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC, did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.</span></p> <p id="xdx_85F_zTmSX9twUzc5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConsolidationPolicyTextBlock_zxuOoEFjyosb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zihAtg5QNZAb">Principles of Consolidation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the Company’s accounts and wholly-owned subsidiaries. The Company has eliminated all intercompany accounts and transactions upon consolidating the Company’s subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zoWt1P98hbO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_z3orOaNotzmf">Segment Reporting</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as <span id="xdx_903_eus-gaap--NumberOfOperatingSegments_pid_dc_uSegment_c20230101__20231231_zdDWl8B4glWc" title="Number of operating segments">one</span> operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 <p id="xdx_841_eus-gaap--UseOfEstimates_zUtXhOyTIDNh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zgf5fqE7wEbb">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--RisksAndUncertaintiesPolicyTextBlock_z6Eq8CcW9dZc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zwquOUCDdGFk">Risks and Uncertainties</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The future impacts of the Russia-Ukraine war and the Israel-Hamas conflict, as well as their residual effects, include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries, remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.</p> <p id="xdx_845_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_z3gwcGHBeK48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zVtWEPQK7Mka">Allowance for Credit Losses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zKlhYlvvCLsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_861_zUVkscJfVP82">Cash and Cash Equivalents</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund as of December 31, 2023, and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zugJiRwfXvci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_z0wBkOe1M6kl">Concentrations</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not possess any off-balance-sheet concentrations of credit risk. Credit risk, defined as the likelihood of a counterparty defaulting on contractual obligations, poses a potential financial loss for the Company. The primary sources of the Company’s credit risk are its cash, investments and accounts receivable. To mitigate the risk of loss exposure, the Company follows a policy of holding its cash in high-credit quality financial institutions. Cash deposits, representing a concentration of credit risk, are the main economic instruments exposing the Company to such risks. <span style="background-color: white">The Company has allocated $5.7 million towards investments in government bonds held to maturity to diversify our credit risk exposure further and enhance our risk mitigation strategies. These bonds, issued by the United States Federal Government, are evaluated for credit risk based on the issuing entity’s creditworthiness. This investment strategy is aligned with our overarching objective to minimize potential financial losses by spreading risk across various high-credit quality assets and instruments. </span>The Federal Deposit Insurance Corporation (“FDIC”) insures up to $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20231231_zqToVlzsKZp3" title="Cash FDIC insured amount">250,000</span> for accounts held within the United States. In the United Kingdom, the Company maintains cash balance accounts at financial institutions insured by the Financial Services Compensation Scheme, covering up to £<span id="xdx_906_ecustom--CashFSCSInsuredAmount_iI_pp0p0_uGBP_c20231231__srt--StatementGeographicalAxis__country--GB_zfXZs8fwCidk" title="Cash FSCS insured amount">85,000</span> (subject to currency translation rates to the United States dollar). Additionally, in the Netherlands, the Company’s cash balance accounts at financial institutions are insured by the “Dutch deposit guarantee scheme,” providing coverage up to €<span id="xdx_902_ecustom--DutchDepositGuaranteeScheme_iI_pp0p0_uEUR_c20231231__srt--StatementGeographicalAxis__country--NL_zCoCsxGEnEvb" title="Dutch deposit guarantee scheme">100,000</span> per person per bank.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, and 2022, the Company held approximately $<span id="xdx_90E_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20231231_znYY6AVFiey6" title="Cash uninsured amount">7.7</span> million and $<span id="xdx_908_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20221231_zOYGz7KuUCNe" title="Cash uninsured amount">24.5</span> million above insured limits, respectively, remaining unaffected by any losses in its bank accounts during this period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ending December 31, 2023, the Company did not report any sales to an individual customer that constituted more than 10% of its total sales. During the year ending December 31, 2022, the Company noted sales to a single customer amounting to $<span id="xdx_90C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn5n6_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zlnSBlkMZ3L" title="Revenue">3.4</span> million, representing <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zSoCzEQ5eId7" title="Concentration risk percentage">12</span>% of the Company’s total sales, in excess of 10% of its total sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, and 2022, the Company’s accounts receivable from a single customer were recorded at approximately $<span id="xdx_904_eus-gaap--AccountsReceivableNet_iI_pn5n6_c20231231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zmXK7iFVIb21" title="Accounts receivable">1.1</span> million (<span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9hvzUKHTEC2" title="Risk percentage">13</span>%) and $<span id="xdx_906_eus-gaap--AccountsReceivableNet_iI_pn5n6_c20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5TMWsPgapEh" title="Accounts receivable">1.1</span> million (<span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9vHrdvkbL3c" title="Risk percentage">19</span>%), respectively. Each instance surpassed the 10% mark of the Company’s total consolidated accounts receivable, indicating a significant concentration in customer receivables.</span></p> 250000 85000 100000 7700000 24500000 3400000 0.12 1100000 0.13 1100000 0.19 <p id="xdx_84A_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zGg84PhgAL89" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zd6TSnDJoe05">Accounts Receivable and Allowance for Doubtful Accounts</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2023, the Company adopted Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments. The Company extends credit to its customers in the ordinary course of business and has applied a new standard in evaluating estimated losses through an allowance for doubtful accounts. The Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_848_eus-gaap--InventoryPolicyTextBlock_zubA4zkaYxta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zbPdEP8RAkGb">Inventories</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--InvestmentInDebtSecuritiesPolicyTextBlock_zYIVgYAYunQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zIm5hfJe6cS7">Investment in Debt Securities</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink Technologies, Inc. invests in government bonds with the intent and ability to hold these investments until maturity. In alignment with ASC Topic 320, Investments—Debt and Equity Securities, such investments are classified as “Held-to-Maturity” (HTM) securities and are measured at amortized cost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification: The Company classifies its investments in government bonds as “Held-to-Maturity” (HTM) securities based on management’s intent and ability to hold the securities to maturity. These HTM securities are recognized in the Company’s financial statements at their amortized cost, adjusted for the amortization of premiums and accretion of discounts to maturity.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Measurement: HTM securities are initially recognized at their acquisition cost, including transaction costs. Subsequently, they are measured at amortized cost using the effective interest method. This method considers the amortization of any discount or premium on the acquisition cost until maturity.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest Income: Interest income is accrued using the security’s effective yield, reflecting the time value of money.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of Discount and Premium: The amortization of the discount (or accretion of the premium) is included as part of the interest income recognized in the income statement, reflecting the adjustment to the investment’s yield.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment: The Company periodically assesses HTM investments for impairment if objective evidence indicates an impairment has been incurred. It recognizes any loss when the present value of estimated future cash flows, discounted at the original effective interest rate, is less than the carrying amount.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derecognition: A Held-to-Maturity investment is removed from the balance sheet when the right to receive cash flows has expired, or the Company has substantially transferred all ownership risks and rewards.</span></td></tr> </table> <p id="xdx_84D_eus-gaap--BusinessCombinationsPolicy_zCBYsHmmRe9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zWqBmbo8zlvl">Business Combinations and Asset Acquisitions</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates acquisitions of assets and other similar transactions to assess whether the transaction should be accounted for as a business combination or asset acquisition by first applying a screen test to determine whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If so, the transaction is accounted for as an asset acquisition. If not, further determination is required as to whether the Company has acquired inputs and processes that can create outputs that would meet the definition of a business. When applying the screen test, significant judgment is required to determine whether an acquisition is a business combination or an acquisition of assets. Accounting for asset acquisitions falls under the guidance of Topic 805, Business Combinations, specifically Subtopic 805-50. A cost accumulation model is used to determine an asset acquisition’s cost. Assets acquired are based on their cost, generally allocated to them on a relative fair value basis. Direct acquisition-related costs are included in the cost of the acquired assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The distinction between business combinations and asset acquisitions involves judgment, particularly when applying the screen test to determine the nature of the transaction. Incorrect judgments or changes in decisions in these areas could materially affect the determination of goodwill, the recognition and measurement of acquired assets and assumed liabilities, and, consequently, our financial position and results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zP2KJkVq5ql5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_z3Ng498QGgd4">Property and Equipment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember_zOtnXEYZhPuf" title="Estimated useful life">1</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember_zKlGDz0RolEd" title="Property and equipment, estimated useful life">14</span> years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in the expenses as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P1Y P14Y <p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zJjLuyqFl1ri" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_z6GNeVYuyfQ3">Intangible Assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Patents and licenses:</i> patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s consolidated balance sheet and amortized on a straight-line basis over their estimated useful lives of <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MinimumMember_zkxXJRUA9kdd" title="Estimated useful life">18.5</span> to <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MaximumMember_zfaQO92vhqJa" title="Estimated useful life">20</span> years. Amortization totaled approximately $-<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_dxL_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zqrDHm7f6CF" title="Amortization::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0765">0</span></span>- and $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zEjthTo8Lok9" title="Amortization">0.5</span> million for the years ended December 31, 2023, and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other intangible assets: </i>the Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink Technologies, Inc., Mobile Viewpoint Corporate B.V. (“MVP”), and the assets of BMS. An independent third-party appraiser evaluated the acquired assets for these business transactions. In the absence of fair market values from potential buyers or comparable transactions, we concluded that the methodologies applied provided a reasonable estimate for the values assigned. The Company amortizes intangible asset costs over their useful lives of <span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zyJ0WESDJqsb" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zwmYzopX9cc" title="Finite-lived intangible asset, useful life">15</span> years with its net book value reported on the balance sheet. Amortization totaled approximately $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z2AClcXJphsb" title="Amortization"><span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pn5n6_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zqcQFvIKDz3b" title="Amortization of intangible assets">1.0</span></span> million each for the years ended December 31, 2023, and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> P18Y6M P20Y 500000 P3Y P15Y 1000000.0 1000000.0 <p id="xdx_841_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zW6zcZUloydh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_z4EZHZ3zzOge">Warranty Reserve</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Company tests its products under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data, required revisions to the estimated warranty liability will occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zWgsg83p3Qui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The claims made during the year ended December 31, 2023, and 2022 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zqevYz5PLem7" style="display: none">SCHEDULE OF PRODUCT WARRANTY LIABILITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty Reserve</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20220101__20221231_zBhJ8rNDHFKa" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Warranty reserve, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">131,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty reserve expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20220101__20221231_zrUKmbfl75Li" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty claims settled and true-up of accrual.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20220101__20221231_zqRQ39EWJqVh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(117,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20230101__20231231_zMXK9XNTK7Eb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty reserve expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20230101__20231231_zhdYrTNzK5Jb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">432,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty claims settled, and true-up of accrual</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20230101__20231231_zGP3y52rWJm5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(411,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20230101__20231231_zvRgeQIaqV09" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zwGzpjKWzYhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zWgsg83p3Qui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The claims made during the year ended December 31, 2023, and 2022 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zqevYz5PLem7" style="display: none">SCHEDULE OF PRODUCT WARRANTY LIABILITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty Reserve</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20220101__20221231_zBhJ8rNDHFKa" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Warranty reserve, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">131,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty reserve expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20220101__20221231_zrUKmbfl75Li" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty claims settled and true-up of accrual.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20220101__20221231_zqRQ39EWJqVh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(117,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20230101__20231231_zMXK9XNTK7Eb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty reserve expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20230101__20231231_zhdYrTNzK5Jb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">432,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty claims settled, and true-up of accrual</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20230101__20231231_zGP3y52rWJm5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(411,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20230101__20231231_zvRgeQIaqV09" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 131000 98000 117000 112000 432000 411000 133000 <p id="xdx_843_ecustom--ShippingAndHandlingCostsPolicyTextBlock_z7UCMtHJaqK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zzaPrkxZN3qe">Shipping and Handling Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2023, and 2022, the shipping and handling costs incurred were $<span id="xdx_90D_ecustom--ShippingAndHandlingCosts_pn5n6_c20230101__20231231_zSKmgkrwHvBj" title="Shipping and handling costs">0.4</span> million and $<span id="xdx_90E_ecustom--ShippingAndHandlingCosts_pn5n6_c20220101__20221231_zdLwNSHvpcJ7" title="Shipping and handling costs">0.7</span> million, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 400000 700000 <p id="xdx_84D_ecustom--TreasuryStockPolicyTextBlock_zOAr7MyoE0q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zAV0mJ8GQOQ2">Treasury Stock</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury stock is recorded at cost upon the repurchasing of common shares, and the cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.</span></p> <p id="xdx_84F_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zDA6gW4HSVfg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zg914laCMNdk">Revenue Recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for its operating results under ASC Topic 606, adopted on January 1, 2019. This comprehensive revenue recognition model requires recognition when the Company transfers control of the promised goods or services to the Company’s customers at an amount that reflects the consideration the Company expects to receive. The application of ASC Topic 606 requires the Company to use more judgment and make more estimates than under previously issued guidance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration the Company expects to receive in exchange for those services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines revenue recognition through the following steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. identification of the contract, or contracts, with a customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. identification of the performance obligations in the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. determination of the transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. allocation of the transaction price to the performance obligations in the contract; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. recognition of revenue when, or as, the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At contract inception, the Company assesses the goods and services promised in the Company’s customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. The Company measures revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges the Company collects concurrent with revenue-producing activities are excluded from income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Remaining Performance Obligations:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--ResearchAndDevelopmentExpensePolicy_zqfB0Wn4lZI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zm8gJKzS7wrb">Research and Development Expenses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the consolidated statements of operations and comprehensive loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.</span></p> <p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_z9GHTfyrEUIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_ztSswVWKvHWf">Leases</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines if an arrangement is a lease at inception. The Company recognizes lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets, such as “Right of use assets, operating leases,” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. The Company recognizes operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all of the Company’s real estate contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2023. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of the Company’s leases do not provide an implicit rate, the Company determines our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zF50OabpYJHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zraOZe1X1ki4">Stock-Based Compensation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from non-employees. The measurement date for equity-classified non-employee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of non-employee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the non-employee share-based payment awards with performance conditions and accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the non-employee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for non-employee awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock-Option Awards — Time-Based and Performance-Based</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For non-employee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock-Based Compensation (continued)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Restricted Stock Unit Awards (“RSUs”) — Time-Based</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Restricted Stock Unit Awards (“RSUs”) — Performance-Based</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_847_ecustom--ImpairmentAndAbandonmentPolicyTextBlock_z7SzIXX80Yk5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_z909QF5pdAs1">Impairment and Abandonment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Right-of-use operating lease abandonment:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately 2,700 square feet of manufacturing space at the Colchester, UK facility were abandoned as part of the Company’s strategic decision to relocate its UK manufacturing division to the United States commencing in September 2023. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and the Company assessed whether the lease ROU assets were impaired. It was determined that approximately $<span id="xdx_909_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pn5n6_c20230101__20231231_z20PZN9TDodf" title="Right-of-use operating assets impaired">0.1</span> million of the Company’s right-of-use operating assets were impaired.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The location’s economic environment precluded subletting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ending December 31, 2023, and 2022, the Company recognized a loss on impairment of ROU assets of approximately $<span id="xdx_90E_eus-gaap--OperatingLeaseImpairmentLoss_pn5n6_c20230101__20231231_zSTi6DHIdY4g" title="Loss on impairment of right-of-use assets"><span id="xdx_90E_eus-gaap--OperatingLeaseImpairmentLoss_pn5n6_c20220101__20221231_zt22XbDJhhS2" title="Loss on impairment of right-of-use assets">0.1</span></span> million each, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 100000 100000 100000 <p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zhx23IkqfZM" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zuYO3dvLppTa">Income Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expenses and penalties as general and administrative expenses.</span></p> <p id="xdx_84E_eus-gaap--AdvertisingCostsPolicyTextBlock_zv5KNFovbAD9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zJEaYjukBDyi">Advertising Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are charged to operations as incurred. For the years ended December 31, 2023, and 2022, respectively, advertising costs amounted to approximately $<span id="xdx_90C_eus-gaap--AdvertisingExpense_pn5n6_c20230101__20231231_z9MoJLkqYnO9" title="Advertising costs">0.7</span> million and $<span id="xdx_906_eus-gaap--AdvertisingExpense_pn5n6_c20220101__20221231_zgMGEMJjEZck" title="Advertising costs">1.0</span> million. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> 700000 1000000.0 <p id="xdx_84C_ecustom--SalesTaxAndValueAddedTaxesPolicyTextBlock_zdmndYocXKR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zqxyDBJCGTZ9">Sales Tax and Value-Added Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zqCbghaa3eBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zoAEL9oGPcs">Loss Per Share</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, excellent for the period determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z8Q8wumjcL63" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zr9Z0XYAAlqk">Foreign Currency and Other Comprehensive (Gains) Losses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. The Company has two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2023, and 2022, respectively. The Company has included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction gains and losses are recognized in the Company’s operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84A_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zZEgN8aFBZW8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_znP043SLgSg">Fair Value of Financial Instruments and Fair Value Measurements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” defines fair value as the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date and in the principal or most advantageous market for that asset or liability. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not assumptions specific to the entity. ASC 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques reflect assumptions other market participants would use based on the market data obtained from independent sources (observable inputs). In accordance with ASC 820, the following summarizes the fair value hierarchy:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 is observable inputs such as quoted prices in active markets,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Fair Value of Financial Instruments and Fair Value Measurements (continued)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments include cash equivalents, investments, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--RedeemablePreferredStockPolicyTextBlock_zxV0wvM4CxEa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_ziR3lsX3IExk">Redeemable Preferred Stock</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2022, <span id="xdx_90B_eus-gaap--PreferredStockRedemptionTerms_c20221101__20221130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zFX1XGUOuh4d" title="Preferred stock redemption terms">the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders relating to the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zFrcPGXnm0Ej" title="Preferred stock, par value">0.00001</span> per share. The Preferred Stock was redeemable upon the holder not participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole on March 24, 2023, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders relating to the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder not participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole on March 24, 2023, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal. 0.00001 <p id="xdx_840_ecustom--NewlyIssuedAccountingPronouncementsPolicyPolicyTextBlock_zMLhVoLDYwFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zM8aWyqwLPKe">Recently Issued Accounting Pronouncements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Adopted</span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable. The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard and did not adjust the opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that they are no longer collectible, as local laws allow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Recently Issued Accounting Pronouncements (continued)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Not yet adopted</span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280). This update revises the reporting requirements for operating segments of public entities, aiming to enhance the transparency and usefulness of segment reporting. As of the date of these financial statements, the Company has not formally adopted ASU 2023-07, which becomes effective for public entities for reporting periods beginning after December 15, 2023. However, it is essential to note that our Company operates as a single reporting segment. Due to this structure, the Company inherently met the updated disclosure requirements of ASU 2023-07 without needing additional segment-specific information. Our current operating segment structure aligns with the objectives of the new standard, emphasizing explicit and meaningful segment reporting. We have assessed that there will be no significant impact on our financial statements upon adopting ASU 2023-07. We will continue to monitor any further guidance FASB provides and ensure compliance with the reporting standards. As the Company formally adopted ASU 2023-07, the Company remained committed to transparency and clarity in our financial reporting. Our subsequent financial statements will provide further updates regarding compliance with this and other accounting standards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-09, enhancing transparency in income tax disclosures. This ASU applies to entities under Topic 740, requiring detailed rate reconciliation and disclosures of taxes paid. It mandates public business entities to disclose rate reconciliation categories annually and specifies a quantitative threshold for reconciling items. Other entities must provide qualitative disclosures. The update is effective for public business entities for annual periods beginning after December 15, 2024, and other entities after December 15, 2025, with early adoption permitted. The Company is evaluating the impact of ASU 2023-09 on its financial statements and will provide updates, if necessary, alongside other accounting standards in future financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zCaIH6raFoS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zY5qhfM0xg7">Recent Accounting Pronouncements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC, did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.</span></p> <p id="xdx_808_eus-gaap--EarningsPerShareTextBlock_zakLvS1Nucy4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 — <span id="xdx_825_zBMsJ6Yxl7Sc">LOSS PER SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z1Or5P6TgbTj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B8_z8NZJraOaXfk" style="display: none">SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230101__20231231_zPkWP9hzi8ng" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zAHkaMDWTiE1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareDilutedOtherDisclosuresAbstract_iB_zAx1GYtwxhAc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zBJw7CYD7aKc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z4lfMeACOO97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">456</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">459</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zUpLwQ6a68R9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">507</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zkzO3Rmaypci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z1Or5P6TgbTj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B8_z8NZJraOaXfk" style="display: none">SCHEDULE OF ANTI-DILUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM CALCULATION OF LOSS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230101__20231231_zPkWP9hzi8ng" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zAHkaMDWTiE1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareDilutedOtherDisclosuresAbstract_iB_zAx1GYtwxhAc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zBJw7CYD7aKc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z4lfMeACOO97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">456</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">459</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zUpLwQ6a68R9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">507</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 51000 41000 456000 459000 507000 500000 <p id="xdx_801_eus-gaap--ForeignCurrencyDisclosureTextBlock_z6lAYfiLdemj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 — <span id="xdx_82E_zXry9Cd94Isk">FOREIGN CURRENCY AND OTHER COMPREHENSIVE (GAINS) LOSSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zNDQ6ewMKKP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive loss approximately as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B9_z6pqozLzCx6i" style="display: none">SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_zdDqeTH5eov7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231_zKqmbFlLMlwa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Net foreign exchange transactions:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pp0p0_zSwFwX1JRbMk" style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">(Gains) Losses</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">49,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">24,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt"> <span style="display: none; font-family: Times New Roman, Times, Serif"></span> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accumulated comprehensive income:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_iN_pp0p0_di_zgZUft6XyxSl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">Unrealized (gains) losses on currency translation adjustment</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(310,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,040,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zifaKHWl8jqf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts were converted from British Pounds to U.S. Dollars and Euros to British Pounds using the following exchange rates:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 – £<span id="xdx_90D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20231231__us-gaap--TradingActivityByTypeAxis__custom--PeriodEndGBPToUSDollarOneExchangeRateMember_z6c3fSAHUYDi" title="Foreign currency exchange rate, translation">1.273840</span> to $<span id="xdx_90C_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20231231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zNJImLQ4VjQl" title="Foreign currency exchange rate, translation">1.00</span>; €<span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20231231__us-gaap--TradingActivityByTypeAxis__custom--PeriodEndEURToUSDollarOneExchangeRateMember_zFcmO5hh3ZX2" title="Foreign currency exchange rate, translation">1.105890</span> to $<span id="xdx_906_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20231231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zVnkVJ8q6a2g" title="Foreign currency exchange rate, translation">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The average exchange rate for the year ended December 31, 2023 – £<span id="xdx_906_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20231231__us-gaap--TradingActivityByTypeAxis__custom--PeriodAverageGBPToUSDollarOneExchangeRateMember_zjbS27Dh7o07" title="Foreign currency exchange rate, translation">1.243463</span> to $<span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20231231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z9ICFnUXFC4" title="Foreign currency exchange rate, remeasurement">1.00</span>; €<span id="xdx_901_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20231231__us-gaap--TradingActivityByTypeAxis__custom--PeriodAverageEURToUSDollarOneExchangeRateMember_zfYtOlXd5ai2" title="Foreign currency exchange rate, translation">1.081317</span> to $<span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20231231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zMzVERpa3Eyb" title="Foreign currency exchange rate, remeasurement">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 – £<span id="xdx_909_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--TradingActivityByTypeAxis__custom--PeriodEndGBPToUSDollarOneExchangeRateMember_zCgVptX4qX09" title="Foreign currency exchange rate, translation"> 1.208970</span> to $<span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zxXzfUBeXOA" title="Foreign currency exchange rate, translation">1.00</span>; € <span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--TradingActivityByTypeAxis__custom--PeriodEndEURToUSDollarOneExchangeRateMember_z4kBHSxTgCza" title="Foreign currency exchange rate, translation">1.069850</span> to $<span id="xdx_902_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zeVYL7zDL9lg" title="Foreign currency exchange rate, translation">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The average exchange rate for the year ended December 31, 2022 – £ <span id="xdx_900_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--TradingActivityByTypeAxis__custom--PeriodAverageGBPToUSDollarOneExchangeRateMember_zM6pnbuXHcH8" title="Foreign currency exchange rate, translation">1.236579</span> to $<span id="xdx_90A_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z2L8Nqas6Gh2" title="Average foreign currency exchange rate remeasurement">1.00</span>; € <span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--TradingActivityByTypeAxis__custom--PeriodAverageEURToUSDollarOneExchangeRateMember_z09aQkjQmSOl" title="Foreign currency exchange rate, translation">1.052082</span> to $<span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zPCQV2lgvik9" title="Average foreign currency exchange rate remeasurement">1.00</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_zNDQ6ewMKKP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive loss approximately as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B9_z6pqozLzCx6i" style="display: none">SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_zdDqeTH5eov7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20220101__20221231_zKqmbFlLMlwa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Net foreign exchange transactions:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pp0p0_zSwFwX1JRbMk" style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">(Gains) Losses</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">49,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">24,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 10pt"> <span style="display: none; font-family: Times New Roman, Times, Serif"></span> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Accumulated comprehensive income:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_iN_pp0p0_di_zgZUft6XyxSl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 10pt">Unrealized (gains) losses on currency translation adjustment</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(310,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,040,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 49000 24000 310000 -1040000 1.273840 1.00 1.105890 1.00 1.243463 1.00 1.081317 1.00 1.208970 1.00 1.069850 1.00 1.236579 1.00 1.052082 1.00 <p id="xdx_803_eus-gaap--CashAndCashEquivalentsDisclosureTextBlock_zdT0aBYiRUr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 — <span id="xdx_822_ziHCSIp7Gbe1">CASH AND CASH EQUIVALENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of unrestricted funds invested in a money market mutual fund. The following table illustrates the Company’s cash and cash equivalents:</span></p> <p id="xdx_891_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zg94gnbyohr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_z0y3KDxIypn4" style="display: none">SCHEDULE OF CASH AND CASH EQUIVALENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20231231_zQf5TjMgGpJ9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20221231_ze13xfjiHEJ2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_maCACEAzGPk_zZJxj0O0E7d9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash on hand</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,776,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,627,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--MoneyMarketFundsAtCarryingValue_iI_pp0p0_maCACEAzGPk_zrXV1YchidN9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federally insured money market mutual funds</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,706,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0911">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iTI_pp0p0_mtCACEAzGPk_zsBofBbosMa4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,482,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,627,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_z8JjuUrVMAT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zg94gnbyohr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_z0y3KDxIypn4" style="display: none">SCHEDULE OF CASH AND CASH EQUIVALENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20231231_zQf5TjMgGpJ9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20221231_ze13xfjiHEJ2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--CashEquivalentsAtCarryingValue_iI_pp0p0_maCACEAzGPk_zZJxj0O0E7d9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash on hand</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,776,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,627,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--MoneyMarketFundsAtCarryingValue_iI_pp0p0_maCACEAzGPk_zrXV1YchidN9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federally insured money market mutual funds</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,706,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0911">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iTI_pp0p0_mtCACEAzGPk_zsBofBbosMa4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,482,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,627,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1776000 25627000 6706000 8482000 25627000 <p id="xdx_80C_eus-gaap--InvestmentTextBlock_zIiQ6BETPwYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 — <span id="xdx_82B_zusu4ESdCRqc">INVESTMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company used cash to purchase the following debt instruments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2023, the Company purchased a bond for $<span id="xdx_905_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20230123__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_zX6QdWJzEza">4,812,500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, “HSBC USA INC CP,” with a face value of $<span id="xdx_90A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_pp0p0_c20230123__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_z2nqvhYPVW76">5,065,789</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, a par value of $<span id="xdx_906_ecustom--InvestmentParValue_iI_pp0p0_c20230123__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_zCFvneHxIQWg">5,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, maturing <span id="xdx_90C_eus-gaap--InvestmentMaturityDate_iI_c20230123__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_zVGVPgGVkpQg">October 24, 2023</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, a <span id="xdx_905_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20230123__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_zBBcpgtyVCEe">5.1948</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% interest rate, at a discount of <span id="xdx_906_ecustom--InvestmentDiscount_iI_pp0p0_c20230123__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_zZAfwTg5EHEa">$253,289</span></span>. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The bond was redeemed on maturity at a loss of approximately $<span id="xdx_90E_eus-gaap--GainLossOnInvestments_pp0p0_c20231024__20231024__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_zbd5wcSLY0X1">82,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 1, 2023, the Company purchased a bond for $<span id="xdx_905_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20230201__us-gaap--InvestmentIssuerNameAxis__custom--FederalHomeLoanBanksMember_zaRoKt7rJOoe">5,025,479</span>, “Federal Home Loan Banks,” with a face value of $</span><span id="xdx_909_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_pp0p0_c20230201__us-gaap--InvestmentIssuerNameAxis__custom--FederalHomeLoanBanksMember_zrwxkK8y5oG3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,999,750</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and accrued interest of $</span><span id="xdx_90F_eus-gaap--InvestmentIncomeInterest_pp0p0_c20230201__20230201__us-gaap--InvestmentIssuerNameAxis__custom--FederalHomeLoanBanksMember_za3KULPoEH6a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,729</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, a par value of $</span><span id="xdx_900_ecustom--InvestmentParValue_iI_pp0p0_c20230201__us-gaap--InvestmentIssuerNameAxis__custom--FederalHomeLoanBanksMember_zgEl392EnYe9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000,000</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, maturing </span><span id="xdx_90F_eus-gaap--InvestmentMaturityDate_iI_c20230201__us-gaap--InvestmentIssuerNameAxis__custom--FederalHomeLoanBanksMember_zlPZtEQllv73" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 22, 2023</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, at an interest rate of </span><span id="xdx_90B_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20230201__us-gaap--InvestmentIssuerNameAxis__custom--FederalHomeLoanBanksMember_zDZfeL8iEaIg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.750</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%. The bond was redeemed at face value on the date of maturity.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2023, the Company purchased a bond for $<span id="xdx_905_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20230228__us-gaap--InvestmentIssuerNameAxis__custom--FederalNationalMortgageAssociationMember_zACZ5Y61rhVg">950,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, “Federal National Mortgage Association,” with a face and par value of $<span id="xdx_908_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_pp0p0_c20230228__us-gaap--InvestmentIssuerNameAxis__custom--FederalNationalMortgageAssociationMember_z2nZ3bsuJZo5">950,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, maturing <span id="xdx_904_eus-gaap--InvestmentMaturityDate_iI_c20230228__us-gaap--InvestmentIssuerNameAxis__custom--FederalNationalMortgageAssociationMember_zDhPDx4xbFgg">February 28, 2024</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, at an interest rate of <span id="xdx_909_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20230228__us-gaap--InvestmentIssuerNameAxis__custom--FederalNationalMortgageAssociationMember_zfnPTrn9YP57">5.07</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span>. The value on December 31, 2023, was <span id="xdx_903_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20231231__us-gaap--InvestmentIssuerNameAxis__custom--FederalNationalMortgageAssociationMember_zmPBSC4nmLLb">$949,000</span>.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 11, 2023, the Company purchased a bond for $<span id="xdx_900_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20231011__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_zx69ggqwUU6a">4,711,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, “HSBC USA INC CP,” with a face value of $<span id="xdx_90A_eus-gaap--InvestmentOwnedBalancePrincipalAmount_iI_pp0p0_c20231011__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_za6edxDbFVre">5,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, maturing <span id="xdx_90F_eus-gaap--InvestmentMaturityDate_iI_c20231011__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_zLPojubAjfK8">October 11, 2024</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, at a <span id="xdx_90B_eus-gaap--InvestmentInterestRate_iI_pid_dp_uPure_c20231011__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_zoZ3MOdRW9Ni">6.262291</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% interest rate</span>. The value on December 31, 2023, was $<span id="xdx_90A_eus-gaap--InvestmentOwnedAtFairValue_iI_pp0p0_c20231231__us-gaap--InvestmentIssuerNameAxis__custom--HSBCUSAINCCPMember_znfbkdnUeoil">4,714,000</span>.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 — INVESTMENTS (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company identified these transactions as investments in debt securities. It applies the guidance under ASC Topic 320, “Investments in debt securities,” and for interest income guidance under ASC Topic 310-20, “Receivables.” As of December 31, the abovementioned investments have a stated maturity of one year or less. Management intends to treat these investments as held to maturity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zQAJnHHU0twg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investments held to maturity are as follows as of December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zOG6iR2QTbZh" style="display: none">SCHEDULE OF INVESTMENTS HELD TO MATURITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gains</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized Losses</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal Bonds</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_z6pYdEpHGPV1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Investments held to maturity, amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,663,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zFCQXU2fxwta" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Investments held to maturity, unrealized gain"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_iI_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zdoWUsoRdYoc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Investments held to maturity, unrealized loss">     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--HeldToMaturitySecuritiesFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zv5SwpJSWco6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Investments held to maturity, fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zWuxxjxJ3pL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 4812500 5065789 5000000 2023-10-24 0.051948 253289 82000 5025479 4999750 25729 5000000 2023-12-22 0.04750 950000 950000 2024-02-28 0.0507 949000 4711000 5000000 2024-10-11 0.06262291 4714000 <p id="xdx_89B_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zQAJnHHU0twg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investments held to maturity are as follows as of December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B1_zOG6iR2QTbZh" style="display: none">SCHEDULE OF INVESTMENTS HELD TO MATURITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unrealized</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gains</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrealized Losses</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal Bonds</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_z6pYdEpHGPV1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Investments held to maturity, amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,663,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zFCQXU2fxwta" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Investments held to maturity, unrealized gain"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_iI_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zdoWUsoRdYoc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Investments held to maturity, unrealized loss">     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--HeldToMaturitySecuritiesFairValue_iI_pn3n3_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsMember_zv5SwpJSWco6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Investments held to maturity, fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 5663000000 68000000 5731000000 <p id="xdx_80B_eus-gaap--FairValueDisclosuresTextBlock_zulHu0IkieQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 — <span id="xdx_82D_z7SNwwbvvIEl">FAIR VALUE OF ASSETS AND LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As defined under ASC 820, “Fair Value Measurement and Disclosures,” the following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis on December 31, 2023, and 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_z9xBliIQn7gd" style="margin: 0; font-family: Times New Roman, Times, Serif"> <span id="xdx_8BA_z6A0RmcALMu5" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices in Active Markets of Identical Assets/Liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 1)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Other Observable Inputs </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 2)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Unobservable Inputs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 3)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify; padding-left: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal Bonds Held to Maturity</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zDjSgnzuscQi" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0955">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_z6TFw2ROtRK6" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zniSFZohuQma" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0959">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zhG2vlwLzmZa" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use asset impairment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zr8nxutRoD8g" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0963">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zr8FZG9pyQk5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0965">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zBkLexhhVBQl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember_zRrAK2X1axqe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zDQyWKHq8Zo" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)">        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0971">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zozlAO3ISeU4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zX9WYWsq9eji" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20231231_z70ul0FLOafh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,814,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zMo0UW27pRlk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0979">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zI6RTnRhRn6d" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0981">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaKKM99rSmQ3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0983">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20231231_zBWtvJUOPwea" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0985">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal Bonds Held to Maturity</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zw35GbqZ9L4k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0987">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zzGDz6QEgoL7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0989">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zk6xGFOjbjz5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0991">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zeDprno8mTZe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0993">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use asset impairment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0KJuH5lbG13" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use asset impairment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0995">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zrT1RI6XYXa1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use asset impairment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0997">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zEOxmTXmQaa3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use asset impairment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember_z9AQ1f5TXVw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use asset impairment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zTePv4nizF89" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets recurring"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1003">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z5beRdpXcXzd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets recurring"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1005">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zaHlNCVvWIjf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20221231_zTenT5UgUpXk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zo9ByaAAe2N" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1011">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKt2QwYiUUM9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1013">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBsTDODZc6x9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1015">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231_zie5oqBA4zU3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1017">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_z7lo9ycQTt07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_z9xBliIQn7gd" style="margin: 0; font-family: Times New Roman, Times, Serif"> <span id="xdx_8BA_z6A0RmcALMu5" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted Prices in Active Markets of Identical Assets/Liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 1)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Other Observable Inputs </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 2)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant Unobservable Inputs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Level 3)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify; padding-left: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal Bonds Held to Maturity</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zDjSgnzuscQi" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0955">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_z6TFw2ROtRK6" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zniSFZohuQma" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0959">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zhG2vlwLzmZa" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use asset impairment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zr8nxutRoD8g" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0963">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zr8FZG9pyQk5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0965">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zBkLexhhVBQl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember_zRrAK2X1axqe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zDQyWKHq8Zo" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)">        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0971">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zozlAO3ISeU4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zX9WYWsq9eji" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20231231_z70ul0FLOafh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,814,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zMo0UW27pRlk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0979">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zI6RTnRhRn6d" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0981">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaKKM99rSmQ3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0983">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20231231_zBWtvJUOPwea" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0985">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal Bonds Held to Maturity</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zw35GbqZ9L4k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0987">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zzGDz6QEgoL7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0989">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zk6xGFOjbjz5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0991">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--FederalBondsHeldToMaturityMember_zeDprno8mTZe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal bonds held to maturity"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0993">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use asset impairment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z0KJuH5lbG13" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use asset impairment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0995">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zrT1RI6XYXa1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use asset impairment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0997">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zEOxmTXmQaa3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use asset impairment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--RightOfUseAssetImpairmentMember_z9AQ1f5TXVw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Right of use asset impairment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zTePv4nizF89" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets recurring"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1003">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z5beRdpXcXzd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets recurring"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1005">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsNonrecurringMember_zaHlNCVvWIjf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20221231_zTenT5UgUpXk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zo9ByaAAe2N" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1011">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKt2QwYiUUM9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1013">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBsTDODZc6x9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1015">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231_zie5oqBA4zU3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1017">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 5731000000 5731000000 83000000 83000000 5731000000 83000000 5814000000 88000000 88000000 88000000 88000000 <p id="xdx_805_eus-gaap--BusinessCombinationDisclosureTextBlock_zG2dEDxAMUT" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 — <span id="xdx_82A_zcGcRPePGpSg">ASSET ACQUISITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 14, 2023, Vislink Poway, LLC (“Poway”), a wholly-owned subsidiary of the Company formed on September 13, 2023, entered into an asset purchase agreement with BMS, acquiring working in process inventory consisting of microwave technology systems involving long-range data transmission and assuming certain liabilities in exchange for $<span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferredOther1_c20230914__20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_z2RQMHRNQfl9" title="Cash consideration paid">200,000 </span>in cash consideration paid at together with a commitment to acquire additional inventory for $<span id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_c20231002__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_zr2GJnvInzma" title="Acquisition of additional inventory price">230,000</span> on October 2, 2023, with title to the inventory passing to Poway on October 2, 2023.The transaction was accounted for as an acquisition of assets under U.S. GAAP. Accordingly, the acquisition cost was allocated on a relative fair value basis, and transaction costs were capitalized as a component of the cost of the assets acquired.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 — ASSET ACQUISITION (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89E_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z9984lAPzaac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded the purchase of this agreement under purchase price accounting, recording the fair value of the assets acquired and the liabilities assumed based upon the purchase price, as summarized in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zgdQqBmncaDl" style="display: none">SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_490_20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_zM0UCRTxRoJ4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_iB_ztfptPU1xNy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets acquired:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_i01I_pp0p0_maBCRIAzgc5_zVQsfHN5HAh3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work-in-process inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,042</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_i01I_pp0p0_maBCRIAzgc5_zqs6unH3eKvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets - customer relationships</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">495,372</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_i01TI_pp0p0_mtBCRIAzgc5_zL2AoblbRsRj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">total assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">561,414</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zlqNmpnzweya" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities assumed:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_i01I_pp0p0_maBCRIAzrrl_zzaU8tnE2m8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">292,014</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_i01TI_pp0p0_mtBCRIAzrrl_zw5JTgCfYQni" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">total liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">292,014</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash used for asset acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20230914__20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember_znsSaX8834nh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash used for asset acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">269,400</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash used in acquisition:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition price</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pp0p0_c20230914__20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_zqN12x6C8dR1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Acquisition price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pp0p0_c20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_zXvDq4QZQz99" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Transaction costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,400</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash used for asset acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20230914__20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_zZU6L52JtA02" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash used for asset acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">269,400</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zYuq7aWnc8b5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 200000 230000 <p id="xdx_89E_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_z9984lAPzaac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recorded the purchase of this agreement under purchase price accounting, recording the fair value of the assets acquired and the liabilities assumed based upon the purchase price, as summarized in the table below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zgdQqBmncaDl" style="display: none">SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_490_20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_zM0UCRTxRoJ4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_iB_ztfptPU1xNy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets acquired:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_i01I_pp0p0_maBCRIAzgc5_zVQsfHN5HAh3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work-in-process inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,042</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_i01I_pp0p0_maBCRIAzgc5_zqs6unH3eKvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets - customer relationships</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">495,372</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_i01TI_pp0p0_mtBCRIAzgc5_zL2AoblbRsRj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">total assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">561,414</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zlqNmpnzweya" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities assumed:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_i01I_pp0p0_maBCRIAzrrl_zzaU8tnE2m8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">292,014</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_i01TI_pp0p0_mtBCRIAzrrl_zw5JTgCfYQni" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">total liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">292,014</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash used for asset acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20230914__20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember_znsSaX8834nh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash used for asset acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">269,400</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash used in acquisition:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition price</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pp0p0_c20230914__20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_zqN12x6C8dR1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Acquisition price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pp0p0_c20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_zXvDq4QZQz99" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Transaction costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,400</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cash used for asset acquisition</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20230914__20230914__us-gaap--BusinessAcquisitionAxis__custom--BMSLLCMember__dei--LegalEntityAxis__custom--VislinkPowayLLCMember_zZU6L52JtA02" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total cash used for asset acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">269,400</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 66042 495372 561414 292014 292014 269400 200000 69400 269400 <p id="xdx_80D_eus-gaap--FinancingReceivablesTextBlock_zaD8wNDcBkQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 — <span id="xdx_824_ziX04yTeFet7">ACCOUNTS RECEIVABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z98vH8zeyN81" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_z0Fbs0nJc7gh" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20231231_ziIg1PvyvB8g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20221231_zmAoIX3tZGca" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCz81W_zCoe6bsLUt4j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,389,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">6,680,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_msARNCz81W_z1YyYFlgyo2l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(709,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(673,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCz81W_zU2ZsPgdBMnj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net accounts receivable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,680,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,007,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zan1bEUeeoEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2023, and 2022, the Company incurred bad debt expenses of $<span id="xdx_904_eus-gaap--ProvisionForDoubtfulAccounts_pp0p0_c20230101__20231231_ze3V3QUDetCf" title="Bad debt expense">25,000</span> and $<span id="xdx_903_eus-gaap--ProvisionForDoubtfulAccounts_pp0p0_c20220101__20221231_zlbfPuJLS0C7" title="Bad debt expense">21,000</span>, respectively. Additionally, for the years ended December 31, 2023, and 2022, we experienced bad debt recoveries of $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_pp0p0_c20230101__20231231_z8jXBnHCJXsj" title="Bad debt recoveries">10,000</span> and $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_pp0p0_c20220101__20221231_z7WiIhBUAP7l" title="Bad debt recoveries">517,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_894_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z98vH8zeyN81" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_z0Fbs0nJc7gh" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20231231_ziIg1PvyvB8g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20221231_zmAoIX3tZGca" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCz81W_zCoe6bsLUt4j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,389,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">6,680,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_msARNCz81W_z1YyYFlgyo2l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(709,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(673,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCz81W_zU2ZsPgdBMnj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net accounts receivable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,680,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,007,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 9389000 6680000 709000 673000 8680000 6007000 25000 21000 10000 517000 <p id="xdx_800_eus-gaap--InventoryDisclosureTextBlock_zBRrjNcnVUc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 —<span id="xdx_82E_zBeK2bbE3XSg"> INVENTORIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zpGvzW0igpvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_ziouNIie0qA9" style="display: none">SCHEDULE OF INVENTORIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20231231_zeDMZd9B0TCl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zAYcMbtWsxF3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pp0p0_maIGzWA3_zEuH5wxWANl8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,890,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,038,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIGzWA3_z9EusOG3oiei" style="vertical-align: bottom; background-color: White"> <td>Work-in-process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,458,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,474,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maIGzWA3_zH0rjMoR3kZi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,599,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,460,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryGross_iTI_pp0p0_mtIGzWA3_maINzLxN_zKl5NE5eiFkc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sub-total inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,947,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,972,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzLxN_zE3TJDY1poYa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Less reserve for slow-moving and excess inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,918,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,951,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_pp0p0_mtINzLxN_ztcUNpa1UjN9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,029,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,021,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zZXOXez1gszh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory valuation adjustments consist primarily of written-off items due to obsolescence or reserved for slow-moving or excess inventory. The Company recorded inventory valuation adjustments of $<span id="xdx_909_eus-gaap--InventoryWriteDown_pp0p0_c20230101__20231231_zBLlti6Tuizg" title="Inventory written-off due to obsolescence">487,000</span> and $<span id="xdx_90A_eus-gaap--InventoryWriteDown_pp0p0_c20220101__20221231_z0474IiVuGW6" title="Inventory written-off due to obsolescence">1,143,000</span> as of December 31, 2023, and 2022, respectively. Additionally, under the Company’s product rationalization program, management eliminated specific product lines impairing $-<span id="xdx_906_eus-gaap--ProductionRelatedImpairmentsOrCharges_pp0p0_c20230101__20231231_z3wrY46d8Nq2" title="Product lines impairing of inventories">0</span>- and $<span id="xdx_90D_eus-gaap--ProductionRelatedImpairmentsOrCharges_pp0p0_c20220101__20221231_zXYcF3CMq1nj" title="Product lines impairing of inventories">1,787,000</span> of inventory as of December 31, 2023, and 2022, respectively.</span></p> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zpGvzW0igpvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_ziouNIie0qA9" style="display: none">SCHEDULE OF INVENTORIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20231231_zeDMZd9B0TCl" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zAYcMbtWsxF3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pp0p0_maIGzWA3_zEuH5wxWANl8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,890,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,038,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIGzWA3_z9EusOG3oiei" style="vertical-align: bottom; background-color: White"> <td>Work-in-process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,458,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,474,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maIGzWA3_zH0rjMoR3kZi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,599,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,460,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryGross_iTI_pp0p0_mtIGzWA3_maINzLxN_zKl5NE5eiFkc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sub-total inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,947,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,972,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzLxN_zE3TJDY1poYa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Less reserve for slow-moving and excess inventory</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,918,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,951,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_pp0p0_mtINzLxN_ztcUNpa1UjN9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total inventories, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,029,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,021,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12890000 12038000 1458000 1474000 5599000 4460000 19947000 17972000 5918000 5951000 14029000 12021000 487000 1143000 0 1787000 <p id="xdx_809_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z4oyMM35tBG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 — <span id="xdx_823_zEzmx7HTsFAl">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zj5o7XRiotx1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BC_zBvtOEXaIeM1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PROPERTY AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20231231_zVluvnDYqUid" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20221231_zFTeNMlC6Cr6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful Life</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 51%; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_z2YuGcEcakP5" title="Estimated useful life">1</span> – <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zW1R12tos4xd" title="Estimated useful life">10</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRbaFRLxdkp3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Furniture and fixtures"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">347,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zEcObtetn37" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Furniture and fixtures"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">308,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements (a)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_fKGEp_znph9hL437la" title="Estimated useful life">1</span> – <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_fKGEp_zeFrzbAyIXH8" title="Estimated useful life">14</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_fKGEp_zMsr1THczDu3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leasehold improvements"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">443,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_fKGEp_zlGNamGPuesd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leasehold improvements"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">443,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers, software, and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zRinHxf2fCJk" title="Estimated useful life">1</span> – <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaRly0tXfQLk" title="Estimated useful life">11</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z1mASXbHAlj6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Computers, software, and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,677,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z742THHN5ZBc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Computers, software, and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,016,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzFs3_zOlubdoI2yXk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,467,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,767,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzFs3_zkZIfYLDtrDk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,565,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,333,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzFs3_zucU8KkMclI8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,902,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,434,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zFJl12JHQv69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment depreciation amounted to $<span id="xdx_90A_eus-gaap--Depreciation_pp0p0_c20230101__20231231_zWAHUSUvFP35" title="Property and equipment, depreciation">232,000</span> and $<span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20220101__20221231_z7ZD6JxFHHs9" title="Property and equipment, depreciation">201,000</span> for the years ended December 31, 2023, and 2022, respectively. Additionally, the Company removed $<span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentDisposals_c20220101__20221231_zcslNxn9y5Oj" title="Depreciation leasehold improvement">228,000</span> of fully depreciated leasehold improvement from its records during December 31, 2022, and <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentDisposals_dn_c20230101__20231231_z2Ap0orUAnTb" title="Depreciation leasehold improvement">none</span> for the year ending December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0E_zFMEgn9qDYn6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1E_zZxjTFUU1Kvi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The shorter economic life or remaining lease term.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zj5o7XRiotx1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BC_zBvtOEXaIeM1" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PROPERTY AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20231231_zVluvnDYqUid" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20221231_zFTeNMlC6Cr6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful Life</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 51%; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixtures</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_z2YuGcEcakP5" title="Estimated useful life">1</span> – <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zW1R12tos4xd" title="Estimated useful life">10</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRbaFRLxdkp3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Furniture and fixtures"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">347,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zEcObtetn37" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Furniture and fixtures"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">308,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements (a)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_fKGEp_znph9hL437la" title="Estimated useful life">1</span> – <span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_fKGEp_zeFrzbAyIXH8" title="Estimated useful life">14</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_fKGEp_zMsr1THczDu3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leasehold improvements"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">443,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_fKGEp_zlGNamGPuesd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Leasehold improvements"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">443,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers, software, and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zRinHxf2fCJk" title="Estimated useful life">1</span> – <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zaRly0tXfQLk" title="Estimated useful life">11</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z1mASXbHAlj6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Computers, software, and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,677,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z742THHN5ZBc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Computers, software, and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,016,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzFs3_zOlubdoI2yXk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,467,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,767,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzFs3_zkZIfYLDtrDk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,565,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,333,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzFs3_zucU8KkMclI8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,902,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,434,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> P1Y P10Y 347000 308000 P1Y P14Y 443000 443000 P1Y P11Y 3677000 3016000 4467000 3767000 2565000 2333000 1902000 1434000 232000 201000 228000 0 <p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zFHCIz6BqFed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 — <span id="xdx_82E_zhsxSUkpFwSk">INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continuously monitors operating results, events, and circumstances that may indicate potential impairment of intangible assets. Management concluded that no triggering events occurred during the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zi87OQM53FD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates finite intangible assets as of December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="margin: 0; font-family: Times New Roman, Times, Serif"> <span id="xdx_8BB_zrAv0zGCDsP5" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Proprietary Technology</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Patents and Licenses</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade Names &amp; Technology</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Customer Relationships</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">December 31, 2023:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance, January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zhYNh9pViU5l" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,132,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zJ13zuojzYYf" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(815,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zJZIMSVDw55e" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zDAmvPZozvU7" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zObKrKdLDP9" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,251,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zjrl1aB1YSyd" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,189,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zTGwG17SRAIb" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,095,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqiTL4bQRNM4" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,074,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pp0p0_c20230101__20231231_zvPBRuTvCZK1" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_984_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zIWNiY2FrHQd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1168">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_980_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zwzOcnQX56h6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">496,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_989_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pp0p0_c20230101__20231231_zKvd5fMF6G3l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">496,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zLkixAoBggI6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(593,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zA6mtn3yI1Ne" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(138,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zjEssGnqilKg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(299,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98F_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20231231_zgEs1vzR2or5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,030,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance, December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_ztXNsaSiYjrd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,132,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zGSnJ9MXL5v3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,408,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zMKjlmD8kp48" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zFn4Z6pqqJA2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zkJjxK4u5uL3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,251,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_ztP5HZTnlHG6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,327,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z1zcMhWE67p" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,591,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsO62l3AZW53" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,373,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pp0p0_c20230101__20231231_zeXXgLz587ll" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,866,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">December 31, 2022:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance, January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zdiKdOiAP7Ic" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,132,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zd9ST9cx3rOc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(223,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zWQQLiVZybll" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zaNEzROWYxY4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11,843,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zMXsMCDlXxL2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,251,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zxWtuHiA0qAa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,052,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyTwB3PZHBre" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,095,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z3j6QxHInlsf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,817,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pp0p0_c20220101__20221231_ztzixxMPJ3U4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,921,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_985_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_z4gdYCNx0e49" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(592,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zKX0iU1a2jy7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(535,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98B_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zIa882pGUoS1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(137,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_ztjiOkK2GyCa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(257,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231_z6pphNT2Vcb6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,521,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zHx64kr4yS48" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,132,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zSNk2OsRkguk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(815,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zwSoQJLrmLme" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zNL4AwdaO8m9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_z6yi8I1uxmLl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,251,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zs4ZEBl3Xafk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,189,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zkeeePAmhzul" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,095,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z0aeelLZ0L48" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,074,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pp0p0_c20220101__20221231_zFt0qb2Rlo83" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> </table> <p id="xdx_8A6_zIAstjzr3jJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 — INTANGIBLE ASSETS (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s groups of intangible assets consist primarily of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Proprietary Technology:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the Company amortizes proprietary technology over <span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember__srt--RangeAxis__srt--MinimumMember_zMG1KQ3XoV4j" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember__srt--RangeAxis__srt--MaximumMember_zcYVcXvYZI06" title="Finite-lived intangible asset, useful life">5</span> years. MVP uses wireless multiplex transmitters and artificial intelligence internally to produce and sell products and services to customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Patents and Licenses:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents and licenses filed by the Company are amortized for <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MinimumMember_zZiCsJuAS67a" title="Finite-lived intangible asset, useful life">18.5</span> to <span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MaximumMember_zNiEDtUOMNR2" title="Finite-lived intangible asset, useful life">20</span> years. The amortization of the costs associated with provisional patents and pending applications begins after successful review and filing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Trade Name, Technology, and Customer Relationships:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other intangible assets are amortized for <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__srt--RangeAxis__srt--MinimumMember_znY9e5vLjgci" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__srt--RangeAxis__srt--MaximumMember_zhAlUwjm8jX8" title="Finite-lived intangible asset, useful life">15</span> years. IMT, Vislink Technologies, Inc., MVP, and Poway acquisitions contributed to developing these intangible assets, including trade names, technology, and customer lists.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zCmXOXlc4OO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized net capitalized intangible costs as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z3p6GnQdG6E3" style="display: none">SCHEDULE OF CAPITALIZED INTANGIBLE COSTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20230101__20231231_zoJZpIXyeNQ5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20220101__20221231_zDTofFRajkMk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zeRZ7IslNUlb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">726,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,319,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zo4FuywopW17" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents and Licenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1263">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1264">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zGV5LEqtpJti" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade Names and Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">922,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,060,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zCYG3lMhwdk4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer Relationships</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,218,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,021,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_zUuVEJct0yt9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net capitalized intangible costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,866,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zyzyVzVhDzqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zKB52DpT08ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized the amortization of intangible assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zYND0hz2LP3j" style="display: none">SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20230101__20231231_zgwBR1L4z2r5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20220101__20221231_zwTqsbOs4O46" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zTxKU3H8HMme" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">593,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">592,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zOT1Obs4Rhub" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents and Licenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1280">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">535,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_z82zASAAnjVh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade Names and Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zP9pDEinTtpg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer Relationships</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">299,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_zFR2UYdyw8s7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of intangible assets </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,030,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,521,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zLk4NH2uEI8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z3M3wGo82UQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining life of the amortization of the Company’s intangible assets is approximately <span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVEFOR0lCTEUgQVNTRVRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20231231_zZETOrKIA4gg" title="Weighted average remaining life of intangible assets">4.9</span> years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zJBSfwcT1ydc" style="display: none">SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Period ending December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_495_20231231_zkiD2xpXxYad" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANzMzA_zd1INT5Am8rh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">783,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANzMzA_zQhIzm3VD8Oa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">781,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANzMzA_z6Jorl8ODYgj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">651,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANzMzA_zyt002FfZp6c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANzMzA_zA6J5skYE9v" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANzMzA_zeX1EvJTjFl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,017,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzMzA_z3LMPSC72nma" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, estimated amortization expense</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,866,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_z5jU59Y0uZi5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zi87OQM53FD6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates finite intangible assets as of December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="margin: 0; font-family: Times New Roman, Times, Serif"> <span id="xdx_8BB_zrAv0zGCDsP5" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Proprietary Technology</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Patents and Licenses</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade Names &amp; Technology</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Customer Relationships</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">December 31, 2023:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance, January 1, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zhYNh9pViU5l" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,132,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zJ13zuojzYYf" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(815,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zJZIMSVDw55e" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zDAmvPZozvU7" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zObKrKdLDP9" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,251,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zjrl1aB1YSyd" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,189,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zTGwG17SRAIb" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,095,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zqiTL4bQRNM4" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,074,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pp0p0_c20230101__20231231_zvPBRuTvCZK1" style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_984_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zIWNiY2FrHQd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1168">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_980_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zwzOcnQX56h6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">496,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_989_eus-gaap--FinitelivedIntangibleAssetsAcquired1_pp0p0_c20230101__20231231_zKvd5fMF6G3l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">496,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zLkixAoBggI6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(593,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zA6mtn3yI1Ne" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(138,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zjEssGnqilKg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(299,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98F_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20230101__20231231_zgEs1vzR2or5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,030,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance, December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_ztXNsaSiYjrd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,132,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zGSnJ9MXL5v3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,408,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zMKjlmD8kp48" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zFn4Z6pqqJA2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zkJjxK4u5uL3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,251,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_ztP5HZTnlHG6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,327,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z1zcMhWE67p" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,591,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zsO62l3AZW53" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,373,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pp0p0_c20230101__20231231_zeXXgLz587ll" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,866,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: underline"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">December 31, 2022:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance, January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zdiKdOiAP7Ic" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,132,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zd9ST9cx3rOc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(223,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zWQQLiVZybll" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zaNEzROWYxY4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11,843,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zMXsMCDlXxL2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,251,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zxWtuHiA0qAa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,052,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zyTwB3PZHBre" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,095,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z3j6QxHInlsf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,817,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iS_pp0p0_c20220101__20221231_ztzixxMPJ3U4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning balance net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,921,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_985_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_z4gdYCNx0e49" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(592,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zKX0iU1a2jy7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(535,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_98B_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zIa882pGUoS1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(137,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_ztjiOkK2GyCa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(257,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td id="xdx_987_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231_z6pphNT2Vcb6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets, amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,521,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance, December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zHx64kr4yS48" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,132,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zSNk2OsRkguk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(815,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zwSoQJLrmLme" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zNL4AwdaO8m9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12,378,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_z6yi8I1uxmLl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,251,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zs4ZEBl3Xafk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,189,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zkeeePAmhzul" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,095,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z0aeelLZ0L48" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,074,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iE_pp0p0_c20220101__20221231_zFt0qb2Rlo83" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending balance net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></td></tr> </table> 2132000 -815000 12378000 -12378000 2251000 -1189000 5095000 -3074000 4400000 496000 496000 593000 138000 299000 1030000 2132000 -1408000 12378000 -12378000 2251000 -1327000 5591000 -3373000 3866000 2132000 -223000 12378000 -11843000 2251000 -1052000 5095000 -2817000 5921000 592000 535000 137000 257000 1521000 2132000 -815000 12378000 -12378000 2251000 -1189000 5095000 -3074000 4400000 P3Y P5Y P18Y6M P20Y P3Y P15Y <p id="xdx_899_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zCmXOXlc4OO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized net capitalized intangible costs as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z3p6GnQdG6E3" style="display: none">SCHEDULE OF CAPITALIZED INTANGIBLE COSTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20230101__20231231_zoJZpIXyeNQ5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20220101__20221231_zDTofFRajkMk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zeRZ7IslNUlb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">726,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,319,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zo4FuywopW17" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents and Licenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1263">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1264">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_zGV5LEqtpJti" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade Names and Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">922,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,060,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zCYG3lMhwdk4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer Relationships</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,218,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,021,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend_pp0p0_zUuVEJct0yt9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net capitalized intangible costs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,866,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 726000 1319000 922000 1060000 2218000 2021000 3866000 4400000 <p id="xdx_89A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zKB52DpT08ik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized the amortization of intangible assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zYND0hz2LP3j" style="display: none">SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20230101__20231231_zgwBR1L4z2r5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20220101__20221231_zwTqsbOs4O46" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zTxKU3H8HMme" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">593,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">592,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zOT1Obs4Rhub" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents and Licenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1280">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">535,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TradeNamesAndTechnologyMember_z82zASAAnjVh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade Names and Technology</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zP9pDEinTtpg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer Relationships</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">299,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_zFR2UYdyw8s7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of intangible assets </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,030,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,521,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 593000 592000 535000 138000 137000 299000 257000 1030000 1521000 <p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_z3M3wGo82UQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average remaining life of the amortization of the Company’s intangible assets is approximately <span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVEFOR0lCTEUgQVNTRVRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_iI_dtY_c20231231_zZETOrKIA4gg" title="Weighted average remaining life of intangible assets">4.9</span> years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zJBSfwcT1ydc" style="display: none">SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Period ending December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_495_20231231_zkiD2xpXxYad" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANzMzA_zd1INT5Am8rh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 78%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">783,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANzMzA_zQhIzm3VD8Oa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">781,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANzMzA_z6Jorl8ODYgj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">651,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANzMzA_zyt002FfZp6c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANzMzA_zA6J5skYE9v" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANzMzA_zeX1EvJTjFl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,017,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzMzA_z3LMPSC72nma" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, estimated amortization expense</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,866,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> P4Y10M24D 783000 781000 651000 346000 288000 1017000 3866000 <p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z4oqjT2XtV0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 — <span id="xdx_821_zcwMLacns7rj">ACCRUED EXPENSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zdvIvFmpgWW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zTNAt0NOtDu4" style="display: none">SCHEDULE OF ACCRUED EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20231231_zn9HItVQmlg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20221231_zWFtumB7pUs8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--WorkersCompensationLiabilityCurrent_iI_pp0p0_maALCzM13_zPvlk3ZZW309" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">567,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">246,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maALCzM13_zc51Unp7AnL1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commissions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maALCzM13_zgxvkF6vXmL9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maALCzM13_zvHDXPpOsesl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">770,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">908,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredCompensationLiabilityCurrent_iI_pp0p0_maALCzM13_ziiqL1OFIzLl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred equity</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1326">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtALCzM13_zwqTjPLE2mBl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,578,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,568,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_z263Tu6XJjyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zdvIvFmpgWW5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zTNAt0NOtDu4" style="display: none">SCHEDULE OF ACCRUED EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20231231_zn9HItVQmlg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20221231_zWFtumB7pUs8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--WorkersCompensationLiabilityCurrent_iI_pp0p0_maALCzM13_zPvlk3ZZW309" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">567,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">246,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maALCzM13_zc51Unp7AnL1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commissions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maALCzM13_zgxvkF6vXmL9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranty</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maALCzM13_zvHDXPpOsesl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">770,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">908,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredCompensationLiabilityCurrent_iI_pp0p0_maALCzM13_ziiqL1OFIzLl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred equity</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1326">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtALCzM13_zwqTjPLE2mBl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,578,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,568,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 567000 246000 106000 47000 135000 112000 770000 908000 255000 1578000 1568000 <p id="xdx_80E_eus-gaap--DebtDisclosureTextBlock_zWL9KGh8vWhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 — <span id="xdx_828_zPZ2RvilZdw8">NOTES PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zIGalLZjQWm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s notes payable as of December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zKJhq2vLAGm7">SCHEDULE OF NOTES PAYABLE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20231231_zSDVo7HZR7t5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20221231_zvnSqzRAcuJd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 5, 2022, </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--NotesPayableCurrent_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z4Wh9yTHsivg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 5, 2022, the Company renewed its D &amp; O insurance policy, decreasing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z2J5Ki70eB4g" title="Debt instrument, face amount">1,037,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zfzKEakCMIQ4" title="Debt instrument down payment">194,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90F_eus-gaap--NotesPayable_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z2pv95UKXxmb" title="Notes Payable">943,000</span>. The loan’s terms are nine months at a<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zrXWGKzKsYQa" title="Debt instrument, interest rate, stated percentage"> 2.09</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20220404__20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zMRm5MDNaeY" title="Debt monthly principal and interest payment">84,000</span>. The Company recorded interest expense of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90A_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zhv0WcXAsXih" title="Interest expense">6,000</span> and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90E_eus-gaap--InterestExpenseDebt_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zo8ujWmO92Di" title="Interest expense">0</span>- for the years ended December 31, 2022, and 2021, respectively.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1336">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--NotesPayableCurrent_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z7z9ciwYoen5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 5, 2023, the Company renewed its D &amp; O insurance policy, reducing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zJwITu4BYMV7" title="Debt instrument, face amount">811,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zua7SEgOlg9d" title="Debt instrument down payment">288,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_eus-gaap--NotesPayable_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zQqEuUZVGmLl" title="Notes Payable">523,000</span>. The loan’s terms are for nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zJltauLyTgae" title="Annual interest rate">6.14</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20230404__20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zzhBNnt3xToi" title="Debt monthly principal and interest payment">67,000</span>. Accordingly, the Company recorded interest expenses of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90C_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zyW4Y7R77RCc" title="Interest expense">12,100</span> and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_eus-gaap--InterestExpenseDebt_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zoeRX6IXQbRl" title="Interest expense">0</span>- for the years ending December 31, 2023, and 2022, respectively.</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1353">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1354">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--NotesPayableCurrent_iI_pp0p0_z9ACpAv0ZTP2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1370">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zw5KkTDqoJf3" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zIGalLZjQWm2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s notes payable as of December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zKJhq2vLAGm7">SCHEDULE OF NOTES PAYABLE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20231231_zSDVo7HZR7t5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49E_20221231_zvnSqzRAcuJd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 5, 2022, </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--NotesPayableCurrent_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z4Wh9yTHsivg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 5, 2022, the Company renewed its D &amp; O insurance policy, decreasing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z2J5Ki70eB4g" title="Debt instrument, face amount">1,037,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zfzKEakCMIQ4" title="Debt instrument down payment">194,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90F_eus-gaap--NotesPayable_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z2pv95UKXxmb" title="Notes Payable">943,000</span>. The loan’s terms are nine months at a<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zrXWGKzKsYQa" title="Debt instrument, interest rate, stated percentage"> 2.09</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_904_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20220404__20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zMRm5MDNaeY" title="Debt monthly principal and interest payment">84,000</span>. The Company recorded interest expense of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90A_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zhv0WcXAsXih" title="Interest expense">6,000</span> and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90E_eus-gaap--InterestExpenseDebt_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zo8ujWmO92Di" title="Interest expense">0</span>- for the years ended December 31, 2022, and 2021, respectively.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1336">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--NotesPayableCurrent_iI_pp0p0_hus-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z7z9ciwYoen5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 5, 2023, the Company renewed its D &amp; O insurance policy, reducing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zJwITu4BYMV7" title="Debt instrument, face amount">811,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zua7SEgOlg9d" title="Debt instrument down payment">288,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_eus-gaap--NotesPayable_iI_pp0p0_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zQqEuUZVGmLl" title="Notes Payable">523,000</span>. The loan’s terms are for nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zJltauLyTgae" title="Annual interest rate">6.14</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_903_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20230404__20230405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zzhBNnt3xToi" title="Debt monthly principal and interest payment">67,000</span>. Accordingly, the Company recorded interest expenses of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90C_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zyW4Y7R77RCc" title="Interest expense">12,100</span> and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_eus-gaap--InterestExpenseDebt_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zoeRX6IXQbRl" title="Interest expense">0</span>- for the years ending December 31, 2023, and 2022, respectively.</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1353">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1354">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--NotesPayableCurrent_iI_pp0p0_z9ACpAv0ZTP2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1370">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1037000 194000 943000 0.0209 84000 6000 0 84000 811000 288000 523000 0.0614 67000 12100 0 84000 <p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_zAv0D5gJMZyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — <span id="xdx_821_zzLgADJ6cXMi">LEASES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aside from renting office spaces, deployment sites, and storage warehouses, the company leases warehouse facilities internationally and domestically. As of December 31, 2023, the operating leases exhibit diverse terms and provisions, with lease durations spanning one to four years. Some individual leases include rent escalation clauses and lease concessions that entail additional rental payments in the latter years of the lease period. Such contracts are accounted for on a straight-line basis throughout the minimum lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfLeasesObligationsAssumedTableTextBlock_zeApnFqgChFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below lists the location and lease expiration date from 2025 through 2027: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z5BFdybPZWj4" style="display: none">SCHEDULE OF LEASE OBLIGATIONS ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Square Footage</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease-End Date</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate Future Payments</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 39%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colchester, U.K. – Waterside House</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zyjDsxoSXI97" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,223</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zDxkzZqILFFf" title="Lease-End Month">Dec</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zrpcc94gGgx5" title="Lease-End Date">2025</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zjRAosG7PQD1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">502,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lutton, UK</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zMZfu5aOxmk8" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">600</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zwPtm8Xy8gzd" title="Lease-End Date">Jan</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zJYecQ5f0JAg" title="Lease-End Date">2025</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zX3QmQAQmKAe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Billerica, MA</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--BillericaMaMember_z981ukaDPWCa" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zKqMv3Tf4pM8" title="Lease-End Date">Dec</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zJOFOqxUwyUb" title="Lease-End Date">2026</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zjks14uOidIa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mount Olive, NJ</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_z6nGa6LbIxZ9" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,979</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zr8xmTOcLTK3" title="Lease-End Date">May</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zTYNgIVq2qg6" title="Lease-End Date">2027</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_z0ZFWpTT2x7c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trivex, Singapore</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_zBsblQZDpLO5" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">950</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_z8wevif3AOfl" title="Lease-End Month">Aug</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_zg5X83qBp50i" title="Lease-End Year">2025</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_zmFxlCd1YR4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zhBGZtMF1vT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — LEASES (continued):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">The following represents lease activity for the year ending December 31, 2023:</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Lutton, UK</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A one-year lease for <span id="xdx_90F_eus-gaap--AreaOfLand_iI_uSquareFeet_c20230901__srt--StatementGeographicalAxis__custom--LuttonUKMember_z9Wo5NDJjuZb" title="Area of Land">600</span> square feet of administrative office space in Lutton, UK, was signed on September 1, 2023, and will run through <span id="xdx_909_eus-gaap--LeaseExpirationDate1_c20230901__20230901__srt--StatementGeographicalAxis__custom--LuttonUKMember_zo19eNbpWOx" title="Lease expiration">May 31, 2024</span>, at approximately $<span id="xdx_90D_eus-gaap--PaymentsForRent_uGBP_c20230901__20230901__srt--StatementGeographicalAxis__custom--LuttonUKMember_zKQaXmkpUuii" title="Payments for rent">2,100</span> per month. A two-year lease for <span id="xdx_900_eus-gaap--AreaOfLand_iI_uSquareFeet_c20230201__srt--StatementGeographicalAxis__custom--LuttonUKMember_znHurCyr1bJg" title="Area of Land">600</span> square feet was executed at another location and will run from February 1, 2023, through <span id="xdx_909_eus-gaap--LeaseExpirationDate1_c20230201__20230201__srt--StatementGeographicalAxis__custom--LuttonUKMember_zkVRgsn8jgCk" title="Lease expiration">January 31, 2025</span>, at approximately $<span id="xdx_90B_eus-gaap--PaymentsForRent_uGBP_c20230201__20230201__srt--StatementGeographicalAxis__custom--LuttonUKMember_zUz3LcWEa1h4" title="Payments for rent">2,500</span> per month.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Dubai, UAE</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company renewed its<span id="xdx_905_eus-gaap--LessorOperatingLeaseDescription_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zWr6ynxxYm94" title="Area of land description"> lease for <span id="xdx_908_eus-gaap--AreaOfLand_iI_uSquareFeet_c20230703__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zLqwoKmA84K7" title="Area of Land">976</span> square feet of administrative office space in Dubai Studio City, UAE, commencing on July 3, 2023, and terminating on <span id="xdx_906_eus-gaap--LeaseExpirationDate1_c20230703__20230703__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zgSJLTK6B0C" title="Lease expiration">July 2, 2024</span>, for approximately $<span id="xdx_90E_eus-gaap--PaymentsForRent_c20230703__20230703__srt--StatementGeographicalAxis__custom--DubaiUAEMember_z1MGlhY5RVZ8" title="Payments for rent">1,632</span> monthly</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Poway, CA</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--LessorOperatingLeaseDescription_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__custom--PowayCAMember_zWqKb6sQ7yS7" title="Area of land">Included in the September 14, 2023, acquisition of assets from Broadcast Microwave Services, LLC (BMS) was a sublease of approximately <span id="xdx_90F_eus-gaap--AreaOfLand_iI_uSquareFeet_c20230914__srt--StatementGeographicalAxis__custom--PowayCAMember_zyTTe5m54iQ5" title="Area of Land">11,715</span> square feet of general office use facilities previously held under a six-month agreement with BMS, with lease responsibilities conveyed to Vislink Poway, LLC. The initial lease term commenced with a monthly rent of approximately $<span id="xdx_90F_eus-gaap--PaymentsForRent_c20230914__20230914__srt--StatementGeographicalAxis__custom--PowayCAMember_zi8yLeWCm24" title="Payments for rent">22,300</span> and concluded on <span id="xdx_906_eus-gaap--LeaseExpirationDate1_c20230914__20230914__srt--StatementGeographicalAxis__custom--PowayCAMember_zUM1OVotEwPe" title="Lease expiration">March 13, 2024</span>. On February 12, 2024, Vislink Poway, LLC signed a renewal agreement for the same space. The renewal term is set for one year and ten and a half months, commencing on March 14, 2024, and ending on <span id="xdx_90D_eus-gaap--LeaseExpirationDate1_c20240212__20240212__srt--StatementGeographicalAxis__custom--PowayCAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0qoolyqkVZe" title="Lease expiration">January 31, 2026</span>. The base rent for the renewal period is established at $<span id="xdx_90A_eus-gaap--PaymentsForRent_c20240214__20240214__srt--StatementGeographicalAxis__custom--PowayCAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zK0lMvTDx3Ab" title="Payments for rent">22,926</span> per month</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Colchester, U.K.</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately <span id="xdx_908_eus-gaap--AreaOfLand_iI_uSquareFeet_c20230930__srt--StatementGeographicalAxis__custom--ColchesterUKMember_zRoKv94v841g" title="Area of Land">2,700</span> square feet of manufacturing space at the Colchester, U.K. facility were abandoned as part of the Company’s strategic decision to relocate its U.K. manufacturing division to the United States commencing in September 2023, with approximately <span id="xdx_90C_eus-gaap--AreaOfLand_iI_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--ColchesterUKMember_zXiuLTGgako7" title="Area of Land">13,200</span> square feet of remaining space. Impracticable conditions made subletting the unused space unachievable, and the Company considered it abandoned. According to ASC 360, leased space abandonment is an impairment indicator, and we assessed whether the lease “Right of use assets, operating leases” (ROU) assets were impaired. It was determined that approximately $<span id="xdx_902_eus-gaap--OperatingLeaseImpairmentLoss_c20230901__20230930__srt--StatementGeographicalAxis__custom--ColchesterUKMember_z4bazJFYkqxa" title="Loss on impairment of right of use asset">83,000</span> of the Company’s right-of-use operating assets were impaired.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Hemel, United Kingdom</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the original lease agreement dated April 28, 2017, a “break clause” signifying a “break date” of October 28, 2020, sighted the following: the Company may terminate this lease on the “break date” by giving the landlord such notice within six months of the “break date.” At the lease’s commencement, it was not reasonably sure if the Company would exercise its right by the break clause’s date. These measures upheld the determination of the lease’s noncancellable period for adopting ASC 842 on January 1, 2019. The lease term of 22 months as of January 1, 2019, helped calculate the remaining lease payments’ net present value assigned to the right-of-use asset and operating lease liability upon the adoption date. The total annual rent under this lease is approximately $<span id="xdx_908_eus-gaap--PaymentsForRent_uGBP_c20230101__20231231__srt--StatementGeographicalAxis__custom--HemelUnitedKingdomMember_zt2JVwCVzOQ8" title="Payments for rent">175,000</span>, covering <span id="xdx_907_eus-gaap--AreaOfLand_iI_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--HemelUnitedKingdomMember_zh2oSbVzFajj" title="Area of Land">12,870</span> square feet of manufacturing and administrative office space. Neither party exercised their unilateral termination rights by the “break date,” triggering a lease extension. Both parties’ inaction creates new enforceable rights and obligations in the extended period, such that the lease agreement terminates on October 27, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Trivex, Singapore</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company renewed its <span id="xdx_906_ecustom--AreaOfLandDescription_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_zfnyhx4Z7pOa" title="Area of land description">lease for <span id="xdx_90D_eus-gaap--AreaOfLand_iI_uSquareFeet_c20230810__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_zJjb6yOnWREl" title="Area of Land">950</span> square feet of administrative office space commencing on August 10, 2023, and terminating on August 92, 2025, for approximately $<span id="xdx_90B_eus-gaap--PaymentsForRent_c20230810__20230810__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_zlI91XMBz47j" title="Payments for rent">3,100</span> monthly</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">The following represents lease activity for the year ending December 31, 2022:</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Lutton, UK</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 28, 2022,<span id="xdx_907_eus-gaap--LessorOperatingLeaseDescription_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zeq2ntE2ybX1" title="Area of land"> the Company entered a one-year lease for <span id="xdx_905_eus-gaap--AreaOfLand_iI_uSquareFeet_c20220428__srt--StatementGeographicalAxis__custom--LuttonUKMember_zvCaTyc159Qc" title="Area of Land">600</span> square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on<span id="xdx_906_eus-gaap--LeaseExpirationDate1_c20220427__20220428__srt--StatementGeographicalAxis__custom--LuttonUKMember" title="Lease expiration"> May 31, 2023</span>, for £<span id="xdx_90B_eus-gaap--PaymentsForRent_uGBP_c20220427__20220428__srt--StatementGeographicalAxis__custom--LuttonUKMember_zq5XWCFvD1X8" title="Payments for rent">1,320</span> monthly or approximately $<span id="xdx_900_eus-gaap--PaymentsForRent_c20220427__20220428__srt--StatementGeographicalAxis__custom--LuttonUKMember_zd89ZRf9zoOa" title="Payments for rent">1,800</span> per month</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Dubai, UAE</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company renewed its <span id="xdx_907_eus-gaap--LessorOperatingLeaseDescription_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zN9rlMT4TDCa" title="Lease description">lease for <span id="xdx_903_eus-gaap--AreaOfLand_iI_uSquareFeet_c20220703__srt--StatementGeographicalAxis__custom--DubaiUAEMember_ziypmwz4jKL6" title="Area of Land">976</span> square feet of administrative office space commencing on July 3, 2022, and terminating on <span id="xdx_906_eus-gaap--LeaseExpirationDate1_c20220701__20220703__srt--StatementGeographicalAxis__custom--DubaiUAEMember" title="Lease expiration">July 2, 2023</span>, in Dubai Studio City, UAE, for AED <span id="xdx_90B_eus-gaap--PaymentsForRent_uAED_c20220701__20220703__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zZM6oWSASXmc" title="Payments for rent">5,995</span> or approximately US$ <span id="xdx_90E_eus-gaap--PaymentsForRent_c20220701__20220703__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zUhTEQttgpJa" title="Payments for rent">1,632</span> monthly</span>. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — LEASES (continued):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">The following represents lease activity for the year ending December 31, 2022 (continued):</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Billerica, MA</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management vacated the Billerica property during the third quarter of the fiscal year 2022. The economic environment of this location precluded subletting an unoccupied site, and the leased facility was determined to be abandoned. Under ASC 360, leased space abandonment is an impairment indicator. The Company assessed the lease ROU assets for impairment, recognizing a loss on impairment of right-of-use assets of approximately $<span id="xdx_908_eus-gaap--OperatingLeaseImpairmentLoss_c20221001__20221231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zPuTGABeZje8" title="Loss on impairment of Right Of Use Asset">88,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--LeaseCostTableTextBlock_zpC5jOgNVcRd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates Right-Of-Use operating lease data recorded for the years ended December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_z5vuF9xI5olj" style="display: none">SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_ztujh5cs9er6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zDqS5KshBiZ" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Right-of-use assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; padding-left: 10pt">Cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--OperatingLeaseRightOfUseAssetLeaseCost_iI_pp0p0_ma1_c20231231_zsBkb5NQDmJg" style="width: 12%; text-align: right" title="Cost">2,385,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--OperatingLeaseRightOfUseAssetLeaseCost_iI_pp0p0_c20221231_zvOG4etnCpP6" style="width: 12%; text-align: right" title="Cost">2,260,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iI_pp0p0_ma1_c20231231_zOhLltbuK5h3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(1,643,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iI_pp0p0_c20221231_zEJZoa3HGee4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(1,185,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pid_mt1_c20231231_zKNDYGlD63Yj" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset">742,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pid_c20221231_zIv3xVOdVI7l" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset">1,075,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10.1pt">Current portion</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pid_ma2_c20231231_zxxYEhowHZW6" style="text-align: right" title="Current portion">463,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pid_c20221231_z32dsbrfBTfc" style="text-align: right" title="Operating lease liability, Current portion">455,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10.1pt">Non-current portion</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pid_ma2_c20231231_ztSWcYRNvpU6" style="text-align: right" title="Non-current portion">755,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pid_c20221231_zTWc6WQCIIdf" style="text-align: right" title="Non-current portion">1,107,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iTI_pid_mt2_c20231231_ztz5j6U0HuCe" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">1,218,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiability_iTI_pid_c20221231_zdHwEqoyMmJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">1,562,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Weighted average discount rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_zUQbdKf8S18" title="Weighted-average discount rate-operating leases">9.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zvyAiziNl3Pa" title="Weighted-average discount rate-operating leases">9.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted average remaining term for lease contracts</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zgbweHwO46w8" title="Weighted-average remaining lease term-operating leases">2.6</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zfQi7LxGgxBf" title="Weighted-average remaining lease term-operating leases">3.4</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Lease maturity dates for right-of-use operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20230101__20231231_zvgj9rpmaYwi" title="Lease maturity dates for right-of-use operating leases">July 2025 to May 2027</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20220101__20221231_zTaJJruTirfj" title="Lease maturity dates for right-of-use operating leases">July 2023 to May 2027</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Lease cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseCost_pp0p0_maLCzF3E_z5iQdetrUHs6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10.1pt">Operating lease cost</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">435,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">438,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ShortTermLeaseCost_pp0p0_maLCzF3E_zgXNvERgbLHg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10.1pt">Short-term lease cost</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">126,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">93,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LeaseCost_iT_pp0p0_mtLCzF3E_zXd2u1qQxg2h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">561,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">531,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pp0p0_zlqVYUWdpws8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10.1pt">Cash flows from operating leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">643,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">543,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_zx4zp6gFE1G6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Right-of-use assets obtained in exchange for new operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">171,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1538">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zsLmk6RlnYi5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zirQEAxRhO5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of our operating lease liabilities were as follows as of December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zTnTXdR0p8P7" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20231231_z2QQnfD6BXT7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzCqh_zBE1eS3TGTji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">559,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3d_maLOLLPzCqh_zNu3kkhotuWi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">513,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3d_maLOLLPzCqh_z6s6XMak3eq2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">249,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3d_maLOLLPzCqh_zJs53weUrhq8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3d_maLOLLPzCqh_z1xUjnyDHi47" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1550">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzCqh_zx97pJcG3Hz2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1552">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3d_mtLOLLPzCqh_zObyGtU56m14" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,380,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3d_zKDEJAC7E4gb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: imputed interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_iI_pn3d_zRcuJQP2RFe5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,218,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3d_zbGPFgwWOSN9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Current lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">463,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3d_zKsybxRfIuEd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">755,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_zKNSWR0HSPtb" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfLeasesObligationsAssumedTableTextBlock_zeApnFqgChFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below lists the location and lease expiration date from 2025 through 2027: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_z5BFdybPZWj4" style="display: none">SCHEDULE OF LEASE OBLIGATIONS ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Square Footage</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="4" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease-End Date</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate Future Payments</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 39%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colchester, U.K. – Waterside House</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zyjDsxoSXI97" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,223</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zDxkzZqILFFf" title="Lease-End Month">Dec</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zrpcc94gGgx5" title="Lease-End Date">2025</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zjRAosG7PQD1" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">502,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lutton, UK</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zMZfu5aOxmk8" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">600</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zwPtm8Xy8gzd" title="Lease-End Date">Jan</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zJYecQ5f0JAg" title="Lease-End Date">2025</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zX3QmQAQmKAe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Billerica, MA</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--BillericaMaMember_z981ukaDPWCa" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zKqMv3Tf4pM8" title="Lease-End Date">Dec</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zJOFOqxUwyUb" title="Lease-End Date">2026</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zjks14uOidIa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mount Olive, NJ</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_z6nGa6LbIxZ9" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,979</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zr8xmTOcLTK3" title="Lease-End Date">May</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zTYNgIVq2qg6" title="Lease-End Date">2027</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_z0ZFWpTT2x7c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trivex, Singapore</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20231231__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_zBsblQZDpLO5" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">950</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--LeaseExpirationMonth_c20230101__20231231__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_z8wevif3AOfl" title="Lease-End Month">Aug</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--LeaseExpirationYear_c20230101__20231231__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_zg5X83qBp50i" title="Lease-End Year">2025</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--TrivexSingaporeMember_zmFxlCd1YR4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 13223 Dec 2025 502000 600 Jan 2025 32000 2000 Dec 2026 316000 7979 May 2027 470000 950 Aug 2025 60000 600 2024-05-31 2100 600 2025-01-31 2500 lease for 976 square feet of administrative office space in Dubai Studio City, UAE, commencing on July 3, 2023, and terminating on July 2, 2024, for approximately $1,632 monthly 976 2024-07-02 1632 Included in the September 14, 2023, acquisition of assets from Broadcast Microwave Services, LLC (BMS) was a sublease of approximately 11,715 square feet of general office use facilities previously held under a six-month agreement with BMS, with lease responsibilities conveyed to Vislink Poway, LLC. The initial lease term commenced with a monthly rent of approximately $22,300 and concluded on March 13, 2024. On February 12, 2024, Vislink Poway, LLC signed a renewal agreement for the same space. The renewal term is set for one year and ten and a half months, commencing on March 14, 2024, and ending on January 31, 2026. The base rent for the renewal period is established at $22,926 per month 11715 22300 2024-03-13 2026-01-31 22926 2700 13200 83000 175000 12870 lease for 950 square feet of administrative office space commencing on August 10, 2023, and terminating on August 92, 2025, for approximately $3,100 monthly 950 3100 the Company entered a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on May 31, 2023, for £1,320 monthly or approximately $1,800 per month 600 2023-05-31 1320 1800 lease for 976 square feet of administrative office space commencing on July 3, 2022, and terminating on July 2, 2023, in Dubai Studio City, UAE, for AED 5,995 or approximately US$ 1,632 monthly 976 2023-07-02 5995 1632 88000 <p id="xdx_894_eus-gaap--LeaseCostTableTextBlock_zpC5jOgNVcRd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates Right-Of-Use operating lease data recorded for the years ended December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_z5vuF9xI5olj" style="display: none">SCHEDULE OF RIGHT OF USE OPERATING LEASE DATA</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230101__20231231_ztujh5cs9er6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zDqS5KshBiZ" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Right-of-use assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; padding-left: 10pt">Cost</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--OperatingLeaseRightOfUseAssetLeaseCost_iI_pp0p0_ma1_c20231231_zsBkb5NQDmJg" style="width: 12%; text-align: right" title="Cost">2,385,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--OperatingLeaseRightOfUseAssetLeaseCost_iI_pp0p0_c20221231_zvOG4etnCpP6" style="width: 12%; text-align: right" title="Cost">2,260,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iI_pp0p0_ma1_c20231231_zOhLltbuK5h3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(1,643,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_iI_pp0p0_c20221231_zEJZoa3HGee4" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated amortization">(1,185,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pid_mt1_c20231231_zKNDYGlD63Yj" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset">742,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseRightOfUseAsset_iTI_pid_c20221231_zIv3xVOdVI7l" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease right of use asset">1,075,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating lease liability:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10.1pt">Current portion</td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pid_ma2_c20231231_zxxYEhowHZW6" style="text-align: right" title="Current portion">463,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pid_c20221231_z32dsbrfBTfc" style="text-align: right" title="Operating lease liability, Current portion">455,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10.1pt">Non-current portion</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pid_ma2_c20231231_ztSWcYRNvpU6" style="text-align: right" title="Non-current portion">755,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pid_c20221231_zTWc6WQCIIdf" style="text-align: right" title="Non-current portion">1,107,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingLeaseLiability_iTI_pid_mt2_c20231231_ztz5j6U0HuCe" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">1,218,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiability_iTI_pid_c20221231_zdHwEqoyMmJ9" style="border-bottom: Black 2.5pt double; text-align: right" title="Operating lease liability">1,562,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Weighted average discount rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20231231_zUQbdKf8S18" title="Weighted-average discount rate-operating leases">9.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zvyAiziNl3Pa" title="Weighted-average discount rate-operating leases">9.4</span></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted average remaining term for lease contracts</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_zgbweHwO46w8" title="Weighted-average remaining lease term-operating leases">2.6</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zfQi7LxGgxBf" title="Weighted-average remaining lease term-operating leases">3.4</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Lease maturity dates for right-of-use operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20230101__20231231_zvgj9rpmaYwi" title="Lease maturity dates for right-of-use operating leases">July 2025 to May 2027</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--LesseeOperatingLeaseOptionToExtend_c20220101__20221231_zTaJJruTirfj" title="Lease maturity dates for right-of-use operating leases">July 2023 to May 2027</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Lease cost:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseCost_pp0p0_maLCzF3E_z5iQdetrUHs6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10.1pt">Operating lease cost</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">435,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">438,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ShortTermLeaseCost_pp0p0_maLCzF3E_zgXNvERgbLHg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10.1pt">Short-term lease cost</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">126,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">93,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10.1pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LeaseCost_iT_pp0p0_mtLCzF3E_zXd2u1qQxg2h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">561,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">531,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash paid for lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pp0p0_zlqVYUWdpws8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 10.1pt">Cash flows from operating leases</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">643,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">543,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_pp0p0_zx4zp6gFE1G6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Right-of-use assets obtained in exchange for new operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">171,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1538">—</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2385000 2260000 -1643000 -1185000 742000 1075000 463000 455000 755000 1107000 1218000 1562000 0.094 0.094 P2Y7M6D P3Y4M24D July 2025 to May 2027 July 2023 to May 2027 435000 438000 126000 93000 561000 531000 643000 543000 171000 <p id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zirQEAxRhO5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of our operating lease liabilities were as follows as of December 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zTnTXdR0p8P7" style="display: none">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20231231_z2QQnfD6BXT7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzCqh_zBE1eS3TGTji" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">559,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3d_maLOLLPzCqh_zNu3kkhotuWi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">513,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3d_maLOLLPzCqh_z6s6XMak3eq2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">249,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3d_maLOLLPzCqh_zJs53weUrhq8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3d_maLOLLPzCqh_z1xUjnyDHi47" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1550">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzCqh_zx97pJcG3Hz2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1552">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3d_mtLOLLPzCqh_zObyGtU56m14" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,380,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3d_zKDEJAC7E4gb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: imputed interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_iI_pn3d_zRcuJQP2RFe5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,218,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3d_zbGPFgwWOSN9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Current lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">463,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3d_zKsybxRfIuEd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">755,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 559000 513000 249000 59000 1380000 162000 1218000 463000 755000 <p id="xdx_803_eus-gaap--PreferredStockTextBlock_zwcPlz6W2X16" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17 — <span id="xdx_82A_zj8yxXNjPC1c">PREFERRED SHARES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2013, the issuance of up to <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pn5n6_c20130331__srt--RangeAxis__srt--MaximumMember_zbAPK3DNziX4">10.0</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million shares of “Blank Check” preferred stock with a par value of $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20130331_zCavhtRB1dq9">0.00001</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share received approval from the stockholders of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following shares were designated as authorized:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three million shares of Series A Convertible Preferred Stock (“Series A Preferred Stock”) on December 31, 2014.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three million shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”) on February 11, 2015.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three million shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”) on February 24, 2015.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 5, 2016, the Company terminated the Series A Preferred Stock and Series C Preferred Stock and increased the number of designated shares of Series B Preferred Stock to <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20160205__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zsRAdxP5Iku5" title="Preferred stock shares authorized">5,000,000</span>. The following shares were designated as authorized: <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_pn6n6_dc_c20160425__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zK7XQT9nuJ5h" title="Preferred stock shares authorized">Five</span> million shares of Series D Convertible Preferred Stock (“Series D Preferred Stock”) on April 25, 2016. On December 6, 2016, the Company terminated the Series B Preferred Stock. The following shares were designated as authorized: <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_dc_c20161221__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zXM48RM3yTf2" title="Preferred stock shares authorized">Five</span> thousand shares of Series E Convertible Preferred Stock (“Series E Preferred Stock”) on December 21, 2016. On November 9, 2022, the Company’s Board of Directors (i) terminated the Series D Preferred Stock and Series E Preferred Stock and (ii) designated the following shares as authorized: <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221109__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNR0ZoTV0Rd8" title="Preferred stock shares authorized">47,500</span> shares of new Series A Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series A Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 9, 2022, the Company’s Board of directors declared a dividend of one one-thousandth of a share of Series A Preferred Stock, par value $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20221109__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zI6ArdmXZJAa" title="Share issued price per share">0.00001</span> per share (“Series A Preferred Stock”), for each outstanding share of the Company’s common stock, to stockholders of record on November 21, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--PreferredStockVotingRights_c20221108__20221109__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zL1pFH5cZBmh" title="Preferred stock voting rights">Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes</span>. The outstanding shares of Series A Preferred Stock voted together with the outstanding shares of the Company’s common stock as a single class exclusively concerning the proposal to adopt an amendment to the Company’s Certificate of Incorporation, as amended, to reclassify the outstanding shares of the Company’s Common Stock into a smaller number of shares of common stock at a ratio specified in or determined under the terms of such amendment (the “Reverse Stock Split”). The Series A Preferred Stock was not entitled to vote on any other matter except to the extent required under the Delaware General Corporation Law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Preferred Stock was not convertible into, or exchangeable for, shares of any other class, series of stock, or other securities of the Company. The Series A Preferred Stock had no stated maturity and is not subject to any sinking fund. The Series A Preferred Stock was not restricted to the Company’s redemption or repurchase of shares when there was any arrearage in the payment of dividends or sinking fund installments. The Certificate of Designation was filed with the Delaware Secretary of State and became effective on November 9, 2022. The holders of Series A Preferred Stock were not entitled to receive dividends.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted on a proposal to authorize the Board, at its discretion, to affect the Reverse Stock Split. All shares of Series A Preferred Stock that were not present in person or by proxy at the Special Meeting held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) were automatically redeemed in whole, but not in part, by the Company at the Initial Redemption Time without further action on the part of the Company or the holder of shares of Series A Preferred Stock (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed according to an Initial Redemption were redeemed in whole but not in part on March 24, 2023 (i) if the Board ordered such redemption in its sole discretion, automatically and effective on such time and date specified by the Board in its sole discretion or (ii) automatically upon the approval by the Company’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on such proposal (“the Subsequent Redemption”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--PreferredStockRedemptionTerms_c20230110__20230123__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zS4HjhxWTRwl" title="Preferred stock redemption terms, description">Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17 — PREFERRED SHARES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series A Preferred Stock (continued)</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was not solely in control of the redemption of the shares of Series A Preferred Stock since the holders had the option of deciding whether to vote in respect of the above-described Reverse Stock Split, which determined whether a given holder’s shares of Series A Preferred Stock were redeemed in the Initial Redemption or the Subsequent Redemption. Since the redemption of the Series A Preferred Stock was not solely in the control of the Company, the shares of Series A Preferred Stock were classified within mezzanine equity in the Company’s audited consolidated balance sheet. The shares of Series A Preferred Stock were measured at redemption value. The value of Series A Preferred Stock shares as of December 31, 2023 and 2022, was de minimis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Certificate of Elimination</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 25, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating <span id="xdx_905_eus-gaap--PreferredStockShareSubscriptions_iI_pid_c20160425__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zt9N1SnDYqT" title="Preferred stock unissued">5,000,000</span> shares out of the Company’s authorized but unissued shares of its preferred stock as Series D Convertible Preferred Stock, par value $<span id="xdx_905_eus-gaap--PreferredStockNoParValue_iI_pid_c20160425__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zPLk1v2nY3y" title="Preferred stock par value">0.00001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 21, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating <span id="xdx_901_eus-gaap--PreferredStockShareSubscriptions_iI_pid_c20161221__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zN6Gy7zNyr06" title="Preferred stock unissued">5,000</span> shares out of the Company’s authorized but unissued shares of its preferred stock as Series E Convertible Preferred Stock, par value $<span id="xdx_909_eus-gaap--PreferredStockNoParValue_iI_pid_c20161221__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z6QDDMbjffhl" title="Preferred stock par value">0.00001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 9, 2022, the Company filed Certificates of Elimination for each of the Series D Preferred Stock and Series E Preferred Stock with the Secretary of State of the State of Delaware, which, effective upon filing, eliminated all matters outlined in the Certificates of Designation of Series D Preferred Stock and Series E Preferred Stock previously filed by the Company. According to the Certificates of Elimination, the shares that were previously designated as Series D Preferred Stock and Series E Preferred Stock resume the status of authorized but unissued shares of preferred stock, par value $<span id="xdx_90C_eus-gaap--PreferredStockNoParValue_iI_pid_c20221109__us-gaap--StatementClassOfStockAxis__custom--SeriesDPreferredStockAndSeriesEPreferredStockMember_zsAe162KVkhf" title="Preferred stock par value">0.00001</span> per share, of the Company, issuable from time to time, in one or more series, under the Certificate of Incorporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 22, 2023, the Board of Directors of the Company (the “Board”) approved a resolution to eliminate the Company’s Certificate of Designation, Preferences, and Rights (the “Certificate of Elimination”) of the Series A Preferred Stock, par value $<span id="xdx_905_eus-gaap--PreferredStockNoParValue_iI_pid_c20230322__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zJu2q1eYOB5f" title="Preferred stock par value">0.00001</span> per share (the “Series A Preferred Stock”), that was filed with the Secretary of State of the State of Delaware on November 9, 2022. Upon the effective filing of this Certificate of Elimination, the shares previously designated under the certificate of designation as Series A Preferred Stock shall resume the status of authorized but unissued shares of the Company’s preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 24, 2023, the Company filed a certificate of elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware for the Series A Preferred Stock. The Certificate of Elimination (i) eliminated the previous designation of <span id="xdx_90D_eus-gaap--PreferredStockShareSubscriptions_iI_pid_c20230324__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zgoPoOE3egc1" title="Preferred stock unissued">47,500 </span>shares of Series A Preferred Stock from the Company’s Certificate of Incorporation, as amended, none of which were outstanding at the time of the filing of such Certificate of Elimination, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of preferred stock of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, -<span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zxjzpFEHcOCe" title="Preferred stock shares authorized">0</span>- shares are authorized, and <span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zAlQ0wj1AePd" title="Preferred stock shares, issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zWHSllPHRnT" title="Preferred stock shares, outstanding">no</span></span> Series A Preferred Stock are issued or outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 10000000.0 0.00001 5000000 5000000 5000 47500 0.00001 Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time 5000000 0.00001 5000 0.00001 0.00001 0.00001 47500 0 0 0 <p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z5FYiz32nzx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 18 — <span id="xdx_82F_zoAlcYoSrOji">STOCKHOLDERS’ EQUITY</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Common Stock</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized to issue up to <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z0x4m1lSAu5i" title="Common stock shares authorized"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zTySHhIPCcs1" title="Common stock shares authorized">100,000,000</span></span> shares of Common Stock, $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zmzoJbJWRNEb" title="Common stock, par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_zF4fvZq4jGoa" title="Common stock, par value">0.00001</span></span> par value per share. As of December 31, 2023, and 2022, the Company had <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zeT8eGjgdzi3" title="Common stock, shares issued">2,439,923</span> and <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zMv3Sf2h1EI7" title="Common stock, shares issued">2,367,362</span> issued and <span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zNy2zBx6z30b" title="Common stock shares outstanding">2,439,790</span> and <span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_ztY69MOXZ5E2" title="Common stock shares outstanding">2,367,229</span> shares outstanding, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Common Stock Activity</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">For the year ending December 31, 2023</span></i></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__srt--TitleOfIndividualAxis__custom--SpecificBoardMembersMember_z7GFSvcUrRs8" title="Issuance of common stock share">10,000</span> shares of common stock to specific board members as part of a commitment agreement valued at $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20230101__20231231__srt--TitleOfIndividualAxis__custom--SpecificBoardMembersMember_zMpV1ajrbKwc" title="Issuance of common stock share value">200,000</span>. The common stock’s value was determined on the agreement’s original date.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_90D_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkUjPW4lzRw" title="Shares attributable to withholding tax">14,193</span> shares of common stock as payment of the minimum withholding tax obligation due upon the vesting of shares restricted stock units.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0yAMBeshYV7" title="Restricted stock options, granted">48,368</span> shares of common stock, net of <span id="xdx_900_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3Y26DEPHXCc" title="Shares attributable to withholding tax">14,193</span> shares attributable to withholding tax, upon the exercise of restricted stock units under the Company’s various stock compensation plans.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognized approximately $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20230101__20231231_zIuIP0hQxvq9" title="Stock compensation costs">1,942,000</span> of stock-based compensation costs associated with outstanding stock options in general and administrative expenses offsetting additional capital investments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">For the year ending December 31, 2022</span></i></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_90D_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zI1VUu6Kfqa1" title="Shares attributable to withholding tax">357,778</span> shares of common stock as payment of the minimum withholding tax obligation due upon the vesting of shares restricted stock units.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXus1z92AD51" title="Restricted stock options, granted">1,159,044</span> shares of common stock, net of <span id="xdx_904_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCsVzrVORZT5" title="Shares attributable to withholding tax">357,778</span> shares attributable to withholding tax, upon the exercise of restricted stock units under the Company’s various stock compensation plans.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of an $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zpmx3rWY54d3" title="Issuance of common stock share value">80,000</span> consulting agreement, on May 4, 2022, <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zaFelmMPeGQ5" title="Stock issued during period for services, shares">38,703</span> shares of common stock were valued at $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220504__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_z2yWNeeZ7TV3" title="Shares issued price per share">0.81</span> per share on the issuance date with a total value of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zpFOjcXmWA1" title="Stock issued during period for services, value+">31,349</span> in satisfaction of $<span id="xdx_905_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zdTFsCWO1UGk" title="Repayment of consulting obligation">40,000</span>. The value of the common stock issued was based on the fair value of the stock at the time of the issuance. On July 19, 2022, <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220719__20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zPYHZzbW4k99" title="Stock issued during period for services, shares">38,703</span> shares of common stock were valued at $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zmwB7qCsnkFd" title="Shares issued price per share">0.59</span> per share on the issuance date, with a total value of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20220719__20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zViVIMFiERT1" title="Stock issued during period for services, value+">22,835</span> in satisfaction of the remaining balance of $<span id="xdx_908_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20220719__20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zyEanf1XCFE8" title="Services liabilities">40,000</span>. The Company recognized a total gain on debt settlement of $<span id="xdx_907_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pp0p0_c20220719__20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zWg2X5HTbzpb" title="Gain on extinguishment debt">25,816</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognized approximately $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220101__20221231_zJKEvZQSuyE" title="Stock compensation costs">1,565,000</span> of stock-based compensation costs associated with outstanding stock options recorded in general and administrative expenses offsetting additional paid-in capital.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 18 — STOCKHOLDERS’ EQUITY (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Common Stock Warrants</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2023, <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zb57uHJaBgO1" title="Warrants expired">2,666</span> warrants expired. As of December 31, 2023, these outstanding warrants contained no intrinsic value. The weighted average exercise price of warrants outstanding on December 31, 2023, is $<span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableOutstandingWeightedAverageExercisePrice_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zkFE7jtIZ8di" title="Weighted average exercise price ending exercisable">65.10</span>, with a weighted average remaining contractual life of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zd6a12q4zpe3" title="Weighted average remaining contractual life">2.1</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zwV5e2STeENg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables set forth common stock purchase warrants outstanding as of December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zIhbRRmpv2ka" style="display: none">SCHEDULE OF WARRANT OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: justify">Outstanding, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_zRzZWYk0KF3b" style="width: 12%; text-align: right" title="Number of warrants beginning balance">460,491</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zKDxFN3DcFK5" style="width: 12%; text-align: right" title="Weighted average exercise price beginning balance">82.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Warrants expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20220101__20221231_zaLdmlLk60m6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants expired">(1,745</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zySP7etgMnp5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price expired">(2624.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Outstanding and exercisable, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231_z5lL9U5Czea9" style="text-align: right" title="Number of warrants beginning balance">458,746</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zBODtg2EOAl2" style="text-align: right" title="Weighted average exercise price beginning outstanding">71.60</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Warrants expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230101__20231231_zqvoSCvzYqXf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants expired">(2,666</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zfpQUxVBhTf7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price expired">(1,200.30</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Outstanding and exercisable, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231_z1xc9dCCXek7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants ending outstanding">456,080</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zhcb7VdMKW2k" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price ending outstanding">65.10</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zYcCFuzvNRW2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_892_ecustom--ScheduleOfWarrantOutstandingExercisePriceTableTextBlock_z0u3QUZrwqu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B4_zVQrcW4FPv0i" style="display: none">SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="20" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock issuable upon exercise of warrants outstanding and exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year-ending</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="8" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year-ending</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of Exercise Prices</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Outstanding and Exercisable (in shares)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Remaining Contractual Life (years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants Outstanding and Exercisable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Remaining Exercisable Contractual Life (years)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zksbfLIeIH22" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1aYRabMX7L5" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">454,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zwsrykf3SxSb" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.11</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zSDKJ8bFDxB8" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zJdYjs5kIYb3" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">454,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zh6vF8LOy113" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.11</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zHE5Pe9SaMFl" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zoHqOhAnkDF7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxF6KG04KFia" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zyXitlG6IcPf" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.18</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zalescommGb8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zueN2TNKaV96" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zjJT2fjP3URj" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.18</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zHmr9XyXJAnh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsUEXUfjbPh9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">600.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zq6GXtZ51D2a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_znl9Bre6Udhd" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.54</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zCOZjhBSwB35" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">600.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zp24uWIAXDS9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zFv9OaJJxS19" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.54</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zPq3434jryj8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">600.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zFJYhOLDhkkf" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z3XdHwgdx9m4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1734">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z2oiPMLXzds" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1736">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zw0JfDnxx0o6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,666</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zOLbqXnbgWV2" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">0.41</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zRn4mWcEJbSg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zwrmKgM4uVKl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">456,080</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zbMPACYkKY5a" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.10</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_z2m4iOoBZ7uh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zMUqga27diP5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">458,746</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zTd6RU799qda" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.10</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zCbc2MMcoN81" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zfEtEcpP52W9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 100000000 100000000 0.00001 0.00001 2439923 2367362 2439790 2367229 10000 200000 14193 48368 14193 1942000 357778 1159044 357778 80000 38703 0.81 31349 40000 38703 0.59 22835 40000 25816 1565000 2666 65.10 P2Y1M6D <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zwV5e2STeENg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables set forth common stock purchase warrants outstanding as of December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zIhbRRmpv2ka" style="display: none">SCHEDULE OF WARRANT OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: justify">Outstanding, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_zRzZWYk0KF3b" style="width: 12%; text-align: right" title="Number of warrants beginning balance">460,491</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zKDxFN3DcFK5" style="width: 12%; text-align: right" title="Weighted average exercise price beginning balance">82.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Warrants expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20220101__20221231_zaLdmlLk60m6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants expired">(1,745</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zySP7etgMnp5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price expired">(2624.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Outstanding and exercisable, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230101__20231231_z5lL9U5Czea9" style="text-align: right" title="Number of warrants beginning balance">458,746</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zBODtg2EOAl2" style="text-align: right" title="Weighted average exercise price beginning outstanding">71.60</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt">Warrants expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230101__20231231_zqvoSCvzYqXf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants expired">(2,666</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zfpQUxVBhTf7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price expired">(1,200.30</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Outstanding and exercisable, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230101__20231231_z1xc9dCCXek7" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants ending outstanding">456,080</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zhcb7VdMKW2k" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price ending outstanding">65.10</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 460491 82.00 1745 -2624.00 458746 71.60 2666 -1200.30 456080 65.10 <p id="xdx_892_ecustom--ScheduleOfWarrantOutstandingExercisePriceTableTextBlock_z0u3QUZrwqu2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_8B4_zVQrcW4FPv0i" style="display: none">SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="20" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock issuable upon exercise of warrants outstanding and exercisable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year-ending</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="8" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year-ending</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of Exercise Prices</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants Outstanding and Exercisable (in shares)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Remaining Contractual Life (years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants Outstanding and Exercisable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted Average Remaining Exercisable Contractual Life (years)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zksbfLIeIH22" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z1aYRabMX7L5" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">454,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zwsrykf3SxSb" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.11</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zSDKJ8bFDxB8" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zJdYjs5kIYb3" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">454,546</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zh6vF8LOy113" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.11</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zHE5Pe9SaMFl" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zoHqOhAnkDF7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zxF6KG04KFia" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zyXitlG6IcPf" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.18</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zalescommGb8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zueN2TNKaV96" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zjJT2fjP3URj" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.18</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zHmr9XyXJAnh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zsUEXUfjbPh9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">600.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zq6GXtZ51D2a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_znl9Bre6Udhd" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.54</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zCOZjhBSwB35" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">600.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zp24uWIAXDS9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zFv9OaJJxS19" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.54</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zPq3434jryj8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">600.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zFJYhOLDhkkf" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z3XdHwgdx9m4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1734">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z2oiPMLXzds" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1736">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zw0JfDnxx0o6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,666</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zOLbqXnbgWV2" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">0.41</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zRn4mWcEJbSg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,200.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zwrmKgM4uVKl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">456,080</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zbMPACYkKY5a" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.10</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20231231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_z2m4iOoBZ7uh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zMUqga27diP5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">458,746</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zTd6RU799qda" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.10</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zCbc2MMcoN81" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 65.00 454546 P3Y1M9D 65.00 454546 P3Y1M9D 65.00 68.20 1500 P1Y2M4D 68.20 1500 P1Y2M4D 68.20 600.00 34 P1Y6M14D 600.00 34 P1Y6M14D 600.00 1200.00 2666 P0Y4M28D 1200.00 456080 P3Y1M6D 65.10 458746 P3Y1M6D 71.60 <p id="xdx_809_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zXRDzCXd6wAk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 19 — <span id="xdx_823_zH1g7myK4ocd">STOCK-BASED COMPENSATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Overview</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink Technologies, Inc. and its subsidiaries (“the Company”) leverage stock-based compensation as a strategic tool to attract, motivate, and retain key personnel. This aligns their interests with those of our shareholders by offering them a stake in the Company’s success. We administer various plans that grant stock options and Restricted Stock Units (RSUs) to our officers, directors, key employees, and consultants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Long-Term Stock Incentive Plan Awards</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates multiple equity incentive plans, including the 2013 Stock Option Plan, 2015 Incentive Compensation Plan, 2016 Incentive Compensation Plan, and 2017 Incentive Compensation Plan. These plans facilitate the granting of stock options, which may be settled in shares or net-settled, emphasizing our flexible approach to compensation. The options vest over three years and are exercisable up to ten years from the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant modifications and enhancements have been made to our plans over time to ensure they continue to serve the intended purpose effectively. This includes the immediate vesting provisions for terminated employees and removing a cap on the annual share awards per participant, reflecting our adaptability to changing business and operational needs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inducement Awards</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company grants time-vested and performance-based stock options under inducement awards, consistent with NASDAQ Listing Rule 5653(c)(4). These inducement awards, granted outside of our existing equity compensation plans, are designed to reward employees for their commitment and performance toward achieving our strategic goals.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Time-Based and Performance-Based Stock Option Awards</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s stock option awards are granted under terms that ensure they vest based on time or performance-based criteria. Performance-based awards are tied to achieving specific financial metrics, aligning employee rewards with the Company’s success. The Company granted time-vested stock options and performance-based stock options to various employees in connection with their employment agreements. The ten-year, non-statutory time-vested, and performance-based option inducement awards were granted under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Time-based and Performance-Based Restricted Stock Unit Awards (“RSUs”)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s RSUs are granted under terms that ensure they vest based on time or performance-based criteria. Performance-based awards are tied to achieving specific financial metrics, aligning employee rewards with the Company’s success.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted awards under the amended plan for time-based restricted stock units (“RSUs”) to various employees subject to continued employment. The RSUs initially vest between 25% and 33% on their one-year anniversary dates and will vest between 24 and 36 equal monthly periods thereafter. Additionally, the Company granted awards under the amended plan for performance-based restricted stock units subject to performance vesting conditions and continued employment. The RSUs will vest in three equal tranches upon reaching performance conditions for each tranche.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>2023 Omnibus Equity Incentive Plan</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company received stockholder approval on August 23, 2023, to adopt the 2023 Omnibus Equity Incentive Plan (the “2023 Plan”), which will enable it to continue to grant equity-based compensation awards to employees (including officers), non-employee consultants, non-employee directors, and affiliates. The 2023 Plan replaces the 2015 Incentive Compensation Plan, 2016 Incentive Compensation Plan, and 2017 Incentive Compensation Plan. The Company has ceased granting awards under the 2015 Incentive Compensation Plan, 2016 Incentive Compensation Plan, and 2017 Incentive Compensation Plan. The Company has been authorized to reserve <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_pid_c20230823__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeOmnibusEquityIncentivePlanMember_zZjl0QxdszAf" title="Share based compensation authorized, shares">166,415</span> shares of its common stock for delivery under the 2023 Plan. The 2023 Plan rewards eligible participants for contributing to the Company’s success and encourages retaining and recruiting qualified personnel. The Company’s Board of Directors and Compensation Committee will administer the 2023 Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2023 Plan generally grants awards without consideration other than prior and future service. The Company’s compensation committee may grant awards under the 2023 Plan either alone or in addition to, in tandem with, or as a substitute for any other award granted under the 2023 Plan or other company plans. It is important to note, however, that if a SAR is granted in conjunction with an ISO, the grant date and term of the SAR and ISO must be the same, and the exercise price of the SAR cannot be lower than the exercise price of the ISO. A written award agreement between us and the grantee will outline the material terms of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_89B_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_z1FzednoI1nb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As shown in the following table, stock-based compensation expense is included in general and administrative costs under the following plans:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zyTGeLsLmDG">SCHEDULE OF STOCK BASED COMPENSATION EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Equity-based plans:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20231231_zMLdhzuVIS76" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zqmsXd4xiBe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Equity-based plans:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_hus-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z1F4Bdh8jod1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 60%; text-align: left">Long-term stock incentive plan awards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1762">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_hus-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zoUjafZnaALk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Time-vested option inducement awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">181,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">179,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_hus-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zMTklSN94Prk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Time-based restricted stock awards</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,761,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,385,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_zSvRiD13r4B2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Stock-based compensation expense</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,942,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,565,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zlh0pTMYVDV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 19 — STOCK-BASED COMPENSATION (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--PlanNameAxis__custom--VariousEquityCompensationPlansMember_znGbifYMHWf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates supplementary data under various equity compensation plans:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zHK7QwdKoJT5" style="display: none">SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantity</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantity</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantity</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantity</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Long-term stock incentive plan awards</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Time-vested option inducement awards</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-January 1, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zyhktofeCIZ9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Number of options beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zyrhoRn8O3Ec" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,756.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zYY77wRHmAtf" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Number of options beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,496</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zdWI7cl9rJma" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,760.80</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zLb6Btf3UN44" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Number of options beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,725</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zGy53eJSZqK" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.90</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zDSV9RHz6vEk" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Number of options beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,725</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z1kySc3LI6Kk" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.20</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled, expired, forfeited</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zv3ftZiAweQ9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(88</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zMhymqCC6BQ3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,431.14</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zjxQJqDKRGbc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(246</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zJ3qImaJqFSg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,934.00</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zuq5rW2S0V79" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,759</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zdGGGDTMw891" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8.63</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zkBGnDRtLFgl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1804">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zzwcPnXxEWP6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1806">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zbafAJlDFZMk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,162</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zLUvMYW2xyJd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,768.46</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_ziLU9YuQ789j" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zwPqj3a4I5Q3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,756.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zWjWHpJcqXXl" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,966</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zbYcymjWA8s6" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.27</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zydshzjBAQVj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,725</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zhih3it6SIEj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.90</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zOYaMJvZLNIa" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,162</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zUw1tiBLO9wf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,768.46</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zvds5fRc8KJ1" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zgtZwumlPat" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,756.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zivt7HlOtKtb" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,592</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zVtrK8RaFnMi" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.23</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z0Uug4hVO11b" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,027</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z50F4o0igOEf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.13</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining compensation expense</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_98F_eus-gaap--ShareBasedCompensation_pp0p0_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zr4Cbl4Re5E2" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1840">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_984_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zYYLPJqQn0a1" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1841">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_982_eus-gaap--ShareBasedCompensation_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z1Hmy6ObM97d" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$113,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_982_eus-gaap--ShareBasedCompensation_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zNLWVvDJKTvk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$319,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining amortization period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zxxdqEAAlYze" title="Remaining amortization period">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zfbMRt0KI1e6" title="Remaining amortization period">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zcVwmzwDlu12" title="Remaining amortization period">0.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zk8Z3pGYHqY" title="Remaining amortization period">1.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zeABJeRltsgg" title="Weighted average remaining contractual life, options outstanding">3.5</span> years and <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zl8jW1BIlxlb" title="Weighted average remaining contractual life, exercisable">3.5</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zrYLLoIHwZze" title="Outstanding and exercisable term">4.5</span> years and <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zG9bw8eS5kw8" title="Outstanding and exercisable term">4.5</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zadpjlp2m1H2" title="Weighted average remaining contractual life - options exercisable">6.1</span> years and <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zvgi3cUtx1C4" title="Weighted average remaining contractual life - options exercisable">6.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zZJwzVKwlRo9" title="Weighted average remaining contractual life, options outstanding">7.1</span> years and <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zRyjGSsOy3rl" title="Weighted average remaining contractual life, exercisable">7.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic value per share</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_c20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zUfXRZa4Dky" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1870">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_c20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zGBcGIgjvcWa" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1872">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zPEqIYDIDUzc" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1874">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zkSh2fRI1Em4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1876">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of exercise prices</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z5CQsP7LHa14" title="Range of exercise prices, lower limit">139.20</span> to $<span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zOdmz7JfmX4e" title="Range of exercise prices, upper limit">1,944.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zKexJquP0l0e" title="Range of exercise prices">139.20</span> to $<span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zsVXbIOChi77" title="Range of exercise prices">1,944.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zjFL5WUiIC15" title="Range of exercise prices">34.20</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zYtOAVZbLTci" title="Range of exercise prices, minimum">19.20</span> to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zWIfSmavonE5" title="Range of exercise prices">34.20</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="13" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Performance-based stock option</i></span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>inducement awards</i></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="13" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Time-based restricted stock awards</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-January 1, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zJ34JTlcMA1e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_znDR0nazRta1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.12</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_ze0JDk6aHw4a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zJnha7kxV061" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.12</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zEjhwal19qYb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,736</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zkh9do40wyF8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-averages exercise price, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.09</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zQ80UkAwZlbf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,933</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z1EjTGO8tJmc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.40</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zOhpaanymZ3j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1908">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zgV6jnppNHhk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1910">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zEYhe0gIziSe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1912">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_z5Lhm9gQsGY1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1914">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zLmuljvNb0dh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,750</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zDyaqyWSxfq3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.17</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z7Gmc2RdIfJd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,053</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zKLTqxslm5Bl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.80</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled, expired, forfeited</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zFYm4EJ4Ji4l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1924">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zoHU9H83L2R" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1926">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zetxf9jtNd67" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1928">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zMpY3zcuSmTd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1930">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z35eajHL7FE" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,415</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_ztrTzLUyrLKb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21.48</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zy4KsMtx8zw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,250</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zZQw9dTrJ8Wg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13.60</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock units exercised</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zUvXq7ColS78" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1940">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zMX4MfklelJa" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1942">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zHaQBhVStHB" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1944">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zZhzWx5vDNu3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1946">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z77Q5WqBLP8h" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(48,368</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zeBKUxOyqrXi" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41.58</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zDIkjNuQ5D4h" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1952">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zhW6yhA1bsJ5" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1954">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zqJtwBoqJWsk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> $</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zJuy14v1J2d6" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.12</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zV9VFoDnn60a" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> $</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zL3sr0wqleT4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.12</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zwdo6hzDcJf1" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding ,Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126,703</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> $</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zmHHDYOBBCwj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.92</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zX9WpuTOMftg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding ,Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,736 </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z8dqy73Zoj94" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.09</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zANzDeN8rDfd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1972">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_znNc3Gcz5mFa" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1974">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zXZYpxXHul0i" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1976">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zKZv1Cq3kMld" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1978">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zcGrvi3MabNb" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,692</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zTK3A2I0piph" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.98</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zU5zITTdCtNd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,794</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zHmhtzNke1Xg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66.60</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining compensation expense</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_98B_eus-gaap--ShareBasedCompensation_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_z8htqrctQzfc" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$414,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_986_eus-gaap--ShareBasedCompensation_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zymXQuJvqjv4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$414,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_983_eus-gaap--ShareBasedCompensation_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zhcHkdWSH8K7" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,511,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_98E_eus-gaap--ShareBasedCompensation_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zKmvcIgYSBjk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,248,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining amortization period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zTtacpLeFfC1" title="Remaining amortization period">1.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zRbCWMkh9EXl" title="Remaining amortization period">2.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zySRHEtPTpU9" title="Remaining amortization period">1.6</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zpLhJZ9AcmCi" title="Remaining amortization period">2.3</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zb8m2ZnfqsL" title="Weighted average remaining contractual life - options exercisable">6.1</span> years and <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zifGBNYomwYj" title="Weighted average remaining contractual life, exercisable">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zeIIg23ngIwl" title="Weighted average remaining contractual life - options exercisable">7.1</span> years and <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zhpG4a9dEAl7" title="Weighted average remaining contractual life - options exercisable">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zrf2xvDZtnGf" title="Weighted average remaining contractual life options outstanding and exercisable">1.9</span> years and <span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zH2HeVDbyjNl" title="Weighted average remaining contractual life options outstanding and exercisable">1.7</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zSweeUf0n2t2" title="Weighted average remaining contractual life, options outstanding">2.5</span> years and <span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zEZeZQ1q7rnd" title="Weighted average remaining contractual life, exercisable">1.4</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic value per share</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zkDYsEeJt1wb" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2018">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zuwiOEt6i5d3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2020">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zv52dI8U24u3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2022">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z9OycvhqTIc7" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2024">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of exercise prices</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zP0kNijl8lA6">34.20</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zouJktX8CHdi">34.20</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zts5E99FGKxa" title="Range of exercise prices, lower">5.71</span> to $<span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zsoGd0xZeP2" title="Range of exercise prices, upper">72.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z3vRAhyR3mIg" title="Range of exercise prices, lower limit">19.60</span> to $<span id="xdx_90A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zxhgbuaJHzhb" title="Range of exercise prices, upper limit">72.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="13" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Performance-based restricted stock awards</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-January 1, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zyEBCT1MqMEc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,303</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zvW3DxORjMl9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-averages exercise price, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zcS36HiV8jhi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,369</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z3NRpI9qNzRg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58.00</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zOA6q3AHqrvi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zRRgf1A2QwMk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.68</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z18LPXwkbR9d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,303</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zRRHzCbTyqYe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled, expired, forfeited</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z9ctpPd2tnK" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,649</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zMt4PVN5Zt14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21.62</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zGNJEqoatzR2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2056">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zuzKz97uKgL7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2058">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock units exercised</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z4mZJFUJiEL2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2060">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zC7nnEhnSKi1" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2062">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z4IOqwVXVNVc" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(63,369</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zycj8dPFNgJ3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(58.00</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z3wq06IKZB9f" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,154</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zOUTTyEgI5dh" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.02</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zziK5nV18D3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,303</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zSx51CGmxSU3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z52ZkvVLGkRf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2076">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zhX2ZDEF8Cbj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2078">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zHR9qolKI8B6" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2080">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z1komhue3IAk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2082">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining compensation expense</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_984_eus-gaap--ShareBasedCompensation_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zgyRbVpKgrea" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,156,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_98A_eus-gaap--ShareBasedCompensation_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zinWDNqaoNT4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,498,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining amortization period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zpDJ9fQFiM4i" title="Remaining amortization period">2.1 </span>years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zlQNwHqLrst5" title="Remaining amortization period">2.8</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zwicebLlLWKa" title="Weighted average remaining contractual life, options outstanding">2.1</span> years and <span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zG7OgsVoplF5" title="Weighted average remaining contractual life, exercisable">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zq2ktTWn4SS6" title="Weighted average remaining contractual life, options outstanding">2.8</span> years and <span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z2yqeN9Kwzy6" title="Weighted average remaining contractual life, exercisable">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic value per share</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z5sW95TgZ4hj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2100">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_ziLmGzWCWOcc" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2102">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of exercise prices</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_ztbOsZOC5sk8" title="RSUs range of exercise prices, lower limit">5.80</span> to $<span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zgOo3V1fevYg" title="Range of exercise prices, upper limit">21.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_905_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zhmJzIYmcYu8" title="Range of exercise prices, lower limit">21.00</span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zfWcj1q7H4O7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 166415 <p id="xdx_89B_eus-gaap--ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_z1FzednoI1nb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As shown in the following table, stock-based compensation expense is included in general and administrative costs under the following plans:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zyTGeLsLmDG">SCHEDULE OF STOCK BASED COMPENSATION EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Equity-based plans:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20230101__20231231_zMLdhzuVIS76" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zqmsXd4xiBe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the years ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Equity-based plans:</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_hus-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z1F4Bdh8jod1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 60%; text-align: left">Long-term stock incentive plan awards</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1762">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_hus-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zoUjafZnaALk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Time-vested option inducement awards</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">181,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">179,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_hus-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zMTklSN94Prk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Time-based restricted stock awards</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,761,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,385,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_zSvRiD13r4B2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif">Stock-based compensation expense</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,942,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,565,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1000 181000 179000 1761000 1385000 1942000 1565000 <p id="xdx_89B_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--PlanNameAxis__custom--VariousEquityCompensationPlansMember_znGbifYMHWf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates supplementary data under various equity compensation plans:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zHK7QwdKoJT5" style="display: none">SCHEDULE OF VARIOUS EQUITY STOCK OPTION PLAN</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the years ended</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantity</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantity</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantity</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quantity</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Long-term stock incentive plan awards</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Time-vested option inducement awards</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-January 1, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zyhktofeCIZ9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Number of options beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zyrhoRn8O3Ec" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,756.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zYY77wRHmAtf" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Number of options beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,496</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zdWI7cl9rJma" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,760.80</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zLb6Btf3UN44" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Number of options beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,725</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zGy53eJSZqK" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.90</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zDSV9RHz6vEk" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Number of options beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,725</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z1kySc3LI6Kk" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.20</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled, expired, forfeited</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zv3ftZiAweQ9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(88</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zMhymqCC6BQ3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,431.14</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zjxQJqDKRGbc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(246</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zJ3qImaJqFSg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,934.00</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zuq5rW2S0V79" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,759</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zdGGGDTMw891" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8.63</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zkBGnDRtLFgl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1804">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zzwcPnXxEWP6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1806">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zbafAJlDFZMk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,162</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zLUvMYW2xyJd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,768.46</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_ziLU9YuQ789j" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zwPqj3a4I5Q3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,756.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zWjWHpJcqXXl" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,966</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zbYcymjWA8s6" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.27</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zydshzjBAQVj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,725</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zhih3it6SIEj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.90</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zOYaMJvZLNIa" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,162</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zUw1tiBLO9wf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,768.46</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zvds5fRc8KJ1" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zgtZwumlPat" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,756.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zivt7HlOtKtb" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,592</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zVtrK8RaFnMi" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.23</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z0Uug4hVO11b" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,027</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z50F4o0igOEf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.13</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining compensation expense</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_98F_eus-gaap--ShareBasedCompensation_pp0p0_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zr4Cbl4Re5E2" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1840">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_984_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zYYLPJqQn0a1" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1841">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_982_eus-gaap--ShareBasedCompensation_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_z1Hmy6ObM97d" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$113,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_982_eus-gaap--ShareBasedCompensation_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zNLWVvDJKTvk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$319,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining amortization period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zxxdqEAAlYze" title="Remaining amortization period">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zfbMRt0KI1e6" title="Remaining amortization period">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zcVwmzwDlu12" title="Remaining amortization period">0.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zk8Z3pGYHqY" title="Remaining amortization period">1.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zeABJeRltsgg" title="Weighted average remaining contractual life, options outstanding">3.5</span> years and <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zl8jW1BIlxlb" title="Weighted average remaining contractual life, exercisable">3.5</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zrYLLoIHwZze" title="Outstanding and exercisable term">4.5</span> years and <span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zG9bw8eS5kw8" title="Outstanding and exercisable term">4.5</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zadpjlp2m1H2" title="Weighted average remaining contractual life - options exercisable">6.1</span> years and <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zvgi3cUtx1C4" title="Weighted average remaining contractual life - options exercisable">6.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zZJwzVKwlRo9" title="Weighted average remaining contractual life, options outstanding">7.1</span> years and <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zRyjGSsOy3rl" title="Weighted average remaining contractual life, exercisable">7.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic value per share</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_c20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zUfXRZa4Dky" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1870">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_c20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zGBcGIgjvcWa" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1872">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zPEqIYDIDUzc" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1874">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zkSh2fRI1Em4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl1876">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of exercise prices</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_904_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_z5CQsP7LHa14" title="Range of exercise prices, lower limit">139.20</span> to $<span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zOdmz7JfmX4e" title="Range of exercise prices, upper limit">1,944.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zKexJquP0l0e" title="Range of exercise prices">139.20</span> to $<span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--LongTermStockIncentivePlanAwardsMember_zsVXbIOChi77" title="Range of exercise prices">1,944.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zjFL5WUiIC15" title="Range of exercise prices">34.20</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zYtOAVZbLTci" title="Range of exercise prices, minimum">19.20</span> to $<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeVestedOptionInducementAwardsMember_zWIfSmavonE5" title="Range of exercise prices">34.20</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="13" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Performance-based stock option</i></span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>inducement awards</i></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="13" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Time-based restricted stock awards</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-January 1, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zJ34JTlcMA1e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_znDR0nazRta1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.12</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_ze0JDk6aHw4a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zJnha7kxV061" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.12</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zEjhwal19qYb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,736</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zkh9do40wyF8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-averages exercise price, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.09</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zQ80UkAwZlbf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,933</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z1EjTGO8tJmc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.40</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zOhpaanymZ3j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1908">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zgV6jnppNHhk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1910">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zEYhe0gIziSe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1912">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_z5Lhm9gQsGY1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1914">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zLmuljvNb0dh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,750</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zDyaqyWSxfq3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.17</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z7Gmc2RdIfJd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,053</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zKLTqxslm5Bl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.80</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled, expired, forfeited</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zFYm4EJ4Ji4l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1924">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zoHU9H83L2R" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1926">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zetxf9jtNd67" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1928">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zMpY3zcuSmTd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1930">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z35eajHL7FE" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,415</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_ztrTzLUyrLKb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21.48</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zy4KsMtx8zw9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,250</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zZQw9dTrJ8Wg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13.60</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock units exercised</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zUvXq7ColS78" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1940">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zMX4MfklelJa" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1942">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zHaQBhVStHB" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1944">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zZhzWx5vDNu3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1946">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z77Q5WqBLP8h" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(48,368</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zeBKUxOyqrXi" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41.58</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zDIkjNuQ5D4h" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1952">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zhW6yhA1bsJ5" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1954">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zqJtwBoqJWsk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> $</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zJuy14v1J2d6" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.12</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zV9VFoDnn60a" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> $</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zL3sr0wqleT4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.12</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zwdo6hzDcJf1" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding ,Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126,703</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> $</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zmHHDYOBBCwj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.92</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zX9WpuTOMftg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding ,Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,736 </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z8dqy73Zoj94" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.09</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zANzDeN8rDfd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1972">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_znNc3Gcz5mFa" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1974">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zXZYpxXHul0i" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1976">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zKZv1Cq3kMld" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1978">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zcGrvi3MabNb" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,692</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zTK3A2I0piph" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.98</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zU5zITTdCtNd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,794</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zHmhtzNke1Xg" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66.60</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining compensation expense</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_98B_eus-gaap--ShareBasedCompensation_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_z8htqrctQzfc" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$414,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_986_eus-gaap--ShareBasedCompensation_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zymXQuJvqjv4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$414,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_983_eus-gaap--ShareBasedCompensation_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zhcHkdWSH8K7" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,511,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_98E_eus-gaap--ShareBasedCompensation_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zKmvcIgYSBjk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,248,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining amortization period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zTtacpLeFfC1" title="Remaining amortization period">1.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zRbCWMkh9EXl" title="Remaining amortization period">2.1</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zySRHEtPTpU9" title="Remaining amortization period">1.6</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zpLhJZ9AcmCi" title="Remaining amortization period">2.3</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zb8m2ZnfqsL" title="Weighted average remaining contractual life - options exercisable">6.1</span> years and <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zifGBNYomwYj" title="Weighted average remaining contractual life, exercisable">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zeIIg23ngIwl" title="Weighted average remaining contractual life - options exercisable">7.1</span> years and <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zhpG4a9dEAl7" title="Weighted average remaining contractual life - options exercisable">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zrf2xvDZtnGf" title="Weighted average remaining contractual life options outstanding and exercisable">1.9</span> years and <span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zH2HeVDbyjNl" title="Weighted average remaining contractual life options outstanding and exercisable">1.7</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zSweeUf0n2t2" title="Weighted average remaining contractual life, options outstanding">2.5</span> years and <span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zEZeZQ1q7rnd" title="Weighted average remaining contractual life, exercisable">1.4</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic value per share</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zkDYsEeJt1wb" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2018">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zuwiOEt6i5d3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2020">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zv52dI8U24u3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2022">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z9OycvhqTIc7" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2024">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of exercise prices</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zP0kNijl8lA6">34.20</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_902_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedStockOptionInducementMember_zouJktX8CHdi">34.20</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_908_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zts5E99FGKxa" title="Range of exercise prices, lower">5.71</span> to $<span id="xdx_900_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zsoGd0xZeP2" title="Range of exercise prices, upper">72.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_z3vRAhyR3mIg" title="Range of exercise prices, lower limit">19.60</span> to $<span id="xdx_90A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--TimeBasedRestrictedStockAwardsMember_zxhgbuaJHzhb" title="Range of exercise prices, upper limit">72.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="13" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Performance-based restricted stock awards</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-January 1, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zyEBCT1MqMEc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,303</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zvW3DxORjMl9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted-averages exercise price, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zcS36HiV8jhi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63,369</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z3NRpI9qNzRg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58.00</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zOA6q3AHqrvi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zRRgf1A2QwMk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.68</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z18LPXwkbR9d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,303</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zRRHzCbTyqYe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canceled, expired, forfeited</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z9ctpPd2tnK" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19,649</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zMt4PVN5Zt14" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21.62</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zGNJEqoatzR2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2056">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zuzKz97uKgL7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Restricted stock units ,Canceled, expired, forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2058">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock units exercised</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z4mZJFUJiEL2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2060">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zC7nnEhnSKi1" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2062">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z4IOqwVXVNVc" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(63,369</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zycj8dPFNgJ3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Stock units exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(58.00</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, outstanding</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z3wq06IKZB9f" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,154</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zOUTTyEgI5dh" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.02</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zziK5nV18D3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,303</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zSx51CGmxSU3" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance-December 31, exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z52ZkvVLGkRf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2076">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zhX2ZDEF8Cbj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2078">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zHR9qolKI8B6" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2080">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z1komhue3IAk" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, restricted stock, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2082">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining compensation expense</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_984_eus-gaap--ShareBasedCompensation_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zgyRbVpKgrea" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,156,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_98A_eus-gaap--ShareBasedCompensation_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zinWDNqaoNT4" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Remaining compensation expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,498,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining amortization period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--AmortizationPeriod_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zpDJ9fQFiM4i" title="Remaining amortization period">2.1 </span>years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zlQNwHqLrst5" title="Remaining amortization period">2.8</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average remaining contractual life – options outstanding and exercisable</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zwicebLlLWKa" title="Weighted average remaining contractual life, options outstanding">2.1</span> years and <span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zG7OgsVoplF5" title="Weighted average remaining contractual life, exercisable">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zq2ktTWn4SS6" title="Weighted average remaining contractual life, options outstanding">2.8</span> years and <span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z2yqeN9Kwzy6" title="Weighted average remaining contractual life, exercisable">0.0</span> years</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic value per share</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_z5sW95TgZ4hj" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2100">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_iI_pid_c20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_ziLmGzWCWOcc" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center" title="Intrinsic value per share"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span style="-sec-ix-hidden: xdx2ixbrl2102">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Range of exercise prices</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_ztbOsZOC5sk8" title="RSUs range of exercise prices, lower limit">5.80</span> to $<span id="xdx_901_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20231231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zgOo3V1fevYg" title="Range of exercise prices, upper limit">21.00</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_905_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockAwardsMember_zhmJzIYmcYu8" title="Range of exercise prices, lower limit">21.00</span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2250 1756.01 2496 1760.80 24725 12.90 24725 20.20 88 1431.14 246 1934.00 6759 8.63 2162 1768.46 2250 1756.01 17966 6.27 24725 12.90 2162 1768.46 2250 1756.01 17592 27.23 18027 21.13 113000000 319000000 P0Y P0Y P0Y1M6D P1Y1M6D P3Y6M P3Y6M P4Y6M P4Y6M P6Y1M6D P6Y1M6D P7Y1M6D P7Y1M6D 139.20 1944.00 139.20 1944.00 34.20 19.20 34.20 12500 33.12 12500 33.12 140736 23.09 39933 63.40 53750 8.17 107053 20.80 19415 21.48 6250 13.60 48368 41.58 12500 33.12 12500 33.12 126703 11.92 140736 23.09 30692 36.98 20794 66.60 414000000 414000000 1511000000 3248000000 P1Y1M6D P2Y1M6D P1Y7M6D P2Y3M18D P6Y1M6D P0Y P7Y1M6D P0Y P1Y10M24D P1Y8M12D P2Y6M P1Y4M24D 34.20 34.20 5.71 72.00 19.60 72.00 71303 21.01 63369 58.00 12500 5.68 71303 21.00 19649 21.62 63369 -58.00 64154 18.02 71303 21.01 1156000000 1498000000 P2Y1M6D P2Y9M18D P2Y1M6D P0Y P2Y9M18D P0Y 5.80 21.00 21.00 <p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z74JU1Q72LS3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 20 — <span id="xdx_825_z8xNfQ15xx9h">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pension:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may make a matching contribution to its employees’ 401(k) plan. Furthermore, Vislink Technologies, Inc. operates a Group Personal Plan through its UK subsidiary, investing funds with Royal London. Employees of the Company in the United Kingdom are entitled to participate in the Company’s employee benefit plan, to which varying amounts are contributed according to their status. Additionally, the Company operates a stakeholder pension plan in the United Kingdom.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--DefinedContributionPlanDisclosuresTableTextBlock_zzSRiL5BAvw5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s matching contributions as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zS59s95OJ2s6" style="display: none">SCHEDULE OF MATCHING CONTRIBUTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company matching contributions - Group Personal Pension Plan, U.K.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20230101__20231231__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zTKHYCXtKRi6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Company matching contributions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20220101__20221231__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zy3gbEvRUgOf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Company matching contributions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">166,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zvBeHek9tEec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--DefinedContributionPlanDisclosuresTableTextBlock_zzSRiL5BAvw5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s matching contributions as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zS59s95OJ2s6" style="display: none">SCHEDULE OF MATCHING CONTRIBUTIONS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company matching contributions - Group Personal Pension Plan, U.K.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20230101__20231231__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zTKHYCXtKRi6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Company matching contributions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20220101__20221231__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zy3gbEvRUgOf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Company matching contributions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">166,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 140000 166000 <p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_zFc6EcG6bjX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 21 — <span id="xdx_826_zfi8Esegglte">CONCENTRATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Customer Concentration Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ending December 31, 2023, the Company did not report any sales to an individual customer that constituted more than 10% of its total sales. Conversely, during the year ending December 31, 2022, the Company noted sales to a single customer amounting to $<span id="xdx_90F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFfjqxalgdyb">3,436,000</span>, representing <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zSO8jY5pv1O6">12</span>% of the Company’s total sales, in excess of 10% of its total sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, and 2022, the Company’s accounts receivable from a single customer were recorded at approximately $<span id="xdx_906_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_zh0hpCI4pzdl" title="Accounts receivable">1,111,000</span> (<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_zHSGpnZ148fk">13</span>%) and $<span id="xdx_90F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_z4ktTCh4Rg84" title="Accounts receivable">1,138,000</span> (<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_zbhQHXvmDvl9">19</span>%), respectively. Each instance surpassed the 10% mark of the Company’s total consolidated accounts receivable, indicating a significant concentration in customer receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Vendor Concentration Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the fiscal year ending December 31, the Company recorded $<span id="xdx_906_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SingleVendorMember_zPDucT0nPoDb" title="Accounts payable">2,132,000 </span>to a single vendor, exceeding <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--SingleVendorMember_zVh5bDIc7B9" title="Concentration risk, percentage">10</span>% of the Company’s total consolidated vendor purchases. During the year ending December 31, 2022, there were no instances where the Company’s purchases from any single vendor exceeded 10% of its total annual consolidated inventory purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However, on December 31 of 2023 and 2022, the Company recorded accounts payable to a particular vendor at approximately $<span id="xdx_90C_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zYA7S1FQY4Ld" title="Accounts payable">652,000</span> (<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zpyqu6FBz8hb">20</span>%) and $<span id="xdx_90E_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zq0jJW8M4yua" title="Accounts payable">273,000 </span>(<span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zHrfvCOGjoch" title="Concentration risk percentage">10</span>%), respectively. Each amount exceeded 10% of the Company’s total consolidated accounts payable, highlighting a concentration risk associated with this vendor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3436000 0.12 1111000 0.13 1138000 0.19 2132000 0.10 652000 0.20 273000 0.10 <p id="xdx_800_eus-gaap--RevenueFromContractWithCustomerTextBlock_zATcssp3rVq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 – <span id="xdx_82F_z1T7S4FHv9F5">REVENUE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zDXrjG9LQM09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zWvDzD6i3Lf3" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary geographical markets:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">North America</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zAGrn92mFSsk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,501,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_znPTuM1GVUIe" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,037,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">South America</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zhOzVOMwXjp8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">528,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--SouthAmericaMember_z4PEkjRNC4dh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">182,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__srt--EuropeMember_zXlIhWpTQar3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,420,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zVFzQzHtWyy6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,958,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__srt--AsiaMember_z5foXruGMAug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,354,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_zwy6BDwF1GTf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,851,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rest of World</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zjEcBIDQBz6e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,679,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_z4yi40TwUpub" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,103,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231_zw5ECFolqdfc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,482,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231_zvzfZU4Dde9e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,131,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary revenue source:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment sales</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zdLclMqvRg98" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,054,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zq7mssyl9OR7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,667,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Installation, integration, and repairs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zskANgrPFo87" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,688,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zbGihi4UmUEd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranties</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zWzu2b0K7zNf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,740,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zP7KY0dhKcC1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,014,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20230101__20231231_zwkiqP35i8Uj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,482,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20220101__20221231_z7JodoO3gja8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,131,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived assets:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__country--US_zf3mJreakPSd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,767,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--US_zdpqDaN7uTH7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,970,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Netherlands</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__country--NL_zqTGFw6xpu05" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--NL_zuB6ciTjvnsa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United Kingdom</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__country--GB_zRAjgUwk4Efb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,723,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--GB_z4H8hL0GzcYb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,912,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20231231_zv7MQFa9w8cj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,510,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20221231_zsaAdlqs4kUk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,909,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_z343Bs1uqYUd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zDXrjG9LQM09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zWvDzD6i3Lf3" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary geographical markets:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">North America</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_zAGrn92mFSsk" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,501,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_znPTuM1GVUIe" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,037,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">South America</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zhOzVOMwXjp8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">528,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--SouthAmericaMember_z4PEkjRNC4dh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">182,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Europe</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__srt--EuropeMember_zXlIhWpTQar3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,420,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zVFzQzHtWyy6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,958,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asia</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__srt--AsiaMember_z5foXruGMAug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,354,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_zwy6BDwF1GTf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,851,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rest of World</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zjEcBIDQBz6e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,679,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_z4yi40TwUpub" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,103,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231_zw5ECFolqdfc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,482,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231_zvzfZU4Dde9e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,131,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primary revenue source:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment sales</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zdLclMqvRg98" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,054,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zq7mssyl9OR7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,667,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Installation, integration, and repairs</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zskANgrPFo87" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,688,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zbGihi4UmUEd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warranties</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zWzu2b0K7zNf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,740,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zP7KY0dhKcC1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,014,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20230101__20231231_zwkiqP35i8Uj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,482,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20220101__20221231_z7JodoO3gja8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,131,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived assets:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__country--US_zf3mJreakPSd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,767,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--US_zdpqDaN7uTH7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,970,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Netherlands</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__country--NL_zqTGFw6xpu05" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--NL_zuB6ciTjvnsa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United Kingdom</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__country--GB_zRAjgUwk4Efb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,723,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--GB_z4H8hL0GzcYb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,912,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20231231_zv7MQFa9w8cj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,510,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--AssetsNoncurrent_iI_pp0p0_c20221231_zsaAdlqs4kUk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,909,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 13501000 12037000 528000 182000 6420000 8958000 3354000 1851000 3679000 5103000 27482000 28131000 24054000 25667000 1688000 1450000 1740000 1014000 27482000 28131000 2767000 1970000 20000 27000 3723000 4912000 6510000 6909000 <p id="xdx_80A_ecustom--IncomeTaxRebatesTextBlock_z4OgeNFxinPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 23 — <span id="xdx_82D_zcCPhKtQvVqc">REBATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--SummaryOfIncomeTaxContingenciesTextBlock_z49uyKrqiCT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary, which are included in other income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zckmARzXxF28" style="display: none">SCHEDULE OF TAX REBATES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total tax rebates</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c20230101__20231231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--HerMajestysRevenueAndCustomsHMRCMember_zazQveukDoPb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total tax rebates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">331,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c20220101__20221231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--HerMajestysRevenueAndCustomsHMRCMember_zgfyGqqWVuai" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total tax rebates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zgbg21yBwYZ8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the Company plans to continue filing rebate forms for the 2023 fiscal year, it cannot guarantee that rebates will be available at a similar level or at all in future years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_eus-gaap--SummaryOfIncomeTaxContingenciesTextBlock_z49uyKrqiCT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represents tax rebates related to the research costs incurred by our U.K. subsidiary, which are included in other income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zckmARzXxF28" style="display: none">SCHEDULE OF TAX REBATES</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the years ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total tax rebates</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c20230101__20231231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--HerMajestysRevenueAndCustomsHMRCMember_zazQveukDoPb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total tax rebates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">331,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c20220101__20221231__us-gaap--IncomeTaxAuthorityNameAxis__us-gaap--HerMajestysRevenueAndCustomsHMRCMember_zgfyGqqWVuai" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total tax rebates"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 331000000 271000000 <p id="xdx_80A_ecustom--GainOnSettlementOfDebtTextBlock_zd0CqXO4DBR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 24 — <span id="xdx_82B_zByDmRZtzhof">GAINS ON SETTLEMENT OF DEBT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_ecustom--GainOnSettlementOfDebtTableTextBlock_zoD6qR7OsBwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_znWboyKJeDI4" style="display: none">SCHEDULE OF GAINS ON SETTLEMENT OF DEBT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20230101__20231231_zHiUIrWGWpG3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zJ8jUCodiI5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zST5mLcxqhM8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 4, 2022, and July 19, 2022, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220504__20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zy8JXF2ZCAE1" title="Shares of common stock issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220719__20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRdoZjmx8rO8" title="Shares of common stock issued">38,703</span></span> shares of common stock on each date with an accumulated value of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20220504__20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znCBJbSHS7Sa" title="Common stock accumulated value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20220719__20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziwIJuXW2W3k" title="Common stock accumulated value">54,184 </span></span>in satisfaction of an amount payable of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zz1eXVgcdqdh" title="Amount payable"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeWIJEJ9Jchi" title="Amount payable">80,000</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2211">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,816</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--DividendsPayableMember_zIKcumUJ37qa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 21, 2022, the Company settled the dividends payable in the amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20221121__20221121_zuyIloqAR1V9" title="Dividends settlement amount">19,916 </span>by issuing <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20221121__20221121__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zaUANzVoKl4g" title="Shares issued for dividend settlement">47,419 </span>Series A Preferred shares with a zero carrying value.</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2226">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_zjeeoTUhCYQ9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains on settlement of debt</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2233">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,732</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_znYYrAtmhNki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_ecustom--GainOnSettlementOfDebtTableTextBlock_zoD6qR7OsBwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2023, and 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_znWboyKJeDI4" style="display: none">SCHEDULE OF GAINS ON SETTLEMENT OF DEBT</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20230101__20231231_zHiUIrWGWpG3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20220101__20221231_zJ8jUCodiI5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zST5mLcxqhM8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 4, 2022, and July 19, 2022, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220504__20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zy8JXF2ZCAE1" title="Shares of common stock issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220719__20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRdoZjmx8rO8" title="Shares of common stock issued">38,703</span></span> shares of common stock on each date with an accumulated value of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20220504__20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znCBJbSHS7Sa" title="Common stock accumulated value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20220719__20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziwIJuXW2W3k" title="Common stock accumulated value">54,184 </span></span>in satisfaction of an amount payable of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zz1eXVgcdqdh" title="Amount payable"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zeWIJEJ9Jchi" title="Amount payable">80,000</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2211">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,816</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--DividendsPayableMember_zIKcumUJ37qa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 21, 2022, the Company settled the dividends payable in the amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20221121__20221121_zuyIloqAR1V9" title="Dividends settlement amount">19,916 </span>by issuing <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20221121__20221121__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zaUANzVoKl4g" title="Shares issued for dividend settlement">47,419 </span>Series A Preferred shares with a zero carrying value.</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2226">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,916</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_zjeeoTUhCYQ9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains on settlement of debt</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2233">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,732</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 38703 38703 54184 54184 80000 80000 25816 19916 47419 19916 45732 <p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zNgXLMB1ScHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 25 — <span id="xdx_822_zIVpku5SR3ae">INCOME TAXES </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z00qq9uCAB1f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision (benefit) for income taxes consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z25Vr2s94SZk" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20231231_zRv0LZeZaXlb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20221231_zciC3FU0Sth4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Years Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zx608sIrOYDh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current tax provision</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_pp0p0_maCITEBzz2Y_zRCGfrRqXSfh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Federal</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2243">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2244">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_maCITEBzz2Y_zFz6K7Db8NCh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; padding-bottom: 1.5pt; padding-left: 10pt">State</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">4,400</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">25,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzz2Y_maITEBzKpW_zqeWnd79u4ji" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax expense, total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4,400</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">25,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zo8RJkB4nqKf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax provision (benefit)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_zEj8cydWRYSe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Federal</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(982,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(532,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_z7jvnVAc9Va2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,457,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(427,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_zJjYPMjdOLf2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Foreign</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,516,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(978,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0_di_msDITEBzvPA_zbGHmeC45Jla" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Change in the valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,737,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,722,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzKpW_mtDITEBzvPA_z1ePUCtVYQdi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total deferred tax provision (benefit)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(218,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(215,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzKpW_zM9xRY9ezKwb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(214,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(190,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AA_zywWr77kG5u8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zcch6oot4Za" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the statutory tax rate to the effective tax rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zQQDsAaYx1r9" style="display: none">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20231231_zkpyqz5MOerf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220101__20221231_zFZoEeIBlQbd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Years Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_ma1k_zkVojBWYovQa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Statutory federal income tax rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_ma1k_zz3ziRqjhNBc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State and local taxes, net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.30</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_ma1k_zSjOVr7mn483" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Permanent differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.28</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--EffectiveIncomeTaxRateReconciliationExecutiveCompensationTaxBenefitPercent_pid_dp_uPure_ma1k_z99tIXupRnKl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Executive compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2.26</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_ma1k_zuLe1uy6Rb3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equity compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3.63</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11.06</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectiveIncomeTaxRateReconciliationProvisionToReturn_pid_dp_uPure_ma1k_zHlbCKsjmbH8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Provision to return</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationTaxContingenciesDtaAdjustmentForStateNol_pid_dp_uPure_ma1k_zELt9OmeWgz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">DTA adjustment for state NOL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_ma1k_zTTcc8fnd42e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Foreign Rate Differential</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.44</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1.27</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_ma1k_zC3zRXe8h336" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27.13</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.66</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_ma1k_zrRPaADmpk09" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(52.73</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13.27</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mt1k_z5RhDRvruvMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2.34</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1.37</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <p id="xdx_8AA_z3DZiEglYTCj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the provisions of ASC 740, the Company may recognize the benefits of uncertain tax positions when it is more likely than not that the merits of the position(s) will be sustained upon audit by the relevant tax authorities. No uncertain tax positions were taken or expected on a tax return that would be determined to be an unrecognized tax benefit recorded on the Company’s financial statements for the years ended December 31, 2023, or 2022. The Company does not expect its unrecognized tax benefit position to change during the next twelve months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 25 — INCOME TAXES (continued)</b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial accounting purposes and the amounts used for income tax reporting. Significant components of the Company’s deferred tax assets are as follows:</span></p> <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zoHqDvFAXI5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z1RjeRya6BHh" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20231231_zFQMFacXnlAc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20221231_zDc9RR8EyHbk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Tax Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pp0p0_maDTAGz8gr_zTc0mdjPrSb2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal R&amp;D credit</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,007,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,007,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsInventory_iI_pp0p0_maDTAGz8gr_zOuTvmt5ujq8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">422,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">576,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0_maDTAGz8gr_zfHBDJkDVEtc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowance for bad debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_iI_pp0p0_maDTAGz8gr_zQpv9mxboaL4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_iI_pp0p0_maDTAGz8gr_zKwX01inX088" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pension</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0_maDTAGz8gr_zx3YmiJWaaLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accruals</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_pp0p0_maDTAGz8gr_zhY7UFFmXQBg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State net operating losses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,235,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,779,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_maDTAGz8gr_z8oyVPnOBSvh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal net operating losses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,296,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,821,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_maDTAGz8gr_z4x7Zf4PNjti" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest disallowance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,150,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,151,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGz8gr_z5iBhyMxykt4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,995,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,172,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGz8gr_zRUHe5uD0sbj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTAGz8gr_z4Vat39qHzte" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation Allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(66,468,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(61,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGz8gr_zqSZFiVxirzd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">276,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Tax Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzIya_zSsLRpdfhtEb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and Equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(178,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(90,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pp0p0_di_maDTLzIya_zfEQTgdjCsrd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(616,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(870,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_pp0p0_di_maDTLzIya_zxgwy2QwNdH" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid Expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(33,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDTLzIya_z54HgjXzmqmj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(822,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(993,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0_di_zjbEPxYDa6ic" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Deferred Tax Liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(546,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(764,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p id="xdx_8AC_zYK94QM3ulyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023, the Company has federal net operating losses (“NOL”) of approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zd5Ro1Z4uphg" title="Operating loss carryforwards">187.3</span> million that will expire beginning in 2027. The Company has federal NOLs of approximately $<span id="xdx_906_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember__us-gaap--TypeOfArrangementAxis__custom--CarriedForwardIndefinitelyMember_z5KJLk5CFi7e" title="Operating loss carryforwards">30.6</span> million that may be carried forward indefinitely. The Company also has state NOL carryforwards of $<span id="xdx_90F_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zxiUAbGFLeBc" title="Operating loss carryforwards">160.9 </span>million, which will expire beginning in 2027. Besides, the Company has foreign NOL carryforwards of approximately $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zil9ukk8xg2l" title="Operating loss carryforwards">30.6</span> million that generally do not expire except under certain circumstances. The Company also has research and development credits of approximately $<span id="xdx_906_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pn6n6_c20231231_zFQkqHL5hGD4" title="Deferred tax assets, tax credit carryforwards, research">3.0</span> million, which will begin to <span id="xdx_90A_ecustom--OperatingLossCarryforwardsExpirationDescription_c20230101__20231231_zG1Xsyhyphri" title="Operating loss carryforwards, expiration description">expire in 2027</span>. The years that remain open for review by taxing authorities are 2020 to 2023 for Federal, Foreign, and State Income Tax returns. Finally, the federal and state NOLs and various income tax credits are subject to annual limitations under Sections 382 and 383 of the Internal Revenue Code, in addition to state provisions, and may not be able to be fully realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realizing the NOL carryforwards and other temporary deferred tax differences is contingent on future taxable earnings. The Company’s deferred tax assets were reviewed for expected utilization using a “more likely than not” approach by assessing the available positive and negative evidence surrounding its recoverability. Accordingly, a valuation allowance has been recorded against the Company’s deferred tax assets, as it was determined, based on past and present losses, that it was “more likely than not” that the Company’s deferred tax assets would not be realized. The valuation allowance was increased to the full carrying amount of the Company’s deferred tax assets. In future years, if management determines that the deferred tax assets are “more likely than not” to be realized, the recognized tax benefits relating to reversing the valuation allowance will be recorded. The Company will continue to assess and evaluate strategies that enable the deferred tax asset, or portion thereof, to be utilized. It will reduce the valuation allowance appropriately when it is determined that the “more likely than not” criteria are satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The net operating loss carryovers may be subject to annual limitations under Internal Revenue Code Section 382 and similar state provisions should there be a greater than 50% ownership change as determined under the applicable income tax regulations. The limitation amount would be determined based on the company’s value immediately before the ownership change, and subsequent ownership changes could further impact the annual limitation amount. An ownership change under Section 382 may have occurred in the past or could happen in the future, such that the NOLs available for utilization could be significantly limited. The Company plans to perform a Section 382 analysis in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 25 — INCOME TAXES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective for tax years beginning after December 31, 2017, <span id="xdx_90E_ecustom--EffectiveForTaxYearsDescription_c20230101__20231231_zjkxCxnuhx5j" title="Effective for tax years, description">the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For tax years beginning after December 31, 2017, the Tax Act introduced a new limitation on the deduction of interest expense. Current-year interest deductions are limited (among other restrictions) to 30% of adjusted taxable income, with various modifications and exceptions. The Company does incur interest expenses and evaluates each year the impact, if any, of the new limitation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not provided for deferred taxes and foreign withholding taxes on the excess of the financial reporting basis over the tax basis in our investments in foreign subsidiaries that are nearly permanent in duration. In general, it is the Company’s practice and intention to reinvest our foreign subsidiary’s earnings in those operations. Generally, our foreign subsidiary’s earnings have become subject to U.S. taxation based on specific U.S. tax law provisions, such as the recently enacted territorial transition tax under section 965 and under certain other circumstances. Due to the complexities of the provisions introduced with the Tax Act, and the underlying assumptions that would have to be made, it is not practicable to estimate the amount of tax provision required to account for these foreign undistributed earnings. The Company will account for any additional expense or deduction in the year it is claimed. The Company will continue to review each year whether this treatment is appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not identify any material uncertain tax positions and is not under any income tax examinations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z00qq9uCAB1f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision (benefit) for income taxes consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z25Vr2s94SZk" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20231231_zRv0LZeZaXlb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20221231_zciC3FU0Sth4" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Years Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zx608sIrOYDh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current tax provision</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_pp0p0_maCITEBzz2Y_zRCGfrRqXSfh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Federal</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2243">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2244">—</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_maCITEBzz2Y_zFz6K7Db8NCh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; padding-bottom: 1.5pt; padding-left: 10pt">State</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">4,400</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">25,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzz2Y_maITEBzKpW_zqeWnd79u4ji" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax expense, total</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4,400</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">25,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zo8RJkB4nqKf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax provision (benefit)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_zEj8cydWRYSe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Federal</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(982,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(532,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_z7jvnVAc9Va2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,457,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(427,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_zJjYPMjdOLf2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Foreign</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,516,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(978,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0_di_msDITEBzvPA_zbGHmeC45Jla" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Change in the valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,737,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,722,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzKpW_mtDITEBzvPA_z1ePUCtVYQdi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total deferred tax provision (benefit)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(218,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(215,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzKpW_zM9xRY9ezKwb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(214,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(190,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 4400 25000 4400 25000 -982000 -532000 -2457000 -427000 -1516000 -978000 -4737000 -1722000 -218000 -215000 -214000 -190000 <p id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zcch6oot4Za" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the statutory tax rate to the effective tax rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zQQDsAaYx1r9" style="display: none">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20231231_zkpyqz5MOerf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220101__20221231_zFZoEeIBlQbd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the Years Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_ma1k_zkVojBWYovQa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; text-align: left">Statutory federal income tax rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_ma1k_zz3ziRqjhNBc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State and local taxes, net of federal benefit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.30</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_pid_dp_uPure_ma1k_zSjOVr7mn483" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Permanent differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.28</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--EffectiveIncomeTaxRateReconciliationExecutiveCompensationTaxBenefitPercent_pid_dp_uPure_ma1k_z99tIXupRnKl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Executive compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2.26</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_ma1k_zuLe1uy6Rb3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equity compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3.63</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(11.06</td><td style="text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectiveIncomeTaxRateReconciliationProvisionToReturn_pid_dp_uPure_ma1k_zHlbCKsjmbH8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Provision to return</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.49</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--EffectiveIncomeTaxRateReconciliationTaxContingenciesDtaAdjustmentForStateNol_pid_dp_uPure_ma1k_zELt9OmeWgz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">DTA adjustment for state NOL</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.00</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pid_dp_uPure_ma1k_zTTcc8fnd42e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Foreign Rate Differential</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.44</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1.27</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_ma1k_zC3zRXe8h336" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27.13</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.66</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_ma1k_zrRPaADmpk09" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(52.73</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13.27</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_mt1k_z5RhDRvruvMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">2.34</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1.37</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> 0.2100 0.2100 0.0115 0.0030 0.0049 0.0528 0.0000 -0.0226 -0.0363 -0.1106 0.0749 0.0000 0.0000 0.0000 0.0144 -0.0127 0.2713 0.0266 -0.5273 -0.1327 0.0234 0.0137 <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zoHqDvFAXI5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z1RjeRya6BHh" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20231231_zFQMFacXnlAc" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20221231_zDc9RR8EyHbk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years Ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Tax Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pp0p0_maDTAGz8gr_zTc0mdjPrSb2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal R&amp;D credit</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,007,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,007,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsInventory_iI_pp0p0_maDTAGz8gr_zOuTvmt5ujq8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">422,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">576,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0_maDTAGz8gr_zfHBDJkDVEtc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowance for bad debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_iI_pp0p0_maDTAGz8gr_zQpv9mxboaL4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_iI_pp0p0_maDTAGz8gr_zKwX01inX088" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pension</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0_maDTAGz8gr_zx3YmiJWaaLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accruals</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_pp0p0_maDTAGz8gr_zhY7UFFmXQBg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State net operating losses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,235,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,779,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_maDTAGz8gr_z8oyVPnOBSvh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal net operating losses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,296,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,821,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_maDTAGz8gr_z4x7Zf4PNjti" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest disallowance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,150,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,151,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGz8gr_z5iBhyMxykt4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,995,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,172,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGz8gr_zRUHe5uD0sbj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">296,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTAGz8gr_z4Vat39qHzte" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation Allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(66,468,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(61,731,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGz8gr_zqSZFiVxirzd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">276,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Tax Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzIya_zSsLRpdfhtEb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and Equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(178,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(90,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pp0p0_di_maDTLzIya_zfEQTgdjCsrd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(616,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(870,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_pp0p0_di_maDTLzIya_zxgwy2QwNdH" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid Expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(33,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDTLzIya_z54HgjXzmqmj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(822,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(993,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0_di_zjbEPxYDa6ic" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Deferred Tax Liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(546,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(764,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> 3007000 3007000 422000 576000 73000 72000 12000 7000 55000 72000 34000 7000 7235000 4779000 47296000 44821000 1150000 1151000 6995000 7172000 465000 296000 66468000 61731000 276000 229000 178000 90000 616000 870000 29000 33000 822000 993000 546000 764000 187300000 30600000 160900000 30600000 3000000.0 expire in 2027 the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary. <p id="xdx_803_ecustom--ReclassificationOfPriorYearPresentationTextBlock_zDPGsZxOcIu4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 26 — <span id="xdx_822_zqAPke9wtBB9">RECLASSIFICATION OF PRIOR YEAR PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For consistency in financial reporting, we’ve updated the presentation of our prior period financial statements. This involved reclassifying certain items for the fiscal years ending December 31, 2023, and December 31, 2022, to align with this year’s reporting standards. The adjustments were only for presentation and did not affect our overall financial results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zmnt0IWOguF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 27 — <span id="xdx_826_zTEgvmWWNppe">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2023, and has determined that it does not have any other material subsequent events to disclose in these financial statements except for the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 12, 2024, Vislink Poway, LLC signed a renewal agreement with CPI Apartment Fund 10 LLC for the premises at 13475 Danielson Street, Suite 100, 130, and 160, Poway, California. The renewal term is set for one year and ten and a half months, commencing on March 14, 2024, and ending on January 31, 2026. The base rent for the renewal period is established at $<span id="xdx_906_eus-gaap--PaymentsForRent_c20240212__20240212__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zO4bmhckJ9r6" title="Base rent">22,926</span> per month.</span></p> 22926 In connection with the reverse stock split implemented by the Company on May 1, 2023, the company’s stock transfer agent calculated a de minimus adjustment to the opening quantity of shares issued. The shorter economic life or remaining lease term.

    •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�PGC0+V,1B\\*X@LT),PY;Z?#:\P&BRJ/R5;[WNRK(V#;SCK+5+7 MA_ %YU_DU1;#P*5D/WE=F2!V.=B1.[$W-UGEX\EYXFS6O\.DV90H0\3P,]6C MT>I0$4LAZ*LAJ.P*@OP-&8N_Z^^7;S>*JJ6]@R!OPJJN("@?TRT8^1Z)6Q$P@/+PKO<\*>[?4C=Y2&YWW*_;@3Q XGJ1;;15Q_DD5A- M[R>JMNA*T$0T=;+2N_V+)O/D/'866R..(8]@AII8:BI\M:F0";RIX&\"YRWQ MJK4?I52KE3FHJ7#('$\F\*;"]@R3HZFPW,/KJTT%?T4U,7E#]?SU^W2RIZCN M:"H<4D1SU%0XFF1G\#>1U&#*!4D5.$+C&!_E@]/SC(J%*K33^YV)I>%$2NP1 M$$O%F!)[!,12,:;$'@&Q5(R/EMB0!Q[GC3.2ASU^?.8YF8?CUN8')/AQI(KZ MF$^W^W]2@_FQ"#,*EOVV4(9C_^.RZW \1AN9!X+8HP&.[#$#AW SO)@^EAX; M'/?M@8.V*S_FS1I-K**$/KFWU*,_O('J[TPL=3HHL4= +!5C2NP1$$O%F!)[ M!,12,3Y:8D,>D BOZSTO0ZML#:60;]6"K@UD!9[$WTLP6A*W,.(D=R([*U8R M3G\C?MV-_(X4XY,P%+0#'4:K=1OJGT8IK;[FYCTM6OJU>7>Q-?&>,\^0\?99;VYV8Z(DF,RMR%O=+ MSNY'HR^0LWY#3C[$>VC\W)_+V5H1TS&-7R!B2[PYE(BY[8.]7L02\;--';"/ M9/D+%;%TK?[RM3I]Z+7:WYKPP?!J6GL>(_<2?\M>IAK9D]U'.&25O@ JCB^- M^3BRT7DD I1_CKY%5'H!.11ZDQ/KZ< F],&).H_.__V?TU.F*B"1_\G[6CLSH;:/?<3!WS8C-D]Q_N=:O7K2+M2NJPW;AH7 MM4HKRM3JI3.F4"\SK?MBJU:N%9KP=2C'5V^T*ZU(N\&4&O56XZ96+K0K9:9: MJQ?JI5KAAFFUX8O;2KWM^_ .*WK+BZG;C?F://%L;X!3@HX#4LJ!RHJSJ"FK#6XLBF$TG"^M[+&\SBW=[ M4&>:35W=QW]G$S>MY&<-@T/,&);(2"+&F$4Q2YM*,55=P26"0S"_HLR#H(J"],JT$3>09%'N"YB8FL2= M,?((*:P&Q++,A2+KHPBX@:HLL2*#?4Q&&\"7_0%YX?TUH^I=5> %5IE$&8%4 M'&+J>KK$JV 4:0,8[@1NO9$E7@8B*A:)V$L&' M#/B"#* A]J[Y"(QRQ&)C31@!?=8=Y@/,(<^9P'21A'J"1D8?Q2QZ'PC<@!D# MJ6:':!UPEKQBQDR\G9OCP*K$5\ M\ (!6XJLIJM@%H!!BOG-BN(D&K%3;^,9 M7/R*!K((ABDS,I2&D. \PK.0B:63+GF^P*XT6"K#1$J(+(B6S&-9G*^):AL; MV&N6V'S)ML3N^JC.=-IJ"C?I8F'\G@[\(HM1P_"@NDB4WQD%C6!$V)YPU!5' M- $A5N')(MRO_@R9> ;Q28LJLVCR%,'D::7S:C[=N$JHF9E\\8(*F $O \5" M)^>MTF6E?']3B32JS&VA7;H$*XA80\U:\;Y= _M^.;E@G[6=7&KW,^O.^3[Q MN&SX,R7!_KI<#H&^92*[L"P$,,&0.=F+3+\96I45(R$+R(7;?X EP",^^ SV MH5C^.TC]:BP^?L \H8,R;(\2!TI=RH@CJ1@RI&0\&MHYH?H3GKE:U9]$6/4' M.R>AG8=0$7M<0I,([3R$<%>?Z5EDV1XM* MLJHU$2?W)5R*TQF-8J/8EK)-?!O.JB]6'!%1L23%%!1\Y?VU56;4OKY\+CUI MUTUAWGIR'A=VDL#-4/K9>4G\Y?..ALW%4:XF9+=*T6USL!2<=%N!C$,J (^( M?+*7.)V@G<2&^#A?\U2D75@D%MR\&M^PGP&U]/>6^X#9)]KN5 MV5-;K6R1L(^F\)B$6H*ZNOV>IK80CW-]ML[TRJ7J7 7F>[+4SSP MTS*KHHFOK:+)=*8](5=14;\OXF[0I4:]5*FWFX7%1!$MFSE$V11?J5WB!9R19PQEW6=$8_)4*"Z2*JTA(\0GPC F3,-M[,:1DT8 M@49*3W!I#OY6 DK^P@4R@J9&-%F#F\BSSN!MTA@6-!\^Q$>ODE^'6EN'C7?+32_RJ1DY6K+O*WV7MX^6+'/3[K;3+\]>+F;(>C( M///M'6=^6+]N&>?2&I[_O F9C*:2&XW(:&16V((%=5E(\YM, #"&\1=L'\7) M3C%^U-'OP"#X+D+9:N1>GM.C<;R1V2:4FW@73.E+Q';9>&;*WVG")H!8%,") M2:P3O;^6"A=GM50VG,:5D SZX$!3\=5S,+=?= R5?X$GNJ!&@/,.2S<^TVAE M<9S-):X!)<6A"MPIC$G]5$_!]:@KR^4[4O#1/[AF%!>/PLH_&BGR!XB9!JOT MZ@)J/_6K8+ZF.7L+B#]IT#D/*"]%6G; D]6G^P0I>X+D=! ;C$JUU&C*B[/H M3V&5\]M0RI&+B_!44!N]U<#O1E!:R[W]<"GA06 E&H_'-ZV*D;\W66N[+83K M$QG')(&7K8N1]">>RO5>/5\+U^8;#BEV28^6P^3:Y? ? J4;_007,+<<4#XF M(4N]:NW2(-7LYU*'@;E=;"^/Y2WM"*X?NCIU@%2SI MB@*3[;E'9SY^SU6FI8]&HK!AE7'HTG0ARSS>DEZ7)6M_)3!XC'L;M1564@VT M+$ZL9SNM2H8&6&O275GGVC'I3BYW5ZVBD3% MR;1(KLWNG[+"] B*V<1J2TL M6ECB[.-:6I?Q1_3&B)DN 3XIUBHXE@N(3'(,(/ M@W2W7..RQ;RM>,4.[PI0%,6GG9A,/8"/>5#Y3GH5;5UKZV^)MMI-J(@A^\Q( M5[@!3+AZQI1WR9 IR(CE2?+,K%.9=_*]$P&SUYB!09SO(^RRZ#!4$/&KX5]6 MDO1E^P]OG9VFA$&=G%SFR('J(]- M@P46'LY.6!KA$HCN$!I>- TR:6?#8&V<)"#AX, )W&CRIF>JQ6ENL#5/'[0E M>K-H>13^3:Q?G]>$?RO[H9D'0;C "==;[.7J,7>;FNCLP=$L<7B1VR$"O.3H M9)..:!8Q12VH4=_ "=RETAN7&AW M8O;O&O\U$2'*#(3^0,3[#XSP[T+(-T)FD%55F1/([:33EC805-/@],IW,#JS MQG!Q_5)'W-ARP;WO6^,]<2AV;B6%+6E5MS-QBBWC^A,"VU.54=)Y>$M$9[-40EC M@LOV^@OK$ M'&WT3'G:V(73?OZ+J_L[T_*3\G*1O_E]&\L'7OCL#7L'K,K($C+;PF(#7D5] MW-;;*#S&/@%V1/!FW-,A^XHOZ).F(8+1IU-%DD!2"(C3L9,!0Y%@8<=/@&&P MPS.FO;#U:,9,< 44@Y61[@0?/@,\F#!])/<5=C3 M@DI3$&X[ZTTNQ8L55W! MZ0ZS1:W1_).D3D@EB<==0(/9IO- #3_+G>GCN#PM9X3D32_IIN%GN=8J7%PT M*Q=D R<#WRR#UN(_M.?G9BLVF(VX:,_/F%//3Y4V_3QJL0](_SG:]/.KYX3J M3WCFZKCZ-]*FGU1H=A8:VO3S@$T_??;<[S:XR3\WSO-7&YW>L#2@?0!];<3F M XV!9".5/RI_85LZ'@<"[EOF?9-H<^V8+[N89=['_^JRH@T(]042@6>]:XD: M5'7^^L:F&<\:4ZW4NI(2K);&:B0 ?V&S$HQ*+/([F71SOJU*K,*%(N43PVI+ M?9T?$6_0%F4DO'M[;T9_<:=2K]I5K5;' C,[J[QYK6O=M,T\&4W'-K;3 M\*13:0C6.0HN6\%EA]3Y7EWO]@$7Z:ZMW\8O'NYKB(*+RS)45^#B10^+1#26 MS!X;N!Q%X,!OXZ\EZYX:?T$%Y<,O;',X+GRQK4?F> F.!XWI0^/V_>EEE/,* MCH\ @IWMNU7^+4&PVQK^#1"<3FQL(A0:EYLBAA>(4?YB \X),5)WE=>79KV4 MX@<4,;88;5L1PX.NP_'7FJ/DTF&XL06 VP#3G@0C,]%\^GC<-=HC,P%WPJJ0,-BWJ.K=V?S[&>% MX6FUL#7=DY\4_>*VH/9\6T)6#S(1R6@RG3H*9*48X05&9+_8 K-C MQ/LD4RR_5^,7[1[%B"WVUUJ,\"!4'H_FTCY50ARE]>5OZ&NA%-QO2ZR)5(V, M0^XQC[(B;MYH%]"*=E='=COL)@B@ "]@=?'K[#FKN1B6CT:/2(:%VB\5KE@K M_RY.,UOJ3OR:AI#B^MKS@%9XO(3PGARHF,GF_4'X-; 5>..0(I6'2)7\.JMR M U*E)D(JUGZ_'^E=BE1>G"&[!:DR'F0,TM%XS+D/Z)$@U9$%""UF)KY@M^L^ MDWX .EV!/*f]*Z*@H/R& FCO$C?+INCT/5TI567QC>]Q>Z"T%WP,*4P[ M-O%:P&,/,C.);#3E5UV,HVZ&TG2DJ+(7JO@7C)R.I[T_]ZDRC_+[>*G?&%56 MC+\E3/$@)Y'(1>-)GP*.P<"4\,8A_>BKL-AED'94",1N<;JCG6Y,XN'\6R;V1\5 TD4M$8+2VB^.'MAMSU1W-] M C_>LD-5G8CY1C-+\6-[FL<%?GB0DTZDHYF,3ST2CM*("^..NQH^25D4B:9& M">4"R&'?.,4L:IY!,&(%A1IT0=YM\TFKSBX%M?G\%R2^:4R^!=3J:Z'>5^ZJ M5WB* M--M-POV0QHLV?=%4^CAV$!]9I.^@9>J/K**PDB9\.NY'JSX]1/W 1 WGXF'! M^^-43W1CU]EI?LVA72:I-7I%%;"V/1_!BLKU>G9*YF7&\G^ M"[NEH(7"RD[5Z3FWN8V-H$++TP,=BO2:03/?,O(-6WM$*8 MRA^5OR]GXS$$ OS)2MV#V8!X0C()^=$:)M]VAQ;(PER7)4Y7%"1I':%F3Q^Y M;!4" J264G5>)/*G'5M1*[[?=C5V)^]%9FZUF]?9G]5DJ< MV*;$GN1C\UE:>?/U[NZA#BU&V@ I(BOQU(SQ/OE<\LV6J=]TIF_MB^I[YF.D MQ]+?"@:7;9GZS1(,>K'-[3@PD*JQ%VI<],V:P6JL%S.7X7117$3DX>_N[RN;?<]S+OB@: MPF*W74RP)>ST(&Z?B:;C!]I'14MBOQD [&IS356VP(MO:NKU_I4"@*,=M00 M'D2L,]%\[$"'_7QM^>H/C069.(]$K('6]2$\A3O_=S23V5PAT9DF4\FB&M?? MGN_Y/<*G0U;I"S R?&G,]Z;)2^,=.0UOX4_7NR\0",P(R-,4'2U)7?[$E."' M6NOFI[&+LE%4>9>3Q8X&RMTT+SOQII;P)-J]%&]^B%(=RCP MS/^W>UYOM"N11)+YW_^7 PS[Q1@/GPTZ4>Y,N=+=X%K[/7YXXT[.FY5BH5UI MS2:L>[XX=Z.@C]E)X#P6L$0L?K($D2U]B'N#-WHSR<'[ @!;D,0):T4N;R\G M&+#_B3Z!C\ M*\*_/*/)C#; 5ZF(5;@!S)<*5PK&ZL,SW0DCZPIS?W9]QJAZ5Q5X =@69=X' M ES,*@A?*NH\7"I(C(S+ / WP-*SD(ER$)^TJ%Z+8%*L IB\#@O-Z=-'-9&; MR28OJ".1A9>!$J*3\U;ILE*^OZE$&E6F77ABEB%G\1\R58;<<$@4S26;V GX M;[B*L_[>>3I- XT#^61'*HS1^O2+>1=X;8"?$OOKQ./0AE=A"PXT""D']DZZ MLL@')]L.\X6__>])YF0O,OUF:%56"*T8SR: 9BJ#) "FX'/8AX@>%7L_Q=YM MR#X@BE%&'.ED08:4C$>#SWRJ$0&7K"%M66-%(SXP#X-^>M;- M027^"G$^V(J^_?5EJ6%[MZ1[24&=@>&&@JX-9$70)G5VB(Q2OME%ETBY95\0 MC%TU6Q 5)-[H.J1>WC9+5@=.=OI[C/37LGPW+_P1]_=[DXNWM\4%G!0I]7D/?:H?B3T&?V_+ 3="7R!X=].U6$)0%F>_V$_%) M\?WY3\[;@@#OXUO_=F- $%$$Y_)*\A >.F%&(BNIN&"!(Z4:.F)Z M@H@+'0R<(=*MXO\G&4!L,< %6)))-C#*"!K#L9(D:TQ?9W&+;X3@2E:;U42\ M"Z+(=!'#CEE!)$EP^)%E5 %&P"H1$51-9.#Q^%NX4I"8GJ[IBIEM7"AX^/=_ M3D^9JH!$_B?3&HF"=MI"?;QUY!>#X1:8&$LRIZ?G(9@(IQJ?SQ)]8BL60J1_ M)SJWL^R.[<-BT$)O.I(XH"27_<4\L**.B2)L(T8!+XS=!YZ-]\^NR!#]V*G4 MP5T!@Y,:SIWT9==;DT>.B#?'T%6$6*J7J)XN")O)LU],>S(""@H*VQ4X2^HP M7^LRYF R;;_KAW4;_FF.BQ8H_OL#6.W =-P#Z[2+0.7@V2,R9R:;85S'Q&-+ M!S8QQLY.S&>#E38!]T9O JW7!UC0<)5IK7X=:5=*E_7&3>.B5FE%F5J]=,84 MZF6F=5]LUJ)=J MA1NFU88O;BOU=CB'M\X>\;E,.1'++I0I7[""U)!:2 .7!2_+C5X9=347Q;RV52P5O:9R7+J;4ER\7.M#@I#YM_M.E [IV<7Q1J]1;3 MJ#.M2KM]0P21:529Z;57*UJ,X-_5O*'GVJ5/.%R M)^(*&.=%8U_Z9\@6ZWW)G*CUVY":&7(7NW3@2$0_( M8D&W;WSUG 1*5Z@Y_XVJ_*F%3H7FVUG= 0':P)6N?9T.[+FU6>8C3'>J-C(]R;4B5#UPYIPOJ8)[Y,/N$#69WX#J'1J^@**S4 M)YD!LR.KF3\IR9)9@5?H*XA<8%4OMMKIX0WW\3:XW:>2*Y"[*+RU5LE? MU"I\L76?;L/G!OQ6?:@V;YOW\6I;_-UOQY[[S9#3YY 6CF[S\YV7X MD5,:N9 P>F,1\.=8O:[X-WT:2\T_S8I_5]BYF'R.IUS6^=;J55MYKT'KUPPT M>QK/SS^Y'FCF4P,%+,[&D@Z5S.M*F\D_C.HLI? !L=R X7$AZKN@#0 I&9;C M]*%N]-D:X^I%?-M_EG4VLUUG2>FC"Y6==]#T QVE4O&JV[IL95OS(V9*=B:L MC/?+M7:)U55?6.T#/@KOM2O]Z3'QF'P-"ZOWP0UWS/88'W.?[Y+Z!8/=#R,3 ML<\/-IV*QG.I[4#)+"*E *+*:H+:,WXFUB/ 'X;%(>[^SXS8":DS<<)$^X;0 M D=."U#OC.M+CAV#O4.Y:1P]/?0Y_HT?S%2OL$#QEZO:$K-*.S/+,YQ"C[6K MRE7^BAL(0676YF;+CNQ:TW)Y)YA))/R&F=UHWPDUW)J0&VC/K6LCO]&\"NNF MU)T)//B.T[T)]7]_I?U)IRKB3H6/TX' \PC>!JB1$#ZZB@@+=QS/!*E2]EA: MZ(9K*MM?L7=X:ZS3Y;9@(]3961OI7#* /5B9$NEH+IXYQFW @3X<,W"@%%0D M"@&:!S\5% (V4OFC\A?FY&19& M@Y_*6$V?YU;5K3A_>7R6S;VQH,I/NSVWV M-DE)**[+8V._5R+NE)XODL B5(Y 1C/#.(A MOB:IFJ*3*2;/B2\<:!5/6+L2\*>I/JF)\ENA&7_(S^(F,UFP;W(S: IV$,4M M0]98L_'X:2(^_[04BO#@^/9X/IIW,%:M>&772%OC78.;(FM;1VDDEHRX;WR> M/EV:>H>P6PG/;:-'PC%+(3G6#MG%U/9:"J>7RMS!AE,@9D1 M8B86"9@9^4-FBA29X5A%F6#9)%F>LT\OJ?00:6^,F/"!Y>"\9Q MR51+J)8$*U#G;/4O&3X>'.:YQO Y$KVF$3L:,:$1D["QD$Y/;]H/3\.Q^:B)OO!],O/&FIO-P@,WOOH1-PIW M$CF_.X0G,R=+]M#LJ*2RH'*BK.K*NH;-L8HMYK#IMLZTWG^ZN2W&6]QE-_"= MFF?]P=-K^X,G.M/:P^A53[>:21:=G(-^-6XK3+OP5&G-=X3Y*W\'.O3$WO+ZZ5" M,=X+O+CBQN(C11X+N'"$^;MKC.@?4@8CD.'B8\G@D3!WJJ!J9!LWKOR:=2,/ M>V_P3&>:2#\H"36?:OUY==,;'+3UKE''JP3^:ZZ]3.7IKE)O59B_BY5ZI5IK M_V.QQB\=LS,^4!W(=^PKOF #+GJEI^\(>_1&\["U50:V^[>T/"XY-M5NCF,W M?] ?]DGL[MA];8D^IS7>:*:W.+0U^>"5)YX6.C8NPL-#DG\KU6O79O$NF"2_2@*#\4C M0$S;MP: H7?24YMM3J[?/U*^IH++D&P_!L@A- MHO9CZW]<<-1MBC#ED"+T4R0\I3WU.=H=)2BS*D&;L<-)CJK3S'6VW,W52_Y MB+TWXAKX=)(Z,I!E'LTVV^^T2+A> N=';6>_M?6/RS]6L.B8 '<,> M]D!'RFVGMDTIP&C*L9V(XZS%UPN 6V[3^7<]_UL2P"D/*ID3Z37=9+R=?K?0 MMR9VUA':%NQI<]@;LN3C]>BQ,WU#CQ*?S>NI%\'[E713"8>7Q5N6738/J3'( MX(/1(U:3-;R&.RX]:VC=59<6BRL^I4'K'[6+VJR1B#WQTH--C^[PTG4!A#-# MZ6QN1;^T!QWX7*+?7I/I"'G9A7VOQ@;%G3U&L[!6SC6O7HLIZ>VZ=R"_T:)X MT7&J49_O9;?"\@V)F7\;20X'+/[ )7U!ZJ]_]M?+CAFU[ZNE>[8;7R%$BFDIG MPZVI>W-ZF[[N93.OX7,J\4DN;W4D9\ E*PANWT%3KUZ>[VY?^,9-;Q]-W64) M-4@+AMALYM-^JIEQV^+#C/MRAE9J]6D^N,E&S.!Z7,V902 M%XZS^)D%7 [$2ARR6 /<**@JTDH#W,>K)AD=C3I"W=107N@,59N2=B\NAZB4 M2E^)[$&^EW4+ M4C2;=+WC^S7L8X=X.=PDGN$L85:$X' W3X"XH%.+0ILMEWEL;:J_DSCKW)NYNA7<= MZ*2SNA>@>>JRQCT.7J\:_?@ M2\;)>6V>Q5PI,CLP;*Q4 ?F"&)[B?W:O]-9:K$@=!_X';R*W0'[6TU!(?MW9 M/]Y _FR?_-:-\I/W1R6;?;U(Z_L<\'M\.\ZRR?4[SBJ]'H)Y&J.96#59#341 MO)431(%X47ML.=O]L9TIQPTRLJRE_NS3_/RPLU:(* M#L7:4J1JKZ9JL3,C" MHN!30369_((LALQ_$52&5QU-WJ;IVP92YM4= MWV03R)PU9<>]9M4_<@75BN+O+A_X'2-TKQG=:Q8.IM&]9L%"CDU);C>V7\&^ M%8U83 L7DW,T^%%'O],5U!FR<3 /7Q_DE^+CLSS^[4]RS;Z-9-49F=')] S" M[770RJ:=)!O]S#TV!'RJW-^#N=DS8N V74(.UC"=S=.$S[[0A8 M9>M?WWNJML4$W%; '6RBMB;PW7#*N0 )J4Y(,TU.A>;;RZ!>Y/R+3)J%< PK M\8R(B3*:E$09"9&&N!;,F)DJG\/!GQ?%=0S>$R[<)B.V2&'\+)[>HW3D("'X M _-\F]Z[K:3;PO'867*?8IVM%D9I1X5O@->@%'@<_,&=3!T5O?72>%"R0RF5 M2QYHD\(= @[C5DP,+\ @%-Q340V\G"WS#ZOU9[T45.Z%OUSJ[*!ZR>JBLD MT&]07)]DFMWDZX&6^LJ;+FB30R+"EL2QYWS>$QS49=%)XVNW&CYQA ]]J?^;&5='7VY76#8&7FD MW;!*0GKUQDVP9<\MG_=4_F1@A/(H)V ;)@3'^7+$A,J.IO_R_D1\1=D,GFD" MZP@&[3;'Y7H2GTIXV'!B=:PF:0PFB;'3%/@HTS:F[JGY'N6.XF>I5% UWP.S M?B_F;]-ZK[VJ^%DBZ^-.>#=\LC;I521X/=F[MZXVH)2<-I]0;I!,9@ZT^)N[ M:>V9_\ JNS,?]U1QC])$B>Q9?!^O/211_!U8OEFQDS&/7*G$668?QWSK8WG_5O:U55L/1[AKWH,%;8NN.(2L%V*=@&A/NZE6LMG*0;$V=7&=BZ2=*9E88[ MJ,.;&B.D$&XMERQH&/_2S4&Y.5;T\:T_59!;RDDW[JF=U-RCSS$].[@Y@VV9U]_V6R?(?H=(7G]NE ME\#OW'/:;QGX\][N)1#P"-X&,]NK3@ZQ*[1*3#85BY(=,CA%R$H3(&W"X-V) M?0F>0'XQ2TC)+3JLOHK&XBY0>.N[K I$BIGW 9(80<.;$H>R@AA1>$7B!&Z' M(4BRAC_@_T,1+ +S(_2L!_RM_L.\"R(N5V548 "\ /&,/L*6LL[#<[L33QM2\)+R"A3*"FDZCGVJ"'ZVL=*0_(E!XKNL MBSRF@D<:4H:$#$W&7\! =&G&&*,CC,D9PB\ $9Z1)3LOR7D:V5\JTQ,D,%L$ M5C0B_*0PBP3\,4A23C''@C&G;)HF700 P7XW1,)BE M:ZFS.($'PAEQ!UY70*<)K1+('J.](W$,DP.2,U#/ KR7M#O30*\/!]WYS/ \ M/3-<\O;,\"P],]P]CY&TS/#/1A?_9N=&1YX@\[AA.V%$[3_Y@Q/ M _'_X!D)HUJ%T.<0\,&1L.1K+#*Q+Z? PPW ML,>084IRK*),L*W&DE:3Y"Z6A,6,K5\"K*4BL8&)03FW-%F.PS? K9&1KH - MB(P[\$.M9^DJF(J+YUP#M4 1ONV,:0&?A!ZL6V!P<[-#P"W;?=G(7>B5:)$( MEO?:)B4>]ZE)QC:5PM/-72P7=R MESNV5#O3>/,%-2=LIG@Y/X1O0\>6V+KN_X* 0OMKJP(@0NZ)T34+$3V*WM&])VOK95'_? @@] M26*!6W8;MK1>V($%_DZ6TPJ/OT)>E17C#,OE3E-!Y_"_JXV:J(@' '@^ MW_8K,+IAI33(D$B#L9#.2:!TA=KNN]M8X=0?:IA3H?F.5K>G0+M_,=ON8&RF M\CP/*C-M]H,Q0HT;I_:K#:U@85TW&' MT\EFF1J\?1;^%K023J[U9.6=57BU(]3F)Z>V"Q?37%_I3-M<;,B_W"FM;F*/ M#,&GMY:X?]6F_K/.)SIZ&/\PFDT2XIO_RPY'O\H,1SC\:6&R-5<-)FAL;$'J M'I<^='7TV!9M7*R++JB-WKH:]_A>APDM'CZ3C,9BZT[*](CM M/LN'1]A-U8VJVTS='#9(?4I#%X_K(R<38]&GI[/-32 M^LO;/N=0?8TC[*^=,6,8=4""8-Q_-93-Q&$'8\'M+M -Z)5:>]9RN!PGJC=4 M;URO^GN=2[^H-^ELYBCTQG&A3VX).%C?F:=N-I&*E#'"1:,%CE-TX%W!VMU> ME96RK'>UGBX6C"+>-;&)WF6Q?/5:?JAH7+!C$X>.1\Q824C&!INE%U\U#=G.T4MWWL-JG;<9CWCF9* M<3.Z@E#O8*6X;,VX SOAQ "=5-:IJ'JF:HXV2\"!AZ5/VY'A, ME#OXCC3!HKE_$VM?#IRXJ_E83*)HA]%OSU4R[UQD7#;?W53 M]#A]%)!'U8NJUR?4R]F@\""I>%-]6NHHP)#J%=6K??3*VU^M#I]^%_O!CE4) [Q#ITQ!;"QH86KFM<6@-60456 M1;S]@I*L:LX615HH#B:W'Y-7C6XC69\.D;E70JX\(@=?4D"D@.B)3NY@A'BP M_2X3S>=I=H3J'-4YET:+)QG)^#$7@.8W9D[6UW8V[R]16B_'U.X^A[8=S381 MPB&*;!39M%V+,5,>;'5+9:@U0'7F*'7&<3U/>9#[.Y;$G^-J'MNTFC^PHFY8 M659LO2/4K;6=%SI#U9:G>&"U9/[M<@J+;_BC"@LG=/AM$LS83$92\"B/\;7' MOIB/=WO42P#5Q?]!>(ZE?^\(IJOZO8,UXL$^N4PFFLKD_ '7-9KLIQ#]0S66 M:FP@--;9%O(@J9F)1[-)GS(R7ZZQC@92=I.!=*'(JMH1VK-XAS8WB-Y:?ZK" MPX>@3/FOBW?L=82:LRF4\!J+VK)FUH%Z?RK7 NILYGB0-DTD?-KZ$@P]I6>" MKCT3]$9@NX(H: +=B7*D >=P'LQ(Y8_*7UB2!S8,O5/P_CYMRDE:0^,J; M+HR&2-*6$@ELN7TSK4W8SK2EWC1'?&^@5;K!+A,X=$FBQ4JC]9/$,S->4J ( M@A)^86S0C<+MX.AZT;TZZU-8/\CQ>ZI(WU:1'#W1M <%._D0;B%R$55?TY?: MQO\+6>;?!5$$UM43N"JI9GJN5L67A0?)/+'J=IL>;PT 73#HU8 MP=I-LMY\^.B_3Q*_W^O\95@C$0 M;'S/)7S:]O[ER$KUE.KIP?74V0#R(#F;SW\K"RB]-2"T& &:OG0K=Q_/93:# M.Z+2G1NK3*\C;;V-,Z$EX0>$SO^$OAI\+P?2O6&3\: #0#IU/-LVO#=LJ'I2 M]72CGH[V3,:#)'$VX],1@U^NGI8]\T-C02;.(Q%KC'5]" _@SO\=S0R=7*'4 MF3Y?YU._;Y.Z.-DG5C-DE;X @\*7QA;'^:*KFM";^*CF(SR\4=")+J@1N0>& M#X>&7:0PR7B4P2M/E-$&B,%]YUAIP@Q8E>D9YYPXGG'"_/V__P^N.& M?(K_^H>!Q[*CD2)_@,!K2)PP_S&HMN8WO]!Y;7TS?])]34I+F0Z'*8O#?YW. M[+Z9]U'0M8&L@+E6^!!4VP7660 EL%0U97)+QMF9\NFF'/^3TD>#_@FC"1IF M9&-A6 QGIV+;+J_U]&]:VBTR.XY4+B&+V^WNI^D9M&16ZEASV;/D.F!A0(1$ M/#1MP&H,3O(SZ&,D*"C212"2$N:,(&'YR)XQ[37R 2*@NIC[S-?-_?SW]F2$ M&KV"HK!2'^%:2.-^#M1,'IZ>8E($Q%<-8FH2CWH"@BA6SCC[$I7!)47R,@MH?D0[@O=B^H-*G)!$)HM M]"Z)A=NPZD80RL3.\BMRP9B"8(%;6:]D!<&B MN2H9D>W@%#N$G%0- I?6)4',ZZ^ON8]^0@R"<#@1N2@16;=%X=X 11])>)F! M6>-E1I(U2S30!X? 8-(!,!2&0XK&@HAP@L+I0T (B4/JXI(UPP\%J8A50-#P M%B0>C9$HD[+X" =>@*#MNI8YM?LMD23B,??;TV?28_L\">ZN*/"3LC<7A/TU>RVJ0$F-6'VJMFPT: M[SC DW-3@TQ(7?'(#'X;VC,!*5 -1530$*L8N (2GFCX>RR U]&=8*G$7&!- MW /W.<+"\^'A,3PW>!CD#O/DQ"AC@DR4J"!9CA@#/4D<5D&:KDB@OE5!PHIO M0+UE;N);9B: 2OX?4&/#LF!5$0N=(5D%^QRB"1R^A M/HO_8( *'H\3%$3D,2BAD24Y8PH<)ROX5ZRC+*BAV=H-UEJS MMQM9<+L($ /?J_ P'+8/**)J=O/-XDR$=UKSX FPW+VSF'&@B$-!0GR4Z;(J M7 ?O&K'P,$S_""^!,!U&A")J@)9YIPM^D6.AN;XU@P1+KACQRQC=7 9#RI?0G_31[8-<\Q@.]%8V&$H8)0(V4F>X[< M,5;RF8@LVFWD5T/;=(R?$4.8R90CXW$@J1HLH.(& MAHACW5"MHX<:@<#0:+#-C9F6H<)_( M*BO&0T0=$(0ATHE?R3)]4#T-+T]88-*QOQCY'1PC=2",&&Z PUG, D*:9!"\ M'XU$@2,*8;.0%-3718-D0^'F8S#!*&*@7!?9'SO#7?QD;@DJL8+ 2X9#,+X, MA>@B[):3BY?I-0PDX*6*WG2RCBY=@!=9("#2TQ6R, OP,LY0I!6VFR3#FB2M M,F;!Q".\QQ,Y8&&MDSE.)^@@&",BJPG WDS7#+"UJ[Q6\0 VRB0#*OJ3*<- M*W2VI.*EV[YB&+LOV3+>/[LB0Q+(),G%<$@4S<0;R?7AOV&TG/7WXCLX M6139D0JD6)]^P<+#:P/,A]A?3MWGYEW/EDMU-'GDF-V;YP[M/W((@]3"ZT[. MJZ=VSED\^\7@T/E/IH"M/^X74P?WT^!K7<8<3.;L=_VP;L,_S1.!5A;PWQ_ M:@>F \*]GAJ(\1,T$<^9R688US'QV-*!38RQLQ/SV6"E3<"]T9M Z_4BGPU6 M>MK'L7N.(RBU^G6D72E= I0W+FJ55I2IU4NPE-3+3.N^V*J5:X4F?/WOC^YY MZ,97;[0KK4B[P90:]5;CIE8NM"MEIEJK%^JE6N&&:;7AB]M*O1W"X872RC3G M)))($W<@GOB%I:UQ6V':A:=*B_G;\G7X?_R>D9"L[KX37>GUL)DU!A,/K#=L M'!MASWGVB>UATWNI:"*>C:[$G2OSN//LJ559:;,?S_B16^/,+Z\?I0])'WRD M7V9QYMF#F 7RHM['E3,+<>4M S@YQT8H:7@.5CEX%GA5 E,85FZ\8 HCPP!& M'VA(KF?4B:JA(0EQL!_D1RN6/\_Q$!<('D-F B^6#*R(.!S%D_ 3 FIPT@9< MCU@&3:R!242Q[Z6PA"G';L6_"S3B'T7 3P=1<#)I@(>NX)4733# M.(+*2""#F]D1-<,%'RN=41 MXK"'0T9P:L1=X(F*+B+U'X.CY-7+W)NDU1<;A M,1Y$'\NZS2$W0P0V7>WAZ\EY["2X+:D(5!![WT 2?GUD]O/L)B,Z:3K+S-\@ M;T":$:;'%RI&W0)(%VA $NLIR#&/N63$^VPQ#X :01O,4D5#F2?.N/D2'$LD M^602#HG8G7)>1B1XJRLKY"\&(54&X7 ['@D9N1&N(%%9>$[4"NTNLHEZ[P<* M[-DK13!ZF@N-D6NQQXC-6;50"DL-7A1( )O\:@HVEA=5M6:U)TBLQ D8[A ) M+10W()W!TQOL)95").8Q F'*LG7SFM*L8"@'5 K'"ZR-28,0X M6@9W\+JQ=)%4@+F 6.N)0Q8!QHQ3ZIR1[L'"+%G)2W@S(8;0M0K0LR=8B2TC M)":KR J6DBCBA;6&1=T^)T*"<%U$EAK;:D:6L-F:-8LYSE88ZW=&9-\7J5G8"D6 ;DEB220/M501-5O T:0HKJ6;R%B;&7,',:%L^DR9"L%A<8N#. M4HE)F20E9M%0$7V0!+@E%W/:[&!)H,@&I$8H%*_SY(VBD1%25=TP%4PQ>#=C MDF,KC3QD21Z:S+7X)WSL@")KWI@F)DI5B.(W%? M8F8.D(IF4XB3@*8I!9-;(GY"*)5I.IF;I:8H,D0?;,6!3.424#3& @G MLJ#-_"((+R>!K.*#.>*^#Y"1O<5FEX9CY20)!G_8,C04;0^,MKQ@V*K8I,3O M(3*!99+HH"Y9JD5D4C;TTBCHJ,EORZWX-B8JL[LGT;O#HPB!?MW=T8.G7S=AI<619E[/5G8 MI(';DUDN[JY/ZDS+=Q?JGX\&5]-3@=_>,8O49&:1FD5W/Y=(=*9OA;M7E'_7 MBL7\R7FS4KHIM%JU:JU4:-<:=:919>Z:M4:3>:X4FO"QTJK4V^2GF0C0&,]Z MHJLD%0<+-5CT$CUHB5-I9%'"Y0+"G'RW+$@BSP2(8J8RZ5\!QR.&LV.8D*2$2); WL%$ M+8R<5+J:4,R2J [A!"GF@875SE(TYD.)2U6>VST]6HZ/ M&=NV"D>E,VY7^>/CX6!^-T,DY MSB]5?M_#HL!4'HPL3%B7!1B])8&AH_T>FYF10JO$Y-+ITWAL=7<)*;[ A6YD MA\#,Z;77KP"*KX'\ ;M:#R9H1F@)8S+QZ?";B(L9F1G(MH")<2)V MO0W?246.BYBU/V*V0,FX9 V6D)\+4Q."N0FE$]20F"KJ*CHN(XXGB"RDHLR# MH(J"],K_L),K .YTYI96.F' @E&:DP\F>.G1"= &NRB4]NPIFW5 SPF63>S$_K%B-<][*\X6_Q M"FLG5R/5'0ZXUZN\DIGE[HK64+;MRUFB\<1I;4Z=QG +@OFG^98^)XJ65NH= M^A0LGR49S2?6[]:".3'F_FRSZ6%;_..QSK1^V[TL\#?OQ:?7P"_LOM:L;:I3 MB_]B&D8(\"=S@TL3:;&:%\5J^3V+U9QJLKP4A< O:TZ*L# !FL5MT/-?3*U, M/G1BN6('"$.2$0G'7".WH:N/ZLM][/K]I?![M6_+9?;\D,M4[I*QKN# MR6.):[^\_GFKQPNMU_95J_1_#W\J3].8^)A^;2EME"D.XS>)K1>5WOC^ MJO@C]MK*)92WJ2PT8K>)0GMXBWZ\UJ]'S]>\U'XJ_]^UTI]^W#7;;?EJ4%-& MHMI]JDMM^4>B]5I_>AZ4E:?8C_^KWXW'_98D_]?@R(^NS$_POP-M*)[_?U!+ M P04 " 3A8-816]=8;6O #SLP $ &9O< MNF547$VT)MQ- TW0D !!&DD@P0D.CG;5>9A^6 (\5915D 4 M'PT#B $ /,P"I $@#(Q_VZ-A/C8L'"PL3$PL7# 8&P8*+]^A0 M\Q2 02!,#!!_X[ZL=?GL1^ 28SU["67)/9S=1/P*Q@)=T!T)@Z]5$4'J<;( M(0./J=.7)[AD+\@I*%^_861B9N'EXQ<0A I)_R,C*R>OH*BII:VC^_Z#GIGY M)PM+*VL;9Q=7-W0:^NK6]L;FT?'9^C4-24Z<17#(&WN771_]2^Q_,_N^(??E_8O;_$_N?O&8 ^"#@X^2! MB 'B@#OEK# FP'\#0*M9Q>IJ@+H,109&F/+XUV%084-.EO^+-S'_]D7+ZCM%0W+IU3@S$ESAFT^CQ<9)U%"..=[V>?&9 MP4>NZI$]8W\7'894;2>!(L8D5[&CWK.L5O*Q!\#G/7O=.T;INJ@S8-")EXM%\"'AF1+ M*[[__:WJX6!F)+UN313MM16K*1'Q5ITBON[/7J(+\U%U"5QQ%BKJ0J8, MC.^\<6I &1(UC)%D12:@D]5Z3!C T%I:0T,-=#'F8\V4 6;5<'CT 57)RO"' M =QDV+D3_*GER/,TAD&-(]6:3E8;O("[ZKCY\:8"H)7(]:A#[@! X#-:=O'7 MCV0>B2>U$=4-V;R ^;R(O!_)3,!ZWKB[Z6P,?PH98:MLJPSL$949IADF8+5F M;1C_,,@J*PS ]/\ ;=YU=.[CN C&X]0EL$C^A3:!_L>?(W36G\NR:R2>L-,# M;[<"O,>=#!A8ANA97B'?/67M$&/PG38D/K3C[C;CWG:W;2=.$Q>Z>KMBN6>_ M,D2=9/)EN80MA4Z.>!:UK)4U7>8361OR%U> M>6CK2]]10_[+X-'M9W&14 M5> $?PQ_'A%CP; MM'7WRY1U05+UW-DH,-U9CC7R0\5D>+SIU(\I42]-L6%?8^?4HP')ILR+'&ML MGEO#M.HRS#T>)^MT6^8+!:-,OA>) EY>&O*Z5AU[LAF&(1_'V0]-&^L1 :DE M7W5R\[MHGTY'F4Q^?GE^HL*:8O'2"W(]%H@AN2G*1(J\[D>[1Y0,]:VPEA'* MZC6*OCV/.YIH3!?NXK;\Z7W6[7$4M4='W) ZQMD#[6[\G/9F]F[)KZ>Q].WY]I%]_JWWW]DY?#=3UG4@$S[8!"5JG:4\YT2D"+BAF;K' M!17( M.E,+WD62V&[G&);!MD!L-?(7>;I[K$8%!J95ZHA).8W8@Y9?8IE>I= MBPBK2X;J9UZB3DF<:UJOYG M]IDJ0&,.+/9NG73J[^W[P])KA_#W=?3SW;Z2I2,&@&[GN[&P!K(J=R)B@S\1 M]_W1[^()=^]\5+\9TD3[?]2;33_O-HCL3OYGT5DMH!7)>K0LHEQ8#/-S(C(Z MRZNVO_4IGRVZ$FH9?>I!8YT=YSTJ;FPZR99'\:X@9?-7GGYB2G;A->5MU)@8 MCT=CCTQ/D]-S*+V;QX#KYQO%RS95+5M1^US[Z4^Q(AJK+WBV?7,\P^"0>][L ML_(__42SC#V3*>Y]D,XV!EUEDQMWCYCQ%2\9YZD#"Z3D"6UF_I:,-ZO9C=]\ M#WBF.L_;=4;&Q!/>*F'A3LL&_N4=,AJ(\_O0!,-O_2X#\1FH M+-Y-49:B>E?5#'+)J,UYU7?/*0,I\>Z]QN/51>C=3[2"&GOF#6EO-G5E\F_A MA\&9U7+%$JHWZ%MKIY_K[ZP;"%A@/2RP= YSU>E>T/,^VZR@A9^>@>/Z 1H;?674O-P5.1R33B MZH]O_JRRCS?_EBN@9ET7)_;HU#OB&YO;GHGOR12F[OJS&OF[6NW-QNPB:=MG M9>[.P4(,B(F,L1U_' M^X,QDO"7,W(9[44*>#YX1#S""0Q-SV/K'^>2DE*JY9A'K6?UIRB3':_='/:@ MS3[KR>Q/.KKCIJ419^^W[$F7B03!T$ M/W#QUNJ>#3EOC1^O[ZY:YAO7%%EN\TV)$-N12Q%5[C#N'^L,2XM0Q/&#A[O_ MAA])]8V1X':%=>/T]O;X43I&ZU)[G!4(D%[Y;(D,)1Z-(:V#O_9(M;N3K&\X M/ %1%Q681@P9F&M^3:EHRI7O2S8@M"[EETX74;;.1#!@?(S.>N\=.[/;QS"-[W='CW"WL;#_W!#69M(ZEAK-1SIMF M(2<93!O/-9UJ3EC=\?9[QRHAE])SNSYQ3OHPXRA.R#WV%[;W)QB%LU%>?D'T M@O0@<<4@"US8CD*3^=? A!T),H%GV1G=C"E#(,86F9B=]"Y*Z^]6F,3)[AAN M=HX> W2Q % Z/&*:>RGU^61*_967' -,Z4D=#S]8I?5TBV&F.36L#*'KB'H3 M5\&2X20\1LP]D$!7ZQ6H*5WPCB3I@[F*4+9I59*LX%+ 9&K];(P?)4;OUM[] M2UN=HQ*WZX@N7$*GRJ=^/VQFOBMK8> M9X-WI^^]1C>Q,4V^=A1OMH6CSIN/)L*Q!+X8N)^5XUHZR![D\JT*SHAR*K/C MBGVON&L4,;/U/\H)V=%W:ZN[^);YZ:1Z+-Y/8-_N */=3<:HBI/VT65Q0=HF =.YC;L*HRA?9\(DO''( M6,+Q^SYF^I?H3-X&4%)Z)=DBN0BS9R!-N8/" \!.)[04W8BTNI?=CZXUXM#.V*UCAQ'?UNT"TXUY8 MN@5D8^=;M'XV2 6?2-HHOM%O+Q*]H]KB5KET,<0WON57YQ[.CI&4H5"_ZL![ MET++=:TIXPW,>P!T2+F^GN'@C4 A]F ?+;X_ +">C'WP;QK+5=7(YA.)S+@: M.4_78UW3)YJ=_25 A1G.]JF)E&]"WW=Z@3#)O9_GG["FI$1'+$8R,7,?H(Q' M;N2>_>'Q)='E#RG_5&\4:=.GFW\\*$\CWWZL$7D #$F^BT=NGFZS1E9=UBQ[ M/0#.]+J+B:XW60T7>RAE>O^X'PH^ #YUY%J\D!T@51$U'#38JX]H1;#\<69H MF.YHC0-<,V5%_0I[E(#_;2"M8Q;X/:G-9%:K'+$\_+J)9E"_6D'(E9E?ZF4V MT?B\_%VT?66RO&H_=BT@8JP(K;R6_TZ " MH[C>V/<&QC&_YVT.XN0>E9[+P^TCO/>!_>M2H@I[1B([A@SCW@H>%_#XW;HZ M_+D^GF>V5'^X85=CM<<"Q-M7E3%ABRZU504 MF-,W)[&:IEKS*G3Z_K!BU1*B41V0E.@R*(X;E%I%,YW'UAU+'3<"([O@ '%8 MIUG([CJ?%21(-]$=S61_P&#>8 3S&I@W(8>5!?N.RU2\M#W,J2I1" T>@B[D M1E@TV=LX,H4FKL93BH' 5FG," M[15$D^_:8"="S$^0<4-)M :. M,(QS2(VDF52QB'79P/2]:3L0WHRPDY78FVC_HP6>"C-J;-C)*!ZXTGC"_1 5T1=$ )[E1UXW&OD'PH( MB7\%B1( M>-Y3RB;R0(Q7DO1B/R%A:2W,#6Q=$-#L0E0O%4R$YJN6J30B8 RA)G\W<*4V MBF5W-L!;!0NX'/69Z/%UR/)G.*'*6*4$?>E/]5/T5_"?AO*.O%F82U^3"+>G MFZ^C$*M^(H DHMZNK,*G$:1/:SP5296W(_&KZAZ&M9GG,'8R&9YANS/?=4;_*FF# Z=;NKGA32L*ARB5@%"]7F7@N+Q#10BAXFL<6E/C9 M@# I3[F&'?4&.O3;FM(H\22RI_@J[#=IP-E*\O0,0,1KY&=_.*<:# 7!3195 MM$)_>M8K0)#C@"9-WR#$63J[9:&M861D,!Z;T]FUIF@ T' IR_]\ZQ' V@C-[65>,\WG^C041E_JJZ]-:Y;&8Y:^+ E,[8_D?]G6V* M#CN"GPO%NQZUUP=QMP'LL]US>HS^P0KO^K[LWWZW]:JU_B[RGOTRLFOA35B_ MYL3K^KH%TUFNM6_4,MX\N45SAE*9 5C!?D+74^?:-?;"/6ED@AWU26OT.\F_ MO7"OT[-(-$9U&.7594@ _V= KM7^=ZD*E'$VY+X,RO!XKAQSH3]N4AD$9)!? MXKK&O6)=J;LEP<716>GO:/1+NRUH3ER6JZ?>FI:;GKD(XRTGT&L9S/?#BF/B M[M'%:/UT67[CZ>'^:X#]>["QT,3*X9LMLMUC]'8Q_R/@R^D;W49"NT"50E2J7V*70Z?^-"02/G_&M M^CG4JZU91/'4&JV+W/G8E,0X(P/+K",$_JBE6@K>QTN4J0P@-J#7XZ\C!7>4 MWGZ11).C;YE+8=.GU)O8BE/@+\_91Y,O\)N?P4TS3QK]_QXHGXAIP(]EX:,8 M%M'G44]6DJM(>_L@&Z14\BU/EE+';COJ?:MQNR+>[')!29JN!M$H2;5:*FMOX'D#&H&AAC'?ZF!RI(OIJN%[A'%;=DEL][Q-W[1[[W0$DH MMKEI.GI\*M4U(9( M,+X'#O'ES3/ IJ J#,\XB[7JYU#F\9CF=A+E4O/L2$2<[UQJID;&$1]%&,/4V/Q7R690 8I&7C2.8 Q_QI,G@(UX\MP3BO=/?5"% MCU)6#4ZDJB?)V4=!AP[3);9TG$=LU)$$2PTAEBS;$XW\\J7KM@9BWZ-P M!0>=Y0O;VT%(SXIHOJ:9L>(?$MGX):I([M80)0.@.WN3WZ9#<2QZSWAQOHN_ M99S6?,+HCQ*K[H[:$X[@>L\O9H983WSV>1X)'53(Z#5BRZ\P2< ?&-V]QP,=@7 MY=*^(+GI%#O=[/AD7YI>"AS_/CB'<3+ 0_NH<4B?,\WPC"=;.7&J:J(> M (8!MWV(+AXF-$A M1>)KTY$H4OJLBATE2]SV9^\G3-N_I/Q46(GB(>T01+?I84[FYL:[O34FY%(] MP?0O')HLW)]Q"SA&6O_2#+SM!KP_(<18-2LXS]O_?:A"I&C9?RL':N']B5=- MF\O)>,()&];T^UJ[>UX@,O";A,:ZDLM@ ]D312;MLPZVWE&LM/LM,)"V4A2, MF^GYV2A7U'R5\(F(&N9NMU1Z$_*,W,_[;$?I1&37_%1DE'5?!_.V[0Z.J9#6 MC&YK89JM6T[G;F"P_J"(Z1U(0E1ZZ9XF)\'R)%MZ5%UR8T11%=FL#';(?W@0$Z MN^6K8].518(.16AZ9+R"OM62]^6 I,TH!L2>$B8DB_]@MW ->BS>_R-OOJN-,_4GJ/ZJ64CI3_5?)7X8 MMS6SSR;P/T[HLAH:PP;)$JS)!*=B_C@R8>B9_:Y830 0^IJ%'0T]BL+/ 6(4 MTIR-$_0MS2H)DZL\SR]UN]LHQ!TBR3P.^RTSS"3&].GA)URT8V&8/N@C//1% MH"]$K^]-8;$$@_I]G@#^QB'IL7A7^2633K[?AMZE2KN>3*]^,?+]38 1N8W> M_'JIV]2+[T[S@QNOUTV[QC24MP'M8A/RA/D]XD^]I=$W&RU3?,+A5_WF3R![ M%*>D0TYMW?XM102K[N P\YAG^@0GI#W+>C@_#9CHJ+M."_[6GHH@?8I(4YR! MXX3 O'>91BAE4$D2[69/6,;5WFI5JSSFG MGNU(VN<'1N\L!"2(C*3Z3$)HX]JK\][JL#I3JB M'-JO)$_S2O+IX+BAJU?^#)^@R?,DL.31/HL,WFR2E5>+)*0E6:/-@:CIAYN+G]X)/3+#3#21W^ X!( MU%ID5(@X++0J\MP:(<%"6FE5GV1BL+]6/\!JX-T"[>'1'C0"T:^MQ JG0&? M@MUT;"7[]6A!R(TF1?A>_^Z9:!'[K.[ZZD;=62Y22I?H$D%LW-O9* M\VL)*J&7=EE;9"CEPH>H5(A3VAS0A81IK_.&8TA7NQMI*JQCM+O<MVSJ#H>#R%BZ']]OE M@[I0[)3U!T!5^\:.-CH6<_5'_;:0QK[XRU4,L6JB M4JXKY_9-469I2S?YWZ>S YQLH?R!/0:IJZ-707T,:(BSML@O3]3A29@(NIKX MQ&7HPLV(E&T(>2M[#$JL\EJ;J4'T@;D5/.T;27CL4;Y"*?[*C M?C7PI6O96DO, J&86V1LEQ+U)+J@BFT_U M%S*K461@[^V@::VVPAQ@E$PEO#]EF\<]Y$)HO5)K8%S? ,\D!<\1.@?$M,;K M ([WV_BMQ6@AOC !,B1,BJW*NYDX=DOI1)IC_DZ( M)E[WCY@18SY@S+NS@X0H\Y,YFT_%8BG/(&X&\U6;7J@%=23K&!]EA6#?1IG- M/_KSU:#'L.'V-4L3UPMAIS?Q%/58TG2/OZ=30 L6U9\R8\ZL.4< M'2-MR&*%&Y_.Q3YN$];4C:NCI.%V*"AT/7Z\[,G'TKTM[:X_19)T)P^ J>P_ M;R\DYZ>NQLB"0H'1\(NM/?F2%AM:P3TG($G E]7G@8M'V4[AB3.YD4-H#63,4I08P+] 1C-#7O>5B-?SK MQW+M%[VR$!H_&Z<][5N$G2/U'&<7@_:T$8D,CT'LK&)QL>FL]"D^6A?3>9!I MOHF3\/%,DNU^5(4F?.V]7TA.B M$&5^\3+D;KU[P\\U61, Z89::N!\;]J*YS9L$C6K&&Z,.!V7NRA02% M!T!"$NB(=$T<:U=)F,,HXJ?B$LV5,<\EX<3F(N@,6'BK-CK?9-#L>2V _=,K MMM'NCL$@7NE:L_#Y?IA>8,%_7:NXS2CG_9 !"& C*%U) '.4S./#0A;^^)2< MGM<:50 BN/*\6!S ^5(=.>YP!=<1"!7YF..A\OM=B]X]%9.VDU(9%L#.7-MK M0&I6-6"]/DV07CUFE!.@V[M(VK:4 2<+V?A[J3.W7<>"5EV0+P63L*.9\]=.^LXLM+>GN^4-" P>H@L[8E$PN_&RAGMA^ [9.,(VE3W<]G:),"U3'P!IU3VQ!\1]6X$2 M(?VPUUT1;,C1WJZ80:>NZ]@==7XOXSMKO.=I5ZM:CSD'4HBQ0T75*/^/?['2*@;JD2P3E9W5(J M_T@H/3A9M_Y'Z&V/W;G1_O7-?379E3PX=D#J_=MYASA6[$B 98MV3XAG2D4_ M,-4B%O;)P$7SMS<4U9TX @C@:>$%A8H$E2;^^+;HE,C!M-B1:U$:. M>8:!89-9S_R( &G,I '] M#IT01V8@/[HE1!IYFI)8]\?)28(F;F#V^T3B6"5_P29\Q7^>Z$2!"A:XN)"H M;_O)2<[0.I4WH.I2DTQVMMJQLR!#*55^VC<$XGP/UYQB/.":G]I1HX N+9E% M:^S/HNJ9M8P/SC[GK'G6M2/BAYNU64-H_?S6]UD^Y/Z&NU1Y@8. MJ/P-]=G%?DLA55MAE!!^,7,'3;[8Z4Z$TX%&A,;V^KL@1#J;O#/B##5%XA_N M5,8553\D5MV#_O';>4Y3>RK+]51D3*"H*'XV=9\\CT%>%T8=*G*R)S^PSGUR MJ>GH=M2'>;JC3.C[.9%,LT?82PTSK)N$MAGK5>ODH!/.D"B7\@DX)8A1L!U4 M0Q4?BNL$Z\; 6#)W$P4[6EG7EB^@QX\N-3\$H^_VN?;4JU,JY>?@[GN3!4_( M3&->(QOV,]G!2S1Y MV=RD/?N<@JA2X34+R.W? 8 "0V[MZI[1,7-%7Y,@ RDX+""'T8J%"Q&@V+5_ MO^.EAA40T64F2*0P]U2U K#CP?:L>0\@"8]=X69248\B2AMZPS5 5[\MBTYSGBG8'W2*W8O>T MGZ$/]NZLBYDMM,U0BE8RE[G':$9QSO6TRJM$*+H5/H$=NXX.RKV1D*4_R^ 8 MH.41O=?CN6E.BT_?X/Y)=THMK/DUJ&&(=B/9G=CU/843L,?S4=_S[PT2JAIH M>W3,CB>@Q&K8K&;#@GN ?;FPYQAN2V@&Q/C.R2>)50AD_!V>R[XLH9"7SI=9 M+*/OZX(4*%.O,:FY8'*W\T&OY 0FE9%Z>Z.3R;RG_E(5@X#K<41FEEFJ/Q S M37#GGJ0]D]6Q3O":*13R@UT3);5,+97I^X1F MXN1[L-]2H9YR5U'RU\;65.>A'W:Q3.=7-M!1-TI=<<5*IGDC,H_/][@"2_,F MW\5>C@WC8]15B& >I;%.>K/>&'B8==.]#I^UT3"#4?K,*,)VD.,-*V(Z7I/; MHK:#N[X"EVY'P/C\FL_[S7Y+-M2VYXA+O^4S\<]'F&2#V-YURT/#FNNJ)GQF MH^[&2-;$H_RN%1G*O4TN=>D>YL>Y:>'J6RE:$1NX M+'T 8#VK,!)7/61/G]E8DUEK_W6Z6B!JBWX T'IK'C0M)1]O S;%DX9H4VBL,^EUYK1IP!9;=J*.W/ ALAS,)T(BD2!0_3Y MH]G6 NY]2S2>F7GX[:#%5*0*"ST=N3%4T.YZK)[ XN/<_I4U @U%#8VEKTD_ MQ=EW5N_]@R*X3*9I?YM('XF((9!9)]7!%TL=_L,?)7AON:-^@-^=N)*0_<*9 M@\@ F1:W^JM,]<^CA%M'Z3#F\ID[)(%%L?A@9.EYX/TA@]ANW.[*)^=\AK(@ MQK2VR-%8MSDN+,DEXXD >H6F-; HJH4WJS+UIX:0ELE/GQ# M>:'^WU5P&A] MZ >M]+:ZP(@6%GZ_EG0ELU:6-U'7JXA43=)&8(S$FX"8NSGJM@@"6$VEW,]N MR?J3'FPG9ZG*!&H?GPB 4DDGY!0JN"<_1F;J;GQ>$&[YF0*U<)$G?V]&:@H5 M[,WS3ZTR+P31+\;*&[G+]@WQ ^1B;V596E Z^9R0YOOT Q?HE1=L\D=[Y8XLK!T".BO: M>[5!GX9:%-VT)I8'I=O @585Q_?[LEZ4-G\$7*_=BHKI88,>JYK_^!_/U?KN M,9HD> ^J\$PQ[JB!"RS\W##MY@R6'G*=I2C%G3J50%$1-EYE@;!/7<$DVJ>WM1Z4M0 MP+TR;^][LP-.QO+)Q%?#3E2"U_"5[P.LO=L*Z+&P@E'D$_&-7&R-KJ><1"3/ MPGUA5F->9@V\H6]&]>GQX6:918CY#^FI)RC:^T9U@=_MDJ=&;D>[N?VO ML<\WW@BZ/LP-$7RU5[/"[DMC>L:930@GNC@E MI?)OV-1--1#VZ?Z"?8HW3T9[-CWCO(C&EE]>!Y3+\D="$+KG[Z<'#W!2D)8G M=.?P\N9O&&[+AQ4 E0_M64YW5KQVVP3:A MZ0[\J31M\5QY,[!(0RN,?A5L0-]9WG=T=$!J@#9PAJ?#P#1^OH%N"4WGENO( MWO09$!C%G.9I<4:JI5PC"Z6X91;IZ!.!+)GZLQ<#OZ_'YQCQ($/.BL*YYGAF MX@060*5TG\IY;#:H5*_64_7=_^2O'6B3J7 3#>RH$J1^<1*>P*DL=K)< _]M5_>_8.[EFT[NF8RV@Q?OGJ7$+Q\-B/=R!.%F6HOUII- M:BWNIE;IC""%T'K[NI*6.#"$.N4'1JG6VLJ8//N!$M;%^]FND M5QF&O]L>P]E!&#X[7?_Q7V.YP\)N*QSU>)5S6?9;>I'(^[KC L8GY][4%3^[ M[!F\0T0'N Q^M9F6?RD*@,4TGVQIQW__PU!' 9HI,WQ:(@]L-_:X][NS&72; MZT0ZG]XRD3\ .$\=) <<+F7'YVTG;?VQ]^8> %6Q0ZNL7-5>6R9A^IBU+8@@ M:_ ,&;\4/%/G]*PLMAUN=[!"RZ+%16KTUO:I^V>6;/*=\?$*T4COUD^CMWPY M>H/3,5(D#N+=U:F^EJ-V&A@F8CQ?_"5\ &R].U+A"U8E MDDO0KFN)I-A760*OL([ZF;411MBB(X+NYU!Y,ZIBJA)2RJ]) M="PR__.H#KQ1=TM&9A&^G-[9>[]Y/Y74QJ1Z.=6[B-%*>LF#$B+,9C^/YQNO MY6$OGNO]@%EIWQ]WIJ;"LV?TT:_#E)[]L'/Y9-6?SU.7OIPS^6IC^6"/[P6B M]-2'5CM6X? ^.MMZ9*;#+IJ-\0\NJ*_>Y]P)#W):F-_O/M#@P\O=;'W#M.FN M1W Z@SG%::/>9?Z%(F?Q>25B5_1J:[*!Z$L;:;/<8?^O"OW-]87Y-Q:>&N]< M+"R&W'J\3%NC)T6L,S:%2!ISDN>_3H8^B?7F"<;GBN+:MEV=YY:)50V62C-* MQ/#\N)N[QHFLTZ59Y M2?1$<&:*4Y&B?9/00T1W,+GN&^_\LZ=3 D &^F]3">)!6J-\9BNREF3'$IKI M',8\=8(#SLUMSU9]FK0/=U.-%1%:M 7S.SIC2P?^S8H95G[$ M;'\3GU7,_FVCEE6_8;,>8?83? MC];P[>H8T(Z)3?3:BE<] ")YH]:5B$8B4^5;*L_ ML/X@(.3TO(3JVVJP,0/1TZ&7XV5@M&%VSOV$H=!8[XWFUDS)1]QY/43T5GRW M"^Q^@HPRQ\3U 0"PKLNYVV)?[1"[_,2G6+4=M#N$/=OB2*@"Z]A(CI"5 U;Z MV&X^/R):*O]&[F?C(72B%'N)P,&A.#B.OBWB/XSL('HFOVAZQ'<>SFK,E/K3 MR,"[/:SF ][?=''Y?*A(6ML=/(ST7_:242 X2#I38KY;SSW_S9:S-W[YP' !$?2<,*%GUU%41F[=!#:&A$D0H3\;$&UL M*5O0BYPD1^10X\PC>91/(BD^SIU(/"?HK^="%UR/\1ST..+L[2E_P)[L(8\- MLQ5@;+MI ;< Q&$6/;N$J6,4X>:(+\S%3 8F/U4-F6EDK^0AZ_ZOYX.&YB47 MHE, 7_QRY>IOV^O&1,((A+5@O=RMJ:R,P-Z2@I. M?EJF2ETUP+%NA\$_BJ%CVOYC&OH V-'@)]2'T4]K_1-LLM>W$:!03] ."41= MG3\2KZAW@N^=[EUJ,KCN1"S@"+][EMTN;'P^L!B?S-S-GEZ/,_/,\,U M_(3=AA>:HT>3CX.-,?:&YFDG,TXD64],(H_,PBBE'*5A:7,K4:&((-C0 \ P M.M=189O(0$L_Q"0&K*[0%!#9B 4T_>079QF+%*W/.7GB@) S\"7%XS+%/1^A.,A&U$9EH!IK)GF]P1O(,NQ;<]NC,^89,'1=)RT3\ M+I)UEI9_!Q"S@,1.:V$K=[DPI&IX=@9M0P$07%UB\:2@7AN_1\E, 15%&4RH M%C((>M7V<4IP4BOW#VSG)/5,7GA]07_!FL M,2J@2_CHT>0_F96>0P;)(8X6@JL;+?1TI$_CSKP0H^)_!76U9^X:.7&O(\!07@;-$]@8,OH5=UN<]C?CG[!Y M%57&7*C/_4&NKL6<6V2I8H[+$';B,P?6']GE-O$?X/O0VR)2!QQ&\JWTD\FT MI@^.QVL1@2D:OQH5]CZ H MY[/"[\)5L!EU:KTU5^,^4=Y;YA7LJ*XSA8*LYB9TAQ3I"63%3C[5( MNV%]E;?63UU'OXY*XT?GJQ$%1 MA\_)H@L=L&!E\Q* R$[?M V6RF9<>>GV"ZOV!PX?RUK1-?ZQL,_4_B"/HO8; M.BU.M[H1,=\07*X]$^V[UL:YU&%+8@'AIT%W;58UV8(:3",BHPY5G.\(>%]Y MO*]ZSDJ&ZR%X)74=>P_7^.@](D]1>XNR&/G"*=ZNI?ZG".7;$]&N285_QRT\ MSOW3UI3<>!]0W\>0U@!NHV[4!(DMZRG@"O0*V9]2+$TP<__I?K**ANU,E1K6 MFU2#$O!S"/]2\USJZ/>^H&K=1A V@/.7E=ANOI602I^^5+U"P<^(OK@5>I:C MJ&0@77,O[?_V3.@XWP:4&$X<$BD'*P3U29FK,_="P;#W*"/[ M!\ /I=IQY>S\RT)>31L=XJ;:M7'[<](E[Z+.1T5__>X<.,(8@^Y*GNCRL,^: M)Q0BZ'H L.GVMSU-7-Q)*"O1[1LG_7VV%1UV$W).5_/I4N/"(< \>3G@&D.B M(+8FAE\_>[.(*2MCV.DBQP9DQNLUC*$N0P(\)+HE(Z(]S+_%X4H00AM?^R[O M'"=Z_UT2*/4M?@!TF,P1?;W'D.RD=I(2QZ%L8YY:[]LR.)Z8:]I4(EZ-_*VF M8&?BW*-:XPX?K''/[W4A$,)9&V=?-JJ>#P6]KL?EYAFCSV0X0Y=Z[NZQ2KSR MIX5>L>7':V.EG)).6K4^3WNG-:;]QR2>@P\\Q+87$^VUA_E\W^9*]RUOT&3O MAKH#K=I;D@AGIL\);AJ2%VIP79EEA;?5\[(K]A>OI;Y-U]-[#IELBOHHN\-5 M0^Q.>\<[R3YX+LQ;7W_)N8U%'(V1AA>4FUG]Z@UPS6;)B#[9]])6*'NGU-?D M. 2NT6AY _D"I(Y41 YJTA/TH^KX8B/.6!/_UD7M]PE_*[[:AJ$RSDHV'2=TJ*0)>7K/ M"BGH? 4=G--^;,O8]P+W9D5M*MC"^X8J2,[B3NEG9P(2^"/: X)!!^Y&N7;6 M8F\F771H_UZ7[B6B[Y0[F7:VDG]]D--,CC:_"J'@Q6I,"S([0O74X@.GS!L- MG.KD*S&_HY5NI%8X5GZ?=0G2CJ@?2FI%9^4CE# >#:_O< M3=R-8H4CS5_P6EWM0^5"QL(ZECE?>C[NSD-; V/#T0OY^!2&$C826J.HM'3% M8[Y/8 :TR)%.O*:CL==*T4%]2=(VSRW5I7LILX] #ZTY^6"?T0,@'(!.[A_W ML[ -]Q^U:GWSLU66?)8?.)2G-446]L**/?I HVML=H_ICZCB,YS;PJ*8CPIK M,A%&Y]Y'/8FH.XR9?;Y!_!?4'IL@X-2.@6_NDA^Q]3^E"T$^8$/O4O1B_ "< M(PD=X:Z@QNZJ7S AN45/?$5K,UMU65?VJW,PF>IG_KWA2QUZ"#I#9+)UX1W, MB]=#I$(!U\)J'D=0>.3[55A967E]X1#%[_1<'PZQM^PS0>.\K*Q?5ZE3@D4] MH"0#XLJ'Z4@.Y1(:_.3SS8@_"5%L7YE$HNL@VJBGUS%;M/R<@KV0&*\C]NJ7..;;9W]MX"093KFO0V@OANGY!N:] 6,.#X!5HI4.1N-8 M3Z>-2/N\FO/>H>@TP;]G':A\/:LA7Z)<.$?AX8NN1M^#-_I4PT)H;\NKI\)3 M H7>T"..Y-R8'DN4C\*:I6@:+,QAK$FX,G^TY.-6W;EP M1$^*%P[H7D]BFO8;:?KY):629Z:!'QY$P,"%+RO&B^O95:#C3IC[X>JXC;L9 MR'&;2\549=?XB_4WD79L50T%L>J4$"G^U-6W-K:6Z] ^L?%4?*1/R(Y$F;"; M$UCD.8KF 3 :G52O'B5TI%!_MC5$T&KG DJ3 8CQ]RAH $4PA"]0H\GO M"_K0X'5J>9*Y^$WGQ2UIY_3O,%#@8C*V2%^-9\?24W%*FS]RF!A")V<[ZO(^ M ,:Z&MX"C8:M:;57,E&KL3_^+EMK_Z@SMZR?@U]K"=>>47MBQ,5V"%(W;$F@ M]F>P/45,TYLYH5MJ#X#F:324NA!['R4>A-' P[D$JK[@H^P5W "5OMEK3RT3 MUG2GKA=!UF?\TVJMY JB+B1-^KX^R#7XKS1S%UG_,@<*:(JN5E,72"2%1XD* MCWXF7S(I(D!][A^#.(_=6BTH2'E<7V3H_I-$[>70<:V!#3&^[6SY)X>KC]8@ M66WV&V.:#USMQ3^SR 5NG)U[7L_LS]XTB8\:9GXL3"EXR75+&_:!V_ =C6Y& M-U:KP5OZ I1-4*H9GK=,=58G*-W-:S].X4G$Q4SP&A5TNMM18 M\6'='+MR:9>WOC4MZF0!<]O6?B]-9X4[QI)@[B7#/9%N0B MQ]#U9/(]4:K)M,#Q]/YY?U_UA2"3$P@:@KS5LD/505QR^J:!V_DT;:48TA<( M5]!A[MQ?\IN%&K*5N:,A$9=L&)IQ2QK#B--'U8!V,M8?Y_XB?TN]KC]-^,X: M./?[4<;YQSK.7B 73I]PI3D1B=_!0UXW[M$=/8K.-8IMH70]0/S'VC08DM/' MA]G,*0<6/3N3=2) BC),6]1S"AP^FK;,R(>1D2G=^=C\$XOGGW/!.)HI*U)T M-)N<#"5Z26ME+&ED S D,I0E!!2KE],WN9 7C10("O;L?A%K8;&ZT@:7:?C@,=OS1+2UQI3__3$Y>H[H=U&V4P/$+#WSHCAATQU8QP QOO?@M7K5 MI3\+#):*/(G\75+L.6J^5,5)U9J=JZ59YZ; >B'KUU."^G:OD9.6GXY*U\-4 M:XL8?N1\BB*]\FYKB?%[CM :F>/"U;K-Q1.80@1H:X=VWC:I"I-O M -S_U39:X9P&J3[HBSCG(=A9'E9NK L;5_QT1O$9^.?&:(QRB;P;7<'.V%1 M-R7#XX4*VOGYN>P8U-F(-'3VVU9Z1PY+QXVRJ"[9#TLLG8 M3SWR=]6:?=%'Y')4)]V&Z/;\^.^1A$VY@7T438URBKM2FM?9UM:64F;8HC-= MX-0P[O6[)0ZDG;2VY=&HS M.RS+=%Z+C&K,":S'+<#V0?HF%224OC+<>%FJ5/>B")L_Y8NCJJ.7[F;([H_, M_@QOXA'3'U7"WZ/_>JV%TN;Z6FY5[7^9<["8]Q3$D#P!M>4O)]^97@J;W7T_ M[._\:89E3XSTD1\Z*TQ8[U]I^*LQJA$6*^EVFN,@F+MO90.P)U&7H$U_ !R^ M?^<6NRP7\'HV/E+/.[WD[3WIE3YEL 9L2(7U+/ >][3_<?R^8S4<',?GLB.,M]UM2CDPO@E#*Q[+ M'KQ+>UNV,Q6]N"C%]L_YY$GBGP JO," &"%M82(2B1*1WM>:Z4M0\>ARE[O$ M9E?7K$OT"F-(:2D['VNIXJ!7/Y[P="=#G=M-(N/M$P%"L9KZ-*K#%Z'>)L6W M[\=/"\J\J8A"V%U9!\BF5B-O%.VZSQV%^;73:5;:=#Q]\>)E]IVJ+ M4M:B5Y+%O]FY4GW] OWPR3E(SK#U;UFF_4;2TB.4AMV(96'V M:[67;63POO0^UV+LQ3&ES#S$W.VE)"--5E5S'!J<+L6Z[(Q@A[#+>V&.QFQ[ MD2M6%;\8&DE:(^?@IU3.X:[8TBMV0.?!E&/>H/Z01E[ C,2/14'"P)_"Z&0C M5E"^JDJ\:[:L^O%R!2)@@"%AIRZ!SK)BT-HJ,%-!]S-%[SZPFT9]#L X[NMJ M;V^^VU]788(\#09'EG@.4?3FO& AG?G+"%D:K]BG?2LYF?O,I-6U1Q!*PD+_ ME.N*Q@I8X8 O9@@^*<:+R'BJX.!.B63J62+]]@ 0M?DG<%UD'U4#4(8TZ&!& M?JRQX/^DWD-BC(3?DZK)O9DPY6XX*[2_Z-D 1(_ELF*%,]U,1?5O]0B-;\4L M+J#;WF0H*/DQ@_\JJV[\,@=F,\$Z+LYYN4/).&%QU(<*6\@'P'WC_LO)M\W0 M)1^6*>4T>^$;#>M]!P[VU))*3[M"2C+('H49. M7*9+F81'XBA8H#!K8POE P\)HG6_:QQ^6C]+..FBM*41]R'1?3 L37 MC[NRR:!Q0VA<6762HT2Q-#M5\_+><>9<#&_Z58B(^CP : RY1MV?^]>=G^C5 M#:>2DNIJ7G+!2EZ1E_#Z?,3IV7G7RRAVB2\I:@N9SG;"_2G^2R B@&2):QT)+?$=@,TP6S=SN9K^5F"G;BI"!/:R1@]/ M41=X$U=56;(Z.W^.K7%7B"(:"8$.N,\(='E$5^5X5+XS.*K;8\O?0DQ]M#T2 M[QJ3E;9UNX[SP9A#03II#U_SS@M%S?,:V&JDC3O(N (\P@6TP6_Z1Z)K>^4$AXBTC78&(YKM2GV4"(K4KS^,L*\C-EX@[ MX7&_F?LGS0@"Z5]Z"8GM$(6\;>%V09&@:-63W('7X[/QM'3]V=NU);^OM4>S M#LD![>=H<.FGEIG.@%?OL*%=W_H11+D^<3/@S@%UU>@5 DUENKO^/1&A@,T/ M5.*YDN(=/K3O$:4A8=54@U1K23/^I;C,Y-)GA7E&;(,JTD&5\; MX!/ZIOY_ &I E;_C]*OVOD2X'AK?*>=I&/I[4#[K!CSCK7H5]\%[J"39%-=Q M28^73V^E8=U\-]:M5+%DD53\N4*X!'?M5^TB3R,Y=F"KT^@I-VUCG\# MW'N/6KT_AO6;5MC6'F8P#Y3@GKSP?QK/F2ZAP;BQN(E SN,9( QTR*?,AI_S^%&XJPQ^5(&&3@@@=*5@,_W<\>E K",VW)I#@9P >GYT;1 MT'X\8S3=HZH*YZ=J=NSCL3R.?\\U&%YX7..A'3\:3)92, X[^ ME4(=YF 3G!ZY^E-:1OF'7@_Y%(Q_SZTT@ $GKCKZ^U(+(DX5A@[1Z4*QZD8Q MTIG+=3N'Z=J16(/!S[4!L2[CU--['Y@HZ4C,3CYL 6 MST/TZ9HR%4]6;L?:HSPQ'8CMQSZT9[ YP*&,7D+M)P>GYT!N>!D&D;.TGISV MIJY.?0BFGYFR!SC [Y^M1[NOS=\@!VX\ G@' MBAF$A&!CT^E)T&#P/Y4T_+G .<'&*0[!T![=QQ2_WL'OC/M2*-_0\X/'4T<[ M@6]2.N.PXH D7KP,8.W/I_G^E/W#@%3G..M0*1@@\<9R:FXP%/(!SM]:9)87 MEFY'/&14@)Y!!/7&.WT]:KP_+A6&6R!COWJ>%OEQV! 'X=Z-@+ SPO4\8 ]A MVJ>,,?NGG)&.X]ZKJW[MB.>"14RMN^]D'/'/3FJN!,'(4_7I5B-@& M /\ NX)ZG/:JRJ6W $G)Z>O/7K5A5+!2,9&/FQUYQ_.@DL+)E>F3@JL<@*NX W$8*XQ_GBGKND\S(VC@ M\>HZ#/\ 3K1<1/YG\&5 &=K <]\<]_\ ZU02*9)&7@\^>YXI=ID4#A M6898J/KGK4$TA\L%FQT!P<9!Z#'UIH+"7$[>4JOS\^<]S_@>U5?,)E*%OWG< M =._>I)IBL?3M,#2\.VHOM:L8(\(KSIO=1_# MGG_/K7T_X2NFA^';22EE+R&7:Q/S;Y&8'/?@+7S+X49O[6\R/=_H\ZJ M?TYKZ?U",V/P]TR!T\MF"%EVXP=B\ '\:S>XNIYS\/?#\^M>*M$TY6$H;6;K M><]5W,U3+GW5W!'D/)#"7 X]0*YOM,I'F^W=K[ #(VC(STZ5[Q\-4$W@C3B 207S_WT M:\+FADM_%$LW/>OHCX3VID\!:<=NX R?,._SFKJ_P )%4]V M=';V)"X8#BKGV48R>@&*O0V)8]".].N+0*K'/ Y-'=:A2J1WLE]Y\:JG+*29C-XTN/B9\=+WQ- M=<2:A=RS(@Z1Q[2$4?10!7U9X7\!Z7XVTCX>3-:(N+ZYL-6:,D>;'&#*&)]= MF5S[5\9_#6/'CK2@3@[F4,..JFOL#P#\0T\'>#_$^E,L@N+V(M83*N?+E9"C MGVRI_2OAN)XQIXF$'_*>SE[YJ3:WN7-+^#OA_P 36^C7J7$VG6%Q;:A>W+IE MV\J&;:@1>I^4BNJ\]VA:,;Y 5C8>C#^5=KJ6G)XR?Q3INEW.FWFN7OA MV&.Y:Q*I#+<"XSQGOMQ7Q\HQE&Z/4YFM&?-6G^#=0U;1]0U.T@\ZTLGBCF^8 M!\R-M0 =\D8JYKWPP\1>%VM1JFBW5D;GY(2T8(=O[HP>OMUKVOX4^%M0\'Q: MWI>LV8M;E=3TJ1XV((VM,=IX]:V]!U"\U75/%T-]ROJHKQ1K3;QC%V16S]A1FP%Y M(ZYZ5'+IHW94,/I0'F9_VA]W*$C%2QS1-]X,AP>Z8V/CU4YIWV.0X MRF>H'K5)7$ARK$W"3*WH&/Z5W?C/S(;7PM"H9@-#ARH/K)*V/UKBHK=.-\#Y M_NXZUW?CJ.*2X\/QACE=#LU/8XPQSQ]156T$]SSK]I"1XM!\K>6"V%B <8'\ M/ KN/B5/J5IX*P_$'QE9Z7 M#JMU807FER /]J1>-N>3E3QT/45ZS#J4,FG+?+(OV8Q";S>VW&=WTQ7!>!;5 M5M_$?@^^7>EJ[!%QUA?D$#V.#^-9NOG4/#?P\TSPX7!U2^D^RJF>1'O_ )8V MC\:]J<(U&E:S_0^?A.5-;W_S-ZQ^-GANX?$C75MUYDAS_+-=9;Z]8^(/#]W< MV$ZW4'E2+YB@XR%/'(KS[Q]HNE^&/!-EIT-C#+JKE26)_'-1.G348RCW'&=3WHR['S2I4MDC;^-6X;N M2W8&*62(CD%&(_E3_#]W'8Z[I]Q-$LL"3H9(W (92V#G/M72?$OP^NF^-IK6 MRA6&"Y$\1:CI.GE&%C(RR7$WRJ "0"<9Y/H*Q='"U-9)&\:V+I.T9,ZJS^ M-4[;!>:7#*.A,9P:U;?XJZ%>*/M5C! M#)(\4H^Z!R<'Z5S#:;>0Z=!J$EM(MC.2L=QCY'(."/TK#^R\#6UBCL6<8^AN M[GNVG>.?"TA4VVIM9..SY4=,8KKO#_C;4;*/_B3^,)HQD?NUNFPWMC)KY55L MY&,=JECDVMN4\],J:YY\/TG\$K'7#B:M'XX7/LS_ (6=XIN(Q'?KINMQG/SW M-I$^1Z'@&F_\)9ILP0:EX,L'4@Y^PL\!'7G&2,_A7R79^(-1LV#17]Q&1Z2' MBMRQ^)/B&T4*FH/*G3;(N:\^?#]=?!),[Z?$^'>E2#1]*MI_P]UED:;1]2LC M(.-K))UQV(4_KWJ.;X0^ -6WI;ZP+61CC;-;R)@D^JEA[?A7A]C\:]7AC5;B MT@N",;FC&PGWQVK>L/C982$?:-/FA8_>,;!Q7GU,GQ<=X7/4IY]@*GV[>IZ% MJ'[*=AJ4;+8:I9W79E\Y"3SSD, 1VXKD=4_8=U.2%YH;>WX&0%W)D#ME3CU( MK8T_XR:)-_R^-;Y)(\U"#D__ %N*[30_BM9GB'5%ECR&&R<*5/YCU]*X)X.O M3^*#1ZE/'86M\%1'S]JW[(?BS3V'EV4SK&V=L*S9M#U" M .9;*=0JELH@E!]!E2>_'/K7ZSVNH:%KEJ%N-(L[A'&65H5<=>G(YX)JAJ'P M@^''B.$^;X3TX.W DA7RF.!UX([C]<5/M)#<58_)DQLK>6X,;<\2 H1QG^(# MBB13#*\3X1XSM8#YN?3(./Q%?J!J'[(_PVU./]S;:E9$C -O=;LG&3PX;L?7 MM7GNL?L!Z!>;?L/B Q,QQ_I]@H"C/3*'M@<^]7[9]43[.Y\ ,N[&&QZYX]_Z MU'Z8^N ?YU]GZE_P3Y\3QQM+IEYI5\$.8U@NGC9SC/1A@5PVO?L-?$?0=Y7P MW=S^7\Q:$QW*G//\)!(SFCVRZH7LV?->=N03SWQ^E#':,@8]*]-U3X$^*?#Z MO_:7A[4HE;&UI+:6$K^:L#FN/;PA?J=C1R;U(5PI5MK=#P"#CZUHJD6+ED8# M,S'G'_UJ!]TC&&QU([8Z5JW'AF^M?OQ%%VYSAO7H>.O^-5/[+N9KAX8PLKQ\ M95A@X&[C.,\5:DF*WA &3V-)N/H./:K#6=S"JEX)1OR%)0Y/3/UXQ M5;=DG_T$4R1W13CGMQVIRC<3MZ#GFH]Q*[NO&?3O0AW$8].A_.GT W/)&)PH/& 1P:21= MN3G';&::V<\<_P">M/W \J=Q(R?ZT#0W=NRH' Z?Y^E"J P)Z?T[&D9NI&6P M!@'_ #TIP8LP91W[^F*H0X'!&>#U(]*DW[5Z88'J.M1^65"J5^Z,[3U'3FIU M#-]W@YYR.10(>O R0#CC.?0?RJPHW,%8E3CCCFJT6,AMO'3\:L1_=&2!C'0X M/UI#)H^G R,N.*GA;=N4\# (/>H-P=,?W1C/X&IX_FDP&P1R !STS^6 M*HEEU,L2&/MZ&K"J55B&)!& 5Y;%5(V&Y6PI4848_3'X&K$>=AP<]\YZG4?W0>_X5-G^(1[0>&''7DYJJC$*/ERY/I^OZT_WI3-S2-E6)4MU4\YZ'(_'%1D)P"&4=?O9.1S^5 M.8G[J,0_3@>_?T/2J :S*L8W[B%'13D@U!-ND3:Y]#R, M?3T_Q]ZAD;9VX!/'X^M ALTRG(4_*2""1^M1?ZN+:&R1]TCC_)]O:F,0K'Y@ MRGKGC'O]?:@HHD.,D,<].F,\Y]:$.QU/@B(WEU<1L?,-UY=HPSC<7=21G\*^ MEO&\_EZ7I]NC' 4L=QR>IQ^&.E>!_"BQ,FL:9^[R)]05V(QNV1(7/7W _.O= MO'RMYEON_AASRWHHX'YUGO(GJ'[.VDRW7Q2\)>2-L$>HR23 =QL.W]:_4%>% M4>U?G;^R#:+J7Q2TK^Z@:;&.F%K]$Z)&L>H4M)14F@[M3:** "BBB@#X:_X* MS0FX^#W@N,=#X@YST_X]Y:^>OV4/%B:@?%_AXQK$=#N(H(MN!YD6"-_OEN<^ MXKZM_P""E'AN[\1?"GPM]DM9;HVNM+*PC0MM'DN,G ]_UKX<\":E=> _$1U> M33VFE^S^28U;R]W 9O7 ZUCSJ$G=&L5H>%?M*0B/\ :0\7A5&#,C !<*/W M2$FO6O@Q:^;\.],?/WC)[_QFO)?CUJ \0_''6-92T>SCOH(I1#(VX@B)%//U M!KV7X%R*_P -=-"@L5DD3/OO/^-9RUHZ#I=3O(=/8QAN&../TKEO'NL6_A_3 MV:9PC/PO>I_''Q-L/!EC+;0NMYKL@Q;6,66=Y#P-P R!7A>O2:[XGUI)/$;P MP7KKN6PADR4Z J.AK)10L6'"RJ5_QKU3P;\./[+MHIIH\,PRW;FN^L]/15"[=H QD5]%1XAQV'2A& M5TCAGE]&IJSP#PG\*_$&@>,-*NKNSC:TCG&^2-P0JX/)'7%>QS6(((QD8P#B MNDDM8Y%X)R.M026?89(]:\S,0N\+==T9(/Z&MLVC,#W/TJ5+%=NW ]*\A-]SLT92M=>UFU>1H]1N=TC M1,Q9RQ8QG='G/]TC]:UM'\>ZUI%Y>S*4N'OKZ+4+CS$Y>5'+@CTR>HJNVGA> M0.2>U TXL<TDGH+E1H:QXXD\0>&;S2M1L5FE^VM?65PK$&V+L3(G/5 M3GIV-<5]GYX# ]QUKJ!8$\$'ZD5'_9J[@2NUO>AR254#+ ?6ME].*[B&..V:BDL90VT@9 MZ4NHC+EM]JC#,H Z 4R.': ZEL]"M:DEK(HY3CK3?+W*,Q?,.Q%,"HEM+'( MS*/E')VX.*[;QK:DW^E$#<%T>SP>_P#J_P#$UR\<*1LR$, >I!/'O78>,H_^ M)EIDAD^4Z5:;>1VB':M%L0UJ>,_M*0@PZX^S.4LEW8XXV\U['J:CS>F!M3_T M$5Y9^TQ']G\.ZBYPYF-NN>X.Y#G],?C7J>IX^T$ X^5<@?[HKV\&N:D?,YAI M5/,_%R_\(WXZT/7@^#?B7#X;\'ZAI4L,KW3>8;211E5++T/H : M^DQ$)2C%P/GZ,HJ34MB;P_JRZ]\;K6]4DQR7SJGKM5&4?RK8\)W%M=^*/&NB M7-]_9\VH.Z0SYVD%6;@'UY''M7$?#>\M]-\<:+=7,ZP6T,Y+RR' V,.?Q-; M-CX+D\?^*/$!L]0MX#%.SHTC?ZWF>.*P+C2+W5/@CH$=G:RW;+=.S+"I8@;GY MJ(U%[J>R8YPW]#S'/R'')[5ZWXR\(6>H>,/!NF6<$=B-0L8?/>% ,GNQ _BP M#S7F,NEW=KNCGMIH&Z8DC*G/XBO=]3LF_P"%H?#L*"0MC%D_@U=>*J-.+BSD MH134HS78S;SPC\-/[6.AB_N;/5$?R?,9SMWD< L1MS7+6OPMO9O'TWA'2=[W5Q\E*NW%1M9V/#M*\(ZGKVNSZ3I\!O+N%G#;3A0%."23TY' MZU5U+3[G1]2GL;Q!%=0-LDC#JVT^F5)&?I7LOCO4D^$WA][?18F_M+6I)))- M3*\)SGCW&>!VY->$QR,TI=RSLQR7;DGWKT,+6G6]Y_">=BL/&C[O4N*WK4ZG M@*Y;GD@5*A/MTS6$L+0G\4%]QM#&XFE\%1KYGH%C\7]=M6 M0GRVVGJI9#^AKK])_:5URQ\HN]R'4@\2A@,?[PKQ:-OE!J4-SBO-J9/A)Z\A MW4^(,QH[5+GTGH?[5US8NK/,S#O'<1$K]?ES7H>@_M>Q<^9#:7$;-E@LN/3G M!&*^+5;:#]2;=?:?/;AOE\T1+(![ J>M=?I/Q0\ ZQ) M#'8>)_L+DC:LDK1=CGAL=_YU\Y:?86VG6L-E:V\5O9Q':D*KE5_Q^IIS:98W M00364,@8X*[,?RKXR5-*347H?H%/'-I<\=3[$TM5U2%9K#Q);WJGE0[)(#^O M'.:I>(/AC::V"NJ>#_#VMQDEAY]JH_'./<_E7R!%X7LH]K0&>T8G %O.R?I6 MWINK^*M 9CI'C+5K-#_RSDE,@/IU-9\AT1Q=.7D>J:]^RQ\.;[>;GP1=::QR M6?2IV&/H-Q _*O.?$/[%OPXUAPUCJFK:9&5(V7B>8@/J6*\=N];VF?'?XHZ& M@0ZOINMH>@OK;YCCW&/U-='9_M6:]#&$UKP%;WTG][3[G;GCN&!QQZ5/*MS9 M5X/J?/&L?\$^$W+=:'XLL)"H;8=K12;C]X*8V/4>U>>Z[^P'X_M8R]M96NIK M@J3;7T9(YSD>;M/Y=C7VHO[1_@+46B_MGPQJNCOG)9H!*H_X$O)Y]JO:;\0O MA[XLU*VLM%UR6WO;AMD5K('B+LJ?#G6-)8(UNRR*V&2?I7.W=NE568_+DY4@<4.K.*T' M[--GXYR>%K]8C)Y4A4#^X')[8RI.._:J T^Z&%,6UN"%D^3[W QNQ^-?K-JG MP0\)>(Y)[V^\,Z8LT8*%;>#8.O4[>G"_J:X+5OV4_ FLQM<6]A?:6H7YE@NB M^UNF=K9R"3^GO5*OW!TC\SOL\@D""-O,8D 8Y)[XI"I0GY=K#^%NN:^[-7_8 MNTNZ!N-+UV3R =Q>^L0NQ<< =OMEAUS_2O=]<_97\2Z9)<0C3)ICO\ MTRVKK*/3 (Q\IR/TK@]3^#VN:7N6>UN82K'+30NN%XXZ8SUY)[BK56#(=.2. M#SGCMT ]J7'S YQCGFMF;P;J<,C?NTE Y&UAR>V>E49M%U*",F2TD&&VXVY/ MU^E6I)BY6BFORX)Z9_.F[AD\8P3GGDQ^4>G&?S_PJ12JYPF3CAL]_P#"H_E;.3@?7/%+PQ)]LA:" MAZJ0N3\^U=I[YXJ6-@Q(R06&#V/)_P :BY^4C&??D>F*L6T#S,D,<;R3,P"( M@RQ)X QZT$$BL-P7\/\ /Y5,KJIVD\^O]:@5S%O5HY@4?:6\IMH(ZY..#4\6 M5FP0"XQ\C9JKC+$:[MN>2O7/.>>*F 55;C/OCDX_^OFJT; XP-O\7L<=!^M6 M58\$DG^$'^+%!).F-F.H)_A'4<#\#[590-M7+